Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2024-05-09
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| A1BG | 0.0766533 |
| A1BG-AS1 | 0.0925632 |
| A1CF | 0.0130198 |
| A2M | 0.0132791 |
| A2M-AS1 | 0.0416329 |
| A2ML1 | -0.0310311 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10461 |
| num_genes_in_profile | 21942 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 17453 |
| num_profile_genes_not_in_sets | 4489 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets:| Gene sets metrics | |
|---|---|
| num_genesets | 10461 |
| num_genesets_excluded | 3186 |
| num_genesets_included | 7275 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP CHORIONIC TROPHOBLAST CELL PROLIFERATION | 5 | 5.41e-04 | 0.893 | 0.1360 |
| GOMF PEPTIDOGLYCAN IMMUNE RECEPTOR ACTIVITY | 5 | 2.24e-03 | -0.789 | 0.2950 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 8 | 6.00e-04 | -0.701 | 0.1380 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT | 5 | 8.26e-03 | 0.682 | 0.5420 |
| GOCC FC RECEPTOR COMPLEX | 5 | 8.58e-03 | 0.679 | 0.5440 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 5.17e-03 | 0.659 | 0.4330 |
| GOBP PEPTIDOGLYCAN METABOLIC PROCESS | 6 | 6.27e-03 | -0.644 | 0.4720 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 5 | 1.39e-02 | 0.635 | 0.6250 |
| GOCC CLATHRIN COMPLEX | 6 | 7.52e-03 | -0.630 | 0.5130 |
| GOCC B CELL RECEPTOR COMPLEX | 5 | 1.63e-02 | 0.620 | 0.6280 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 1.86e-02 | 0.608 | 0.6410 |
| GOBP SPERMIDINE TRANSPORT | 5 | 2.01e-02 | 0.600 | 0.6410 |
| GOBP CILIARY BODY MORPHOGENESIS | 5 | 2.13e-02 | -0.595 | 0.6410 |
| GOBP ACTIN FILAMENT NETWORK FORMATION | 8 | 3.61e-03 | -0.594 | 0.3570 |
| GOBP NEGATIVE REGULATION OF FEEDING BEHAVIOR | 6 | 1.28e-02 | -0.587 | 0.6110 |
| GOMF ALCOHOL DEHYDROGENASE ACTIVITY ZINC DEPENDENT | 7 | 7.46e-03 | -0.584 | 0.5130 |
| GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY | 7 | 7.89e-03 | 0.580 | 0.5350 |
| GOMF NFAT PROTEIN BINDING | 5 | 2.55e-02 | 0.577 | 0.6690 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 1.44e-02 | -0.577 | 0.6250 |
| GOBP POSITIVE REGULATION OF IMMATURE T CELL PROLIFERATION | 5 | 2.58e-02 | 0.576 | 0.6690 |
| GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE | 8 | 5.06e-03 | 0.572 | 0.4310 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 1.55e-02 | -0.571 | 0.6250 |
| GOMF METAL ION SENSOR ACTIVITY | 5 | 2.83e-02 | -0.566 | 0.6860 |
| GOBP REGULATION OF APOPTOTIC PROCESS IN BONE MARROW CELL | 5 | 2.85e-02 | 0.565 | 0.6860 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 7 | 1.00e-02 | 0.562 | 0.5570 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 7 | 1.00e-02 | 0.562 | 0.5570 |
| GOBP LOBAR BRONCHUS EPITHELIUM DEVELOPMENT | 5 | 3.00e-02 | -0.560 | 0.7010 |
| GOBP FOREBRAIN NEURON FATE COMMITMENT | 7 | 1.03e-02 | 0.560 | 0.5640 |
| GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY | 5 | 3.04e-02 | 0.559 | 0.7020 |
| GOBP SKELETAL MUSCLE SATELLITE CELL MAINTENANCE INVOLVED IN SKELETAL MUSCLE REGENERATION | 5 | 3.06e-02 | -0.558 | 0.7020 |
| GOMF PROTEIN ARGININE DEIMINASE ACTIVITY | 5 | 3.08e-02 | -0.558 | 0.7020 |
| GOMF PHOSPHOLIPASE A2 INHIBITOR ACTIVITY | 6 | 1.81e-02 | -0.557 | 0.6410 |
| GOBP REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 11 | 1.42e-03 | -0.556 | 0.2300 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN | 6 | 1.88e-02 | -0.554 | 0.6410 |
| GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 5 | 3.35e-02 | -0.549 | 0.7140 |
| GOBP DETOXIFICATION OF NITROGEN COMPOUND | 5 | 3.37e-02 | 0.548 | 0.7140 |
| GOBP APOPTOTIC PROCESS IN BONE MARROW CELL | 6 | 2.05e-02 | 0.546 | 0.6410 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 19 | 4.01e-05 | -0.544 | 0.0228 |
| GOBP REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 12 | 1.13e-03 | -0.543 | 0.2030 |
| GOBP NEGATIVE REGULATION OF PHOTORECEPTOR CELL DIFFERENTIATION | 6 | 2.16e-02 | 0.542 | 0.6410 |
| GOBP NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION | 6 | 2.16e-02 | 0.541 | 0.6410 |
| GOBP NEGATIVE REGULATION OF GONADOTROPIN SECRETION | 7 | 1.33e-02 | -0.541 | 0.6150 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 2.22e-02 | -0.539 | 0.6410 |
| GOBP SPONTANEOUS NEUROTRANSMITTER SECRETION | 8 | 8.52e-03 | -0.537 | 0.5440 |
| GOCC ALPHA BETA T CELL RECEPTOR COMPLEX | 5 | 3.80e-02 | 0.536 | 0.7440 |
| GOCC VOLTAGE GATED SODIUM CHANNEL COMPLEX | 14 | 5.25e-04 | -0.535 | 0.1360 |
| GOBP URATE METABOLIC PROCESS | 12 | 1.43e-03 | -0.532 | 0.2300 |
| GOMF ALCOHOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.42e-02 | -0.531 | 0.6580 |
| GOBP HISTONE H3 ACETYLATION | 6 | 2.50e-02 | 0.528 | 0.6640 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 2.56e-02 | -0.526 | 0.6690 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP CHORIONIC TROPHOBLAST CELL PROLIFERATION | 5 | 5.41e-04 | 8.93e-01 | 1.36e-01 |
| GOMF PEPTIDOGLYCAN IMMUNE RECEPTOR ACTIVITY | 5 | 2.24e-03 | -7.89e-01 | 2.95e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 8 | 6.00e-04 | -7.01e-01 | 1.38e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT | 5 | 8.26e-03 | 6.82e-01 | 5.42e-01 |
| GOCC FC RECEPTOR COMPLEX | 5 | 8.58e-03 | 6.79e-01 | 5.44e-01 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 5.17e-03 | 6.59e-01 | 4.33e-01 |
| GOBP PEPTIDOGLYCAN METABOLIC PROCESS | 6 | 6.27e-03 | -6.44e-01 | 4.72e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 5 | 1.39e-02 | 6.35e-01 | 6.25e-01 |
| GOCC CLATHRIN COMPLEX | 6 | 7.52e-03 | -6.30e-01 | 5.13e-01 |
| GOCC B CELL RECEPTOR COMPLEX | 5 | 1.63e-02 | 6.20e-01 | 6.28e-01 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 1.86e-02 | 6.08e-01 | 6.41e-01 |
| GOBP SPERMIDINE TRANSPORT | 5 | 2.01e-02 | 6.00e-01 | 6.41e-01 |
| GOBP CILIARY BODY MORPHOGENESIS | 5 | 2.13e-02 | -5.95e-01 | 6.41e-01 |
| GOBP ACTIN FILAMENT NETWORK FORMATION | 8 | 3.61e-03 | -5.94e-01 | 3.57e-01 |
| GOBP NEGATIVE REGULATION OF FEEDING BEHAVIOR | 6 | 1.28e-02 | -5.87e-01 | 6.11e-01 |
| GOMF ALCOHOL DEHYDROGENASE ACTIVITY ZINC DEPENDENT | 7 | 7.46e-03 | -5.84e-01 | 5.13e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY | 7 | 7.89e-03 | 5.80e-01 | 5.35e-01 |
| GOMF NFAT PROTEIN BINDING | 5 | 2.55e-02 | 5.77e-01 | 6.69e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 1.44e-02 | -5.77e-01 | 6.25e-01 |
| GOBP POSITIVE REGULATION OF IMMATURE T CELL PROLIFERATION | 5 | 2.58e-02 | 5.76e-01 | 6.69e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE | 8 | 5.06e-03 | 5.72e-01 | 4.31e-01 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 1.55e-02 | -5.71e-01 | 6.25e-01 |
| GOMF METAL ION SENSOR ACTIVITY | 5 | 2.83e-02 | -5.66e-01 | 6.86e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS IN BONE MARROW CELL | 5 | 2.85e-02 | 5.65e-01 | 6.86e-01 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 7 | 1.00e-02 | 5.62e-01 | 5.57e-01 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 7 | 1.00e-02 | 5.62e-01 | 5.57e-01 |
| GOBP LOBAR BRONCHUS EPITHELIUM DEVELOPMENT | 5 | 3.00e-02 | -5.60e-01 | 7.01e-01 |
| GOBP FOREBRAIN NEURON FATE COMMITMENT | 7 | 1.03e-02 | 5.60e-01 | 5.64e-01 |
| GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY | 5 | 3.04e-02 | 5.59e-01 | 7.02e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL MAINTENANCE INVOLVED IN SKELETAL MUSCLE REGENERATION | 5 | 3.06e-02 | -5.58e-01 | 7.02e-01 |
| GOMF PROTEIN ARGININE DEIMINASE ACTIVITY | 5 | 3.08e-02 | -5.58e-01 | 7.02e-01 |
| GOMF PHOSPHOLIPASE A2 INHIBITOR ACTIVITY | 6 | 1.81e-02 | -5.57e-01 | 6.41e-01 |
| GOBP REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 11 | 1.42e-03 | -5.56e-01 | 2.30e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN | 6 | 1.88e-02 | -5.54e-01 | 6.41e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 5 | 3.35e-02 | -5.49e-01 | 7.14e-01 |
| GOBP DETOXIFICATION OF NITROGEN COMPOUND | 5 | 3.37e-02 | 5.48e-01 | 7.14e-01 |
| GOBP APOPTOTIC PROCESS IN BONE MARROW CELL | 6 | 2.05e-02 | 5.46e-01 | 6.41e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 19 | 4.01e-05 | -5.44e-01 | 2.28e-02 |
| GOBP REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 12 | 1.13e-03 | -5.43e-01 | 2.03e-01 |
| GOBP NEGATIVE REGULATION OF PHOTORECEPTOR CELL DIFFERENTIATION | 6 | 2.16e-02 | 5.42e-01 | 6.41e-01 |
| GOBP NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION | 6 | 2.16e-02 | 5.41e-01 | 6.41e-01 |
| GOBP NEGATIVE REGULATION OF GONADOTROPIN SECRETION | 7 | 1.33e-02 | -5.41e-01 | 6.15e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 2.22e-02 | -5.39e-01 | 6.41e-01 |
| GOBP SPONTANEOUS NEUROTRANSMITTER SECRETION | 8 | 8.52e-03 | -5.37e-01 | 5.44e-01 |
| GOCC ALPHA BETA T CELL RECEPTOR COMPLEX | 5 | 3.80e-02 | 5.36e-01 | 7.44e-01 |
| GOCC VOLTAGE GATED SODIUM CHANNEL COMPLEX | 14 | 5.25e-04 | -5.35e-01 | 1.36e-01 |
| GOBP URATE METABOLIC PROCESS | 12 | 1.43e-03 | -5.32e-01 | 2.30e-01 |
| GOMF ALCOHOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.42e-02 | -5.31e-01 | 6.58e-01 |
| GOBP HISTONE H3 ACETYLATION | 6 | 2.50e-02 | 5.28e-01 | 6.64e-01 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 2.56e-02 | -5.26e-01 | 6.69e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE | 6 | 2.62e-02 | -5.24e-01 | 6.71e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE | 5 | 4.31e-02 | -5.22e-01 | 7.59e-01 |
| GOBP NEGATIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 5 | 4.31e-02 | 5.22e-01 | 7.59e-01 |
| GOBP DENTINOGENESIS | 6 | 2.69e-02 | -5.22e-01 | 6.73e-01 |
| GOBP ASCENDING AORTA DEVELOPMENT | 5 | 4.39e-02 | 5.20e-01 | 7.59e-01 |
| GOMF IGG BINDING | 6 | 2.73e-02 | 5.20e-01 | 6.78e-01 |
| GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 5 | 4.49e-02 | 5.18e-01 | 7.59e-01 |
| GOBP POSITIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE | 7 | 1.79e-02 | 5.17e-01 | 6.41e-01 |
| GOMF TAP BINDING | 7 | 1.83e-02 | -5.15e-01 | 6.41e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX | 10 | 4.93e-03 | 5.13e-01 | 4.28e-01 |
| GOBP LOBAR BRONCHUS DEVELOPMENT | 6 | 2.95e-02 | -5.13e-01 | 6.94e-01 |
| GOBP DTMP METABOLIC PROCESS | 6 | 2.98e-02 | -5.12e-01 | 6.99e-01 |
| GOBP CARDIAC SEPTUM CELL DIFFERENTIATION | 5 | 4.75e-02 | 5.12e-01 | 7.65e-01 |
| GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 7 | 1.95e-02 | 5.10e-01 | 6.41e-01 |
| GOMF N ACETYLGLUCOSAMINE 6 O SULFOTRANSFERASE ACTIVITY | 6 | 3.05e-02 | -5.10e-01 | 7.02e-01 |
| GOCC STEREOCILIUM MEMBRANE | 6 | 3.06e-02 | -5.10e-01 | 7.02e-01 |
| GOCC PHAGOLYSOSOME | 5 | 4.96e-02 | -5.07e-01 | 7.77e-01 |
| GOBP REGULATION OF CORE PROMOTER BINDING | 5 | 4.97e-02 | 5.07e-01 | 7.77e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 7 | 2.10e-02 | 5.04e-01 | 6.41e-01 |
| GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY | 5 | 5.22e-02 | 5.01e-01 | 7.81e-01 |
| GOCC LIPOPOLYSACCHARIDE RECEPTOR COMPLEX | 5 | 5.23e-02 | -5.01e-01 | 7.81e-01 |
| GOMF MYOSIN HEAVY CHAIN BINDING | 12 | 2.77e-03 | -4.99e-01 | 3.18e-01 |
| GOBP INTERLEUKIN 21 PRODUCTION | 5 | 5.42e-02 | -4.97e-01 | 7.87e-01 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 1.49e-02 | -4.97e-01 | 6.25e-01 |
| GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 2.28e-02 | -4.97e-01 | 6.42e-01 |
| GOMF ALPHA 2A ADRENERGIC RECEPTOR BINDING | 5 | 5.62e-02 | 4.93e-01 | 7.90e-01 |
| GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT | 7 | 2.42e-02 | -4.92e-01 | 6.58e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 5.69e-02 | 4.92e-01 | 7.90e-01 |
| GOBP OVIDUCT DEVELOPMENT | 5 | 5.76e-02 | 4.90e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION | 8 | 1.65e-02 | 4.89e-01 | 6.34e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 12 | 3.40e-03 | -4.88e-01 | 3.55e-01 |
| GOCC KAINATE SELECTIVE GLUTAMATE RECEPTOR COMPLEX | 5 | 5.87e-02 | -4.88e-01 | 7.90e-01 |
| GOMF KAINATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY | 5 | 5.87e-02 | -4.88e-01 | 7.90e-01 |
| GOBP MESANGIAL CELL DEVELOPMENT | 6 | 3.87e-02 | 4.87e-01 | 7.45e-01 |
| GOBP RESPONSE TO COBALT ION | 9 | 1.16e-02 | 4.86e-01 | 6.00e-01 |
| GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 6.16e-02 | 4.83e-01 | 7.97e-01 |
| GOBP NEGATIVE REGULATION OF BEHAVIOR | 12 | 3.85e-03 | -4.82e-01 | 3.61e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 4.11e-02 | -4.81e-01 | 7.56e-01 |
| GOBP POSITIVE REGULATION OF THYROID HORMONE GENERATION | 5 | 6.23e-02 | -4.81e-01 | 7.98e-01 |
| GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS | 6 | 4.19e-02 | -4.80e-01 | 7.56e-01 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 8 | 1.91e-02 | 4.78e-01 | 6.41e-01 |
| GOMF METAL ION SEQUESTERING ACTIVITY | 5 | 6.40e-02 | -4.78e-01 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION | 8 | 1.97e-02 | -4.76e-01 | 6.41e-01 |
| GOCC PI BODY | 10 | 9.27e-03 | 4.75e-01 | 5.55e-01 |
| GOCC SORTING ENDOSOME | 6 | 4.41e-02 | -4.75e-01 | 7.59e-01 |
| GOBP ROUNDABOUT SIGNALING PATHWAY | 5 | 6.61e-02 | -4.75e-01 | 7.99e-01 |
| GOMF PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ACTIVITY | 9 | 1.40e-02 | -4.73e-01 | 6.25e-01 |
| GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 6 | 4.50e-02 | -4.72e-01 | 7.59e-01 |
| GOMF GLUTAMATE SODIUM SYMPORTER ACTIVITY | 5 | 6.76e-02 | -4.72e-01 | 7.99e-01 |
| GOBP FLAVONE METABOLIC PROCESS | 6 | 4.55e-02 | -4.71e-01 | 7.59e-01 |
| GOBP FATTY ACID OMEGA OXIDATION | 5 | 6.85e-02 | -4.70e-01 | 7.99e-01 |
| GOBP RESPONSE TO ERYTHROPOIETIN | 7 | 3.14e-02 | -4.70e-01 | 7.07e-01 |
| GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 5 | 6.91e-02 | 4.69e-01 | 8.00e-01 |
| GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE | 6 | 4.70e-02 | -4.68e-01 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 6 | 4.72e-02 | -4.68e-01 | 7.65e-01 |
| GOBP REGULATION OF OSTEOCLAST PROLIFERATION | 6 | 4.76e-02 | 4.67e-01 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 6 | 4.78e-02 | -4.67e-01 | 7.65e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 9 | 1.54e-02 | 4.66e-01 | 6.25e-01 |
| GOBP SYMPATHETIC NEURON PROJECTION EXTENSION | 5 | 7.19e-02 | -4.65e-01 | 8.03e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 9 | 1.58e-02 | -4.64e-01 | 6.27e-01 |
| GOBP REGULATION OF FEMALE RECEPTIVITY | 7 | 3.38e-02 | 4.63e-01 | 7.14e-01 |
| GOBP VOLUNTARY SKELETAL MUSCLE CONTRACTION | 5 | 7.43e-02 | 4.61e-01 | 8.13e-01 |
| GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB | 7 | 3.55e-02 | -4.59e-01 | 7.25e-01 |
| GOMF BETA GALACTOSIDASE ACTIVITY | 5 | 7.57e-02 | -4.59e-01 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF GONADOTROPIN SECRETION | 7 | 3.58e-02 | -4.58e-01 | 7.27e-01 |
| GOBP PROGESTERONE BIOSYNTHETIC PROCESS | 6 | 5.21e-02 | 4.58e-01 | 7.81e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 7 | 3.65e-02 | -4.56e-01 | 7.31e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY | 6 | 5.30e-02 | -4.56e-01 | 7.84e-01 |
| GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 6 | 5.39e-02 | 4.54e-01 | 7.87e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURAL PLASTICITY | 7 | 3.75e-02 | -4.54e-01 | 7.40e-01 |
| GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 7 | 3.75e-02 | 4.54e-01 | 7.40e-01 |
| GOBP LUNG LOBE DEVELOPMENT | 7 | 3.76e-02 | 4.54e-01 | 7.41e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE | 6 | 5.46e-02 | 4.53e-01 | 7.88e-01 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 5 | 7.96e-02 | 4.53e-01 | 8.31e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 6 | 5.52e-02 | -4.52e-01 | 7.90e-01 |
| GOBP PROTEIN DE ADP RIBOSYLATION | 5 | 8.05e-02 | -4.51e-01 | 8.35e-01 |
| GOBP REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR | 9 | 1.92e-02 | -4.51e-01 | 6.41e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 5.64e-02 | 4.50e-01 | 7.90e-01 |
| GOMF CILIARY NEUROTROPHIC FACTOR RECEPTOR BINDING | 6 | 5.79e-02 | 4.47e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 5 | 8.36e-02 | -4.47e-01 | 8.39e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE A2 ACTIVITY | 5 | 8.38e-02 | -4.47e-01 | 8.39e-01 |
| GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS | 5 | 8.42e-02 | -4.46e-01 | 8.39e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 5 | 8.43e-02 | 4.46e-01 | 8.39e-01 |
| GOBP ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT | 6 | 5.95e-02 | 4.44e-01 | 7.90e-01 |
| GOBP CONSTITUTIVE SECRETORY PATHWAY | 7 | 4.18e-02 | 4.44e-01 | 7.56e-01 |
| GOBP FATTY ACID ALPHA OXIDATION | 8 | 3.03e-02 | 4.42e-01 | 7.02e-01 |
| GOMF ALCOHOL DEHYDROGENASE NAD P PLUS ACTIVITY | 10 | 1.55e-02 | -4.42e-01 | 6.25e-01 |
| GOMF C X C CHEMOKINE RECEPTOR ACTIVITY | 7 | 4.30e-02 | -4.42e-01 | 7.59e-01 |
| GOMF PROTEIN KINASE B BINDING | 10 | 1.57e-02 | 4.41e-01 | 6.27e-01 |
| GOBP MESENCHYMAL CELL DEVELOPMENT | 6 | 6.23e-02 | 4.39e-01 | 7.98e-01 |
| GOBP ETHANOL OXIDATION | 9 | 2.31e-02 | -4.37e-01 | 6.47e-01 |
| GOBP AMMONIUM HOMEOSTASIS | 5 | 9.05e-02 | 4.37e-01 | 8.53e-01 |
| GOBP AUTOCRINE SIGNALING | 6 | 6.41e-02 | -4.37e-01 | 7.99e-01 |
| GOBP REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 8 | 3.26e-02 | -4.36e-01 | 7.07e-01 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 11 | 1.23e-02 | 4.36e-01 | 6.07e-01 |
| GOBP B CELL CHEMOTAXIS | 6 | 6.46e-02 | -4.36e-01 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION IN BONE MARROW | 6 | 6.58e-02 | 4.34e-01 | 7.99e-01 |
| GOCC SMAD PROTEIN COMPLEX | 9 | 2.44e-02 | -4.33e-01 | 6.58e-01 |
| GOBP MALE MEIOSIS I | 27 | 9.80e-05 | 4.33e-01 | 4.56e-02 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 6 | 6.68e-02 | -4.32e-01 | 7.99e-01 |
| GOBP PHOTORECEPTOR CELL MORPHOGENESIS | 5 | 9.44e-02 | -4.32e-01 | 8.55e-01 |
| GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CARDIAC CONDUCTION ELECTRICAL COUPLING | 5 | 9.53e-02 | -4.31e-01 | 8.58e-01 |
| GOCC ATG1 ULK1 KINASE COMPLEX | 6 | 6.81e-02 | 4.30e-01 | 7.99e-01 |
| GOBP CRANIAL NERVE FORMATION | 10 | 1.88e-02 | 4.29e-01 | 6.41e-01 |
| GOMF N N DIMETHYLANILINE MONOOXYGENASE ACTIVITY | 5 | 9.67e-02 | 4.29e-01 | 8.61e-01 |
| GOBP AXONEMAL CENTRAL APPARATUS ASSEMBLY | 6 | 6.89e-02 | -4.29e-01 | 8.00e-01 |
| GOBP RESPONSE TO SORBITOL | 6 | 6.98e-02 | 4.27e-01 | 8.00e-01 |
| GOMF BENZODIAZEPINE RECEPTOR ACTIVITY | 9 | 2.66e-02 | 4.27e-01 | 6.73e-01 |
| GOBP TRICUSPID VALVE DEVELOPMENT | 6 | 7.02e-02 | 4.27e-01 | 8.00e-01 |
| GOBP REGULATION OF RENAL SODIUM EXCRETION | 8 | 3.69e-02 | -4.26e-01 | 7.35e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 9 | 2.69e-02 | -4.26e-01 | 6.73e-01 |
| GOBP D ASPARTATE IMPORT ACROSS PLASMA MEMBRANE | 5 | 9.96e-02 | -4.25e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION | 6 | 7.12e-02 | 4.25e-01 | 8.00e-01 |
| GOBP FAT SOLUBLE VITAMIN CATABOLIC PROCESS | 11 | 1.46e-02 | 4.25e-01 | 6.25e-01 |
| GOBP GLOMERULAR MESANGIAL CELL DEVELOPMENT | 5 | 9.98e-02 | 4.25e-01 | 8.64e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 9 | 2.73e-02 | -4.25e-01 | 6.78e-01 |
| GOBP MONOCYTE EXTRAVASATION | 10 | 2.01e-02 | 4.24e-01 | 6.41e-01 |
| GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 9 | 2.75e-02 | 4.24e-01 | 6.78e-01 |
| GOMF INHIBITORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 11 | 1.51e-02 | 4.23e-01 | 6.25e-01 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 13 | 8.33e-03 | -4.23e-01 | 5.43e-01 |
| GOMF OXYSTEROL BINDING | 8 | 3.87e-02 | -4.22e-01 | 7.45e-01 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 1.03e-01 | 4.21e-01 | 8.66e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 14 | 6.36e-03 | 4.21e-01 | 4.74e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION | 7 | 5.42e-02 | -4.20e-01 | 7.87e-01 |
| GOBP THROMBOPOIETIN MEDIATED SIGNALING PATHWAY | 5 | 1.04e-01 | -4.20e-01 | 8.67e-01 |
| GOBP REGULATION OF EXCRETION | 11 | 1.59e-02 | -4.20e-01 | 6.27e-01 |
| GOBP URETER MORPHOGENESIS | 7 | 5.45e-02 | 4.20e-01 | 7.88e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 5 | 1.04e-01 | 4.19e-01 | 8.67e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 11 | 1.61e-02 | 4.19e-01 | 6.28e-01 |
| GOBP RHOMBOMERE DEVELOPMENT | 8 | 4.03e-02 | 4.19e-01 | 7.56e-01 |
| GOCC CEREBELLAR CLIMBING FIBER TO PURKINJE CELL SYNAPSE | 7 | 5.54e-02 | 4.18e-01 | 7.90e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 6 | 7.63e-02 | -4.18e-01 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF COA TRANSFERASE ACTIVITY | 8 | 4.08e-02 | -4.18e-01 | 7.56e-01 |
| GOBP REGULATION OF PRIMARY MIRNA PROCESSING | 5 | 1.06e-01 | -4.18e-01 | 8.67e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEDIFFERENTIATION | 5 | 1.06e-01 | 4.18e-01 | 8.67e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 1.06e-01 | -4.17e-01 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 10 | 2.25e-02 | -4.17e-01 | 6.41e-01 |
| GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY | 8 | 4.13e-02 | 4.17e-01 | 7.56e-01 |
| GOBP OTIC VESICLE FORMATION | 8 | 4.13e-02 | 4.16e-01 | 7.56e-01 |
| GOBP INTERKINETIC NUCLEAR MIGRATION | 5 | 1.07e-01 | 4.16e-01 | 8.70e-01 |
| GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 8 | 4.17e-02 | -4.16e-01 | 7.56e-01 |
| GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 6 | 7.82e-02 | 4.15e-01 | 8.27e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS | 8 | 4.25e-02 | -4.14e-01 | 7.59e-01 |
| GOBP FORMATION OF ANATOMICAL BOUNDARY | 7 | 5.86e-02 | 4.13e-01 | 7.90e-01 |
| GOMF BETA 2 ADRENERGIC RECEPTOR BINDING | 6 | 8.00e-02 | 4.13e-01 | 8.34e-01 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 5 | 1.10e-01 | 4.12e-01 | 8.76e-01 |
| GOMF PORIN ACTIVITY | 6 | 8.02e-02 | 4.12e-01 | 8.35e-01 |
| GOBP METANEPHRIC MESENCHYMAL CELL DIFFERENTIATION | 5 | 1.10e-01 | 4.12e-01 | 8.76e-01 |
| GOCC SODIUM CHANNEL COMPLEX | 24 | 4.78e-04 | -4.12e-01 | 1.30e-01 |
| GOBP REGULATION OF PHENOTYPIC SWITCHING | 6 | 8.13e-02 | 4.11e-01 | 8.36e-01 |
| GOBP CARDIAC PACEMAKER CELL DIFFERENTIATION | 11 | 1.84e-02 | 4.11e-01 | 6.41e-01 |
| GOCC WASH COMPLEX | 8 | 4.47e-02 | -4.10e-01 | 7.59e-01 |
| GOMF MELANOCORTIN RECEPTOR BINDING | 5 | 1.12e-01 | 4.10e-01 | 8.77e-01 |
| GOBP FLAVONOID GLUCURONIDATION | 5 | 1.13e-01 | -4.09e-01 | 8.78e-01 |
| GOBP GONADOTROPIN SECRETION | 17 | 3.50e-03 | -4.09e-01 | 3.57e-01 |
| GOBP REGULATION OF GONADOTROPIN SECRETION | 11 | 1.91e-02 | -4.08e-01 | 6.41e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING | 5 | 1.14e-01 | 4.08e-01 | 8.80e-01 |
| GOCC COHESIN COMPLEX | 8 | 4.60e-02 | 4.07e-01 | 7.62e-01 |
| GOBP REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION | 9 | 3.43e-02 | 4.07e-01 | 7.20e-01 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 11 | 1.95e-02 | -4.07e-01 | 6.41e-01 |
| GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION | 9 | 3.47e-02 | -4.07e-01 | 7.25e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY | 8 | 4.67e-02 | 4.06e-01 | 7.65e-01 |
| GOCC MEIOTIC COHESIN COMPLEX | 6 | 8.50e-02 | 4.06e-01 | 8.39e-01 |
| GOBP REGULATION OF LUTEINIZING HORMONE SECRETION | 6 | 8.53e-02 | -4.06e-01 | 8.39e-01 |
| GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CELL COMMUNICATION BY ELECTRICAL COUPLING | 8 | 4.70e-02 | -4.06e-01 | 7.65e-01 |
| GOBP TRICUSPID VALVE MORPHOGENESIS | 5 | 1.16e-01 | 4.05e-01 | 8.82e-01 |
| GOMF CUPRIC ION BINDING | 5 | 1.17e-01 | -4.05e-01 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF GASTRULATION | 6 | 8.57e-02 | 4.05e-01 | 8.39e-01 |
| GOMF CARBON SULFUR LYASE ACTIVITY | 12 | 1.52e-02 | 4.05e-01 | 6.25e-01 |
| GOBP OTIC VESICLE MORPHOGENESIS | 10 | 2.69e-02 | 4.04e-01 | 6.73e-01 |
| GOBP NEURON FATE DETERMINATION | 10 | 2.70e-02 | 4.04e-01 | 6.73e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY | 9 | 3.59e-02 | 4.04e-01 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE EXTRAVASATION | 5 | 1.18e-01 | 4.04e-01 | 8.83e-01 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 5 | 1.18e-01 | -4.04e-01 | 8.83e-01 |
| GOMF PEPTIDOGLYCAN MURALYTIC ACTIVITY | 13 | 1.17e-02 | -4.04e-01 | 6.00e-01 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 2.06e-02 | -4.03e-01 | 6.41e-01 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 11 | 2.07e-02 | -4.03e-01 | 6.41e-01 |
| GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.65e-02 | 4.03e-01 | 7.31e-01 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 13 | 1.20e-02 | 4.02e-01 | 6.02e-01 |
| GOCC INTERPHOTORECEPTOR MATRIX | 6 | 8.88e-02 | 4.01e-01 | 8.47e-01 |
| GOBP R LOOP PROCESSING | 6 | 8.92e-02 | 4.01e-01 | 8.48e-01 |
| GOBP FOREBRAIN DORSAL VENTRAL PATTERN FORMATION | 7 | 6.66e-02 | 4.00e-01 | 7.99e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 8 | 5.01e-02 | 4.00e-01 | 7.77e-01 |
| GOMF NEUROLIGIN FAMILY PROTEIN BINDING | 5 | 1.22e-01 | -3.99e-01 | 8.86e-01 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 11 | 2.19e-02 | 3.99e-01 | 6.41e-01 |
| GOBP CARDIOBLAST PROLIFERATION | 11 | 2.20e-02 | 3.99e-01 | 6.41e-01 |
| GOBP OPTIC CUP MORPHOGENESIS INVOLVED IN CAMERA TYPE EYE DEVELOPMENT | 7 | 6.79e-02 | 3.98e-01 | 7.99e-01 |
| GOBP RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 6 | 9.11e-02 | 3.98e-01 | 8.53e-01 |
| GOBP CALCIUM ACTIVATED PHOSPHOLIPID SCRAMBLING | 5 | 1.23e-01 | -3.98e-01 | 8.89e-01 |
| GOCC LATERAL ELEMENT | 14 | 9.99e-03 | 3.98e-01 | 5.57e-01 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 12 | 1.72e-02 | -3.97e-01 | 6.41e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL | 7 | 6.90e-02 | 3.97e-01 | 8.00e-01 |
| GOBP SUCCINATE METABOLIC PROCESS | 5 | 1.25e-01 | -3.97e-01 | 8.91e-01 |
| GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY | 6 | 9.34e-02 | 3.95e-01 | 8.55e-01 |
| GOMF INOSITOL 1 3 4 5 TETRAKISPHOSPHATE BINDING | 5 | 1.26e-01 | -3.95e-01 | 8.91e-01 |
| GOBP TRUNK SEGMENTATION | 5 | 1.28e-01 | -3.93e-01 | 8.91e-01 |
| GOBP MESANGIAL CELL DIFFERENTIATION | 7 | 7.15e-02 | 3.93e-01 | 8.01e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 9.52e-02 | -3.93e-01 | 8.58e-01 |
| GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING | 8 | 5.43e-02 | -3.93e-01 | 7.87e-01 |
| GOMF CHONDROITIN SULFATE BINDING | 10 | 3.16e-02 | 3.93e-01 | 7.07e-01 |
| GOBP PROPIONATE METABOLIC PROCESS | 5 | 1.29e-01 | 3.92e-01 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 9 | 4.18e-02 | -3.92e-01 | 7.56e-01 |
| GOBP ANTIBACTERIAL INNATE IMMUNE RESPONSE | 6 | 9.67e-02 | 3.92e-01 | 8.61e-01 |
| GOBP MIDBRAIN HINDBRAIN BOUNDARY DEVELOPMENT | 7 | 7.35e-02 | 3.91e-01 | 8.11e-01 |
| GOMF GABA GATED CHLORIDE ION CHANNEL ACTIVITY | 11 | 2.49e-02 | 3.91e-01 | 6.63e-01 |
| GOBP N TERMINAL PROTEIN LIPIDATION | 6 | 9.79e-02 | -3.90e-01 | 8.61e-01 |
| GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE | 6 | 9.79e-02 | 3.90e-01 | 8.61e-01 |
| GOBP FATTY ACYL COA CATABOLIC PROCESS | 5 | 1.32e-01 | 3.89e-01 | 8.96e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION | 14 | 1.17e-02 | -3.89e-01 | 6.00e-01 |
| GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 8 | 5.71e-02 | 3.88e-01 | 7.90e-01 |
| GOBP CELLULAR RESPONSE TO TEMPERATURE STIMULUS | 5 | 1.33e-01 | 3.88e-01 | 8.96e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE A2 ACTIVITY | 8 | 5.79e-02 | -3.87e-01 | 7.90e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 20 | 2.74e-03 | 3.87e-01 | 3.18e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 10 | 3.43e-02 | -3.87e-01 | 7.20e-01 |
| GOBP AGGRESSIVE BEHAVIOR | 7 | 7.67e-02 | 3.86e-01 | 8.23e-01 |
| GOBP OUTER EAR MORPHOGENESIS | 7 | 7.73e-02 | 3.86e-01 | 8.25e-01 |
| GOBP DE NOVO CENTRIOLE ASSEMBLY | 6 | 1.02e-01 | -3.85e-01 | 8.66e-01 |
| GOBP PROTEIN SIDE CHAIN DEGLUTAMYLATION | 5 | 1.36e-01 | 3.85e-01 | 9.00e-01 |
| GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 9 | 4.53e-02 | -3.85e-01 | 7.59e-01 |
| GOBP PULMONARY ARTERY MORPHOGENESIS | 6 | 1.02e-01 | -3.85e-01 | 8.66e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES | 6 | 1.03e-01 | 3.85e-01 | 8.66e-01 |
| GOBP PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL COMMUNICATION | 6 | 1.03e-01 | -3.84e-01 | 8.66e-01 |
| GOMF DEUBIQUITINASE ACTIVATOR ACTIVITY | 5 | 1.37e-01 | 3.84e-01 | 9.02e-01 |
| GOBP SNRNA MODIFICATION | 6 | 1.03e-01 | 3.84e-01 | 8.66e-01 |
| GOBP PANCREATIC A CELL DIFFERENTIATION | 11 | 2.74e-02 | 3.84e-01 | 6.78e-01 |
| GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 9 | 4.62e-02 | 3.84e-01 | 7.64e-01 |
| GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 6 | 1.04e-01 | 3.84e-01 | 8.66e-01 |
| GOBP AMYGDALA DEVELOPMENT | 5 | 1.38e-01 | 3.83e-01 | 9.02e-01 |
| GOBP CELLULAR RESPONSE TO UV B | 12 | 2.17e-02 | 3.83e-01 | 6.41e-01 |
| GOMF TOLL LIKE RECEPTOR 4 BINDING | 5 | 1.38e-01 | -3.83e-01 | 9.02e-01 |
| GOMF POLYSOME BINDING | 6 | 1.05e-01 | -3.82e-01 | 8.67e-01 |
| GOBP ELASTIC FIBER ASSEMBLY | 9 | 4.77e-02 | 3.81e-01 | 7.65e-01 |
| GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 2.87e-02 | -3.81e-01 | 6.86e-01 |
| GOBP SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION | 12 | 2.24e-02 | 3.81e-01 | 6.41e-01 |
| GOBP PHENYLPROPANOID METABOLIC PROCESS | 6 | 1.07e-01 | -3.80e-01 | 8.68e-01 |
| GOBP NEUTROPHIL MEDIATED KILLING OF GRAM NEGATIVE BACTERIUM | 6 | 1.07e-01 | 3.80e-01 | 8.70e-01 |
| GOBP REGULATION OF LYSOSOME SIZE | 8 | 6.33e-02 | 3.79e-01 | 7.99e-01 |
| GOCC BORC COMPLEX | 8 | 6.33e-02 | 3.79e-01 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 14 | 1.42e-02 | -3.79e-01 | 6.25e-01 |
| GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 7 | 8.33e-02 | 3.78e-01 | 8.39e-01 |
| GOBP REGULATION OF BLOOD VOLUME BY RENIN ANGIOTENSIN | 6 | 1.09e-01 | -3.78e-01 | 8.76e-01 |
| GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 12 | 2.35e-02 | -3.78e-01 | 6.49e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DEVELOPMENT | 5 | 1.44e-01 | 3.78e-01 | 9.02e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE REGULATOR ACTIVITY | 5 | 1.44e-01 | -3.78e-01 | 9.02e-01 |
| GOBP POLAR BODY EXTRUSION AFTER MEIOTIC DIVISIONS | 5 | 1.44e-01 | -3.77e-01 | 9.02e-01 |
| GOBP DE NOVO CENTRIOLE ASSEMBLY INVOLVED IN MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 5 | 1.44e-01 | -3.77e-01 | 9.02e-01 |
| GOMF CCR3 CHEMOKINE RECEPTOR BINDING | 5 | 1.45e-01 | -3.77e-01 | 9.02e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING | 11 | 3.09e-02 | -3.76e-01 | 7.02e-01 |
| GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 7 | 8.52e-02 | -3.76e-01 | 8.39e-01 |
| GOBP DORSAL SPINAL CORD DEVELOPMENT | 20 | 3.75e-03 | 3.74e-01 | 3.58e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 6 | 1.12e-01 | 3.74e-01 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 7 | 8.67e-02 | 3.74e-01 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS | 5 | 1.48e-01 | 3.74e-01 | 9.04e-01 |
| GOMF UREA TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.68e-02 | -3.74e-01 | 8.41e-01 |
| GOBP DEHYDROASCORBIC ACID TRANSPORT | 9 | 5.24e-02 | 3.73e-01 | 7.81e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 5 | 1.49e-01 | 3.73e-01 | 9.04e-01 |
| GOBP REGULATION OF NEUTROPHIL MEDIATED CYTOTOXICITY | 5 | 1.49e-01 | 3.73e-01 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 15 | 1.24e-02 | 3.73e-01 | 6.07e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL ELONGATION | 5 | 1.49e-01 | 3.73e-01 | 9.04e-01 |
| GOBP REGULATION OF NK T CELL DIFFERENTIATION | 6 | 1.14e-01 | 3.73e-01 | 8.80e-01 |
| GOBP SIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION | 11 | 3.24e-02 | 3.72e-01 | 7.07e-01 |
| GOBP RESPONSE TO MERCURY ION | 10 | 4.14e-02 | -3.72e-01 | 7.56e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 11 | 3.27e-02 | -3.72e-01 | 7.07e-01 |
| GOBP TERPENOID CATABOLIC PROCESS | 8 | 6.92e-02 | 3.71e-01 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF G0 TO G1 TRANSITION | 5 | 1.52e-01 | -3.70e-01 | 9.04e-01 |
| GOBP CATECHOL CONTAINING COMPOUND CATABOLIC PROCESS | 5 | 1.52e-01 | -3.70e-01 | 9.04e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 5 | 1.52e-01 | 3.70e-01 | 9.04e-01 |
| GOCC GINS COMPLEX | 5 | 1.52e-01 | 3.70e-01 | 9.04e-01 |
| GOMF SODIUM PHOSPHATE SYMPORTER ACTIVITY | 13 | 2.10e-02 | -3.70e-01 | 6.41e-01 |
| GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 7.11e-02 | 3.69e-01 | 8.00e-01 |
| GOBP RESPONSE TO INTERLEUKIN 2 | 9 | 5.58e-02 | -3.68e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING | 6 | 1.18e-01 | 3.68e-01 | 8.83e-01 |
| GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING | 10 | 4.46e-02 | 3.67e-01 | 7.59e-01 |
| GOMF LIPOPROTEIN LIPASE ACTIVITY | 9 | 5.68e-02 | 3.67e-01 | 7.90e-01 |
| GOBP AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS | 6 | 1.21e-01 | 3.66e-01 | 8.86e-01 |
| GOBP MESENCHYMAL STEM CELL PROLIFERATION | 10 | 4.54e-02 | 3.65e-01 | 7.59e-01 |
| GOCC T CELL RECEPTOR COMPLEX | 13 | 2.26e-02 | 3.65e-01 | 6.41e-01 |
| GOBP LIPID DROPLET FORMATION | 13 | 2.27e-02 | -3.65e-01 | 6.41e-01 |
| GOBP REGULATION OF RRNA PROCESSING | 16 | 1.15e-02 | 3.65e-01 | 6.00e-01 |
| GOBP POSITIVE REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 5 | 1.58e-01 | 3.64e-01 | 9.06e-01 |
| GOBP URETER DEVELOPMENT | 18 | 7.48e-03 | 3.64e-01 | 5.13e-01 |
| GOBP PROLACTIN SECRETION | 5 | 1.59e-01 | -3.64e-01 | 9.06e-01 |
| GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 1.59e-01 | -3.64e-01 | 9.06e-01 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 8 | 7.55e-02 | 3.63e-01 | 8.18e-01 |
| GOBP DGMP METABOLIC PROCESS | 5 | 1.60e-01 | -3.63e-01 | 9.06e-01 |
| GOBP REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS | 6 | 1.25e-01 | -3.62e-01 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 18 | 7.94e-03 | -3.61e-01 | 5.35e-01 |
| GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 10 | 4.79e-02 | 3.61e-01 | 7.66e-01 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 13 | 2.42e-02 | 3.61e-01 | 6.58e-01 |
| GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 15 | 1.55e-02 | -3.61e-01 | 6.25e-01 |
| GOBP ENDOCARDIAL CUSHION TO MESENCHYMAL TRANSITION | 6 | 1.26e-01 | 3.60e-01 | 8.91e-01 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 9 | 6.13e-02 | -3.60e-01 | 7.96e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 6 | 1.27e-01 | 3.60e-01 | 8.91e-01 |
| GOBP REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 5 | 1.64e-01 | -3.60e-01 | 9.12e-01 |
| GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 11 | 3.89e-02 | 3.60e-01 | 7.46e-01 |
| GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 14 | 2.00e-02 | 3.59e-01 | 6.41e-01 |
| GOBP REGULATION OF VESICLE FUSION | 24 | 2.38e-03 | -3.58e-01 | 3.07e-01 |
| GOBP REGULATION OF EATING BEHAVIOR | 7 | 1.01e-01 | -3.58e-01 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 6 | 1.29e-01 | 3.58e-01 | 8.94e-01 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 1.66e-01 | -3.58e-01 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF B CELL DIFFERENTIATION | 6 | 1.29e-01 | -3.58e-01 | 8.94e-01 |
| GOBP RESPONSE TO INTERFERON ALPHA | 17 | 1.07e-02 | 3.58e-01 | 5.73e-01 |
| GOBP PERICENTRIC HETEROCHROMATIN FORMATION | 5 | 1.66e-01 | 3.58e-01 | 9.15e-01 |
| GOBP REGULATION OF GLYCOGEN STARCH SYNTHASE ACTIVITY | 5 | 1.66e-01 | -3.57e-01 | 9.15e-01 |
| GOBP CARDIAC PACEMAKER CELL DEVELOPMENT | 9 | 6.37e-02 | 3.57e-01 | 7.99e-01 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 8 | 8.05e-02 | -3.57e-01 | 8.35e-01 |
| GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES | 6 | 1.30e-01 | 3.57e-01 | 8.96e-01 |
| GOBP LIMB JOINT MORPHOGENESIS | 5 | 1.67e-01 | 3.57e-01 | 9.15e-01 |
| GOMF HISTONE H3K36 TRIMETHYLTRANSFERASE ACTIVITY | 5 | 1.67e-01 | 3.57e-01 | 9.15e-01 |
| GOBP EOSINOPHIL MEDIATED IMMUNITY | 8 | 8.07e-02 | 3.57e-01 | 8.35e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 3.25e-02 | 3.56e-01 | 7.07e-01 |
| GOCC WEIBEL PALADE BODY | 5 | 1.68e-01 | -3.56e-01 | 9.15e-01 |
| GOBP RRNA PSEUDOURIDINE SYNTHESIS | 7 | 1.03e-01 | 3.56e-01 | 8.66e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 11 | 4.07e-02 | 3.56e-01 | 7.56e-01 |
| GOBP REGULATION OF G2 MI TRANSITION OF MEIOTIC CELL CYCLE | 5 | 1.68e-01 | -3.56e-01 | 9.16e-01 |
| GOBP VITAMIN CATABOLIC PROCESS | 14 | 2.13e-02 | 3.55e-01 | 6.41e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION | 5 | 1.69e-01 | 3.55e-01 | 9.18e-01 |
| GOBP HEMIDESMOSOME ASSEMBLY | 6 | 1.33e-01 | -3.55e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 5.24e-02 | 3.54e-01 | 7.81e-01 |
| GOBP RESPONSE TO INSECTICIDE | 6 | 1.33e-01 | -3.54e-01 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 8 | 8.32e-02 | -3.54e-01 | 8.39e-01 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 1.16e-02 | 3.53e-01 | 6.00e-01 |
| GOMF KETOSTEROID MONOOXYGENASE ACTIVITY | 5 | 1.72e-01 | -3.53e-01 | 9.21e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 16 | 1.46e-02 | -3.53e-01 | 6.25e-01 |
| GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 6.71e-02 | -3.52e-01 | 7.99e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 17 | 1.19e-02 | -3.52e-01 | 6.02e-01 |
| GOBP TRANSLATIONAL READTHROUGH | 9 | 6.72e-02 | 3.52e-01 | 7.99e-01 |
| GOBP ATRIOVENTRICULAR NODE DEVELOPMENT | 9 | 6.73e-02 | 3.52e-01 | 7.99e-01 |
| GOCC NSL COMPLEX | 9 | 6.77e-02 | 3.52e-01 | 7.99e-01 |
| GOBP ASPARAGINE METABOLIC PROCESS | 5 | 1.73e-01 | -3.52e-01 | 9.21e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED IRON SULFUR PROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 9 | 6.80e-02 | -3.51e-01 | 7.99e-01 |
| GOMF ROUNDABOUT BINDING | 8 | 8.54e-02 | -3.51e-01 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 6 | 1.37e-01 | 3.51e-01 | 9.02e-01 |
| GOBP REGULATION OF CELL PROLIFERATION IN BONE MARROW | 8 | 8.61e-02 | 3.50e-01 | 8.39e-01 |
| GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 6 | 1.37e-01 | 3.50e-01 | 9.02e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 23 | 3.66e-03 | -3.50e-01 | 3.57e-01 |
| GOBP TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION | 10 | 5.54e-02 | -3.50e-01 | 7.90e-01 |
| GOBP IMP CATABOLIC PROCESS | 5 | 1.76e-01 | -3.50e-01 | 9.21e-01 |
| GOMF ICOSANOID RECEPTOR ACTIVITY | 14 | 2.35e-02 | 3.50e-01 | 6.49e-01 |
| GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 4.47e-02 | -3.49e-01 | 7.59e-01 |
| GOCC SMN COMPLEX | 9 | 6.99e-02 | 3.49e-01 | 8.00e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 7 | 1.10e-01 | -3.48e-01 | 8.76e-01 |
| GOBP SEQUESTERING OF ACTIN MONOMERS | 6 | 1.40e-01 | 3.48e-01 | 9.02e-01 |
| GOBP INTERNEURON MIGRATION | 14 | 2.41e-02 | 3.48e-01 | 6.58e-01 |
| GOBP L ASCORBIC ACID METABOLIC PROCESS | 9 | 7.08e-02 | 3.48e-01 | 8.00e-01 |
| GOCC CLATHRIN SCULPTED MONOAMINE TRANSPORT VESICLE | 5 | 1.78e-01 | -3.48e-01 | 9.22e-01 |
| GOBP MAST CELL CYTOKINE PRODUCTION | 6 | 1.40e-01 | -3.48e-01 | 9.02e-01 |
| GOBP GEPHYRIN CLUSTERING INVOLVED IN POSTSYNAPTIC DENSITY ASSEMBLY | 5 | 1.78e-01 | 3.48e-01 | 9.22e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 14 | 2.43e-02 | -3.48e-01 | 6.58e-01 |
| GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 9 | 7.13e-02 | -3.47e-01 | 8.00e-01 |
| GOCC PICLN SM PROTEIN COMPLEX | 6 | 1.41e-01 | 3.47e-01 | 9.02e-01 |
| GOCC INO80 COMPLEX | 15 | 2.00e-02 | 3.47e-01 | 6.41e-01 |
| GOMF GALACTOSIDASE ACTIVITY | 6 | 1.42e-01 | -3.47e-01 | 9.02e-01 |
| GOBP AMACRINE CELL DIFFERENTIATION | 12 | 3.79e-02 | 3.46e-01 | 7.44e-01 |
| GOBP RESPONSE TO ZINC ION STARVATION | 9 | 7.27e-02 | -3.46e-01 | 8.07e-01 |
| GOCC JUNCTIONAL MEMBRANE COMPLEX | 6 | 1.43e-01 | 3.45e-01 | 9.02e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN HEART MORPHOGENESIS | 7 | 1.14e-01 | 3.45e-01 | 8.80e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE BY EPINEPHRINE NOREPINEPHRINE | 6 | 1.43e-01 | 3.45e-01 | 9.02e-01 |
| GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX | 8 | 9.10e-02 | -3.45e-01 | 8.53e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 10 | 5.93e-02 | 3.44e-01 | 7.90e-01 |
| GOBP PRIMITIVE STREAK FORMATION | 10 | 5.93e-02 | 3.44e-01 | 7.90e-01 |
| GOBP OTIC VESICLE DEVELOPMENT | 15 | 2.09e-02 | 3.44e-01 | 6.41e-01 |
| GOMF ALPHA N ACETYLNEURAMINATE ALPHA 2 8 SIALYLTRANSFERASE ACTIVITY | 6 | 1.44e-01 | -3.44e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 16 | 1.71e-02 | 3.44e-01 | 6.41e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 9 | 7.39e-02 | -3.44e-01 | 8.12e-01 |
| GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 5.97e-02 | -3.44e-01 | 7.90e-01 |
| GOBP ADENOSINE TRANSPORT | 5 | 1.83e-01 | -3.44e-01 | 9.28e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS | 17 | 1.44e-02 | 3.43e-01 | 6.25e-01 |
| GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 6.05e-02 | 3.43e-01 | 7.94e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT | 12 | 3.98e-02 | 3.43e-01 | 7.56e-01 |
| GOBP CELLULAR RESPONSE TO NICOTINE | 8 | 9.33e-02 | -3.43e-01 | 8.55e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 34 | 5.45e-04 | -3.43e-01 | 1.36e-01 |
| GOBP RESPONSE TO UV B | 21 | 6.58e-03 | 3.43e-01 | 4.74e-01 |
| GOMF HMG BOX DOMAIN BINDING | 13 | 3.25e-02 | 3.42e-01 | 7.07e-01 |
| GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 8 | 9.36e-02 | 3.42e-01 | 8.55e-01 |
| GOBP POSITIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 1.47e-01 | 3.42e-01 | 9.03e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 17 | 1.46e-02 | 3.42e-01 | 6.25e-01 |
| GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 1.17e-01 | 3.42e-01 | 8.83e-01 |
| GOCC SMN SM PROTEIN COMPLEX | 16 | 1.79e-02 | 3.42e-01 | 6.41e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 10 | 6.14e-02 | -3.42e-01 | 7.97e-01 |
| GOCC INTERCELLULAR CANALICULUS | 6 | 1.48e-01 | -3.41e-01 | 9.04e-01 |
| GOCC PERINUCLEOLAR COMPARTMENT | 5 | 1.87e-01 | -3.41e-01 | 9.28e-01 |
| GOCC EARLY ENDOSOME LUMEN | 5 | 1.87e-01 | -3.41e-01 | 9.28e-01 |
| GOBP CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS | 9 | 7.68e-02 | -3.41e-01 | 8.23e-01 |
| GOCC POSTSYNAPTIC ENDOCYTIC ZONE | 5 | 1.87e-01 | 3.40e-01 | 9.28e-01 |
| GOBP MINERALOCORTICOID SECRETION | 7 | 1.19e-01 | -3.40e-01 | 8.83e-01 |
| GOBP ENDOSOMAL LUMEN ACIDIFICATION | 12 | 4.12e-02 | 3.40e-01 | 7.56e-01 |
| GOBP REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY | 7 | 1.19e-01 | -3.40e-01 | 8.83e-01 |
| GOBP ACTIN MYOSIN FILAMENT SLIDING | 16 | 1.86e-02 | -3.40e-01 | 6.41e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY | 9 | 7.82e-02 | 3.39e-01 | 8.27e-01 |
| GOBP REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 10 | 6.43e-02 | -3.38e-01 | 7.99e-01 |
| GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 10 | 6.46e-02 | -3.37e-01 | 7.99e-01 |
| GOMF VASOPRESSIN RECEPTOR ACTIVITY | 6 | 1.53e-01 | -3.37e-01 | 9.04e-01 |
| GOBP AMELOBLAST DIFFERENTIATION | 5 | 1.92e-01 | -3.37e-01 | 9.28e-01 |
| GOBP DETECTION OF VIRUS | 6 | 1.53e-01 | 3.37e-01 | 9.04e-01 |
| GOCC CALCINEURIN COMPLEX | 6 | 1.53e-01 | -3.37e-01 | 9.04e-01 |
| GOBP ISOPRENOID TRANSPORT | 5 | 1.92e-01 | -3.37e-01 | 9.28e-01 |
| GOMF SPLICING FACTOR BINDING | 5 | 1.92e-01 | -3.37e-01 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 5 | 1.92e-01 | -3.37e-01 | 9.28e-01 |
| GOBP DEFENSE RESPONSE TO TUMOR CELL | 13 | 3.56e-02 | 3.37e-01 | 7.26e-01 |
| GOBP NEUTROPHIL APOPTOTIC PROCESS | 8 | 9.96e-02 | -3.36e-01 | 8.64e-01 |
| GOBP TELENCEPHALON REGIONALIZATION | 13 | 3.59e-02 | 3.36e-01 | 7.27e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION | 5 | 1.94e-01 | 3.36e-01 | 9.28e-01 |
| GOMF C X C CHEMOKINE BINDING | 5 | 1.94e-01 | -3.36e-01 | 9.28e-01 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 2.98e-02 | 3.35e-01 | 6.99e-01 |
| GOMF GAMMA AMINOBUTYRIC ACID SODIUM CHLORIDE SYMPORTER ACTIVITY | 5 | 1.95e-01 | -3.35e-01 | 9.29e-01 |
| GOBP EOSINOPHIL ACTIVATION | 8 | 1.01e-01 | 3.35e-01 | 8.66e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS OXYGEN AS ACCEPTOR | 5 | 1.95e-01 | 3.35e-01 | 9.29e-01 |
| GOBP L ASPARTATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 1.56e-01 | -3.34e-01 | 9.06e-01 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 7 | 1.26e-01 | -3.34e-01 | 8.91e-01 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 11 | 5.52e-02 | 3.34e-01 | 7.90e-01 |
| GOBP LUTEINIZING HORMONE SECRETION | 10 | 6.75e-02 | -3.34e-01 | 7.99e-01 |
| GOMF ESTROGEN 2 HYDROXYLASE ACTIVITY | 5 | 1.96e-01 | -3.34e-01 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 25 | 3.88e-03 | 3.34e-01 | 3.61e-01 |
| GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 23 | 5.70e-03 | -3.33e-01 | 4.52e-01 |
| GOCC LAMELLAR BODY | 17 | 1.75e-02 | 3.33e-01 | 6.41e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY NOREPINEPHRINE EPINEPHRINE | 8 | 1.03e-01 | 3.33e-01 | 8.66e-01 |
| GOCC MUSCLE MYOSIN COMPLEX | 15 | 2.57e-02 | -3.33e-01 | 6.69e-01 |
| GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 1.03e-01 | 3.33e-01 | 8.66e-01 |
| GOCC DEUTEROSOME | 6 | 1.58e-01 | -3.33e-01 | 9.06e-01 |
| GOCC SYNAPTOBREVIN 2 SNAP 25 SYNTAXIN 1A COMPLEX | 5 | 1.98e-01 | 3.32e-01 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 13 | 3.85e-02 | 3.31e-01 | 7.45e-01 |
| GOBP CARDIAC FIBROBLAST CELL DIFFERENTIATION | 5 | 2.00e-01 | -3.31e-01 | 9.36e-01 |
| GOBP GABAERGIC NEURON DIFFERENTIATION | 19 | 1.26e-02 | 3.31e-01 | 6.10e-01 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 15 | 2.66e-02 | 3.31e-01 | 6.73e-01 |
| GOCC G PROTEIN COUPLED RECEPTOR DIMERIC COMPLEX | 7 | 1.30e-01 | -3.30e-01 | 8.96e-01 |
| GOMF CHONDROITIN SULFOTRANSFERASE ACTIVITY | 5 | 2.01e-01 | -3.30e-01 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT | 5 | 2.01e-01 | -3.30e-01 | 9.36e-01 |
| GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 7 | 1.31e-01 | 3.30e-01 | 8.96e-01 |
| GOBP D AMINO ACID TRANSPORT | 6 | 1.62e-01 | -3.30e-01 | 9.12e-01 |
| GOBP FORELIMB MORPHOGENESIS | 39 | 3.70e-04 | 3.29e-01 | 1.18e-01 |
| GOCC STEREOCILIA COUPLING LINK | 7 | 1.32e-01 | -3.29e-01 | 8.96e-01 |
| GOMF ALPHA N ACETYLGALACTOSAMINIDE ALPHA 2 6 SIALYLTRANSFERASE ACTIVITY | 6 | 1.63e-01 | -3.29e-01 | 9.12e-01 |
| GOBP L SERINE BIOSYNTHETIC PROCESS | 5 | 2.04e-01 | 3.28e-01 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 2.04e-01 | 3.28e-01 | 9.36e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 14 | 3.37e-02 | 3.28e-01 | 7.14e-01 |
| GOCC FHF COMPLEX | 5 | 2.05e-01 | 3.28e-01 | 9.36e-01 |
| GOBP SEQUESTERING OF IRON ION | 6 | 1.65e-01 | 3.27e-01 | 9.15e-01 |
| GOBP SINOATRIAL NODE CELL DIFFERENTIATION | 6 | 1.66e-01 | 3.26e-01 | 9.15e-01 |
| GOBP RESPONSE TO YEAST | 7 | 1.35e-01 | 3.26e-01 | 8.98e-01 |
| GOBP L CYSTINE TRANSPORT | 6 | 1.67e-01 | -3.26e-01 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 5 | 2.07e-01 | 3.26e-01 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 6 | 1.67e-01 | 3.26e-01 | 9.15e-01 |
| GOBP ERBB3 SIGNALING PATHWAY | 5 | 2.09e-01 | -3.25e-01 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 9 | 9.16e-02 | 3.25e-01 | 8.54e-01 |
| GOBP REGULATION OF INOSITOL 1 4 5 TRISPHOSPHATE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 5 | 2.09e-01 | 3.24e-01 | 9.38e-01 |
| GOMF O PALMITOYLTRANSFERASE ACTIVITY | 5 | 2.09e-01 | 3.24e-01 | 9.38e-01 |
| GOBP REVERSIBLE DIFFERENTIATION | 11 | 6.29e-02 | 3.24e-01 | 7.98e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 34 | 1.09e-03 | 3.24e-01 | 2.03e-01 |
| GOMF INOSITOL 1 3 4 5 6 PENTAKISPHOSPHATE KINASE ACTIVITY | 5 | 2.10e-01 | -3.23e-01 | 9.40e-01 |
| GOCC NODE OF RANVIER | 16 | 2.52e-02 | -3.23e-01 | 6.67e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS | 11 | 6.35e-02 | -3.23e-01 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 8 | 1.14e-01 | -3.23e-01 | 8.79e-01 |
| GOBP QUINOLINATE METABOLIC PROCESS | 5 | 2.12e-01 | 3.23e-01 | 9.40e-01 |
| GOCC LAMININ COMPLEX | 9 | 9.42e-02 | -3.22e-01 | 8.55e-01 |
| GOBP PROTEIN K27 LINKED UBIQUITINATION | 7 | 1.40e-01 | -3.22e-01 | 9.02e-01 |
| GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS | 9 | 9.43e-02 | -3.22e-01 | 8.55e-01 |
| GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 1.72e-01 | 3.22e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE | 8 | 1.16e-01 | -3.21e-01 | 8.82e-01 |
| GOBP REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION | 8 | 1.16e-01 | 3.21e-01 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR PH REDUCTION | 5 | 2.16e-01 | 3.19e-01 | 9.42e-01 |
| GOBP CEREBELLAR GRANULAR LAYER FORMATION | 6 | 1.75e-01 | 3.19e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 6 | 1.76e-01 | -3.19e-01 | 9.21e-01 |
| GOMF LEUCINE BINDING | 6 | 1.76e-01 | 3.19e-01 | 9.21e-01 |
| GOBP RESPONSE TO L ASCORBIC ACID | 6 | 1.76e-01 | 3.19e-01 | 9.21e-01 |
| GOBP NEURAL CREST CELL FATE COMMITMENT | 6 | 1.76e-01 | 3.19e-01 | 9.21e-01 |
| GOMF MHC CLASS IB RECEPTOR ACTIVITY | 7 | 1.44e-01 | 3.19e-01 | 9.02e-01 |
| GOCC LSM1 7 PAT1 COMPLEX | 5 | 2.17e-01 | 3.19e-01 | 9.43e-01 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 54 | 5.00e-05 | 3.19e-01 | 2.56e-02 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION | 8 | 1.18e-01 | 3.19e-01 | 8.83e-01 |
| GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION | 10 | 8.10e-02 | 3.19e-01 | 8.36e-01 |
| GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 6 | 1.76e-01 | -3.19e-01 | 9.21e-01 |
| GOMF BILE ACID BINDING | 10 | 8.11e-02 | -3.19e-01 | 8.36e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 7 | 1.45e-01 | 3.18e-01 | 9.02e-01 |
| GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 2.18e-01 | 3.18e-01 | 9.43e-01 |
| GOMF GPI LINKED EPHRIN RECEPTOR ACTIVITY | 6 | 1.77e-01 | -3.18e-01 | 9.21e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 6 | 1.77e-01 | -3.18e-01 | 9.22e-01 |
| GOBP LIPID PHOSPHORYLATION | 10 | 8.21e-02 | 3.17e-01 | 8.38e-01 |
| GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 10 | 8.21e-02 | 3.17e-01 | 8.38e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 5 | 2.19e-01 | 3.17e-01 | 9.43e-01 |
| GOMF ACETYLESTERASE ACTIVITY | 5 | 2.20e-01 | -3.17e-01 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF ACTION POTENTIAL | 6 | 1.79e-01 | 3.17e-01 | 9.23e-01 |
| GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 14 | 4.03e-02 | -3.17e-01 | 7.56e-01 |
| GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 5 | 2.22e-01 | 3.15e-01 | 9.45e-01 |
| GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 8 | 1.22e-01 | -3.15e-01 | 8.86e-01 |
| GOMF D1 DOPAMINE RECEPTOR BINDING | 6 | 1.81e-01 | 3.15e-01 | 9.27e-01 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 1.49e-01 | 3.15e-01 | 9.04e-01 |
| GOBP ISOLEUCINE TRANSPORT | 5 | 2.23e-01 | 3.15e-01 | 9.46e-01 |
| GOBP ANTERIOR HEAD DEVELOPMENT | 7 | 1.50e-01 | 3.15e-01 | 9.04e-01 |
| GOBP MAGNESIUM ION TRANSPORT | 16 | 2.94e-02 | 3.15e-01 | 6.94e-01 |
| GOBP SODIUM DEPENDENT PHOSPHATE TRANSPORT | 12 | 5.94e-02 | -3.14e-01 | 7.90e-01 |
| GOBP REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS | 7 | 1.51e-01 | 3.14e-01 | 9.04e-01 |
| GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 25 | 6.74e-03 | 3.13e-01 | 4.83e-01 |
| GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION | 10 | 8.68e-02 | 3.13e-01 | 8.41e-01 |
| GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY | 14 | 4.28e-02 | 3.13e-01 | 7.59e-01 |
| GOCC SYNAPTONEMAL STRUCTURE | 35 | 1.37e-03 | 3.13e-01 | 2.30e-01 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 8 | 1.26e-01 | 3.13e-01 | 8.91e-01 |
| GOBP ALLANTOIN METABOLIC PROCESS | 9 | 1.05e-01 | -3.12e-01 | 8.67e-01 |
| GOBP PROTEIN SULFATION | 6 | 1.85e-01 | -3.12e-01 | 9.28e-01 |
| GOBP REGULATION OF ENDODERMAL CELL DIFFERENTIATION | 7 | 1.53e-01 | -3.12e-01 | 9.04e-01 |
| GOBP ERK5 CASCADE | 5 | 2.27e-01 | -3.12e-01 | 9.50e-01 |
| GOMF GLUCOSE SODIUM SYMPORTER ACTIVITY | 7 | 1.53e-01 | -3.12e-01 | 9.04e-01 |
| GOBP FOREBRAIN NEUROBLAST DIVISION | 5 | 2.27e-01 | 3.12e-01 | 9.50e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 2.28e-01 | 3.11e-01 | 9.50e-01 |
| GOMF DOPAMINE NEUROTRANSMITTER RECEPTOR ACTIVITY | 5 | 2.28e-01 | 3.11e-01 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 7 | 1.54e-01 | -3.11e-01 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 8 | 1.28e-01 | 3.11e-01 | 8.91e-01 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 10 | 8.89e-02 | 3.11e-01 | 8.47e-01 |
| GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 8 | 1.28e-01 | 3.11e-01 | 8.91e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK | 11 | 7.45e-02 | -3.11e-01 | 8.15e-01 |
| GOBP FUCOSE CATABOLIC PROCESS | 9 | 1.07e-01 | 3.10e-01 | 8.69e-01 |
| GOMF POTASSIUM CHANNEL INHIBITOR ACTIVITY | 5 | 2.30e-01 | -3.10e-01 | 9.50e-01 |
| GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 11 | 7.51e-02 | -3.10e-01 | 8.18e-01 |
| GOBP CYCLIC NUCLEOTIDE TRANSPORT | 9 | 1.08e-01 | 3.10e-01 | 8.70e-01 |
| GOBP SINOATRIAL NODE CELL DEVELOPMENT | 5 | 2.31e-01 | 3.10e-01 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION | 6 | 1.89e-01 | -3.09e-01 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 6 | 1.89e-01 | 3.09e-01 | 9.28e-01 |
| GOMF NMDA GLUTAMATE RECEPTOR ACTIVITY | 8 | 1.30e-01 | 3.09e-01 | 8.96e-01 |
| GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 10 | 9.05e-02 | -3.09e-01 | 8.53e-01 |
| GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 7 | 1.57e-01 | 3.09e-01 | 9.06e-01 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 4.54e-02 | -3.09e-01 | 7.59e-01 |
| GOCC BASEMENT MEMBRANE COLLAGEN TRIMER | 6 | 1.90e-01 | -3.09e-01 | 9.28e-01 |
| GOMF CELL ADHESIVE PROTEIN BINDING INVOLVED IN BUNDLE OF HIS CELL PURKINJE MYOCYTE COMMUNICATION | 5 | 2.33e-01 | -3.08e-01 | 9.51e-01 |
| GOBP RETINAL ROD CELL DEVELOPMENT | 8 | 1.32e-01 | -3.08e-01 | 8.96e-01 |
| GOBP FOREBRAIN REGIONALIZATION | 24 | 9.07e-03 | 3.08e-01 | 5.54e-01 |
| GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM | 9 | 1.10e-01 | 3.08e-01 | 8.76e-01 |
| GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 2.34e-01 | -3.07e-01 | 9.52e-01 |
| GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 1.11e-01 | 3.07e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 9 | 1.11e-01 | 3.07e-01 | 8.77e-01 |
| GOCC GEMINI OF COILED BODIES | 11 | 7.83e-02 | 3.07e-01 | 8.27e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR RECYCLING | 5 | 2.35e-01 | -3.06e-01 | 9.52e-01 |
| GOMF GLUTAMATE GATED CALCIUM ION CHANNEL ACTIVITY | 5 | 2.36e-01 | 3.06e-01 | 9.52e-01 |
| GOMF FATTY ACYL COA SYNTHASE ACTIVITY | 6 | 1.95e-01 | -3.06e-01 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MATRIX ADHESION VIA FIBRONECTIN | 5 | 2.36e-01 | -3.06e-01 | 9.52e-01 |
| GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 2.37e-01 | 3.06e-01 | 9.52e-01 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 14 | 4.78e-02 | 3.05e-01 | 7.65e-01 |
| GOBP HINDLIMB MORPHOGENESIS | 35 | 1.78e-03 | 3.05e-01 | 2.66e-01 |
| GOBP REGULATION OF MATRIX METALLOPEPTIDASE SECRETION | 10 | 9.51e-02 | 3.05e-01 | 8.58e-01 |
| GOBP RENAL WATER TRANSPORT | 9 | 1.13e-01 | -3.05e-01 | 8.79e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY ACYL GROUPS CONVERTED INTO ALKYL ON TRANSFER | 5 | 2.38e-01 | 3.05e-01 | 9.55e-01 |
| GOBP SUGAR MEDIATED SIGNALING PATHWAY | 9 | 1.14e-01 | 3.04e-01 | 8.80e-01 |
| GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY | 10 | 9.60e-02 | 3.04e-01 | 8.60e-01 |
| GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 2.39e-01 | 3.04e-01 | 9.55e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 9 | 1.15e-01 | -3.04e-01 | 8.80e-01 |
| GOMF C X3 C CHEMOKINE BINDING | 5 | 2.40e-01 | 3.04e-01 | 9.55e-01 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 11 | 8.13e-02 | -3.04e-01 | 8.36e-01 |
| GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL | 12 | 6.87e-02 | 3.04e-01 | 7.99e-01 |
| GOMF RETROMER COMPLEX BINDING | 7 | 1.65e-01 | 3.03e-01 | 9.15e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 2.21e-02 | 3.03e-01 | 6.41e-01 |
| GOBP DIAPEDESIS | 6 | 1.98e-01 | 3.03e-01 | 9.36e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 6 | 1.99e-01 | 3.03e-01 | 9.36e-01 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 27 | 6.42e-03 | 3.03e-01 | 4.74e-01 |
| GOMF BITTER TASTE RECEPTOR ACTIVITY | 23 | 1.20e-02 | 3.03e-01 | 6.02e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 2.41e-01 | -3.03e-01 | 9.57e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 10 | 9.76e-02 | 3.02e-01 | 8.61e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 6 | 2.00e-01 | 3.02e-01 | 9.36e-01 |
| GOBP MINERALOCORTICOID BIOSYNTHETIC PROCESS | 11 | 8.31e-02 | -3.02e-01 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 14 | 5.07e-02 | 3.02e-01 | 7.81e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 7 | 1.67e-01 | 3.02e-01 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF DOPAMINE SECRETION | 6 | 2.01e-01 | -3.02e-01 | 9.36e-01 |
| GOBP ESTABLISHMENT OF LEFT RIGHT ASYMMETRY | 6 | 2.01e-01 | 3.02e-01 | 9.36e-01 |
| GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY | 10 | 9.88e-02 | 3.01e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR WOUND HEALING | 5 | 2.43e-01 | 3.01e-01 | 9.58e-01 |
| GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 6 | 2.01e-01 | 3.01e-01 | 9.36e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 5 | 2.43e-01 | 3.01e-01 | 9.58e-01 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 49 | 2.65e-04 | 3.01e-01 | 1.00e-01 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 12 | 7.10e-02 | -3.01e-01 | 8.00e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 7 | 1.68e-01 | 3.01e-01 | 9.15e-01 |
| GOBP NEUROBLAST MIGRATION | 6 | 2.02e-01 | 3.01e-01 | 9.36e-01 |
| GOBP REGULATION OF THYROID HORMONE GENERATION | 7 | 1.68e-01 | -3.01e-01 | 9.16e-01 |
| GOCC HEMIDESMOSOME | 8 | 1.41e-01 | -3.01e-01 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 5 | 2.44e-01 | 3.01e-01 | 9.58e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT OF NEUROTRANSMITTER RECEPTOR COMPLEX | 5 | 2.44e-01 | -3.01e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 26 | 8.00e-03 | 3.00e-01 | 5.35e-01 |
| GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 8 | 1.41e-01 | 3.00e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 5 | 2.45e-01 | -3.00e-01 | 9.58e-01 |
| GOBP CEREBRAL CORTEX REGIONALIZATION | 7 | 1.70e-01 | 3.00e-01 | 9.19e-01 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 10 | 1.01e-01 | -3.00e-01 | 8.66e-01 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 11 | 8.54e-02 | 3.00e-01 | 8.39e-01 |
| GOBP REGULATION OF SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 5 | 2.46e-01 | 2.99e-01 | 9.58e-01 |
| GOMF 7S RNA BINDING | 7 | 1.70e-01 | 2.99e-01 | 9.20e-01 |
| GOBP ADULT FEEDING BEHAVIOR | 9 | 1.20e-01 | 2.99e-01 | 8.85e-01 |
| GOMF CARDIOLIPIN BINDING | 11 | 8.62e-02 | 2.99e-01 | 8.39e-01 |
| GOBP PREVENTION OF POLYSPERMY | 7 | 1.71e-01 | -2.99e-01 | 9.21e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 SIGNALING PATHWAY | 6 | 2.05e-01 | 2.99e-01 | 9.38e-01 |
| GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 8 | 1.44e-01 | 2.98e-01 | 9.02e-01 |
| GOBP CELL PROLIFERATION IN BONE MARROW | 10 | 1.02e-01 | 2.98e-01 | 8.66e-01 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 2.48e-01 | 2.98e-01 | 9.58e-01 |
| GOBP DESMOSOME ORGANIZATION | 10 | 1.02e-01 | -2.98e-01 | 8.66e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 18 | 2.86e-02 | -2.98e-01 | 6.86e-01 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 11 | 8.70e-02 | -2.98e-01 | 8.41e-01 |
| GOBP DNA PROTECTION | 6 | 2.06e-01 | 2.98e-01 | 9.38e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 15 | 4.58e-02 | 2.98e-01 | 7.60e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 10 | 1.03e-01 | 2.98e-01 | 8.66e-01 |
| GOBP 2FE 2S CLUSTER ASSEMBLY | 9 | 1.22e-01 | -2.97e-01 | 8.86e-01 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 14 | 5.42e-02 | 2.97e-01 | 7.87e-01 |
| GOBP MEIOTIC SISTER CHROMATID COHESION | 13 | 6.35e-02 | 2.97e-01 | 7.99e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRANSPORT | 6 | 2.07e-01 | -2.97e-01 | 9.38e-01 |
| GOMF SODIUM CHANNEL ACTIVITY | 42 | 8.64e-04 | -2.97e-01 | 1.80e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 14 | 5.46e-02 | 2.97e-01 | 7.88e-01 |
| GOBP REGULATION OF FEMALE GONAD DEVELOPMENT | 7 | 1.74e-01 | -2.97e-01 | 9.21e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 7 | 1.74e-01 | -2.97e-01 | 9.21e-01 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 13 | 6.43e-02 | 2.96e-01 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 10 | 1.05e-01 | -2.96e-01 | 8.67e-01 |
| GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 6 | 2.09e-01 | -2.96e-01 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF HAIR FOLLICLE MATURATION | 5 | 2.52e-01 | 2.96e-01 | 9.58e-01 |
| GOBP CELL PROLIFERATION IN MIDBRAIN | 8 | 1.47e-01 | 2.96e-01 | 9.04e-01 |
| GOMF NEUROPEPTIDE Y RECEPTOR ACTIVITY | 10 | 1.05e-01 | 2.96e-01 | 8.67e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 1.24e-01 | -2.96e-01 | 8.91e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL LEADING EDGE | 5 | 2.52e-01 | -2.96e-01 | 9.58e-01 |
| GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 8 | 1.48e-01 | 2.96e-01 | 9.04e-01 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 10 | 1.06e-01 | -2.96e-01 | 8.67e-01 |
| GOMF LIGAND GATED MONOATOMIC ANION CHANNEL ACTIVITY | 16 | 4.09e-02 | 2.95e-01 | 7.56e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 25 | 1.07e-02 | -2.95e-01 | 5.73e-01 |
| GOBP PROTEIN K29 LINKED UBIQUITINATION | 7 | 1.77e-01 | -2.95e-01 | 9.21e-01 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 13 | 6.62e-02 | 2.94e-01 | 7.99e-01 |
| GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 1.50e-01 | -2.94e-01 | 9.04e-01 |
| GOBP MALATE METABOLIC PROCESS | 9 | 1.27e-01 | -2.94e-01 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 9 | 1.27e-01 | 2.94e-01 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 11 | 9.13e-02 | -2.94e-01 | 8.53e-01 |
| GOBP ALDITOL BIOSYNTHETIC PROCESS | 5 | 2.55e-01 | 2.94e-01 | 9.58e-01 |
| GOBP ASYMMETRIC NEUROBLAST DIVISION | 5 | 2.55e-01 | -2.94e-01 | 9.58e-01 |
| GOBP STEROID HORMONE SECRETION | 27 | 8.20e-03 | -2.94e-01 | 5.41e-01 |
| GOBP SEGMENT SPECIFICATION | 16 | 4.21e-02 | 2.94e-01 | 7.56e-01 |
| GOBP NEURON FATE COMMITMENT | 73 | 1.45e-05 | 2.93e-01 | 1.24e-02 |
| GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 8 | 1.51e-01 | -2.93e-01 | 9.04e-01 |
| GOBP MEIOTIC ATTACHMENT OF TELOMERE TO NUCLEAR ENVELOPE | 5 | 2.56e-01 | 2.93e-01 | 9.58e-01 |
| GOBP GLYCOSIDE TRANSPORT | 5 | 2.56e-01 | -2.93e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 5 | 2.57e-01 | -2.93e-01 | 9.58e-01 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 33 | 3.67e-03 | 2.92e-01 | 3.57e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 7 | 1.81e-01 | 2.92e-01 | 9.27e-01 |
| GOBP REGULATION OF ATPASE COUPLED CALCIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.16e-01 | -2.92e-01 | 9.42e-01 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 6 | 2.17e-01 | -2.91e-01 | 9.42e-01 |
| GOMF TELOMERASE ACTIVITY | 6 | 2.17e-01 | -2.91e-01 | 9.42e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS | 7 | 1.82e-01 | -2.91e-01 | 9.27e-01 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 12 | 8.06e-02 | 2.91e-01 | 8.35e-01 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 25 | 1.18e-02 | -2.91e-01 | 6.02e-01 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 14 | 5.96e-02 | -2.91e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER UPTAKE | 6 | 2.18e-01 | -2.91e-01 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 1.83e-01 | 2.91e-01 | 9.28e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 11 | 9.55e-02 | -2.90e-01 | 8.59e-01 |
| GOMF O ACETYLTRANSFERASE ACTIVITY | 8 | 1.55e-01 | -2.90e-01 | 9.06e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 8 | 1.55e-01 | -2.90e-01 | 9.06e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 2.61e-01 | -2.90e-01 | 9.62e-01 |
| GOMF NUCLEOSIDE KINASE ACTIVITY | 9 | 1.32e-01 | 2.90e-01 | 8.96e-01 |
| GOMF CARBOXYLESTERASE ACTIVITY | 6 | 2.19e-01 | 2.90e-01 | 9.43e-01 |
| GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 6 | 2.19e-01 | -2.90e-01 | 9.43e-01 |
| GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 9 | 1.32e-01 | 2.90e-01 | 8.96e-01 |
| GOMF PEPTIDOGLYCAN BINDING | 18 | 3.34e-02 | -2.90e-01 | 7.14e-01 |
| GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION | 11 | 9.64e-02 | -2.89e-01 | 8.61e-01 |
| GOBP RENAL SODIUM EXCRETION | 11 | 9.65e-02 | -2.89e-01 | 8.61e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 1.85e-01 | -2.89e-01 | 9.28e-01 |
| GOBP FLAVONOID METABOLIC PROCESS | 11 | 9.68e-02 | -2.89e-01 | 8.61e-01 |
| GOBP PROTEIN DEMETHYLATION | 9 | 1.33e-01 | 2.89e-01 | 8.96e-01 |
| GOMF ATPASE INHIBITOR ACTIVITY | 5 | 2.63e-01 | 2.89e-01 | 9.64e-01 |
| GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 5 | 2.64e-01 | 2.89e-01 | 9.64e-01 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 11 | 9.76e-02 | -2.88e-01 | 8.61e-01 |
| GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 6 | 2.21e-01 | -2.88e-01 | 9.45e-01 |
| GOCC CARDIAC MYOFIBRIL | 6 | 2.22e-01 | -2.88e-01 | 9.45e-01 |
| GOBP NEUROTRANSMITTER LOADING INTO SYNAPTIC VESICLE | 7 | 1.87e-01 | -2.88e-01 | 9.28e-01 |
| GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT | 8 | 1.59e-01 | -2.88e-01 | 9.06e-01 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 11 | 9.87e-02 | -2.88e-01 | 8.64e-01 |
| GOBP L PROLINE BIOSYNTHETIC PROCESS | 6 | 2.23e-01 | 2.87e-01 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 6 | 2.23e-01 | -2.87e-01 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING | 10 | 1.16e-01 | 2.87e-01 | 8.82e-01 |
| GOMF NF KAPPAB INDUCING KINASE ACTIVITY | 5 | 2.67e-01 | -2.87e-01 | 9.67e-01 |
| GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 7 | 1.89e-01 | 2.87e-01 | 9.28e-01 |
| GOMF AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.24e-01 | 2.87e-01 | 9.48e-01 |
| GOMF SUMO TRANSFERASE ACTIVITY | 25 | 1.32e-02 | 2.86e-01 | 6.15e-01 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 18 | 3.54e-02 | -2.86e-01 | 7.25e-01 |
| GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.90e-01 | -2.86e-01 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 19 | 3.08e-02 | 2.86e-01 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 14 | 6.37e-02 | 2.86e-01 | 7.99e-01 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 27 | 1.01e-02 | -2.86e-01 | 5.57e-01 |
| GOBP RESPONSE TO PROTOZOAN | 31 | 5.90e-03 | 2.86e-01 | 4.57e-01 |
| GOBP RESPONSE TO TYPE III INTERFERON | 11 | 1.01e-01 | 2.86e-01 | 8.66e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 11 | 1.01e-01 | -2.85e-01 | 8.66e-01 |
| GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION | 8 | 1.62e-01 | 2.85e-01 | 9.12e-01 |
| GOBP PATTERN SPECIFICATION INVOLVED IN KIDNEY DEVELOPMENT | 8 | 1.62e-01 | 2.85e-01 | 9.12e-01 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 50 | 4.83e-04 | -2.85e-01 | 1.30e-01 |
| GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 1.91e-01 | -2.85e-01 | 9.28e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 8 | 1.63e-01 | -2.85e-01 | 9.12e-01 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 9 | 1.39e-01 | 2.85e-01 | 9.02e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 12 | 8.74e-02 | 2.85e-01 | 8.44e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 15 | 5.62e-02 | 2.85e-01 | 7.90e-01 |
| GOBP REGULATION OF ANTIMICROBIAL PEPTIDE PRODUCTION | 9 | 1.39e-01 | -2.85e-01 | 9.02e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 15 | 5.62e-02 | -2.85e-01 | 7.90e-01 |
| GOMF LACTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.27e-01 | -2.85e-01 | 9.50e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 31 | 6.13e-03 | 2.84e-01 | 4.68e-01 |
| GOBP MAINTENANCE OF CENTROSOME LOCATION | 6 | 2.28e-01 | 2.84e-01 | 9.50e-01 |
| GOBP TRANS SYNAPTIC SIGNALING BY LIPID | 7 | 1.93e-01 | -2.84e-01 | 9.28e-01 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 14 | 6.57e-02 | 2.84e-01 | 7.99e-01 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 15 | 5.68e-02 | -2.84e-01 | 7.90e-01 |
| GOBP CELLULAR RESPONSE TO MANGANESE ION | 10 | 1.20e-01 | -2.84e-01 | 8.85e-01 |
| GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 9 | 1.40e-01 | 2.84e-01 | 9.02e-01 |
| GOBP DETECTION OF BACTERIUM | 16 | 4.95e-02 | -2.84e-01 | 7.77e-01 |
| GOBP MITOTIC SPINDLE ELONGATION | 11 | 1.03e-01 | 2.84e-01 | 8.66e-01 |
| GOBP TRANSITION BETWEEN FAST AND SLOW FIBER | 9 | 1.41e-01 | 2.83e-01 | 9.02e-01 |
| GOBP ER TO GOLGI CERAMIDE TRANSPORT | 5 | 2.72e-01 | 2.83e-01 | 9.73e-01 |
| GOMF GLYCEROL CHANNEL ACTIVITY | 5 | 2.73e-01 | -2.83e-01 | 9.73e-01 |
| GOBP RESPONSE TO GONADOTROPIN | 27 | 1.09e-02 | -2.83e-01 | 5.80e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 6 | 2.30e-01 | -2.83e-01 | 9.50e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 14 | 6.67e-02 | -2.83e-01 | 7.99e-01 |
| GOMF RNA DNA HYBRID RIBONUCLEASE ACTIVITY | 6 | 2.30e-01 | -2.83e-01 | 9.50e-01 |
| GOMF HETEROTRIMERIC G PROTEIN BINDING | 5 | 2.74e-01 | -2.82e-01 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 14 | 6.74e-02 | 2.82e-01 | 7.99e-01 |
| GOBP PLATELET DEGRANULATION | 7 | 1.96e-01 | 2.82e-01 | 9.31e-01 |
| GOBP IMMUNOLOGICAL MEMORY PROCESS | 17 | 4.40e-02 | 2.82e-01 | 7.59e-01 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 9 | 1.43e-01 | -2.82e-01 | 9.02e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 11 | 1.05e-01 | 2.82e-01 | 8.67e-01 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 14 | 6.77e-02 | 2.82e-01 | 7.99e-01 |
| GOMF SINGLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY | 5 | 2.75e-01 | 2.82e-01 | 9.73e-01 |
| GOBP RESPONSE TO CORTICOSTERONE | 12 | 9.14e-02 | 2.81e-01 | 8.53e-01 |
| GOMF ANKYRIN REPEAT BINDING | 6 | 2.33e-01 | 2.81e-01 | 9.51e-01 |
| GOBP SOMATOTROPIN SECRETING CELL DIFFERENTIATION | 5 | 2.76e-01 | -2.81e-01 | 9.73e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION | 15 | 5.96e-02 | -2.81e-01 | 7.90e-01 |
| GOMF DOUBLE STRANDED METHYLATED DNA BINDING | 5 | 2.77e-01 | -2.81e-01 | 9.73e-01 |
| GOCC MYOSIN COMPLEX | 56 | 2.78e-04 | -2.81e-01 | 1.02e-01 |
| GOMF 11 CIS RETINAL BINDING | 7 | 1.98e-01 | -2.81e-01 | 9.36e-01 |
| GOBP RENAL TUBULAR SECRETION | 19 | 3.42e-02 | -2.81e-01 | 7.20e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 15 | 5.98e-02 | 2.81e-01 | 7.90e-01 |
| GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 10 | 1.25e-01 | 2.80e-01 | 8.91e-01 |
| GOBP REGULATION OF COA TRANSFERASE ACTIVITY | 10 | 1.25e-01 | -2.80e-01 | 8.91e-01 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 18 | 4.00e-02 | 2.80e-01 | 7.56e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 12 | 9.35e-02 | 2.80e-01 | 8.55e-01 |
| GOBP CHEMOREPULSION OF AXON | 6 | 2.36e-01 | 2.79e-01 | 9.52e-01 |
| GOBP SPHINGOSINE BIOSYNTHETIC PROCESS | 14 | 7.02e-02 | 2.79e-01 | 8.00e-01 |
| GOCC U4 SNRNP | 10 | 1.26e-01 | 2.79e-01 | 8.91e-01 |
| GOBP REGULATION OF AMACRINE CELL DIFFERENTIATION | 6 | 2.36e-01 | 2.79e-01 | 9.52e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN ANOTHER COMPOUND AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 6 | 2.37e-01 | 2.79e-01 | 9.52e-01 |
| GOBP PIRNA PROCESSING | 23 | 2.06e-02 | 2.79e-01 | 6.41e-01 |
| GOBP POSITIVE REGULATION OF DNA CATABOLIC PROCESS | 5 | 2.81e-01 | -2.79e-01 | 9.73e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 14 | 7.12e-02 | -2.79e-01 | 8.00e-01 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 7 | 2.02e-01 | 2.78e-01 | 9.36e-01 |
| GOCC CLATHRIN SCULPTED GAMMA AMINOBUTYRIC ACID TRANSPORT VESICLE | 8 | 1.73e-01 | 2.78e-01 | 9.21e-01 |
| GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY | 6 | 2.38e-01 | 2.78e-01 | 9.53e-01 |
| GOBP ACYLGLYCEROL TRANSPORT | 8 | 1.73e-01 | -2.78e-01 | 9.21e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 8 | 1.73e-01 | 2.78e-01 | 9.21e-01 |
| GOBP NEURONAL ION CHANNEL CLUSTERING | 12 | 9.56e-02 | -2.78e-01 | 8.59e-01 |
| GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 2.82e-01 | 2.78e-01 | 9.73e-01 |
| GOMF INOSITOL TETRAKISPHOSPHATE KINASE ACTIVITY | 5 | 2.82e-01 | 2.78e-01 | 9.73e-01 |
| GOMF COLLAGEN RECEPTOR ACTIVITY | 5 | 2.82e-01 | -2.78e-01 | 9.73e-01 |
| GOBP CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION | 7 | 2.03e-01 | -2.78e-01 | 9.36e-01 |
| GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.49e-01 | 2.78e-01 | 9.04e-01 |
| GOBP ISOCITRATE METABOLIC PROCESS | 5 | 2.82e-01 | 2.78e-01 | 9.73e-01 |
| GOBP CELLULAR RESPONSE TO LUTEINIZING HORMONE STIMULUS | 5 | 2.83e-01 | -2.77e-01 | 9.73e-01 |
| GOBP VESTIBULOCOCHLEAR NERVE FORMATION | 5 | 2.83e-01 | 2.77e-01 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 20 | 3.21e-02 | -2.77e-01 | 7.07e-01 |
| GOBP GLOSSOPHARYNGEAL NERVE DEVELOPMENT | 5 | 2.84e-01 | -2.77e-01 | 9.74e-01 |
| GOBP ENTRY OF BACTERIUM INTO HOST CELL | 9 | 1.51e-01 | 2.77e-01 | 9.04e-01 |
| GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 2.41e-01 | -2.77e-01 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF HEPATIC STELLATE CELL ACTIVATION | 5 | 2.84e-01 | 2.76e-01 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 35 | 4.66e-03 | 2.76e-01 | 4.11e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 17 | 4.87e-02 | 2.76e-01 | 7.71e-01 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 12 | 9.78e-02 | 2.76e-01 | 8.61e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 5 | 2.85e-01 | -2.76e-01 | 9.75e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 7 | 2.07e-01 | 2.76e-01 | 9.38e-01 |
| GOBP REGULATION OF MONOCYTE EXTRAVASATION | 7 | 2.07e-01 | 2.75e-01 | 9.38e-01 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 8 | 1.78e-01 | 2.75e-01 | 9.22e-01 |
| GOMF MRF BINDING | 5 | 2.87e-01 | -2.75e-01 | 9.75e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 52 | 6.05e-04 | -2.75e-01 | 1.38e-01 |
| GOBP REGULATION OF ANGIOTENSIN LEVELS IN BLOOD | 8 | 1.78e-01 | -2.75e-01 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 10 | 1.33e-01 | 2.75e-01 | 8.96e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS | 7 | 2.08e-01 | 2.75e-01 | 9.38e-01 |
| GOBP CELLULAR RESPONSE TO ETHER | 6 | 2.44e-01 | -2.74e-01 | 9.58e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 17 | 5.01e-02 | -2.74e-01 | 7.77e-01 |
| GOBP TYPE III INTERFERON PRODUCTION | 5 | 2.88e-01 | 2.74e-01 | 9.75e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH | 9 | 1.55e-01 | 2.74e-01 | 9.06e-01 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 28 | 1.22e-02 | 2.74e-01 | 6.06e-01 |
| GOMF MOLYBDOPTERIN COFACTOR BINDING | 6 | 2.46e-01 | 2.73e-01 | 9.58e-01 |
| GOMF LIPOTEICHOIC ACID BINDING | 5 | 2.90e-01 | -2.73e-01 | 9.78e-01 |
| GOMF HISTAMINE RECEPTOR ACTIVITY | 6 | 2.47e-01 | -2.73e-01 | 9.58e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 9 | 1.56e-01 | 2.73e-01 | 9.06e-01 |
| GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY | 5 | 2.91e-01 | 2.73e-01 | 9.79e-01 |
| GOMF MELANOCORTIN RECEPTOR ACTIVITY | 6 | 2.47e-01 | 2.73e-01 | 9.58e-01 |
| GOBP PARAXIAL MESODERM FORMATION | 7 | 2.11e-01 | 2.73e-01 | 9.40e-01 |
| GOMF INTERLEUKIN 12 RECEPTOR BINDING | 5 | 2.91e-01 | 2.73e-01 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 6 | 2.48e-01 | 2.73e-01 | 9.58e-01 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 55 | 4.72e-04 | 2.73e-01 | 1.30e-01 |
| GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 1.82e-01 | 2.72e-01 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 10 | 1.36e-01 | 2.72e-01 | 9.00e-01 |
| GOBP INTRACELLULAR NITROGEN HOMEOSTASIS | 5 | 2.92e-01 | -2.72e-01 | 9.79e-01 |
| GOMF NITRITE REDUCTASE ACTIVITY | 5 | 2.92e-01 | 2.72e-01 | 9.79e-01 |
| GOBP ESTABLISHMENT OF MEIOTIC SPINDLE LOCALIZATION | 6 | 2.49e-01 | -2.72e-01 | 9.58e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES | 10 | 1.37e-01 | -2.72e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 2.93e-01 | -2.72e-01 | 9.79e-01 |
| GOBP MIDDLE EAR MORPHOGENESIS | 20 | 3.54e-02 | 2.72e-01 | 7.25e-01 |
| GOBP PUTRESCINE BIOSYNTHETIC PROCESS | 5 | 2.93e-01 | -2.72e-01 | 9.79e-01 |
| GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 9 | 1.59e-01 | 2.71e-01 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 7 | 2.14e-01 | 2.71e-01 | 9.40e-01 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 16 | 6.04e-02 | -2.71e-01 | 7.94e-01 |
| GOBP HYALOID VASCULAR PLEXUS REGRESSION | 7 | 2.14e-01 | -2.71e-01 | 9.41e-01 |
| GOBP PRO B CELL DIFFERENTIATION | 12 | 1.04e-01 | 2.71e-01 | 8.67e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 16 | 6.08e-02 | 2.71e-01 | 7.94e-01 |
| GOMF AMINOACYLASE ACTIVITY | 6 | 2.51e-01 | 2.71e-01 | 9.58e-01 |
| GOMF FOLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.95e-01 | 2.70e-01 | 9.82e-01 |
| GOMF 4 GALACTOSYL N ACETYLGLUCOSAMINIDE 3 ALPHA L FUCOSYLTRANSFERASE ACTIVITY | 6 | 2.52e-01 | 2.70e-01 | 9.58e-01 |
| GOBP MELANOSOME ASSEMBLY | 18 | 4.74e-02 | 2.70e-01 | 7.65e-01 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 22 | 2.85e-02 | 2.70e-01 | 6.86e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN VENTRAL SPINAL CORD PATTERNING | 8 | 1.87e-01 | -2.69e-01 | 9.28e-01 |
| GOCC SERINE PROTEASE INHIBITOR COMPLEX | 6 | 2.53e-01 | -2.69e-01 | 9.58e-01 |
| GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 1.41e-01 | 2.69e-01 | 9.02e-01 |
| GOMF RETINOIC ACID 4 HYDROXYLASE ACTIVITY | 10 | 1.41e-01 | 2.69e-01 | 9.02e-01 |
| GOCC HFE TRANSFERRIN RECEPTOR COMPLEX | 8 | 1.88e-01 | -2.69e-01 | 9.28e-01 |
| GOBP CEREBELLAR PURKINJE CELL GRANULE CELL PRECURSOR CELL SIGNALING INVOLVED IN REGULATION OF GRANULE CELL PRECURSOR CELL PROLIFERATION | 5 | 2.98e-01 | 2.69e-01 | 9.83e-01 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 16 | 6.29e-02 | -2.69e-01 | 7.98e-01 |
| GOMF BMP BINDING | 19 | 4.28e-02 | 2.68e-01 | 7.59e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 5 | 2.99e-01 | 2.68e-01 | 9.85e-01 |
| GOMF MALATE DEHYDROGENASE ACTIVITY | 8 | 1.89e-01 | -2.68e-01 | 9.28e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 14 | 8.25e-02 | 2.68e-01 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 8 | 1.89e-01 | 2.68e-01 | 9.28e-01 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 6 | 2.56e-01 | -2.68e-01 | 9.58e-01 |
| GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 2.56e-01 | -2.68e-01 | 9.58e-01 |
| GOMF 5 3 DNA HELICASE ACTIVITY | 8 | 1.90e-01 | -2.68e-01 | 9.28e-01 |
| GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 6 | 2.56e-01 | 2.68e-01 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 12 | 1.09e-01 | -2.67e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 17 | 5.63e-02 | 2.67e-01 | 7.90e-01 |
| GOBP L PHENYLALANINE METABOLIC PROCESS | 8 | 1.91e-01 | -2.67e-01 | 9.28e-01 |
| GOBP BRONCHUS DEVELOPMENT | 11 | 1.25e-01 | -2.67e-01 | 8.91e-01 |
| GOCC MYELIN SHEATH ADAXONAL REGION | 6 | 2.57e-01 | 2.67e-01 | 9.58e-01 |
| GOBP TERMINAL BUTTON ORGANIZATION | 6 | 2.58e-01 | 2.67e-01 | 9.58e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 36 | 5.58e-03 | -2.67e-01 | 4.49e-01 |
| GOBP REGULATION OF WNT PROTEIN SECRETION | 5 | 3.02e-01 | -2.67e-01 | 9.87e-01 |
| GOBP WNT PROTEIN SECRETION | 5 | 3.02e-01 | -2.67e-01 | 9.87e-01 |
| GOMF GLYCINE BINDING | 10 | 1.44e-01 | 2.67e-01 | 9.02e-01 |
| GOBP TRANS SYNAPTIC SIGNALING BY TRANS SYNAPTIC COMPLEX | 6 | 2.58e-01 | -2.66e-01 | 9.58e-01 |
| GOBP TRYPTOPHAN TRANSPORT | 5 | 3.02e-01 | 2.66e-01 | 9.87e-01 |
| GOBP GLYCEROL TRANSMEMBRANE TRANSPORT | 7 | 2.22e-01 | -2.66e-01 | 9.45e-01 |
| GOMF GLYCEROL TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.22e-01 | -2.66e-01 | 9.45e-01 |
| GOBP MESODERMAL CELL FATE SPECIFICATION | 12 | 1.10e-01 | 2.66e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 9 | 1.67e-01 | 2.66e-01 | 9.15e-01 |
| GOBP DORSAL AORTA MORPHOGENESIS | 8 | 1.92e-01 | 2.66e-01 | 9.28e-01 |
| GOBP NUCLEOSIDE TRANSPORT | 10 | 1.46e-01 | -2.66e-01 | 9.02e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 12 | 1.11e-01 | -2.66e-01 | 8.77e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 15 | 7.48e-02 | -2.66e-01 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 10 | 1.46e-01 | 2.65e-01 | 9.02e-01 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 21 | 3.52e-02 | 2.65e-01 | 7.25e-01 |
| GOBP RECOGNITION OF APOPTOTIC CELL | 7 | 2.24e-01 | 2.65e-01 | 9.48e-01 |
| GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY | 8 | 1.94e-01 | -2.65e-01 | 9.28e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 17 | 5.84e-02 | -2.65e-01 | 7.90e-01 |
| GOMF HEXOKINASE ACTIVITY | 5 | 3.05e-01 | -2.65e-01 | 9.87e-01 |
| GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE | 15 | 7.56e-02 | 2.65e-01 | 8.18e-01 |
| GOBP DEDIFFERENTIATION | 11 | 1.28e-01 | 2.65e-01 | 8.91e-01 |
| GOBP ANAGEN | 5 | 3.05e-01 | 2.65e-01 | 9.87e-01 |
| GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 13 | 9.85e-02 | -2.65e-01 | 8.63e-01 |
| GOMF CONNEXIN BINDING | 5 | 3.05e-01 | -2.65e-01 | 9.87e-01 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 12 | 1.13e-01 | -2.65e-01 | 8.77e-01 |
| GOBP MALONYL COA METABOLIC PROCESS | 6 | 2.62e-01 | 2.64e-01 | 9.63e-01 |
| GOMF ALKANE 1 MONOOXYGENASE ACTIVITY | 5 | 3.06e-01 | -2.64e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 28 | 1.55e-02 | -2.64e-01 | 6.25e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 15 | 7.65e-02 | 2.64e-01 | 8.23e-01 |
| GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 3.07e-01 | -2.64e-01 | 9.87e-01 |
| GOMF THIOL OXIDASE ACTIVITY | 6 | 2.63e-01 | 2.64e-01 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 7 | 2.27e-01 | -2.64e-01 | 9.50e-01 |
| GOBP LYSINE METABOLIC PROCESS | 8 | 1.97e-01 | -2.63e-01 | 9.34e-01 |
| GOMF FUCOSE BINDING | 8 | 1.97e-01 | -2.63e-01 | 9.35e-01 |
| GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY | 17 | 6.02e-02 | -2.63e-01 | 7.94e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 8 | 1.97e-01 | -2.63e-01 | 9.35e-01 |
| GOBP REGULATION OF FOREBRAIN NEURON DIFFERENTIATION | 5 | 3.08e-01 | 2.63e-01 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO L GLUTAMATE | 5 | 3.08e-01 | 2.63e-01 | 9.87e-01 |
| GOCC SPERMATOPROTEASOME COMPLEX | 5 | 3.09e-01 | -2.63e-01 | 9.87e-01 |
| GOBP RESPONSE TO INTERLEUKIN 18 | 11 | 1.31e-01 | 2.63e-01 | 8.96e-01 |
| GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 31 | 1.14e-02 | 2.63e-01 | 5.98e-01 |
| GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 1.98e-01 | 2.63e-01 | 9.36e-01 |
| GOCC PRC1 COMPLEX | 16 | 6.91e-02 | 2.62e-01 | 8.00e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 28 | 1.62e-02 | -2.62e-01 | 6.28e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 22 | 3.31e-02 | -2.62e-01 | 7.10e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 7 | 2.29e-01 | 2.62e-01 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF FERTILIZATION | 5 | 3.10e-01 | 2.62e-01 | 9.87e-01 |
| GOCC 9PLUS0 MOTILE CILIUM | 5 | 3.10e-01 | -2.62e-01 | 9.87e-01 |
| GOBP HISTONE H3 K9 METHYLATION | 5 | 3.10e-01 | 2.62e-01 | 9.87e-01 |
| GOBP FOLLICLE STIMULATING HORMONE SECRETION | 8 | 2.00e-01 | -2.62e-01 | 9.36e-01 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 12 | 1.16e-01 | -2.62e-01 | 8.82e-01 |
| GOCC ALVEOLAR LAMELLAR BODY | 7 | 2.30e-01 | 2.62e-01 | 9.50e-01 |
| GOMF L LACTATE DEHYDROGENASE ACTIVITY | 5 | 3.11e-01 | 2.62e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 7 | 2.31e-01 | 2.62e-01 | 9.50e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 9 | 1.74e-01 | 2.61e-01 | 9.21e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 17 | 6.20e-02 | 2.61e-01 | 7.98e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 32 | 1.05e-02 | -2.61e-01 | 5.73e-01 |
| GOBP LEUKOTRIENE D4 METABOLIC PROCESS | 7 | 2.31e-01 | 2.61e-01 | 9.50e-01 |
| GOMF PH DOMAIN BINDING | 8 | 2.01e-01 | -2.61e-01 | 9.36e-01 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 1.03e-01 | 2.61e-01 | 8.66e-01 |
| GOBP NEURAL CREST CELL MIGRATION INVOLVED IN AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 6 | 2.68e-01 | -2.61e-01 | 9.70e-01 |
| GOMF MACROLIDE BINDING | 12 | 1.18e-01 | -2.61e-01 | 8.83e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 10 | 1.54e-01 | 2.61e-01 | 9.06e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 12 | 1.18e-01 | -2.60e-01 | 8.83e-01 |
| GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX | 6 | 2.70e-01 | 2.60e-01 | 9.71e-01 |
| GOBP SIRNA PROCESSING | 9 | 1.77e-01 | 2.60e-01 | 9.21e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 12 | 1.19e-01 | -2.60e-01 | 8.83e-01 |
| GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 14 | 9.24e-02 | 2.60e-01 | 8.55e-01 |
| GOBP UV DAMAGE EXCISION REPAIR | 12 | 1.19e-01 | 2.60e-01 | 8.83e-01 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 10 | 1.55e-01 | 2.60e-01 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY | 10 | 1.55e-01 | -2.60e-01 | 9.06e-01 |
| GOBP REGULATION OF STEROID HORMONE SECRETION | 22 | 3.51e-02 | -2.59e-01 | 7.25e-01 |
| GOBP CELLULAR RESPONSE TO IRON ION | 8 | 2.04e-01 | -2.59e-01 | 9.36e-01 |
| GOCC NUCLEAR OUTER MEMBRANE | 28 | 1.76e-02 | 2.59e-01 | 6.41e-01 |
| GOBP POLYOL TRANSMEMBRANE TRANSPORT | 10 | 1.56e-01 | -2.59e-01 | 9.06e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 10 | 1.56e-01 | 2.59e-01 | 9.06e-01 |
| GOBP ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS | 5 | 3.16e-01 | -2.59e-01 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 16 | 7.28e-02 | -2.59e-01 | 8.07e-01 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 26 | 2.22e-02 | 2.59e-01 | 6.41e-01 |
| GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 9 | 1.79e-01 | -2.59e-01 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 7 | 2.36e-01 | -2.59e-01 | 9.52e-01 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 9 | 1.79e-01 | 2.59e-01 | 9.23e-01 |
| GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX | 5 | 3.16e-01 | -2.59e-01 | 9.87e-01 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 27 | 2.01e-02 | 2.58e-01 | 6.41e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 5 | 3.17e-01 | 2.58e-01 | 9.87e-01 |
| GOBP CELL MIGRATION INVOLVED IN METANEPHROS DEVELOPMENT | 5 | 3.17e-01 | 2.58e-01 | 9.87e-01 |
| GOMF DEATH RECEPTOR BINDING | 19 | 5.13e-02 | 2.58e-01 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 13 | 1.07e-01 | 2.58e-01 | 8.69e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 5 | 3.17e-01 | -2.58e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 2.37e-01 | -2.58e-01 | 9.52e-01 |
| GOBP OSTEOBLAST DEVELOPMENT | 17 | 6.55e-02 | 2.58e-01 | 7.99e-01 |
| GOBP RESPONSE TO POTASSIUM ION | 17 | 6.55e-02 | -2.58e-01 | 7.99e-01 |
| GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING | 6 | 2.74e-01 | 2.58e-01 | 9.73e-01 |
| GOMF CARNITINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.18e-01 | 2.58e-01 | 9.87e-01 |
| GOBP MAMMALIAN OOGENESIS STAGE | 12 | 1.22e-01 | 2.58e-01 | 8.86e-01 |
| GOMF VIRION BINDING | 13 | 1.08e-01 | -2.58e-01 | 8.71e-01 |
| GOBP RESPONSE TO WATER DEPRIVATION | 5 | 3.19e-01 | 2.57e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 11 | 1.40e-01 | -2.57e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 3.20e-01 | 2.57e-01 | 9.87e-01 |
| GOBP DITERPENOID BIOSYNTHETIC PROCESS | 10 | 1.59e-01 | -2.57e-01 | 9.06e-01 |
| GOMF RECEPTOR SIGNALING PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 5 | 3.20e-01 | -2.57e-01 | 9.87e-01 |
| GOMF POTASSIUM CHANNEL ACTIVATOR ACTIVITY | 5 | 3.20e-01 | -2.57e-01 | 9.87e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING | 16 | 7.53e-02 | -2.57e-01 | 8.18e-01 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 33 | 1.07e-02 | -2.57e-01 | 5.73e-01 |
| GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER | 6 | 2.76e-01 | -2.57e-01 | 9.73e-01 |
| GOMF GAP JUNCTION HEMI CHANNEL ACTIVITY | 6 | 2.77e-01 | -2.56e-01 | 9.73e-01 |
| GOBP UTERINE SMOOTH MUSCLE CONTRACTION | 9 | 1.84e-01 | -2.55e-01 | 9.28e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 8 | 2.11e-01 | -2.55e-01 | 9.40e-01 |
| GOBP REGULATION OF BONE DEVELOPMENT | 9 | 1.85e-01 | 2.55e-01 | 9.28e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION | 11 | 1.43e-01 | 2.55e-01 | 9.02e-01 |
| GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 6 | 2.79e-01 | 2.55e-01 | 9.73e-01 |
| GOCC INO80 TYPE COMPLEX | 26 | 2.43e-02 | 2.55e-01 | 6.58e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 15 | 8.70e-02 | 2.55e-01 | 8.41e-01 |
| GOBP XENOPHAGY | 14 | 9.82e-02 | 2.55e-01 | 8.63e-01 |
| GOCC BOX H ACA RNP COMPLEX | 7 | 2.43e-01 | 2.55e-01 | 9.58e-01 |
| GOCC BCL 2 FAMILY PROTEIN COMPLEX | 10 | 1.63e-01 | 2.55e-01 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF AMINE METABOLIC PROCESS | 6 | 2.80e-01 | -2.55e-01 | 9.73e-01 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 32 | 1.26e-02 | 2.55e-01 | 6.10e-01 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 13 | 1.12e-01 | 2.55e-01 | 8.77e-01 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 52 | 1.49e-03 | 2.55e-01 | 2.32e-01 |
| GOBP GASTRIC ACID SECRETION | 13 | 1.12e-01 | -2.54e-01 | 8.77e-01 |
| GOBP CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM | 5 | 3.24e-01 | 2.54e-01 | 9.87e-01 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 20 | 4.88e-02 | 2.54e-01 | 7.71e-01 |
| GOBP CMP METABOLIC PROCESS | 8 | 2.13e-01 | 2.54e-01 | 9.40e-01 |
| GOBP RETINAL CONE CELL DEVELOPMENT | 11 | 1.45e-01 | -2.54e-01 | 9.02e-01 |
| GOMF SNRNP BINDING | 9 | 1.87e-01 | 2.54e-01 | 9.28e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE FORMATION | 11 | 1.45e-01 | 2.54e-01 | 9.02e-01 |
| GOBP MEIOTIC DNA DOUBLE STRAND BREAK FORMATION | 6 | 2.82e-01 | 2.54e-01 | 9.73e-01 |
| GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 2.45e-01 | -2.54e-01 | 9.58e-01 |
| GOBP ENDODERMAL CELL FATE SPECIFICATION | 8 | 2.14e-01 | -2.54e-01 | 9.40e-01 |
| GOBP NUCLEAR RNA SURVEILLANCE | 14 | 1.00e-01 | 2.54e-01 | 8.65e-01 |
| GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING | 6 | 2.82e-01 | 2.54e-01 | 9.73e-01 |
| GOMF PROSTANOID RECEPTOR ACTIVITY | 11 | 1.45e-01 | 2.54e-01 | 9.02e-01 |
| GOBP GAP JUNCTION MEDIATED INTERCELLULAR TRANSPORT | 6 | 2.83e-01 | -2.53e-01 | 9.73e-01 |
| GOBP INOSINE METABOLIC PROCESS | 5 | 3.27e-01 | -2.53e-01 | 9.87e-01 |
| GOMF NETRIN RECEPTOR ACTIVITY | 5 | 3.27e-01 | -2.53e-01 | 9.87e-01 |
| GOBP OXALATE TRANSPORT | 12 | 1.29e-01 | -2.53e-01 | 8.94e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 31 | 1.49e-02 | 2.53e-01 | 6.25e-01 |
| GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 9 | 1.89e-01 | 2.53e-01 | 9.28e-01 |
| GOBP VESICLE FUSION TO PLASMA MEMBRANE | 24 | 3.22e-02 | -2.53e-01 | 7.07e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 10 | 1.67e-01 | 2.52e-01 | 9.15e-01 |
| GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT | 21 | 4.52e-02 | 2.52e-01 | 7.59e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 10 | 1.67e-01 | 2.52e-01 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION | 5 | 3.28e-01 | 2.52e-01 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 6 | 2.85e-01 | 2.52e-01 | 9.75e-01 |
| GOBP APOPTOTIC CHROMOSOME CONDENSATION | 6 | 2.85e-01 | 2.52e-01 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 15 | 9.19e-02 | -2.51e-01 | 8.55e-01 |
| GOMF C C CHEMOKINE BINDING | 23 | 3.73e-02 | -2.51e-01 | 7.39e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MATURATION | 6 | 2.87e-01 | 2.51e-01 | 9.75e-01 |
| GOBP LUTEINIZATION | 12 | 1.32e-01 | -2.51e-01 | 8.96e-01 |
| GOMF MICROFIBRIL BINDING | 5 | 3.32e-01 | -2.51e-01 | 9.88e-01 |
| GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.88e-01 | 2.51e-01 | 9.75e-01 |
| GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 9 | 1.93e-01 | 2.50e-01 | 9.28e-01 |
| GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 8 | 2.20e-01 | -2.50e-01 | 9.44e-01 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 15 | 9.32e-02 | 2.50e-01 | 8.55e-01 |
| GOBP REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT | 5 | 3.32e-01 | -2.50e-01 | 9.88e-01 |
| GOMF ORNITHINE DECARBOXYLASE REGULATOR ACTIVITY | 5 | 3.32e-01 | -2.50e-01 | 9.88e-01 |
| GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 7 | 2.52e-01 | -2.50e-01 | 9.58e-01 |
| GOBP LEUCINE IMPORT ACROSS PLASMA MEMBRANE | 5 | 3.33e-01 | 2.50e-01 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE LIPASE ACTIVITY | 9 | 1.94e-01 | 2.50e-01 | 9.28e-01 |
| GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 15 | 9.38e-02 | 2.50e-01 | 8.55e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 6 | 2.89e-01 | -2.50e-01 | 9.77e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 37 | 8.57e-03 | 2.50e-01 | 5.44e-01 |
| GOBP DENDRITIC CELL APOPTOTIC PROCESS | 11 | 1.52e-01 | -2.50e-01 | 9.04e-01 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 28 | 2.23e-02 | 2.50e-01 | 6.41e-01 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 27 | 2.48e-02 | -2.49e-01 | 6.63e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS | 5 | 3.34e-01 | -2.49e-01 | 9.88e-01 |
| GOCC LEWY BODY | 8 | 2.22e-01 | -2.49e-01 | 9.45e-01 |
| GOBP REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 2.91e-01 | -2.49e-01 | 9.79e-01 |
| GOBP LUNG VASCULATURE DEVELOPMENT | 8 | 2.23e-01 | 2.49e-01 | 9.46e-01 |
| GOBP RESPONSE TO NEMATODE | 7 | 2.54e-01 | -2.49e-01 | 9.58e-01 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 10 | 1.73e-01 | 2.49e-01 | 9.21e-01 |
| GOBP ADULT HEART DEVELOPMENT | 13 | 1.21e-01 | 2.49e-01 | 8.86e-01 |
| GOMF SUMO LIGASE ACTIVITY | 13 | 1.21e-01 | 2.49e-01 | 8.86e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 5 | 3.37e-01 | 2.48e-01 | 9.88e-01 |
| GOMF THIAMINE PYROPHOSPHATE BINDING | 7 | 2.57e-01 | 2.48e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 3.38e-01 | -2.47e-01 | 9.88e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 8 | 2.26e-01 | -2.47e-01 | 9.49e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL CELL ADHESION | 5 | 3.38e-01 | -2.47e-01 | 9.88e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 12 | 1.38e-01 | -2.47e-01 | 9.02e-01 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 28 | 2.35e-02 | 2.47e-01 | 6.49e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 5 | 3.38e-01 | -2.47e-01 | 9.88e-01 |
| GOMF ADRENERGIC RECEPTOR ACTIVITY | 9 | 1.99e-01 | 2.47e-01 | 9.36e-01 |
| GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 6 | 2.94e-01 | 2.47e-01 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 3.39e-01 | 2.47e-01 | 9.88e-01 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 10 | 1.77e-01 | 2.47e-01 | 9.21e-01 |
| GOMF HEPARAN SULFATE GLUCOSAMINE 3 SULFOTRANSFERASE 1 ACTIVITY | 7 | 2.59e-01 | 2.47e-01 | 9.58e-01 |
| GOBP TRNA TRANSPORT | 6 | 2.96e-01 | -2.47e-01 | 9.82e-01 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 1.77e-01 | 2.47e-01 | 9.21e-01 |
| GOBP ANDROGEN CATABOLIC PROCESS | 5 | 3.40e-01 | -2.46e-01 | 9.88e-01 |
| GOBP ENDOCRINE HORMONE SECRETION | 56 | 1.44e-03 | -2.46e-01 | 2.30e-01 |
| GOCC NEURONAL DENSE CORE VESICLE | 25 | 3.31e-02 | 2.46e-01 | 7.10e-01 |
| GOBP STRAND INVASION | 6 | 2.97e-01 | 2.46e-01 | 9.82e-01 |
| GOBP INHIBITORY SYNAPSE ASSEMBLY | 18 | 7.07e-02 | 2.46e-01 | 8.00e-01 |
| GOBP CELLULAR RESPONSE TO COCAINE | 8 | 2.29e-01 | -2.46e-01 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 13 | 1.25e-01 | 2.46e-01 | 8.91e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 7 | 2.60e-01 | -2.46e-01 | 9.60e-01 |
| GOBP PARATHYROID GLAND DEVELOPMENT | 7 | 2.61e-01 | -2.45e-01 | 9.62e-01 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 18 | 7.19e-02 | 2.45e-01 | 8.03e-01 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 2.03e-02 | -2.45e-01 | 6.41e-01 |
| GOBP PERICYTE CELL DIFFERENTIATION | 11 | 1.60e-01 | 2.45e-01 | 9.06e-01 |
| GOBP REGULATION OF GAP JUNCTION ASSEMBLY | 9 | 2.04e-01 | -2.45e-01 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 19 | 6.49e-02 | 2.45e-01 | 7.99e-01 |
| GOMF GLUTATHIONE BINDING | 10 | 1.81e-01 | 2.44e-01 | 9.27e-01 |
| GOMF PATCHED BINDING | 8 | 2.32e-01 | 2.44e-01 | 9.50e-01 |
| GOBP REGULATION OF AXON GUIDANCE | 13 | 1.28e-01 | 2.44e-01 | 8.91e-01 |
| GOBP REGULATION OF LIGASE ACTIVITY | 7 | 2.64e-01 | 2.44e-01 | 9.65e-01 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 7 | 2.64e-01 | -2.44e-01 | 9.65e-01 |
| GOBP REGULATION OF XENOPHAGY | 9 | 2.06e-01 | 2.43e-01 | 9.38e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 15 | 1.03e-01 | -2.43e-01 | 8.66e-01 |
| GOBP ISOPRENOID CATABOLIC PROCESS | 10 | 1.83e-01 | 2.43e-01 | 9.27e-01 |
| GOCC NASCENT POLYPEPTIDE ASSOCIATED COMPLEX | 5 | 3.46e-01 | -2.43e-01 | 9.92e-01 |
| GOBP GAP JUNCTION ASSEMBLY | 16 | 9.20e-02 | -2.43e-01 | 8.55e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 8 | 2.33e-01 | -2.43e-01 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT | 9 | 2.07e-01 | 2.43e-01 | 9.38e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 10 | 1.83e-01 | -2.43e-01 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 7 | 2.65e-01 | -2.43e-01 | 9.66e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR | 5 | 3.47e-01 | -2.43e-01 | 9.92e-01 |
| GOBP VESICLE TETHERING TO GOLGI | 5 | 3.47e-01 | 2.43e-01 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 2.35e-01 | -2.43e-01 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 10 | 1.84e-01 | -2.43e-01 | 9.28e-01 |
| GOBP LEUCINE METABOLIC PROCESS | 8 | 2.35e-01 | 2.42e-01 | 9.52e-01 |
| GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.48e-01 | 2.42e-01 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF GAP JUNCTION ASSEMBLY | 6 | 3.04e-01 | -2.42e-01 | 9.87e-01 |
| GOBP EPITHELIAL CELL CELL ADHESION | 15 | 1.05e-01 | -2.42e-01 | 8.67e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 11 | 1.65e-01 | -2.42e-01 | 9.15e-01 |
| GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 8 | 2.36e-01 | -2.42e-01 | 9.52e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 12 | 1.47e-01 | -2.42e-01 | 9.04e-01 |
| GOBP SPERM DNA CONDENSATION | 17 | 8.47e-02 | 2.42e-01 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 35 | 1.34e-02 | -2.41e-01 | 6.15e-01 |
| GOCC CELL TIP | 5 | 3.50e-01 | 2.41e-01 | 9.94e-01 |
| GOMF INTERLEUKIN 2 RECEPTOR BINDING | 5 | 3.50e-01 | 2.41e-01 | 9.94e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 17 | 8.50e-02 | -2.41e-01 | 8.39e-01 |
| GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY | 5 | 3.50e-01 | 2.41e-01 | 9.94e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING BY LIPID | 5 | 3.51e-01 | -2.41e-01 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 24 | 4.09e-02 | 2.41e-01 | 7.56e-01 |
| GOBP NORADRENERGIC NEURON DIFFERENTIATION | 10 | 1.87e-01 | 2.41e-01 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 12 | 1.48e-01 | 2.41e-01 | 9.04e-01 |
| GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 6 | 3.07e-01 | 2.41e-01 | 9.87e-01 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 10 | 1.88e-01 | -2.41e-01 | 9.28e-01 |
| GOCC CORTICAL GRANULE | 6 | 3.07e-01 | -2.41e-01 | 9.87e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE TRANSPORT | 5 | 3.52e-01 | 2.41e-01 | 9.94e-01 |
| GOBP LEUCINE CATABOLIC PROCESS | 6 | 3.08e-01 | 2.41e-01 | 9.87e-01 |
| GOBP REGULATION OF INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 9 | 2.12e-01 | 2.40e-01 | 9.40e-01 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 13 | 1.34e-01 | 2.40e-01 | 8.96e-01 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 21 | 5.66e-02 | 2.40e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE | 8 | 2.39e-01 | -2.40e-01 | 9.55e-01 |
| GOBP MANGANESE ION TRANSPORT | 11 | 1.68e-01 | 2.40e-01 | 9.15e-01 |
| GOMF COMPLEMENT COMPONENT C3B BINDING | 9 | 2.12e-01 | -2.40e-01 | 9.40e-01 |
| GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING | 6 | 3.09e-01 | 2.40e-01 | 9.87e-01 |
| GOBP VALINE METABOLIC PROCESS | 7 | 2.72e-01 | 2.40e-01 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 10 | 1.89e-01 | -2.40e-01 | 9.28e-01 |
| GOMF MHC CLASS IB PROTEIN BINDING | 7 | 2.72e-01 | -2.40e-01 | 9.73e-01 |
| GOMF FK506 BINDING | 10 | 1.90e-01 | -2.39e-01 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT | 9 | 2.14e-01 | 2.39e-01 | 9.40e-01 |
| GOMF CHEMOKINE ACTIVITY | 45 | 5.54e-03 | -2.39e-01 | 4.49e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 27 | 3.16e-02 | 2.39e-01 | 7.07e-01 |
| GOBP POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY | 8 | 2.42e-01 | -2.39e-01 | 9.58e-01 |
| GOCC MYOSIN II COMPLEX | 26 | 3.50e-02 | -2.39e-01 | 7.25e-01 |
| GOBP REGULATION OF GLOMERULUS DEVELOPMENT | 5 | 3.55e-01 | -2.39e-01 | 9.95e-01 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 3.11e-01 | 2.39e-01 | 9.87e-01 |
| GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 8 | 2.43e-01 | -2.38e-01 | 9.58e-01 |
| GOMF PROTEIN PHOSPHATASE 2B BINDING | 6 | 3.12e-01 | 2.38e-01 | 9.87e-01 |
| GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION | 13 | 1.37e-01 | 2.38e-01 | 9.02e-01 |
| GOBP REGULATION OF OPSONIZATION | 10 | 1.92e-01 | -2.38e-01 | 9.28e-01 |
| GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY | 7 | 2.76e-01 | 2.38e-01 | 9.73e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 3.57e-01 | 2.38e-01 | 9.95e-01 |
| GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 2.76e-01 | 2.38e-01 | 9.73e-01 |
| GOBP NOREPINEPHRINE UPTAKE | 8 | 2.45e-01 | 2.38e-01 | 9.58e-01 |
| GOBP ACETATE ESTER METABOLIC PROCESS | 6 | 3.14e-01 | -2.38e-01 | 9.87e-01 |
| GOBP RESPONSE TO FOLIC ACID | 10 | 1.94e-01 | -2.37e-01 | 9.28e-01 |
| GOBP NITRIC OXIDE TRANSPORT | 5 | 3.59e-01 | 2.37e-01 | 9.95e-01 |
| GOMF ACTIVIN RECEPTOR BINDING | 8 | 2.46e-01 | -2.37e-01 | 9.58e-01 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 7 | 2.78e-01 | 2.37e-01 | 9.73e-01 |
| GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION | 13 | 1.40e-01 | 2.37e-01 | 9.02e-01 |
| GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 7 | 2.78e-01 | 2.37e-01 | 9.73e-01 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 21 | 6.08e-02 | 2.36e-01 | 7.94e-01 |
| GOBP NEURONAL ACTION POTENTIAL PROPAGATION | 9 | 2.19e-01 | -2.36e-01 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 8 | 2.47e-01 | -2.36e-01 | 9.58e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 23 | 5.01e-02 | -2.36e-01 | 7.77e-01 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 11 | 1.75e-01 | 2.36e-01 | 9.21e-01 |
| GOMF NEUROPEPTIDE BINDING | 31 | 2.30e-02 | 2.36e-01 | 6.46e-01 |
| GOBP URETERIC BUD ELONGATION | 8 | 2.48e-01 | 2.36e-01 | 9.58e-01 |
| GOBP REGULATION OF ALDOSTERONE METABOLIC PROCESS | 8 | 2.48e-01 | -2.36e-01 | 9.58e-01 |
| GOMF PROTEINASE ACTIVATED RECEPTOR ACTIVITY | 5 | 3.61e-01 | 2.36e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 5 | 3.62e-01 | -2.36e-01 | 9.95e-01 |
| GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 7 | 2.81e-01 | 2.35e-01 | 9.73e-01 |
| GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX | 9 | 2.22e-01 | 2.35e-01 | 9.45e-01 |
| GOBP UREA CYCLE | 10 | 1.98e-01 | 2.35e-01 | 9.36e-01 |
| GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT | 8 | 2.49e-01 | -2.35e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 13 | 1.42e-01 | -2.35e-01 | 9.02e-01 |
| GOBP GDP METABOLIC PROCESS | 9 | 2.22e-01 | -2.35e-01 | 9.45e-01 |
| GOBP PUTRESCINE METABOLIC PROCESS | 7 | 2.81e-01 | -2.35e-01 | 9.73e-01 |
| GOBP HEAT GENERATION | 17 | 9.33e-02 | 2.35e-01 | 8.55e-01 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 26 | 3.80e-02 | -2.35e-01 | 7.44e-01 |
| GOCC U5 SNRNP | 22 | 5.64e-02 | 2.35e-01 | 7.90e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 14 | 1.28e-01 | 2.35e-01 | 8.91e-01 |
| GOBP REGULATION OF SEROTONIN SECRETION | 6 | 3.19e-01 | 2.35e-01 | 9.87e-01 |
| GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 7 | 2.83e-01 | -2.35e-01 | 9.73e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 26 | 3.85e-02 | 2.34e-01 | 7.45e-01 |
| GOBP POLYAMINE METABOLIC PROCESS | 15 | 1.16e-01 | -2.34e-01 | 8.82e-01 |
| GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 6 | 3.20e-01 | 2.34e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 5 | 3.64e-01 | 2.34e-01 | 9.95e-01 |
| GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 8 | 2.51e-01 | 2.34e-01 | 9.58e-01 |
| GOBP SNRNA TRANSPORT | 6 | 3.20e-01 | -2.34e-01 | 9.87e-01 |
| GOCC ELASTIC FIBER | 5 | 3.64e-01 | 2.34e-01 | 9.95e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 6 | 3.20e-01 | -2.34e-01 | 9.87e-01 |
| GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 10 | 2.00e-01 | 2.34e-01 | 9.36e-01 |
| GOBP PROTEIN DEGLUTAMYLATION | 6 | 3.21e-01 | 2.34e-01 | 9.87e-01 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 24 | 4.72e-02 | 2.34e-01 | 7.65e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT | 18 | 8.57e-02 | 2.34e-01 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 24 | 4.73e-02 | -2.34e-01 | 7.65e-01 |
| GOBP HEME TRANSPORT | 9 | 2.25e-01 | 2.34e-01 | 9.49e-01 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 8.61e-02 | -2.34e-01 | 8.39e-01 |
| GOBP MESENDODERM DEVELOPMENT | 9 | 2.25e-01 | 2.34e-01 | 9.49e-01 |
| GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 10 | 2.01e-01 | -2.34e-01 | 9.36e-01 |
| GOMF AMINE BINDING | 11 | 1.80e-01 | 2.33e-01 | 9.26e-01 |
| GOBP REGULATION OF LYMPHANGIOGENESIS | 6 | 3.22e-01 | 2.33e-01 | 9.87e-01 |
| GOBP LUNG SACCULE DEVELOPMENT | 10 | 2.01e-01 | 2.33e-01 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 17 | 9.60e-02 | 2.33e-01 | 8.60e-01 |
| GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 6 | 3.23e-01 | -2.33e-01 | 9.87e-01 |
| GOMF ERBB 3 CLASS RECEPTOR BINDING | 5 | 3.67e-01 | -2.33e-01 | 9.95e-01 |
| GOBP TELOMERE TETHERING AT NUCLEAR PERIPHERY | 6 | 3.23e-01 | 2.33e-01 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL ACTIVATION | 6 | 3.23e-01 | -2.33e-01 | 9.87e-01 |
| GOMF ARGININE BINDING | 8 | 2.54e-01 | 2.33e-01 | 9.58e-01 |
| GOCC CIA COMPLEX | 5 | 3.68e-01 | 2.33e-01 | 9.95e-01 |
| GOBP AMINE CATABOLIC PROCESS | 15 | 1.19e-01 | -2.33e-01 | 8.83e-01 |
| GOBP UREA TRANSMEMBRANE TRANSPORT | 9 | 2.27e-01 | -2.32e-01 | 9.50e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION | 6 | 3.24e-01 | 2.32e-01 | 9.87e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 33 | 2.08e-02 | 2.32e-01 | 6.41e-01 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 42 | 9.15e-03 | 2.32e-01 | 5.54e-01 |
| GOMF WW DOMAIN BINDING | 22 | 5.92e-02 | 2.32e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 35 | 1.74e-02 | -2.32e-01 | 6.41e-01 |
| GOBP PHENOTYPIC SWITCHING | 16 | 1.08e-01 | 2.32e-01 | 8.72e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 5 | 3.69e-01 | 2.32e-01 | 9.95e-01 |
| GOBP HEART FIELD SPECIFICATION | 17 | 9.77e-02 | -2.32e-01 | 8.61e-01 |
| GOBP LYMPHOCYTE ANERGY | 7 | 2.88e-01 | 2.32e-01 | 9.75e-01 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 1.64e-01 | -2.32e-01 | 9.15e-01 |
| GOMF NERVE GROWTH FACTOR BINDING | 6 | 3.25e-01 | -2.32e-01 | 9.87e-01 |
| GOBP DCMP CATABOLIC PROCESS | 6 | 3.26e-01 | -2.32e-01 | 9.87e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 3.70e-01 | 2.32e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 10 | 2.05e-01 | 2.32e-01 | 9.36e-01 |
| GOBP RESPONSE TO STILBENOID | 8 | 2.57e-01 | -2.31e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 8 | 2.57e-01 | -2.31e-01 | 9.58e-01 |
| GOBP INSULIN METABOLIC PROCESS | 16 | 1.09e-01 | 2.31e-01 | 8.76e-01 |
| GOBP COPI COATED VESICLE BUDDING | 6 | 3.27e-01 | 2.31e-01 | 9.87e-01 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 25 | 4.54e-02 | 2.31e-01 | 7.59e-01 |
| GOBP SPERMIDINE METABOLIC PROCESS | 6 | 3.27e-01 | -2.31e-01 | 9.87e-01 |
| GOBP REGULATION OF TORC2 SIGNALING | 6 | 3.27e-01 | -2.31e-01 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 8 | 2.58e-01 | -2.31e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 9 | 2.30e-01 | 2.31e-01 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 19 | 8.14e-02 | 2.31e-01 | 8.36e-01 |
| GOMF CXCR3 CHEMOKINE RECEPTOR BINDING | 5 | 3.71e-01 | -2.31e-01 | 9.95e-01 |
| GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION | 6 | 3.27e-01 | -2.31e-01 | 9.87e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 29 | 3.15e-02 | 2.31e-01 | 7.07e-01 |
| GOBP ATRIAL CARDIAC MUSCLE TISSUE MORPHOGENESIS | 6 | 3.28e-01 | 2.31e-01 | 9.87e-01 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 15 | 1.22e-01 | 2.31e-01 | 8.86e-01 |
| GOBP LEUCINE TRANSPORT | 10 | 2.07e-01 | 2.30e-01 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 11 | 1.86e-01 | 2.30e-01 | 9.28e-01 |
| GOMF C METHYLTRANSFERASE ACTIVITY | 6 | 3.28e-01 | -2.30e-01 | 9.87e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 3.29e-01 | 2.30e-01 | 9.87e-01 |
| GOMF LYSOZYME ACTIVITY | 9 | 2.32e-01 | -2.30e-01 | 9.50e-01 |
| GOCC MANCHETTE | 16 | 1.11e-01 | -2.30e-01 | 8.77e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 22 | 6.17e-02 | -2.30e-01 | 7.98e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 2.92e-01 | 2.30e-01 | 9.79e-01 |
| GOBP REGULATION OF PROTON TRANSPORT | 16 | 1.12e-01 | 2.30e-01 | 8.77e-01 |
| GOBP MESODERMAL CELL MIGRATION | 5 | 3.74e-01 | 2.29e-01 | 9.95e-01 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 27 | 3.91e-02 | -2.29e-01 | 7.46e-01 |
| GOBP ZYMOGEN INHIBITION | 7 | 2.93e-01 | -2.29e-01 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 10 | 2.09e-01 | 2.29e-01 | 9.38e-01 |
| GOCC POLE PLASM | 24 | 5.20e-02 | 2.29e-01 | 7.81e-01 |
| GOBP TOOTH ERUPTION | 5 | 3.75e-01 | 2.29e-01 | 9.95e-01 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 39 | 1.34e-02 | -2.29e-01 | 6.15e-01 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 37 | 1.62e-02 | 2.28e-01 | 6.28e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY | 17 | 1.03e-01 | -2.28e-01 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 11 | 1.90e-01 | -2.28e-01 | 9.28e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 29 | 3.36e-02 | -2.28e-01 | 7.14e-01 |
| GOCC MICROTUBULE BUNDLE | 6 | 3.34e-01 | 2.28e-01 | 9.88e-01 |
| GOBP RESPONSE TO PARATHYROID HORMONE | 10 | 2.13e-01 | 2.28e-01 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF RELAXATION OF MUSCLE | 7 | 2.97e-01 | 2.28e-01 | 9.83e-01 |
| GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION | 15 | 1.27e-01 | 2.28e-01 | 8.91e-01 |
| GOBP SKELETAL MUSCLE THIN FILAMENT ASSEMBLY | 7 | 2.98e-01 | 2.27e-01 | 9.83e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 7 | 2.98e-01 | -2.27e-01 | 9.83e-01 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 44 | 9.14e-03 | 2.27e-01 | 5.54e-01 |
| GOBP RESPONSE TO CHEMOKINE | 93 | 1.54e-04 | -2.27e-01 | 6.31e-02 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 9 | 2.38e-01 | 2.27e-01 | 9.55e-01 |
| GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 16 | 1.16e-01 | 2.27e-01 | 8.82e-01 |
| GOBP AXON MIDLINE CHOICE POINT RECOGNITION | 5 | 3.80e-01 | 2.27e-01 | 9.95e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 3.37e-01 | -2.26e-01 | 9.88e-01 |
| GOBP AXONOGENESIS INVOLVED IN INNERVATION | 9 | 2.39e-01 | -2.26e-01 | 9.55e-01 |
| GOBP DNA STRAND ELONGATION | 36 | 1.88e-02 | 2.26e-01 | 6.41e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 25 | 5.03e-02 | 2.26e-01 | 7.79e-01 |
| GOBP RESPONSE TO CORTICOTROPIN RELEASING HORMONE | 5 | 3.81e-01 | 2.26e-01 | 9.95e-01 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 12 | 1.75e-01 | -2.26e-01 | 9.21e-01 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 14 | 1.43e-01 | 2.26e-01 | 9.02e-01 |
| GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION | 13 | 1.59e-01 | -2.26e-01 | 9.06e-01 |
| GOBP ALDITOL CATABOLIC PROCESS | 6 | 3.38e-01 | 2.26e-01 | 9.88e-01 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 21 | 7.33e-02 | -2.26e-01 | 8.11e-01 |
| GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 3.01e-01 | 2.26e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF PINOCYTOSIS | 5 | 3.82e-01 | -2.26e-01 | 9.95e-01 |
| GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS | 5 | 3.83e-01 | -2.25e-01 | 9.95e-01 |
| GOCC CENTRAL ELEMENT | 7 | 3.02e-01 | 2.25e-01 | 9.87e-01 |
| GOBP CARDIAC ATRIUM MORPHOGENESIS | 29 | 3.58e-02 | 2.25e-01 | 7.27e-01 |
| GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 2.70e-01 | -2.25e-01 | 9.72e-01 |
| GOBP RENAL VESICLE DEVELOPMENT | 18 | 9.84e-02 | 2.25e-01 | 8.63e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 22 | 6.77e-02 | -2.25e-01 | 7.99e-01 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 19 | 8.95e-02 | 2.25e-01 | 8.49e-01 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 13 | 1.60e-01 | 2.25e-01 | 9.06e-01 |
| GOBP SMOOTH MUSCLE ADAPTATION | 5 | 3.84e-01 | 2.25e-01 | 9.95e-01 |
| GOBP BICARBONATE TRANSPORT | 35 | 2.14e-02 | -2.25e-01 | 6.41e-01 |
| GOBP REGULATION OF LIPID TRANSPORTER ACTIVITY | 6 | 3.41e-01 | 2.25e-01 | 9.89e-01 |
| GOBP MOTOR NEURON MIGRATION | 13 | 1.61e-01 | 2.25e-01 | 9.08e-01 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 14 | 1.46e-01 | -2.24e-01 | 9.02e-01 |
| GOBP SENSORY PERCEPTION OF SOUR TASTE | 9 | 2.44e-01 | -2.24e-01 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 10 | 2.19e-01 | -2.24e-01 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 6 | 3.42e-01 | 2.24e-01 | 9.89e-01 |
| GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 9.98e-02 | -2.24e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF ACROSOME REACTION | 11 | 1.98e-01 | -2.24e-01 | 9.36e-01 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 40 | 1.43e-02 | 2.24e-01 | 6.25e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPSE ORGANIZATION | 11 | 1.99e-01 | -2.24e-01 | 9.36e-01 |
| GOBP INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE | 8 | 2.73e-01 | 2.24e-01 | 9.73e-01 |
| GOBP RETINAL BLOOD VESSEL MORPHOGENESIS | 5 | 3.86e-01 | 2.24e-01 | 9.95e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 12 | 1.80e-01 | -2.24e-01 | 9.26e-01 |
| GOMF RETINAL BINDING | 19 | 9.17e-02 | -2.23e-01 | 8.54e-01 |
| GOBP CELLULAR RESPONSE TO MAGNESIUM ION | 7 | 3.06e-01 | -2.23e-01 | 9.87e-01 |
| GOMF NEUROTROPHIN BINDING | 10 | 2.21e-01 | -2.23e-01 | 9.45e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 54 | 4.57e-03 | -2.23e-01 | 4.07e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 8 | 2.75e-01 | 2.23e-01 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 7 | 3.07e-01 | -2.23e-01 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION | 12 | 1.82e-01 | 2.22e-01 | 9.27e-01 |
| GOBP RESPONSE TO LITHIUM ION | 15 | 1.36e-01 | 2.22e-01 | 9.00e-01 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 17 | 1.12e-01 | 2.22e-01 | 8.77e-01 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 18 | 1.02e-01 | 2.22e-01 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE BY EPINEPHRINE NOREPINEPHRINE | 5 | 3.89e-01 | 2.22e-01 | 9.95e-01 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 27 | 4.57e-02 | -2.22e-01 | 7.60e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR BINDING | 11 | 2.02e-01 | 2.22e-01 | 9.36e-01 |
| GOBP RNA SECONDARY STRUCTURE UNWINDING | 8 | 2.77e-01 | -2.22e-01 | 9.73e-01 |
| GOCC OTHER ORGANISM PART | 5 | 3.90e-01 | -2.22e-01 | 9.95e-01 |
| GOMF OXYGEN SENSOR ACTIVITY | 5 | 3.90e-01 | 2.22e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 41 | 1.40e-02 | -2.22e-01 | 6.25e-01 |
| GOBP ANTIMICROBIAL PEPTIDE PRODUCTION | 11 | 2.03e-01 | -2.22e-01 | 9.36e-01 |
| GOCC INNER DYNEIN ARM | 5 | 3.91e-01 | 2.22e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 3.91e-01 | 2.22e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 6 | 3.47e-01 | 2.22e-01 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 29 | 3.89e-02 | 2.22e-01 | 7.46e-01 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 26 | 5.07e-02 | 2.21e-01 | 7.81e-01 |
| GOBP ENDOTHELIAL CELL FATE COMMITMENT | 8 | 2.78e-01 | 2.21e-01 | 9.73e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE A | 8 | 2.79e-01 | 2.21e-01 | 9.73e-01 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 37 | 2.00e-02 | -2.21e-01 | 6.41e-01 |
| GOBP POSITIVE REGULATION OF SODIUM PROTON ANTIPORTER ACTIVITY | 5 | 3.92e-01 | 2.21e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 3.12e-01 | 2.21e-01 | 9.87e-01 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 36 | 2.20e-02 | -2.21e-01 | 6.41e-01 |
| GOMF DELTA CATENIN BINDING | 9 | 2.52e-01 | -2.21e-01 | 9.58e-01 |
| GOCC GID COMPLEX | 5 | 3.93e-01 | -2.20e-01 | 9.95e-01 |
| GOBP SINOATRIAL NODE DEVELOPMENT | 12 | 1.86e-01 | 2.20e-01 | 9.28e-01 |
| GOBP REGULATION OF PRE MIRNA PROCESSING | 6 | 3.50e-01 | -2.20e-01 | 9.94e-01 |
| GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 3.94e-01 | 2.20e-01 | 9.95e-01 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 18 | 1.06e-01 | 2.20e-01 | 8.67e-01 |
| GOBP CORTISOL METABOLIC PROCESS | 12 | 1.87e-01 | -2.20e-01 | 9.28e-01 |
| GOCC UNCONVENTIONAL MYOSIN COMPLEX | 9 | 2.53e-01 | -2.20e-01 | 9.58e-01 |
| GOBP GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION | 5 | 3.94e-01 | 2.20e-01 | 9.95e-01 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 20 | 8.87e-02 | 2.20e-01 | 8.47e-01 |
| GOBP CHONDROBLAST DIFFERENTIATION | 5 | 3.95e-01 | 2.20e-01 | 9.95e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ACTIVITY | 7 | 3.14e-01 | -2.20e-01 | 9.87e-01 |
| GOBP ZINC ION IMPORT INTO ORGANELLE | 9 | 2.54e-01 | 2.20e-01 | 9.58e-01 |
| GOBP REGULATION OF XENOBIOTIC DETOXIFICATION BY TRANSMEMBRANE EXPORT ACROSS THE PLASMA MEMBRANE | 12 | 1.88e-01 | -2.20e-01 | 9.28e-01 |
| GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 11 | 2.07e-01 | -2.20e-01 | 9.38e-01 |
| GOBP ASTROCYTE CELL MIGRATION | 9 | 2.54e-01 | 2.20e-01 | 9.58e-01 |
| GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY | 8 | 2.83e-01 | -2.19e-01 | 9.73e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 43 | 1.28e-02 | 2.19e-01 | 6.11e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 9 | 2.55e-01 | -2.19e-01 | 9.58e-01 |
| GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 25 | 5.79e-02 | -2.19e-01 | 7.90e-01 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 63 | 2.64e-03 | 2.19e-01 | 3.18e-01 |
| GOMF I SMAD BINDING | 16 | 1.29e-01 | -2.19e-01 | 8.94e-01 |
| GOMF CXCR CHEMOKINE RECEPTOR BINDING | 18 | 1.08e-01 | -2.19e-01 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 11 | 2.09e-01 | 2.19e-01 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 41 | 1.54e-02 | 2.19e-01 | 6.25e-01 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 19 | 9.88e-02 | 2.19e-01 | 8.64e-01 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 74 | 1.14e-03 | 2.19e-01 | 2.03e-01 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 25 | 5.86e-02 | 2.19e-01 | 7.90e-01 |
| GOBP ACTIVATION OF MEIOSIS | 6 | 3.54e-01 | 2.19e-01 | 9.95e-01 |
| GOBP CILIARY NEUROTROPHIC FACTOR MEDIATED SIGNALING PATHWAY | 5 | 3.98e-01 | 2.18e-01 | 9.95e-01 |
| GOBP RESPONSE TO HUMAN CHORIONIC GONADOTROPIN | 5 | 3.98e-01 | -2.18e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 15 | 1.43e-01 | -2.18e-01 | 9.02e-01 |
| GOCC CONE PHOTORECEPTOR OUTER SEGMENT | 8 | 2.85e-01 | 2.18e-01 | 9.75e-01 |
| GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY | 6 | 3.55e-01 | -2.18e-01 | 9.95e-01 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 39 | 1.84e-02 | -2.18e-01 | 6.41e-01 |
| GOMF TRANSLATION ACTIVATOR ACTIVITY | 9 | 2.57e-01 | 2.18e-01 | 9.58e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 6 | 3.55e-01 | 2.18e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 15 | 1.44e-01 | 2.18e-01 | 9.02e-01 |
| GOBP FUNGIFORM PAPILLA DEVELOPMENT | 6 | 3.56e-01 | 2.18e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 8 | 2.86e-01 | 2.18e-01 | 9.75e-01 |
| GOBP MRNA POLYADENYLATION | 24 | 6.53e-02 | 2.17e-01 | 7.99e-01 |
| GOBP NOTOCHORD MORPHOGENESIS | 8 | 2.87e-01 | -2.17e-01 | 9.75e-01 |
| GOMF NATURAL KILLER CELL LECTIN LIKE RECEPTOR BINDING | 8 | 2.87e-01 | -2.17e-01 | 9.75e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 12 | 1.93e-01 | 2.17e-01 | 9.28e-01 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 51 | 7.32e-03 | 2.17e-01 | 5.13e-01 |
| GOBP RESPONSE TO SODIUM PHOSPHATE | 7 | 3.20e-01 | 2.17e-01 | 9.87e-01 |
| GOBP PHAGOSOME ACIDIFICATION | 7 | 3.20e-01 | 2.17e-01 | 9.87e-01 |
| GOBP REGULATION OF RELAXATION OF CARDIAC MUSCLE | 6 | 3.58e-01 | 2.17e-01 | 9.95e-01 |
| GOBP AORTA MORPHOGENESIS | 38 | 2.08e-02 | 2.17e-01 | 6.41e-01 |
| GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 6 | 3.58e-01 | -2.17e-01 | 9.95e-01 |
| GOMF PRERIBOSOME BINDING | 6 | 3.58e-01 | 2.17e-01 | 9.95e-01 |
| GOBP INTESTINAL HEXOSE ABSORPTION | 5 | 4.02e-01 | -2.17e-01 | 9.95e-01 |
| GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 5 | 4.02e-01 | 2.17e-01 | 9.95e-01 |
| GOBP HINDBRAIN MATURATION | 5 | 4.02e-01 | 2.17e-01 | 9.95e-01 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 70 | 1.74e-03 | 2.16e-01 | 2.65e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 49 | 8.76e-03 | 2.16e-01 | 5.47e-01 |
| GOBP PENILE ERECTION | 7 | 3.22e-01 | 2.16e-01 | 9.87e-01 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 16 | 1.34e-01 | 2.16e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION | 5 | 4.02e-01 | -2.16e-01 | 9.95e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 24 | 6.67e-02 | 2.16e-01 | 7.99e-01 |
| GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 15 | 1.47e-01 | -2.16e-01 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 12 | 1.95e-01 | -2.16e-01 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT | 7 | 3.22e-01 | 2.16e-01 | 9.87e-01 |
| GOBP OXYGEN METABOLIC PROCESS | 5 | 4.03e-01 | 2.16e-01 | 9.95e-01 |
| GOBP SEPTUM PRIMUM DEVELOPMENT | 5 | 4.03e-01 | 2.16e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 3.60e-01 | 2.16e-01 | 9.95e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY NITROGENOUS GROUP AS ACCEPTOR | 6 | 3.60e-01 | -2.16e-01 | 9.95e-01 |
| GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 3.61e-01 | -2.15e-01 | 9.95e-01 |
| GOMF RETINOL BINDING | 16 | 1.36e-01 | -2.15e-01 | 9.00e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 9 | 2.64e-01 | -2.15e-01 | 9.64e-01 |
| GOBP POST EMBRYONIC EYE MORPHOGENESIS | 7 | 3.24e-01 | 2.15e-01 | 9.87e-01 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 11 | 2.17e-01 | 2.15e-01 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 8 | 2.93e-01 | 2.15e-01 | 9.79e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 34 | 3.02e-02 | -2.15e-01 | 7.02e-01 |
| GOBP NADPH OXIDATION | 5 | 4.06e-01 | 2.15e-01 | 9.95e-01 |
| GOMF PROSTAGLANDIN E RECEPTOR ACTIVITY | 5 | 4.06e-01 | -2.14e-01 | 9.95e-01 |
| GOMF DNA METHYLTRANSFERASE ACTIVITY | 7 | 3.26e-01 | 2.14e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 15 | 1.51e-01 | 2.14e-01 | 9.04e-01 |
| GOBP ETHANOL METABOLIC PROCESS | 19 | 1.06e-01 | -2.14e-01 | 8.67e-01 |
| GOMF MYOSIN LIGHT CHAIN BINDING | 8 | 2.94e-01 | -2.14e-01 | 9.80e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS | 11 | 2.19e-01 | 2.14e-01 | 9.43e-01 |
| GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 12 | 1.99e-01 | 2.14e-01 | 9.36e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 10 | 2.41e-01 | -2.14e-01 | 9.57e-01 |
| GOMF MAP KINASE KINASE ACTIVITY | 17 | 1.27e-01 | 2.14e-01 | 8.91e-01 |
| GOBP INTERCELLULAR TRANSPORT | 10 | 2.41e-01 | -2.14e-01 | 9.57e-01 |
| GOBP LACTATE TRANSMEMBRANE TRANSPORT | 7 | 3.27e-01 | -2.14e-01 | 9.87e-01 |
| GOCC CELL TRAILING EDGE | 13 | 1.82e-01 | 2.14e-01 | 9.27e-01 |
| GOCC AXON HILLOCK | 7 | 3.27e-01 | 2.14e-01 | 9.87e-01 |
| GOBP CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION | 7 | 3.28e-01 | -2.14e-01 | 9.87e-01 |
| GOBP T HELPER 2 CELL CYTOKINE PRODUCTION | 12 | 2.01e-01 | 2.13e-01 | 9.36e-01 |
| GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX | 5 | 4.09e-01 | -2.13e-01 | 9.95e-01 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 14 | 1.67e-01 | -2.13e-01 | 9.15e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 3.66e-01 | 2.13e-01 | 9.95e-01 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 45 | 1.33e-02 | 2.13e-01 | 6.15e-01 |
| GOBP REGULATION OF NODAL SIGNALING PATHWAY | 9 | 2.68e-01 | 2.13e-01 | 9.69e-01 |
| GOBP CARDIAC MUSCLE TISSUE REGENERATION | 8 | 2.97e-01 | 2.13e-01 | 9.82e-01 |
| GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 13 | 1.83e-01 | -2.13e-01 | 9.28e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 11 | 2.21e-01 | -2.13e-01 | 9.45e-01 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 15 | 1.53e-01 | -2.13e-01 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF GROWTH HORMONE SECRETION | 9 | 2.69e-01 | -2.13e-01 | 9.71e-01 |
| GOMF AXON GUIDANCE RECEPTOR ACTIVITY | 10 | 2.44e-01 | -2.13e-01 | 9.58e-01 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 44 | 1.49e-02 | 2.12e-01 | 6.25e-01 |
| GOBP REGULATION OF BILE ACID SECRETION | 6 | 3.69e-01 | -2.12e-01 | 9.95e-01 |
| GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 2.04e-01 | -2.12e-01 | 9.36e-01 |
| GOBP INTERLEUKIN 13 PRODUCTION | 21 | 9.29e-02 | 2.12e-01 | 8.55e-01 |
| GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 14 | 1.70e-01 | -2.12e-01 | 9.20e-01 |
| GOMF ADRENERGIC RECEPTOR BINDING | 18 | 1.20e-01 | 2.12e-01 | 8.85e-01 |
| GOMF E BOX BINDING | 58 | 5.28e-03 | 2.12e-01 | 4.33e-01 |
| GOBP OXIDATIVE RNA DEMETHYLATION | 5 | 4.14e-01 | 2.11e-01 | 9.95e-01 |
| GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 4.14e-01 | 2.11e-01 | 9.95e-01 |
| GOBP FUSED ANTRUM STAGE | 6 | 3.71e-01 | 2.11e-01 | 9.95e-01 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 24 | 7.37e-02 | -2.11e-01 | 8.12e-01 |
| GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 4.14e-01 | -2.11e-01 | 9.95e-01 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 13 | 1.88e-01 | -2.11e-01 | 9.28e-01 |
| GOBP GOLGI DISASSEMBLY | 6 | 3.72e-01 | 2.11e-01 | 9.95e-01 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 63 | 3.86e-03 | 2.10e-01 | 3.61e-01 |
| GOCC PERICILIARY MEMBRANE COMPARTMENT | 5 | 4.15e-01 | -2.10e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 17 | 1.33e-01 | 2.10e-01 | 8.96e-01 |
| GOBP PLASMA MEMBRANE RAFT ASSEMBLY | 7 | 3.35e-01 | 2.10e-01 | 9.88e-01 |
| GOBP MATING BEHAVIOR | 36 | 2.89e-02 | 2.10e-01 | 6.89e-01 |
| GOBP SULFUR AMINO ACID TRANSPORT | 12 | 2.07e-01 | -2.10e-01 | 9.38e-01 |
| GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY | 8 | 3.03e-01 | 2.10e-01 | 9.87e-01 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 18 | 1.22e-01 | 2.10e-01 | 8.86e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 13 | 1.89e-01 | -2.10e-01 | 9.28e-01 |
| GOMF ALPHA CATENIN BINDING | 10 | 2.50e-01 | -2.10e-01 | 9.58e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 17 | 1.34e-01 | 2.10e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF PINOCYTOSIS | 7 | 3.36e-01 | 2.10e-01 | 9.88e-01 |
| GOBP EPOXIDE METABOLIC PROCESS | 5 | 4.16e-01 | 2.10e-01 | 9.95e-01 |
| GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 8 | 3.04e-01 | 2.10e-01 | 9.87e-01 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 24 | 7.53e-02 | 2.10e-01 | 8.18e-01 |
| GOBP REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT | 7 | 3.37e-01 | 2.10e-01 | 9.88e-01 |
| GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 9 | 2.76e-01 | -2.10e-01 | 9.73e-01 |
| GOCC BRUSH BORDER MEMBRANE | 57 | 6.18e-03 | -2.10e-01 | 4.68e-01 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 15 | 1.60e-01 | 2.10e-01 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 18 | 1.24e-01 | 2.10e-01 | 8.90e-01 |
| GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 7 | 3.37e-01 | 2.10e-01 | 9.88e-01 |
| GOBP HOST MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION | 9 | 2.77e-01 | -2.09e-01 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 7 | 3.37e-01 | 2.09e-01 | 9.88e-01 |
| GOBP REGULATION OF ENDOSOME SIZE | 13 | 1.91e-01 | 2.09e-01 | 9.28e-01 |
| GOMF CYCLASE INHIBITOR ACTIVITY | 5 | 4.18e-01 | -2.09e-01 | 9.95e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE SIGNALING | 7 | 3.39e-01 | -2.09e-01 | 9.88e-01 |
| GOBP HAIR CYCLE PHASE | 9 | 2.78e-01 | 2.09e-01 | 9.73e-01 |
| GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 6 | 3.76e-01 | -2.09e-01 | 9.95e-01 |
| GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.19e-01 | -2.09e-01 | 9.95e-01 |
| GOCC FILTRATION DIAPHRAGM | 8 | 3.07e-01 | -2.09e-01 | 9.87e-01 |
| GOBP REGULATION OF ENDOTHELIAL TUBE MORPHOGENESIS | 6 | 3.76e-01 | -2.09e-01 | 9.95e-01 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 4.19e-01 | 2.09e-01 | 9.95e-01 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 14 | 1.77e-01 | -2.09e-01 | 9.21e-01 |
| GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 9 | 2.79e-01 | 2.09e-01 | 9.73e-01 |
| GOBP STRIATED MUSCLE ATROPHY | 7 | 3.39e-01 | 2.09e-01 | 9.88e-01 |
| GOBP GLYCOSIDE CATABOLIC PROCESS | 8 | 3.07e-01 | -2.08e-01 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 28 | 5.63e-02 | 2.08e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 15 | 1.62e-01 | -2.08e-01 | 9.12e-01 |
| GOMF SUMO POLYMER BINDING | 5 | 4.20e-01 | -2.08e-01 | 9.95e-01 |
| GOCC SCHMIDT LANTERMAN INCISURE | 11 | 2.32e-01 | 2.08e-01 | 9.50e-01 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 72 | 2.25e-03 | 2.08e-01 | 2.95e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 12 | 2.12e-01 | 2.08e-01 | 9.40e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN PARTURITION | 5 | 4.20e-01 | -2.08e-01 | 9.95e-01 |
| GOCC SPHERICAL HIGH DENSITY LIPOPROTEIN PARTICLE | 8 | 3.08e-01 | -2.08e-01 | 9.87e-01 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 23 | 8.42e-02 | 2.08e-01 | 8.39e-01 |
| GOBP REGULATION OF HELICASE ACTIVITY | 10 | 2.55e-01 | 2.08e-01 | 9.58e-01 |
| GOBP LIPID DROPLET DISASSEMBLY | 6 | 3.78e-01 | 2.08e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION | 7 | 3.41e-01 | 2.08e-01 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 9.95e-02 | -2.08e-01 | 8.64e-01 |
| GOBP CARDIAC VENTRICLE FORMATION | 8 | 3.09e-01 | 2.08e-01 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 9 | 2.81e-01 | -2.07e-01 | 9.73e-01 |
| GOBP SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION | 10 | 2.56e-01 | 2.07e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 12 | 2.14e-01 | 2.07e-01 | 9.40e-01 |
| GOBP ELASTIN METABOLIC PROCESS | 8 | 3.10e-01 | 2.07e-01 | 9.87e-01 |
| GOBP GOLGI LUMEN ACIDIFICATION | 10 | 2.56e-01 | 2.07e-01 | 9.58e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN D | 5 | 4.22e-01 | 2.07e-01 | 9.95e-01 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 14 | 1.80e-01 | 2.07e-01 | 9.25e-01 |
| GOBP RESPONSE TO CORTISOL | 6 | 3.80e-01 | -2.07e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 10 | 2.57e-01 | 2.07e-01 | 9.58e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 2.57e-01 | 2.07e-01 | 9.58e-01 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 23 | 8.58e-02 | -2.07e-01 | 8.39e-01 |
| GOBP VOCALIZATION BEHAVIOR | 15 | 1.65e-01 | -2.07e-01 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 5 | 4.23e-01 | -2.07e-01 | 9.95e-01 |
| GOMF HEMOGLOBIN BINDING | 9 | 2.83e-01 | -2.07e-01 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 12 | 2.15e-01 | 2.07e-01 | 9.42e-01 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 21 | 1.01e-01 | 2.07e-01 | 8.66e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 10 | 2.58e-01 | -2.07e-01 | 9.58e-01 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 18 | 1.29e-01 | -2.06e-01 | 8.94e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION | 5 | 4.24e-01 | -2.06e-01 | 9.95e-01 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 11 | 2.36e-01 | 2.06e-01 | 9.52e-01 |
| GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 8 | 3.12e-01 | 2.06e-01 | 9.87e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT | 10 | 2.59e-01 | 2.06e-01 | 9.58e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 8 | 3.12e-01 | -2.06e-01 | 9.87e-01 |
| GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 8 | 3.12e-01 | -2.06e-01 | 9.87e-01 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 11 | 2.37e-01 | -2.06e-01 | 9.52e-01 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 15 | 1.67e-01 | 2.06e-01 | 9.15e-01 |
| GOBP GUANINE NUCLEOTIDE TRANSPORT | 9 | 2.85e-01 | 2.06e-01 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 10 | 2.59e-01 | 2.06e-01 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION | 5 | 4.25e-01 | -2.06e-01 | 9.95e-01 |
| GOMF DESUMOYLASE ACTIVITY | 7 | 3.45e-01 | -2.06e-01 | 9.92e-01 |
| GOBP DETECTION OF MUSCLE STRETCH | 7 | 3.46e-01 | -2.06e-01 | 9.92e-01 |
| GOBP REGULATION OF HISTONE H3 K4 METHYLATION | 11 | 2.37e-01 | 2.06e-01 | 9.53e-01 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 88 | 8.54e-04 | 2.06e-01 | 1.80e-01 |
| GOCC DENDRITE MEMBRANE | 36 | 3.27e-02 | 2.06e-01 | 7.07e-01 |
| GOBP POSITIVE REGULATION OF CILIUM MOVEMENT | 11 | 2.38e-01 | -2.06e-01 | 9.53e-01 |
| GOBP REGULATION OF SOMITOGENESIS | 6 | 3.83e-01 | 2.05e-01 | 9.95e-01 |
| GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 2.86e-01 | 2.05e-01 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 14 | 1.83e-01 | 2.05e-01 | 9.28e-01 |
| GOBP NEURAL CREST FORMATION | 15 | 1.69e-01 | 2.05e-01 | 9.17e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 24 | 8.21e-02 | -2.05e-01 | 8.38e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY | 11 | 2.39e-01 | -2.05e-01 | 9.55e-01 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 9 | 2.87e-01 | -2.05e-01 | 9.75e-01 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 20 | 1.13e-01 | -2.05e-01 | 8.78e-01 |
| GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 8 | 3.16e-01 | 2.05e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 18 | 1.33e-01 | 2.05e-01 | 8.96e-01 |
| GOBP LIPOXYGENASE PATHWAY | 11 | 2.40e-01 | -2.05e-01 | 9.56e-01 |
| GOBP GLANDULAR EPITHELIAL CELL MATURATION | 9 | 2.88e-01 | 2.05e-01 | 9.75e-01 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 35 | 3.63e-02 | 2.04e-01 | 7.30e-01 |
| GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS | 14 | 1.85e-01 | 2.04e-01 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 6 | 3.86e-01 | 2.04e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 11 | 2.41e-01 | -2.04e-01 | 9.57e-01 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 32 | 4.56e-02 | 2.04e-01 | 7.59e-01 |
| GOCC SEPTIN CYTOSKELETON | 14 | 1.86e-01 | 2.04e-01 | 9.28e-01 |
| GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY | 5 | 4.29e-01 | -2.04e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 9 | 2.89e-01 | 2.04e-01 | 9.77e-01 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 23 | 9.04e-02 | 2.04e-01 | 8.53e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 9 | 2.89e-01 | 2.04e-01 | 9.77e-01 |
| GOBP RESPONSE TO LECTIN | 21 | 1.06e-01 | 2.04e-01 | 8.67e-01 |
| GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 3.18e-01 | -2.04e-01 | 9.87e-01 |
| GOBP UREA TRANSPORT | 11 | 2.42e-01 | -2.04e-01 | 9.58e-01 |
| GOBP MESENCHYMAL CELL APOPTOTIC PROCESS | 15 | 1.72e-01 | 2.04e-01 | 9.21e-01 |
| GOBP CLUSTERING OF VOLTAGE GATED SODIUM CHANNELS | 6 | 3.88e-01 | -2.03e-01 | 9.95e-01 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 30 | 5.40e-02 | 2.03e-01 | 7.87e-01 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 37 | 3.24e-02 | 2.03e-01 | 7.07e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 8 | 3.20e-01 | -2.03e-01 | 9.87e-01 |
| GOBP RESPONSE TO PHEROMONE | 7 | 3.52e-01 | -2.03e-01 | 9.94e-01 |
| GOBP EGG ACTIVATION | 11 | 2.44e-01 | -2.03e-01 | 9.58e-01 |
| GOMF SYNDECAN BINDING | 5 | 4.32e-01 | -2.03e-01 | 9.95e-01 |
| GOBP STRIATUM DEVELOPMENT | 20 | 1.16e-01 | -2.03e-01 | 8.82e-01 |
| GOMF TASTE RECEPTOR ACTIVITY | 29 | 5.87e-02 | 2.03e-01 | 7.90e-01 |
| GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 8 | 3.22e-01 | -2.02e-01 | 9.87e-01 |
| GOBP DETECTION OF OTHER ORGANISM | 19 | 1.27e-01 | -2.02e-01 | 8.91e-01 |
| GOCC A BAND | 33 | 4.44e-02 | -2.02e-01 | 7.59e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 4.34e-01 | 2.02e-01 | 9.95e-01 |
| GOBP RESPONSE TO THYROXINE | 5 | 4.34e-01 | 2.02e-01 | 9.95e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 21 | 1.09e-01 | -2.02e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF ATP BIOSYNTHETIC PROCESS | 5 | 4.35e-01 | -2.02e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 22 | 1.01e-01 | 2.02e-01 | 8.66e-01 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 20 | 1.19e-01 | 2.02e-01 | 8.83e-01 |
| GOBP BIOLOGICAL PHASE | 11 | 2.47e-01 | 2.02e-01 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 4.35e-01 | 2.02e-01 | 9.95e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 18 | 1.39e-01 | -2.02e-01 | 9.02e-01 |
| GOBP INDOLALKYLAMINE METABOLIC PROCESS | 11 | 2.47e-01 | -2.01e-01 | 9.58e-01 |
| GOBP TRNA TRANSCRIPTION | 11 | 2.47e-01 | 2.01e-01 | 9.58e-01 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 31 | 5.23e-02 | 2.01e-01 | 7.81e-01 |
| GOBP GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS | 6 | 3.93e-01 | 2.01e-01 | 9.95e-01 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 2.70e-01 | 2.01e-01 | 9.72e-01 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 27 | 7.03e-02 | -2.01e-01 | 8.00e-01 |
| GOBP REGULATION OF FEAR RESPONSE | 9 | 2.96e-01 | -2.01e-01 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE | 8 | 3.25e-01 | 2.01e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 7 | 3.57e-01 | 2.01e-01 | 9.95e-01 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 73 | 3.00e-03 | 2.01e-01 | 3.30e-01 |
| GOBP ENDOCRINE PROCESS | 87 | 1.21e-03 | -2.01e-01 | 2.10e-01 |
| GOBP GDP MANNOSE METABOLIC PROCESS | 7 | 3.58e-01 | -2.01e-01 | 9.95e-01 |
| GOBP RESPONSE TO INTERLEUKIN 12 | 12 | 2.29e-01 | 2.01e-01 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 56 | 9.41e-03 | -2.01e-01 | 5.57e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 12 | 2.29e-01 | 2.00e-01 | 9.50e-01 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 23 | 9.61e-02 | -2.00e-01 | 8.61e-01 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 15 | 1.79e-01 | -2.00e-01 | 9.23e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 14 | 1.94e-01 | 2.00e-01 | 9.28e-01 |
| GOMF TESTOSTERONE 17 BETA DEHYDROGENASE NADPPLUS ACTIVITY | 9 | 2.98e-01 | -2.00e-01 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 9 | 2.98e-01 | 2.00e-01 | 9.83e-01 |
| GOCC U1 SNRNP | 19 | 1.31e-01 | 2.00e-01 | 8.96e-01 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 40 | 2.85e-02 | 2.00e-01 | 6.86e-01 |
| GOBP OBSERVATIONAL LEARNING | 7 | 3.60e-01 | -2.00e-01 | 9.95e-01 |
| GOBP SECONDARY HEART FIELD SPECIFICATION | 11 | 2.51e-01 | -2.00e-01 | 9.58e-01 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 7 | 3.60e-01 | -2.00e-01 | 9.95e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 62 | 6.54e-03 | -2.00e-01 | 4.74e-01 |
| GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 9 | 3.00e-01 | 2.00e-01 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 3.28e-01 | -2.00e-01 | 9.87e-01 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 21 | 1.13e-01 | 2.00e-01 | 8.79e-01 |
| GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 3.97e-01 | 1.99e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 33 | 4.74e-02 | 1.99e-01 | 7.65e-01 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 21 | 1.14e-01 | 1.99e-01 | 8.80e-01 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 12 | 2.33e-01 | 1.99e-01 | 9.50e-01 |
| GOCC MEMBRANE ATTACK COMPLEX | 7 | 3.62e-01 | -1.99e-01 | 9.95e-01 |
| GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H | 6 | 3.99e-01 | -1.99e-01 | 9.95e-01 |
| GOBP HYDROCARBON METABOLIC PROCESS | 7 | 3.63e-01 | -1.99e-01 | 9.95e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 21 | 1.15e-01 | -1.99e-01 | 8.81e-01 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 19 | 1.34e-01 | -1.99e-01 | 8.96e-01 |
| GOCC TORC1 COMPLEX | 6 | 4.00e-01 | 1.99e-01 | 9.95e-01 |
| GOMF TAT PROTEIN BINDING | 10 | 2.77e-01 | -1.99e-01 | 9.73e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 25 | 8.59e-02 | -1.98e-01 | 8.39e-01 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 8 | 3.31e-01 | 1.98e-01 | 9.88e-01 |
| GOMF COMPLEMENT COMPONENT C1Q COMPLEX BINDING | 8 | 3.31e-01 | -1.98e-01 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 3.31e-01 | 1.98e-01 | 9.88e-01 |
| GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 2.55e-01 | 1.98e-01 | 9.58e-01 |
| GOBP MIRNA CATABOLIC PROCESS | 18 | 1.46e-01 | -1.98e-01 | 9.02e-01 |
| GOMF PHOSPHATIDYLCHOLINE STEROL O ACYLTRANSFERASE ACTIVATOR ACTIVITY | 6 | 4.01e-01 | -1.98e-01 | 9.95e-01 |
| GOBP PERICARDIUM MORPHOGENESIS | 8 | 3.32e-01 | 1.98e-01 | 9.88e-01 |
| GOCC SEX CHROMOSOME | 33 | 4.92e-02 | 1.98e-01 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 15 | 1.85e-01 | -1.98e-01 | 9.28e-01 |
| GOBP COMPARTMENT PATTERN SPECIFICATION | 5 | 4.44e-01 | 1.98e-01 | 9.95e-01 |
| GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 9 | 3.04e-01 | 1.98e-01 | 9.87e-01 |
| GOBP PROTEIN HEXAMERIZATION | 9 | 3.05e-01 | 1.98e-01 | 9.87e-01 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 11 | 2.56e-01 | -1.98e-01 | 9.58e-01 |
| GOMF BH DOMAIN BINDING | 9 | 3.05e-01 | 1.98e-01 | 9.87e-01 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 6 | 4.02e-01 | 1.97e-01 | 9.95e-01 |
| GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 2.80e-01 | -1.97e-01 | 9.73e-01 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 22 | 1.09e-01 | -1.97e-01 | 8.76e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 4.03e-01 | -1.97e-01 | 9.95e-01 |
| GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 3.34e-01 | -1.97e-01 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 7 | 3.66e-01 | 1.97e-01 | 9.95e-01 |
| GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 5 | 4.45e-01 | -1.97e-01 | 9.95e-01 |
| GOBP G2 MI TRANSITION OF MEIOTIC CELL CYCLE | 7 | 3.67e-01 | -1.97e-01 | 9.95e-01 |
| GOBP NUCLEOTIDE SALVAGE | 17 | 1.60e-01 | 1.97e-01 | 9.06e-01 |
| GOMF FOLIC ACID BINDING | 13 | 2.19e-01 | 1.97e-01 | 9.43e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 6 | 4.04e-01 | 1.97e-01 | 9.95e-01 |
| GOBP T CELL EXTRAVASATION | 10 | 2.81e-01 | -1.97e-01 | 9.73e-01 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 13 | 2.19e-01 | 1.97e-01 | 9.43e-01 |
| GOBP REGULATION OF T CIRCLE FORMATION | 5 | 4.46e-01 | -1.97e-01 | 9.95e-01 |
| GOBP LACRIMAL GLAND DEVELOPMENT | 7 | 3.67e-01 | 1.97e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 13 | 2.19e-01 | 1.97e-01 | 9.43e-01 |
| GOBP NEURON FATE SPECIFICATION | 34 | 4.72e-02 | 1.97e-01 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 26 | 8.26e-02 | 1.97e-01 | 8.38e-01 |
| GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 6 | 4.04e-01 | 1.97e-01 | 9.95e-01 |
| GOBP PRIMITIVE HEMOPOIESIS | 8 | 3.36e-01 | 1.97e-01 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 21 | 1.19e-01 | -1.97e-01 | 8.83e-01 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 15 | 1.87e-01 | 1.97e-01 | 9.28e-01 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 13 | 2.20e-01 | -1.97e-01 | 9.43e-01 |
| GOMF ARYL HYDROCARBON RECEPTOR BINDING | 8 | 3.36e-01 | -1.97e-01 | 9.88e-01 |
| GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT | 7 | 3.68e-01 | -1.96e-01 | 9.95e-01 |
| GOBP SIGNAL COMPLEX ASSEMBLY | 8 | 3.36e-01 | 1.96e-01 | 9.88e-01 |
| GOMF PRIMARY MIRNA BINDING | 9 | 3.08e-01 | -1.96e-01 | 9.87e-01 |
| GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY | 7 | 3.69e-01 | 1.96e-01 | 9.95e-01 |
| GOCC COMPACT MYELIN | 14 | 2.04e-01 | 1.96e-01 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 10 | 2.83e-01 | 1.96e-01 | 9.73e-01 |
| GOBP PH REDUCTION | 6 | 4.06e-01 | -1.96e-01 | 9.95e-01 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 46 | 2.14e-02 | 1.96e-01 | 6.41e-01 |
| GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 16 | 1.75e-01 | 1.96e-01 | 9.21e-01 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 16 | 1.75e-01 | -1.96e-01 | 9.21e-01 |
| GOCC XY BODY | 15 | 1.89e-01 | 1.96e-01 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 10 | 2.83e-01 | 1.96e-01 | 9.73e-01 |
| GOCC ER UBIQUITIN LIGASE COMPLEX | 9 | 3.09e-01 | -1.96e-01 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL REMODELING | 6 | 4.06e-01 | 1.96e-01 | 9.95e-01 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 24 | 9.69e-02 | -1.96e-01 | 8.61e-01 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 21 | 1.21e-01 | -1.96e-01 | 8.86e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 47 | 2.03e-02 | 1.96e-01 | 6.41e-01 |
| GOCC NEUROFILAMENT | 9 | 3.09e-01 | -1.96e-01 | 9.87e-01 |
| GOBP ACROSOME ASSEMBLY | 27 | 7.85e-02 | -1.96e-01 | 8.27e-01 |
| GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY | 8 | 3.38e-01 | 1.96e-01 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 11 | 2.61e-01 | 1.96e-01 | 9.62e-01 |
| GOBP FUCOSE METABOLIC PROCESS | 16 | 1.76e-01 | 1.96e-01 | 9.21e-01 |
| GOMF UBIQUINONE BINDING | 5 | 4.49e-01 | 1.95e-01 | 9.95e-01 |
| GOBP LUNG SECRETORY CELL DIFFERENTIATION | 11 | 2.62e-01 | -1.95e-01 | 9.63e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 18 | 1.51e-01 | 1.95e-01 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 7 | 3.71e-01 | 1.95e-01 | 9.95e-01 |
| GOBP INTRACELLULAR PH REDUCTION | 50 | 1.69e-02 | 1.95e-01 | 6.37e-01 |
| GOMF FERRIC IRON BINDING | 9 | 3.11e-01 | -1.95e-01 | 9.87e-01 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 16 | 1.77e-01 | -1.95e-01 | 9.21e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 8 | 3.40e-01 | 1.95e-01 | 9.88e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 15 | 1.91e-01 | 1.95e-01 | 9.28e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 9 | 3.11e-01 | 1.95e-01 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 15 | 1.91e-01 | -1.95e-01 | 9.28e-01 |
| GOMF RETINAL DEHYDROGENASE ACTIVITY | 8 | 3.40e-01 | -1.95e-01 | 9.88e-01 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 20 | 1.31e-01 | 1.95e-01 | 8.96e-01 |
| GOBP ENTERIC NERVOUS SYSTEM DEVELOPMENT | 12 | 2.43e-01 | 1.95e-01 | 9.58e-01 |
| GOCC DENDRITIC GROWTH CONE | 8 | 3.40e-01 | 1.95e-01 | 9.88e-01 |
| GOBP RESPONSE TO ATP | 31 | 6.06e-02 | 1.95e-01 | 7.94e-01 |
| GOBP VESTIBULOCOCHLEAR NERVE DEVELOPMENT | 11 | 2.64e-01 | 1.95e-01 | 9.64e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED PTERIDINE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 7 | 3.73e-01 | -1.95e-01 | 9.95e-01 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 20 | 1.32e-01 | -1.94e-01 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPSE ASSEMBLY | 8 | 3.41e-01 | -1.94e-01 | 9.89e-01 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 1.93e-01 | 1.94e-01 | 9.28e-01 |
| GOBP LUNG GROWTH | 6 | 4.10e-01 | 1.94e-01 | 9.95e-01 |
| GOCC TORC2 COMPLEX | 9 | 3.13e-01 | 1.94e-01 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 21 | 1.24e-01 | 1.94e-01 | 8.90e-01 |
| GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR | 9 | 3.13e-01 | 1.94e-01 | 9.87e-01 |
| GOBP ANDROGEN METABOLIC PROCESS | 29 | 7.06e-02 | -1.94e-01 | 8.00e-01 |
| GOBP RESPONSE TO AMPHETAMINE | 29 | 7.06e-02 | -1.94e-01 | 8.00e-01 |
| GOBP SUCCINATE TRANSMEMBRANE TRANSPORT | 6 | 4.11e-01 | 1.94e-01 | 9.95e-01 |
| GOMF SUCCINATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.11e-01 | 1.94e-01 | 9.95e-01 |
| GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 24 | 1.00e-01 | 1.94e-01 | 8.65e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 4.11e-01 | 1.94e-01 | 9.95e-01 |
| GOMF PROTEIN ANTIGEN BINDING | 7 | 3.75e-01 | 1.94e-01 | 9.95e-01 |
| GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY | 15 | 1.94e-01 | -1.94e-01 | 9.28e-01 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 11 | 2.67e-01 | 1.93e-01 | 9.68e-01 |
| GOCC STEREOCILIUM BASE | 5 | 4.54e-01 | -1.93e-01 | 9.95e-01 |
| GOBP ACETYL COA METABOLIC PROCESS | 31 | 6.25e-02 | 1.93e-01 | 7.98e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING AV NODE CELL ACTION POTENTIAL | 6 | 4.13e-01 | -1.93e-01 | 9.95e-01 |
| GOBP PROTEIN POLYUFMYLATION | 5 | 4.55e-01 | -1.93e-01 | 9.95e-01 |
| GOBP REACTIVE GLIOSIS | 6 | 4.13e-01 | -1.93e-01 | 9.95e-01 |
| GOCC ORIGIN RECOGNITION COMPLEX | 9 | 3.16e-01 | 1.93e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 9 | 3.16e-01 | 1.93e-01 | 9.87e-01 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 17 | 1.68e-01 | 1.93e-01 | 9.16e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 41 | 3.26e-02 | 1.93e-01 | 7.07e-01 |
| GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 12 | 2.47e-01 | -1.93e-01 | 9.58e-01 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 14 | 2.12e-01 | -1.93e-01 | 9.40e-01 |
| GOCC BRISC COMPLEX | 5 | 4.55e-01 | -1.93e-01 | 9.95e-01 |
| GOCC FILAMENTOUS ACTIN | 28 | 7.75e-02 | -1.93e-01 | 8.25e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 16 | 1.82e-01 | 1.93e-01 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 50 | 1.84e-02 | 1.93e-01 | 6.41e-01 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 30 | 6.78e-02 | 1.93e-01 | 7.99e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 5 | 4.56e-01 | 1.93e-01 | 9.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 5 | 4.56e-01 | -1.93e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 16 | 1.83e-01 | -1.92e-01 | 9.27e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 10 | 2.92e-01 | 1.92e-01 | 9.79e-01 |
| GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 23 | 1.10e-01 | -1.92e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 7 | 3.78e-01 | -1.92e-01 | 9.95e-01 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 21 | 1.27e-01 | 1.92e-01 | 8.91e-01 |
| GOBP SYNAPTIC VESICLE COATING | 5 | 4.57e-01 | -1.92e-01 | 9.95e-01 |
| GOBP NEURAL PLATE MORPHOGENESIS | 5 | 4.57e-01 | -1.92e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 5 | 4.57e-01 | -1.92e-01 | 9.95e-01 |
| GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 6 | 4.16e-01 | 1.92e-01 | 9.95e-01 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 18 | 1.59e-01 | -1.92e-01 | 9.06e-01 |
| GOBP TONIC SMOOTH MUSCLE CONTRACTION | 11 | 2.71e-01 | -1.92e-01 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION OF STAT PROTEIN | 16 | 1.84e-01 | 1.92e-01 | 9.28e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 7 | 3.80e-01 | 1.92e-01 | 9.95e-01 |
| GOMF N ACYLSPHINGOSINE AMIDOHYDROLASE ACTIVITY | 7 | 3.80e-01 | 1.92e-01 | 9.95e-01 |
| GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS | 6 | 4.16e-01 | -1.92e-01 | 9.95e-01 |
| GOBP LOOP OF HENLE DEVELOPMENT | 12 | 2.50e-01 | 1.92e-01 | 9.58e-01 |
| GOBP MONOCYTE ACTIVATION | 12 | 2.50e-01 | 1.92e-01 | 9.58e-01 |
| GOBP TELOMERE CAPPING | 39 | 3.84e-02 | 1.92e-01 | 7.45e-01 |
| GOBP CLEAVAGE FURROW FORMATION | 7 | 3.80e-01 | -1.92e-01 | 9.95e-01 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 15 | 1.99e-01 | 1.91e-01 | 9.36e-01 |
| GOBP MITOCHONDRION MORPHOGENESIS | 20 | 1.39e-01 | -1.91e-01 | 9.02e-01 |
| GOBP B CELL LINEAGE COMMITMENT | 6 | 4.17e-01 | 1.91e-01 | 9.95e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 18 | 1.60e-01 | 1.91e-01 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN LIPASE ACTIVITY | 8 | 3.49e-01 | 1.91e-01 | 9.94e-01 |
| GOCC ANNULATE LAMELLAE | 5 | 4.60e-01 | 1.91e-01 | 9.95e-01 |
| GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 5 | 4.60e-01 | 1.91e-01 | 9.95e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 17 | 1.73e-01 | -1.91e-01 | 9.21e-01 |
| GOBP AMYLOID FIBRIL FORMATION | 38 | 4.20e-02 | -1.91e-01 | 7.56e-01 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 6 | 4.19e-01 | -1.91e-01 | 9.95e-01 |
| GOMF EXTRACELLULAR MATRIX PROTEIN BINDING | 6 | 4.19e-01 | 1.91e-01 | 9.95e-01 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 2.74e-01 | -1.90e-01 | 9.73e-01 |
| GOBP ARTICULAR CARTILAGE DEVELOPMENT | 5 | 4.61e-01 | -1.90e-01 | 9.95e-01 |
| GOMF URATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.23e-01 | -1.90e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 24 | 1.06e-01 | 1.90e-01 | 8.68e-01 |
| GOBP RESPONSE TO MANGANESE ION | 17 | 1.74e-01 | -1.90e-01 | 9.21e-01 |
| GOBP FOAM CELL DIFFERENTIATION | 41 | 3.50e-02 | -1.90e-01 | 7.25e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 5 | 4.61e-01 | 1.90e-01 | 9.95e-01 |
| GOBP ENDOCARDIAL CELL DIFFERENTIATION | 6 | 4.20e-01 | -1.90e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDOGLYCAN | 6 | 4.20e-01 | -1.90e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SARCOMERE ORGANIZATION | 6 | 4.20e-01 | 1.90e-01 | 9.95e-01 |
| GOMF MANNOSE BINDING | 24 | 1.07e-01 | -1.90e-01 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 6 | 4.20e-01 | -1.90e-01 | 9.95e-01 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 4.62e-01 | -1.90e-01 | 9.95e-01 |
| GOBP REGULATION OF ASYMMETRIC CELL DIVISION | 5 | 4.62e-01 | 1.90e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 9 | 3.24e-01 | -1.90e-01 | 9.87e-01 |
| GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY | 7 | 3.84e-01 | 1.90e-01 | 9.95e-01 |
| GOBP DETECTION OF CELL DENSITY | 9 | 3.24e-01 | -1.90e-01 | 9.87e-01 |
| GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 2.99e-01 | -1.90e-01 | 9.84e-01 |
| GOBP RESPONSE TO ETHER | 11 | 2.76e-01 | -1.90e-01 | 9.73e-01 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 35 | 5.21e-02 | -1.90e-01 | 7.81e-01 |
| GOBP NEGATIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 5 | 4.63e-01 | 1.90e-01 | 9.95e-01 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 31 | 6.76e-02 | -1.90e-01 | 7.99e-01 |
| GOBP REGULATION OF METANEPHROS DEVELOPMENT | 5 | 4.63e-01 | -1.90e-01 | 9.95e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 5 | 4.63e-01 | 1.90e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 12 | 2.56e-01 | -1.89e-01 | 9.58e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 10 | 3.00e-01 | -1.89e-01 | 9.85e-01 |
| GOBP AGGRESOME ASSEMBLY | 5 | 4.63e-01 | -1.89e-01 | 9.95e-01 |
| GOMF U1 SNRNP BINDING | 6 | 4.22e-01 | 1.89e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST | 6 | 4.22e-01 | 1.89e-01 | 9.95e-01 |
| GOBP VENTRAL MIDLINE DEVELOPMENT | 6 | 4.22e-01 | 1.89e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 12 | 2.57e-01 | -1.89e-01 | 9.58e-01 |
| GOBP TELOMERE LOCALIZATION | 12 | 2.57e-01 | 1.89e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 8 | 3.55e-01 | 1.89e-01 | 9.95e-01 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 9 | 3.27e-01 | 1.89e-01 | 9.87e-01 |
| GOCC SARCOPLASMIC RETICULUM LUMEN | 9 | 3.27e-01 | -1.89e-01 | 9.87e-01 |
| GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY | 16 | 1.91e-01 | 1.89e-01 | 9.28e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS NAD OR NADP AS ACCEPTOR | 6 | 4.23e-01 | 1.89e-01 | 9.95e-01 |
| GOBP REGULATION OF MICROTUBULE BINDING | 7 | 3.88e-01 | 1.89e-01 | 9.95e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 15 | 2.06e-01 | 1.88e-01 | 9.38e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPTIC ACTIN CYTOSKELETON | 6 | 4.24e-01 | 1.88e-01 | 9.95e-01 |
| GOBP GOLGI LOCALIZATION | 14 | 2.22e-01 | 1.88e-01 | 9.45e-01 |
| GOMF MORPHOGEN ACTIVITY | 8 | 3.57e-01 | 1.88e-01 | 9.95e-01 |
| GOBP BASOLATERAL PROTEIN SECRETION | 5 | 4.66e-01 | 1.88e-01 | 9.95e-01 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 2.23e-01 | 1.88e-01 | 9.46e-01 |
| GOBP SYNAPTIC VESICLE MATURATION | 23 | 1.18e-01 | 1.88e-01 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 26 | 9.71e-02 | -1.88e-01 | 8.61e-01 |
| GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 6 | 4.25e-01 | -1.88e-01 | 9.95e-01 |
| GOBP TELOMERIC D LOOP DISASSEMBLY | 7 | 3.89e-01 | -1.88e-01 | 9.95e-01 |
| GOBP PROLINE METABOLIC PROCESS | 10 | 3.04e-01 | 1.88e-01 | 9.87e-01 |
| GOBP STRIATED MUSCLE ADAPTATION | 55 | 1.59e-02 | 1.88e-01 | 6.27e-01 |
| GOBP CARDIAC CHAMBER FORMATION | 12 | 2.60e-01 | 1.88e-01 | 9.60e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL DIFFERENTIATION | 9 | 3.29e-01 | -1.88e-01 | 9.87e-01 |
| GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DEVELOPMENT | 6 | 4.26e-01 | 1.88e-01 | 9.95e-01 |
| GOBP FOREBRAIN MORPHOGENESIS | 13 | 2.41e-01 | 1.88e-01 | 9.57e-01 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 16 | 1.94e-01 | 1.88e-01 | 9.28e-01 |
| GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 4.26e-01 | 1.87e-01 | 9.95e-01 |
| GOBP MONOACYLGLYCEROL CATABOLIC PROCESS | 7 | 3.91e-01 | 1.87e-01 | 9.95e-01 |
| GOMF ARYLESTERASE ACTIVITY | 6 | 4.27e-01 | -1.87e-01 | 9.95e-01 |
| GOBP REGULATION OF VESICLE SIZE | 19 | 1.58e-01 | 1.87e-01 | 9.06e-01 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 14 | 2.25e-01 | 1.87e-01 | 9.49e-01 |
| GOBP RECEPTOR CATABOLIC PROCESS | 27 | 9.21e-02 | -1.87e-01 | 8.55e-01 |
| GOMF N ACETYLLACTOSAMINIDE BETA 1 3 N ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 5 | 4.69e-01 | 1.87e-01 | 9.95e-01 |
| GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 13 | 2.43e-01 | -1.87e-01 | 9.58e-01 |
| GOBP RESPONSE TO HYDROSTATIC PRESSURE | 7 | 3.91e-01 | -1.87e-01 | 9.95e-01 |
| GOBP PROSTATE GLAND GROWTH | 10 | 3.06e-01 | 1.87e-01 | 9.87e-01 |
| GOBP XENOBIOTIC GLUCURONIDATION | 6 | 4.28e-01 | -1.87e-01 | 9.95e-01 |
| GOCC GABA RECEPTOR COMPLEX | 18 | 1.70e-01 | 1.87e-01 | 9.20e-01 |
| GOBP SURFACTANT HOMEOSTASIS | 17 | 1.83e-01 | -1.87e-01 | 9.27e-01 |
| GOBP AZOLE TRANSMEMBRANE TRANSPORT | 13 | 2.44e-01 | -1.87e-01 | 9.58e-01 |
| GOCC MEIOTIC SPINDLE | 15 | 2.11e-01 | 1.87e-01 | 9.40e-01 |
| GOBP REGULATION OF ENAMEL MINERALIZATION | 7 | 3.93e-01 | -1.87e-01 | 9.95e-01 |
| GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 9 | 3.33e-01 | -1.87e-01 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF OPSONIZATION | 8 | 3.61e-01 | -1.86e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 26 | 9.98e-02 | -1.86e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 14 | 2.27e-01 | 1.86e-01 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 21 | 1.39e-01 | 1.86e-01 | 9.02e-01 |
| GOBP GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS | 8 | 3.61e-01 | -1.86e-01 | 9.95e-01 |
| GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 8 | 3.62e-01 | -1.86e-01 | 9.95e-01 |
| GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 13 | 2.45e-01 | 1.86e-01 | 9.58e-01 |
| GOCC AUTOLYSOSOME | 11 | 2.85e-01 | 1.86e-01 | 9.75e-01 |
| GOBP RESPONSE TO ACIDIC PH | 28 | 8.85e-02 | -1.86e-01 | 8.47e-01 |
| GOMF MEMBRANE POTENTIAL DRIVEN UNIPORTER ACTIVITY | 5 | 4.72e-01 | -1.86e-01 | 9.95e-01 |
| GOBP INSULIN PROCESSING | 8 | 3.63e-01 | 1.86e-01 | 9.95e-01 |
| GOBP PROTEIN LIPOYLATION | 5 | 4.72e-01 | 1.86e-01 | 9.95e-01 |
| GOMF ER RETENTION SEQUENCE BINDING | 5 | 4.72e-01 | -1.86e-01 | 9.95e-01 |
| GOMF METHYL CPG BINDING | 24 | 1.15e-01 | 1.86e-01 | 8.82e-01 |
| GOMF HEXOSAMINIDASE ACTIVITY | 15 | 2.13e-01 | 1.86e-01 | 9.40e-01 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 15 | 2.13e-01 | -1.86e-01 | 9.40e-01 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 34 | 6.11e-02 | 1.86e-01 | 7.95e-01 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 35 | 5.74e-02 | 1.86e-01 | 7.90e-01 |
| GOMF LNCRNA BINDING | 18 | 1.73e-01 | -1.86e-01 | 9.21e-01 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 34 | 6.12e-02 | -1.86e-01 | 7.95e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 11 | 2.87e-01 | -1.85e-01 | 9.75e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE | 19 | 1.62e-01 | 1.85e-01 | 9.12e-01 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 29 | 8.44e-02 | 1.85e-01 | 8.39e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 7 | 3.96e-01 | -1.85e-01 | 9.95e-01 |
| GOCC DYNEIN AXONEMAL PARTICLE | 20 | 1.52e-01 | 1.85e-01 | 9.04e-01 |
| GOCC SPERM CONNECTING PIECE | 9 | 3.36e-01 | -1.85e-01 | 9.88e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 12 | 2.67e-01 | -1.85e-01 | 9.68e-01 |
| GOBP REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY | 9 | 3.36e-01 | 1.85e-01 | 9.88e-01 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 8 | 3.65e-01 | -1.85e-01 | 9.95e-01 |
| GOBP FUNGIFORM PAPILLA MORPHOGENESIS | 5 | 4.74e-01 | 1.85e-01 | 9.95e-01 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 13 | 2.48e-01 | 1.85e-01 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 4.74e-01 | -1.85e-01 | 9.95e-01 |
| GOBP RESPONSE TO VASOPRESSIN | 8 | 3.65e-01 | -1.85e-01 | 9.95e-01 |
| GOBP SYMPATHETIC GANGLION DEVELOPMENT | 9 | 3.37e-01 | -1.85e-01 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 13 | 2.49e-01 | 1.85e-01 | 9.58e-01 |
| GOMF XMP 5 NUCLEOSIDASE ACTIVITY | 6 | 4.33e-01 | 1.85e-01 | 9.95e-01 |
| GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 9 | 3.37e-01 | -1.85e-01 | 9.88e-01 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 30 | 8.00e-02 | 1.85e-01 | 8.34e-01 |
| GOBP MAST CELL DIFFERENTIATION | 6 | 4.33e-01 | -1.85e-01 | 9.95e-01 |
| GOBP GROWTH HORMONE SECRETION | 13 | 2.49e-01 | -1.85e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 18 | 1.75e-01 | 1.85e-01 | 9.21e-01 |
| GOMF SIALIC ACID BINDING | 22 | 1.34e-01 | 1.85e-01 | 8.96e-01 |
| GOBP HEART TRABECULA FORMATION | 15 | 2.16e-01 | -1.84e-01 | 9.42e-01 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 28 | 9.13e-02 | -1.84e-01 | 8.53e-01 |
| GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 3.67e-01 | 1.84e-01 | 9.95e-01 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 14 | 2.33e-01 | 1.84e-01 | 9.51e-01 |
| GOBP METANEPHRIC S SHAPED BODY MORPHOGENESIS | 5 | 4.76e-01 | -1.84e-01 | 9.95e-01 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 52 | 2.18e-02 | 1.84e-01 | 6.41e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION | 5 | 4.76e-01 | -1.84e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO SODIUM ARSENITE | 5 | 4.77e-01 | -1.84e-01 | 9.95e-01 |
| GOBP POLY N ACETYLLACTOSAMINE METABOLIC PROCESS | 7 | 4.00e-01 | 1.84e-01 | 9.95e-01 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 24 | 1.19e-01 | 1.84e-01 | 8.83e-01 |
| GOCC AXONAL GROWTH CONE | 25 | 1.12e-01 | -1.84e-01 | 8.77e-01 |
| GOMF TROPOMYOSIN BINDING | 15 | 2.18e-01 | -1.84e-01 | 9.43e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 15 | 2.18e-01 | -1.84e-01 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 31 | 7.71e-02 | 1.83e-01 | 8.25e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 33 | 6.82e-02 | 1.83e-01 | 7.99e-01 |
| GOBP V D J RECOMBINATION | 19 | 1.66e-01 | 1.83e-01 | 9.15e-01 |
| GOBP THIAMINE CONTAINING COMPOUND METABOLIC PROCESS | 6 | 4.37e-01 | -1.83e-01 | 9.95e-01 |
| GOBP REGULATION OF HEART MORPHOGENESIS | 10 | 3.15e-01 | -1.83e-01 | 9.87e-01 |
| GOBP PROTEIN IMPORT | 7 | 4.01e-01 | 1.83e-01 | 9.95e-01 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 33 | 6.86e-02 | 1.83e-01 | 7.99e-01 |
| GOCC COMMITMENT COMPLEX | 5 | 4.78e-01 | 1.83e-01 | 9.95e-01 |
| GOMF ALKANESULFONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.78e-01 | -1.83e-01 | 9.95e-01 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 17 | 1.91e-01 | 1.83e-01 | 9.28e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 54 | 2.01e-02 | 1.83e-01 | 6.41e-01 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 31 | 7.83e-02 | 1.83e-01 | 8.27e-01 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 19 | 1.68e-01 | 1.83e-01 | 9.16e-01 |
| GOBP SUCCINYL COA METABOLIC PROCESS | 10 | 3.18e-01 | -1.82e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 11 | 2.95e-01 | -1.82e-01 | 9.81e-01 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 3.43e-01 | -1.82e-01 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 27 | 1.01e-01 | -1.82e-01 | 8.66e-01 |
| GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 3.72e-01 | 1.82e-01 | 9.95e-01 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 4.03e-01 | -1.82e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 17 | 1.93e-01 | 1.82e-01 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 24 | 1.22e-01 | 1.82e-01 | 8.86e-01 |
| GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS | 5 | 4.80e-01 | -1.82e-01 | 9.95e-01 |
| GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS | 16 | 2.07e-01 | 1.82e-01 | 9.38e-01 |
| GOBP ENDOTHELIAL CELL MORPHOGENESIS | 9 | 3.44e-01 | -1.82e-01 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 46 | 3.27e-02 | 1.82e-01 | 7.07e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION | 21 | 1.49e-01 | -1.82e-01 | 9.04e-01 |
| GOBP T CELL CYTOKINE PRODUCTION | 35 | 6.26e-02 | 1.82e-01 | 7.98e-01 |
| GOBP THIAMINE DIPHOSPHATE METABOLIC PROCESS | 5 | 4.81e-01 | -1.82e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 19 | 1.70e-01 | 1.82e-01 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 17 | 1.95e-01 | -1.82e-01 | 9.28e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 126 | 4.29e-04 | 1.82e-01 | 1.26e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 20 | 1.60e-01 | 1.82e-01 | 9.06e-01 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 19 | 1.71e-01 | -1.82e-01 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 12 | 2.76e-01 | -1.81e-01 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 24 | 1.24e-01 | 1.81e-01 | 8.91e-01 |
| GOBP TRYPTOPHAN METABOLIC PROCESS | 10 | 3.20e-01 | -1.81e-01 | 9.87e-01 |
| GOBP REGULATION OF BILE ACID BIOSYNTHETIC PROCESS | 12 | 2.77e-01 | 1.81e-01 | 9.73e-01 |
| GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 7 | 4.06e-01 | 1.81e-01 | 9.95e-01 |
| GOBP LEUKOTRIENE TRANSPORT | 7 | 4.06e-01 | -1.81e-01 | 9.95e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 8 | 3.75e-01 | -1.81e-01 | 9.95e-01 |
| GOBP STRESS INDUCED PREMATURE SENESCENCE | 8 | 3.75e-01 | 1.81e-01 | 9.95e-01 |
| GOBP N ACYLETHANOLAMINE METABOLIC PROCESS | 5 | 4.83e-01 | 1.81e-01 | 9.95e-01 |
| GOMF IMMUNOGLOBULIN BINDING | 19 | 1.72e-01 | 1.81e-01 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 9 | 3.47e-01 | 1.81e-01 | 9.93e-01 |
| GOBP SYNAPTIC VESICLE UNCOATING | 6 | 4.43e-01 | -1.81e-01 | 9.95e-01 |
| GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 4.08e-01 | 1.81e-01 | 9.95e-01 |
| GOBP AXON CHOICE POINT RECOGNITION | 7 | 4.08e-01 | 1.80e-01 | 9.95e-01 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 16 | 2.11e-01 | 1.80e-01 | 9.40e-01 |
| GOBP WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY | 5 | 4.85e-01 | -1.80e-01 | 9.95e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 15 | 2.27e-01 | 1.80e-01 | 9.50e-01 |
| GOMF HISTONE KINASE ACTIVITY | 20 | 1.63e-01 | 1.80e-01 | 9.12e-01 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 22 | 1.44e-01 | -1.80e-01 | 9.02e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 10 | 3.24e-01 | 1.80e-01 | 9.87e-01 |
| GOBP TENDON DEVELOPMENT | 5 | 4.86e-01 | 1.80e-01 | 9.95e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION | 6 | 4.46e-01 | -1.80e-01 | 9.95e-01 |
| GOMF AMMONIA LYASE ACTIVITY | 5 | 4.86e-01 | -1.80e-01 | 9.95e-01 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 31 | 8.32e-02 | -1.80e-01 | 8.39e-01 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 11 | 3.02e-01 | 1.80e-01 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 19 | 1.75e-01 | 1.80e-01 | 9.21e-01 |
| GOBP COPPER ION TRANSPORT | 15 | 2.29e-01 | 1.80e-01 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 10 | 3.25e-01 | -1.80e-01 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN STARVATION | 12 | 2.81e-01 | -1.80e-01 | 9.73e-01 |
| GOBP PEPTIDE CROSS LINKING | 26 | 1.13e-01 | -1.80e-01 | 8.79e-01 |
| GOBP MISMATCH REPAIR | 32 | 7.88e-02 | 1.80e-01 | 8.27e-01 |
| GOMF TUMOR NECROSIS FACTOR BINDING | 7 | 4.11e-01 | 1.80e-01 | 9.95e-01 |
| GOCC GOLGI CIS CISTERNA | 14 | 2.45e-01 | 1.79e-01 | 9.58e-01 |
| GOBP PRESYNAPTIC MEMBRANE ORGANIZATION | 6 | 4.46e-01 | 1.79e-01 | 9.95e-01 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 27 | 1.07e-01 | 1.79e-01 | 8.68e-01 |
| GOCC TOR COMPLEX | 11 | 3.03e-01 | 1.79e-01 | 9.87e-01 |
| GOBP SULFATION | 20 | 1.65e-01 | -1.79e-01 | 9.15e-01 |
| GOCC PIP BODY | 5 | 4.88e-01 | 1.79e-01 | 9.95e-01 |
| GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 7 | 4.11e-01 | 1.79e-01 | 9.95e-01 |
| GOMF INTERLEUKIN 6 RECEPTOR BINDING | 7 | 4.12e-01 | -1.79e-01 | 9.95e-01 |
| GOCC AP 1 ADAPTOR COMPLEX | 11 | 3.03e-01 | 1.79e-01 | 9.87e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 12 | 2.83e-01 | -1.79e-01 | 9.73e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 23 | 1.37e-01 | -1.79e-01 | 9.02e-01 |
| GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 6 | 4.48e-01 | -1.79e-01 | 9.95e-01 |
| GOBP T HELPER 1 CELL CYTOKINE PRODUCTION | 7 | 4.12e-01 | 1.79e-01 | 9.95e-01 |
| GOCC CILIARY TRANSITION FIBER | 8 | 3.81e-01 | -1.79e-01 | 9.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 8 | 3.81e-01 | 1.79e-01 | 9.95e-01 |
| GOCC TETRASPANIN ENRICHED MICRODOMAIN | 10 | 3.27e-01 | 1.79e-01 | 9.87e-01 |
| GOBP TRNA 3 END PROCESSING | 6 | 4.48e-01 | -1.79e-01 | 9.95e-01 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 70 | 9.65e-03 | 1.79e-01 | 5.57e-01 |
| GOCC U7 SNRNP | 7 | 4.13e-01 | 1.79e-01 | 9.95e-01 |
| GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION | 7 | 4.13e-01 | -1.79e-01 | 9.95e-01 |
| GOBP MOTOR NEURON AXON GUIDANCE | 23 | 1.38e-01 | -1.79e-01 | 9.02e-01 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 119 | 7.65e-04 | 1.79e-01 | 1.70e-01 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 8 | 3.82e-01 | -1.79e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 8 | 3.82e-01 | -1.78e-01 | 9.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 5 | 4.90e-01 | 1.78e-01 | 9.95e-01 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 18 | 1.90e-01 | -1.78e-01 | 9.28e-01 |
| GOCC NEURONAL DENSE CORE VESICLE MEMBRANE | 5 | 4.90e-01 | -1.78e-01 | 9.95e-01 |
| GOBP PERISTALSIS | 12 | 2.85e-01 | 1.78e-01 | 9.75e-01 |
| GOBP REGULATION OF APOPTOTIC CELL CLEARANCE | 10 | 3.29e-01 | 1.78e-01 | 9.87e-01 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 38 | 5.73e-02 | 1.78e-01 | 7.90e-01 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 3.29e-01 | -1.78e-01 | 9.87e-01 |
| GOMF EPHRIN RECEPTOR ACTIVITY | 18 | 1.91e-01 | -1.78e-01 | 9.28e-01 |
| GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 3.83e-01 | 1.78e-01 | 9.95e-01 |
| GOBP PEPTIDYL HISTIDINE MODIFICATION | 8 | 3.83e-01 | -1.78e-01 | 9.95e-01 |
| GOCC BOX C D RNP COMPLEX | 6 | 4.50e-01 | -1.78e-01 | 9.95e-01 |
| GOMF ANDROSTAN 3 ALPHA 17 BETA DIOL DEHYDROGENASE ACTIVITY | 8 | 3.84e-01 | -1.78e-01 | 9.95e-01 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 21 | 1.59e-01 | 1.78e-01 | 9.06e-01 |
| GOBP REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION | 7 | 4.16e-01 | -1.78e-01 | 9.95e-01 |
| GOBP RESPONSE TO LUTEINIZING HORMONE | 7 | 4.16e-01 | -1.78e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 9 | 3.56e-01 | 1.78e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL EFFLUX | 22 | 1.49e-01 | 1.78e-01 | 9.04e-01 |
| GOBP CHITIN METABOLIC PROCESS | 6 | 4.51e-01 | -1.78e-01 | 9.95e-01 |
| GOMF CHITINASE ACTIVITY | 6 | 4.51e-01 | -1.78e-01 | 9.95e-01 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 32 | 8.23e-02 | 1.77e-01 | 8.38e-01 |
| GOBP CELL MIGRATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 4.52e-01 | 1.77e-01 | 9.95e-01 |
| GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 3.57e-01 | 1.77e-01 | 9.95e-01 |
| GOMF STRUCTURAL CONSTITUENT OF EYE LENS | 23 | 1.41e-01 | -1.77e-01 | 9.02e-01 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 39 | 5.56e-02 | 1.77e-01 | 7.90e-01 |
| GOBP REGULATION OF RENAL SYSTEM PROCESS | 21 | 1.60e-01 | -1.77e-01 | 9.06e-01 |
| GOCC PRONUCLEUS | 14 | 2.52e-01 | -1.77e-01 | 9.58e-01 |
| GOBP NK T CELL DIFFERENTIATION | 11 | 3.10e-01 | 1.77e-01 | 9.87e-01 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 60 | 1.78e-02 | -1.77e-01 | 6.41e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 9 | 3.58e-01 | 1.77e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY | 15 | 2.36e-01 | 1.77e-01 | 9.52e-01 |
| GOBP RRNA BASE METHYLATION | 9 | 3.58e-01 | -1.77e-01 | 9.95e-01 |
| GOBP GLYCOLIPID TRANSPORT | 8 | 3.87e-01 | 1.77e-01 | 9.95e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 15 | 2.36e-01 | -1.77e-01 | 9.52e-01 |
| GOBP EMBRYONIC HEART TUBE LEFT RIGHT PATTERN FORMATION | 5 | 4.94e-01 | 1.76e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 41 | 5.07e-02 | -1.76e-01 | 7.81e-01 |
| GOMF NEUROPEPTIDE ACTIVITY | 29 | 1.00e-01 | 1.76e-01 | 8.65e-01 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 4.55e-01 | 1.76e-01 | 9.95e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 42 | 4.82e-02 | 1.76e-01 | 7.68e-01 |
| GOBP NATURAL KILLER CELL PROLIFERATION | 14 | 2.54e-01 | 1.76e-01 | 9.58e-01 |
| GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 4.95e-01 | 1.76e-01 | 9.95e-01 |
| GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 4.55e-01 | -1.76e-01 | 9.95e-01 |
| GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY | 13 | 2.72e-01 | -1.76e-01 | 9.73e-01 |
| GOBP ANDROGEN BIOSYNTHETIC PROCESS | 10 | 3.36e-01 | -1.76e-01 | 9.88e-01 |
| GOBP SEROTONIN SECRETION | 9 | 3.61e-01 | 1.76e-01 | 9.95e-01 |
| GOBP MITOTIC RECOMBINATION | 25 | 1.28e-01 | 1.76e-01 | 8.91e-01 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 29 | 1.02e-01 | -1.76e-01 | 8.66e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 16 | 2.24e-01 | -1.76e-01 | 9.47e-01 |
| GOBP PIGMENT ACCUMULATION | 11 | 3.13e-01 | -1.76e-01 | 9.87e-01 |
| GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 9 | 3.62e-01 | 1.76e-01 | 9.95e-01 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 32 | 8.55e-02 | -1.76e-01 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF CELL VOLUME | 5 | 4.97e-01 | -1.76e-01 | 9.95e-01 |
| GOBP DOSAGE COMPENSATION | 27 | 1.14e-01 | 1.76e-01 | 8.80e-01 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 52 | 2.85e-02 | 1.76e-01 | 6.86e-01 |
| GOMF GALACTOSYLCERAMIDASE ACTIVITY | 5 | 4.97e-01 | -1.76e-01 | 9.95e-01 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 12 | 2.93e-01 | 1.75e-01 | 9.79e-01 |
| GOBP TRANSLOCATION OF MOLECULES INTO HOST | 6 | 4.57e-01 | -1.75e-01 | 9.95e-01 |
| GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 3.62e-01 | -1.75e-01 | 9.95e-01 |
| GOBP EXCRETION | 29 | 1.02e-01 | -1.75e-01 | 8.66e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 8 | 3.91e-01 | -1.75e-01 | 9.95e-01 |
| GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 16 | 2.25e-01 | -1.75e-01 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 20 | 1.75e-01 | -1.75e-01 | 9.21e-01 |
| GOBP SEROTONIN TRANSPORT | 20 | 1.75e-01 | 1.75e-01 | 9.21e-01 |
| GOBP REGULATION OF GASTRIC ACID SECRETION | 6 | 4.58e-01 | -1.75e-01 | 9.95e-01 |
| GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 27 | 1.16e-01 | -1.75e-01 | 8.82e-01 |
| GOMF CO RECEPTOR BINDING | 13 | 2.75e-01 | -1.75e-01 | 9.73e-01 |
| GOBP LONG CHAIN FATTY ACID CATABOLIC PROCESS | 8 | 3.92e-01 | 1.75e-01 | 9.95e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 17 | 2.12e-01 | -1.75e-01 | 9.40e-01 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 21 | 1.66e-01 | 1.75e-01 | 9.15e-01 |
| GOCC APICAL DENDRITE | 15 | 2.41e-01 | -1.75e-01 | 9.57e-01 |
| GOBP INTERNEURON MIGRATION FROM THE SUBPALLIUM TO THE CORTEX | 7 | 4.23e-01 | 1.75e-01 | 9.95e-01 |
| GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL | 7 | 4.24e-01 | -1.75e-01 | 9.95e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 24 | 1.39e-01 | 1.75e-01 | 9.02e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 93 | 3.62e-03 | 1.75e-01 | 3.57e-01 |
| GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 24 | 1.39e-01 | 1.75e-01 | 9.02e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 17 | 2.13e-01 | -1.74e-01 | 9.40e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID IMPORT | 6 | 4.60e-01 | 1.74e-01 | 9.95e-01 |
| GOMF CHEMOKINE RECEPTOR BINDING | 62 | 1.77e-02 | -1.74e-01 | 6.41e-01 |
| GOBP AMP BIOSYNTHETIC PROCESS | 12 | 2.97e-01 | 1.74e-01 | 9.82e-01 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 89 | 4.57e-03 | 1.74e-01 | 4.07e-01 |
| GOMF HORMONE RECEPTOR BINDING | 29 | 1.05e-01 | 1.74e-01 | 8.67e-01 |
| GOBP SERTOLI CELL DIFFERENTIATION | 17 | 2.15e-01 | 1.74e-01 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF RNA BINDING | 6 | 4.61e-01 | -1.74e-01 | 9.95e-01 |
| GOBP PROTEIN REPAIR | 7 | 4.26e-01 | -1.74e-01 | 9.95e-01 |
| GOBP VISUAL BEHAVIOR | 55 | 2.60e-02 | -1.74e-01 | 6.71e-01 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 12 | 2.98e-01 | 1.73e-01 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE ADAPTATION | 13 | 2.79e-01 | 1.73e-01 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 33 | 8.49e-02 | 1.73e-01 | 8.39e-01 |
| GOBP POINTED END ACTIN FILAMENT CAPPING | 7 | 4.27e-01 | -1.73e-01 | 9.95e-01 |
| GOBP MITOCHONDRION LOCALIZATION | 46 | 4.22e-02 | 1.73e-01 | 7.57e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 5.03e-01 | 1.73e-01 | 9.95e-01 |
| GOBP COPULATION | 19 | 1.92e-01 | 1.73e-01 | 9.28e-01 |
| GOBP SMOOTH MUSCLE CELL MATRIX ADHESION | 6 | 4.63e-01 | 1.73e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 15 | 2.46e-01 | 1.73e-01 | 9.58e-01 |
| GOMF GROWTH HORMONE RECEPTOR BINDING | 7 | 4.28e-01 | 1.73e-01 | 9.95e-01 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 18 | 2.04e-01 | 1.73e-01 | 9.36e-01 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 24 | 1.43e-01 | 1.73e-01 | 9.02e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 45 | 4.48e-02 | -1.73e-01 | 7.59e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 10 | 3.44e-01 | -1.73e-01 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF TUBULIN DEACETYLATION | 5 | 5.04e-01 | 1.73e-01 | 9.95e-01 |
| GOBP REGULATION OF HISTONE METHYLATION | 16 | 2.32e-01 | 1.73e-01 | 9.50e-01 |
| GOMF LYSOPHOSPHATIDIC ACID BINDING | 7 | 4.29e-01 | 1.73e-01 | 9.95e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 23 | 1.52e-01 | -1.73e-01 | 9.04e-01 |
| GOBP METANEPHRIC NEPHRON TUBULE MORPHOGENESIS | 8 | 3.98e-01 | 1.73e-01 | 9.95e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 12 | 3.01e-01 | -1.72e-01 | 9.86e-01 |
| GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION | 8 | 3.98e-01 | -1.72e-01 | 9.95e-01 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 77 | 8.92e-03 | -1.72e-01 | 5.50e-01 |
| GOBP EPOXYGENASE P450 PATHWAY | 17 | 2.19e-01 | -1.72e-01 | 9.43e-01 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 16 | 2.33e-01 | -1.72e-01 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 59 | 2.21e-02 | -1.72e-01 | 6.41e-01 |
| GOCC STEREOCILIUM BUNDLE | 60 | 2.11e-02 | -1.72e-01 | 6.41e-01 |
| GOBP SEMICIRCULAR CANAL MORPHOGENESIS | 7 | 4.30e-01 | 1.72e-01 | 9.95e-01 |
| GOBP SODIUM ION HOMEOSTASIS | 46 | 4.34e-02 | -1.72e-01 | 7.59e-01 |
| GOCC AP 2 ADAPTOR COMPLEX | 10 | 3.46e-01 | -1.72e-01 | 9.92e-01 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 17 | 2.19e-01 | -1.72e-01 | 9.43e-01 |
| GOBP MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER | 5 | 5.05e-01 | -1.72e-01 | 9.95e-01 |
| GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 11 | 3.24e-01 | 1.72e-01 | 9.87e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS | 7 | 4.31e-01 | 1.72e-01 | 9.95e-01 |
| GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 31 | 9.78e-02 | 1.72e-01 | 8.61e-01 |
| GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME | 9 | 3.72e-01 | 1.72e-01 | 9.95e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 14 | 2.66e-01 | 1.72e-01 | 9.67e-01 |
| GOBP MYOFIBROBLAST DIFFERENTIATION | 14 | 2.66e-01 | 1.72e-01 | 9.67e-01 |
| GOBP NEURONAL SIGNAL TRANSDUCTION | 7 | 4.32e-01 | 1.72e-01 | 9.95e-01 |
| GOBP EYE PIGMENTATION | 5 | 5.06e-01 | 1.72e-01 | 9.95e-01 |
| GOBP POLYAMINE TRANSPORT | 16 | 2.35e-01 | 1.72e-01 | 9.52e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 9 | 3.73e-01 | 1.72e-01 | 9.95e-01 |
| GOBP EOSINOPHIL DIFFERENTIATION | 6 | 4.67e-01 | 1.72e-01 | 9.95e-01 |
| GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT | 7 | 4.32e-01 | -1.72e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 28 | 1.16e-01 | 1.72e-01 | 8.82e-01 |
| GOBP SPINAL CORD DEVELOPMENT | 99 | 3.20e-03 | 1.71e-01 | 3.41e-01 |
| GOBP STRESS GRANULE DISASSEMBLY | 5 | 5.07e-01 | 1.71e-01 | 9.95e-01 |
| GOBP REGULATION OF DNA BINDING | 82 | 7.33e-03 | 1.71e-01 | 5.13e-01 |
| GOCC PRE SNORNP COMPLEX | 7 | 4.33e-01 | -1.71e-01 | 9.95e-01 |
| GOBP APPENDAGE MORPHOGENESIS | 142 | 4.26e-04 | 1.71e-01 | 1.26e-01 |
| GOBP OUTER DYNEIN ARM ASSEMBLY | 23 | 1.55e-01 | 1.71e-01 | 9.06e-01 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 3.26e-01 | 1.71e-01 | 9.87e-01 |
| GOCC GAMMA TUBULIN RING COMPLEX | 7 | 4.33e-01 | 1.71e-01 | 9.95e-01 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 3.26e-01 | -1.71e-01 | 9.87e-01 |
| GOBP GLIAL CELL ACTIVATION | 57 | 2.55e-02 | 1.71e-01 | 6.69e-01 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 26 | 1.31e-01 | -1.71e-01 | 8.96e-01 |
| GOBP CELLULAR DEFENSE RESPONSE | 48 | 4.05e-02 | -1.71e-01 | 7.56e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 18 | 2.10e-01 | 1.71e-01 | 9.39e-01 |
| GOCC DNA REPAIR COMPLEX | 22 | 1.66e-01 | 1.71e-01 | 9.15e-01 |
| GOBP SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 5 | 5.09e-01 | 1.71e-01 | 9.95e-01 |
| GOBP NATURAL KILLER CELL CHEMOTAXIS | 9 | 3.76e-01 | 1.71e-01 | 9.95e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 14 | 2.70e-01 | -1.70e-01 | 9.71e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 22 | 1.66e-01 | 1.70e-01 | 9.15e-01 |
| GOCC GAMMA SECRETASE COMPLEX | 7 | 4.35e-01 | 1.70e-01 | 9.95e-01 |
| GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY | 9 | 3.76e-01 | 1.70e-01 | 9.95e-01 |
| GOBP SEROTONIN UPTAKE | 12 | 3.07e-01 | 1.70e-01 | 9.87e-01 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 24 | 1.49e-01 | -1.70e-01 | 9.04e-01 |
| GOCC FILOPODIUM TIP | 18 | 2.11e-01 | -1.70e-01 | 9.40e-01 |
| GOBP REGULATION OF GLUCAGON SECRETION | 8 | 4.05e-01 | 1.70e-01 | 9.95e-01 |
| GOBP MEMBRANE DISASSEMBLY | 11 | 3.29e-01 | -1.70e-01 | 9.87e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 15 | 2.54e-01 | 1.70e-01 | 9.58e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR II BINDING | 8 | 4.05e-01 | 1.70e-01 | 9.95e-01 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 91 | 5.05e-03 | 1.70e-01 | 4.31e-01 |
| GOBP MEIOTIC CYTOKINESIS | 8 | 4.05e-01 | -1.70e-01 | 9.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 28 | 1.19e-01 | -1.70e-01 | 8.83e-01 |
| GOCC BBAF COMPLEX | 10 | 3.52e-01 | 1.70e-01 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 21 | 1.78e-01 | -1.70e-01 | 9.22e-01 |
| GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT | 13 | 2.89e-01 | -1.70e-01 | 9.77e-01 |
| GOBP PROXIMAL TUBULE DEVELOPMENT | 10 | 3.53e-01 | -1.70e-01 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATURATION | 8 | 4.06e-01 | 1.70e-01 | 9.95e-01 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 14 | 2.72e-01 | 1.70e-01 | 9.73e-01 |
| GOBP ARTERIAL ENDOTHELIAL CELL DIFFERENTIATION | 6 | 4.72e-01 | 1.70e-01 | 9.95e-01 |
| GOBP HISTIDINE CATABOLIC PROCESS | 8 | 4.06e-01 | -1.70e-01 | 9.95e-01 |
| GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 9 | 3.78e-01 | -1.70e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 8 | 4.07e-01 | -1.69e-01 | 9.95e-01 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 138 | 5.91e-04 | 1.69e-01 | 1.38e-01 |
| GOBP REGULATION OF BONE MINERALIZATION INVOLVED IN BONE MATURATION | 7 | 4.38e-01 | 1.69e-01 | 9.95e-01 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 25 | 1.43e-01 | 1.69e-01 | 9.02e-01 |
| GOCC EGG COAT | 5 | 5.12e-01 | -1.69e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 68 | 1.58e-02 | 1.69e-01 | 6.27e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 17 | 2.27e-01 | 1.69e-01 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 14 | 2.73e-01 | -1.69e-01 | 9.73e-01 |
| GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 5.13e-01 | 1.69e-01 | 9.95e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID BIOSYNTHETIC PROCESS | 6 | 4.74e-01 | -1.69e-01 | 9.95e-01 |
| GOBP REGULATION OF CELLULAR PH REDUCTION | 7 | 4.39e-01 | 1.69e-01 | 9.95e-01 |
| GOMF MIRNA BINDING | 39 | 6.80e-02 | -1.69e-01 | 7.99e-01 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 18 | 2.15e-01 | 1.69e-01 | 9.42e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 28 | 1.22e-01 | -1.69e-01 | 8.86e-01 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 1.52e-01 | 1.69e-01 | 9.04e-01 |
| GOCC AXONEMAL DYNEIN COMPLEX | 22 | 1.71e-01 | 1.69e-01 | 9.21e-01 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 11 | 3.33e-01 | -1.69e-01 | 9.88e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 3.81e-01 | 1.69e-01 | 9.95e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 17 | 2.29e-01 | 1.69e-01 | 9.50e-01 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 20 | 1.92e-01 | -1.69e-01 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF HISTONE METHYLATION | 14 | 2.75e-01 | 1.69e-01 | 9.73e-01 |
| GOMF CHANNEL ACTIVATOR ACTIVITY | 6 | 4.75e-01 | -1.69e-01 | 9.95e-01 |
| GOBP PARAXIAL MESODERM MORPHOGENESIS | 10 | 3.57e-01 | 1.68e-01 | 9.95e-01 |
| GOBP CGMP BIOSYNTHETIC PROCESS | 10 | 3.57e-01 | 1.68e-01 | 9.95e-01 |
| GOMF NEUROTRANSMITTER BINDING | 16 | 2.44e-01 | 1.68e-01 | 9.58e-01 |
| GOBP PLATELET MORPHOGENESIS | 22 | 1.72e-01 | -1.68e-01 | 9.21e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 9 | 3.83e-01 | 1.68e-01 | 9.95e-01 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 19 | 2.05e-01 | 1.68e-01 | 9.37e-01 |
| GOCC PINOSOME | 7 | 4.42e-01 | 1.68e-01 | 9.95e-01 |
| GOBP ADRENAL GLAND DEVELOPMENT | 27 | 1.31e-01 | -1.68e-01 | 8.96e-01 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 40 | 6.61e-02 | -1.68e-01 | 7.99e-01 |
| GOMF STEROL TRANSPORTER ACTIVITY | 36 | 8.14e-02 | -1.68e-01 | 8.36e-01 |
| GOBP REGULATION OF ACROSOME REACTION | 17 | 2.32e-01 | -1.68e-01 | 9.50e-01 |
| GOCC MKS COMPLEX | 13 | 2.96e-01 | 1.68e-01 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF UTERINE SMOOTH MUSCLE CONTRACTION | 7 | 4.43e-01 | -1.68e-01 | 9.95e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 45 | 5.19e-02 | -1.68e-01 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF THE FORCE OF HEART CONTRACTION | 5 | 5.17e-01 | -1.67e-01 | 9.95e-01 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 17 | 2.32e-01 | 1.67e-01 | 9.50e-01 |
| GOBP CARTILAGE CONDENSATION | 19 | 2.07e-01 | 1.67e-01 | 9.38e-01 |
| GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 8 | 4.13e-01 | -1.67e-01 | 9.95e-01 |
| GOBP CHIASMA ASSEMBLY | 6 | 4.78e-01 | 1.67e-01 | 9.95e-01 |
| GOCC NUCLEAR CHROMOSOME | 213 | 2.62e-05 | 1.67e-01 | 1.68e-02 |
| GOBP REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 12 | 3.17e-01 | -1.67e-01 | 9.87e-01 |
| GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 5.18e-01 | -1.67e-01 | 9.95e-01 |
| GOBP ODONTOBLAST DIFFERENTIATION | 11 | 3.38e-01 | -1.67e-01 | 9.88e-01 |
| GOBP RESPONSE TO THYROID HORMONE | 28 | 1.26e-01 | -1.67e-01 | 8.91e-01 |
| GOBP GOLGI VESICLE BUDDING | 10 | 3.61e-01 | 1.67e-01 | 9.95e-01 |
| GOBP LEUKOTRIENE D4 BIOSYNTHETIC PROCESS | 5 | 5.18e-01 | 1.67e-01 | 9.95e-01 |
| GOBP PROTEIN SUMOYLATION | 64 | 2.10e-02 | 1.67e-01 | 6.41e-01 |
| GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 4.79e-01 | -1.67e-01 | 9.95e-01 |
| GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 15 | 2.64e-01 | 1.67e-01 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 8 | 4.14e-01 | 1.67e-01 | 9.95e-01 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 16 | 2.48e-01 | 1.67e-01 | 9.58e-01 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 47 | 4.81e-02 | -1.67e-01 | 7.68e-01 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 150 | 4.27e-04 | -1.67e-01 | 1.26e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES | 6 | 4.80e-01 | 1.67e-01 | 9.95e-01 |
| GOBP REGULATION OF FERTILIZATION | 17 | 2.35e-01 | -1.66e-01 | 9.52e-01 |
| GOBP FOLIC ACID METABOLIC PROCESS | 15 | 2.64e-01 | 1.66e-01 | 9.65e-01 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 26 | 1.42e-01 | 1.66e-01 | 9.02e-01 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 11 | 3.40e-01 | 1.66e-01 | 9.88e-01 |
| GOBP DIRECT OSSIFICATION | 7 | 4.46e-01 | 1.66e-01 | 9.95e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 4.81e-01 | -1.66e-01 | 9.95e-01 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 18 | 2.22e-01 | 1.66e-01 | 9.45e-01 |
| GOBP INHIBITION OF NEUROEPITHELIAL CELL DIFFERENTIATION | 5 | 5.20e-01 | 1.66e-01 | 9.95e-01 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 32 | 1.04e-01 | -1.66e-01 | 8.67e-01 |
| GOBP ADHERENS JUNCTION MAINTENANCE | 7 | 4.47e-01 | -1.66e-01 | 9.95e-01 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 15 | 2.66e-01 | 1.66e-01 | 9.67e-01 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 17 | 2.36e-01 | 1.66e-01 | 9.52e-01 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 6 | 4.82e-01 | -1.66e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 10 | 3.64e-01 | -1.66e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 12 | 3.20e-01 | -1.66e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 11 | 3.41e-01 | 1.66e-01 | 9.89e-01 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 44 | 5.72e-02 | -1.66e-01 | 7.90e-01 |
| GOMF D LOOP DNA BINDING | 5 | 5.21e-01 | 1.66e-01 | 9.95e-01 |
| GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 5 | 5.22e-01 | 1.66e-01 | 9.95e-01 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 14 | 2.84e-01 | 1.65e-01 | 9.74e-01 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 19 | 2.12e-01 | -1.65e-01 | 9.40e-01 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 132 | 1.03e-03 | 1.65e-01 | 1.99e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 11 | 3.43e-01 | 1.65e-01 | 9.91e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 18 | 2.25e-01 | 1.65e-01 | 9.49e-01 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING | 12 | 3.22e-01 | -1.65e-01 | 9.87e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM MEMBRANE | 7 | 4.49e-01 | 1.65e-01 | 9.95e-01 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 50 | 4.35e-02 | -1.65e-01 | 7.59e-01 |
| GOBP SKELETAL MUSCLE TISSUE GROWTH | 9 | 3.91e-01 | 1.65e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION | 16 | 2.53e-01 | -1.65e-01 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 7 | 4.50e-01 | -1.65e-01 | 9.95e-01 |
| GOCC TRANSLOCON COMPLEX | 5 | 5.23e-01 | 1.65e-01 | 9.95e-01 |
| GOCC CELL POLE | 7 | 4.50e-01 | 1.65e-01 | 9.95e-01 |
| GOBP XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER | 6 | 4.85e-01 | 1.65e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 12 | 3.23e-01 | 1.65e-01 | 9.87e-01 |
| GOBP OSTEOCLAST PROLIFERATION | 11 | 3.44e-01 | 1.65e-01 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 8 | 4.20e-01 | 1.65e-01 | 9.95e-01 |
| GOBP NEURAL PLATE PATTERN SPECIFICATION | 8 | 4.20e-01 | 1.65e-01 | 9.95e-01 |
| GOCC IKAPPAB KINASE COMPLEX | 6 | 4.85e-01 | -1.64e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 21 | 1.92e-01 | 1.64e-01 | 9.28e-01 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 23 | 1.72e-01 | -1.64e-01 | 9.21e-01 |
| GOCC MYELIN SHEATH ABAXONAL REGION | 6 | 4.86e-01 | 1.64e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 42 | 6.53e-02 | -1.64e-01 | 7.99e-01 |
| GOBP RESPONSE TO AMINE | 45 | 5.65e-02 | -1.64e-01 | 7.90e-01 |
| GOBP NEGATIVE REGULATION OF CELL FATE COMMITMENT | 11 | 3.45e-01 | -1.64e-01 | 9.92e-01 |
| GOBP PYRUVATE TRANSPORT | 7 | 4.52e-01 | 1.64e-01 | 9.95e-01 |
| GOMF SNAP RECEPTOR ACTIVITY | 36 | 8.87e-02 | 1.64e-01 | 8.47e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION | 6 | 4.87e-01 | -1.64e-01 | 9.95e-01 |
| GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 9 | 3.94e-01 | 1.64e-01 | 9.95e-01 |
| GOBP NEUROBLAST DIFFERENTIATION | 8 | 4.22e-01 | 1.64e-01 | 9.95e-01 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 16 | 2.56e-01 | 1.64e-01 | 9.58e-01 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 7 | 4.53e-01 | 1.64e-01 | 9.95e-01 |
| GOCC PREFOLDIN COMPLEX | 6 | 4.87e-01 | 1.64e-01 | 9.95e-01 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 2.57e-01 | 1.64e-01 | 9.58e-01 |
| GOCC INTERCALATED DISC | 49 | 4.75e-02 | -1.64e-01 | 7.65e-01 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 37 | 8.50e-02 | -1.64e-01 | 8.39e-01 |
| GOBP MONOCYTE CHEMOTAXIS | 66 | 2.15e-02 | -1.64e-01 | 6.41e-01 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 16 | 2.57e-01 | 1.64e-01 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 26 | 1.49e-01 | -1.63e-01 | 9.04e-01 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 26 | 1.49e-01 | 1.63e-01 | 9.04e-01 |
| GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN | 20 | 2.06e-01 | 1.63e-01 | 9.38e-01 |
| GOBP MAINTENANCE OF ANIMAL ORGAN IDENTITY | 5 | 5.27e-01 | -1.63e-01 | 9.95e-01 |
| GOMF ADENOSINE RECEPTOR BINDING | 7 | 4.54e-01 | -1.63e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 30 | 1.22e-01 | 1.63e-01 | 8.86e-01 |
| GOBP LIPID EXPORT FROM CELL | 47 | 5.30e-02 | -1.63e-01 | 7.84e-01 |
| GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY | 6 | 4.89e-01 | -1.63e-01 | 9.95e-01 |
| GOMF MRNA 5 PHOSPHATASE ACTIVITY | 11 | 3.49e-01 | 1.63e-01 | 9.94e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE C ACTIVITY | 5 | 5.28e-01 | -1.63e-01 | 9.95e-01 |
| GOMF NEUREGULIN BINDING | 5 | 5.28e-01 | -1.63e-01 | 9.95e-01 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 23 | 1.76e-01 | 1.63e-01 | 9.21e-01 |
| GOMF CARGO RECEPTOR ACTIVITY | 63 | 2.53e-02 | -1.63e-01 | 6.68e-01 |
| GOBP DNA METHYLATION ON CYTOSINE | 6 | 4.90e-01 | 1.63e-01 | 9.95e-01 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 10 | 3.72e-01 | -1.63e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 37 | 8.64e-02 | 1.63e-01 | 8.39e-01 |
| GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE | 20 | 2.08e-01 | 1.63e-01 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 7 | 4.56e-01 | -1.63e-01 | 9.95e-01 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 24 | 1.68e-01 | -1.63e-01 | 9.15e-01 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 24 | 1.68e-01 | 1.63e-01 | 9.15e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 22 | 1.87e-01 | -1.63e-01 | 9.28e-01 |
| GOMF MAP KINASE ACTIVITY | 16 | 2.60e-01 | 1.63e-01 | 9.60e-01 |
| GOBP PRONEPHROS DEVELOPMENT | 9 | 3.99e-01 | 1.62e-01 | 9.95e-01 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 13 | 3.11e-01 | -1.62e-01 | 9.87e-01 |
| GOBP ORGANELLE INHERITANCE | 15 | 2.76e-01 | 1.62e-01 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 11 | 3.51e-01 | -1.62e-01 | 9.94e-01 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 42 | 6.86e-02 | 1.62e-01 | 7.99e-01 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 15 | 2.76e-01 | 1.62e-01 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 14 | 2.93e-01 | 1.62e-01 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 27 | 1.44e-01 | 1.62e-01 | 9.02e-01 |
| GOBP DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM | 6 | 4.91e-01 | 1.62e-01 | 9.95e-01 |
| GOBP NUCLEOLUS ORGANIZATION | 16 | 2.61e-01 | 1.62e-01 | 9.62e-01 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 16 | 2.62e-01 | -1.62e-01 | 9.63e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 5 | 5.30e-01 | 1.62e-01 | 9.95e-01 |
| GOMF RETINOIC ACID RESPONSIVE ELEMENT BINDING | 6 | 4.92e-01 | 1.62e-01 | 9.95e-01 |
| GOBP MOTOR LEARNING | 7 | 4.58e-01 | 1.62e-01 | 9.95e-01 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 29 | 1.31e-01 | 1.62e-01 | 8.96e-01 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 18 | 2.34e-01 | 1.62e-01 | 9.52e-01 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 10 | 3.76e-01 | 1.62e-01 | 9.95e-01 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 13 | 3.12e-01 | 1.62e-01 | 9.87e-01 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 17 | 2.49e-01 | -1.62e-01 | 9.58e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 13 | 3.13e-01 | 1.61e-01 | 9.87e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 11 | 3.54e-01 | 1.61e-01 | 9.95e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 5.32e-01 | 1.61e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 7 | 4.60e-01 | 1.61e-01 | 9.95e-01 |
| GOCC CORE MEDIATOR COMPLEX | 25 | 1.62e-01 | -1.61e-01 | 9.12e-01 |
| GOCC BARR BODY | 7 | 4.60e-01 | 1.61e-01 | 9.95e-01 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 14 | 2.96e-01 | 1.61e-01 | 9.82e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 13 | 3.14e-01 | 1.61e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 17 | 2.50e-01 | 1.61e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 14 | 2.97e-01 | 1.61e-01 | 9.82e-01 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 5.33e-01 | -1.61e-01 | 9.95e-01 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 57 | 3.54e-02 | 1.61e-01 | 7.25e-01 |
| GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 9 | 4.03e-01 | 1.61e-01 | 9.95e-01 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 33 | 1.10e-01 | 1.61e-01 | 8.76e-01 |
| GOBP T CELL HOMEOSTASIS | 44 | 6.49e-02 | -1.61e-01 | 7.99e-01 |
| GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 4.95e-01 | 1.61e-01 | 9.95e-01 |
| GOMF DNA EXONUCLEASE ACTIVITY | 23 | 1.82e-01 | 1.61e-01 | 9.27e-01 |
| GOMF CD4 RECEPTOR BINDING | 8 | 4.31e-01 | 1.61e-01 | 9.95e-01 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 51 | 4.72e-02 | 1.61e-01 | 7.65e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 10 | 3.79e-01 | -1.61e-01 | 9.95e-01 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 77 | 1.48e-02 | -1.61e-01 | 6.25e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL DEGRANULATION | 5 | 5.34e-01 | 1.60e-01 | 9.95e-01 |
| GOBP BRONCHIOLE DEVELOPMENT | 5 | 5.34e-01 | -1.60e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 31 | 1.22e-01 | -1.60e-01 | 8.86e-01 |
| GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 6 | 4.96e-01 | -1.60e-01 | 9.95e-01 |
| GOBP NUCLEOSIDE SALVAGE | 8 | 4.32e-01 | 1.60e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 38 | 8.75e-02 | 1.60e-01 | 8.44e-01 |
| GOMF SULFATIDE BINDING | 6 | 4.97e-01 | 1.60e-01 | 9.95e-01 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 15 | 2.83e-01 | -1.60e-01 | 9.73e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 18 | 2.40e-01 | 1.60e-01 | 9.55e-01 |
| GOMF BILE ACID SODIUM SYMPORTER ACTIVITY | 5 | 5.35e-01 | -1.60e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 7 | 4.63e-01 | 1.60e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 14 | 3.00e-01 | 1.60e-01 | 9.85e-01 |
| GOCC HAPTOGLOBIN HEMOGLOBIN COMPLEX | 11 | 3.59e-01 | 1.60e-01 | 9.95e-01 |
| GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY | 8 | 4.34e-01 | 1.60e-01 | 9.95e-01 |
| GOBP RESPONSE TO MAGNESIUM ION | 20 | 2.16e-01 | -1.60e-01 | 9.42e-01 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 56 | 3.87e-02 | -1.60e-01 | 7.45e-01 |
| GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE | 6 | 4.98e-01 | -1.60e-01 | 9.95e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN | 9 | 4.07e-01 | -1.60e-01 | 9.95e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 27 | 1.51e-01 | 1.60e-01 | 9.04e-01 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 11 | 3.59e-01 | 1.60e-01 | 9.95e-01 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 38 | 8.88e-02 | -1.60e-01 | 8.47e-01 |
| GOBP FLAVIN CONTAINING COMPOUND METABOLIC PROCESS | 6 | 4.99e-01 | 1.59e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 39 | 8.49e-02 | -1.59e-01 | 8.39e-01 |
| GOBP COCHLEA MORPHOGENESIS | 23 | 1.86e-01 | 1.59e-01 | 9.28e-01 |
| GOCC ZONULA ADHERENS | 8 | 4.35e-01 | -1.59e-01 | 9.95e-01 |
| GOBP INDOLE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 5 | 5.37e-01 | -1.59e-01 | 9.95e-01 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 41 | 7.75e-02 | -1.59e-01 | 8.25e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 24 | 1.77e-01 | -1.59e-01 | 9.21e-01 |
| GOBP MECHANOSENSORY BEHAVIOR | 14 | 3.02e-01 | -1.59e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 12 | 3.39e-01 | 1.59e-01 | 9.88e-01 |
| GOBP MAST CELL MIGRATION | 13 | 3.20e-01 | -1.59e-01 | 9.87e-01 |
| GOMF CARBOXY LYASE ACTIVITY | 33 | 1.14e-01 | -1.59e-01 | 8.79e-01 |
| GOBP ORNITHINE METABOLIC PROCESS | 9 | 4.08e-01 | -1.59e-01 | 9.95e-01 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 5.00e-01 | 1.59e-01 | 9.95e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 81 | 1.34e-02 | -1.59e-01 | 6.15e-01 |
| GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 4.67e-01 | 1.59e-01 | 9.95e-01 |
| GOBP LATE NUCLEOPHAGY | 8 | 4.36e-01 | -1.59e-01 | 9.95e-01 |
| GOCC FACIT COLLAGEN TRIMER | 6 | 5.01e-01 | -1.59e-01 | 9.95e-01 |
| GOBP MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION | 5 | 5.39e-01 | 1.59e-01 | 9.95e-01 |
| GOMF COMPLEMENT BINDING | 24 | 1.78e-01 | -1.59e-01 | 9.22e-01 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 10 | 3.85e-01 | 1.59e-01 | 9.95e-01 |
| GOCC FASCIA ADHERENS | 8 | 4.37e-01 | -1.59e-01 | 9.95e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES | 11 | 3.63e-01 | -1.59e-01 | 9.95e-01 |
| GOBP CARNITINE TRANSMEMBRANE TRANSPORT | 6 | 5.01e-01 | 1.58e-01 | 9.95e-01 |
| GOBP B CELL HOMEOSTASIS | 31 | 1.27e-01 | 1.58e-01 | 8.91e-01 |
| GOBP RNA SURVEILLANCE | 17 | 2.58e-01 | 1.58e-01 | 9.58e-01 |
| GOMF NEUROPEPTIDE RECEPTOR BINDING | 33 | 1.15e-01 | 1.58e-01 | 8.82e-01 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 9 | 4.11e-01 | -1.58e-01 | 9.95e-01 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 21 | 2.09e-01 | 1.58e-01 | 9.38e-01 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 19 | 2.33e-01 | -1.58e-01 | 9.50e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 20 | 2.21e-01 | 1.58e-01 | 9.45e-01 |
| GOMF CHITIN BINDING | 8 | 4.39e-01 | -1.58e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 6 | 5.03e-01 | 1.58e-01 | 9.95e-01 |
| GOMF INTERLEUKIN 1 BINDING | 9 | 4.12e-01 | 1.58e-01 | 9.95e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 25 | 1.72e-01 | -1.58e-01 | 9.21e-01 |
| GOBP OPTIC NERVE DEVELOPMENT | 20 | 2.21e-01 | -1.58e-01 | 9.45e-01 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 27 | 1.55e-01 | 1.58e-01 | 9.06e-01 |
| GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY | 5 | 5.41e-01 | 1.58e-01 | 9.95e-01 |
| GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 10 | 3.87e-01 | -1.58e-01 | 9.95e-01 |
| GOBP TUBULIN COMPLEX ASSEMBLY | 8 | 4.40e-01 | 1.58e-01 | 9.95e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 5.03e-01 | 1.58e-01 | 9.95e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 5.41e-01 | 1.58e-01 | 9.95e-01 |
| GOBP NOREPINEPHRINE METABOLIC PROCESS | 12 | 3.45e-01 | -1.57e-01 | 9.92e-01 |
| GOBP CHOLESTEROL IMPORT | 9 | 4.14e-01 | -1.57e-01 | 9.95e-01 |
| GOBP ERBB4 ERBB4 SIGNALING PATHWAY | 6 | 5.04e-01 | -1.57e-01 | 9.95e-01 |
| GOBP SKELETAL MUSCLE ADAPTATION | 25 | 1.73e-01 | 1.57e-01 | 9.21e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 34 | 1.12e-01 | 1.57e-01 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 27 | 1.57e-01 | -1.57e-01 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 9 | 4.14e-01 | -1.57e-01 | 9.95e-01 |
| GOCC BLOC COMPLEX | 14 | 3.09e-01 | 1.57e-01 | 9.87e-01 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 22 | 2.02e-01 | -1.57e-01 | 9.36e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 12 | 3.46e-01 | -1.57e-01 | 9.92e-01 |
| GOCC BASEMENT MEMBRANE | 85 | 1.23e-02 | -1.57e-01 | 6.07e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 16 | 2.77e-01 | -1.57e-01 | 9.73e-01 |
| GOBP PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING | 6 | 5.06e-01 | -1.57e-01 | 9.95e-01 |
| GOBP REGULATION OF OSSIFICATION | 116 | 3.52e-03 | 1.57e-01 | 3.57e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 9 | 4.15e-01 | -1.57e-01 | 9.95e-01 |
| GOMF ALKALINE PHOSPHATASE ACTIVITY | 6 | 5.06e-01 | -1.57e-01 | 9.95e-01 |
| GOMF DEATH RECEPTOR ACTIVITY | 11 | 3.68e-01 | 1.57e-01 | 9.95e-01 |
| GOCC RAGULATOR COMPLEX | 5 | 5.44e-01 | 1.57e-01 | 9.95e-01 |
| GOBP REGULATION OF NADP METABOLIC PROCESS | 9 | 4.16e-01 | -1.57e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 7 | 4.73e-01 | -1.57e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 13 | 3.28e-01 | 1.57e-01 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 11 | 3.69e-01 | -1.57e-01 | 9.95e-01 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 2.78e-01 | -1.57e-01 | 9.73e-01 |
| GOMF INTERFERON RECEPTOR ACTIVITY | 5 | 5.45e-01 | 1.56e-01 | 9.95e-01 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 24 | 1.85e-01 | 1.56e-01 | 9.28e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 3.69e-01 | -1.56e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 8 | 4.44e-01 | 1.56e-01 | 9.95e-01 |
| GOBP RETINAL CELL APOPTOTIC PROCESS | 7 | 4.74e-01 | 1.56e-01 | 9.95e-01 |
| GOMF INSULIN BINDING | 5 | 5.45e-01 | 1.56e-01 | 9.95e-01 |
| GOBP RESPONSE TO INTERFERON BETA | 33 | 1.20e-01 | 1.56e-01 | 8.85e-01 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 1.38e-01 | 1.56e-01 | 9.02e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 7 | 4.74e-01 | 1.56e-01 | 9.95e-01 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 17 | 2.65e-01 | -1.56e-01 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 5.08e-01 | 1.56e-01 | 9.95e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE | 19 | 2.39e-01 | -1.56e-01 | 9.55e-01 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.08e-01 | 1.56e-01 | 9.95e-01 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 12 | 3.49e-01 | -1.56e-01 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION | 8 | 4.45e-01 | 1.56e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 52 | 5.15e-02 | 1.56e-01 | 7.81e-01 |
| GOBP RESPONSE TO HEPARIN | 7 | 4.75e-01 | -1.56e-01 | 9.95e-01 |
| GOBP PROTEIN UFMYLATION | 6 | 5.08e-01 | -1.56e-01 | 9.95e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 64 | 3.09e-02 | -1.56e-01 | 7.02e-01 |
| GOBP NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 9 | 4.18e-01 | -1.56e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR WOUND HEALING | 7 | 4.76e-01 | -1.56e-01 | 9.95e-01 |
| GOBP CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY | 8 | 4.46e-01 | -1.56e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 11 | 3.72e-01 | -1.56e-01 | 9.95e-01 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 30 | 1.40e-01 | 1.56e-01 | 9.02e-01 |
| GOBP RESPONSE TO FRUCTOSE | 8 | 4.46e-01 | 1.55e-01 | 9.95e-01 |
| GOBP TYROSINE METABOLIC PROCESS | 17 | 2.67e-01 | -1.55e-01 | 9.68e-01 |
| GOBP REGULATION OF MITOPHAGY | 15 | 2.97e-01 | 1.55e-01 | 9.83e-01 |
| GOBP INTESTINAL CHOLESTEROL ABSORPTION | 18 | 2.54e-01 | -1.55e-01 | 9.58e-01 |
| GOBP VACUOLAR ACIDIFICATION | 32 | 1.28e-01 | 1.55e-01 | 8.91e-01 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 12 | 3.52e-01 | 1.55e-01 | 9.94e-01 |
| GOBP THYROID STIMULATING HORMONE SECRETING CELL DIFFERENTIATION | 6 | 5.11e-01 | -1.55e-01 | 9.95e-01 |
| GOBP T CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE | 5 | 5.48e-01 | -1.55e-01 | 9.95e-01 |
| GOBP INNER EAR RECEPTOR CELL FATE COMMITMENT | 5 | 5.49e-01 | 1.55e-01 | 9.95e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 56 | 4.49e-02 | 1.55e-01 | 7.59e-01 |
| GOBP CEREBELLAR GRANULAR LAYER MORPHOGENESIS | 8 | 4.48e-01 | 1.55e-01 | 9.95e-01 |
| GOBP RESPONSE TO GLYCOPROTEIN | 11 | 3.74e-01 | 1.55e-01 | 9.95e-01 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 17 | 2.69e-01 | 1.55e-01 | 9.71e-01 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 3.00e-01 | 1.55e-01 | 9.85e-01 |
| GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY | 5 | 5.49e-01 | 1.55e-01 | 9.95e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY | 9 | 4.22e-01 | 1.55e-01 | 9.95e-01 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 60 | 3.84e-02 | -1.55e-01 | 7.45e-01 |
| GOBP MESODERMAL CELL FATE COMMITMENT | 17 | 2.70e-01 | 1.55e-01 | 9.72e-01 |
| GOBP REGULATION OF TELOMERE CAPPING | 26 | 1.73e-01 | 1.54e-01 | 9.21e-01 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 33 | 1.25e-01 | -1.54e-01 | 8.91e-01 |
| GOMF MYOSIN BINDING | 71 | 2.45e-02 | -1.54e-01 | 6.59e-01 |
| GOMF GLYCOLIPID BINDING | 28 | 1.57e-01 | 1.54e-01 | 9.06e-01 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 34 | 1.19e-01 | -1.54e-01 | 8.83e-01 |
| GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER | 6 | 5.13e-01 | -1.54e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 14 | 3.18e-01 | 1.54e-01 | 9.87e-01 |
| GOCC MITOTIC SPINDLE MIDZONE | 13 | 3.36e-01 | 1.54e-01 | 9.88e-01 |
| GOMF LIGAND GATED SODIUM CHANNEL ACTIVITY | 11 | 3.76e-01 | -1.54e-01 | 9.95e-01 |
| GOBP OSTEOBLAST PROLIFERATION | 36 | 1.10e-01 | 1.54e-01 | 8.76e-01 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 11 | 3.76e-01 | -1.54e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 7 | 4.80e-01 | -1.54e-01 | 9.95e-01 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 5.13e-01 | 1.54e-01 | 9.95e-01 |
| GOMF TBP CLASS PROTEIN BINDING | 24 | 1.92e-01 | 1.54e-01 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 14 | 3.19e-01 | 1.54e-01 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 14 | 3.19e-01 | 1.54e-01 | 9.87e-01 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 39 | 9.69e-02 | 1.54e-01 | 8.61e-01 |
| GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 4.52e-01 | 1.54e-01 | 9.95e-01 |
| GOBP LENS FIBER CELL DEVELOPMENT | 14 | 3.20e-01 | -1.54e-01 | 9.87e-01 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 42 | 8.51e-02 | -1.54e-01 | 8.39e-01 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 13 | 3.38e-01 | 1.53e-01 | 9.88e-01 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 13 | 3.38e-01 | 1.53e-01 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 23 | 2.03e-01 | 1.53e-01 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 11 | 3.79e-01 | -1.53e-01 | 9.95e-01 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 36 | 1.12e-01 | 1.53e-01 | 8.77e-01 |
| GOBP REELIN MEDIATED SIGNALING PATHWAY | 7 | 4.83e-01 | 1.53e-01 | 9.95e-01 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 19 | 2.48e-01 | 1.53e-01 | 9.58e-01 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 22 | 2.14e-01 | -1.53e-01 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 33 | 1.28e-01 | -1.53e-01 | 8.91e-01 |
| GOMF RECEPTOR ANTAGONIST ACTIVITY | 16 | 2.89e-01 | -1.53e-01 | 9.77e-01 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 41 | 9.01e-02 | -1.53e-01 | 8.53e-01 |
| GOMF ACETYLCHOLINE RECEPTOR INHIBITOR ACTIVITY | 6 | 5.17e-01 | -1.53e-01 | 9.95e-01 |
| GOBP INTESTINAL STEM CELL HOMEOSTASIS | 6 | 5.17e-01 | -1.53e-01 | 9.95e-01 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 40 | 9.46e-02 | -1.53e-01 | 8.55e-01 |
| GOBP REGULATION OF CARDIOBLAST DIFFERENTIATION | 5 | 5.54e-01 | 1.53e-01 | 9.95e-01 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 39 | 9.90e-02 | 1.53e-01 | 8.64e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 51 | 5.94e-02 | -1.53e-01 | 7.90e-01 |
| GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 6 | 5.18e-01 | -1.52e-01 | 9.95e-01 |
| GOBP KERATINOCYTE APOPTOTIC PROCESS | 7 | 4.85e-01 | 1.52e-01 | 9.95e-01 |
| GOCC PRESPLICEOSOME | 16 | 2.91e-01 | 1.52e-01 | 9.79e-01 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 54 | 5.29e-02 | -1.52e-01 | 7.84e-01 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 45 | 7.72e-02 | 1.52e-01 | 8.25e-01 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 17 | 2.77e-01 | 1.52e-01 | 9.73e-01 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 5.56e-01 | 1.52e-01 | 9.95e-01 |
| GOCC DENDRITE TERMINUS | 12 | 3.62e-01 | 1.52e-01 | 9.95e-01 |
| GOBP RIBOFLAVIN METABOLIC PROCESS | 5 | 5.56e-01 | 1.52e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO ETHANOL | 11 | 3.83e-01 | -1.52e-01 | 9.95e-01 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 20 | 2.39e-01 | -1.52e-01 | 9.55e-01 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 14 | 3.25e-01 | 1.52e-01 | 9.87e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN OSTEOBLAST DIFFERENTIATION | 7 | 4.87e-01 | -1.52e-01 | 9.95e-01 |
| GOBP PROTEIN DEPALMITOYLATION | 8 | 4.58e-01 | -1.52e-01 | 9.95e-01 |
| GOBP VAGINA DEVELOPMENT | 10 | 4.06e-01 | -1.52e-01 | 9.95e-01 |
| GOBP MICROGLIAL CELL MIGRATION | 8 | 4.58e-01 | 1.52e-01 | 9.95e-01 |
| GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 10 | 4.07e-01 | 1.52e-01 | 9.95e-01 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 26 | 1.81e-01 | -1.52e-01 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 18 | 2.66e-01 | 1.51e-01 | 9.67e-01 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 2.53e-01 | 1.51e-01 | 9.58e-01 |
| GOBP CRANIAL GANGLION DEVELOPMENT | 5 | 5.58e-01 | -1.51e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC | 6 | 5.21e-01 | -1.51e-01 | 9.95e-01 |
| GOCC AZUROPHIL GRANULE LUMEN | 88 | 1.41e-02 | 1.51e-01 | 6.25e-01 |
| GOMF ADP PHOSPHATASE ACTIVITY | 5 | 5.58e-01 | -1.51e-01 | 9.95e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 34 | 1.27e-01 | -1.51e-01 | 8.91e-01 |
| GOBP REGULATION OF CENTROMERE COMPLEX ASSEMBLY | 6 | 5.21e-01 | 1.51e-01 | 9.95e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 60 | 4.27e-02 | 1.51e-01 | 7.59e-01 |
| GOCC PARANODAL JUNCTION | 8 | 4.59e-01 | 1.51e-01 | 9.95e-01 |
| GOMF 5ALPHA ANDROSTANE 3BETA 17BETA DIOL DEHYDROGENASE ACTIVITY | 6 | 5.22e-01 | -1.51e-01 | 9.95e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL | 10 | 4.08e-01 | -1.51e-01 | 9.95e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 82 | 1.81e-02 | 1.51e-01 | 6.41e-01 |
| GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX | 7 | 4.89e-01 | 1.51e-01 | 9.95e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS | 11 | 3.86e-01 | 1.51e-01 | 9.95e-01 |
| GOMF TELETHONIN BINDING | 7 | 4.89e-01 | -1.51e-01 | 9.95e-01 |
| GOBP SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION | 10 | 4.09e-01 | 1.51e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 8 | 4.60e-01 | 1.51e-01 | 9.95e-01 |
| GOBP NEURON PROJECTION ARBORIZATION | 31 | 1.46e-01 | -1.51e-01 | 9.02e-01 |
| GOBP INTERFERON ALPHA PRODUCTION | 27 | 1.75e-01 | 1.51e-01 | 9.21e-01 |
| GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 9 | 4.33e-01 | -1.51e-01 | 9.95e-01 |
| GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 12 | 3.66e-01 | 1.51e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 4.33e-01 | -1.51e-01 | 9.95e-01 |
| GOBP HISTAMINE SECRETION | 12 | 3.66e-01 | -1.51e-01 | 9.95e-01 |
| GOCC GRANULAR COMPONENT | 7 | 4.90e-01 | 1.51e-01 | 9.95e-01 |
| GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY | 5 | 5.59e-01 | 1.51e-01 | 9.95e-01 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 26 | 1.83e-01 | 1.51e-01 | 9.28e-01 |
| GOBP NEURON PROJECTION MAINTENANCE | 11 | 3.87e-01 | -1.51e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 13 | 3.47e-01 | 1.51e-01 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 6 | 5.23e-01 | 1.51e-01 | 9.95e-01 |
| GOCC T TUBULE | 51 | 6.29e-02 | -1.51e-01 | 7.98e-01 |
| GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 10 | 4.10e-01 | -1.51e-01 | 9.95e-01 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 10 | 4.10e-01 | 1.51e-01 | 9.95e-01 |
| GOBP TUBULIN DEACETYLATION | 19 | 2.57e-01 | 1.50e-01 | 9.58e-01 |
| GOBP C 5 METHYLATION OF CYTOSINE | 5 | 5.60e-01 | 1.50e-01 | 9.95e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 23 | 2.12e-01 | 1.50e-01 | 9.40e-01 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 15 | 3.14e-01 | 1.50e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 27 | 1.77e-01 | 1.50e-01 | 9.21e-01 |
| GOBP CELL FATE DETERMINATION | 42 | 9.20e-02 | 1.50e-01 | 8.55e-01 |
| GOBP COLLECTING DUCT DEVELOPMENT | 15 | 3.14e-01 | 1.50e-01 | 9.87e-01 |
| GOBP RESPONSE TO THYROGLOBULIN TRIIODOTHYRONINE | 5 | 5.61e-01 | -1.50e-01 | 9.95e-01 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 45 | 8.16e-02 | 1.50e-01 | 8.36e-01 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 5.25e-01 | 1.50e-01 | 9.95e-01 |
| GOBP P38MAPK CASCADE | 57 | 5.01e-02 | 1.50e-01 | 7.77e-01 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 32 | 1.42e-01 | -1.50e-01 | 9.02e-01 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 24 | 2.03e-01 | 1.50e-01 | 9.36e-01 |
| GOBP REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS | 7 | 4.92e-01 | 1.50e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 66 | 3.51e-02 | 1.50e-01 | 7.25e-01 |
| GOCC STEREOCILIUM TIP | 19 | 2.58e-01 | -1.50e-01 | 9.58e-01 |
| GOMF TOLL LIKE RECEPTOR BINDING | 14 | 3.31e-01 | -1.50e-01 | 9.88e-01 |
| GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 12 | 3.69e-01 | -1.50e-01 | 9.95e-01 |
| GOBP LEARNING | 145 | 1.85e-03 | -1.50e-01 | 2.69e-01 |
| GOMF OPIOID RECEPTOR BINDING | 7 | 4.93e-01 | -1.50e-01 | 9.95e-01 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 11 | 3.90e-01 | -1.50e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 27 | 1.78e-01 | -1.50e-01 | 9.22e-01 |
| GOBP COMMON BILE DUCT DEVELOPMENT | 5 | 5.62e-01 | 1.50e-01 | 9.95e-01 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 46 | 7.91e-02 | -1.50e-01 | 8.29e-01 |
| GOCC GLYCOGEN GRANULE | 7 | 4.93e-01 | 1.50e-01 | 9.95e-01 |
| GOBP NUCLEAR MIGRATION ALONG MICROTUBULE | 5 | 5.62e-01 | 1.50e-01 | 9.95e-01 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 7 | 4.93e-01 | -1.50e-01 | 9.95e-01 |
| GOBP RESPONSE TO 2 3 7 8 TETRACHLORODIBENZODIOXINE | 5 | 5.63e-01 | 1.50e-01 | 9.95e-01 |
| GOBP VITAMIN D METABOLIC PROCESS | 20 | 2.47e-01 | -1.49e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 11 | 3.91e-01 | -1.49e-01 | 9.95e-01 |
| GOBP CELL AGGREGATION | 23 | 2.15e-01 | 1.49e-01 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 20 | 2.47e-01 | 1.49e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD | 10 | 4.13e-01 | -1.49e-01 | 9.95e-01 |
| GOCC GERM CELL NUCLEUS | 68 | 3.32e-02 | 1.49e-01 | 7.11e-01 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 12 | 3.71e-01 | 1.49e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 5 | 5.63e-01 | 1.49e-01 | 9.95e-01 |
| GOCC PLATELET DENSE GRANULE LUMEN | 14 | 3.34e-01 | -1.49e-01 | 9.88e-01 |
| GOBP PYROPTOSIS | 36 | 1.21e-01 | 1.49e-01 | 8.86e-01 |
| GOMF NADPLUS PROTEIN ARGININE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 5.27e-01 | -1.49e-01 | 9.95e-01 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 29 | 1.64e-01 | 1.49e-01 | 9.15e-01 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 27 | 1.80e-01 | -1.49e-01 | 9.25e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 11 | 3.92e-01 | -1.49e-01 | 9.95e-01 |
| GOBP RESPONSE TO DSRNA | 52 | 6.28e-02 | 1.49e-01 | 7.98e-01 |
| GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 6 | 5.27e-01 | 1.49e-01 | 9.95e-01 |
| GOCC R2TP COMPLEX | 5 | 5.64e-01 | 1.49e-01 | 9.95e-01 |
| GOMF UBIQUITIN LIGASE ACTIVATOR ACTIVITY | 7 | 4.95e-01 | -1.49e-01 | 9.95e-01 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 24 | 2.06e-01 | 1.49e-01 | 9.38e-01 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 9 | 4.39e-01 | 1.49e-01 | 9.95e-01 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 36 | 1.22e-01 | 1.49e-01 | 8.86e-01 |
| GOCC APICOLATERAL PLASMA MEMBRANE | 22 | 2.27e-01 | -1.49e-01 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 18 | 2.74e-01 | -1.49e-01 | 9.73e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN AXIS ELONGATION | 6 | 5.28e-01 | -1.49e-01 | 9.95e-01 |
| GOBP MESENCHYMAL STEM CELL MAINTENANCE INVOLVED IN NEPHRON MORPHOGENESIS | 6 | 5.28e-01 | -1.49e-01 | 9.95e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 15 | 3.19e-01 | -1.49e-01 | 9.87e-01 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 9 | 4.40e-01 | 1.49e-01 | 9.95e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 7 | 4.96e-01 | -1.49e-01 | 9.95e-01 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 17 | 2.89e-01 | -1.49e-01 | 9.77e-01 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 10 | 4.16e-01 | -1.49e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 15 | 3.19e-01 | 1.49e-01 | 9.87e-01 |
| GOBP VIRAL RELEASE FROM HOST CELL | 28 | 1.74e-01 | 1.49e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS BY VEGF ACTIVATED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 5.65e-01 | 1.49e-01 | 9.95e-01 |
| GOBP GLUTAMATE CATABOLIC PROCESS | 7 | 4.96e-01 | 1.49e-01 | 9.95e-01 |
| GOBP VESICLE TETHERING | 31 | 1.52e-01 | 1.49e-01 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 5 | 5.65e-01 | -1.49e-01 | 9.95e-01 |
| GOMF MICROTUBULE SEVERING ATPASE ACTIVITY | 9 | 4.41e-01 | 1.48e-01 | 9.95e-01 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 37 | 1.19e-01 | -1.48e-01 | 8.83e-01 |
| GOBP MALE MATING BEHAVIOR | 6 | 5.30e-01 | 1.48e-01 | 9.95e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 17 | 2.90e-01 | -1.48e-01 | 9.78e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 5.66e-01 | 1.48e-01 | 9.95e-01 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 102 | 9.74e-03 | 1.48e-01 | 5.57e-01 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 18 | 2.77e-01 | -1.48e-01 | 9.73e-01 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 21 | 2.40e-01 | 1.48e-01 | 9.57e-01 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 24 | 2.09e-01 | 1.48e-01 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 31 | 1.54e-01 | 1.48e-01 | 9.06e-01 |
| GOBP REGULATION OF PROSTATIC BUD FORMATION | 5 | 5.67e-01 | 1.48e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 11 | 3.96e-01 | 1.48e-01 | 9.95e-01 |
| GOBP FORMATE METABOLIC PROCESS | 6 | 5.31e-01 | 1.48e-01 | 9.95e-01 |
| GOCC CELL BODY MEMBRANE | 32 | 1.49e-01 | 1.48e-01 | 9.04e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 66 | 3.82e-02 | 1.48e-01 | 7.45e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 20 | 2.53e-01 | 1.48e-01 | 9.58e-01 |
| GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 4.44e-01 | 1.47e-01 | 9.95e-01 |
| GOMF SPHINGOLIPID TRANSFER ACTIVITY | 9 | 4.44e-01 | 1.47e-01 | 9.95e-01 |
| GOBP EPINEPHRINE TRANSPORT | 11 | 3.98e-01 | 1.47e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT | 6 | 5.32e-01 | -1.47e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 44 | 9.13e-02 | 1.47e-01 | 8.53e-01 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 31 | 1.56e-01 | -1.47e-01 | 9.06e-01 |
| GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 4.46e-01 | 1.47e-01 | 9.95e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 54 | 6.19e-02 | 1.47e-01 | 7.98e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 16 | 3.09e-01 | 1.47e-01 | 9.87e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE | 46 | 8.50e-02 | 1.47e-01 | 8.39e-01 |
| GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 5.34e-01 | 1.47e-01 | 9.95e-01 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 45 | 8.86e-02 | 1.47e-01 | 8.47e-01 |
| GOBP KERATINOCYTE MIGRATION | 20 | 2.56e-01 | 1.47e-01 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 26 | 1.95e-01 | 1.47e-01 | 9.30e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 5.34e-01 | 1.47e-01 | 9.95e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 31 | 1.58e-01 | 1.47e-01 | 9.06e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 11 | 4.00e-01 | -1.47e-01 | 9.95e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 175 | 8.24e-04 | 1.47e-01 | 1.79e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 44 | 9.27e-02 | 1.47e-01 | 8.55e-01 |
| GOBP POLYKETIDE METABOLIC PROCESS | 10 | 4.22e-01 | 1.46e-01 | 9.95e-01 |
| GOMF UNMETHYLATED CPG BINDING | 9 | 4.47e-01 | 1.46e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 30 | 1.65e-01 | -1.46e-01 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 12 | 3.80e-01 | 1.46e-01 | 9.95e-01 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 11 | 4.01e-01 | 1.46e-01 | 9.95e-01 |
| GOMF DYNEIN COMPLEX BINDING | 23 | 2.25e-01 | 1.46e-01 | 9.49e-01 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 18 | 2.83e-01 | -1.46e-01 | 9.73e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS | 9 | 4.47e-01 | -1.46e-01 | 9.95e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT | 9 | 4.48e-01 | 1.46e-01 | 9.95e-01 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 10 | 4.24e-01 | -1.46e-01 | 9.95e-01 |
| GOBP SNO S RNA PROCESSING | 12 | 3.81e-01 | 1.46e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 24 | 2.15e-01 | 1.46e-01 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 31 | 1.59e-01 | 1.46e-01 | 9.06e-01 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 53 | 6.60e-02 | 1.46e-01 | 7.99e-01 |
| GOBP METHIONINE METABOLIC PROCESS | 15 | 3.28e-01 | 1.46e-01 | 9.87e-01 |
| GOBP FACIAL NERVE STRUCTURAL ORGANIZATION | 7 | 5.05e-01 | -1.46e-01 | 9.95e-01 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 23 | 2.27e-01 | 1.46e-01 | 9.50e-01 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 22 | 2.37e-01 | 1.46e-01 | 9.52e-01 |
| GOBP BONE TRABECULA FORMATION | 10 | 4.26e-01 | 1.45e-01 | 9.95e-01 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 2.99e-01 | -1.45e-01 | 9.85e-01 |
| GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 8 | 4.76e-01 | 1.45e-01 | 9.95e-01 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 15 | 3.30e-01 | -1.45e-01 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 5 | 5.74e-01 | -1.45e-01 | 9.95e-01 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 13 | 3.65e-01 | 1.45e-01 | 9.95e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 17 | 3.00e-01 | 1.45e-01 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 18 | 2.87e-01 | 1.45e-01 | 9.75e-01 |
| GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 7 | 5.07e-01 | 1.45e-01 | 9.95e-01 |
| GOMF EXTRACELLULARLY ATP GATED MONOATOMIC CATION CHANNEL ACTIVITY | 7 | 5.07e-01 | 1.45e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 13 | 3.66e-01 | 1.45e-01 | 9.95e-01 |
| GOMF TYPE 1 ANGIOTENSIN RECEPTOR BINDING | 6 | 5.39e-01 | 1.45e-01 | 9.95e-01 |
| GOMF TYPE I INTERFERON RECEPTOR BINDING | 13 | 3.66e-01 | 1.45e-01 | 9.95e-01 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 33 | 1.50e-01 | -1.45e-01 | 9.04e-01 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 25 | 2.10e-01 | 1.45e-01 | 9.40e-01 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 28 | 1.85e-01 | 1.45e-01 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 33 | 1.50e-01 | 1.45e-01 | 9.04e-01 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 27 | 1.93e-01 | -1.45e-01 | 9.28e-01 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 7 | 5.08e-01 | 1.45e-01 | 9.95e-01 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 15 | 3.32e-01 | -1.45e-01 | 9.88e-01 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 19 | 2.75e-01 | 1.45e-01 | 9.73e-01 |
| GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 10 | 4.29e-01 | 1.45e-01 | 9.95e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS | 10 | 4.29e-01 | 1.45e-01 | 9.95e-01 |
| GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 11 | 4.07e-01 | -1.45e-01 | 9.95e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 18 | 2.89e-01 | -1.44e-01 | 9.77e-01 |
| GOBP DISACCHARIDE METABOLIC PROCESS | 11 | 4.07e-01 | -1.44e-01 | 9.95e-01 |
| GOMF GABA RECEPTOR ACTIVITY | 19 | 2.76e-01 | 1.44e-01 | 9.73e-01 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 21 | 2.52e-01 | -1.44e-01 | 9.58e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 44 | 9.77e-02 | 1.44e-01 | 8.61e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 5.41e-01 | -1.44e-01 | 9.95e-01 |
| GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 4.80e-01 | 1.44e-01 | 9.95e-01 |
| GOBP RESPONSE TO AMYLOID BETA | 54 | 6.69e-02 | -1.44e-01 | 7.99e-01 |
| GOBP PEPTIDE MODIFICATION | 5 | 5.77e-01 | -1.44e-01 | 9.96e-01 |
| GOMF POTASSIUM ION LEAK CHANNEL ACTIVITY | 16 | 3.19e-01 | -1.44e-01 | 9.87e-01 |
| GOBP PLASMA MEMBRANE FUSION | 30 | 1.72e-01 | -1.44e-01 | 9.21e-01 |
| GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS | 10 | 4.31e-01 | -1.44e-01 | 9.95e-01 |
| GOBP NUCLEOBASE CATABOLIC PROCESS | 10 | 4.31e-01 | -1.44e-01 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 5.78e-01 | 1.44e-01 | 9.96e-01 |
| GOCC SPECTRIN | 9 | 4.55e-01 | -1.44e-01 | 9.95e-01 |
| GOBP SNRNA TRANSCRIPTION | 19 | 2.78e-01 | 1.44e-01 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 7 | 5.10e-01 | 1.44e-01 | 9.95e-01 |
| GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 5 | 5.78e-01 | -1.44e-01 | 9.96e-01 |
| GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 5.42e-01 | 1.44e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 6 | 5.42e-01 | 1.44e-01 | 9.95e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 13 | 3.70e-01 | 1.44e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 16 | 3.20e-01 | -1.44e-01 | 9.87e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 70 | 3.78e-02 | 1.44e-01 | 7.44e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 45 | 9.58e-02 | 1.43e-01 | 8.60e-01 |
| GOCC FEMALE GERM CELL NUCLEUS | 17 | 3.06e-01 | 1.43e-01 | 9.87e-01 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 16 | 3.20e-01 | 1.43e-01 | 9.87e-01 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 71 | 3.66e-02 | 1.43e-01 | 7.31e-01 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 28 | 1.89e-01 | -1.43e-01 | 9.28e-01 |
| GOBP I KAPPAB PHOSPHORYLATION | 15 | 3.36e-01 | 1.43e-01 | 9.88e-01 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 109 | 9.70e-03 | -1.43e-01 | 5.57e-01 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 32 | 1.60e-01 | -1.43e-01 | 9.06e-01 |
| GOBP MONOACYLGLYCEROL BIOSYNTHETIC PROCESS | 5 | 5.79e-01 | -1.43e-01 | 9.96e-01 |
| GOBP COMPLEMENT ACTIVATION | 56 | 6.37e-02 | -1.43e-01 | 7.99e-01 |
| GOMF TPR DOMAIN BINDING | 7 | 5.12e-01 | 1.43e-01 | 9.95e-01 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 23 | 2.35e-01 | 1.43e-01 | 9.52e-01 |
| GOBP NEURON NEURON SYNAPTIC TRANSMISSION | 6 | 5.44e-01 | -1.43e-01 | 9.95e-01 |
| GOBP RESPONSE TO GRAM POSITIVE BACTERIUM | 5 | 5.79e-01 | -1.43e-01 | 9.96e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 28 | 1.90e-01 | 1.43e-01 | 9.28e-01 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 17 | 3.07e-01 | -1.43e-01 | 9.87e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 12 | 3.91e-01 | 1.43e-01 | 9.95e-01 |
| GOBP WYBUTOSINE METABOLIC PROCESS | 6 | 5.44e-01 | -1.43e-01 | 9.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 10 | 4.34e-01 | -1.43e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO UV A | 10 | 4.34e-01 | 1.43e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 5.12e-01 | 1.43e-01 | 9.95e-01 |
| GOBP ORNITHINE TRANSPORT | 6 | 5.44e-01 | -1.43e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 10 | 4.34e-01 | -1.43e-01 | 9.95e-01 |
| GOCC RNA POLYMERASE III COMPLEX | 18 | 2.94e-01 | 1.43e-01 | 9.80e-01 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 157 | 2.00e-03 | -1.43e-01 | 2.84e-01 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 12 | 3.91e-01 | -1.43e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 9 | 4.58e-01 | 1.43e-01 | 9.95e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 21 | 2.57e-01 | -1.43e-01 | 9.58e-01 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 43 | 1.05e-01 | 1.43e-01 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 36 | 1.38e-01 | 1.43e-01 | 9.02e-01 |
| GOBP MRNA 3 END PROCESSING | 49 | 8.39e-02 | 1.43e-01 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 5.45e-01 | 1.43e-01 | 9.95e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 10 | 4.35e-01 | -1.43e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 21 | 2.58e-01 | 1.43e-01 | 9.58e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 10 | 4.35e-01 | -1.43e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 7 | 5.14e-01 | 1.43e-01 | 9.95e-01 |
| GOBP TOLERANCE INDUCTION | 29 | 1.84e-01 | 1.42e-01 | 9.28e-01 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 35 | 1.45e-01 | 1.42e-01 | 9.02e-01 |
| GOCC ENDOLYSOSOME MEMBRANE | 17 | 3.10e-01 | -1.42e-01 | 9.87e-01 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 63 | 5.08e-02 | 1.42e-01 | 7.81e-01 |
| GOMF INITIATOR METHIONYL AMINOPEPTIDASE ACTIVITY | 5 | 5.82e-01 | 1.42e-01 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 39 | 1.24e-01 | 1.42e-01 | 8.91e-01 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 36 | 1.40e-01 | -1.42e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 13 | 3.75e-01 | 1.42e-01 | 9.95e-01 |
| GOCC GBAF COMPLEX | 14 | 3.57e-01 | 1.42e-01 | 9.95e-01 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 21 | 2.60e-01 | 1.42e-01 | 9.59e-01 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 16 | 3.25e-01 | -1.42e-01 | 9.87e-01 |
| GOCC EXON EXON JUNCTION COMPLEX | 10 | 4.37e-01 | -1.42e-01 | 9.95e-01 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 25 | 2.19e-01 | 1.42e-01 | 9.43e-01 |
| GOMF AMIDINE LYASE ACTIVITY | 7 | 5.16e-01 | 1.42e-01 | 9.95e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 25 | 2.19e-01 | -1.42e-01 | 9.43e-01 |
| GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 5 | 5.83e-01 | 1.42e-01 | 9.96e-01 |
| GOCC 90S PRERIBOSOME | 28 | 1.94e-01 | 1.42e-01 | 9.28e-01 |
| GOBP PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE | 8 | 4.88e-01 | 1.42e-01 | 9.95e-01 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 59 | 5.98e-02 | -1.42e-01 | 7.90e-01 |
| GOBP CONVERGENT EXTENSION | 15 | 3.42e-01 | -1.42e-01 | 9.91e-01 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 49 | 8.64e-02 | 1.42e-01 | 8.39e-01 |
| GOBP TRNA THIO MODIFICATION | 5 | 5.84e-01 | -1.42e-01 | 9.96e-01 |
| GOBP THERMOCEPTION | 8 | 4.88e-01 | -1.42e-01 | 9.95e-01 |
| GOCC BBSOME | 8 | 4.88e-01 | -1.42e-01 | 9.95e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 | 12 | 3.96e-01 | 1.42e-01 | 9.95e-01 |
| GOMF BUTYRATE COA LIGASE ACTIVITY | 8 | 4.89e-01 | -1.41e-01 | 9.95e-01 |
| GOBP ACROSOMAL VESICLE EXOCYTOSIS | 9 | 4.63e-01 | -1.41e-01 | 9.95e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 27 | 2.04e-01 | -1.41e-01 | 9.36e-01 |
| GOBP TRYPTOPHAN CATABOLIC PROCESS | 9 | 4.63e-01 | -1.41e-01 | 9.95e-01 |
| GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 12 | 3.97e-01 | -1.41e-01 | 9.95e-01 |
| GOMF ARP2 3 COMPLEX BINDING | 14 | 3.60e-01 | 1.41e-01 | 9.95e-01 |
| GOMF WNT RECEPTOR ACTIVITY | 17 | 3.14e-01 | 1.41e-01 | 9.87e-01 |
| GOBP CHROMOSOME ATTACHMENT TO THE NUCLEAR ENVELOPE | 7 | 5.18e-01 | 1.41e-01 | 9.95e-01 |
| GOBP POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING | 9 | 4.63e-01 | 1.41e-01 | 9.95e-01 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 12 | 3.97e-01 | 1.41e-01 | 9.95e-01 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 38 | 1.33e-01 | 1.41e-01 | 8.96e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 9 | 4.64e-01 | 1.41e-01 | 9.95e-01 |
| GOBP HEART VALVE FORMATION | 15 | 3.45e-01 | 1.41e-01 | 9.92e-01 |
| GOBP TYROSINE CATABOLIC PROCESS | 6 | 5.50e-01 | -1.41e-01 | 9.95e-01 |
| GOCC ELONGIN COMPLEX | 5 | 5.86e-01 | -1.41e-01 | 9.96e-01 |
| GOBP PROTEIN NITROSYLATION | 15 | 3.45e-01 | -1.41e-01 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MOLECULE PRODUCTION | 10 | 4.41e-01 | 1.41e-01 | 9.95e-01 |
| GOBP AMINO ACID NEUROTRANSMITTER REUPTAKE | 10 | 4.41e-01 | -1.41e-01 | 9.95e-01 |
| GOMF OMEGA PEPTIDASE ACTIVITY | 13 | 3.80e-01 | -1.41e-01 | 9.95e-01 |
| GOBP MICROVILLUS ORGANIZATION | 28 | 1.98e-01 | -1.41e-01 | 9.36e-01 |
| GOBP SECRETORY GRANULE LOCALIZATION | 13 | 3.80e-01 | 1.41e-01 | 9.95e-01 |
| GOMF DNA REPLICATION ORIGIN BINDING | 15 | 3.46e-01 | -1.40e-01 | 9.92e-01 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 28 | 1.99e-01 | 1.40e-01 | 9.36e-01 |
| GOMF PROTON CHANNEL ACTIVITY | 24 | 2.34e-01 | -1.40e-01 | 9.52e-01 |
| GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 16 | 3.32e-01 | -1.40e-01 | 9.88e-01 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 5.87e-01 | -1.40e-01 | 9.97e-01 |
| GOBP RELAXATION OF MUSCLE | 33 | 1.64e-01 | 1.40e-01 | 9.12e-01 |
| GOMF ALPHA ADRENERGIC RECEPTOR ACTIVITY | 6 | 5.52e-01 | 1.40e-01 | 9.95e-01 |
| GOBP RESPONSE TO UV A | 13 | 3.82e-01 | 1.40e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 22 | 2.55e-01 | -1.40e-01 | 9.58e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 33 | 1.64e-01 | -1.40e-01 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 22 | 2.55e-01 | 1.40e-01 | 9.58e-01 |
| GOBP PROTEIN LOCALIZATION TO AXON | 9 | 4.67e-01 | -1.40e-01 | 9.95e-01 |
| GOMF ATP ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 5.53e-01 | -1.40e-01 | 9.95e-01 |
| GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY | 6 | 5.53e-01 | -1.40e-01 | 9.95e-01 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 19 | 2.91e-01 | -1.40e-01 | 9.79e-01 |
| GOMF ACTIVIN BINDING | 11 | 4.22e-01 | 1.40e-01 | 9.95e-01 |
| GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 8 | 4.93e-01 | 1.40e-01 | 9.95e-01 |
| GOCC BLEB | 9 | 4.67e-01 | 1.40e-01 | 9.95e-01 |
| GOBP RESPONSE TO IRON II ION | 6 | 5.53e-01 | 1.40e-01 | 9.95e-01 |
| GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 6 | 5.53e-01 | -1.40e-01 | 9.95e-01 |
| GOBP HOMOLOGOUS RECOMBINATION | 65 | 5.11e-02 | 1.40e-01 | 7.81e-01 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 63 | 5.49e-02 | 1.40e-01 | 7.90e-01 |
| GOMF ALL TRANS RETINAL BINDING | 5 | 5.88e-01 | -1.40e-01 | 9.97e-01 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 4.94e-01 | -1.40e-01 | 9.95e-01 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 58 | 6.58e-02 | 1.40e-01 | 7.99e-01 |
| GOBP FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY | 5 | 5.89e-01 | -1.40e-01 | 9.97e-01 |
| GOMF CENTROMERIC DNA BINDING | 6 | 5.54e-01 | -1.40e-01 | 9.95e-01 |
| GOBP MICROVILLUS ASSEMBLY | 20 | 2.80e-01 | -1.40e-01 | 9.73e-01 |
| GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION | 7 | 5.23e-01 | 1.40e-01 | 9.95e-01 |
| GOBP MINERALOCORTICOID METABOLIC PROCESS | 13 | 3.84e-01 | -1.39e-01 | 9.95e-01 |
| GOBP MITOCHONDRION DISTRIBUTION | 16 | 3.35e-01 | 1.39e-01 | 9.88e-01 |
| GOCC PROTEASE INHIBITOR COMPLEX | 8 | 4.95e-01 | -1.39e-01 | 9.95e-01 |
| GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING | 10 | 4.46e-01 | -1.39e-01 | 9.95e-01 |
| GOMF AMINO ACID PROTON SYMPORTER ACTIVITY | 6 | 5.55e-01 | 1.39e-01 | 9.95e-01 |
| GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 16 | 3.35e-01 | -1.39e-01 | 9.88e-01 |
| GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 10 | 4.46e-01 | 1.39e-01 | 9.95e-01 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 19 | 2.94e-01 | -1.39e-01 | 9.80e-01 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 43 | 1.14e-01 | -1.39e-01 | 8.80e-01 |
| GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 8 | 4.96e-01 | -1.39e-01 | 9.95e-01 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 8 | 4.96e-01 | 1.39e-01 | 9.95e-01 |
| GOBP FRUCTOSE METABOLIC PROCESS | 13 | 3.85e-01 | 1.39e-01 | 9.95e-01 |
| GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 4.04e-01 | -1.39e-01 | 9.95e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 35 | 1.55e-01 | -1.39e-01 | 9.06e-01 |
| GOBP REGULATION OF IRON ION TRANSPORT | 7 | 5.24e-01 | 1.39e-01 | 9.95e-01 |
| GOBP BEHAVIORAL RESPONSE TO ETHANOL | 10 | 4.47e-01 | -1.39e-01 | 9.95e-01 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 28 | 2.04e-01 | 1.39e-01 | 9.36e-01 |
| GOMF CHEMOREPELLENT ACTIVITY | 28 | 2.04e-01 | -1.39e-01 | 9.36e-01 |
| GOBP SEROTONIN METABOLIC PROCESS | 10 | 4.48e-01 | -1.39e-01 | 9.95e-01 |
| GOMF ACID THIOL LIGASE ACTIVITY | 29 | 1.97e-01 | -1.39e-01 | 9.33e-01 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 32 | 1.75e-01 | 1.38e-01 | 9.21e-01 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 58 | 6.82e-02 | 1.38e-01 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 5.57e-01 | 1.38e-01 | 9.95e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 17 | 3.24e-01 | 1.38e-01 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF KIDNEY DEVELOPMENT | 9 | 4.73e-01 | -1.38e-01 | 9.95e-01 |
| GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 13 | 3.88e-01 | 1.38e-01 | 9.95e-01 |
| GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 15 | 3.55e-01 | 1.38e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 15 | 3.55e-01 | -1.38e-01 | 9.95e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 25 | 2.33e-01 | 1.38e-01 | 9.50e-01 |
| GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS | 8 | 5.00e-01 | 1.38e-01 | 9.95e-01 |
| GOMF FLAP ENDONUCLEASE ACTIVITY | 6 | 5.59e-01 | 1.38e-01 | 9.95e-01 |
| GOMF N ACETYLGALACTOSAMINE 4 O SULFOTRANSFERASE ACTIVITY | 5 | 5.94e-01 | 1.38e-01 | 9.98e-01 |
| GOBP RESPONSE TO UV C | 14 | 3.72e-01 | 1.38e-01 | 9.95e-01 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 12 | 4.09e-01 | 1.38e-01 | 9.95e-01 |
| GOBP SULFATE TRANSPORT | 17 | 3.26e-01 | -1.38e-01 | 9.87e-01 |
| GOCC GROWTH FACTOR COMPLEX | 8 | 5.00e-01 | 1.38e-01 | 9.95e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 6 | 5.59e-01 | -1.38e-01 | 9.95e-01 |
| GOBP BRAIN MORPHOGENESIS | 37 | 1.48e-01 | 1.38e-01 | 9.04e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 21 | 2.75e-01 | -1.38e-01 | 9.73e-01 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 17 | 3.26e-01 | 1.37e-01 | 9.87e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 51 | 8.94e-02 | -1.37e-01 | 8.49e-01 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 20 | 2.87e-01 | 1.37e-01 | 9.75e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 38 | 1.43e-01 | 1.37e-01 | 9.02e-01 |
| GOMF CATECHOLAMINE BINDING | 12 | 4.10e-01 | 1.37e-01 | 9.95e-01 |
| GOBP MEIOTIC TELOMERE CLUSTERING | 10 | 4.52e-01 | 1.37e-01 | 9.95e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 6 | 5.60e-01 | 1.37e-01 | 9.95e-01 |
| GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 3.13e-01 | -1.37e-01 | 9.87e-01 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 31 | 1.86e-01 | 1.37e-01 | 9.28e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 12 | 4.11e-01 | 1.37e-01 | 9.95e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 38 | 1.44e-01 | 1.37e-01 | 9.02e-01 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 28 | 2.09e-01 | -1.37e-01 | 9.38e-01 |
| GOBP MANCHETTE ASSEMBLY | 6 | 5.61e-01 | 1.37e-01 | 9.95e-01 |
| GOCC DNA POLYMERASE COMPLEX | 18 | 3.14e-01 | 1.37e-01 | 9.87e-01 |
| GOBP DUMP METABOLIC PROCESS | 7 | 5.30e-01 | -1.37e-01 | 9.95e-01 |
| GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 9 | 4.77e-01 | 1.37e-01 | 9.95e-01 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 21 | 2.78e-01 | 1.37e-01 | 9.73e-01 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 18 | 3.15e-01 | 1.37e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 11 | 4.32e-01 | 1.37e-01 | 9.95e-01 |
| GOMF RAGE RECEPTOR BINDING | 10 | 4.54e-01 | -1.37e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON BETA | 26 | 2.28e-01 | 1.37e-01 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF IMMATURE T CELL PROLIFERATION | 5 | 5.97e-01 | -1.37e-01 | 9.98e-01 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 37 | 1.50e-01 | 1.37e-01 | 9.04e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 26 | 2.28e-01 | -1.37e-01 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 61 | 6.51e-02 | 1.37e-01 | 7.99e-01 |
| GOMF ARACHIDONIC ACID MONOOXYGENASE ACTIVITY | 17 | 3.30e-01 | -1.36e-01 | 9.88e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 12 | 4.13e-01 | 1.36e-01 | 9.95e-01 |
| GOBP ESTROGEN BIOSYNTHETIC PROCESS | 11 | 4.33e-01 | 1.36e-01 | 9.95e-01 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 23 | 2.58e-01 | 1.36e-01 | 9.58e-01 |
| GOBP EOSINOPHIL MIGRATION | 28 | 2.12e-01 | -1.36e-01 | 9.40e-01 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 8 | 5.04e-01 | -1.36e-01 | 9.95e-01 |
| GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 8 | 5.04e-01 | -1.36e-01 | 9.95e-01 |
| GOMF DNA INSERTION OR DELETION BINDING | 6 | 5.63e-01 | 1.36e-01 | 9.95e-01 |
| GOBP LYTIC VACUOLE ORGANIZATION | 103 | 1.69e-02 | 1.36e-01 | 6.37e-01 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 91 | 2.48e-02 | -1.36e-01 | 6.63e-01 |
| GOBP RENAL VESICLE FORMATION | 8 | 5.05e-01 | 1.36e-01 | 9.95e-01 |
| GOBP CYTOPLASM ORGANIZATION | 15 | 3.61e-01 | 1.36e-01 | 9.95e-01 |
| GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 5.05e-01 | -1.36e-01 | 9.95e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 12 | 4.14e-01 | 1.36e-01 | 9.95e-01 |
| GOCC METHYLOSOME | 13 | 3.96e-01 | 1.36e-01 | 9.95e-01 |
| GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 5.34e-01 | -1.36e-01 | 9.95e-01 |
| GOBP METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT | 9 | 4.80e-01 | 1.36e-01 | 9.95e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 38 | 1.47e-01 | 1.36e-01 | 9.04e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 9 | 4.81e-01 | -1.36e-01 | 9.95e-01 |
| GOCC CELL BODY FIBER | 7 | 5.34e-01 | 1.36e-01 | 9.95e-01 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 29 | 2.06e-01 | -1.36e-01 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 5.99e-01 | -1.36e-01 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 31 | 1.91e-01 | 1.36e-01 | 9.28e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 5.65e-01 | 1.36e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION | 7 | 5.34e-01 | -1.36e-01 | 9.95e-01 |
| GOBP ICOSANOID CATABOLIC PROCESS | 9 | 4.81e-01 | -1.36e-01 | 9.95e-01 |
| GOMF FMN BINDING | 15 | 3.63e-01 | 1.36e-01 | 9.95e-01 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 22 | 2.71e-01 | 1.36e-01 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 7 | 5.35e-01 | 1.35e-01 | 9.95e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 17 | 3.34e-01 | 1.35e-01 | 9.88e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 8 | 5.07e-01 | 1.35e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 27 | 2.23e-01 | 1.35e-01 | 9.46e-01 |
| GOBP AUTOPHAGOSOME LYSOSOME FUSION | 9 | 4.82e-01 | 1.35e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 9 | 4.82e-01 | -1.35e-01 | 9.95e-01 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 22 | 2.72e-01 | 1.35e-01 | 9.73e-01 |
| GOBP REGULATION OF MESONEPHROS DEVELOPMENT | 5 | 6.00e-01 | 1.35e-01 | 9.98e-01 |
| GOBP C X C CHEMOKINE RECEPTOR CXCR4 SIGNALING PATHWAY | 5 | 6.00e-01 | 1.35e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 7 | 5.35e-01 | 1.35e-01 | 9.95e-01 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 39 | 1.44e-01 | 1.35e-01 | 9.02e-01 |
| GOBP COLLAGEN CATABOLIC PROCESS | 44 | 1.21e-01 | -1.35e-01 | 8.86e-01 |
| GOBP LIPOXIN METABOLIC PROCESS | 5 | 6.01e-01 | 1.35e-01 | 9.98e-01 |
| GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 10 | 4.60e-01 | -1.35e-01 | 9.95e-01 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 54 | 8.62e-02 | -1.35e-01 | 8.39e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 5.67e-01 | -1.35e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS | 11 | 4.39e-01 | -1.35e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 23 | 2.63e-01 | -1.35e-01 | 9.64e-01 |
| GOMF STEROL ESTERASE ACTIVITY | 7 | 5.37e-01 | -1.35e-01 | 9.95e-01 |
| GOMF S ADENOSYL L METHIONINE BINDING | 19 | 3.09e-01 | 1.35e-01 | 9.87e-01 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 22 | 2.74e-01 | 1.35e-01 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 12 | 4.19e-01 | -1.35e-01 | 9.95e-01 |
| GOMF OPSONIN BINDING | 19 | 3.10e-01 | -1.35e-01 | 9.87e-01 |
| GOMF MUTSALPHA COMPLEX BINDING | 7 | 5.37e-01 | 1.35e-01 | 9.95e-01 |
| GOBP KETONE CATABOLIC PROCESS | 14 | 3.84e-01 | 1.34e-01 | 9.95e-01 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 16 | 3.52e-01 | 1.34e-01 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 27 | 2.27e-01 | 1.34e-01 | 9.50e-01 |
| GOBP NEUTROPHIL CHEMOTAXIS | 99 | 2.09e-02 | -1.34e-01 | 6.41e-01 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 52 | 9.38e-02 | 1.34e-01 | 8.55e-01 |
| GOMF JUN KINASE BINDING | 11 | 4.41e-01 | 1.34e-01 | 9.95e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT | 6 | 5.69e-01 | -1.34e-01 | 9.95e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.85e-01 | -1.34e-01 | 9.95e-01 |
| GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY | 5 | 6.03e-01 | 1.34e-01 | 9.98e-01 |
| GOBP U4 SNRNA 3 END PROCESSING | 8 | 5.11e-01 | 1.34e-01 | 9.95e-01 |
| GOCC RIBBON SYNAPSE | 15 | 3.68e-01 | -1.34e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 5 | 6.03e-01 | 1.34e-01 | 9.98e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY | 5 | 6.03e-01 | 1.34e-01 | 9.98e-01 |
| GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 9 | 4.86e-01 | 1.34e-01 | 9.95e-01 |
| GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.86e-01 | 1.34e-01 | 9.95e-01 |
| GOBP REGULATION OF SERINE TYPE PEPTIDASE ACTIVITY | 6 | 5.69e-01 | -1.34e-01 | 9.95e-01 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 49 | 1.04e-01 | 1.34e-01 | 8.67e-01 |
| GOMF ATP GATED ION CHANNEL ACTIVITY | 9 | 4.86e-01 | 1.34e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 33 | 1.83e-01 | 1.34e-01 | 9.27e-01 |
| GOCC ACTIN FILAMENT BUNDLE | 76 | 4.34e-02 | -1.34e-01 | 7.59e-01 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 3.85e-01 | 1.34e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 24 | 2.56e-01 | 1.34e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 60 | 7.29e-02 | -1.34e-01 | 8.07e-01 |
| GOBP COP9 SIGNALOSOME ASSEMBLY | 5 | 6.04e-01 | -1.34e-01 | 9.98e-01 |
| GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 7 | 5.40e-01 | -1.34e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 14 | 3.86e-01 | 1.34e-01 | 9.95e-01 |
| GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 5.40e-01 | 1.34e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 12 | 4.22e-01 | 1.34e-01 | 9.95e-01 |
| GOMF ADENYLATE KINASE ACTIVITY | 9 | 4.87e-01 | 1.34e-01 | 9.95e-01 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 320 | 3.91e-05 | 1.34e-01 | 2.28e-02 |
| GOCC MYOSIN FILAMENT | 24 | 2.57e-01 | -1.34e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 14 | 3.87e-01 | 1.34e-01 | 9.95e-01 |
| GOBP HYPEROSMOTIC SALINITY RESPONSE | 10 | 4.65e-01 | 1.34e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 38 | 1.54e-01 | 1.34e-01 | 9.06e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 10 | 4.65e-01 | 1.34e-01 | 9.95e-01 |
| GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 6 | 5.71e-01 | 1.34e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 15 | 3.71e-01 | 1.33e-01 | 9.95e-01 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 57 | 8.15e-02 | 1.33e-01 | 8.36e-01 |
| GOMF PYRUVATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.05e-01 | 1.33e-01 | 9.98e-01 |
| GOBP APPENDAGE DEVELOPMENT | 177 | 2.21e-03 | 1.33e-01 | 2.95e-01 |
| GOCC TROPONIN COMPLEX | 9 | 4.89e-01 | 1.33e-01 | 9.95e-01 |
| GOMF TELOMERASE INHIBITOR ACTIVITY | 5 | 6.06e-01 | 1.33e-01 | 9.98e-01 |
| GOCC GATOR2 COMPLEX | 5 | 6.06e-01 | 1.33e-01 | 9.98e-01 |
| GOBP REPRODUCTIVE BEHAVIOR | 42 | 1.35e-01 | 1.33e-01 | 8.98e-01 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 94 | 2.57e-02 | -1.33e-01 | 6.69e-01 |
| GOBP AORTIC VALVE MORPHOGENESIS | 38 | 1.56e-01 | 1.33e-01 | 9.06e-01 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 36 | 1.67e-01 | -1.33e-01 | 9.15e-01 |
| GOCC ACTOMYOSIN | 76 | 4.48e-02 | -1.33e-01 | 7.59e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 13 | 4.06e-01 | -1.33e-01 | 9.95e-01 |
| GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 13 | 4.07e-01 | 1.33e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 6.07e-01 | -1.33e-01 | 9.98e-01 |
| GOCC PARASPECKLES | 7 | 5.42e-01 | -1.33e-01 | 9.95e-01 |
| GOCC CHROMOSOME PASSENGER COMPLEX | 6 | 5.73e-01 | 1.33e-01 | 9.95e-01 |
| GOMF OLFACTORY RECEPTOR BINDING | 6 | 5.73e-01 | 1.33e-01 | 9.95e-01 |
| GOMF STEROL BINDING | 61 | 7.29e-02 | -1.33e-01 | 8.07e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 10 | 4.67e-01 | -1.33e-01 | 9.95e-01 |
| GOBP NADH METABOLIC PROCESS | 11 | 4.46e-01 | -1.33e-01 | 9.95e-01 |
| GOCC CATSPER COMPLEX | 14 | 3.90e-01 | 1.33e-01 | 9.95e-01 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 54 | 9.18e-02 | 1.33e-01 | 8.55e-01 |
| GOBP CORTISOL BIOSYNTHETIC PROCESS | 10 | 4.68e-01 | -1.33e-01 | 9.95e-01 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 48 | 1.12e-01 | 1.32e-01 | 8.77e-01 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 34 | 1.81e-01 | -1.32e-01 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 31 | 2.02e-01 | 1.32e-01 | 9.36e-01 |
| GOCC MHC PROTEIN COMPLEX | 24 | 2.61e-01 | -1.32e-01 | 9.62e-01 |
| GOMF HSP90 PROTEIN BINDING | 40 | 1.47e-01 | -1.32e-01 | 9.04e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 1.70e-01 | 1.32e-01 | 9.19e-01 |
| GOCC CALCIUM AND CALMODULIN DEPENDENT PROTEIN KINASE COMPLEX | 5 | 6.08e-01 | -1.32e-01 | 9.98e-01 |
| GOBP GALACTOLIPID BIOSYNTHETIC PROCESS | 6 | 5.75e-01 | -1.32e-01 | 9.96e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY VIA JNK CASCADE | 6 | 5.75e-01 | -1.32e-01 | 9.96e-01 |
| GOBP PANCREATIC JUICE SECRETION | 11 | 4.48e-01 | 1.32e-01 | 9.95e-01 |
| GOCC BRUSH BORDER | 103 | 2.04e-02 | -1.32e-01 | 6.41e-01 |
| GOCC MEDIATOR COMPLEX | 34 | 1.82e-01 | -1.32e-01 | 9.27e-01 |
| GOCC FLOTILLIN COMPLEX | 9 | 4.93e-01 | 1.32e-01 | 9.95e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 46 | 1.21e-01 | 1.32e-01 | 8.86e-01 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 14 | 3.92e-01 | -1.32e-01 | 9.95e-01 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 88 | 3.23e-02 | 1.32e-01 | 7.07e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 8 | 5.18e-01 | 1.32e-01 | 9.95e-01 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 58 | 8.21e-02 | 1.32e-01 | 8.38e-01 |
| GOMF DOPAMINE RECEPTOR BINDING | 14 | 3.93e-01 | 1.32e-01 | 9.95e-01 |
| GOBP L GLUTAMATE IMPORT | 38 | 1.59e-01 | -1.32e-01 | 9.06e-01 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 17 | 3.47e-01 | 1.32e-01 | 9.92e-01 |
| GOBP RESPONSE TO CGMP | 8 | 5.18e-01 | -1.32e-01 | 9.95e-01 |
| GOBP GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 4.93e-01 | 1.32e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 38 | 1.60e-01 | 1.32e-01 | 9.06e-01 |
| GOBP ECTODERM DEVELOPMENT | 21 | 2.96e-01 | 1.32e-01 | 9.82e-01 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 19 | 3.20e-01 | -1.32e-01 | 9.87e-01 |
| GOBP EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION | 10 | 4.70e-01 | 1.32e-01 | 9.95e-01 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 44 | 1.30e-01 | -1.32e-01 | 8.96e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 9 | 4.94e-01 | -1.32e-01 | 9.95e-01 |
| GOCC TRAMP COMPLEX | 5 | 6.10e-01 | -1.32e-01 | 9.98e-01 |
| GOMF THIOESTERASE BINDING | 9 | 4.94e-01 | -1.32e-01 | 9.95e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY | 9 | 4.94e-01 | 1.32e-01 | 9.95e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR ACTIVITY | 9 | 4.94e-01 | 1.32e-01 | 9.95e-01 |
| GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 7 | 5.47e-01 | -1.32e-01 | 9.95e-01 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 4.50e-01 | -1.32e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 59 | 8.06e-02 | 1.32e-01 | 8.35e-01 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 32 | 1.98e-01 | -1.31e-01 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 79 | 4.34e-02 | 1.31e-01 | 7.59e-01 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 26 | 2.46e-01 | 1.31e-01 | 9.58e-01 |
| GOBP INOSITOL METABOLIC PROCESS | 8 | 5.20e-01 | -1.31e-01 | 9.95e-01 |
| GOBP MITOCHONDRIAL DNA REPAIR | 5 | 6.11e-01 | 1.31e-01 | 9.98e-01 |
| GOBP OSTEOCLAST FUSION | 6 | 5.77e-01 | -1.31e-01 | 9.96e-01 |
| GOBP PLASMINOGEN ACTIVATION | 26 | 2.46e-01 | -1.31e-01 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 44 | 1.32e-01 | 1.31e-01 | 8.96e-01 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 13 | 4.13e-01 | 1.31e-01 | 9.95e-01 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 100 | 2.33e-02 | 1.31e-01 | 6.49e-01 |
| GOBP SENSORY PERCEPTION OF BITTER TASTE | 44 | 1.32e-01 | 1.31e-01 | 8.96e-01 |
| GOBP RESPONSE TO INTERLEUKIN 9 | 5 | 6.12e-01 | -1.31e-01 | 9.98e-01 |
| GOBP UTERUS MORPHOGENESIS | 6 | 5.78e-01 | -1.31e-01 | 9.96e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 16 | 3.64e-01 | -1.31e-01 | 9.95e-01 |
| GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 5.78e-01 | -1.31e-01 | 9.96e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 43 | 1.37e-01 | 1.31e-01 | 9.02e-01 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 17 | 3.50e-01 | 1.31e-01 | 9.94e-01 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 34 | 1.86e-01 | -1.31e-01 | 9.28e-01 |
| GOBP L SERINE METABOLIC PROCESS | 12 | 4.32e-01 | 1.31e-01 | 9.95e-01 |
| GOMF LEUCINE ZIPPER DOMAIN BINDING | 11 | 4.52e-01 | 1.31e-01 | 9.95e-01 |
| GOBP REGULATION OF RIBOSOME BIOGENESIS | 9 | 4.97e-01 | 1.31e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 46 | 1.25e-01 | 1.31e-01 | 8.91e-01 |
| GOCC CHROMOCENTER | 13 | 4.14e-01 | 1.31e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 35 | 1.81e-01 | -1.31e-01 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 8 | 5.22e-01 | 1.31e-01 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 14 | 3.97e-01 | 1.31e-01 | 9.95e-01 |
| GOMF PHOSPHATIDYLCHOLINE TRANSFER ACTIVITY | 5 | 6.13e-01 | 1.31e-01 | 9.98e-01 |
| GOBP CHORIONIC TROPHOBLAST CELL DIFFERENTIATION | 7 | 5.49e-01 | -1.31e-01 | 9.95e-01 |
| GOCC PROXIMAL DENDRITE | 6 | 5.79e-01 | -1.31e-01 | 9.96e-01 |
| GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 19 | 3.24e-01 | -1.31e-01 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 93 | 2.94e-02 | 1.31e-01 | 6.94e-01 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 10 | 4.75e-01 | 1.31e-01 | 9.95e-01 |
| GOMF THIAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.50e-01 | -1.30e-01 | 9.95e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 25 | 2.59e-01 | -1.30e-01 | 9.59e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION | 14 | 3.98e-01 | 1.30e-01 | 9.95e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 19 | 3.25e-01 | -1.30e-01 | 9.87e-01 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 12 | 4.34e-01 | 1.30e-01 | 9.95e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 14 | 3.99e-01 | -1.30e-01 | 9.95e-01 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 14 | 3.99e-01 | 1.30e-01 | 9.95e-01 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 27 | 2.41e-01 | 1.30e-01 | 9.57e-01 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 8 | 5.23e-01 | 1.30e-01 | 9.95e-01 |
| GOBP TRANSPOSITION | 38 | 1.65e-01 | 1.30e-01 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 18 | 3.39e-01 | 1.30e-01 | 9.88e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY | 8 | 5.24e-01 | 1.30e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 107 | 2.01e-02 | 1.30e-01 | 6.41e-01 |
| GOBP MACROPHAGE CHEMOTAXIS | 41 | 1.50e-01 | 1.30e-01 | 9.04e-01 |
| GOCC SWR1 COMPLEX | 13 | 4.17e-01 | 1.30e-01 | 9.95e-01 |
| GOBP RESPONSE TO IONIZING RADIATION | 136 | 8.86e-03 | 1.30e-01 | 5.50e-01 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 46 | 1.27e-01 | -1.30e-01 | 8.91e-01 |
| GOBP INTRACELLULAR GLUTAMATE HOMEOSTASIS | 5 | 6.15e-01 | 1.30e-01 | 9.98e-01 |
| GOBP URATE TRANSPORT | 11 | 4.56e-01 | -1.30e-01 | 9.95e-01 |
| GOBP RESPONSE TO NITRIC OXIDE | 19 | 3.27e-01 | -1.30e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 7 | 5.52e-01 | -1.30e-01 | 9.95e-01 |
| GOBP VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 5 | 6.15e-01 | -1.30e-01 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF VASOCONSTRICTION | 8 | 5.25e-01 | 1.30e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 19 | 3.27e-01 | -1.30e-01 | 9.87e-01 |
| GOBP ACETYLCHOLINE SECRETION | 5 | 6.15e-01 | 1.30e-01 | 9.98e-01 |
| GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY | 7 | 5.52e-01 | -1.30e-01 | 9.95e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 51 | 1.09e-01 | -1.30e-01 | 8.76e-01 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 63 | 7.51e-02 | -1.30e-01 | 8.18e-01 |
| GOBP PIGMENT GRANULE MATURATION | 10 | 4.78e-01 | -1.30e-01 | 9.95e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 53 | 1.03e-01 | 1.30e-01 | 8.66e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 34 | 1.91e-01 | -1.30e-01 | 9.28e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 6 | 5.83e-01 | 1.29e-01 | 9.96e-01 |
| GOCC PLATELET DENSE GRANULE MEMBRANE | 5 | 6.16e-01 | -1.29e-01 | 9.98e-01 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 18 | 3.42e-01 | 1.29e-01 | 9.90e-01 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 8 | 5.26e-01 | -1.29e-01 | 9.95e-01 |
| GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 25 | 2.63e-01 | 1.29e-01 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT | 10 | 4.79e-01 | 1.29e-01 | 9.95e-01 |
| GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 7 | 5.54e-01 | 1.29e-01 | 9.95e-01 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 53 | 1.04e-01 | 1.29e-01 | 8.67e-01 |
| GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 4.58e-01 | -1.29e-01 | 9.95e-01 |
| GOBP ACTIVATED T CELL PROLIFERATION | 47 | 1.26e-01 | 1.29e-01 | 8.91e-01 |
| GOBP MACROPHAGE FUSION | 6 | 5.84e-01 | 1.29e-01 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 24 | 2.74e-01 | 1.29e-01 | 9.73e-01 |
| GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 9 | 5.03e-01 | 1.29e-01 | 9.95e-01 |
| GOCC SPINDLE MICROTUBULE | 76 | 5.19e-02 | 1.29e-01 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 6 | 5.84e-01 | 1.29e-01 | 9.96e-01 |
| GOBP NADH OXIDATION | 6 | 5.85e-01 | -1.29e-01 | 9.96e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 5.28e-01 | 1.29e-01 | 9.95e-01 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 15 | 3.88e-01 | 1.29e-01 | 9.95e-01 |
| GOCC FIBRINOGEN COMPLEX | 8 | 5.28e-01 | 1.29e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 145 | 7.42e-03 | 1.29e-01 | 5.13e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 29 | 2.30e-01 | 1.29e-01 | 9.50e-01 |
| GOCC MULTIVESICULAR BODY LUMEN | 6 | 5.85e-01 | 1.29e-01 | 9.96e-01 |
| GOBP RENAL PROTEIN ABSORPTION | 7 | 5.56e-01 | 1.29e-01 | 9.95e-01 |
| GOBP REGULATION OF KIDNEY SIZE | 5 | 6.18e-01 | -1.29e-01 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 16 | 3.73e-01 | -1.29e-01 | 9.95e-01 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 19 | 3.32e-01 | -1.29e-01 | 9.88e-01 |
| GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 5 | 6.18e-01 | 1.29e-01 | 9.98e-01 |
| GOBP INTESTINE SMOOTH MUSCLE CONTRACTION | 8 | 5.29e-01 | -1.29e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 8 | 5.29e-01 | 1.29e-01 | 9.95e-01 |
| GOMF MHC CLASS I PROTEIN BINDING | 18 | 3.45e-01 | 1.29e-01 | 9.92e-01 |
| GOBP MEMBRANE DEPOLARIZATION | 78 | 4.97e-02 | -1.29e-01 | 7.77e-01 |
| GOMF VITAMIN D BINDING | 6 | 5.86e-01 | -1.29e-01 | 9.96e-01 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 41 | 1.55e-01 | -1.29e-01 | 9.06e-01 |
| GOMF STEROID BINDING | 97 | 2.87e-02 | -1.28e-01 | 6.86e-01 |
| GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 6.19e-01 | 1.28e-01 | 9.98e-01 |
| GOMF GLYCOSPHINGOLIPID BINDING | 10 | 4.82e-01 | 1.28e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 7 | 5.56e-01 | -1.28e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 13 | 4.23e-01 | 1.28e-01 | 9.95e-01 |
| GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 9 | 5.05e-01 | -1.28e-01 | 9.95e-01 |
| GOCC SPERM MIDPIECE | 51 | 1.13e-01 | -1.28e-01 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS | 9 | 5.05e-01 | -1.28e-01 | 9.95e-01 |
| GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 18 | 3.46e-01 | 1.28e-01 | 9.92e-01 |
| GOMF DINUCLEOTIDE PHOSPHATASE ACTIVITY | 8 | 5.30e-01 | 1.28e-01 | 9.95e-01 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 16 | 3.75e-01 | 1.28e-01 | 9.95e-01 |
| GOBP RETINAL CELL PROGRAMMED CELL DEATH | 6 | 5.87e-01 | 1.28e-01 | 9.97e-01 |
| GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 10 | 4.83e-01 | -1.28e-01 | 9.95e-01 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 69 | 6.59e-02 | 1.28e-01 | 7.99e-01 |
| GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 56 | 9.75e-02 | 1.28e-01 | 8.61e-01 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 33 | 2.03e-01 | 1.28e-01 | 9.36e-01 |
| GOCC I BAND | 141 | 8.71e-03 | -1.28e-01 | 5.47e-01 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 4.07e-01 | 1.28e-01 | 9.95e-01 |
| GOBP PRIMARY MIRNA PROCESSING | 18 | 3.48e-01 | -1.28e-01 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 27 | 2.50e-01 | 1.28e-01 | 9.58e-01 |
| GOBP NEGATIVE CHEMOTAXIS | 46 | 1.34e-01 | -1.28e-01 | 8.96e-01 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 7 | 5.58e-01 | 1.28e-01 | 9.95e-01 |
| GOBP PIGMENT GRANULE ORGANIZATION | 37 | 1.79e-01 | 1.28e-01 | 9.23e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CLUSTERING | 6 | 5.88e-01 | 1.28e-01 | 9.97e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 12 | 4.43e-01 | 1.28e-01 | 9.95e-01 |
| GOBP RESPONSE TO L GLUTAMATE | 14 | 4.08e-01 | -1.28e-01 | 9.95e-01 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 36 | 1.85e-01 | 1.28e-01 | 9.28e-01 |
| GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 8 | 5.32e-01 | -1.28e-01 | 9.95e-01 |
| GOBP ANTERIOR COMMISSURE MORPHOGENESIS | 7 | 5.59e-01 | 1.28e-01 | 9.95e-01 |
| GOBP SPINDLE ELONGATION | 13 | 4.25e-01 | 1.28e-01 | 9.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 19 | 3.35e-01 | -1.28e-01 | 9.88e-01 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 31 | 2.19e-01 | -1.28e-01 | 9.43e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 21 | 3.11e-01 | -1.28e-01 | 9.87e-01 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 226 | 9.51e-04 | 1.28e-01 | 1.87e-01 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 30 | 2.27e-01 | -1.28e-01 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 6.21e-01 | -1.28e-01 | 9.98e-01 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 44 | 1.43e-01 | -1.28e-01 | 9.02e-01 |
| GOCC PERICHROMATIN FIBRILS | 5 | 6.22e-01 | -1.27e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF TOOTH MINERALIZATION | 7 | 5.60e-01 | -1.27e-01 | 9.95e-01 |
| GOBP ER OVERLOAD RESPONSE | 11 | 4.65e-01 | -1.27e-01 | 9.95e-01 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 48 | 1.28e-01 | -1.27e-01 | 8.91e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 17 | 3.64e-01 | 1.27e-01 | 9.95e-01 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 104 | 2.52e-02 | 1.27e-01 | 6.67e-01 |
| GOCC POLYSOMAL RIBOSOME | 28 | 2.45e-01 | -1.27e-01 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 7 | 5.61e-01 | 1.27e-01 | 9.95e-01 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 44 | 1.45e-01 | 1.27e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 91 | 3.63e-02 | 1.27e-01 | 7.30e-01 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 9 | 5.10e-01 | -1.27e-01 | 9.95e-01 |
| GOBP DISTAL CONVOLUTED TUBULE DEVELOPMENT | 5 | 6.23e-01 | -1.27e-01 | 9.98e-01 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 14 | 4.11e-01 | -1.27e-01 | 9.95e-01 |
| GOCC CALCIUM CHANNEL COMPLEX | 77 | 5.43e-02 | -1.27e-01 | 7.87e-01 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 114 | 1.93e-02 | -1.27e-01 | 6.41e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 5.61e-01 | 1.27e-01 | 9.95e-01 |
| GOCC VARICOSITY | 8 | 5.35e-01 | 1.27e-01 | 9.95e-01 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 43 | 1.50e-01 | 1.27e-01 | 9.04e-01 |
| GOMF FUCOSYLTRANSFERASE ACTIVITY | 13 | 4.29e-01 | 1.27e-01 | 9.95e-01 |
| GOMF ACYL COA OXIDASE ACTIVITY | 7 | 5.62e-01 | 1.27e-01 | 9.95e-01 |
| GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY | 5 | 6.24e-01 | -1.27e-01 | 9.98e-01 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 42 | 1.56e-01 | 1.27e-01 | 9.06e-01 |
| GOBP CERAMIDE 1 PHOSPHATE TRANSPORT | 7 | 5.62e-01 | 1.27e-01 | 9.95e-01 |
| GOMF CERAMIDE 1 PHOSPHATE TRANSFER ACTIVITY | 7 | 5.62e-01 | 1.27e-01 | 9.95e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 8 | 5.35e-01 | 1.27e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 8 | 5.35e-01 | 1.27e-01 | 9.95e-01 |
| GOMF ISOPRENOID BINDING | 44 | 1.47e-01 | -1.27e-01 | 9.03e-01 |
| GOBP NEURAL TUBE PATTERNING | 39 | 1.72e-01 | 1.26e-01 | 9.21e-01 |
| GOBP NEPHRON TUBULE FORMATION | 20 | 3.28e-01 | 1.26e-01 | 9.87e-01 |
| GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY | 14 | 4.13e-01 | 1.26e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO WATER STIMULUS | 6 | 5.92e-01 | 1.26e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF RESPIRATORY BURST | 7 | 5.63e-01 | 1.26e-01 | 9.95e-01 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 20 | 3.28e-01 | -1.26e-01 | 9.87e-01 |
| GOBP OPTIC NERVE MORPHOGENESIS | 6 | 5.92e-01 | -1.26e-01 | 9.98e-01 |
| GOBP WATER TRANSPORT | 28 | 2.48e-01 | -1.26e-01 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 53 | 1.12e-01 | 1.26e-01 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 5.37e-01 | -1.26e-01 | 9.95e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 5.93e-01 | -1.26e-01 | 9.98e-01 |
| GOBP REGULATION OF BONE MINERALIZATION | 76 | 5.74e-02 | 1.26e-01 | 7.90e-01 |
| GOBP SYNAPTIC SIGNALING VIA NEUROPEPTIDE | 6 | 5.93e-01 | 1.26e-01 | 9.98e-01 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 11 | 4.69e-01 | -1.26e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 5 | 6.26e-01 | 1.26e-01 | 9.98e-01 |
| GOBP ALDITOL METABOLIC PROCESS | 21 | 3.18e-01 | 1.26e-01 | 9.87e-01 |
| GOMF SYMPORTER ACTIVITY | 146 | 8.61e-03 | -1.26e-01 | 5.44e-01 |
| GOMF CHOLINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.64e-01 | -1.26e-01 | 9.95e-01 |
| GOCC RECYCLING ENDOSOME | 194 | 2.49e-03 | -1.26e-01 | 3.15e-01 |
| GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 5.64e-01 | 1.26e-01 | 9.95e-01 |
| GOMF SHORT CHAIN CARBOXYLESTERASE ACTIVITY | 6 | 5.93e-01 | -1.26e-01 | 9.98e-01 |
| GOBP REGULATION OF SALIVA SECRETION | 7 | 5.64e-01 | -1.26e-01 | 9.95e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 77 | 5.62e-02 | -1.26e-01 | 7.90e-01 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 17 | 3.69e-01 | 1.26e-01 | 9.95e-01 |
| GOBP BLASTOCYST FORMATION | 45 | 1.44e-01 | 1.26e-01 | 9.02e-01 |
| GOBP UBIQUITIN RECYCLING | 13 | 4.32e-01 | 1.26e-01 | 9.95e-01 |
| GOBP SERTOLI CELL DEVELOPMENT | 12 | 4.50e-01 | 1.26e-01 | 9.95e-01 |
| GOBP HIS PURKINJE SYSTEM DEVELOPMENT | 7 | 5.64e-01 | 1.26e-01 | 9.95e-01 |
| GOCC CAJAL BODY | 77 | 5.63e-02 | 1.26e-01 | 7.90e-01 |
| GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 10 | 4.91e-01 | -1.26e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 14 | 4.15e-01 | 1.26e-01 | 9.95e-01 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 11 | 4.70e-01 | -1.26e-01 | 9.95e-01 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 40 | 1.69e-01 | 1.26e-01 | 9.18e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT | 11 | 4.71e-01 | 1.26e-01 | 9.95e-01 |
| GOBP BILE ACID SIGNALING PATHWAY | 11 | 4.71e-01 | -1.26e-01 | 9.95e-01 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 50 | 1.24e-01 | 1.26e-01 | 8.91e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 12 | 4.52e-01 | -1.26e-01 | 9.95e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 28 | 2.51e-01 | -1.25e-01 | 9.58e-01 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 15 | 4.00e-01 | 1.25e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 32 | 2.20e-01 | 1.25e-01 | 9.43e-01 |
| GOMF AMINO ACID BINDING | 47 | 1.37e-01 | 1.25e-01 | 9.02e-01 |
| GOBP ACROSOME REACTION | 40 | 1.70e-01 | -1.25e-01 | 9.20e-01 |
| GOBP ASSOCIATIVE LEARNING | 84 | 4.72e-02 | -1.25e-01 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF ENAMEL MINERALIZATION | 5 | 6.28e-01 | -1.25e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 27 | 2.60e-01 | -1.25e-01 | 9.60e-01 |
| GOBP VIRAL TRANSLATION | 20 | 3.32e-01 | -1.25e-01 | 9.88e-01 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 12 | 4.53e-01 | -1.25e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 5 | 6.28e-01 | 1.25e-01 | 9.98e-01 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 83 | 4.86e-02 | 1.25e-01 | 7.71e-01 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 6 | 5.95e-01 | 1.25e-01 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI MEMBRANE | 5 | 6.28e-01 | -1.25e-01 | 9.98e-01 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 14 | 4.18e-01 | 1.25e-01 | 9.95e-01 |
| GOBP DENDRITE ARBORIZATION | 10 | 4.93e-01 | -1.25e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 23 | 2.99e-01 | 1.25e-01 | 9.84e-01 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 89 | 4.14e-02 | 1.25e-01 | 7.56e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 38 | 1.82e-01 | -1.25e-01 | 9.27e-01 |
| GOCC COSTAMERE | 16 | 3.87e-01 | -1.25e-01 | 9.95e-01 |
| GOCC HETEROCHROMATIN | 76 | 5.97e-02 | 1.25e-01 | 7.90e-01 |
| GOBP ERBB2 SIGNALING PATHWAY | 17 | 3.73e-01 | -1.25e-01 | 9.95e-01 |
| GOBP NEURON GLIAL CELL SIGNALING | 5 | 6.29e-01 | 1.25e-01 | 9.98e-01 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 4.94e-01 | 1.25e-01 | 9.95e-01 |
| GOBP RESPONSE TO LEUCINE | 15 | 4.03e-01 | 1.25e-01 | 9.95e-01 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 12 | 4.54e-01 | 1.25e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO CAFFEINE | 11 | 4.74e-01 | -1.25e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 6.29e-01 | 1.25e-01 | 9.98e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 6 | 5.97e-01 | -1.25e-01 | 9.98e-01 |
| GOMF CHEMOKINE BINDING | 31 | 2.30e-01 | -1.25e-01 | 9.50e-01 |
| GOMF LACTATE DEHYDROGENASE ACTIVITY | 6 | 5.97e-01 | 1.25e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 67 | 7.79e-02 | 1.25e-01 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 14 | 4.20e-01 | 1.24e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 17 | 3.74e-01 | 1.24e-01 | 9.95e-01 |
| GOBP MATURATION OF LSU RRNA | 27 | 2.63e-01 | 1.24e-01 | 9.64e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 19 | 3.48e-01 | 1.24e-01 | 9.93e-01 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 45 | 1.49e-01 | 1.24e-01 | 9.04e-01 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 10 | 4.96e-01 | 1.24e-01 | 9.95e-01 |
| GOBP ANTIBACTERIAL PEPTIDE PRODUCTION | 9 | 5.18e-01 | -1.24e-01 | 9.95e-01 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 12 | 4.56e-01 | 1.24e-01 | 9.95e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 10 | 4.96e-01 | -1.24e-01 | 9.95e-01 |
| GOBP ACTIN NUCLEATION | 53 | 1.17e-01 | -1.24e-01 | 8.83e-01 |
| GOMF FATTY ACID OMEGA HYDROXYLASE ACTIVITY | 7 | 5.69e-01 | -1.24e-01 | 9.95e-01 |
| GOBP RETINOL METABOLIC PROCESS | 50 | 1.28e-01 | -1.24e-01 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 22 | 3.13e-01 | -1.24e-01 | 9.87e-01 |
| GOBP REGULATION OF CILIUM MOVEMENT | 38 | 1.85e-01 | -1.24e-01 | 9.28e-01 |
| GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX | 6 | 5.98e-01 | -1.24e-01 | 9.98e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 63 | 8.82e-02 | 1.24e-01 | 8.47e-01 |
| GOCC SPERM MITOCHONDRIAL SHEATH | 5 | 6.31e-01 | -1.24e-01 | 9.98e-01 |
| GOBP EAR MORPHOGENESIS | 123 | 1.75e-02 | 1.24e-01 | 6.41e-01 |
| GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 10 | 4.97e-01 | 1.24e-01 | 9.95e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 53 | 1.19e-01 | 1.24e-01 | 8.83e-01 |
| GOCC PCG PROTEIN COMPLEX | 35 | 2.05e-01 | 1.24e-01 | 9.36e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 21 | 3.26e-01 | -1.24e-01 | 9.87e-01 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 43 | 1.60e-01 | 1.24e-01 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 18 | 3.63e-01 | 1.24e-01 | 9.95e-01 |
| GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 6.32e-01 | 1.24e-01 | 9.98e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 14 | 4.23e-01 | 1.24e-01 | 9.95e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 16 | 3.92e-01 | 1.24e-01 | 9.95e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE GROWTH | 6 | 6.00e-01 | 1.24e-01 | 9.98e-01 |
| GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS | 6 | 6.00e-01 | 1.24e-01 | 9.98e-01 |
| GOBP INSEMINATION | 12 | 4.59e-01 | 1.24e-01 | 9.95e-01 |
| GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS | 12 | 4.59e-01 | 1.24e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 10 | 4.99e-01 | -1.23e-01 | 9.95e-01 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 73 | 6.81e-02 | -1.23e-01 | 7.99e-01 |
| GOMF REGULATORY RNA BINDING | 49 | 1.35e-01 | -1.23e-01 | 8.98e-01 |
| GOCC MPP7 DLG1 LIN7 COMPLEX | 5 | 6.33e-01 | -1.23e-01 | 9.98e-01 |
| GOBP SPLEEN DEVELOPMENT | 38 | 1.88e-01 | 1.23e-01 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 72 | 7.06e-02 | 1.23e-01 | 8.00e-01 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 69 | 7.68e-02 | 1.23e-01 | 8.23e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 12 | 4.60e-01 | 1.23e-01 | 9.95e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 92 | 4.11e-02 | 1.23e-01 | 7.56e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS | 6 | 6.01e-01 | 1.23e-01 | 9.98e-01 |
| GOMF PROTEOGLYCAN BINDING | 36 | 2.01e-01 | -1.23e-01 | 9.36e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 26 | 2.77e-01 | 1.23e-01 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 24 | 2.97e-01 | -1.23e-01 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 21 | 3.29e-01 | -1.23e-01 | 9.87e-01 |
| GOBP TRYPTOPHAN CATABOLIC PROCESS TO KYNURENINE | 5 | 6.34e-01 | -1.23e-01 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO CAMP | 49 | 1.36e-01 | -1.23e-01 | 9.00e-01 |
| GOMF FRUCTOSE BINDING | 6 | 6.02e-01 | -1.23e-01 | 9.98e-01 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 209 | 2.20e-03 | 1.23e-01 | 2.95e-01 |
| GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 7 | 5.74e-01 | -1.23e-01 | 9.95e-01 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 7 | 5.74e-01 | 1.23e-01 | 9.95e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 47 | 1.46e-01 | 1.23e-01 | 9.02e-01 |
| GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION | 11 | 4.81e-01 | -1.23e-01 | 9.95e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 10 | 5.02e-01 | 1.23e-01 | 9.95e-01 |
| GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 10 | 5.02e-01 | 1.23e-01 | 9.95e-01 |
| GOMF OLEATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.03e-01 | -1.23e-01 | 9.98e-01 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 11 | 4.81e-01 | -1.23e-01 | 9.95e-01 |
| GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS | 6 | 6.03e-01 | -1.23e-01 | 9.98e-01 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 13 | 4.44e-01 | -1.23e-01 | 9.95e-01 |
| GOCC MALE GERM CELL NUCLEUS | 52 | 1.27e-01 | 1.22e-01 | 8.91e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 55 | 1.16e-01 | -1.22e-01 | 8.82e-01 |
| GOBP DNA TOPOLOGICAL CHANGE | 9 | 5.25e-01 | 1.22e-01 | 9.95e-01 |
| GOCC COLLAGEN TRIMER | 83 | 5.39e-02 | -1.22e-01 | 7.87e-01 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 19 | 3.56e-01 | 1.22e-01 | 9.95e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 21 | 3.32e-01 | -1.22e-01 | 9.88e-01 |
| GOBP PROTEIN DESUMOYLATION | 8 | 5.49e-01 | -1.22e-01 | 9.95e-01 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 17 | 3.83e-01 | 1.22e-01 | 9.95e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 31 | 2.39e-01 | 1.22e-01 | 9.55e-01 |
| GOBP PROTEIN TARGETING TO PEROXISOME | 19 | 3.56e-01 | -1.22e-01 | 9.95e-01 |
| GOBP NEUTROPHIL HOMEOSTASIS | 20 | 3.44e-01 | -1.22e-01 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 7 | 5.76e-01 | -1.22e-01 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 9 | 5.26e-01 | -1.22e-01 | 9.95e-01 |
| GOMF DNA POLYMERASE BINDING | 22 | 3.22e-01 | 1.22e-01 | 9.87e-01 |
| GOBP DIAPHRAGM DEVELOPMENT | 8 | 5.50e-01 | -1.22e-01 | 9.95e-01 |
| GOBP HISTAMINE METABOLIC PROCESS | 6 | 6.05e-01 | 1.22e-01 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 11 | 4.84e-01 | 1.22e-01 | 9.95e-01 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 23 | 3.12e-01 | 1.22e-01 | 9.87e-01 |
| GOBP INTESTINAL ABSORPTION | 41 | 1.77e-01 | -1.22e-01 | 9.21e-01 |
| GOMF ALDO KETO REDUCTASE NADP ACTIVITY | 30 | 2.48e-01 | -1.22e-01 | 9.58e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 16 | 3.99e-01 | -1.22e-01 | 9.95e-01 |
| GOCC COMPLEX OF COLLAGEN TRIMERS | 19 | 3.58e-01 | -1.22e-01 | 9.95e-01 |
| GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 8 | 5.51e-01 | -1.22e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 11 | 4.85e-01 | 1.22e-01 | 9.95e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 38 | 1.95e-01 | -1.22e-01 | 9.28e-01 |
| GOBP COMPLEMENT ACTIVATION LECTIN PATHWAY | 11 | 4.85e-01 | -1.22e-01 | 9.95e-01 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 67 | 8.53e-02 | 1.22e-01 | 8.39e-01 |
| GOMF TOXIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 5.28e-01 | 1.22e-01 | 9.95e-01 |
| GOBP IMMATURE T CELL PROLIFERATION | 12 | 4.66e-01 | 1.22e-01 | 9.95e-01 |
| GOBP CELLULAR SENESCENCE | 106 | 3.07e-02 | 1.21e-01 | 7.02e-01 |
| GOBP BOX C D SNORNP ASSEMBLY | 10 | 5.06e-01 | -1.21e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 58 | 1.10e-01 | -1.21e-01 | 8.76e-01 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 45 | 1.59e-01 | 1.21e-01 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 47 | 1.50e-01 | -1.21e-01 | 9.04e-01 |
| GOMF CORTICOTROPIN RELEASING HORMONE RECEPTOR BINDING | 5 | 6.39e-01 | 1.21e-01 | 9.98e-01 |
| GOMF CALCIUM SENSITIVE GUANYLATE CYCLASE ACTIVATOR ACTIVITY | 5 | 6.39e-01 | -1.21e-01 | 9.98e-01 |
| GOBP FEVER GENERATION | 11 | 4.86e-01 | 1.21e-01 | 9.95e-01 |
| GOCC KNL1 SPC105 COMPLEX | 6 | 6.07e-01 | -1.21e-01 | 9.98e-01 |
| GOBP RIBOSOME DISASSEMBLY | 12 | 4.67e-01 | 1.21e-01 | 9.95e-01 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 20 | 3.48e-01 | 1.21e-01 | 9.93e-01 |
| GOBP REGULATION OF LIPOPHAGY | 5 | 6.39e-01 | 1.21e-01 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 8 | 5.53e-01 | -1.21e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 26 | 2.85e-01 | -1.21e-01 | 9.75e-01 |
| GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 11 | 4.87e-01 | 1.21e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 34 | 2.22e-01 | 1.21e-01 | 9.45e-01 |
| GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY | 6 | 6.08e-01 | 1.21e-01 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 21 | 3.37e-01 | -1.21e-01 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 21 | 3.37e-01 | 1.21e-01 | 9.88e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 11 | 4.87e-01 | 1.21e-01 | 9.95e-01 |
| GOMF GLUTAMATE RECEPTOR ACTIVITY | 26 | 2.86e-01 | 1.21e-01 | 9.75e-01 |
| GOBP INTERLEUKIN 23 PRODUCTION | 9 | 5.30e-01 | -1.21e-01 | 9.95e-01 |
| GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 6.40e-01 | -1.21e-01 | 9.98e-01 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 26 | 2.86e-01 | -1.21e-01 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 27 | 2.77e-01 | -1.21e-01 | 9.73e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 209 | 2.61e-03 | 1.21e-01 | 3.18e-01 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 26 | 2.86e-01 | 1.21e-01 | 9.75e-01 |
| GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 14 | 4.34e-01 | 1.21e-01 | 9.95e-01 |
| GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 5.80e-01 | 1.21e-01 | 9.96e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT | 8 | 5.54e-01 | -1.21e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 17 | 3.90e-01 | 1.21e-01 | 9.95e-01 |
| GOBP REDUCTION OF FOOD INTAKE IN RESPONSE TO DIETARY EXCESS | 5 | 6.41e-01 | 1.21e-01 | 9.98e-01 |
| GOCC PRESYNAPTIC CYTOSKELETON | 11 | 4.89e-01 | 1.20e-01 | 9.95e-01 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 33 | 2.31e-01 | -1.20e-01 | 9.50e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 68 | 8.58e-02 | -1.20e-01 | 8.39e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 21 | 3.39e-01 | -1.20e-01 | 9.88e-01 |
| GOMF DOPAMINE BINDING | 6 | 6.09e-01 | 1.20e-01 | 9.98e-01 |
| GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 8 | 5.55e-01 | 1.20e-01 | 9.95e-01 |
| GOBP POSITIVE T CELL SELECTION | 39 | 1.93e-01 | 1.20e-01 | 9.28e-01 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 5 | 6.41e-01 | -1.20e-01 | 9.98e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 49 | 1.45e-01 | 1.20e-01 | 9.02e-01 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 20 | 3.52e-01 | 1.20e-01 | 9.94e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 13 | 4.53e-01 | 1.20e-01 | 9.95e-01 |
| GOBP LYSOSOMAL TRANSPORT | 128 | 1.89e-02 | 1.20e-01 | 6.41e-01 |
| GOBP BILE ACID METABOLIC PROCESS | 49 | 1.46e-01 | -1.20e-01 | 9.02e-01 |
| GOMF GPI ANCHOR BINDING | 7 | 5.82e-01 | 1.20e-01 | 9.96e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME | 13 | 4.53e-01 | -1.20e-01 | 9.95e-01 |
| GOCC PERICENTRIC HETEROCHROMATIN | 29 | 2.63e-01 | 1.20e-01 | 9.64e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 8 | 5.56e-01 | 1.20e-01 | 9.95e-01 |
| GOBP REGULATION OF GAMMA AMINOBUTYRIC ACID SECRETION | 8 | 5.56e-01 | 1.20e-01 | 9.95e-01 |
| GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 3.92e-01 | -1.20e-01 | 9.95e-01 |
| GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 5.11e-01 | 1.20e-01 | 9.95e-01 |
| GOBP DENDRITE SELF AVOIDANCE | 14 | 4.37e-01 | -1.20e-01 | 9.95e-01 |
| GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY | 7 | 5.83e-01 | 1.20e-01 | 9.96e-01 |
| GOBP DENSE CORE GRANULE EXOCYTOSIS | 10 | 5.11e-01 | -1.20e-01 | 9.95e-01 |
| GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 6 | 6.11e-01 | 1.20e-01 | 9.98e-01 |
| GOBP NEURAL FOLD FORMATION | 7 | 5.83e-01 | 1.20e-01 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 28 | 2.73e-01 | -1.20e-01 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION | 13 | 4.55e-01 | -1.20e-01 | 9.95e-01 |
| GOMF MEDIUM CHAIN FATTY ACID COA LIGASE ACTIVITY | 8 | 5.58e-01 | -1.20e-01 | 9.95e-01 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 46 | 1.60e-01 | -1.20e-01 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 6.12e-01 | 1.20e-01 | 9.98e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 26 | 2.91e-01 | -1.20e-01 | 9.79e-01 |
| GOCC SPECTRIN ASSOCIATED CYTOSKELETON | 9 | 5.34e-01 | -1.20e-01 | 9.95e-01 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 48 | 1.52e-01 | -1.20e-01 | 9.04e-01 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 16 | 4.08e-01 | -1.20e-01 | 9.95e-01 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 74 | 7.54e-02 | -1.20e-01 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 33 | 2.35e-01 | 1.20e-01 | 9.52e-01 |
| GOCC ATAC COMPLEX | 13 | 4.56e-01 | 1.20e-01 | 9.95e-01 |
| GOCC DYNACTIN COMPLEX | 8 | 5.58e-01 | -1.19e-01 | 9.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 42 | 1.80e-01 | -1.19e-01 | 9.27e-01 |
| GOBP RESPONSE TO VITAMIN A | 15 | 4.23e-01 | 1.19e-01 | 9.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 10 | 5.13e-01 | 1.19e-01 | 9.95e-01 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 4.56e-01 | -1.19e-01 | 9.95e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 51 | 1.40e-01 | 1.19e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 8 | 5.59e-01 | -1.19e-01 | 9.95e-01 |
| GOBP IMP BIOSYNTHETIC PROCESS | 10 | 5.13e-01 | 1.19e-01 | 9.95e-01 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 13 | 4.57e-01 | 1.19e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 19 | 3.68e-01 | -1.19e-01 | 9.95e-01 |
| GOMF ALPHA 1 3 FUCOSYLTRANSFERASE ACTIVITY | 8 | 5.59e-01 | 1.19e-01 | 9.95e-01 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 28 | 2.75e-01 | 1.19e-01 | 9.73e-01 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 19 | 3.68e-01 | 1.19e-01 | 9.95e-01 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 30 | 2.59e-01 | -1.19e-01 | 9.58e-01 |
| GOMF ACETYLCHOLINE BINDING | 10 | 5.14e-01 | 1.19e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 14 | 4.40e-01 | 1.19e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CELL FATE COMMITMENT | 13 | 4.57e-01 | 1.19e-01 | 9.95e-01 |
| GOCC OUTER DYNEIN ARM | 11 | 4.94e-01 | 1.19e-01 | 9.95e-01 |
| GOBP CELL MIGRATION IN HINDBRAIN | 16 | 4.10e-01 | -1.19e-01 | 9.95e-01 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 13 | 4.58e-01 | -1.19e-01 | 9.95e-01 |
| GOBP BLEB ASSEMBLY | 11 | 4.95e-01 | -1.19e-01 | 9.95e-01 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 54 | 1.31e-01 | 1.19e-01 | 8.96e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 12 | 4.76e-01 | -1.19e-01 | 9.95e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 20 | 3.58e-01 | -1.19e-01 | 9.95e-01 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 11 | 4.95e-01 | 1.19e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 6 | 6.14e-01 | 1.19e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 21 | 3.46e-01 | 1.19e-01 | 9.92e-01 |
| GOBP CELLULAR RESPONSE TO VIRUS | 79 | 6.83e-02 | 1.19e-01 | 7.99e-01 |
| GOBP PROTEIN DEACETYLATION | 51 | 1.43e-01 | 1.19e-01 | 9.02e-01 |
| GOMF CELL MATRIX ADHESION MEDIATOR ACTIVITY | 7 | 5.87e-01 | 1.19e-01 | 9.97e-01 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 97 | 4.36e-02 | 1.19e-01 | 7.59e-01 |
| GOBP REGULATION OF ICOSANOID SECRETION | 20 | 3.59e-01 | -1.19e-01 | 9.95e-01 |
| GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 8 | 5.62e-01 | 1.19e-01 | 9.95e-01 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 56 | 1.25e-01 | -1.18e-01 | 8.91e-01 |
| GOCC SPERM FIBROUS SHEATH | 6 | 6.15e-01 | 1.18e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 20 | 3.59e-01 | -1.18e-01 | 9.95e-01 |
| GOMF CHROMATIN DNA BINDING | 110 | 3.20e-02 | 1.18e-01 | 7.07e-01 |
| GOMF 5S RRNA BINDING | 9 | 5.39e-01 | 1.18e-01 | 9.95e-01 |
| GOBP RNA IMPORT INTO MITOCHONDRION | 5 | 6.47e-01 | -1.18e-01 | 9.98e-01 |
| GOBP HAIR FOLLICLE MATURATION | 15 | 4.28e-01 | 1.18e-01 | 9.95e-01 |
| GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION | 7 | 5.88e-01 | 1.18e-01 | 9.97e-01 |
| GOBP MELANIN METABOLIC PROCESS | 24 | 3.16e-01 | 1.18e-01 | 9.87e-01 |
| GOBP REGULATION OF BLOOD VESSEL REMODELING | 12 | 4.78e-01 | 1.18e-01 | 9.95e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 37 | 2.13e-01 | 1.18e-01 | 9.40e-01 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 27 | 2.88e-01 | 1.18e-01 | 9.75e-01 |
| GOBP KETONE BODY METABOLIC PROCESS | 9 | 5.39e-01 | 1.18e-01 | 9.95e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 25 | 3.07e-01 | 1.18e-01 | 9.87e-01 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 26 | 2.97e-01 | -1.18e-01 | 9.83e-01 |
| GOBP REGULATION OF PROTEIN MATURATION | 68 | 9.22e-02 | -1.18e-01 | 8.55e-01 |
| GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING | 10 | 5.18e-01 | -1.18e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 16 | 4.14e-01 | -1.18e-01 | 9.95e-01 |
| GOBP VACUOLAR TRANSPORT | 163 | 9.36e-03 | 1.18e-01 | 5.57e-01 |
| GOBP IRON ION IMPORT ACROSS PLASMA MEMBRANE | 5 | 6.48e-01 | 1.18e-01 | 9.98e-01 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 14 | 4.45e-01 | 1.18e-01 | 9.95e-01 |
| GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 14 | 4.45e-01 | 1.18e-01 | 9.95e-01 |
| GOCC TERTIARY GRANULE LUMEN | 53 | 1.38e-01 | 1.18e-01 | 9.02e-01 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 128 | 2.14e-02 | 1.18e-01 | 6.41e-01 |
| GOBP COPPER ION IMPORT | 6 | 6.18e-01 | 1.18e-01 | 9.98e-01 |
| GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 5.41e-01 | -1.18e-01 | 9.95e-01 |
| GOMF SIRNA BINDING | 7 | 5.90e-01 | 1.18e-01 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 43 | 1.82e-01 | -1.18e-01 | 9.27e-01 |
| GOMF STAT FAMILY PROTEIN BINDING | 11 | 4.99e-01 | 1.18e-01 | 9.95e-01 |
| GOBP GROOMING BEHAVIOR | 17 | 4.01e-01 | 1.18e-01 | 9.95e-01 |
| GOBP IP 10 PRODUCTION | 5 | 6.49e-01 | 1.18e-01 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 37 | 2.16e-01 | -1.18e-01 | 9.42e-01 |
| GOCC ATG12 ATG5 ATG16 COMPLEX | 5 | 6.49e-01 | -1.18e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 5 | 6.49e-01 | -1.17e-01 | 9.98e-01 |
| GOBP DIGESTION | 128 | 2.17e-02 | -1.17e-01 | 6.41e-01 |
| GOMF GUANYLATE KINASE ACTIVITY | 7 | 5.90e-01 | -1.17e-01 | 9.98e-01 |
| GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 8 | 5.65e-01 | 1.17e-01 | 9.95e-01 |
| GOMF RNA POLYMERASE BINDING | 57 | 1.25e-01 | 1.17e-01 | 8.91e-01 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION | 8 | 5.65e-01 | 1.17e-01 | 9.95e-01 |
| GOBP REGULATION OF PANCREATIC JUICE SECRETION | 7 | 5.91e-01 | 1.17e-01 | 9.98e-01 |
| GOBP RETROGRADE AXONAL TRANSPORT | 21 | 3.52e-01 | 1.17e-01 | 9.94e-01 |
| GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 87 | 5.86e-02 | 1.17e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 23 | 3.30e-01 | -1.17e-01 | 9.88e-01 |
| GOBP AMP METABOLIC PROCESS | 22 | 3.41e-01 | 1.17e-01 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 15 | 4.32e-01 | -1.17e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 44 | 1.79e-01 | 1.17e-01 | 9.23e-01 |
| GOBP FLUID TRANSPORT | 37 | 2.18e-01 | -1.17e-01 | 9.43e-01 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 31 | 2.59e-01 | 1.17e-01 | 9.59e-01 |
| GOMF GTPASE INHIBITOR ACTIVITY | 12 | 4.83e-01 | -1.17e-01 | 9.95e-01 |
| GOBP CYTOLYSIS BY HOST OF SYMBIONT CELLS | 6 | 6.20e-01 | 1.17e-01 | 9.98e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 72 | 8.61e-02 | -1.17e-01 | 8.39e-01 |
| GOBP DEFENSE RESPONSE TO SYMBIONT | 323 | 3.02e-04 | 1.17e-01 | 1.07e-01 |
| GOMF AMYLOID BETA BINDING | 82 | 6.73e-02 | -1.17e-01 | 7.99e-01 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 15 | 4.33e-01 | -1.17e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 13 | 4.66e-01 | 1.17e-01 | 9.95e-01 |
| GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY | 6 | 6.20e-01 | 1.17e-01 | 9.98e-01 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 59 | 1.21e-01 | -1.17e-01 | 8.86e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 70 | 9.10e-02 | 1.17e-01 | 8.53e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 83 | 6.59e-02 | 1.17e-01 | 7.99e-01 |
| GOCC SCAR COMPLEX | 12 | 4.84e-01 | -1.17e-01 | 9.95e-01 |
| GOBP LIMB BUD FORMATION | 9 | 5.44e-01 | 1.17e-01 | 9.95e-01 |
| GOBP TACHYKININ RECEPTOR SIGNALING PATHWAY | 8 | 5.67e-01 | 1.17e-01 | 9.95e-01 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 232 | 2.19e-03 | -1.17e-01 | 2.95e-01 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 35 | 2.32e-01 | -1.17e-01 | 9.50e-01 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 192 | 5.29e-03 | 1.17e-01 | 4.33e-01 |
| GOBP NUCLEOPHAGY | 18 | 3.92e-01 | 1.17e-01 | 9.95e-01 |
| GOBP GLIAL CELL FATE COMMITMENT | 13 | 4.67e-01 | 1.17e-01 | 9.95e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 18 | 3.92e-01 | 1.17e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 10 | 5.23e-01 | -1.17e-01 | 9.95e-01 |
| GOBP PEROXISOMAL TRANSPORT | 22 | 3.44e-01 | -1.16e-01 | 9.92e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 42 | 1.91e-01 | -1.16e-01 | 9.28e-01 |
| GOBP NEPHRIC DUCT MORPHOGENESIS | 10 | 5.24e-01 | 1.16e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 14 | 4.51e-01 | 1.16e-01 | 9.95e-01 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 8 | 5.69e-01 | 1.16e-01 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 9 | 5.46e-01 | -1.16e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 38 | 2.15e-01 | 1.16e-01 | 9.42e-01 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 87 | 6.08e-02 | 1.16e-01 | 7.94e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 27 | 2.96e-01 | 1.16e-01 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 46 | 1.72e-01 | -1.16e-01 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 74 | 8.38e-02 | 1.16e-01 | 8.39e-01 |
| GOCC CYTOSOLIC REGION | 19 | 3.80e-01 | -1.16e-01 | 9.95e-01 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 3.35e-01 | 1.16e-01 | 9.88e-01 |
| GOCC FIBRILLAR COLLAGEN TRIMER | 12 | 4.86e-01 | -1.16e-01 | 9.95e-01 |
| GOBP PROTEIN AUTOUBIQUITINATION | 67 | 1.00e-01 | -1.16e-01 | 8.65e-01 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 5.47e-01 | -1.16e-01 | 9.95e-01 |
| GOBP REGULATION OF LYASE ACTIVITY | 57 | 1.30e-01 | 1.16e-01 | 8.94e-01 |
| GOBP REGULATION OF MYOBLAST FUSION | 21 | 3.57e-01 | 1.16e-01 | 9.95e-01 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 13 | 4.69e-01 | -1.16e-01 | 9.95e-01 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 38 | 2.16e-01 | 1.16e-01 | 9.42e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 26 | 3.06e-01 | 1.16e-01 | 9.87e-01 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 41 | 1.99e-01 | 1.16e-01 | 9.36e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 1361 | 7.11e-13 | 1.16e-01 | 7.28e-09 |
| GOBP DETECTION OF BIOTIC STIMULUS | 37 | 2.22e-01 | -1.16e-01 | 9.45e-01 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 50 | 1.57e-01 | -1.16e-01 | 9.06e-01 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 6.54e-01 | 1.16e-01 | 9.98e-01 |
| GOBP TRACHEA CARTILAGE DEVELOPMENT | 7 | 5.96e-01 | -1.16e-01 | 9.98e-01 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 14 | 4.53e-01 | -1.16e-01 | 9.95e-01 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 25 | 3.16e-01 | 1.16e-01 | 9.87e-01 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 20 | 3.70e-01 | -1.16e-01 | 9.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 34 | 2.43e-01 | -1.16e-01 | 9.58e-01 |
| GOBP CARBOHYDRATE MEDIATED SIGNALING | 11 | 5.07e-01 | 1.16e-01 | 9.95e-01 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 452 | 2.53e-05 | 1.16e-01 | 1.68e-02 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 22 | 3.48e-01 | 1.16e-01 | 9.93e-01 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 16 | 4.24e-01 | 1.15e-01 | 9.95e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS | 5 | 6.55e-01 | 1.15e-01 | 9.98e-01 |
| GOCC B WICH COMPLEX | 7 | 5.97e-01 | 1.15e-01 | 9.98e-01 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 34 | 2.44e-01 | -1.15e-01 | 9.58e-01 |
| GOBP EPIDERMIS MORPHOGENESIS | 35 | 2.38e-01 | 1.15e-01 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 25 | 3.18e-01 | 1.15e-01 | 9.87e-01 |
| GOBP SNRNA CATABOLIC PROCESS | 5 | 6.55e-01 | -1.15e-01 | 9.98e-01 |
| GOMF BIOTIN BINDING | 5 | 6.55e-01 | -1.15e-01 | 9.98e-01 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 10 | 5.28e-01 | -1.15e-01 | 9.95e-01 |
| GOCC GLYCOPROTEIN COMPLEX | 21 | 3.61e-01 | -1.15e-01 | 9.95e-01 |
| GOMF ALDITOL NADPPLUS 1 OXIDOREDUCTASE ACTIVITY | 12 | 4.89e-01 | -1.15e-01 | 9.95e-01 |
| GOBP VITAMIN B6 METABOLIC PROCESS | 5 | 6.56e-01 | 1.15e-01 | 9.98e-01 |
| GOMF STRUCTURAL CONSTITUENT OF PRESYNAPTIC ACTIVE ZONE | 5 | 6.56e-01 | -1.15e-01 | 9.98e-01 |
| GOBP CARNITINE TRANSPORT | 8 | 5.73e-01 | 1.15e-01 | 9.95e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 159 | 1.22e-02 | 1.15e-01 | 6.06e-01 |
| GOMF BETA GLUCOSIDASE ACTIVITY | 6 | 6.25e-01 | -1.15e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 7 | 5.98e-01 | -1.15e-01 | 9.98e-01 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 90 | 5.90e-02 | 1.15e-01 | 7.90e-01 |
| GOBP NATURAL KILLER CELL DEGRANULATION | 10 | 5.28e-01 | 1.15e-01 | 9.95e-01 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 27 | 3.01e-01 | 1.15e-01 | 9.86e-01 |
| GOMF GLYCOGEN BINDING | 7 | 5.98e-01 | 1.15e-01 | 9.98e-01 |
| GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT | 10 | 5.29e-01 | 1.15e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 12 | 4.90e-01 | -1.15e-01 | 9.95e-01 |
| GOMF NEUTRAL L AMINO ACID SODIUM SYMPORTER ACTIVITY | 8 | 5.73e-01 | -1.15e-01 | 9.95e-01 |
| GOBP MONOTERPENOID METABOLIC PROCESS | 6 | 6.26e-01 | -1.15e-01 | 9.98e-01 |
| GOBP NUCLEOBASE TRANSPORT | 12 | 4.91e-01 | -1.15e-01 | 9.95e-01 |
| GOBP TRANSFERRIN TRANSPORT | 10 | 5.29e-01 | -1.15e-01 | 9.95e-01 |
| GOMF KERATIN FILAMENT BINDING | 6 | 6.26e-01 | -1.15e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 121 | 2.90e-02 | -1.15e-01 | 6.90e-01 |
| GOMF ACTIN MONOMER BINDING | 24 | 3.30e-01 | -1.15e-01 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 13 | 4.73e-01 | 1.15e-01 | 9.95e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 49 | 1.64e-01 | 1.15e-01 | 9.15e-01 |
| GOBP REGULATION OF POTASSIUM ION IMPORT | 5 | 6.57e-01 | -1.15e-01 | 9.98e-01 |
| GOBP DRINKING BEHAVIOR | 8 | 5.74e-01 | -1.15e-01 | 9.95e-01 |
| GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 9 | 5.51e-01 | 1.15e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 14 | 4.57e-01 | -1.15e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 24 | 3.31e-01 | -1.15e-01 | 9.88e-01 |
| GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY | 10 | 5.30e-01 | 1.15e-01 | 9.95e-01 |
| GOMF EPINEPHRINE BINDING | 6 | 6.27e-01 | 1.15e-01 | 9.98e-01 |
| GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 8 | 5.74e-01 | 1.15e-01 | 9.96e-01 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 17 | 4.13e-01 | 1.15e-01 | 9.95e-01 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 25 | 3.21e-01 | -1.15e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 18 | 4.00e-01 | -1.15e-01 | 9.95e-01 |
| GOMF NAD RETINOL DEHYDROGENASE ACTIVITY | 21 | 3.64e-01 | -1.15e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 55 | 1.42e-01 | 1.15e-01 | 9.02e-01 |
| GOBP FATTY ACID CATABOLIC PROCESS | 104 | 4.37e-02 | 1.14e-01 | 7.59e-01 |
| GOCC RETROMER COMPLEX | 11 | 5.11e-01 | 1.14e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 17 | 4.14e-01 | 1.14e-01 | 9.95e-01 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 91 | 5.94e-02 | -1.14e-01 | 7.90e-01 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 26 | 3.13e-01 | 1.14e-01 | 9.87e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 59 | 1.29e-01 | 1.14e-01 | 8.93e-01 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 52 | 1.54e-01 | 1.14e-01 | 9.06e-01 |
| GOBP CATECHOLAMINE UPTAKE | 18 | 4.02e-01 | 1.14e-01 | 9.95e-01 |
| GOCC PWP2P CONTAINING SUBCOMPLEX OF 90S PRERIBOSOME | 5 | 6.59e-01 | -1.14e-01 | 9.98e-01 |
| GOMF GUANYLYLTRANSFERASE ACTIVITY | 7 | 6.01e-01 | -1.14e-01 | 9.98e-01 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 97 | 5.23e-02 | 1.14e-01 | 7.81e-01 |
| GOCC DENDRITIC SPINE MEMBRANE | 13 | 4.77e-01 | 1.14e-01 | 9.95e-01 |
| GOMF MICROTUBULE PLUS END BINDING | 21 | 3.66e-01 | 1.14e-01 | 9.95e-01 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 30 | 2.80e-01 | -1.14e-01 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF ANOIKIS | 6 | 6.29e-01 | -1.14e-01 | 9.98e-01 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 132 | 2.39e-02 | 1.14e-01 | 6.57e-01 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 54 | 1.48e-01 | -1.14e-01 | 9.04e-01 |
| GOBP HEXOSE CATABOLIC PROCESS | 42 | 2.02e-01 | 1.14e-01 | 9.36e-01 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 25 | 3.25e-01 | 1.14e-01 | 9.87e-01 |
| GOCC CHITOSOME | 19 | 3.90e-01 | 1.14e-01 | 9.95e-01 |
| GOBP RNA 3 URIDYLATION | 5 | 6.60e-01 | -1.14e-01 | 9.98e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 14 | 4.61e-01 | 1.14e-01 | 9.95e-01 |
| GOBP DOPAMINE METABOLIC PROCESS | 35 | 2.44e-01 | -1.14e-01 | 9.58e-01 |
| GOMF PHOSPHOLIPASE BINDING | 20 | 3.79e-01 | 1.14e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 7 | 6.03e-01 | -1.14e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 18 | 4.05e-01 | 1.13e-01 | 9.95e-01 |
| GOBP RESPONSE TO ACETYLCHOLINE | 36 | 2.39e-01 | 1.13e-01 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF ODONTOGENESIS | 7 | 6.03e-01 | -1.13e-01 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 20 | 3.80e-01 | 1.13e-01 | 9.95e-01 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 53 | 1.53e-01 | -1.13e-01 | 9.06e-01 |
| GOBP REGULATION OF SYNAPSE PRUNING | 6 | 6.31e-01 | 1.13e-01 | 9.98e-01 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE | 18 | 4.06e-01 | 1.13e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF LENS FIBER CELL DIFFERENTIATION | 6 | 6.31e-01 | 1.13e-01 | 9.98e-01 |
| GOMF STEROID HYDROXYLASE ACTIVITY | 25 | 3.27e-01 | -1.13e-01 | 9.87e-01 |
| GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 8 | 5.79e-01 | -1.13e-01 | 9.96e-01 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 60 | 1.30e-01 | 1.13e-01 | 8.94e-01 |
| GOBP DIGESTIVE SYSTEM PROCESS | 102 | 4.83e-02 | -1.13e-01 | 7.68e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 9 | 5.57e-01 | -1.13e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 30 | 2.84e-01 | 1.13e-01 | 9.74e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 17 | 4.20e-01 | 1.13e-01 | 9.95e-01 |
| GOBP REGULATION OF LUNG BLOOD PRESSURE | 5 | 6.62e-01 | 1.13e-01 | 9.98e-01 |
| GOCC LUMENAL SIDE OF MEMBRANE | 35 | 2.47e-01 | -1.13e-01 | 9.58e-01 |
| GOBP RESPONSE TO GLUCAGON | 20 | 3.82e-01 | 1.13e-01 | 9.95e-01 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 12 | 4.98e-01 | 1.13e-01 | 9.95e-01 |
| GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 12 | 4.98e-01 | -1.13e-01 | 9.95e-01 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 23 | 3.49e-01 | -1.13e-01 | 9.94e-01 |
| GOBP ASTROCYTE ACTIVATION | 25 | 3.29e-01 | 1.13e-01 | 9.87e-01 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 120 | 3.28e-02 | -1.13e-01 | 7.07e-01 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 31 | 2.77e-01 | 1.13e-01 | 9.73e-01 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 13 | 4.81e-01 | -1.13e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 8 | 5.81e-01 | 1.13e-01 | 9.96e-01 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 14 | 4.65e-01 | 1.13e-01 | 9.95e-01 |
| GOCC X CHROMOSOME | 11 | 5.18e-01 | 1.13e-01 | 9.95e-01 |
| GOCC SPERM PRINCIPAL PIECE | 32 | 2.70e-01 | -1.13e-01 | 9.72e-01 |
| GOBP REGULATION OF HAIR CYCLE | 27 | 3.11e-01 | -1.13e-01 | 9.87e-01 |
| GOBP REGULATION OF PROTEIN NEDDYLATION | 19 | 3.96e-01 | -1.13e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 16 | 4.36e-01 | 1.13e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 8 | 5.82e-01 | -1.12e-01 | 9.96e-01 |
| GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION | 5 | 6.63e-01 | -1.12e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 11 | 5.19e-01 | 1.12e-01 | 9.95e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 11 | 5.19e-01 | -1.12e-01 | 9.95e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION | 9 | 5.59e-01 | -1.12e-01 | 9.95e-01 |
| GOCC LATE ENDOSOME LUMEN | 8 | 5.82e-01 | 1.12e-01 | 9.96e-01 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 31 | 2.79e-01 | -1.12e-01 | 9.73e-01 |
| GOBP VACUOLE ORGANIZATION | 219 | 4.17e-03 | 1.12e-01 | 3.81e-01 |
| GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 9 | 5.60e-01 | -1.12e-01 | 9.95e-01 |
| GOCC CALYX OF HELD | 19 | 3.97e-01 | 1.12e-01 | 9.95e-01 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 12 | 5.01e-01 | 1.12e-01 | 9.95e-01 |
| GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 10 | 5.39e-01 | -1.12e-01 | 9.95e-01 |
| GOCC SPERM HEAD | 17 | 4.23e-01 | -1.12e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 5 | 6.64e-01 | 1.12e-01 | 9.98e-01 |
| GOCC REPLICATION FORK | 64 | 1.21e-01 | 1.12e-01 | 8.86e-01 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 10 | 5.39e-01 | -1.12e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 6.08e-01 | -1.12e-01 | 9.98e-01 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 10 | 5.40e-01 | -1.12e-01 | 9.95e-01 |
| GOMF RIBONUCLEASE P RNA BINDING | 10 | 5.40e-01 | -1.12e-01 | 9.95e-01 |
| GOBP TRACHEA FORMATION | 7 | 6.08e-01 | 1.12e-01 | 9.98e-01 |
| GOBP GENITALIA MORPHOGENESIS | 11 | 5.20e-01 | 1.12e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 19 | 3.98e-01 | -1.12e-01 | 9.95e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 27 | 3.14e-01 | 1.12e-01 | 9.87e-01 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 43 | 2.04e-01 | 1.12e-01 | 9.36e-01 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 10 | 5.40e-01 | -1.12e-01 | 9.95e-01 |
| GOMF DNA NUCLEASE ACTIVITY | 58 | 1.40e-01 | 1.12e-01 | 9.02e-01 |
| GOBP DETECTION OF ABIOTIC STIMULUS | 132 | 2.64e-02 | -1.12e-01 | 6.73e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 14 | 4.69e-01 | 1.12e-01 | 9.95e-01 |
| GOBP SEMICIRCULAR CANAL DEVELOPMENT | 9 | 5.61e-01 | 1.12e-01 | 9.95e-01 |
| GOBP GENERAL ADAPTATION SYNDROME BEHAVIORAL PROCESS | 5 | 6.65e-01 | 1.12e-01 | 9.98e-01 |
| GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 9 | 5.61e-01 | 1.12e-01 | 9.95e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 8 | 5.84e-01 | 1.12e-01 | 9.96e-01 |
| GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY | 13 | 4.86e-01 | -1.12e-01 | 9.95e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 15 | 4.54e-01 | 1.12e-01 | 9.95e-01 |
| GOBP CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION | 12 | 5.03e-01 | 1.12e-01 | 9.95e-01 |
| GOMF SNORNA BINDING | 31 | 2.82e-01 | 1.12e-01 | 9.73e-01 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 38 | 2.34e-01 | -1.12e-01 | 9.51e-01 |
| GOBP BASE EXCISION REPAIR GAP FILLING | 14 | 4.70e-01 | 1.12e-01 | 9.95e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 17 | 4.26e-01 | -1.11e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 14 | 4.70e-01 | 1.11e-01 | 9.95e-01 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 128 | 2.95e-02 | -1.11e-01 | 6.94e-01 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 99 | 5.55e-02 | -1.11e-01 | 7.90e-01 |
| GOBP COBALT ION TRANSPORT | 6 | 6.37e-01 | 1.11e-01 | 9.98e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 152 | 1.78e-02 | 1.11e-01 | 6.41e-01 |
| GOMF ADENYLATE CYCLASE BINDING | 12 | 5.04e-01 | 1.11e-01 | 9.95e-01 |
| GOBP TYPE I INTERFERON PRODUCTION | 115 | 3.92e-02 | 1.11e-01 | 7.47e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 5.86e-01 | 1.11e-01 | 9.96e-01 |
| GOCC SPECIFIC GRANULE MEMBRANE | 88 | 7.11e-02 | 1.11e-01 | 8.00e-01 |
| GOBP KERATINIZATION | 75 | 9.58e-02 | -1.11e-01 | 8.60e-01 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 102 | 5.23e-02 | 1.11e-01 | 7.81e-01 |
| GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 5 | 6.67e-01 | 1.11e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 62 | 1.30e-01 | 1.11e-01 | 8.96e-01 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 150 | 1.88e-02 | -1.11e-01 | 6.41e-01 |
| GOBP BONE MORPHOGENESIS | 98 | 5.74e-02 | 1.11e-01 | 7.90e-01 |
| GOBP FEAR RESPONSE | 43 | 2.08e-01 | -1.11e-01 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 6.38e-01 | 1.11e-01 | 9.98e-01 |
| GOBP ANIMAL ORGAN MATURATION | 29 | 3.01e-01 | 1.11e-01 | 9.86e-01 |
| GOBP REGULATION OF P38MAPK CASCADE | 46 | 1.93e-01 | 1.11e-01 | 9.28e-01 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 8 | 5.87e-01 | -1.11e-01 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 6.68e-01 | 1.11e-01 | 9.98e-01 |
| GOBP HIPPO SIGNALING | 42 | 2.14e-01 | -1.11e-01 | 9.40e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 41 | 2.19e-01 | -1.11e-01 | 9.43e-01 |
| GOBP DIET INDUCED THERMOGENESIS | 13 | 4.89e-01 | 1.11e-01 | 9.95e-01 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 42 | 2.14e-01 | 1.11e-01 | 9.40e-01 |
| GOBP CELLULAR RESPONSE TO RADIATION | 170 | 1.27e-02 | 1.11e-01 | 6.10e-01 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 5.87e-01 | 1.11e-01 | 9.97e-01 |
| GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 15 | 4.58e-01 | -1.11e-01 | 9.95e-01 |
| GOCC GOLGI LUMEN | 96 | 6.09e-02 | -1.11e-01 | 7.94e-01 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 48 | 1.85e-01 | 1.11e-01 | 9.28e-01 |
| GOMF FATTY ACID LIGASE ACTIVITY | 20 | 3.92e-01 | -1.11e-01 | 9.95e-01 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 262 | 2.06e-03 | 1.11e-01 | 2.89e-01 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 39 | 2.32e-01 | 1.11e-01 | 9.50e-01 |
| GOBP MEIOTIC CHROMOSOME SEPARATION | 8 | 5.88e-01 | 1.11e-01 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 34 | 2.65e-01 | 1.10e-01 | 9.65e-01 |
| GOMF G QUADRUPLEX RNA BINDING | 5 | 6.69e-01 | 1.10e-01 | 9.98e-01 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 95 | 6.28e-02 | 1.10e-01 | 7.98e-01 |
| GOBP SCHWANN CELL MIGRATION | 5 | 6.69e-01 | -1.10e-01 | 9.98e-01 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 7 | 6.13e-01 | 1.10e-01 | 9.98e-01 |
| GOBP MONOCYTE DIFFERENTIATION | 34 | 2.65e-01 | -1.10e-01 | 9.66e-01 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 27 | 3.21e-01 | -1.10e-01 | 9.87e-01 |
| GOBP PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS | 5 | 6.69e-01 | -1.10e-01 | 9.98e-01 |
| GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 9 | 5.67e-01 | 1.10e-01 | 9.95e-01 |
| GOMF HISTONE DEACETYLASE BINDING | 109 | 4.69e-02 | 1.10e-01 | 7.65e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 5 | 6.70e-01 | 1.10e-01 | 9.98e-01 |
| GOBP PIGMENT GRANULE LOCALIZATION | 23 | 3.61e-01 | -1.10e-01 | 9.95e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 17 | 4.32e-01 | -1.10e-01 | 9.95e-01 |
| GOBP SKELETAL MYOFIBRIL ASSEMBLY | 10 | 5.47e-01 | 1.10e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 10 | 5.47e-01 | -1.10e-01 | 9.95e-01 |
| GOMF FLIPPASE ACTIVITY | 15 | 4.61e-01 | -1.10e-01 | 9.95e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION | 7 | 6.15e-01 | 1.10e-01 | 9.98e-01 |
| GOBP ENDOSOMAL VESICLE FUSION | 12 | 5.10e-01 | 1.10e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 7 | 6.15e-01 | 1.10e-01 | 9.98e-01 |
| GOMF NOTCH BINDING | 23 | 3.62e-01 | -1.10e-01 | 9.95e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 29 | 3.06e-01 | 1.10e-01 | 9.87e-01 |
| GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION | 12 | 5.11e-01 | 1.10e-01 | 9.95e-01 |
| GOCC ACROSOMAL MEMBRANE | 32 | 2.83e-01 | -1.10e-01 | 9.73e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CHROMATIN | 78 | 9.42e-02 | 1.10e-01 | 8.55e-01 |
| GOBP NEUROBLAST PROLIFERATION | 80 | 9.03e-02 | 1.10e-01 | 8.53e-01 |
| GOBP UMP CATABOLIC PROCESS | 5 | 6.71e-01 | -1.10e-01 | 9.98e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 5.11e-01 | -1.09e-01 | 9.95e-01 |
| GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 14 | 4.78e-01 | -1.09e-01 | 9.95e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 34 | 2.70e-01 | -1.09e-01 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 39 | 2.37e-01 | -1.09e-01 | 9.53e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 11 | 5.30e-01 | 1.09e-01 | 9.95e-01 |
| GOBP SPINAL CORD OLIGODENDROCYTE CELL DIFFERENTIATION | 5 | 6.72e-01 | -1.09e-01 | 9.98e-01 |
| GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 138 | 2.66e-02 | 1.09e-01 | 6.73e-01 |
| GOCC SIN3 TYPE COMPLEX | 20 | 3.98e-01 | 1.09e-01 | 9.95e-01 |
| GOMF APOLIPOPROTEIN RECEPTOR BINDING | 7 | 6.17e-01 | -1.09e-01 | 9.98e-01 |
| GOBP CARDIAC CELL FATE COMMITMENT | 16 | 4.49e-01 | 1.09e-01 | 9.95e-01 |
| GOCC BETA CATENIN TCF COMPLEX | 13 | 4.95e-01 | 1.09e-01 | 9.95e-01 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 4.36e-01 | 1.09e-01 | 9.95e-01 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 16 | 4.50e-01 | 1.09e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 8 | 5.93e-01 | 1.09e-01 | 9.98e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 17 | 4.36e-01 | 1.09e-01 | 9.95e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC | 9 | 5.71e-01 | 1.09e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 24 | 3.55e-01 | 1.09e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 6.44e-01 | -1.09e-01 | 9.98e-01 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 13 | 4.96e-01 | 1.09e-01 | 9.95e-01 |
| GOBP REGULATION OF GUANYLATE CYCLASE ACTIVITY | 6 | 6.44e-01 | 1.09e-01 | 9.98e-01 |
| GOCC DENDRITIC SHAFT | 40 | 2.33e-01 | -1.09e-01 | 9.50e-01 |
| GOBP DENDRITIC TRANSPORT | 12 | 5.13e-01 | -1.09e-01 | 9.95e-01 |
| GOBP MEIOTIC CELL CYCLE | 275 | 1.86e-03 | 1.09e-01 | 2.69e-01 |
| GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR | 10 | 5.51e-01 | 1.09e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 17 | 4.37e-01 | 1.09e-01 | 9.95e-01 |
| GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY | 21 | 3.87e-01 | 1.09e-01 | 9.95e-01 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 117 | 4.19e-02 | -1.09e-01 | 7.56e-01 |
| GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 3.46e-01 | -1.09e-01 | 9.92e-01 |
| GOBP GASTRIC MOTILITY | 5 | 6.73e-01 | -1.09e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 32 | 2.87e-01 | 1.09e-01 | 9.75e-01 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 5.94e-01 | -1.09e-01 | 9.98e-01 |
| GOBP OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT | 9 | 5.72e-01 | -1.09e-01 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 57 | 1.56e-01 | 1.09e-01 | 9.06e-01 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 24 | 3.57e-01 | 1.09e-01 | 9.95e-01 |
| GOMF MHC CLASS I PROTEIN COMPLEX BINDING | 6 | 6.45e-01 | 1.09e-01 | 9.98e-01 |
| GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 6.45e-01 | 1.09e-01 | 9.98e-01 |
| GOBP NEUROTRANSMITTER BIOSYNTHETIC PROCESS | 14 | 4.82e-01 | -1.09e-01 | 9.95e-01 |
| GOBP TERPENOID METABOLIC PROCESS | 96 | 6.61e-02 | -1.09e-01 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 7 | 6.19e-01 | -1.09e-01 | 9.98e-01 |
| GOBP MACROPHAGE ACTIVATION | 108 | 5.13e-02 | 1.09e-01 | 7.81e-01 |
| GOCC DYSTROGLYCAN COMPLEX | 7 | 6.19e-01 | 1.08e-01 | 9.98e-01 |
| GOMF POLYSACCHARIDE BINDING | 21 | 3.89e-01 | -1.08e-01 | 9.95e-01 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 46 | 2.03e-01 | 1.08e-01 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINESIS | 7 | 6.19e-01 | -1.08e-01 | 9.98e-01 |
| GOBP OTOLITH MORPHOGENESIS | 5 | 6.75e-01 | -1.08e-01 | 9.98e-01 |
| GOBP ENDOCANNABINOID SIGNALING PATHWAY | 5 | 6.75e-01 | -1.08e-01 | 9.98e-01 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 41 | 2.30e-01 | 1.08e-01 | 9.50e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 51 | 1.81e-01 | -1.08e-01 | 9.27e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 97 | 6.54e-02 | -1.08e-01 | 7.99e-01 |
| GOBP TOLL SIGNALING PATHWAY | 10 | 5.53e-01 | 1.08e-01 | 9.95e-01 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 1138 | 7.29e-10 | 1.08e-01 | 1.24e-06 |
| GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE | 46 | 2.04e-01 | 1.08e-01 | 9.36e-01 |
| GOMF OXO ACID LYASE ACTIVITY | 7 | 6.20e-01 | 1.08e-01 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 15 | 4.68e-01 | -1.08e-01 | 9.95e-01 |
| GOMF CLATHRIN LIGHT CHAIN BINDING | 7 | 6.21e-01 | -1.08e-01 | 9.98e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 25 | 3.50e-01 | 1.08e-01 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 85 | 8.52e-02 | 1.08e-01 | 8.39e-01 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 23 | 3.70e-01 | 1.08e-01 | 9.95e-01 |
| GOBP LOCOMOTOR RHYTHM | 15 | 4.69e-01 | 1.08e-01 | 9.95e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 12 | 5.17e-01 | 1.08e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 27 | 3.32e-01 | -1.08e-01 | 9.88e-01 |
| GOBP RECEPTOR METABOLIC PROCESS | 71 | 1.16e-01 | -1.08e-01 | 8.82e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 5.97e-01 | 1.08e-01 | 9.98e-01 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 58 | 1.56e-01 | 1.08e-01 | 9.06e-01 |
| GOCC PROTEIN DNA COMPLEX | 1325 | 4.38e-11 | 1.08e-01 | 8.96e-08 |
| GOBP RUFFLE ORGANIZATION | 57 | 1.59e-01 | -1.08e-01 | 9.06e-01 |
| GOBP KIDNEY MESENCHYME DEVELOPMENT | 16 | 4.55e-01 | 1.08e-01 | 9.95e-01 |
| GOCC ANAPHASE PROMOTING COMPLEX | 21 | 3.93e-01 | 1.08e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 47 | 2.02e-01 | 1.08e-01 | 9.36e-01 |
| GOBP MACROMOLECULE DEACYLATION | 63 | 1.40e-01 | 1.08e-01 | 9.02e-01 |
| GOBP NEUTROPHIL DIFFERENTIATION | 11 | 5.37e-01 | -1.08e-01 | 9.95e-01 |
| GOMF G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR ACTIVITY | 7 | 6.22e-01 | -1.08e-01 | 9.98e-01 |
| GOBP RESPONSE TO CAFFEINE | 15 | 4.71e-01 | -1.08e-01 | 9.95e-01 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 72 | 1.15e-01 | 1.08e-01 | 8.80e-01 |
| GOBP MEMBRANE HYPERPOLARIZATION | 10 | 5.56e-01 | -1.08e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 30 | 3.08e-01 | -1.08e-01 | 9.87e-01 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 44 | 2.18e-01 | 1.07e-01 | 9.43e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 98 | 6.65e-02 | 1.07e-01 | 7.99e-01 |
| GOBP RETINAL CONE CELL DIFFERENTIATION | 13 | 5.03e-01 | -1.07e-01 | 9.95e-01 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 12 | 5.20e-01 | -1.07e-01 | 9.95e-01 |
| GOBP L KYNURENINE METABOLIC PROCESS | 7 | 6.23e-01 | 1.07e-01 | 9.98e-01 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 60 | 1.51e-01 | -1.07e-01 | 9.04e-01 |
| GOBP CHROMATIN LOOPING | 11 | 5.38e-01 | 1.07e-01 | 9.95e-01 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 60 | 1.51e-01 | -1.07e-01 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 65 | 1.35e-01 | 1.07e-01 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 104 | 5.92e-02 | 1.07e-01 | 7.90e-01 |
| GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 6 | 6.50e-01 | -1.07e-01 | 9.98e-01 |
| GOBP SKIN MORPHOGENESIS | 13 | 5.04e-01 | 1.07e-01 | 9.95e-01 |
| GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS | 5 | 6.79e-01 | 1.07e-01 | 9.98e-01 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 26 | 3.45e-01 | 1.07e-01 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 7 | 6.24e-01 | 1.07e-01 | 9.98e-01 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 24 | 3.64e-01 | -1.07e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 24 | 3.64e-01 | 1.07e-01 | 9.95e-01 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 24 | 3.65e-01 | -1.07e-01 | 9.95e-01 |
| GOBP LUNG MORPHOGENESIS | 54 | 1.74e-01 | 1.07e-01 | 9.21e-01 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 12 | 5.21e-01 | 1.07e-01 | 9.95e-01 |
| GOBP DEMETHYLATION | 51 | 1.87e-01 | 1.07e-01 | 9.28e-01 |
| GOBP RESPONSE TO MUSCLE INACTIVITY | 9 | 5.79e-01 | 1.07e-01 | 9.96e-01 |
| GOBP TELOMERE ORGANIZATION | 178 | 1.39e-02 | 1.07e-01 | 6.25e-01 |
| GOBP CERAMIDE TRANSPORT | 17 | 4.46e-01 | 1.07e-01 | 9.95e-01 |
| GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE | 6 | 6.51e-01 | 1.07e-01 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 61 | 1.49e-01 | 1.07e-01 | 9.04e-01 |
| GOBP MYCOTOXIN METABOLIC PROCESS | 6 | 6.51e-01 | 1.07e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 42 | 2.31e-01 | 1.07e-01 | 9.50e-01 |
| GOBP REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 8 | 6.01e-01 | -1.07e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 27 | 3.37e-01 | -1.07e-01 | 9.88e-01 |
| GOMF LYSOPHOSPHATIDIC ACID PHOSPHATASE ACTIVITY | 6 | 6.51e-01 | 1.07e-01 | 9.98e-01 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 34 | 2.82e-01 | 1.07e-01 | 9.73e-01 |
| GOBP ZYGOTIC DETERMINATION OF ANTERIOR POSTERIOR AXIS EMBRYO | 6 | 6.51e-01 | -1.07e-01 | 9.98e-01 |
| GOBP ALPHA KETOGLUTARATE TRANSPORT | 7 | 6.25e-01 | 1.07e-01 | 9.98e-01 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 26 | 3.46e-01 | 1.07e-01 | 9.92e-01 |
| GOBP BONE CELL DEVELOPMENT | 17 | 4.46e-01 | -1.07e-01 | 9.95e-01 |
| GOCC CONDENSED CHROMOSOME | 265 | 2.80e-03 | 1.07e-01 | 3.18e-01 |
| GOBP CORTICOSTERONE SECRETION | 5 | 6.80e-01 | -1.07e-01 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT | 14 | 4.90e-01 | 1.07e-01 | 9.95e-01 |
| GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 18 | 4.33e-01 | -1.07e-01 | 9.95e-01 |
| GOBP PROTEIN RETENTION IN ER LUMEN | 8 | 6.01e-01 | -1.07e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 28 | 3.29e-01 | 1.07e-01 | 9.87e-01 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 12 | 5.22e-01 | -1.07e-01 | 9.95e-01 |
| GOBP REGULATION OF MRNA 3 END PROCESSING | 12 | 5.22e-01 | 1.07e-01 | 9.95e-01 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 21 | 3.98e-01 | 1.07e-01 | 9.95e-01 |
| GOBP NUCLEAR MIGRATION | 25 | 3.56e-01 | 1.07e-01 | 9.95e-01 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 10 | 5.60e-01 | 1.06e-01 | 9.95e-01 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 46 | 2.12e-01 | 1.06e-01 | 9.40e-01 |
| GOBP THIAMINE TRANSPORT | 8 | 6.02e-01 | -1.06e-01 | 9.98e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 17 | 4.48e-01 | -1.06e-01 | 9.95e-01 |
| GOBP FATTY ACID ELONGATION SATURATED FATTY ACID | 7 | 6.26e-01 | 1.06e-01 | 9.98e-01 |
| GOMF FATTY ACID ELONGASE ACTIVITY | 7 | 6.26e-01 | 1.06e-01 | 9.98e-01 |
| GOBP MICTURITION | 8 | 6.02e-01 | 1.06e-01 | 9.98e-01 |
| GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 8 | 6.02e-01 | 1.06e-01 | 9.98e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MYELIN MAINTENANCE | 5 | 6.81e-01 | 1.06e-01 | 9.98e-01 |
| GOMF LIPASE BINDING | 7 | 6.26e-01 | -1.06e-01 | 9.98e-01 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 19 | 4.23e-01 | -1.06e-01 | 9.95e-01 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 21 | 3.99e-01 | -1.06e-01 | 9.95e-01 |
| GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 6.81e-01 | 1.06e-01 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 18 | 4.36e-01 | -1.06e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 22 | 3.89e-01 | 1.06e-01 | 9.95e-01 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 27 | 3.40e-01 | -1.06e-01 | 9.88e-01 |
| GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 6 | 6.53e-01 | 1.06e-01 | 9.98e-01 |
| GOCC MCM COMPLEX | 8 | 6.03e-01 | -1.06e-01 | 9.98e-01 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 24 | 3.68e-01 | 1.06e-01 | 9.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED ASCORBATE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 5 | 6.81e-01 | -1.06e-01 | 9.98e-01 |
| GOMF TRAIL BINDING | 5 | 6.82e-01 | 1.06e-01 | 9.98e-01 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 26 | 3.50e-01 | 1.06e-01 | 9.94e-01 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 49 | 1.99e-01 | -1.06e-01 | 9.36e-01 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 42 | 2.35e-01 | -1.06e-01 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 6 | 6.53e-01 | 1.06e-01 | 9.98e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 10 | 5.62e-01 | 1.06e-01 | 9.95e-01 |
| GOBP HISTIDINE METABOLIC PROCESS | 10 | 5.62e-01 | -1.06e-01 | 9.95e-01 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 1562 | 2.76e-12 | 1.06e-01 | 1.05e-08 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 18 | 4.37e-01 | -1.06e-01 | 9.95e-01 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 58 | 1.63e-01 | -1.06e-01 | 9.12e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 32 | 3.00e-01 | 1.06e-01 | 9.85e-01 |
| GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 9 | 5.83e-01 | 1.06e-01 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF MELANOCYTE DIFFERENTIATION | 5 | 6.82e-01 | -1.06e-01 | 9.98e-01 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 26 | 3.50e-01 | -1.06e-01 | 9.94e-01 |
| GOCC SYNAPSE ASSOCIATED EXTRACELLULAR MATRIX | 12 | 5.26e-01 | -1.06e-01 | 9.95e-01 |
| GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX | 11 | 5.44e-01 | -1.06e-01 | 9.95e-01 |
| GOBP ESTROUS CYCLE | 16 | 4.64e-01 | -1.06e-01 | 9.95e-01 |
| GOBP PREPULSE INHIBITION | 13 | 5.09e-01 | 1.06e-01 | 9.95e-01 |
| GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 13 | 5.09e-01 | 1.06e-01 | 9.95e-01 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 39 | 2.53e-01 | -1.06e-01 | 9.58e-01 |
| GOBP CHROMOSOME LOCALIZATION | 117 | 4.83e-02 | 1.06e-01 | 7.68e-01 |
| GOBP INNER DYNEIN ARM ASSEMBLY | 16 | 4.64e-01 | 1.06e-01 | 9.95e-01 |
| GOCC GAP JUNCTION | 29 | 3.25e-01 | -1.06e-01 | 9.87e-01 |
| GOCC SEROTONIN ACTIVATED CATION SELECTIVE CHANNEL COMPLEX | 5 | 6.82e-01 | -1.06e-01 | 9.98e-01 |
| GOMF SEROTONIN GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY | 5 | 6.82e-01 | -1.06e-01 | 9.98e-01 |
| GOBP KETONE BODY BIOSYNTHETIC PROCESS | 6 | 6.54e-01 | 1.06e-01 | 9.98e-01 |
| GOBP TAURINE METABOLIC PROCESS | 9 | 5.83e-01 | 1.06e-01 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 17 | 4.51e-01 | 1.06e-01 | 9.95e-01 |
| GOMF D GLUCOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 5.27e-01 | 1.06e-01 | 9.95e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 23 | 3.81e-01 | -1.05e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 14 | 4.95e-01 | 1.05e-01 | 9.95e-01 |
| GOBP INTESTINAL LIPID ABSORPTION | 22 | 3.92e-01 | -1.05e-01 | 9.95e-01 |
| GOCC DOPAMINERGIC SYNAPSE | 14 | 4.95e-01 | -1.05e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 89 | 8.60e-02 | 1.05e-01 | 8.39e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 13 | 5.11e-01 | -1.05e-01 | 9.95e-01 |
| GOBP INNERVATION | 26 | 3.53e-01 | 1.05e-01 | 9.94e-01 |
| GOMF GDP BINDING | 69 | 1.31e-01 | -1.05e-01 | 8.96e-01 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 29 | 3.27e-01 | 1.05e-01 | 9.87e-01 |
| GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 6 | 6.56e-01 | -1.05e-01 | 9.98e-01 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 17 | 4.53e-01 | 1.05e-01 | 9.95e-01 |
| GOBP SCHWANN CELL DEVELOPMENT | 30 | 3.19e-01 | -1.05e-01 | 9.87e-01 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 49 | 2.03e-01 | -1.05e-01 | 9.36e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 110 | 5.70e-02 | -1.05e-01 | 7.90e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 17 | 4.54e-01 | 1.05e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 10 | 5.65e-01 | 1.05e-01 | 9.95e-01 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 12 | 5.29e-01 | 1.05e-01 | 9.95e-01 |
| GOBP RESPONSE TO COPPER ION | 35 | 2.83e-01 | -1.05e-01 | 9.73e-01 |
| GOCC MAIN AXON | 67 | 1.38e-01 | -1.05e-01 | 9.02e-01 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 14 | 4.97e-01 | 1.05e-01 | 9.95e-01 |
| GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY | 19 | 4.29e-01 | 1.05e-01 | 9.95e-01 |
| GOCC ENZYME ACTIVATOR COMPLEX | 16 | 4.68e-01 | 1.05e-01 | 9.95e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 56 | 1.75e-01 | 1.05e-01 | 9.21e-01 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 13 | 5.14e-01 | 1.05e-01 | 9.95e-01 |
| GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY | 11 | 5.48e-01 | 1.05e-01 | 9.95e-01 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 5 | 6.85e-01 | 1.05e-01 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 15 | 4.83e-01 | 1.05e-01 | 9.95e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 6.32e-01 | -1.05e-01 | 9.98e-01 |
| GOCC GABA ERGIC SYNAPSE | 73 | 1.23e-01 | 1.05e-01 | 8.86e-01 |
| GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT | 7 | 6.32e-01 | -1.04e-01 | 9.98e-01 |
| GOBP EMBRYONIC SKELETAL JOINT MORPHOGENESIS | 11 | 5.49e-01 | 1.04e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 7 | 6.32e-01 | -1.04e-01 | 9.98e-01 |
| GOBP PROTEIN OXIDATION | 13 | 5.15e-01 | -1.04e-01 | 9.95e-01 |
| GOBP AMINE METABOLIC PROCESS | 107 | 6.21e-02 | -1.04e-01 | 7.98e-01 |
| GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 8 | 6.09e-01 | 1.04e-01 | 9.98e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 17 | 4.56e-01 | -1.04e-01 | 9.95e-01 |
| GOBP DTTP METABOLIC PROCESS | 5 | 6.86e-01 | 1.04e-01 | 9.98e-01 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 276 | 2.85e-03 | -1.04e-01 | 3.20e-01 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 36 | 2.79e-01 | -1.04e-01 | 9.73e-01 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 11 | 5.49e-01 | -1.04e-01 | 9.95e-01 |
| GOMF CALCIUM POTASSIUM SODIUM ANTIPORTER ACTIVITY | 5 | 6.86e-01 | -1.04e-01 | 9.98e-01 |
| GOBP GRANULOCYTE DIFFERENTIATION | 40 | 2.54e-01 | 1.04e-01 | 9.58e-01 |
| GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 6.86e-01 | 1.04e-01 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 17 | 4.57e-01 | 1.04e-01 | 9.95e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 12 | 5.32e-01 | 1.04e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 891 | 1.29e-07 | 1.04e-01 | 1.89e-04 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 11 | 5.50e-01 | -1.04e-01 | 9.95e-01 |
| GOBP RESPONSE TO INTERLEUKIN 3 | 6 | 6.59e-01 | -1.04e-01 | 9.98e-01 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 20 | 4.20e-01 | -1.04e-01 | 9.95e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 6.33e-01 | 1.04e-01 | 9.98e-01 |
| GOMF ARYL SULFOTRANSFERASE ACTIVITY | 7 | 6.34e-01 | -1.04e-01 | 9.98e-01 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 68 | 1.38e-01 | 1.04e-01 | 9.02e-01 |
| GOBP RESPONSE TO GAMMA RADIATION | 50 | 2.04e-01 | 1.04e-01 | 9.36e-01 |
| GOBP GOLGI RIBBON FORMATION | 10 | 5.70e-01 | 1.04e-01 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 112 | 5.77e-02 | 1.04e-01 | 7.90e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN REGULATION OF CELL PROLIFERATION | 6 | 6.60e-01 | 1.04e-01 | 9.98e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN PATTERN SPECIFICATION | 11 | 5.51e-01 | -1.04e-01 | 9.95e-01 |
| GOMF MHC CLASS II PROTEIN BINDING | 7 | 6.35e-01 | 1.04e-01 | 9.98e-01 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 27 | 3.51e-01 | 1.04e-01 | 9.94e-01 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 25 | 3.70e-01 | -1.04e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 6.60e-01 | -1.04e-01 | 9.98e-01 |
| GOBP MACROPHAGE MIGRATION | 61 | 1.62e-01 | 1.04e-01 | 9.10e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY | 18 | 4.47e-01 | 1.04e-01 | 9.95e-01 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 16 | 4.73e-01 | -1.04e-01 | 9.95e-01 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 47 | 2.19e-01 | -1.04e-01 | 9.43e-01 |
| GOMF ACID PHOSPHATASE ACTIVITY | 9 | 5.91e-01 | -1.04e-01 | 9.98e-01 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 36 | 2.83e-01 | -1.03e-01 | 9.73e-01 |
| GOMF U4 SNRNA BINDING | 6 | 6.61e-01 | -1.03e-01 | 9.98e-01 |
| GOBP REGULATION OF URINE VOLUME | 20 | 4.23e-01 | -1.03e-01 | 9.95e-01 |
| GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 11 | 5.52e-01 | -1.03e-01 | 9.95e-01 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 50 | 2.06e-01 | 1.03e-01 | 9.38e-01 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 78 | 1.14e-01 | 1.03e-01 | 8.80e-01 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 66 | 1.46e-01 | 1.03e-01 | 9.03e-01 |
| GOBP MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL | 7 | 6.36e-01 | 1.03e-01 | 9.98e-01 |
| GOCC EUCHROMATIN | 56 | 1.81e-01 | 1.03e-01 | 9.27e-01 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 180 | 1.69e-02 | 1.03e-01 | 6.37e-01 |
| GOBP DNA LIGATION | 16 | 4.75e-01 | 1.03e-01 | 9.95e-01 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 13 | 5.19e-01 | -1.03e-01 | 9.95e-01 |
| GOCC KERATIN FILAMENT | 90 | 9.08e-02 | -1.03e-01 | 8.53e-01 |
| GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 10 | 5.72e-01 | 1.03e-01 | 9.95e-01 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 26 | 3.63e-01 | -1.03e-01 | 9.95e-01 |
| GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION | 7 | 6.37e-01 | -1.03e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 10 | 5.72e-01 | -1.03e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 60 | 1.67e-01 | -1.03e-01 | 9.15e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 15 | 4.90e-01 | 1.03e-01 | 9.95e-01 |
| GOCC RNA CAP BINDING COMPLEX | 19 | 4.37e-01 | -1.03e-01 | 9.95e-01 |
| GOBP MEDIUM CHAIN FATTY ACID CATABOLIC PROCESS | 5 | 6.90e-01 | -1.03e-01 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 85 | 1.01e-01 | 1.03e-01 | 8.66e-01 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 15 | 4.90e-01 | 1.03e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 12 | 5.37e-01 | 1.03e-01 | 9.95e-01 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 291 | 2.54e-03 | 1.03e-01 | 3.16e-01 |
| GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 10 | 5.73e-01 | -1.03e-01 | 9.95e-01 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 6 | 6.63e-01 | 1.03e-01 | 9.98e-01 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 68 | 1.43e-01 | 1.03e-01 | 9.02e-01 |
| GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 10 | 5.74e-01 | -1.03e-01 | 9.95e-01 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 481 | 1.15e-04 | 1.03e-01 | 5.11e-02 |
| GOMF ADENOSINE DEAMINASE ACTIVITY | 13 | 5.22e-01 | 1.03e-01 | 9.95e-01 |
| GOCC TRNA METHYLTRANSFERASE COMPLEX | 6 | 6.63e-01 | -1.03e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 81 | 1.10e-01 | 1.03e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 8 | 6.15e-01 | -1.03e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 11 | 5.56e-01 | -1.03e-01 | 9.95e-01 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 22 | 4.05e-01 | -1.03e-01 | 9.95e-01 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 20 | 4.27e-01 | -1.03e-01 | 9.95e-01 |
| GOBP RESPONSE TO HYPEROXIA | 18 | 4.52e-01 | 1.03e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 59 | 1.73e-01 | -1.03e-01 | 9.21e-01 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 31 | 3.23e-01 | 1.02e-01 | 9.87e-01 |
| GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 8 | 6.16e-01 | 1.02e-01 | 9.98e-01 |
| GOBP SINGLE STRAND BREAK REPAIR | 11 | 5.56e-01 | -1.02e-01 | 9.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 26 | 3.66e-01 | 1.02e-01 | 9.95e-01 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 27 | 3.57e-01 | 1.02e-01 | 9.95e-01 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 29 | 3.40e-01 | -1.02e-01 | 9.88e-01 |
| GOBP GANGLIOSIDE CATABOLIC PROCESS | 7 | 6.39e-01 | 1.02e-01 | 9.98e-01 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 46 | 2.30e-01 | 1.02e-01 | 9.50e-01 |
| GOBP RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION | 15 | 4.93e-01 | 1.02e-01 | 9.95e-01 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 42 | 2.52e-01 | 1.02e-01 | 9.58e-01 |
| GOBP BASE EXCISION REPAIR | 42 | 2.52e-01 | 1.02e-01 | 9.58e-01 |
| GOCC ACTIN FILAMENT | 105 | 7.06e-02 | -1.02e-01 | 8.00e-01 |
| GOBP REGULATION OF ASTROCYTE ACTIVATION | 8 | 6.17e-01 | -1.02e-01 | 9.98e-01 |
| GOBP LUNG CELL DIFFERENTIATION | 28 | 3.50e-01 | -1.02e-01 | 9.94e-01 |
| GOMF ANNEALING ACTIVITY | 8 | 6.17e-01 | 1.02e-01 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION | 48 | 2.21e-01 | 1.02e-01 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 37 | 2.83e-01 | 1.02e-01 | 9.73e-01 |
| GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION | 12 | 5.41e-01 | 1.02e-01 | 9.95e-01 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 35 | 2.96e-01 | 1.02e-01 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 38 | 2.77e-01 | -1.02e-01 | 9.73e-01 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 24 | 3.87e-01 | -1.02e-01 | 9.95e-01 |
| GOBP REGULATION OF SODIUM DEPENDENT PHOSPHATE TRANSPORT | 5 | 6.93e-01 | -1.02e-01 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS | 69 | 1.43e-01 | 1.02e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 15 | 4.94e-01 | -1.02e-01 | 9.95e-01 |
| GOMF SERINE HYDROLASE ACTIVITY | 190 | 1.54e-02 | -1.02e-01 | 6.25e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 23 | 3.98e-01 | -1.02e-01 | 9.95e-01 |
| GOBP IODIDE TRANSPORT | 9 | 5.97e-01 | -1.02e-01 | 9.98e-01 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 68 | 1.46e-01 | 1.02e-01 | 9.03e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 23 | 3.98e-01 | 1.02e-01 | 9.95e-01 |
| GOBP ORGANELLE FISSION | 478 | 1.38e-04 | 1.02e-01 | 5.87e-02 |
| GOBP BILE ACID SECRETION | 12 | 5.42e-01 | -1.02e-01 | 9.95e-01 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 51 | 2.09e-01 | 1.02e-01 | 9.38e-01 |
| GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 8 | 6.19e-01 | -1.02e-01 | 9.98e-01 |
| GOBP VASCULAR WOUND HEALING | 22 | 4.09e-01 | 1.02e-01 | 9.95e-01 |
| GOBP PIGMENT CATABOLIC PROCESS | 11 | 5.60e-01 | 1.02e-01 | 9.95e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 37 | 2.85e-01 | -1.02e-01 | 9.75e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 17 | 4.69e-01 | -1.01e-01 | 9.95e-01 |
| GOMF MRNA 5 UTR BINDING | 23 | 4.00e-01 | -1.01e-01 | 9.95e-01 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 21 | 4.21e-01 | -1.01e-01 | 9.95e-01 |
| GOBP ACETATE ESTER TRANSPORT | 9 | 5.98e-01 | 1.01e-01 | 9.98e-01 |
| GOBP NEUROINFLAMMATORY RESPONSE | 82 | 1.12e-01 | 1.01e-01 | 8.77e-01 |
| GOBP TELOMERE MAINTENANCE | 149 | 3.27e-02 | 1.01e-01 | 7.07e-01 |
| GOBP REGULATION OF TOOTH MINERALIZATION | 10 | 5.79e-01 | -1.01e-01 | 9.96e-01 |
| GOCC TERMINAL BOUTON | 43 | 2.50e-01 | -1.01e-01 | 9.58e-01 |
| GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 7 | 6.42e-01 | 1.01e-01 | 9.98e-01 |
| GOCC CONTRACTILE FIBER | 238 | 7.09e-03 | -1.01e-01 | 5.04e-01 |
| GOBP POSITIVE REGULATION OF FEAR RESPONSE | 6 | 6.67e-01 | -1.01e-01 | 9.98e-01 |
| GOCC PRECATALYTIC SPLICEOSOME | 50 | 2.15e-01 | 1.01e-01 | 9.42e-01 |
| GOBP HYDROGEN SULFIDE METABOLIC PROCESS | 6 | 6.67e-01 | -1.01e-01 | 9.98e-01 |
| GOMF TOXIC SUBSTANCE BINDING | 10 | 5.79e-01 | -1.01e-01 | 9.96e-01 |
| GOBP MONOCYTE AGGREGATION | 5 | 6.95e-01 | 1.01e-01 | 9.98e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 21 | 4.22e-01 | -1.01e-01 | 9.95e-01 |
| GOMF NARROW PORE CHANNEL ACTIVITY | 19 | 4.45e-01 | -1.01e-01 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 61 | 1.72e-01 | -1.01e-01 | 9.21e-01 |
| GOBP CITRATE METABOLIC PROCESS | 5 | 6.95e-01 | 1.01e-01 | 9.98e-01 |
| GOCC PERICENTRIOLAR MATERIAL | 22 | 4.12e-01 | 1.01e-01 | 9.95e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 7 | 6.43e-01 | 1.01e-01 | 9.98e-01 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 5.45e-01 | 1.01e-01 | 9.95e-01 |
| GOCC POSTSYNAPTIC CYTOSOL | 13 | 5.28e-01 | -1.01e-01 | 9.95e-01 |
| GOCC APOLIPOPROTEIN B MRNA EDITING ENZYME COMPLEX | 5 | 6.96e-01 | -1.01e-01 | 9.98e-01 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 101 | 7.96e-02 | -1.01e-01 | 8.31e-01 |
| GOBP CELLULAR RESPONSE TO CGMP | 7 | 6.44e-01 | -1.01e-01 | 9.98e-01 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 24 | 3.93e-01 | 1.01e-01 | 9.95e-01 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 39 | 2.76e-01 | -1.01e-01 | 9.73e-01 |
| GOBP THYMOCYTE MIGRATION | 6 | 6.69e-01 | -1.01e-01 | 9.98e-01 |
| GOBP BEHAVIORAL RESPONSE TO NICOTINE | 9 | 6.01e-01 | 1.01e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING | 8 | 6.22e-01 | -1.01e-01 | 9.98e-01 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 37 | 2.89e-01 | -1.01e-01 | 9.77e-01 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 13 | 5.30e-01 | 1.01e-01 | 9.95e-01 |
| GOMF DNA CLAMP LOADER ACTIVITY | 9 | 6.01e-01 | 1.01e-01 | 9.98e-01 |
| GOCC CHROMAFFIN GRANULE MEMBRANE | 9 | 6.02e-01 | -1.01e-01 | 9.98e-01 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 32 | 3.26e-01 | 1.00e-01 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 15 | 5.01e-01 | -1.00e-01 | 9.95e-01 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 128 | 4.99e-02 | -1.00e-01 | 7.77e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 13 | 5.31e-01 | 1.00e-01 | 9.95e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 7 | 6.46e-01 | 1.00e-01 | 9.98e-01 |
| GOBP INTERLEUKIN 5 PRODUCTION | 19 | 4.49e-01 | 1.00e-01 | 9.95e-01 |
| GOBP STARTLE RESPONSE | 26 | 3.76e-01 | 1.00e-01 | 9.95e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY | 7 | 6.46e-01 | 1.00e-01 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 15 | 5.01e-01 | -1.00e-01 | 9.95e-01 |
| GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY | 7 | 6.46e-01 | 1.00e-01 | 9.98e-01 |
| GOBP TONGUE MORPHOGENESIS | 10 | 5.83e-01 | 1.00e-01 | 9.96e-01 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 160 | 2.88e-02 | 1.00e-01 | 6.86e-01 |
| GOBP CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 8 | 6.24e-01 | -1.00e-01 | 9.98e-01 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 11 | 5.65e-01 | -1.00e-01 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 10 | 5.84e-01 | -1.00e-01 | 9.96e-01 |
| GOBP MESODERM DEVELOPMENT | 124 | 5.42e-02 | 1.00e-01 | 7.87e-01 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 48 | 2.31e-01 | 1.00e-01 | 9.50e-01 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 22 | 4.17e-01 | 1.00e-01 | 9.95e-01 |
| GOBP REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA | 5 | 6.99e-01 | -1.00e-01 | 9.98e-01 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 220 | 1.06e-02 | 1.00e-01 | 5.73e-01 |
| GOBP NOREPINEPHRINE TRANSPORT | 22 | 4.17e-01 | 9.99e-02 | 9.95e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 10 | 5.84e-01 | -9.99e-02 | 9.96e-01 |
| GOBP MAMMARY GLAND FORMATION | 7 | 6.47e-01 | -9.99e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 52 | 2.13e-01 | 9.99e-02 | 9.40e-01 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 111 | 6.92e-02 | -9.98e-02 | 8.00e-01 |
| GOBP HEXOSE PHOSPHATE TRANSPORT | 7 | 6.47e-01 | 9.98e-02 | 9.98e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 17 | 4.76e-01 | -9.98e-02 | 9.95e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 20 | 4.40e-01 | 9.98e-02 | 9.95e-01 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 17 | 4.76e-01 | -9.98e-02 | 9.95e-01 |
| GOBP NEUROTRANSMITTER CATABOLIC PROCESS | 8 | 6.25e-01 | -9.98e-02 | 9.98e-01 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 34 | 3.14e-01 | 9.97e-02 | 9.87e-01 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 150 | 3.50e-02 | 9.97e-02 | 7.25e-01 |
| GOBP SNARE COMPLEX ASSEMBLY | 22 | 4.18e-01 | 9.97e-02 | 9.95e-01 |
| GOBP OMEGA HYDROXYLASE P450 PATHWAY | 11 | 5.67e-01 | 9.97e-02 | 9.95e-01 |
| GOBP ENDOTHELIAL CELL MATRIX ADHESION | 8 | 6.25e-01 | -9.97e-02 | 9.98e-01 |
| GOBP AMINO ACID BETAINE TRANSPORT | 13 | 5.34e-01 | 9.97e-02 | 9.95e-01 |
| GOCC M BAND | 21 | 4.29e-01 | -9.97e-02 | 9.95e-01 |
| GOBP BONE MATURATION | 25 | 3.88e-01 | 9.97e-02 | 9.95e-01 |
| GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 8 | 6.25e-01 | -9.97e-02 | 9.98e-01 |
| GOCC NUCLEAR PORE OUTER RING | 9 | 6.05e-01 | 9.97e-02 | 9.98e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 18 | 4.64e-01 | -9.97e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 15 | 5.04e-01 | 9.96e-02 | 9.95e-01 |
| GOBP STEM CELL FATE COMMITMENT | 10 | 5.86e-01 | 9.96e-02 | 9.96e-01 |
| GOBP ACINAR CELL DIFFERENTIATION | 5 | 7.00e-01 | 9.96e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 88 | 1.07e-01 | 9.95e-02 | 8.68e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 8 | 6.26e-01 | -9.95e-02 | 9.98e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 6 | 6.73e-01 | 9.95e-02 | 9.98e-01 |
| GOBP MESODERM MORPHOGENESIS | 76 | 1.34e-01 | 9.95e-02 | 8.96e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 93 | 9.76e-02 | 9.94e-02 | 8.61e-01 |
| GOBP APOPTOTIC CELL CLEARANCE | 47 | 2.38e-01 | 9.94e-02 | 9.55e-01 |
| GOCC ATPASE COMPLEX | 140 | 4.23e-02 | 9.94e-02 | 7.58e-01 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 33 | 3.23e-01 | -9.94e-02 | 9.87e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 21 | 4.31e-01 | -9.93e-02 | 9.95e-01 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 445 | 3.27e-04 | 9.93e-02 | 1.11e-01 |
| GOMF C ACETYLTRANSFERASE ACTIVITY | 7 | 6.49e-01 | 9.93e-02 | 9.98e-01 |
| GOBP FOREGUT MORPHOGENESIS | 10 | 5.87e-01 | 9.93e-02 | 9.97e-01 |
| GOBP EMBRYONIC CLEAVAGE | 8 | 6.27e-01 | 9.93e-02 | 9.98e-01 |
| GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 27 | 3.72e-01 | 9.93e-02 | 9.95e-01 |
| GOBP RECEPTOR RECYCLING | 46 | 2.44e-01 | -9.92e-02 | 9.58e-01 |
| GOBP FLOOR PLATE DEVELOPMENT | 11 | 5.69e-01 | 9.92e-02 | 9.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 9 | 6.07e-01 | -9.91e-02 | 9.98e-01 |
| GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 6.50e-01 | 9.91e-02 | 9.98e-01 |
| GOCC GTPASE ACTIVATOR COMPLEX | 11 | 5.69e-01 | 9.91e-02 | 9.95e-01 |
| GOBP AXIS SPECIFICATION | 91 | 1.02e-01 | 9.91e-02 | 8.66e-01 |
| GOBP MAMMARY GLAND INVOLUTION | 8 | 6.27e-01 | -9.91e-02 | 9.98e-01 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 87 | 1.10e-01 | -9.91e-02 | 8.76e-01 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 240 | 8.19e-03 | 9.91e-02 | 5.41e-01 |
| GOCC CD40 RECEPTOR COMPLEX | 11 | 5.69e-01 | 9.91e-02 | 9.95e-01 |
| GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 9 | 6.07e-01 | 9.90e-02 | 9.98e-01 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 18 | 4.67e-01 | 9.90e-02 | 9.95e-01 |
| GOCC PLATELET DENSE GRANULE | 20 | 4.43e-01 | -9.90e-02 | 9.95e-01 |
| GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 6.75e-01 | 9.90e-02 | 9.98e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 11 | 5.70e-01 | 9.90e-02 | 9.95e-01 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 57 | 1.96e-01 | 9.89e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 80 | 1.26e-01 | 9.89e-02 | 8.91e-01 |
| GOCC PRP19 COMPLEX | 12 | 5.53e-01 | 9.89e-02 | 9.95e-01 |
| GOCC FILOPODIUM MEMBRANE | 17 | 4.80e-01 | 9.89e-02 | 9.95e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 17 | 4.80e-01 | 9.89e-02 | 9.95e-01 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 16 | 4.93e-01 | 9.89e-02 | 9.95e-01 |
| GOBP OTOLITH DEVELOPMENT | 10 | 5.88e-01 | 9.89e-02 | 9.97e-01 |
| GOBP FIBROBLAST ACTIVATION | 15 | 5.07e-01 | 9.89e-02 | 9.95e-01 |
| GOBP RECEPTOR CLUSTERING | 53 | 2.13e-01 | 9.88e-02 | 9.40e-01 |
| GOBP SPHINGOLIPID CATABOLIC PROCESS | 32 | 3.33e-01 | 9.88e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 158 | 3.21e-02 | 9.88e-02 | 7.07e-01 |
| GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR | 11 | 5.71e-01 | 9.88e-02 | 9.95e-01 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 21 | 4.33e-01 | -9.88e-02 | 9.95e-01 |
| GOMF L ASCORBIC ACID BINDING | 20 | 4.45e-01 | -9.87e-02 | 9.95e-01 |
| GOCC CHROMOSOME | 1811 | 3.07e-12 | 9.87e-02 | 1.05e-08 |
| GOBP NEGATIVE REGULATION OF MYOBLAST PROLIFERATION | 9 | 6.08e-01 | 9.87e-02 | 9.98e-01 |
| GOBP REGULATION OF T CELL CHEMOTAXIS | 15 | 5.08e-01 | -9.87e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF ATP METABOLIC PROCESS | 7 | 6.51e-01 | -9.87e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO ATP | 16 | 4.94e-01 | 9.87e-02 | 9.95e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 23 | 4.13e-01 | 9.86e-02 | 9.95e-01 |
| GOMF EPHRIN RECEPTOR BINDING | 26 | 3.84e-01 | 9.86e-02 | 9.95e-01 |
| GOBP ARTERY MORPHOGENESIS | 81 | 1.25e-01 | 9.86e-02 | 8.91e-01 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 23 | 4.13e-01 | 9.86e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 5 | 7.03e-01 | -9.86e-02 | 9.98e-01 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 12 | 5.55e-01 | 9.85e-02 | 9.95e-01 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 14 | 5.23e-01 | -9.85e-02 | 9.95e-01 |
| GOBP RESPONSE TO REDOX STATE | 14 | 5.24e-01 | -9.85e-02 | 9.95e-01 |
| GOCC TERTIARY GRANULE MEMBRANE | 69 | 1.57e-01 | 9.84e-02 | 9.06e-01 |
| GOCC SIGNAL RECOGNITION PARTICLE | 8 | 6.30e-01 | 9.83e-02 | 9.98e-01 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 41 | 2.76e-01 | 9.83e-02 | 9.73e-01 |
| GOBP HUMORAL IMMUNE RESPONSE | 232 | 9.90e-03 | -9.83e-02 | 5.57e-01 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 538 | 9.66e-05 | -9.83e-02 | 4.56e-02 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 60 | 1.88e-01 | 9.82e-02 | 9.28e-01 |
| GOCC CHLORIDE CHANNEL COMPLEX | 50 | 2.29e-01 | 9.82e-02 | 9.50e-01 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 91 | 1.06e-01 | -9.82e-02 | 8.67e-01 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 15 | 5.10e-01 | -9.82e-02 | 9.95e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS | 8 | 6.31e-01 | -9.81e-02 | 9.98e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 14 | 5.25e-01 | -9.81e-02 | 9.95e-01 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 23 | 4.16e-01 | -9.81e-02 | 9.95e-01 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 12 | 5.56e-01 | 9.81e-02 | 9.95e-01 |
| GOBP L LYSINE TRANSPORT | 7 | 6.53e-01 | -9.80e-02 | 9.98e-01 |
| GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.53e-01 | -9.80e-02 | 9.98e-01 |
| GOBP RRNA METHYLATION | 24 | 4.06e-01 | -9.80e-02 | 9.95e-01 |
| GOBP MUSCLE ADAPTATION | 117 | 6.72e-02 | 9.80e-02 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 6 | 6.78e-01 | 9.79e-02 | 9.98e-01 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 36 | 3.09e-01 | 9.79e-02 | 9.87e-01 |
| GOMF MANNOSIDASE ACTIVITY | 15 | 5.11e-01 | 9.79e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 16 | 4.98e-01 | -9.79e-02 | 9.95e-01 |
| GOBP PANCREAS DEVELOPMENT | 78 | 1.35e-01 | 9.79e-02 | 8.98e-01 |
| GOMF COPPER CHAPERONE ACTIVITY | 6 | 6.78e-01 | 9.79e-02 | 9.98e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 312 | 2.95e-03 | 9.79e-02 | 3.28e-01 |
| GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 10 | 5.92e-01 | -9.78e-02 | 9.98e-01 |
| GOBP METANEPHRIC LOOP OF HENLE DEVELOPMENT | 6 | 6.78e-01 | 9.78e-02 | 9.98e-01 |
| GOBP PERICARDIUM DEVELOPMENT | 19 | 4.60e-01 | 9.78e-02 | 9.95e-01 |
| GOMF IGE BINDING | 5 | 7.05e-01 | -9.78e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 216 | 1.33e-02 | -9.78e-02 | 6.15e-01 |
| GOBP DNA DEALKYLATION | 37 | 3.04e-01 | 9.77e-02 | 9.87e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 33 | 3.31e-01 | -9.77e-02 | 9.88e-01 |
| GOBP MIDBRAIN DEVELOPMENT | 86 | 1.17e-01 | 9.77e-02 | 8.83e-01 |
| GOBP METANEPHRIC PART OF URETERIC BUD DEVELOPMENT | 6 | 6.79e-01 | -9.77e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 6 | 6.79e-01 | -9.77e-02 | 9.98e-01 |
| GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 15 | 5.13e-01 | -9.76e-02 | 9.95e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 66 | 1.70e-01 | 9.76e-02 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 24 | 4.08e-01 | 9.76e-02 | 9.95e-01 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 7 | 6.55e-01 | -9.76e-02 | 9.98e-01 |
| GOMF LAMININ 1 BINDING | 7 | 6.55e-01 | -9.76e-02 | 9.98e-01 |
| GOCC DENTATE GYRUS MOSSY FIBER | 6 | 6.79e-01 | 9.76e-02 | 9.98e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 77 | 1.39e-01 | -9.75e-02 | 9.02e-01 |
| GOBP MITOPHAGY | 34 | 3.25e-01 | 9.75e-02 | 9.87e-01 |
| GOBP STEROL HOMEOSTASIS | 99 | 9.38e-02 | -9.75e-02 | 8.55e-01 |
| GOBP OXIDATIVE DEMETHYLATION | 14 | 5.28e-01 | 9.74e-02 | 9.95e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 26 | 3.90e-01 | 9.74e-02 | 9.95e-01 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 11 | 5.76e-01 | -9.74e-02 | 9.96e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 72 | 1.53e-01 | -9.74e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 9 | 6.13e-01 | 9.74e-02 | 9.98e-01 |
| GOBP CILIARY BASAL BODY ORGANIZATION | 5 | 7.06e-01 | 9.74e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 8 | 6.33e-01 | -9.74e-02 | 9.98e-01 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 10 | 5.94e-01 | 9.73e-02 | 9.98e-01 |
| GOBP PIGMENT METABOLIC PROCESS | 74 | 1.48e-01 | 9.73e-02 | 9.04e-01 |
| GOBP SEGMENTATION | 99 | 9.44e-02 | 9.73e-02 | 8.55e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 13 | 5.44e-01 | 9.72e-02 | 9.95e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 27 | 3.82e-01 | 9.72e-02 | 9.95e-01 |
| GOBP REGULATION OF T CELL COSTIMULATION | 5 | 7.07e-01 | -9.72e-02 | 9.98e-01 |
| GOBP REGULATION OF MACROAUTOPHAGY | 150 | 4.00e-02 | 9.72e-02 | 7.56e-01 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 13 | 5.44e-01 | 9.71e-02 | 9.95e-01 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 92 | 1.07e-01 | 9.71e-02 | 8.70e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 23 | 4.20e-01 | 9.71e-02 | 9.95e-01 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE | 7 | 6.56e-01 | -9.71e-02 | 9.98e-01 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 33 | 3.34e-01 | 9.71e-02 | 9.88e-01 |
| GOBP VITAMIN TRANSPORT | 52 | 2.26e-01 | 9.71e-02 | 9.50e-01 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 26 | 3.91e-01 | 9.71e-02 | 9.95e-01 |
| GOMF HISTONE CHAPERONE ACTIVITY | 12 | 5.60e-01 | -9.71e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO UV | 87 | 1.18e-01 | 9.70e-02 | 8.83e-01 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 43 | 2.71e-01 | 9.70e-02 | 9.73e-01 |
| GOMF PROLINE SODIUM SYMPORTER ACTIVITY | 5 | 7.07e-01 | 9.70e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 9 | 6.14e-01 | -9.70e-02 | 9.98e-01 |
| GOCC SUMO LIGASE COMPLEX | 13 | 5.45e-01 | 9.69e-02 | 9.95e-01 |
| GOBP RENAL WATER HOMEOSTASIS | 24 | 4.11e-01 | -9.69e-02 | 9.95e-01 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 34 | 3.28e-01 | 9.69e-02 | 9.87e-01 |
| GOBP GMP BIOSYNTHETIC PROCESS | 13 | 5.45e-01 | 9.69e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF GLUTAMATE SECRETION | 6 | 6.81e-01 | 9.68e-02 | 9.98e-01 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 31 | 3.51e-01 | 9.68e-02 | 9.94e-01 |
| GOCC INNER ACROSOMAL MEMBRANE | 5 | 7.08e-01 | -9.68e-02 | 9.98e-01 |
| GOMF ALCOHOL BINDING | 87 | 1.19e-01 | -9.68e-02 | 8.83e-01 |
| GOMF MHC PROTEIN BINDING | 32 | 3.43e-01 | 9.68e-02 | 9.92e-01 |
| GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT | 7 | 6.57e-01 | -9.68e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 107 | 8.37e-02 | 9.68e-02 | 8.39e-01 |
| GOBP ATP METABOLIC PROCESS | 124 | 6.28e-02 | 9.67e-02 | 7.98e-01 |
| GOBP RESPONSE TO TUMOR CELL | 42 | 2.78e-01 | 9.67e-02 | 9.73e-01 |
| GOBP AUTOPHAGY OF PEROXISOME | 10 | 5.97e-01 | 9.67e-02 | 9.98e-01 |
| GOBP RESPONSE TO TYPE I INTERFERON | 83 | 1.28e-01 | 9.66e-02 | 8.91e-01 |
| GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 7 | 6.58e-01 | -9.66e-02 | 9.98e-01 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 32 | 3.44e-01 | -9.66e-02 | 9.92e-01 |
| GOCC MALE PRONUCLEUS | 8 | 6.36e-01 | -9.66e-02 | 9.98e-01 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 26 | 3.94e-01 | 9.65e-02 | 9.95e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 41 | 2.85e-01 | 9.65e-02 | 9.75e-01 |
| GOBP RESPONSE TO UV | 147 | 4.34e-02 | 9.65e-02 | 7.59e-01 |
| GOBP REGULATION OF CHONDROCYTE DEVELOPMENT | 6 | 6.82e-01 | -9.65e-02 | 9.98e-01 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 26 | 3.95e-01 | 9.65e-02 | 9.95e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 10 | 5.97e-01 | 9.65e-02 | 9.98e-01 |
| GOBP REGULATION OF ERAD PATHWAY | 19 | 4.67e-01 | -9.65e-02 | 9.95e-01 |
| GOMF HISTONE READER ACTIVITY | 12 | 5.63e-01 | 9.64e-02 | 9.95e-01 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 306 | 3.71e-03 | 9.64e-02 | 3.58e-01 |
| GOCC AZUROPHIL GRANULE | 151 | 4.09e-02 | 9.64e-02 | 7.56e-01 |
| GOBP RETINA HOMEOSTASIS | 75 | 1.49e-01 | -9.64e-02 | 9.04e-01 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 5.33e-01 | -9.63e-02 | 9.95e-01 |
| GOBP LACTATION | 37 | 3.11e-01 | -9.63e-02 | 9.87e-01 |
| GOBP MYOSIN FILAMENT ORGANIZATION | 6 | 6.83e-01 | 9.63e-02 | 9.98e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 7 | 6.59e-01 | -9.63e-02 | 9.98e-01 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 169 | 3.09e-02 | -9.62e-02 | 7.02e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 7 | 6.59e-01 | 9.62e-02 | 9.98e-01 |
| GOBP SALIVARY GLAND DEVELOPMENT | 33 | 3.39e-01 | -9.62e-02 | 9.88e-01 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 21 | 4.46e-01 | 9.62e-02 | 9.95e-01 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 20 | 4.57e-01 | -9.61e-02 | 9.95e-01 |
| GOBP RESPONSE TO INDOLE 3 METHANOL | 6 | 6.84e-01 | 9.60e-02 | 9.98e-01 |
| GOBP REGULATION OF PH | 95 | 1.06e-01 | 9.60e-02 | 8.67e-01 |
| GOBP NEGATIVE REGULATION OF STEROL TRANSPORT | 31 | 3.55e-01 | 9.59e-02 | 9.95e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 11 | 5.82e-01 | 9.59e-02 | 9.96e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 26 | 3.98e-01 | -9.59e-02 | 9.95e-01 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 6.84e-01 | -9.59e-02 | 9.98e-01 |
| GOCC CATION CHANNEL COMPLEX | 188 | 2.34e-02 | -9.58e-02 | 6.49e-01 |
| GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT | 15 | 5.21e-01 | -9.58e-02 | 9.95e-01 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 3.56e-01 | -9.58e-02 | 9.95e-01 |
| GOBP GERM CELL MIGRATION | 8 | 6.39e-01 | -9.58e-02 | 9.98e-01 |
| GOBP BASE EXCISION REPAIR AP SITE FORMATION | 12 | 5.66e-01 | 9.57e-02 | 9.95e-01 |
| GOBP DUMP CATABOLIC PROCESS | 6 | 6.85e-01 | -9.57e-02 | 9.98e-01 |
| GOBP ETHER METABOLIC PROCESS | 26 | 3.98e-01 | 9.57e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 36 | 3.20e-01 | 9.57e-02 | 9.87e-01 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 19 | 4.70e-01 | 9.57e-02 | 9.95e-01 |
| GOBP REGULATION OF NAD P H OXIDASE ACTIVITY | 7 | 6.61e-01 | -9.57e-02 | 9.98e-01 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 14 | 5.36e-01 | 9.56e-02 | 9.95e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 169 | 3.21e-02 | 9.56e-02 | 7.07e-01 |
| GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 26 | 3.99e-01 | -9.55e-02 | 9.95e-01 |
| GOBP LIPID DROPLET ORGANIZATION | 34 | 3.35e-01 | -9.55e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 18 | 4.83e-01 | -9.55e-02 | 9.95e-01 |
| GOBP REGULATION OF FIBRINOLYSIS | 18 | 4.83e-01 | -9.55e-02 | 9.95e-01 |
| GOMF S100 PROTEIN BINDING | 14 | 5.36e-01 | -9.54e-02 | 9.95e-01 |
| GOMF COA HYDROLASE ACTIVITY | 21 | 4.49e-01 | 9.54e-02 | 9.95e-01 |
| GOBP COBALAMIN METABOLIC PROCESS | 9 | 6.20e-01 | 9.54e-02 | 9.98e-01 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 98 | 1.03e-01 | -9.54e-02 | 8.66e-01 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 13 | 5.52e-01 | 9.54e-02 | 9.95e-01 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 21 | 4.49e-01 | -9.53e-02 | 9.95e-01 |
| GOBP INDUCTION OF BACTERIAL AGGLUTINATION | 6 | 6.86e-01 | 9.52e-02 | 9.98e-01 |
| GOBP REGULATION OF CORTICOTROPIN SECRETION | 5 | 7.12e-01 | -9.52e-02 | 9.98e-01 |
| GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 13 | 5.52e-01 | 9.52e-02 | 9.95e-01 |
| GOBP THYROID HORMONE GENERATION | 22 | 4.40e-01 | -9.52e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 12 | 5.68e-01 | 9.52e-02 | 9.95e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 51 | 2.40e-01 | 9.51e-02 | 9.56e-01 |
| GOMF APOLIPOPROTEIN A I BINDING | 5 | 7.13e-01 | -9.51e-02 | 9.98e-01 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 42 | 2.87e-01 | -9.50e-02 | 9.75e-01 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 19 | 4.73e-01 | -9.50e-02 | 9.95e-01 |
| GOBP HETEROCHROMATIN ORGANIZATION | 89 | 1.21e-01 | 9.50e-02 | 8.86e-01 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 9 | 6.22e-01 | 9.50e-02 | 9.98e-01 |
| GOBP DORSAL VENTRAL AXIS SPECIFICATION | 12 | 5.69e-01 | 9.50e-02 | 9.95e-01 |
| GOBP THREONINE METABOLIC PROCESS | 5 | 7.13e-01 | -9.49e-02 | 9.98e-01 |
| GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY | 9 | 6.22e-01 | 9.49e-02 | 9.98e-01 |
| GOBP LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING | 10 | 6.03e-01 | -9.49e-02 | 9.98e-01 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 32 | 3.53e-01 | -9.48e-02 | 9.95e-01 |
| GOBP SULFUR COMPOUND TRANSPORT | 53 | 2.33e-01 | -9.48e-02 | 9.50e-01 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 13 | 5.54e-01 | 9.47e-02 | 9.95e-01 |
| GOBP ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS | 8 | 6.43e-01 | -9.47e-02 | 9.98e-01 |
| GOCC RIPOPTOSOME | 6 | 6.88e-01 | -9.47e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 28 | 3.86e-01 | -9.47e-02 | 9.95e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 31 | 3.62e-01 | -9.47e-02 | 9.95e-01 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 74 | 1.59e-01 | 9.47e-02 | 9.06e-01 |
| GOBP CELLULAR RESPONSE TO POTASSIUM ION | 12 | 5.70e-01 | -9.47e-02 | 9.95e-01 |
| GOBP LIPID OXIDATION | 112 | 8.35e-02 | 9.47e-02 | 8.39e-01 |
| GOBP MAST CELL PROLIFERATION | 7 | 6.65e-01 | 9.46e-02 | 9.98e-01 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 17 | 5.00e-01 | -9.45e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO STEROL | 25 | 4.13e-01 | -9.45e-02 | 9.95e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 13 | 5.55e-01 | 9.45e-02 | 9.95e-01 |
| GOBP LEYDIG CELL DIFFERENTIATION | 9 | 6.24e-01 | 9.44e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 20 | 4.65e-01 | -9.43e-02 | 9.95e-01 |
| GOBP ANTERIOR POSTERIOR AXON GUIDANCE | 7 | 6.66e-01 | 9.43e-02 | 9.98e-01 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 77 | 1.53e-01 | 9.43e-02 | 9.04e-01 |
| GOCC NADH DEHYDROGENASE COMPLEX | 40 | 3.02e-01 | 9.43e-02 | 9.87e-01 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 40 | 3.02e-01 | 9.43e-02 | 9.87e-01 |
| GOBP MICROGLIA DIFFERENTIATION | 11 | 5.88e-01 | 9.42e-02 | 9.97e-01 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 26 | 4.06e-01 | 9.42e-02 | 9.95e-01 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 23 | 4.35e-01 | 9.41e-02 | 9.95e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 7.15e-01 | -9.41e-02 | 9.98e-01 |
| GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 12 | 5.72e-01 | -9.41e-02 | 9.95e-01 |
| GOMF AMP BINDING | 15 | 5.28e-01 | 9.41e-02 | 9.95e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 11 | 5.89e-01 | -9.40e-02 | 9.97e-01 |
| GOCC NPBAF COMPLEX | 14 | 5.43e-01 | 9.40e-02 | 9.95e-01 |
| GOBP MUSCLE CELL PROLIFERATION | 230 | 1.41e-02 | 9.40e-02 | 6.25e-01 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 22 | 4.46e-01 | 9.39e-02 | 9.95e-01 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 45 | 2.76e-01 | 9.39e-02 | 9.73e-01 |
| GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 8 | 6.46e-01 | -9.39e-02 | 9.98e-01 |
| GOBP NETRIN ACTIVATED SIGNALING PATHWAY | 9 | 6.26e-01 | -9.39e-02 | 9.98e-01 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 24 | 4.26e-01 | 9.38e-02 | 9.95e-01 |
| GOCC MYELIN SHEATH | 42 | 2.93e-01 | 9.37e-02 | 9.80e-01 |
| GOBP NEUTROPHIL MIGRATION | 118 | 7.87e-02 | -9.37e-02 | 8.27e-01 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 95 | 1.15e-01 | 9.37e-02 | 8.80e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 15 | 5.30e-01 | 9.36e-02 | 9.95e-01 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 21 | 4.58e-01 | 9.36e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 12 | 5.74e-01 | -9.36e-02 | 9.96e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1821 | 3.44e-11 | 9.36e-02 | 8.80e-08 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 21 | 4.58e-01 | -9.35e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 86 | 1.34e-01 | 9.35e-02 | 8.96e-01 |
| GOBP UTERUS DEVELOPMENT | 23 | 4.38e-01 | -9.35e-02 | 9.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 8 | 6.47e-01 | 9.34e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 14 | 5.45e-01 | 9.34e-02 | 9.95e-01 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 126 | 7.02e-02 | -9.34e-02 | 8.00e-01 |
| GOCC RNA POLYMERASE COMPLEX | 97 | 1.12e-01 | 9.34e-02 | 8.77e-01 |
| GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION | 6 | 6.92e-01 | 9.34e-02 | 9.98e-01 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 6 | 6.92e-01 | 9.34e-02 | 9.98e-01 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 77 | 1.57e-01 | -9.34e-02 | 9.06e-01 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 14 | 5.45e-01 | 9.33e-02 | 9.95e-01 |
| GOCC SNARE COMPLEX | 47 | 2.68e-01 | 9.33e-02 | 9.70e-01 |
| GOMF DIACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 5 | 7.18e-01 | 9.33e-02 | 9.98e-01 |
| GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 7 | 6.69e-01 | 9.33e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 14 | 5.46e-01 | -9.33e-02 | 9.95e-01 |
| GOMF CYTOKINE ACTIVITY | 223 | 1.64e-02 | -9.32e-02 | 6.32e-01 |
| GOBP ADENOSINE TO INOSINE EDITING | 7 | 6.69e-01 | 9.32e-02 | 9.98e-01 |
| GOBP SPERM MITOCHONDRIAL SHEATH ASSEMBLY | 6 | 6.93e-01 | -9.32e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 6 | 6.93e-01 | 9.31e-02 | 9.98e-01 |
| GOBP FACIAL NERVE MORPHOGENESIS | 9 | 6.29e-01 | -9.31e-02 | 9.98e-01 |
| GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 19 | 4.82e-01 | 9.31e-02 | 9.95e-01 |
| GOBP CORNIFIED ENVELOPE ASSEMBLY | 6 | 6.93e-01 | -9.31e-02 | 9.98e-01 |
| GOBP REGULATION OF MACROPHAGE FUSION | 5 | 7.19e-01 | 9.31e-02 | 9.98e-01 |
| GOBP UV PROTECTION | 12 | 5.77e-01 | -9.30e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 98 | 1.12e-01 | 9.30e-02 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 8 | 6.49e-01 | 9.29e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF KIDNEY DEVELOPMENT | 5 | 7.19e-01 | 9.29e-02 | 9.98e-01 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 28 | 3.95e-01 | -9.28e-02 | 9.95e-01 |
| GOBP CENTRIOLE ELONGATION | 8 | 6.49e-01 | 9.28e-02 | 9.98e-01 |
| GOBP FOREBRAIN VENTRICULAR ZONE PROGENITOR CELL DIVISION | 5 | 7.19e-01 | 9.28e-02 | 9.98e-01 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 323 | 4.15e-03 | -9.28e-02 | 3.81e-01 |
| GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 16 | 5.21e-01 | -9.27e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 61 | 2.10e-01 | -9.27e-02 | 9.40e-01 |
| GOCC CLATHRIN SCULPTED VESICLE | 12 | 5.78e-01 | 9.27e-02 | 9.96e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB | 5 | 7.20e-01 | -9.27e-02 | 9.98e-01 |
| GOMF LIPID ANTIGEN BINDING | 5 | 7.20e-01 | -9.27e-02 | 9.98e-01 |
| GOBP DNA RECOMBINATION | 318 | 4.50e-03 | 9.26e-02 | 4.07e-01 |
| GOBP EXOCRINE PANCREAS DEVELOPMENT | 7 | 6.71e-01 | 9.26e-02 | 9.98e-01 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 19 | 4.84e-01 | -9.26e-02 | 9.95e-01 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 34 | 3.50e-01 | -9.26e-02 | 9.94e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 14 | 5.49e-01 | 9.26e-02 | 9.95e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 19 | 4.85e-01 | 9.25e-02 | 9.95e-01 |
| GOBP PSEUDOURIDINE SYNTHESIS | 17 | 5.09e-01 | 9.25e-02 | 9.95e-01 |
| GOBP REGULATION OF DNA RECOMBINATION | 128 | 7.08e-02 | 9.25e-02 | 8.00e-01 |
| GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 5 | 7.20e-01 | -9.25e-02 | 9.98e-01 |
| GOCC NURD COMPLEX | 15 | 5.35e-01 | 9.24e-02 | 9.95e-01 |
| GOBP RESPIRATORY BURST | 32 | 3.65e-01 | 9.24e-02 | 9.95e-01 |
| GOBP NECROPTOTIC SIGNALING PATHWAY | 8 | 6.51e-01 | -9.24e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 49 | 2.63e-01 | 9.24e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 17 | 5.10e-01 | 9.24e-02 | 9.95e-01 |
| GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION | 8 | 6.51e-01 | -9.24e-02 | 9.98e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 11 | 5.96e-01 | 9.24e-02 | 9.98e-01 |
| GOBP SOMATOSTATIN RECEPTOR SIGNALING PATHWAY | 5 | 7.21e-01 | 9.23e-02 | 9.98e-01 |
| GOMF SOMATOSTATIN RECEPTOR ACTIVITY | 5 | 7.21e-01 | 9.23e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION | 7 | 6.72e-01 | 9.23e-02 | 9.98e-01 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 24 | 4.34e-01 | 9.23e-02 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 32 | 3.66e-01 | -9.23e-02 | 9.95e-01 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 20 | 4.75e-01 | -9.23e-02 | 9.95e-01 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 30 | 3.82e-01 | 9.22e-02 | 9.95e-01 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 9 | 6.32e-01 | 9.22e-02 | 9.98e-01 |
| GOBP PEPTIDYL ARGININE METHYLATION | 7 | 6.73e-01 | 9.22e-02 | 9.98e-01 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 22 | 4.54e-01 | -9.22e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY | 5 | 7.21e-01 | -9.21e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 216 | 1.96e-02 | -9.21e-02 | 6.41e-01 |
| GOCC PHOSPHATASE COMPLEX | 51 | 2.55e-01 | -9.21e-02 | 9.58e-01 |
| GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 10 | 6.14e-01 | -9.21e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 43 | 2.96e-01 | 9.21e-02 | 9.82e-01 |
| GOBP RELAXATION OF SMOOTH MUSCLE | 9 | 6.33e-01 | -9.21e-02 | 9.98e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 24 | 4.35e-01 | -9.21e-02 | 9.95e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 10 | 6.14e-01 | 9.20e-02 | 9.98e-01 |
| GOCC CHOLINERGIC SYNAPSE | 11 | 5.97e-01 | -9.20e-02 | 9.98e-01 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 11 | 5.97e-01 | -9.20e-02 | 9.98e-01 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 11 | 5.97e-01 | 9.20e-02 | 9.98e-01 |
| GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 27 | 4.08e-01 | -9.20e-02 | 9.95e-01 |
| GOBP REGULATION OF OVARIAN FOLLICLE DEVELOPMENT | 6 | 6.96e-01 | -9.20e-02 | 9.98e-01 |
| GOMF CARBON CARBON LYASE ACTIVITY | 51 | 2.56e-01 | -9.20e-02 | 9.58e-01 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 57 | 2.30e-01 | 9.19e-02 | 9.50e-01 |
| GOCC ENDOLYSOSOME | 26 | 4.17e-01 | -9.19e-02 | 9.95e-01 |
| GOMF GLUTAMATE RECEPTOR BINDING | 42 | 3.03e-01 | 9.19e-02 | 9.87e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 16 | 5.25e-01 | 9.19e-02 | 9.95e-01 |
| GOBP REFLEX | 21 | 4.66e-01 | -9.18e-02 | 9.95e-01 |
| GOCC CCR4 NOT COMPLEX | 14 | 5.52e-01 | 9.18e-02 | 9.95e-01 |
| GOBP SENSORY PERCEPTION OF UMAMI TASTE | 7 | 6.74e-01 | 9.18e-02 | 9.98e-01 |
| GOBP MESENCHYME MORPHOGENESIS | 60 | 2.19e-01 | 9.17e-02 | 9.43e-01 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 98 | 1.17e-01 | 9.17e-02 | 8.82e-01 |
| GOMF PHOSPHATIDYLSERINE BINDING | 61 | 2.16e-01 | -9.17e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 26 | 4.19e-01 | -9.17e-02 | 9.95e-01 |
| GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 6.34e-01 | -9.16e-02 | 9.98e-01 |
| GOBP TRNA 5 LEADER REMOVAL | 13 | 5.68e-01 | -9.16e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 86 | 1.42e-01 | -9.15e-02 | 9.02e-01 |
| GOBP RECOMBINATIONAL REPAIR | 169 | 4.02e-02 | 9.15e-02 | 7.56e-01 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 10 | 6.17e-01 | -9.14e-02 | 9.98e-01 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 19 | 4.90e-01 | -9.14e-02 | 9.95e-01 |
| GOBP REGULATION OF B CELL PROLIFERATION | 62 | 2.14e-01 | 9.13e-02 | 9.40e-01 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 22 | 4.58e-01 | 9.13e-02 | 9.95e-01 |
| GOBP ENAMEL MINERALIZATION | 19 | 4.91e-01 | -9.13e-02 | 9.95e-01 |
| GOBP SARCOMERE ORGANIZATION | 45 | 2.89e-01 | -9.13e-02 | 9.77e-01 |
| GOBP RESPONSE TO DIETARY EXCESS | 34 | 3.57e-01 | 9.13e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 21 | 4.69e-01 | -9.13e-02 | 9.95e-01 |
| GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 13 | 5.69e-01 | 9.12e-02 | 9.95e-01 |
| GOCC MLL1 2 COMPLEX | 29 | 3.95e-01 | 9.12e-02 | 9.95e-01 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 80 | 1.59e-01 | 9.12e-02 | 9.06e-01 |
| GOBP SPINAL CORD PATTERNING | 21 | 4.70e-01 | -9.12e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 10 | 6.18e-01 | -9.12e-02 | 9.98e-01 |
| GOMF NUCLEOSOMAL DNA BINDING | 39 | 3.25e-01 | 9.11e-02 | 9.87e-01 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 9 | 6.36e-01 | -9.11e-02 | 9.98e-01 |
| GOMF PROTEIN SELF ASSOCIATION | 70 | 1.88e-01 | -9.11e-02 | 9.28e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 6.99e-01 | 9.10e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 21 | 4.70e-01 | 9.10e-02 | 9.95e-01 |
| GOCC CHYLOMICRON | 12 | 5.85e-01 | -9.10e-02 | 9.96e-01 |
| GOBP REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE | 12 | 5.85e-01 | -9.09e-02 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 5.86e-01 | -9.09e-02 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 16 | 5.29e-01 | 9.09e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 114 | 9.38e-02 | 9.08e-02 | 8.55e-01 |
| GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY | 22 | 4.61e-01 | 9.08e-02 | 9.95e-01 |
| GOMF HISTONE MODIFYING ACTIVITY | 188 | 3.18e-02 | 9.08e-02 | 7.07e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 6 | 7.00e-01 | -9.08e-02 | 9.98e-01 |
| GOMF PEPTIDE HORMONE RECEPTOR BINDING | 19 | 4.93e-01 | 9.08e-02 | 9.95e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION | 6 | 7.01e-01 | 9.07e-02 | 9.98e-01 |
| GOBP SPERM EJACULATION | 5 | 7.26e-01 | 9.06e-02 | 9.98e-01 |
| GOBP CELL FATE COMMITMENT | 279 | 9.21e-03 | 9.06e-02 | 5.54e-01 |
| GOBP MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY | 6 | 7.01e-01 | -9.06e-02 | 9.98e-01 |
| GOBP ONE CARBON METABOLIC PROCESS | 37 | 3.41e-01 | 9.05e-02 | 9.89e-01 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 38 | 3.34e-01 | 9.05e-02 | 9.88e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 18 | 5.06e-01 | -9.05e-02 | 9.95e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS | 7 | 6.78e-01 | -9.05e-02 | 9.98e-01 |
| GOCC KATANIN COMPLEX | 5 | 7.26e-01 | -9.05e-02 | 9.98e-01 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 168 | 4.30e-02 | 9.05e-02 | 7.59e-01 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 132 | 7.26e-02 | -9.05e-02 | 8.07e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY | 7 | 6.79e-01 | -9.05e-02 | 9.98e-01 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 165 | 4.49e-02 | 9.05e-02 | 7.59e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 24 | 4.43e-01 | 9.05e-02 | 9.95e-01 |
| GOCC POLYSOME | 60 | 2.26e-01 | -9.04e-02 | 9.49e-01 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 41 | 3.16e-01 | 9.04e-02 | 9.87e-01 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 20 | 4.84e-01 | -9.04e-02 | 9.95e-01 |
| GOCC SPERM HEAD PLASMA MEMBRANE | 6 | 7.01e-01 | -9.04e-02 | 9.98e-01 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 37 | 3.41e-01 | 9.04e-02 | 9.89e-01 |
| GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING | 6 | 7.02e-01 | -9.04e-02 | 9.98e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 23 | 4.53e-01 | 9.03e-02 | 9.95e-01 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 8 | 6.58e-01 | -9.03e-02 | 9.98e-01 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 67 | 2.01e-01 | 9.03e-02 | 9.36e-01 |
| GOCC AMINOACYL TRNA SYNTHETASE MULTIENZYME COMPLEX | 10 | 6.21e-01 | 9.03e-02 | 9.98e-01 |
| GOBP RENAL SODIUM ION TRANSPORT | 15 | 5.45e-01 | 9.02e-02 | 9.95e-01 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 28 | 4.09e-01 | -9.02e-02 | 9.95e-01 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 49 | 2.75e-01 | -9.02e-02 | 9.73e-01 |
| GOMF SODIUM CHANNEL INHIBITOR ACTIVITY | 8 | 6.59e-01 | -9.02e-02 | 9.98e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 32 | 3.77e-01 | 9.02e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT | 11 | 6.05e-01 | -9.02e-02 | 9.98e-01 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 15 | 5.46e-01 | -9.01e-02 | 9.95e-01 |
| GOBP DNA REPLICATION INITIATION | 35 | 3.56e-01 | 9.01e-02 | 9.95e-01 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 19 | 4.96e-01 | 9.01e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 14 | 5.60e-01 | -9.00e-02 | 9.95e-01 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 49 | 2.76e-01 | 8.99e-02 | 9.73e-01 |
| GOBP REGULATION OF GTPASE ACTIVITY | 279 | 9.72e-03 | -8.99e-02 | 5.57e-01 |
| GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 6.80e-01 | 8.99e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 111 | 1.02e-01 | -8.99e-02 | 8.66e-01 |
| GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 6 | 7.03e-01 | 8.99e-02 | 9.98e-01 |
| GOMF CLATHRIN BINDING | 68 | 2.00e-01 | -8.99e-02 | 9.36e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 99 | 1.22e-01 | -8.98e-02 | 8.86e-01 |
| GOBP PYRIMIDINE DIMER REPAIR | 9 | 6.41e-01 | 8.98e-02 | 9.98e-01 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 6 | 7.03e-01 | 8.98e-02 | 9.98e-01 |
| GOBP NADP METABOLIC PROCESS | 41 | 3.20e-01 | 8.97e-02 | 9.87e-01 |
| GOBP PROTEIN C LINKED GLYCOSYLATION | 5 | 7.28e-01 | -8.97e-02 | 9.98e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 83 | 1.58e-01 | -8.97e-02 | 9.06e-01 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 44 | 3.03e-01 | -8.97e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 26 | 4.29e-01 | 8.97e-02 | 9.95e-01 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 18 | 5.10e-01 | -8.97e-02 | 9.95e-01 |
| GOBP HISTAMINE TRANSPORT | 15 | 5.48e-01 | -8.97e-02 | 9.95e-01 |
| GOBP REGULATION OF MITOTIC RECOMBINATION | 7 | 6.81e-01 | -8.96e-02 | 9.98e-01 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 4.88e-01 | 8.96e-02 | 9.95e-01 |
| GOBP NAD METABOLIC PROCESS | 42 | 3.15e-01 | 8.96e-02 | 9.87e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 140 | 6.73e-02 | 8.96e-02 | 7.99e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 23 | 4.57e-01 | 8.96e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 7 | 6.82e-01 | -8.95e-02 | 9.98e-01 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 50 | 2.73e-01 | -8.95e-02 | 9.73e-01 |
| GOBP ANOIKIS | 33 | 3.73e-01 | 8.95e-02 | 9.95e-01 |
| GOBP ORGANELLE DISASSEMBLY | 137 | 7.05e-02 | 8.95e-02 | 8.00e-01 |
| GOBP NUCLEOSOME ORGANIZATION | 117 | 9.45e-02 | 8.95e-02 | 8.55e-01 |
| GOBP RESPONSE TO X RAY | 28 | 4.12e-01 | 8.95e-02 | 9.95e-01 |
| GOBP EXPLORATION BEHAVIOR | 28 | 4.13e-01 | 8.95e-02 | 9.95e-01 |
| GOMF GUANYLATE CYCLASE REGULATOR ACTIVITY | 8 | 6.61e-01 | -8.94e-02 | 9.98e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 32 | 3.81e-01 | -8.94e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 39 | 3.34e-01 | 8.94e-02 | 9.88e-01 |
| GOBP HEAD DEVELOPMENT | 721 | 4.35e-05 | 8.94e-02 | 2.34e-02 |
| GOBP REGULATION OF T CELL MIGRATION | 46 | 2.95e-01 | -8.93e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 12 | 5.92e-01 | 8.93e-02 | 9.98e-01 |
| GOBP DENSE CORE GRANULE LOCALIZATION | 10 | 6.25e-01 | 8.93e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 26 | 4.31e-01 | 8.93e-02 | 9.95e-01 |
| GOBP GRANULOCYTE CHEMOTAXIS | 122 | 8.87e-02 | -8.92e-02 | 8.47e-01 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 34 | 3.68e-01 | -8.92e-02 | 9.95e-01 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 41 | 3.23e-01 | 8.91e-02 | 9.87e-01 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 31 | 3.91e-01 | 8.90e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 170 | 4.53e-02 | 8.90e-02 | 7.59e-01 |
| GOBP FILOPODIUM ASSEMBLY | 65 | 2.15e-01 | -8.90e-02 | 9.42e-01 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 54 | 2.58e-01 | -8.89e-02 | 9.58e-01 |
| GOBP TELOMERIC LOOP DISASSEMBLY | 9 | 6.44e-01 | -8.89e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 3.92e-01 | 8.89e-02 | 9.95e-01 |
| GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 8 | 6.63e-01 | -8.89e-02 | 9.98e-01 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 4.51e-01 | -8.89e-02 | 9.95e-01 |
| GOBP PATTERN SPECIFICATION PROCESS | 456 | 1.14e-03 | 8.89e-02 | 2.03e-01 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 16 | 5.38e-01 | 8.89e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 37 | 3.50e-01 | 8.89e-02 | 9.94e-01 |
| GOBP PROTEIN NEDDYLATION | 28 | 4.16e-01 | -8.89e-02 | 9.95e-01 |
| GOBP PHOSPHOLIPID TRANSLOCATION | 50 | 2.77e-01 | -8.89e-02 | 9.73e-01 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 14 | 5.65e-01 | 8.88e-02 | 9.95e-01 |
| GOBP REGULATION OF NEUTROPHIL ACTIVATION | 14 | 5.65e-01 | -8.88e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 18 | 5.15e-01 | -8.87e-02 | 9.95e-01 |
| GOBP GLUCOCORTICOID SECRETION | 12 | 5.95e-01 | -8.87e-02 | 9.98e-01 |
| GOBP REGULATION OF EPINEPHRINE SECRETION | 7 | 6.84e-01 | 8.87e-02 | 9.98e-01 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 28 | 4.17e-01 | -8.87e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 26 | 4.34e-01 | 8.87e-02 | 9.95e-01 |
| GOBP BONE MINERALIZATION | 116 | 9.91e-02 | 8.87e-02 | 8.64e-01 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 47 | 2.93e-01 | 8.87e-02 | 9.79e-01 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 27 | 4.25e-01 | 8.86e-02 | 9.95e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 5.15e-01 | 8.86e-02 | 9.95e-01 |
| GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 6 | 7.07e-01 | 8.86e-02 | 9.98e-01 |
| GOCC UNIPLEX COMPLEX | 6 | 7.07e-01 | -8.86e-02 | 9.98e-01 |
| GOCC NEUROMUSCULAR JUNCTION | 73 | 1.91e-01 | -8.86e-02 | 9.28e-01 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 53 | 2.65e-01 | 8.86e-02 | 9.65e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 37 | 3.51e-01 | -8.86e-02 | 9.94e-01 |
| GOMF PEROXIREDOXIN ACTIVITY | 7 | 6.85e-01 | -8.85e-02 | 9.98e-01 |
| GOBP REGULATION OF HEAT GENERATION | 12 | 5.95e-01 | 8.85e-02 | 9.98e-01 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 84 | 1.61e-01 | 8.85e-02 | 9.08e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 29 | 4.10e-01 | 8.84e-02 | 9.95e-01 |
| GOMF BH3 DOMAIN BINDING | 6 | 7.08e-01 | 8.84e-02 | 9.98e-01 |
| GOMF PROTEIN FOLDING CHAPERONE | 61 | 2.32e-01 | 8.84e-02 | 9.50e-01 |
| GOBP CHROMOSOME ORGANIZATION | 604 | 2.07e-04 | 8.84e-02 | 8.14e-02 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 12 | 5.96e-01 | -8.84e-02 | 9.98e-01 |
| GOMF ANKYRIN BINDING | 19 | 5.05e-01 | -8.84e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 124 | 8.93e-02 | 8.84e-02 | 8.48e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 13 | 5.81e-01 | 8.83e-02 | 9.96e-01 |
| GOCC DENSE CORE GRANULE | 38 | 3.46e-01 | 8.83e-02 | 9.92e-01 |
| GOCC PAR POLARITY COMPLEX | 6 | 7.08e-01 | -8.83e-02 | 9.98e-01 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 23 | 4.64e-01 | 8.83e-02 | 9.95e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 83 | 1.64e-01 | 8.83e-02 | 9.15e-01 |
| GOMF 14 3 3 PROTEIN BINDING | 32 | 3.88e-01 | 8.82e-02 | 9.95e-01 |
| GOBP SPINDLE ASSEMBLY | 125 | 8.84e-02 | 8.82e-02 | 8.47e-01 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 16 | 5.41e-01 | 8.82e-02 | 9.95e-01 |
| GOBP DECIDUALIZATION | 24 | 4.55e-01 | 8.82e-02 | 9.95e-01 |
| GOBP SEQUESTERING OF METAL ION | 10 | 6.29e-01 | 8.82e-02 | 9.98e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY BARORECEPTOR FEEDBACK | 5 | 7.33e-01 | -8.82e-02 | 9.98e-01 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 41 | 3.29e-01 | -8.82e-02 | 9.87e-01 |
| GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 6.29e-01 | 8.81e-02 | 9.98e-01 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 10 | 6.29e-01 | -8.81e-02 | 9.98e-01 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 793 | 2.43e-05 | 8.81e-02 | 1.68e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 142 | 7.00e-02 | 8.81e-02 | 8.00e-01 |
| GOBP CELLULAR RESPONSE TO ALDOSTERONE | 7 | 6.87e-01 | -8.81e-02 | 9.98e-01 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 153 | 6.05e-02 | -8.79e-02 | 7.94e-01 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 48 | 2.92e-01 | -8.79e-02 | 9.79e-01 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 50 | 2.83e-01 | 8.78e-02 | 9.73e-01 |
| GOBP HISTONE H3 K4 METHYLATION | 18 | 5.19e-01 | 8.78e-02 | 9.95e-01 |
| GOCC EXTRINSIC COMPONENT OF PRESYNAPTIC MEMBRANE | 6 | 7.10e-01 | 8.78e-02 | 9.98e-01 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 58 | 2.48e-01 | 8.78e-02 | 9.58e-01 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 17 | 5.31e-01 | -8.78e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 1211 | 2.71e-07 | 8.77e-02 | 3.47e-04 |
| GOCC PROTEIN KINASE COMPLEX | 135 | 7.84e-02 | 8.77e-02 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 15 | 5.56e-01 | -8.77e-02 | 9.95e-01 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 33 | 3.83e-01 | 8.77e-02 | 9.95e-01 |
| GOBP NOSE DEVELOPMENT | 16 | 5.44e-01 | 8.77e-02 | 9.95e-01 |
| GOMF HAPTOGLOBIN BINDING | 10 | 6.31e-01 | 8.76e-02 | 9.98e-01 |
| GOCC DENSE CORE GRANULE MEMBRANE | 7 | 6.88e-01 | -8.76e-02 | 9.98e-01 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 177 | 4.45e-02 | -8.76e-02 | 7.59e-01 |
| GOBP MRNA 5 SPLICE SITE RECOGNITION | 10 | 6.32e-01 | 8.75e-02 | 9.98e-01 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 19 | 5.09e-01 | -8.75e-02 | 9.95e-01 |
| GOMF DAMAGED DNA BINDING | 70 | 2.06e-01 | 8.75e-02 | 9.38e-01 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 20 | 4.98e-01 | -8.75e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 28 | 4.23e-01 | -8.75e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 13 | 5.85e-01 | -8.75e-02 | 9.96e-01 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 40 | 3.39e-01 | 8.74e-02 | 9.88e-01 |
| GOCC AXONEMAL MICROTUBULE | 38 | 3.52e-01 | -8.73e-02 | 9.94e-01 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 12 | 6.01e-01 | 8.73e-02 | 9.98e-01 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 37 | 3.58e-01 | 8.73e-02 | 9.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 17 | 5.33e-01 | 8.73e-02 | 9.95e-01 |
| GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 6 | 7.12e-01 | -8.72e-02 | 9.98e-01 |
| GOBP ZYMOGEN ACTIVATION | 57 | 2.55e-01 | -8.72e-02 | 9.58e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 11 | 6.17e-01 | -8.71e-02 | 9.98e-01 |
| GOCC LAMELLIPODIUM MEMBRANE | 22 | 4.79e-01 | -8.71e-02 | 9.95e-01 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 18 | 5.22e-01 | 8.71e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 20 | 5.00e-01 | 8.71e-02 | 9.95e-01 |
| GOBP RESPONSE TO PH | 41 | 3.35e-01 | -8.70e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 15 | 5.60e-01 | 8.70e-02 | 9.95e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 20 | 5.01e-01 | 8.70e-02 | 9.95e-01 |
| GOCC SMC5 SMC6 COMPLEX | 9 | 6.51e-01 | 8.70e-02 | 9.98e-01 |
| GOCC ASTROCYTE PROJECTION | 19 | 5.12e-01 | -8.70e-02 | 9.95e-01 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 6.34e-01 | 8.70e-02 | 9.98e-01 |
| GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 23 | 4.70e-01 | -8.69e-02 | 9.95e-01 |
| GOMF POLY G BINDING | 7 | 6.91e-01 | 8.69e-02 | 9.98e-01 |
| GOBP RESPONSE TO TYPE II INTERFERON | 134 | 8.25e-02 | 8.69e-02 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 66 | 2.23e-01 | 8.68e-02 | 9.45e-01 |
| GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY | 5 | 7.37e-01 | -8.68e-02 | 9.98e-01 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 21 | 4.91e-01 | -8.68e-02 | 9.95e-01 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 185 | 4.18e-02 | -8.67e-02 | 7.56e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 70 | 2.10e-01 | -8.67e-02 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF NEURON MIGRATION | 9 | 6.52e-01 | -8.67e-02 | 9.98e-01 |
| GOCC NUCLEAR STRESS GRANULE | 6 | 7.13e-01 | 8.67e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 31 | 4.04e-01 | -8.67e-02 | 9.95e-01 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 76 | 1.92e-01 | 8.67e-02 | 9.28e-01 |
| GOBP VASCULAR TRANSPORT | 84 | 1.70e-01 | -8.66e-02 | 9.20e-01 |
| GOBP LACTATE METABOLIC PROCESS | 18 | 5.25e-01 | 8.66e-02 | 9.95e-01 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 26 | 4.45e-01 | 8.66e-02 | 9.95e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 18 | 5.25e-01 | -8.66e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 6.92e-01 | 8.66e-02 | 9.98e-01 |
| GOBP DETECTION OF LIPOPOLYSACCHARIDE | 5 | 7.38e-01 | 8.65e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 30 | 4.12e-01 | 8.65e-02 | 9.95e-01 |
| GOMF IODIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 7.38e-01 | -8.65e-02 | 9.98e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR REGULATOR ACTIVITY | 13 | 5.89e-01 | -8.65e-02 | 9.97e-01 |
| GOCC CYTOLYTIC GRANULE | 13 | 5.89e-01 | 8.65e-02 | 9.97e-01 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 101 | 1.33e-01 | -8.65e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 28 | 4.28e-01 | 8.65e-02 | 9.95e-01 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 21 | 4.93e-01 | 8.65e-02 | 9.95e-01 |
| GOMF GAMMA TUBULIN BINDING | 30 | 4.12e-01 | -8.65e-02 | 9.95e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 27 | 4.37e-01 | 8.64e-02 | 9.95e-01 |
| GOBP SUBPALLIUM DEVELOPMENT | 26 | 4.46e-01 | -8.64e-02 | 9.95e-01 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 35 | 3.77e-01 | 8.64e-02 | 9.95e-01 |
| GOBP CELL VOLUME HOMEOSTASIS | 34 | 3.83e-01 | -8.64e-02 | 9.95e-01 |
| GOCC CALCITONIN FAMILY RECEPTOR COMPLEX | 5 | 7.38e-01 | -8.63e-02 | 9.98e-01 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 49 | 2.96e-01 | 8.63e-02 | 9.82e-01 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 14 | 5.76e-01 | -8.63e-02 | 9.96e-01 |
| GOBP REGULATION OF GLUCONEOGENESIS | 51 | 2.86e-01 | 8.63e-02 | 9.75e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 7.15e-01 | 8.62e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 101 | 1.34e-01 | 8.62e-02 | 8.96e-01 |
| GOMF MUTLALPHA COMPLEX BINDING | 7 | 6.93e-01 | 8.61e-02 | 9.98e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT | 6 | 7.15e-01 | 8.61e-02 | 9.98e-01 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 25 | 4.56e-01 | 8.61e-02 | 9.95e-01 |
| GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 7 | 6.93e-01 | -8.61e-02 | 9.98e-01 |
| GOCC KINETOCHORE MICROTUBULE | 20 | 5.06e-01 | 8.60e-02 | 9.95e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 8 | 6.74e-01 | -8.60e-02 | 9.98e-01 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 172 | 5.21e-02 | -8.59e-02 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 15 | 5.65e-01 | -8.58e-02 | 9.95e-01 |
| GOBP REGULATION OF VASOCONSTRICTION | 61 | 2.46e-01 | -8.58e-02 | 9.58e-01 |
| GOBP RECEPTOR DIFFUSION TRAPPING | 10 | 6.38e-01 | 8.58e-02 | 9.98e-01 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 37 | 3.67e-01 | -8.58e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 11 | 6.22e-01 | 8.57e-02 | 9.98e-01 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 28 | 4.32e-01 | 8.57e-02 | 9.95e-01 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 44 | 3.25e-01 | 8.57e-02 | 9.87e-01 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 9 | 6.56e-01 | 8.57e-02 | 9.98e-01 |
| GOBP CHROMOSOME SEGREGATION | 406 | 3.06e-03 | 8.56e-02 | 3.30e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 26 | 4.50e-01 | -8.56e-02 | 9.95e-01 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 11 | 6.23e-01 | 8.56e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 8 | 6.75e-01 | 8.56e-02 | 9.98e-01 |
| GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 8 | 6.75e-01 | 8.56e-02 | 9.98e-01 |
| GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 14 | 5.79e-01 | -8.56e-02 | 9.96e-01 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 38 | 3.61e-01 | 8.55e-02 | 9.95e-01 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 18 | 5.30e-01 | 8.55e-02 | 9.95e-01 |
| GOCC SWI SNF COMPLEX | 30 | 4.17e-01 | 8.55e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF DOPAMINE SECRETION | 5 | 7.41e-01 | 8.55e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 16 | 5.54e-01 | 8.55e-02 | 9.95e-01 |
| GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 6 | 7.17e-01 | -8.55e-02 | 9.98e-01 |
| GOMF DEAD H BOX RNA HELICASE BINDING | 8 | 6.75e-01 | -8.55e-02 | 9.98e-01 |
| GOBP PLASMA MEMBRANE REPAIR | 27 | 4.42e-01 | -8.55e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 11 | 6.24e-01 | 8.54e-02 | 9.98e-01 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 143 | 7.78e-02 | 8.54e-02 | 8.26e-01 |
| GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 10 | 6.40e-01 | 8.54e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 15 | 5.67e-01 | 8.54e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 9 | 6.58e-01 | 8.53e-02 | 9.98e-01 |
| GOBP NUCLEUS LOCALIZATION | 33 | 3.97e-01 | 8.53e-02 | 9.95e-01 |
| GOMF PEPTIDE HORMONE BINDING | 48 | 3.07e-01 | -8.53e-02 | 9.87e-01 |
| GOBP AORTA DEVELOPMENT | 65 | 2.35e-01 | 8.52e-02 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 15 | 5.68e-01 | 8.52e-02 | 9.95e-01 |
| GOCC SPLICEOSOMAL COMPLEX | 184 | 4.63e-02 | 8.52e-02 | 7.65e-01 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 458 | 1.79e-03 | 8.51e-02 | 2.66e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 9 | 6.58e-01 | 8.51e-02 | 9.98e-01 |
| GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.77e-01 | -8.50e-02 | 9.98e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 37 | 3.71e-01 | 8.50e-02 | 9.95e-01 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 57 | 2.67e-01 | 8.50e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY | 7 | 6.97e-01 | 8.50e-02 | 9.98e-01 |
| GOBP MACROPINOCYTOSIS | 10 | 6.42e-01 | -8.50e-02 | 9.98e-01 |
| GOBP BASEMENT MEMBRANE ASSEMBLY | 9 | 6.59e-01 | -8.50e-02 | 9.98e-01 |
| GOCC LATERAL PART OF CELL | 5 | 7.42e-01 | -8.49e-02 | 9.98e-01 |
| GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 560 | 5.89e-04 | -8.49e-02 | 1.38e-01 |
| GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 11 | 6.26e-01 | -8.49e-02 | 9.98e-01 |
| GOCC CORTICAL CYTOSKELETON | 101 | 1.40e-01 | -8.49e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 34 | 3.92e-01 | 8.49e-02 | 9.95e-01 |
| GOBP FEMALE GAMETE GENERATION | 158 | 6.56e-02 | 8.49e-02 | 7.99e-01 |
| GOBP KILLING BY HOST OF SYMBIONT CELLS | 25 | 4.63e-01 | 8.48e-02 | 9.95e-01 |
| GOBP VACUOLAR LOCALIZATION | 82 | 1.84e-01 | 8.48e-02 | 9.28e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 8 | 6.78e-01 | 8.48e-02 | 9.98e-01 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 9 | 6.60e-01 | 8.48e-02 | 9.98e-01 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 178 | 5.11e-02 | 8.48e-02 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 96 | 1.51e-01 | 8.47e-02 | 9.04e-01 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 28 | 4.38e-01 | -8.47e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 18 | 5.34e-01 | -8.47e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 10 | 6.43e-01 | -8.47e-02 | 9.98e-01 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 55 | 2.77e-01 | 8.47e-02 | 9.73e-01 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 86 | 1.75e-01 | -8.46e-02 | 9.21e-01 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 426 | 2.73e-03 | -8.46e-02 | 3.18e-01 |
| GOBP SHORT TERM MEMORY | 10 | 6.43e-01 | -8.46e-02 | 9.98e-01 |
| GOCC CHECKPOINT CLAMP COMPLEX | 5 | 7.43e-01 | 8.46e-02 | 9.98e-01 |
| GOCC STRIATED MUSCLE THIN FILAMENT | 22 | 4.92e-01 | 8.45e-02 | 9.95e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 35 | 3.87e-01 | 8.45e-02 | 9.95e-01 |
| GOMF MISFOLDED PROTEIN BINDING | 19 | 5.24e-01 | -8.45e-02 | 9.95e-01 |
| GOBP AXIAL MESODERM DEVELOPMENT | 8 | 6.79e-01 | -8.45e-02 | 9.98e-01 |
| GOBP GLYCINE IMPORT ACROSS PLASMA MEMBRANE | 5 | 7.44e-01 | -8.45e-02 | 9.98e-01 |
| GOCC NUCLEOSOME | 114 | 1.19e-01 | 8.44e-02 | 8.83e-01 |
| GOBP REGULATION OF RESPONSE TO DRUG | 15 | 5.71e-01 | -8.44e-02 | 9.95e-01 |
| GOBP RESPONSE TO VIRUS | 419 | 3.03e-03 | 8.44e-02 | 3.30e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 307 | 1.09e-02 | 8.44e-02 | 5.81e-01 |
| GOBP POTASSIUM ION TRANSPORT | 234 | 2.62e-02 | -8.44e-02 | 6.71e-01 |
| GOBP COPII COATED VESICLE CARGO LOADING | 16 | 5.59e-01 | -8.44e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 29 | 4.32e-01 | -8.43e-02 | 9.95e-01 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 31 | 4.17e-01 | 8.43e-02 | 9.95e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 37 | 3.75e-01 | 8.43e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS | 5 | 7.44e-01 | -8.43e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 43 | 3.39e-01 | 8.42e-02 | 9.88e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY TYPE I | 5 | 7.44e-01 | 8.42e-02 | 9.98e-01 |
| GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 11 | 6.29e-01 | -8.42e-02 | 9.98e-01 |
| GOBP NEUROMUSCULAR PROCESS | 159 | 6.70e-02 | 8.42e-02 | 7.99e-01 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 15 | 5.73e-01 | -8.41e-02 | 9.95e-01 |
| GOMF FERROUS IRON BINDING | 24 | 4.76e-01 | 8.41e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 16 | 5.60e-01 | -8.41e-02 | 9.95e-01 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 133 | 9.43e-02 | 8.40e-02 | 8.55e-01 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 62 | 2.53e-01 | -8.40e-02 | 9.58e-01 |
| GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 8 | 6.81e-01 | -8.40e-02 | 9.98e-01 |
| GOBP OSMOSENSORY SIGNALING PATHWAY | 5 | 7.45e-01 | 8.40e-02 | 9.98e-01 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 7.01e-01 | 8.39e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 36 | 3.83e-01 | 8.39e-02 | 9.95e-01 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 217 | 3.31e-02 | 8.39e-02 | 7.10e-01 |
| GOMF ADP BINDING | 35 | 3.90e-01 | -8.39e-02 | 9.95e-01 |
| GOBP EXOCYST LOCALIZATION | 5 | 7.45e-01 | -8.39e-02 | 9.98e-01 |
| GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 44 | 3.36e-01 | -8.39e-02 | 9.88e-01 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 13 | 6.01e-01 | 8.38e-02 | 9.98e-01 |
| GOBP METENCEPHALON DEVELOPMENT | 106 | 1.36e-01 | 8.38e-02 | 9.00e-01 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 48 | 3.15e-01 | 8.38e-02 | 9.87e-01 |
| GOBP HISTONE MODIFICATION | 106 | 1.36e-01 | 8.38e-02 | 9.00e-01 |
| GOBP RENAL SYSTEM PROCESS | 117 | 1.18e-01 | -8.38e-02 | 8.83e-01 |
| GOBP INNER EAR MORPHOGENESIS | 103 | 1.42e-01 | 8.37e-02 | 9.02e-01 |
| GOCC BASAL DENDRITE | 6 | 7.23e-01 | -8.37e-02 | 9.98e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 41 | 3.54e-01 | -8.37e-02 | 9.95e-01 |
| GOBP REGULATION OF DENDRITE EXTENSION | 25 | 4.69e-01 | -8.37e-02 | 9.95e-01 |
| GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 7 | 7.02e-01 | 8.37e-02 | 9.98e-01 |
| GOCC CILIARY BASE | 44 | 3.37e-01 | 8.36e-02 | 9.88e-01 |
| GOBP VIRAL TRANSCRIPTION | 50 | 3.06e-01 | 8.36e-02 | 9.87e-01 |
| GOCC POTASSIUM CHANNEL COMPLEX | 88 | 1.75e-01 | -8.36e-02 | 9.21e-01 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 14 | 5.88e-01 | 8.36e-02 | 9.97e-01 |
| GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY | 7 | 7.02e-01 | -8.36e-02 | 9.98e-01 |
| GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 6.47e-01 | 8.36e-02 | 9.98e-01 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 155 | 7.28e-02 | 8.35e-02 | 8.07e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 7.46e-01 | 8.35e-02 | 9.98e-01 |
| GOCC APICAL PART OF CELL | 450 | 2.40e-03 | -8.35e-02 | 3.07e-01 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 7 | 7.02e-01 | -8.35e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 7.02e-01 | -8.35e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 21 | 5.08e-01 | 8.34e-02 | 9.95e-01 |
| GOBP PEPTIDYL LYSINE METHYLATION | 48 | 3.17e-01 | 8.34e-02 | 9.87e-01 |
| GOMF PHOSPHOLIPASE D ACTIVITY | 6 | 7.23e-01 | -8.34e-02 | 9.98e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 53 | 2.94e-01 | -8.34e-02 | 9.80e-01 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 272 | 1.79e-02 | 8.34e-02 | 6.41e-01 |
| GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 19 | 5.29e-01 | 8.34e-02 | 9.95e-01 |
| GOCC NETWORK FORMING COLLAGEN TRIMER | 6 | 7.24e-01 | -8.34e-02 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 39 | 3.68e-01 | 8.33e-02 | 9.95e-01 |
| GOBP NUCLEAR PORE LOCALIZATION | 5 | 7.47e-01 | 8.32e-02 | 9.98e-01 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 37 | 3.81e-01 | 8.32e-02 | 9.95e-01 |
| GOBP RENAL WATER ABSORPTION | 6 | 7.24e-01 | -8.31e-02 | 9.98e-01 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 204 | 4.07e-02 | 8.31e-02 | 7.56e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 44 | 3.40e-01 | 8.31e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 75 | 2.14e-01 | -8.31e-02 | 9.40e-01 |
| GOMF DEATH DOMAIN BINDING | 11 | 6.33e-01 | -8.30e-02 | 9.98e-01 |
| GOBP STRESS GRANULE ASSEMBLY | 29 | 4.39e-01 | -8.30e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE | 8 | 6.84e-01 | -8.30e-02 | 9.98e-01 |
| GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE | 6 | 7.25e-01 | -8.30e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 57 | 2.78e-01 | -8.30e-02 | 9.73e-01 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 46 | 3.30e-01 | 8.30e-02 | 9.88e-01 |
| GOBP CHEMOSENSORY BEHAVIOR | 18 | 5.42e-01 | 8.30e-02 | 9.95e-01 |
| GOMF PROTEIN KINASE A BINDING | 49 | 3.15e-01 | 8.29e-02 | 9.87e-01 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 113 | 1.28e-01 | 8.29e-02 | 8.91e-01 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 19 | 5.32e-01 | -8.29e-02 | 9.95e-01 |
| GOBP INTRACILIARY TRANSPORT | 45 | 3.36e-01 | 8.29e-02 | 9.88e-01 |
| GOBP REGULATION OF RECEPTOR BINDING | 17 | 5.54e-01 | 8.29e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 16 | 5.66e-01 | -8.29e-02 | 9.95e-01 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 45 | 3.36e-01 | 8.29e-02 | 9.88e-01 |
| GOBP LYMPH VESSEL DEVELOPMENT | 31 | 4.25e-01 | 8.28e-02 | 9.95e-01 |
| GOCC BLOOD MICROPARTICLE | 111 | 1.32e-01 | -8.28e-02 | 8.96e-01 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 10 | 6.50e-01 | -8.28e-02 | 9.98e-01 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 25 | 4.74e-01 | -8.27e-02 | 9.95e-01 |
| GOBP DNA INTEGRATION | 8 | 6.85e-01 | 8.27e-02 | 9.98e-01 |
| GOMF NUCLEOTIDASE ACTIVITY | 14 | 5.92e-01 | 8.27e-02 | 9.98e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 22 | 5.03e-01 | 8.25e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 11 | 6.36e-01 | -8.25e-02 | 9.98e-01 |
| GOBP TRNA 5 END PROCESSING | 15 | 5.80e-01 | -8.25e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 8 | 6.86e-01 | 8.25e-02 | 9.98e-01 |
| GOBP RIGHTING REFLEX | 8 | 6.86e-01 | -8.24e-02 | 9.98e-01 |
| GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING | 18 | 5.45e-01 | -8.24e-02 | 9.95e-01 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 67 | 2.43e-01 | 8.24e-02 | 9.58e-01 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 173 | 6.15e-02 | -8.24e-02 | 7.97e-01 |
| GOCC PARANODE REGION OF AXON | 12 | 6.22e-01 | -8.23e-02 | 9.98e-01 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 35 | 3.99e-01 | 8.23e-02 | 9.95e-01 |
| GOBP CARNITINE METABOLIC PROCESS | 11 | 6.36e-01 | 8.23e-02 | 9.98e-01 |
| GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 37 | 3.86e-01 | 8.23e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 10 | 6.52e-01 | 8.23e-02 | 9.98e-01 |
| GOBP MYELOID DENDRITIC CELL CHEMOTAXIS | 5 | 7.50e-01 | -8.23e-02 | 9.98e-01 |
| GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 13 | 6.08e-01 | 8.23e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 12 | 6.22e-01 | -8.23e-02 | 9.98e-01 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 38 | 3.80e-01 | 8.23e-02 | 9.95e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 14 | 5.94e-01 | -8.22e-02 | 9.98e-01 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 115 | 1.28e-01 | 8.22e-02 | 8.91e-01 |
| GOCC PROTEASOME COMPLEX | 59 | 2.75e-01 | 8.22e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF T CELL MIGRATION | 32 | 4.21e-01 | -8.22e-02 | 9.95e-01 |
| GOCC MITOCHONDRIAL CRISTA | 8 | 6.87e-01 | 8.22e-02 | 9.98e-01 |
| GOBP CEREBRAL CORTEX TANGENTIAL MIGRATION | 5 | 7.50e-01 | -8.21e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 22 | 5.06e-01 | -8.20e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 15 | 5.82e-01 | 8.20e-02 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 43 | 3.52e-01 | 8.20e-02 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 6 | 7.28e-01 | -8.20e-02 | 9.98e-01 |
| GOBP RESPONSE TO SYMBIONT | 6 | 7.28e-01 | -8.20e-02 | 9.98e-01 |
| GOMF RNA POLYMERASE II ACTIVITY | 9 | 6.70e-01 | 8.20e-02 | 9.98e-01 |
| GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 22 | 5.06e-01 | 8.19e-02 | 9.95e-01 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 52 | 3.07e-01 | -8.19e-02 | 9.87e-01 |
| GOBP REGULATION OF MUCUS SECRETION | 8 | 6.88e-01 | -8.19e-02 | 9.98e-01 |
| GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 7 | 7.08e-01 | 8.19e-02 | 9.98e-01 |
| GOBP REGULATION OF CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP | 5 | 7.51e-01 | 8.19e-02 | 9.98e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 52 | 3.07e-01 | 8.19e-02 | 9.87e-01 |
| GOBP NEGATIVE T CELL SELECTION | 13 | 6.09e-01 | 8.18e-02 | 9.98e-01 |
| GOBP LIPOPROTEIN LOCALIZATION | 21 | 5.16e-01 | -8.18e-02 | 9.95e-01 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 29 | 4.46e-01 | 8.18e-02 | 9.95e-01 |
| GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 11 | 6.39e-01 | -8.18e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 19 | 5.37e-01 | -8.18e-02 | 9.95e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 7.08e-01 | -8.17e-02 | 9.98e-01 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 19 | 5.38e-01 | 8.16e-02 | 9.95e-01 |
| GOMF SODIUM BICARBONATE SYMPORTER ACTIVITY | 6 | 7.29e-01 | -8.16e-02 | 9.98e-01 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 12 | 6.24e-01 | -8.16e-02 | 9.98e-01 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 12 | 6.24e-01 | 8.16e-02 | 9.98e-01 |
| GOBP KERATINOCYTE DEVELOPMENT | 13 | 6.10e-01 | -8.16e-02 | 9.98e-01 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 45 | 3.44e-01 | -8.16e-02 | 9.92e-01 |
| GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 7.29e-01 | 8.15e-02 | 9.98e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 7.29e-01 | 8.15e-02 | 9.98e-01 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 19 | 5.38e-01 | 8.15e-02 | 9.95e-01 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 205 | 4.42e-02 | -8.15e-02 | 7.59e-01 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 27 | 4.63e-01 | 8.15e-02 | 9.95e-01 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 191 | 5.21e-02 | -8.15e-02 | 7.81e-01 |
| GOBP RUFFLE ASSEMBLY | 45 | 3.44e-01 | -8.15e-02 | 9.92e-01 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 72 | 2.32e-01 | 8.15e-02 | 9.50e-01 |
| GOCC DENDRITIC SPINE HEAD | 7 | 7.09e-01 | 8.15e-02 | 9.98e-01 |
| GOBP PROTEIN KINASE A SIGNALING | 37 | 3.91e-01 | -8.14e-02 | 9.95e-01 |
| GOMF GANGLIOSIDE BINDING | 5 | 7.53e-01 | 8.14e-02 | 9.98e-01 |
| GOBP MAINTENANCE OF CELL POLARITY | 17 | 5.61e-01 | -8.14e-02 | 9.95e-01 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 57 | 2.88e-01 | 8.14e-02 | 9.75e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 47 | 3.35e-01 | -8.13e-02 | 9.88e-01 |
| GOBP HISTONE METHYLATION | 35 | 4.05e-01 | 8.13e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 6 | 7.30e-01 | 8.12e-02 | 9.98e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 32 | 4.27e-01 | -8.12e-02 | 9.95e-01 |
| GOCC REPLISOME | 13 | 6.13e-01 | 8.11e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 25 | 4.83e-01 | 8.11e-02 | 9.95e-01 |
| GOMF HISTONE H3K9ME2 H3K9ME3 DEMETHYLASE ACTIVITY | 5 | 7.54e-01 | 8.11e-02 | 9.98e-01 |
| GOBP OOGENESIS | 108 | 1.46e-01 | 8.11e-02 | 9.02e-01 |
| GOBP CHROMATIN REMODELING | 577 | 8.78e-04 | 8.10e-02 | 1.80e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 41 | 3.70e-01 | -8.09e-02 | 9.95e-01 |
| GOMF TELOMERASE RNA BINDING | 21 | 5.21e-01 | 8.09e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 31 | 4.35e-01 | -8.09e-02 | 9.95e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 14 | 6.00e-01 | 8.09e-02 | 9.98e-01 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 34 | 4.15e-01 | -8.09e-02 | 9.95e-01 |
| GOMF U2 SNRNA BINDING | 6 | 7.32e-01 | 8.09e-02 | 9.98e-01 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 25 | 4.84e-01 | -8.08e-02 | 9.95e-01 |
| GOBP LENS FIBER CELL MORPHOGENESIS | 6 | 7.32e-01 | -8.08e-02 | 9.98e-01 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 101 | 1.61e-01 | -8.08e-02 | 9.06e-01 |
| GOBP PROSTATE GLANDULAR ACINUS MORPHOGENESIS | 6 | 7.32e-01 | 8.08e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 34 | 4.15e-01 | -8.08e-02 | 9.95e-01 |
| GOBP FUCOSYLATION | 17 | 5.64e-01 | 8.08e-02 | 9.95e-01 |
| GOBP GLUTAMATE REUPTAKE | 6 | 7.32e-01 | 8.08e-02 | 9.98e-01 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 17 | 5.64e-01 | 8.07e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 190 | 5.50e-02 | 8.07e-02 | 7.90e-01 |
| GOCC SARCOLEMMA | 136 | 1.04e-01 | -8.07e-02 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 6 | 7.32e-01 | 8.07e-02 | 9.98e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 57 | 2.92e-01 | -8.07e-02 | 9.79e-01 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 59 | 2.84e-01 | 8.07e-02 | 9.74e-01 |
| GOBP MAINTENANCE OF PRESYNAPTIC ACTIVE ZONE STRUCTURE | 6 | 7.32e-01 | -8.06e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 158 | 8.05e-02 | 8.06e-02 | 8.35e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 16 | 5.77e-01 | -8.05e-02 | 9.96e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 17 | 5.65e-01 | 8.05e-02 | 9.95e-01 |
| GOBP PROTEIN AUTOPROCESSING | 28 | 4.61e-01 | 8.05e-02 | 9.95e-01 |
| GOBP REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 7 | 7.12e-01 | -8.05e-02 | 9.98e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT | 11 | 6.44e-01 | 8.05e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 7.33e-01 | -8.04e-02 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 7.33e-01 | 8.04e-02 | 9.98e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 79 | 2.17e-01 | 8.04e-02 | 9.43e-01 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 233 | 3.47e-02 | -8.03e-02 | 7.25e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 83 | 2.06e-01 | 8.03e-02 | 9.38e-01 |
| GOBP RNA 5 END PROCESSING | 21 | 5.24e-01 | -8.03e-02 | 9.95e-01 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 39 | 3.86e-01 | 8.03e-02 | 9.95e-01 |
| GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION | 5 | 7.56e-01 | 8.03e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 26 | 4.79e-01 | 8.02e-02 | 9.95e-01 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 24 | 4.96e-01 | 8.02e-02 | 9.95e-01 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 967 | 2.42e-05 | 8.02e-02 | 1.68e-02 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 8 | 6.95e-01 | 8.02e-02 | 9.98e-01 |
| GOMF MAGNESIUM ION BINDING | 212 | 4.45e-02 | 8.01e-02 | 7.59e-01 |
| GOBP SPHINGOID METABOLIC PROCESS | 22 | 5.16e-01 | 8.01e-02 | 9.95e-01 |
| GOCC HISTONE DEACETYLASE COMPLEX | 76 | 2.28e-01 | 8.00e-02 | 9.50e-01 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 40 | 3.82e-01 | 7.99e-02 | 9.95e-01 |
| GOMF MANGANESE ION BINDING | 63 | 2.73e-01 | 7.99e-02 | 9.73e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 6 | 7.35e-01 | -7.99e-02 | 9.98e-01 |
| GOCC ACETYLCHOLINE GATED CHANNEL COMPLEX | 15 | 5.92e-01 | 7.98e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 318 | 1.44e-02 | 7.98e-02 | 6.25e-01 |
| GOCC IMMUNOLOGICAL SYNAPSE | 45 | 3.55e-01 | 7.97e-02 | 9.95e-01 |
| GOBP AXONAL TRANSPORT | 62 | 2.78e-01 | 7.97e-02 | 9.73e-01 |
| GOBP LEUKOTRIENE B4 METABOLIC PROCESS | 5 | 7.58e-01 | -7.97e-02 | 9.98e-01 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 407 | 5.81e-03 | -7.97e-02 | 4.54e-01 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 54 | 3.11e-01 | 7.97e-02 | 9.87e-01 |
| GOMF COBALAMIN BINDING | 9 | 6.79e-01 | 7.97e-02 | 9.98e-01 |
| GOBP UTP BIOSYNTHETIC PROCESS | 10 | 6.63e-01 | -7.97e-02 | 9.98e-01 |
| GOBP RESPONSE TO CADMIUM ION | 56 | 3.03e-01 | 7.96e-02 | 9.87e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 113 | 1.44e-01 | 7.96e-02 | 9.02e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 51 | 3.25e-01 | 7.96e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 17 | 5.70e-01 | -7.96e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 15 | 5.93e-01 | -7.96e-02 | 9.98e-01 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 52 | 3.21e-01 | -7.96e-02 | 9.87e-01 |
| GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 8 | 6.97e-01 | 7.96e-02 | 9.98e-01 |
| GOBP MODULATION BY VIRUS OF HOST PROCESS | 7 | 7.16e-01 | 7.95e-02 | 9.98e-01 |
| GOBP GERMINAL CENTER FORMATION | 14 | 6.07e-01 | -7.95e-02 | 9.98e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 7.16e-01 | 7.95e-02 | 9.98e-01 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 57 | 3.00e-01 | -7.94e-02 | 9.85e-01 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 216 | 4.42e-02 | -7.94e-02 | 7.59e-01 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 28 | 4.67e-01 | 7.94e-02 | 9.95e-01 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 170 | 7.43e-02 | -7.93e-02 | 8.13e-01 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 20 | 5.39e-01 | -7.93e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 99 | 1.73e-01 | 7.93e-02 | 9.21e-01 |
| GOBP HORMONE CATABOLIC PROCESS | 11 | 6.49e-01 | -7.92e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 51 | 3.28e-01 | -7.92e-02 | 9.87e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 6.35e-01 | 7.92e-02 | 9.98e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 20 | 5.40e-01 | 7.92e-02 | 9.95e-01 |
| GOBP RESPONSE TO OZONE | 5 | 7.59e-01 | -7.92e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 36 | 4.11e-01 | 7.92e-02 | 9.95e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 29 | 4.61e-01 | -7.92e-02 | 9.95e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 23 | 5.11e-01 | 7.92e-02 | 9.95e-01 |
| GOBP GLUTATHIONE TRANSPORT | 9 | 6.81e-01 | -7.92e-02 | 9.98e-01 |
| GOMF FATTY ACID BINDING | 47 | 3.48e-01 | -7.91e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 36 | 4.11e-01 | 7.91e-02 | 9.95e-01 |
| GOBP RESPONSE TO LEPTIN | 21 | 5.30e-01 | -7.91e-02 | 9.95e-01 |
| GOMF RNA POLYMERASE I ACTIVITY | 10 | 6.65e-01 | 7.91e-02 | 9.98e-01 |
| GOBP ISOPRENOID METABOLIC PROCESS | 130 | 1.20e-01 | -7.90e-02 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 52 | 3.24e-01 | 7.90e-02 | 9.87e-01 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 37 | 4.06e-01 | -7.90e-02 | 9.95e-01 |
| GOCC APICAL CORTEX | 8 | 6.99e-01 | 7.90e-02 | 9.98e-01 |
| GOMF ADENYLATE CYCLASE ACTIVITY | 15 | 5.96e-01 | -7.90e-02 | 9.98e-01 |
| GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 9 | 6.82e-01 | -7.89e-02 | 9.98e-01 |
| GOMF ICOSANOID BINDING | 8 | 6.99e-01 | -7.89e-02 | 9.98e-01 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 15 | 5.97e-01 | -7.89e-02 | 9.98e-01 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 498 | 2.56e-03 | 7.89e-02 | 3.16e-01 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 6.36e-01 | -7.89e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 27 | 4.78e-01 | 7.89e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 32 | 4.40e-01 | -7.88e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 63 | 2.79e-01 | 7.88e-02 | 9.73e-01 |
| GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS | 6 | 7.38e-01 | 7.88e-02 | 9.98e-01 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 6 | 7.38e-01 | 7.88e-02 | 9.98e-01 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 11 | 6.51e-01 | 7.88e-02 | 9.98e-01 |
| GOBP INTERLEUKIN 18 PRODUCTION | 14 | 6.10e-01 | -7.87e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN RELEASING HORMONE | 5 | 7.60e-01 | -7.87e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY | 7 | 7.18e-01 | 7.87e-02 | 9.98e-01 |
| GOBP SENSORY PERCEPTION OF SMELL | 363 | 9.99e-03 | 7.87e-02 | 5.57e-01 |
| GOMF INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED MONOATOMIC CATION CHANNEL ACTIVITY | 10 | 6.67e-01 | -7.87e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 7.00e-01 | -7.87e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 112 | 1.51e-01 | 7.86e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1430 | 6.57e-07 | 7.85e-02 | 7.46e-04 |
| GOMF SPHINGOLIPID BINDING | 28 | 4.72e-01 | 7.85e-02 | 9.95e-01 |
| GOBP HORMONE METABOLIC PROCESS | 229 | 4.07e-02 | -7.85e-02 | 7.56e-01 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 50 | 3.37e-01 | 7.85e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 7.61e-01 | -7.85e-02 | 9.98e-01 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 48 | 3.47e-01 | 7.84e-02 | 9.93e-01 |
| GOBP PALLIUM DEVELOPMENT | 180 | 6.97e-02 | 7.84e-02 | 8.00e-01 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 32 | 4.43e-01 | 7.84e-02 | 9.95e-01 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 29 | 4.65e-01 | 7.83e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 90 | 1.99e-01 | -7.83e-02 | 9.36e-01 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 22 | 5.25e-01 | 7.83e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 5 | 7.62e-01 | 7.83e-02 | 9.98e-01 |
| GOCC SPINDLE POLE CENTROSOME | 13 | 6.25e-01 | 7.82e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 48 | 3.49e-01 | 7.82e-02 | 9.94e-01 |
| GOBP B CELL PROLIFERATION | 96 | 1.86e-01 | 7.82e-02 | 9.28e-01 |
| GOBP RNA SPLICING | 420 | 6.02e-03 | 7.81e-02 | 4.63e-01 |
| GOBP TUBE FORMATION | 149 | 9.97e-02 | 7.81e-02 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION | 5 | 7.62e-01 | -7.81e-02 | 9.98e-01 |
| GOMF CCR1 CHEMOKINE RECEPTOR BINDING | 5 | 7.62e-01 | 7.81e-02 | 9.98e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 17 | 5.78e-01 | -7.80e-02 | 9.96e-01 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 37 | 4.11e-01 | 7.80e-02 | 9.95e-01 |
| GOBP OLFACTORY BEHAVIOR | 10 | 6.69e-01 | 7.80e-02 | 9.98e-01 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 42 | 3.82e-01 | -7.79e-02 | 9.95e-01 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 28 | 4.76e-01 | -7.79e-02 | 9.95e-01 |
| GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 6.70e-01 | -7.79e-02 | 9.98e-01 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 9 | 6.86e-01 | 7.79e-02 | 9.98e-01 |
| GOBP TONGUE DEVELOPMENT | 20 | 5.47e-01 | 7.79e-02 | 9.95e-01 |
| GOMF SINGLE STRANDED DNA BINDING | 114 | 1.51e-01 | 7.79e-02 | 9.04e-01 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 21 | 5.37e-01 | -7.79e-02 | 9.95e-01 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 125 | 1.33e-01 | 7.78e-02 | 8.96e-01 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 71 | 2.57e-01 | 7.77e-02 | 9.58e-01 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 58 | 3.06e-01 | 7.77e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 51 | 3.37e-01 | 7.77e-02 | 9.88e-01 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 30 | 4.62e-01 | -7.77e-02 | 9.95e-01 |
| GOBP LYMPH NODE DEVELOPMENT | 18 | 5.69e-01 | 7.76e-02 | 9.95e-01 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 11 | 6.56e-01 | 7.76e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 24 | 5.11e-01 | -7.76e-02 | 9.95e-01 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 54 | 3.24e-01 | 7.75e-02 | 9.87e-01 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 14 | 6.15e-01 | -7.75e-02 | 9.98e-01 |
| GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 12 | 6.42e-01 | -7.75e-02 | 9.98e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 24 | 5.11e-01 | 7.74e-02 | 9.95e-01 |
| GOBP REGULATION OF RNA SPLICING | 163 | 8.80e-02 | 7.74e-02 | 8.47e-01 |
| GOBP REGULATION OF MESODERMAL CELL FATE SPECIFICATION | 5 | 7.64e-01 | -7.74e-02 | 9.98e-01 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 29 | 4.71e-01 | -7.74e-02 | 9.95e-01 |
| GOBP EPIBOLY | 37 | 4.15e-01 | 7.74e-02 | 9.95e-01 |
| GOCC PALMITOYLTRANSFERASE COMPLEX | 10 | 6.72e-01 | -7.74e-02 | 9.98e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION | 8 | 7.05e-01 | -7.73e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 6 | 7.43e-01 | 7.73e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 23 | 5.21e-01 | -7.73e-02 | 9.95e-01 |
| GOBP LIVER REGENERATION | 28 | 4.79e-01 | 7.73e-02 | 9.95e-01 |
| GOBP ORGAN INDUCTION | 22 | 5.30e-01 | -7.73e-02 | 9.95e-01 |
| GOBP VESICLE TARGETING | 65 | 2.82e-01 | 7.72e-02 | 9.73e-01 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 35 | 4.29e-01 | 7.72e-02 | 9.95e-01 |
| GOBP TOXIN METABOLIC PROCESS | 14 | 6.17e-01 | 7.71e-02 | 9.98e-01 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 84 | 2.22e-01 | 7.71e-02 | 9.45e-01 |
| GOBP ATP BIOSYNTHETIC PROCESS | 89 | 2.09e-01 | 7.71e-02 | 9.38e-01 |
| GOCC AZUROPHIL GRANULE MEMBRANE | 56 | 3.18e-01 | 7.71e-02 | 9.87e-01 |
| GOCC SPLICEOSOMAL SNRNP COMPLEX | 70 | 2.65e-01 | 7.70e-02 | 9.66e-01 |
| GOCC GTPASE COMPLEX | 38 | 4.11e-01 | 7.70e-02 | 9.95e-01 |
| GOBP STOMACH DEVELOPMENT | 5 | 7.66e-01 | -7.70e-02 | 9.98e-01 |
| GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 5 | 7.66e-01 | -7.70e-02 | 9.98e-01 |
| GOBP MUCOCILIARY CLEARANCE | 8 | 7.06e-01 | 7.69e-02 | 9.98e-01 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 16 | 5.94e-01 | 7.69e-02 | 9.98e-01 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 101 | 1.82e-01 | -7.69e-02 | 9.27e-01 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 21 | 5.42e-01 | -7.69e-02 | 9.95e-01 |
| GOBP CARDIAC MUSCLE CELL FATE COMMITMENT | 11 | 6.59e-01 | 7.69e-02 | 9.98e-01 |
| GOBP PHOSPHOLIPID TRANSPORT | 101 | 1.82e-01 | -7.69e-02 | 9.27e-01 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 24 | 5.15e-01 | -7.68e-02 | 9.95e-01 |
| GOBP OVULATION FROM OVARIAN FOLLICLE | 8 | 7.07e-01 | 7.68e-02 | 9.98e-01 |
| GOMF PRE MRNA BINDING | 39 | 4.06e-01 | -7.68e-02 | 9.95e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 6 | 7.45e-01 | -7.68e-02 | 9.98e-01 |
| GOMF OLFACTORY RECEPTOR ACTIVITY | 337 | 1.55e-02 | 7.67e-02 | 6.25e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CARDIAC MUSCLE CELL FATE COMMITMENT | 5 | 7.66e-01 | 7.67e-02 | 9.98e-01 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 57 | 3.16e-01 | 7.67e-02 | 9.87e-01 |
| GOCC ACETYLTRANSFERASE COMPLEX | 90 | 2.08e-01 | 7.67e-02 | 9.38e-01 |
| GOCC CATENIN COMPLEX | 31 | 4.60e-01 | 7.67e-02 | 9.95e-01 |
| GOBP CELLULAR GLUCURONIDATION | 18 | 5.73e-01 | -7.66e-02 | 9.95e-01 |
| GOBP DNA MODIFICATION | 99 | 1.88e-01 | 7.66e-02 | 9.28e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 85 | 2.23e-01 | 7.65e-02 | 9.45e-01 |
| GOBP P BODY ASSEMBLY | 20 | 5.54e-01 | -7.65e-02 | 9.95e-01 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 47 | 3.64e-01 | 7.65e-02 | 9.95e-01 |
| GOBP REGULATION OF ACTIN NUCLEATION | 36 | 4.27e-01 | -7.65e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO HEPARIN | 5 | 7.67e-01 | -7.65e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 110 | 1.66e-01 | 7.64e-02 | 9.15e-01 |
| GOCC CELL CELL CONTACT ZONE | 70 | 2.69e-01 | -7.64e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 1191 | 9.14e-06 | 7.63e-02 | 8.51e-03 |
| GOBP REGULATION OF TRANSLATIONAL FIDELITY | 18 | 5.75e-01 | 7.63e-02 | 9.96e-01 |
| GOBP REGULATION OF PROTEIN KINASE C ACTIVITY | 5 | 7.68e-01 | -7.63e-02 | 9.98e-01 |
| GOBP TRICARBOXYLIC ACID CYCLE | 29 | 4.77e-01 | -7.63e-02 | 9.95e-01 |
| GOBP REGULATION OF GONAD DEVELOPMENT | 12 | 6.47e-01 | -7.63e-02 | 9.98e-01 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 36 | 4.28e-01 | -7.63e-02 | 9.95e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 33 | 4.49e-01 | 7.62e-02 | 9.95e-01 |
| GOCC CLEAVAGE FURROW | 51 | 3.46e-01 | -7.62e-02 | 9.92e-01 |
| GOBP FOREBRAIN DEVELOPMENT | 389 | 9.87e-03 | 7.62e-02 | 5.57e-01 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 24 | 5.18e-01 | 7.62e-02 | 9.95e-01 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 90 | 2.12e-01 | 7.62e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 9 | 6.93e-01 | 7.61e-02 | 9.98e-01 |
| GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 11 | 6.62e-01 | 7.61e-02 | 9.98e-01 |
| GOCC MICROFIBRIL | 13 | 6.35e-01 | -7.61e-02 | 9.98e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 38 | 4.17e-01 | 7.60e-02 | 9.95e-01 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 24 | 5.19e-01 | 7.60e-02 | 9.95e-01 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 163 | 9.42e-02 | 7.60e-02 | 8.55e-01 |
| GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 9 | 6.93e-01 | -7.60e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 35 | 4.37e-01 | 7.60e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 26 | 5.03e-01 | -7.60e-02 | 9.95e-01 |
| GOBP CYTIDINE METABOLIC PROCESS | 12 | 6.49e-01 | 7.59e-02 | 9.98e-01 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 12 | 6.49e-01 | 7.59e-02 | 9.98e-01 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 117 | 1.56e-01 | -7.59e-02 | 9.06e-01 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 71 | 2.69e-01 | -7.59e-02 | 9.71e-01 |
| GOMF HEPARIN BINDING | 169 | 8.87e-02 | -7.59e-02 | 8.47e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 43 | 3.89e-01 | 7.59e-02 | 9.95e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 14 | 6.23e-01 | -7.59e-02 | 9.98e-01 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 20 | 5.57e-01 | 7.59e-02 | 9.95e-01 |
| GOBP AMINO ACID BETAINE BIOSYNTHETIC PROCESS | 5 | 7.69e-01 | -7.58e-02 | 9.98e-01 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 24 | 5.20e-01 | 7.58e-02 | 9.95e-01 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 48 | 3.63e-01 | -7.58e-02 | 9.95e-01 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 230 | 4.75e-02 | -7.58e-02 | 7.65e-01 |
| GOBP EQUILIBRIOCEPTION | 7 | 7.28e-01 | -7.58e-02 | 9.98e-01 |
| GOMF THYROID HORMONE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.29e-01 | 7.57e-02 | 9.98e-01 |
| GOMF BMP RECEPTOR ACTIVITY | 7 | 7.29e-01 | -7.57e-02 | 9.98e-01 |
| GOBP SISTER CHROMATID SEGREGATION | 221 | 5.24e-02 | 7.57e-02 | 7.81e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 20 | 5.58e-01 | 7.57e-02 | 9.95e-01 |
| GOCC CHROMOSOME TELOMERIC REGION | 164 | 9.44e-02 | 7.57e-02 | 8.55e-01 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 160 | 9.85e-02 | -7.57e-02 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 27 | 4.96e-01 | -7.57e-02 | 9.95e-01 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 14 | 6.24e-01 | -7.57e-02 | 9.98e-01 |
| GOBP CAMP BIOSYNTHETIC PROCESS | 10 | 6.79e-01 | -7.57e-02 | 9.98e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC | 20 | 5.58e-01 | 7.56e-02 | 9.95e-01 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 15 | 6.12e-01 | -7.56e-02 | 9.98e-01 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 9 | 6.95e-01 | 7.56e-02 | 9.98e-01 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 271 | 3.23e-02 | 7.56e-02 | 7.07e-01 |
| GOBP CORTICOSPINAL TRACT MORPHOGENESIS | 8 | 7.11e-01 | -7.55e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 34 | 4.46e-01 | 7.55e-02 | 9.95e-01 |
| GOMF LIPID TRANSPORTER ACTIVITY | 169 | 9.05e-02 | -7.55e-02 | 8.53e-01 |
| GOBP ATRIOVENTRICULAR VALVE FORMATION | 8 | 7.12e-01 | 7.55e-02 | 9.98e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 79 | 2.46e-01 | -7.55e-02 | 9.58e-01 |
| GOBP NEURONAL ACTION POTENTIAL | 32 | 4.60e-01 | 7.55e-02 | 9.95e-01 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 239 | 4.45e-02 | 7.55e-02 | 7.59e-01 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 12 | 6.51e-01 | 7.54e-02 | 9.98e-01 |
| GOBP ENDODERMAL CELL DIFFERENTIATION | 48 | 3.66e-01 | -7.54e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 17 | 5.90e-01 | -7.54e-02 | 9.98e-01 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 36 | 4.34e-01 | 7.54e-02 | 9.95e-01 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 117 | 1.59e-01 | 7.54e-02 | 9.06e-01 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 27 | 4.98e-01 | -7.53e-02 | 9.95e-01 |
| GOBP FATTY ACID HOMEOSTASIS | 16 | 6.02e-01 | 7.53e-02 | 9.98e-01 |
| GOBP GLUTAMATE METABOLIC PROCESS | 32 | 4.61e-01 | 7.52e-02 | 9.95e-01 |
| GOBP RETINAL METABOLIC PROCESS | 18 | 5.81e-01 | -7.52e-02 | 9.96e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 15 | 6.14e-01 | -7.52e-02 | 9.98e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 55 | 3.35e-01 | 7.52e-02 | 9.88e-01 |
| GOBP NEURONAL DENSE CORE VESICLE EXOCYTOSIS | 7 | 7.31e-01 | -7.52e-02 | 9.98e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 9 | 6.96e-01 | 7.52e-02 | 9.98e-01 |
| GOCC GLIAL CELL PROJECTION | 36 | 4.35e-01 | -7.51e-02 | 9.95e-01 |
| GOBP MUSCLE ATROPHY | 10 | 6.81e-01 | 7.51e-02 | 9.98e-01 |
| GOBP CGMP CATABOLIC PROCESS | 5 | 7.71e-01 | -7.51e-02 | 9.98e-01 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 13 | 6.40e-01 | -7.50e-02 | 9.98e-01 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 36 | 4.36e-01 | 7.50e-02 | 9.95e-01 |
| GOMF SH2 DOMAIN BINDING | 40 | 4.12e-01 | -7.50e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF BINDING | 118 | 1.60e-01 | 7.49e-02 | 9.06e-01 |
| GOCC MICROTUBULE END | 34 | 4.50e-01 | -7.49e-02 | 9.95e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 16 | 6.04e-01 | -7.49e-02 | 9.98e-01 |
| GOBP REGULATION OF MYELOID DENDRITIC CELL ACTIVATION | 5 | 7.72e-01 | 7.49e-02 | 9.98e-01 |
| GOMF SODIUM INDEPENDENT ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 6.04e-01 | -7.49e-02 | 9.98e-01 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 198 | 6.94e-02 | 7.49e-02 | 8.00e-01 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 12 | 6.54e-01 | 7.48e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 19 | 5.72e-01 | 7.48e-02 | 9.95e-01 |
| GOBP CELL FATE SPECIFICATION | 107 | 1.81e-01 | 7.48e-02 | 9.27e-01 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 27 | 5.01e-01 | -7.48e-02 | 9.95e-01 |
| GOBP REGULATION OF NOREPINEPHRINE SECRETION | 13 | 6.41e-01 | 7.48e-02 | 9.98e-01 |
| GOBP GLYCOSYLCERAMIDE CATABOLIC PROCESS | 6 | 7.51e-01 | -7.48e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 20 | 5.63e-01 | 7.48e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 65 | 2.97e-01 | -7.47e-02 | 9.83e-01 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 200 | 6.86e-02 | 7.47e-02 | 7.99e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 19 | 5.73e-01 | 7.47e-02 | 9.95e-01 |
| GOBP REGULATION OF VASCULOGENESIS | 16 | 6.05e-01 | -7.47e-02 | 9.98e-01 |
| GOBP REGULATION OF GLIOGENESIS | 106 | 1.84e-01 | 7.46e-02 | 9.28e-01 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 12 | 6.55e-01 | -7.46e-02 | 9.98e-01 |
| GOCC NUCLEAR REPLICATION FORK | 32 | 4.65e-01 | 7.46e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 12 | 6.55e-01 | 7.46e-02 | 9.98e-01 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 26 | 5.10e-01 | 7.46e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 49 | 3.67e-01 | 7.46e-02 | 9.95e-01 |
| GOBP MRNA ALTERNATIVE POLYADENYLATION | 5 | 7.73e-01 | -7.45e-02 | 9.98e-01 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 25 | 5.19e-01 | -7.45e-02 | 9.95e-01 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 13 | 6.42e-01 | 7.45e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 15 | 6.18e-01 | -7.44e-02 | 9.98e-01 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 20 | 5.65e-01 | 7.44e-02 | 9.95e-01 |
| GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 25 | 5.20e-01 | 7.44e-02 | 9.95e-01 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 19 | 5.75e-01 | 7.44e-02 | 9.96e-01 |
| GOBP TELENCEPHALON DEVELOPMENT | 265 | 3.71e-02 | 7.44e-02 | 7.37e-01 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 31 | 4.74e-01 | 7.44e-02 | 9.95e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 12 | 6.56e-01 | -7.43e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 65 | 3.00e-01 | 7.43e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 28 | 4.97e-01 | -7.42e-02 | 9.95e-01 |
| GOBP RESPONSE TO NITROSATIVE STRESS | 10 | 6.84e-01 | -7.42e-02 | 9.98e-01 |
| GOCC LATERAL PLASMA MEMBRANE | 64 | 3.05e-01 | -7.42e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 67 | 2.94e-01 | 7.42e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 34 | 4.54e-01 | 7.42e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 31 | 4.75e-01 | 7.41e-02 | 9.95e-01 |
| GOBP REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION | 11 | 6.70e-01 | -7.41e-02 | 9.98e-01 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 35 | 4.48e-01 | 7.41e-02 | 9.95e-01 |
| GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 11 | 6.70e-01 | 7.41e-02 | 9.98e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 12 | 6.57e-01 | 7.41e-02 | 9.98e-01 |
| GOBP REGULATION OF MACROPHAGE PROLIFERATION | 7 | 7.35e-01 | 7.40e-02 | 9.98e-01 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 22 | 5.48e-01 | -7.40e-02 | 9.95e-01 |
| GOBP TRABECULA FORMATION | 26 | 5.14e-01 | -7.39e-02 | 9.95e-01 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 22 | 5.48e-01 | 7.39e-02 | 9.95e-01 |
| GOBP REGULATION OF INTESTINAL ABSORPTION | 12 | 6.58e-01 | 7.39e-02 | 9.98e-01 |
| GOBP STEROID CATABOLIC PROCESS | 24 | 5.31e-01 | 7.38e-02 | 9.95e-01 |
| GOCC POLAR MICROTUBULE | 5 | 7.75e-01 | 7.38e-02 | 9.98e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 29 | 4.92e-01 | -7.38e-02 | 9.95e-01 |
| GOBP DETERMINATION OF LIVER LEFT RIGHT ASYMMETRY | 5 | 7.75e-01 | 7.37e-02 | 9.98e-01 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 39 | 4.26e-01 | 7.37e-02 | 9.95e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 9 | 7.02e-01 | -7.37e-02 | 9.98e-01 |
| GOBP MATURATION OF SSU RRNA | 51 | 3.62e-01 | 7.37e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 10 | 6.87e-01 | 7.37e-02 | 9.98e-01 |
| GOBP POSTSYNAPSE ASSEMBLY | 35 | 4.51e-01 | 7.37e-02 | 9.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 54 | 3.49e-01 | 7.37e-02 | 9.94e-01 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 15 | 6.21e-01 | -7.37e-02 | 9.98e-01 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 35 | 4.51e-01 | 7.37e-02 | 9.95e-01 |
| GOBP CERAMIDE CATABOLIC PROCESS | 20 | 5.69e-01 | 7.37e-02 | 9.95e-01 |
| GOBP STRESS FIBER ASSEMBLY | 108 | 1.86e-01 | -7.37e-02 | 9.28e-01 |
| GOBP PARTURITION | 14 | 6.33e-01 | -7.37e-02 | 9.98e-01 |
| GOBP UBIQUINONE METABOLIC PROCESS | 19 | 5.78e-01 | -7.36e-02 | 9.96e-01 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 11 | 6.72e-01 | 7.36e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 9 | 7.02e-01 | 7.36e-02 | 9.98e-01 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 7.76e-01 | -7.36e-02 | 9.98e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 113 | 1.76e-01 | 7.36e-02 | 9.21e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT POSTSYNAPTIC ENDOSOME TO LYSOSOME | 7 | 7.36e-01 | 7.35e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 38 | 4.33e-01 | 7.35e-02 | 9.95e-01 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 46 | 3.88e-01 | -7.35e-02 | 9.95e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION BY CHEMICAL SIGNAL | 6 | 7.55e-01 | 7.35e-02 | 9.98e-01 |
| GOBP MRNA TRANSCRIPTION | 47 | 3.84e-01 | 7.35e-02 | 9.95e-01 |
| GOBP PEPTIDYL LYSINE HYDROXYLATION | 8 | 7.19e-01 | 7.34e-02 | 9.98e-01 |
| GOMF OXIDIZED DNA BINDING | 11 | 6.73e-01 | 7.34e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 12 | 6.60e-01 | 7.34e-02 | 9.98e-01 |
| GOBP BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 7.56e-01 | 7.34e-02 | 9.98e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 12 | 6.60e-01 | -7.34e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 29 | 4.94e-01 | -7.34e-02 | 9.95e-01 |
| GOMF PALMITOYL COA HYDROLASE ACTIVITY | 15 | 6.23e-01 | 7.33e-02 | 9.98e-01 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 42 | 4.11e-01 | 7.33e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 46 | 3.90e-01 | 7.33e-02 | 9.95e-01 |
| GOCC NUCLEAR PERIPHERY | 142 | 1.32e-01 | 7.33e-02 | 8.96e-01 |
| GOCC TERTIARY GRANULE | 157 | 1.13e-01 | 7.32e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 85 | 2.43e-01 | -7.32e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 39 | 4.29e-01 | 7.32e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 18 | 5.91e-01 | 7.32e-02 | 9.98e-01 |
| GOBP BLASTOCYST GROWTH | 21 | 5.62e-01 | 7.32e-02 | 9.95e-01 |
| GOMF PIRNA BINDING | 5 | 7.77e-01 | -7.32e-02 | 9.98e-01 |
| GOMF SINGLE STRANDED RNA BINDING | 80 | 2.58e-01 | 7.32e-02 | 9.58e-01 |
| GOCC MICROTUBULE PLUS END | 24 | 5.35e-01 | -7.32e-02 | 9.95e-01 |
| GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 7.77e-01 | 7.31e-02 | 9.98e-01 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 58 | 3.36e-01 | -7.30e-02 | 9.88e-01 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 92 | 2.26e-01 | 7.30e-02 | 9.50e-01 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 155 | 1.17e-01 | -7.30e-02 | 8.82e-01 |
| GOBP MESENCHYMAL EPITHELIAL CELL SIGNALING | 7 | 7.38e-01 | -7.30e-02 | 9.98e-01 |
| GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 7 | 7.38e-01 | -7.30e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 51 | 3.67e-01 | 7.30e-02 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 11 | 6.75e-01 | 7.29e-02 | 9.98e-01 |
| GOBP REGULATION OF LIPID KINASE ACTIVITY | 38 | 4.37e-01 | -7.29e-02 | 9.95e-01 |
| GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 7 | 7.38e-01 | 7.29e-02 | 9.98e-01 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 16 | 6.14e-01 | 7.28e-02 | 9.98e-01 |
| GOBP CORTISOL SECRETION | 5 | 7.78e-01 | -7.28e-02 | 9.98e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 10 | 6.90e-01 | 7.28e-02 | 9.98e-01 |
| GOBP ADULT BEHAVIOR | 141 | 1.36e-01 | 7.28e-02 | 9.00e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 101 | 2.07e-01 | 7.27e-02 | 9.38e-01 |
| GOBP REGULATION OF DNA REPAIR | 205 | 7.27e-02 | 7.27e-02 | 8.07e-01 |
| GOBP REGULATORY NCRNA PROCESSING | 83 | 2.52e-01 | 7.27e-02 | 9.58e-01 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 26 | 5.21e-01 | 7.27e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 189 | 8.48e-02 | 7.27e-02 | 8.39e-01 |
| GOMF EPOXIDE HYDROLASE ACTIVITY | 6 | 7.58e-01 | 7.27e-02 | 9.98e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY | 5 | 7.79e-01 | 7.26e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 9 | 7.06e-01 | 7.26e-02 | 9.98e-01 |
| GOBP INNATE IMMUNE RESPONSE IN MUCOSA | 26 | 5.22e-01 | 7.26e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO KETONE | 96 | 2.19e-01 | 7.26e-02 | 9.43e-01 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 44 | 4.05e-01 | -7.25e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 48 | 3.85e-01 | -7.25e-02 | 9.95e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 7 | 7.40e-01 | -7.25e-02 | 9.98e-01 |
| GOMF THYROID HORMONE BINDING | 6 | 7.58e-01 | -7.25e-02 | 9.98e-01 |
| GOCC RSC TYPE COMPLEX | 15 | 6.27e-01 | 7.25e-02 | 9.98e-01 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 202 | 7.57e-02 | -7.25e-02 | 8.18e-01 |
| GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 7 | 7.40e-01 | -7.25e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 14 | 6.39e-01 | 7.24e-02 | 9.98e-01 |
| GOBP CHROMOSOME CONDENSATION | 46 | 3.96e-01 | 7.24e-02 | 9.95e-01 |
| GOBP LIPID GLYCOSYLATION | 12 | 6.64e-01 | 7.24e-02 | 9.98e-01 |
| GOCC INSULIN LIKE GROWTH FACTOR BINDING PROTEIN COMPLEX | 5 | 7.79e-01 | -7.24e-02 | 9.98e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING | 9 | 7.07e-01 | 7.24e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 75 | 2.79e-01 | -7.23e-02 | 9.73e-01 |
| GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 7.07e-01 | 7.23e-02 | 9.98e-01 |
| GOMF SPECTRIN BINDING | 26 | 5.23e-01 | -7.23e-02 | 9.95e-01 |
| GOBP EPITHELIAL FLUID TRANSPORT | 11 | 6.78e-01 | -7.23e-02 | 9.98e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 48 | 3.86e-01 | 7.23e-02 | 9.95e-01 |
| GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 7.59e-01 | 7.23e-02 | 9.98e-01 |
| GOBP FATTY ACID BETA OXIDATION | 74 | 2.83e-01 | 7.23e-02 | 9.73e-01 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 165 | 1.09e-01 | 7.23e-02 | 8.76e-01 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 105 | 2.01e-01 | 7.22e-02 | 9.36e-01 |
| GOBP NEURAL TUBE DEVELOPMENT | 160 | 1.15e-01 | 7.22e-02 | 8.81e-01 |
| GOBP URONIC ACID METABOLIC PROCESS | 23 | 5.49e-01 | 7.22e-02 | 9.95e-01 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 19 | 5.86e-01 | -7.22e-02 | 9.96e-01 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 31 | 4.87e-01 | -7.22e-02 | 9.95e-01 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 7.80e-01 | -7.22e-02 | 9.98e-01 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 177 | 9.79e-02 | 7.21e-02 | 8.61e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 128 | 1.59e-01 | -7.21e-02 | 9.06e-01 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 18 | 5.96e-01 | -7.21e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 7 | 7.41e-01 | 7.21e-02 | 9.98e-01 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 438 | 9.74e-03 | 7.20e-02 | 5.57e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 12 | 6.66e-01 | 7.20e-02 | 9.98e-01 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 274 | 4.03e-02 | -7.20e-02 | 7.56e-01 |
| GOMF ENONE REDUCTASE ACTIVITY | 5 | 7.81e-01 | -7.20e-02 | 9.98e-01 |
| GOBP SODIUM ION TRANSPORT | 235 | 5.75e-02 | -7.19e-02 | 7.90e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 42 | 4.20e-01 | -7.19e-02 | 9.95e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 10 | 6.94e-01 | 7.19e-02 | 9.98e-01 |
| GOBP LYMPHANGIOGENESIS | 18 | 5.98e-01 | 7.19e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 18 | 5.98e-01 | 7.19e-02 | 9.98e-01 |
| GOBP TYPE 2 IMMUNE RESPONSE | 41 | 4.26e-01 | 7.18e-02 | 9.95e-01 |
| GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 7 | 7.42e-01 | -7.18e-02 | 9.98e-01 |
| GOBP HINDBRAIN DEVELOPMENT | 148 | 1.32e-01 | 7.18e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 30 | 4.97e-01 | -7.17e-02 | 9.95e-01 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 13 | 6.54e-01 | 7.17e-02 | 9.98e-01 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 34 | 4.70e-01 | -7.17e-02 | 9.95e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 43 | 4.16e-01 | 7.16e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 51 | 3.76e-01 | 7.16e-02 | 9.95e-01 |
| GOMF MOLECULAR CARRIER ACTIVITY | 92 | 2.35e-01 | -7.16e-02 | 9.52e-01 |
| GOBP PRIMARY ALCOHOL CATABOLIC PROCESS | 13 | 6.55e-01 | 7.16e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MYELINATION | 17 | 6.09e-01 | 7.16e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DNA DEMETHYLATION | 8 | 7.26e-01 | -7.16e-02 | 9.98e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 18 | 5.99e-01 | -7.16e-02 | 9.98e-01 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 24 | 5.44e-01 | 7.16e-02 | 9.95e-01 |
| GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY | 6 | 7.61e-01 | -7.16e-02 | 9.98e-01 |
| GOCC CHROMOSOMAL REGION | 379 | 1.68e-02 | 7.16e-02 | 6.37e-01 |
| GOBP VACUOLE FUSION | 12 | 6.68e-01 | 7.15e-02 | 9.98e-01 |
| GOBP NADPH REGENERATION | 21 | 5.70e-01 | 7.15e-02 | 9.95e-01 |
| GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 7 | 7.43e-01 | -7.15e-02 | 9.98e-01 |
| GOCC PRESYNAPTIC CYTOSOL | 12 | 6.68e-01 | -7.15e-02 | 9.98e-01 |
| GOMF P TYPE POTASSIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.43e-01 | 7.15e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 68 | 3.08e-01 | 7.15e-02 | 9.87e-01 |
| GOBP METANEPHROS DEVELOPMENT | 91 | 2.39e-01 | 7.15e-02 | 9.55e-01 |
| GOCC VACUOLAR LUMEN | 167 | 1.11e-01 | 7.14e-02 | 8.77e-01 |
| GOBP MESENCHYME MIGRATION | 5 | 7.82e-01 | 7.14e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 13 | 6.56e-01 | 7.14e-02 | 9.98e-01 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 15 | 6.32e-01 | 7.14e-02 | 9.98e-01 |
| GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 6.32e-01 | 7.13e-02 | 9.98e-01 |
| GOBP REGULATION OF DNA LIGATION | 6 | 7.62e-01 | 7.13e-02 | 9.98e-01 |
| GOBP CENTROSOME SEPARATION | 15 | 6.32e-01 | -7.13e-02 | 9.98e-01 |
| GOBP DENDRITIC CELL MIGRATION | 32 | 4.85e-01 | -7.13e-02 | 9.95e-01 |
| GOMF CHOLESTEROL BINDING | 51 | 3.79e-01 | -7.13e-02 | 9.95e-01 |
| GOBP CHOLINE METABOLIC PROCESS | 6 | 7.62e-01 | -7.13e-02 | 9.98e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 17 | 6.11e-01 | -7.12e-02 | 9.98e-01 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 47 | 3.98e-01 | -7.12e-02 | 9.95e-01 |
| GOBP AMMONIUM TRANSMEMBRANE TRANSPORT | 12 | 6.69e-01 | 7.12e-02 | 9.98e-01 |
| GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 6.69e-01 | 7.12e-02 | 9.98e-01 |
| GOCC WNT SIGNALOSOME | 13 | 6.57e-01 | -7.12e-02 | 9.98e-01 |
| GOBP SOMITOGENESIS | 64 | 3.25e-01 | 7.12e-02 | 9.87e-01 |
| GOBP DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS | 6 | 7.63e-01 | -7.11e-02 | 9.98e-01 |
| GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 12 | 6.70e-01 | 7.11e-02 | 9.98e-01 |
| GOCC SEX CHROMATIN | 6 | 7.63e-01 | -7.11e-02 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 13 | 6.57e-01 | 7.11e-02 | 9.98e-01 |
| GOBP RESPONSE TO STEROL DEPLETION | 18 | 6.02e-01 | -7.10e-02 | 9.98e-01 |
| GOBP CEREBELLAR CORTEX FORMATION | 24 | 5.47e-01 | 7.10e-02 | 9.95e-01 |
| GOBP CLATHRIN COATED VESICLE CARGO LOADING | 7 | 7.45e-01 | -7.10e-02 | 9.98e-01 |
| GOBP TRIGEMINAL NERVE DEVELOPMENT | 10 | 6.97e-01 | 7.10e-02 | 9.98e-01 |
| GOCC ESCRT I COMPLEX | 11 | 6.84e-01 | 7.10e-02 | 9.98e-01 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 26 | 5.31e-01 | 7.10e-02 | 9.95e-01 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 29 | 5.09e-01 | 7.09e-02 | 9.95e-01 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 80 | 2.73e-01 | 7.09e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 29 | 5.09e-01 | -7.09e-02 | 9.95e-01 |
| GOBP STEM CELL DEVELOPMENT | 87 | 2.53e-01 | 7.08e-02 | 9.58e-01 |
| GOBP ALANINE TRANSPORT | 16 | 6.24e-01 | -7.08e-02 | 9.98e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 75 | 2.89e-01 | -7.08e-02 | 9.77e-01 |
| GOCC PML BODY | 104 | 2.12e-01 | 7.08e-02 | 9.40e-01 |
| GOBP RNA 3 END PROCESSING | 90 | 2.46e-01 | 7.08e-02 | 9.58e-01 |
| GOMF CARGO ADAPTOR ACTIVITY | 18 | 6.03e-01 | -7.07e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 14 | 6.47e-01 | 7.07e-02 | 9.98e-01 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 16 | 6.24e-01 | -7.07e-02 | 9.98e-01 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 286 | 3.97e-02 | 7.07e-02 | 7.54e-01 |
| GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 7.13e-01 | 7.07e-02 | 9.98e-01 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 25 | 5.41e-01 | 7.07e-02 | 9.95e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 72 | 3.01e-01 | 7.05e-02 | 9.86e-01 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 51 | 3.84e-01 | 7.05e-02 | 9.95e-01 |
| GOBP PEPTIDYL LYSINE MONOMETHYLATION | 9 | 7.14e-01 | -7.05e-02 | 9.98e-01 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 25 | 5.42e-01 | 7.04e-02 | 9.95e-01 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 21 | 5.76e-01 | -7.04e-02 | 9.96e-01 |
| GOBP DORSAL ROOT GANGLION DEVELOPMENT | 7 | 7.47e-01 | -7.04e-02 | 9.98e-01 |
| GOBP GLOMERULUS MORPHOGENESIS | 9 | 7.14e-01 | -7.04e-02 | 9.98e-01 |
| GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 7.30e-01 | 7.04e-02 | 9.98e-01 |
| GOBP RESPONSE TO VITAMIN E | 8 | 7.30e-01 | -7.04e-02 | 9.98e-01 |
| GOMF MHC CLASS I RECEPTOR ACTIVITY | 13 | 6.60e-01 | 7.04e-02 | 9.98e-01 |
| GOBP MIRNA PROCESSING | 45 | 4.14e-01 | -7.04e-02 | 9.95e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 26 | 5.35e-01 | -7.03e-02 | 9.95e-01 |
| GOMF KINASE REGULATOR ACTIVITY | 245 | 5.81e-02 | 7.03e-02 | 7.90e-01 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 210 | 7.93e-02 | 7.03e-02 | 8.30e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 10 | 7.00e-01 | -7.03e-02 | 9.98e-01 |
| GOBP ECTODERMAL CELL DIFFERENTIATION | 6 | 7.66e-01 | 7.02e-02 | 9.98e-01 |
| GOBP SEX DIFFERENTIATION | 266 | 4.87e-02 | 7.02e-02 | 7.71e-01 |
| GOBP ARACHIDONIC ACID SECRETION | 31 | 4.99e-01 | -7.02e-02 | 9.95e-01 |
| GOBP GLUCOSE CATABOLIC PROCESS | 25 | 5.44e-01 | 7.02e-02 | 9.95e-01 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 18 | 6.06e-01 | -7.02e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 43 | 4.26e-01 | -7.01e-02 | 9.95e-01 |
| GOBP RESPONSE TO ANTIBIOTIC | 36 | 4.67e-01 | -7.01e-02 | 9.95e-01 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 186 | 9.94e-02 | -7.01e-02 | 8.64e-01 |
| GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING | 9 | 7.16e-01 | -7.00e-02 | 9.98e-01 |
| GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 7 | 7.48e-01 | 7.00e-02 | 9.98e-01 |
| GOBP EMBRYONIC MORPHOGENESIS | 603 | 3.31e-03 | 7.00e-02 | 3.49e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 132 | 1.65e-01 | -7.00e-02 | 9.15e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 28 | 5.22e-01 | 7.00e-02 | 9.95e-01 |
| GOMF KINASE ACTIVATOR ACTIVITY | 126 | 1.75e-01 | 7.00e-02 | 9.21e-01 |
| GOCC NEURON PROJECTION MEMBRANE | 56 | 3.65e-01 | 6.99e-02 | 9.95e-01 |
| GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 7 | 7.49e-01 | -6.99e-02 | 9.98e-01 |
| GOCC INTEGRIN COMPLEX | 30 | 5.07e-01 | -6.99e-02 | 9.95e-01 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 28 | 5.22e-01 | 6.99e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 50 | 3.92e-01 | -6.99e-02 | 9.95e-01 |
| GOCC SPERM PLASMA MEMBRANE | 14 | 6.51e-01 | -6.98e-02 | 9.98e-01 |
| GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 21 | 5.80e-01 | -6.98e-02 | 9.96e-01 |
| GOCC RNA POLYMERASE II HOLOENZYME | 67 | 3.24e-01 | 6.97e-02 | 9.87e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 23 | 5.63e-01 | -6.97e-02 | 9.95e-01 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 27 | 5.31e-01 | 6.96e-02 | 9.95e-01 |
| GOCC SAGA TYPE COMPLEX | 35 | 4.76e-01 | 6.96e-02 | 9.95e-01 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 30 | 5.10e-01 | -6.96e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 133 | 1.66e-01 | -6.96e-02 | 9.15e-01 |
| GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 7 | 7.50e-01 | -6.95e-02 | 9.98e-01 |
| GOCC PERIKARYON | 142 | 1.53e-01 | -6.95e-02 | 9.04e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 7 | 7.50e-01 | 6.95e-02 | 9.98e-01 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 14 | 6.53e-01 | 6.95e-02 | 9.98e-01 |
| GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 8 | 7.34e-01 | -6.94e-02 | 9.98e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 12 | 6.77e-01 | 6.94e-02 | 9.98e-01 |
| GOCC 9PLUS2 MOTILE CILIUM | 166 | 1.23e-01 | -6.94e-02 | 8.88e-01 |
| GOMF PEPTIDE ANTIGEN BINDING | 35 | 4.78e-01 | -6.93e-02 | 9.95e-01 |
| GOBP REGULATION OF RESPONSE TO FOOD | 14 | 6.53e-01 | 6.93e-02 | 9.98e-01 |
| GOBP SECONDARY METABOLIC PROCESS | 54 | 3.78e-01 | 6.93e-02 | 9.95e-01 |
| GOBP SERTOLI CELL PROLIFERATION | 5 | 7.88e-01 | 6.93e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 35 | 4.78e-01 | 6.93e-02 | 9.95e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 61 | 3.49e-01 | 6.93e-02 | 9.94e-01 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 17 | 6.21e-01 | -6.93e-02 | 9.98e-01 |
| GOBP L SERINE TRANSPORT | 7 | 7.51e-01 | 6.93e-02 | 9.98e-01 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.51e-01 | 6.93e-02 | 9.98e-01 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 67 | 3.27e-01 | -6.92e-02 | 9.87e-01 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 93 | 2.49e-01 | -6.92e-02 | 9.58e-01 |
| GOMF G PROTEIN COUPLED NEUROTRANSMITTER RECEPTOR ACTIVITY | 11 | 6.91e-01 | 6.91e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 14 | 6.54e-01 | -6.91e-02 | 9.98e-01 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 15 | 6.43e-01 | 6.91e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 23 | 5.66e-01 | 6.91e-02 | 9.95e-01 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 15 | 6.43e-01 | 6.91e-02 | 9.98e-01 |
| GOMF PROTEIN KINASE C BINDING | 50 | 3.98e-01 | -6.90e-02 | 9.95e-01 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 43 | 4.34e-01 | 6.90e-02 | 9.95e-01 |
| GOBP SELECTIVE AUTOPHAGY | 92 | 2.53e-01 | 6.90e-02 | 9.58e-01 |
| GOCC OMEGASOME | 5 | 7.89e-01 | -6.90e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL | 5 | 7.89e-01 | 6.90e-02 | 9.98e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 18 | 6.12e-01 | 6.90e-02 | 9.98e-01 |
| GOBP COLLAGEN METABOLIC PROCESS | 103 | 2.27e-01 | -6.89e-02 | 9.50e-01 |
| GOMF ACTININ BINDING | 35 | 4.80e-01 | -6.89e-02 | 9.95e-01 |
| GOCC MRNA EDITING COMPLEX | 15 | 6.44e-01 | 6.89e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 13 | 6.67e-01 | -6.89e-02 | 9.98e-01 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 5.00e-01 | -6.89e-02 | 9.95e-01 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 24 | 5.59e-01 | 6.89e-02 | 9.95e-01 |
| GOBP ACTIN FILAMENT BASED PROCESS | 771 | 1.15e-03 | -6.88e-02 | 2.03e-01 |
| GOBP MYELIN MAINTENANCE | 17 | 6.23e-01 | 6.88e-02 | 9.98e-01 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 6.93e-01 | 6.88e-02 | 9.98e-01 |
| GOMF CHROMATIN BINDING | 551 | 5.75e-03 | 6.88e-02 | 4.52e-01 |
| GOBP INTRACELLULAR WATER HOMEOSTASIS | 6 | 7.71e-01 | -6.87e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL FISSION | 40 | 4.52e-01 | 6.87e-02 | 9.95e-01 |
| GOMF HORMONE BINDING | 83 | 2.79e-01 | -6.87e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS | 7 | 7.53e-01 | 6.86e-02 | 9.98e-01 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 25 | 5.53e-01 | -6.86e-02 | 9.95e-01 |
| GOCC NADPH OXIDASE COMPLEX | 13 | 6.68e-01 | 6.86e-02 | 9.98e-01 |
| GOCC NUCLEAR SPECK | 395 | 1.93e-02 | 6.86e-02 | 6.41e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 11 | 6.94e-01 | 6.85e-02 | 9.98e-01 |
| GOCC SPECIFIC GRANULE | 155 | 1.41e-01 | 6.85e-02 | 9.02e-01 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 91 | 2.59e-01 | 6.85e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 59 | 3.63e-01 | -6.85e-02 | 9.95e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 7 | 7.54e-01 | -6.84e-02 | 9.98e-01 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 27 | 5.38e-01 | -6.84e-02 | 9.95e-01 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 21 | 5.87e-01 | 6.84e-02 | 9.97e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 36 | 4.78e-01 | -6.84e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 11 | 6.95e-01 | 6.84e-02 | 9.98e-01 |
| GOBP PROTEIN KINASE C SIGNALING | 35 | 4.84e-01 | 6.84e-02 | 9.95e-01 |
| GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 7.38e-01 | -6.83e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 45 | 4.28e-01 | 6.83e-02 | 9.95e-01 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 98 | 2.43e-01 | 6.83e-02 | 9.58e-01 |
| GOBP LEUKOTRIENE CATABOLIC PROCESS | 6 | 7.72e-01 | 6.83e-02 | 9.98e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 30 | 5.18e-01 | -6.83e-02 | 9.95e-01 |
| GOBP MRNA PROCESSING | 449 | 1.32e-02 | 6.82e-02 | 6.15e-01 |
| GOBP METANEPHRIC PROXIMAL TUBULE DEVELOPMENT | 5 | 7.92e-01 | 6.82e-02 | 9.98e-01 |
| GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 10 | 7.09e-01 | 6.82e-02 | 9.98e-01 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 127 | 1.85e-01 | 6.81e-02 | 9.28e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 18 | 6.17e-01 | -6.81e-02 | 9.98e-01 |
| GOCC CILIARY ROOTLET | 15 | 6.48e-01 | 6.80e-02 | 9.98e-01 |
| GOCC G PROTEIN COUPLED RECEPTOR COMPLEX | 11 | 6.96e-01 | -6.80e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 351 | 2.86e-02 | 6.80e-02 | 6.86e-01 |
| GOMF SULFUR COMPOUND BINDING | 263 | 5.77e-02 | -6.80e-02 | 7.90e-01 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 87 | 2.73e-01 | -6.80e-02 | 9.73e-01 |
| GOBP REGULATION OF EOSINOPHIL MIGRATION | 6 | 7.73e-01 | 6.79e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 31 | 5.13e-01 | -6.79e-02 | 9.95e-01 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 140 | 1.66e-01 | 6.79e-02 | 9.15e-01 |
| GOBP ADENOSINE METABOLIC PROCESS | 10 | 7.10e-01 | 6.79e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 72 | 3.19e-01 | 6.79e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 18 | 6.18e-01 | 6.79e-02 | 9.98e-01 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 7 | 7.56e-01 | -6.78e-02 | 9.98e-01 |
| GOBP L ALANINE TRANSPORT | 10 | 7.10e-01 | -6.78e-02 | 9.98e-01 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 23 | 5.74e-01 | 6.78e-02 | 9.95e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 24 | 5.66e-01 | 6.78e-02 | 9.95e-01 |
| GOBP REGULATION OF HISTONE MODIFICATION | 36 | 4.82e-01 | 6.77e-02 | 9.95e-01 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 89 | 2.69e-01 | 6.77e-02 | 9.71e-01 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 30 | 5.21e-01 | 6.77e-02 | 9.95e-01 |
| GOBP REGULATION OF NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 5 | 7.93e-01 | 6.77e-02 | 9.98e-01 |
| GOBP REGULATION OF GASTRULATION | 16 | 6.39e-01 | 6.77e-02 | 9.98e-01 |
| GOMF SEROTONIN RECEPTOR ACTIVITY | 26 | 5.50e-01 | 6.77e-02 | 9.95e-01 |
| GOCC CCR4 NOT CORE COMPLEX | 6 | 7.74e-01 | 6.77e-02 | 9.98e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 7 | 7.57e-01 | -6.77e-02 | 9.98e-01 |
| GOBP REGULATION OF CHLORIDE TRANSPORT | 6 | 7.74e-01 | 6.77e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 14 | 6.61e-01 | -6.76e-02 | 9.98e-01 |
| GOBP GRANULOCYTE ACTIVATION | 48 | 4.18e-01 | 6.76e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 43 | 4.43e-01 | -6.76e-02 | 9.95e-01 |
| GOBP DISRUPTION OF CELLULAR ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 10 | 7.11e-01 | -6.76e-02 | 9.98e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 30 | 5.22e-01 | 6.76e-02 | 9.95e-01 |
| GOBP MAINTENANCE OF CELL NUMBER | 179 | 1.19e-01 | 6.76e-02 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 15 | 6.51e-01 | 6.75e-02 | 9.98e-01 |
| GOBP DIOL METABOLIC PROCESS | 30 | 5.22e-01 | -6.75e-02 | 9.95e-01 |
| GOBP ORGANELLE LOCALIZATION | 588 | 5.14e-03 | 6.75e-02 | 4.33e-01 |
| GOBP THYMIC T CELL SELECTION | 23 | 5.75e-01 | 6.75e-02 | 9.96e-01 |
| GOBP RESPONSE TO HYDROPEROXIDE | 18 | 6.20e-01 | 6.75e-02 | 9.98e-01 |
| GOBP METHIONINE BIOSYNTHETIC PROCESS | 12 | 6.86e-01 | 6.74e-02 | 9.98e-01 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 12 | 6.86e-01 | -6.74e-02 | 9.98e-01 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 36 | 4.84e-01 | 6.74e-02 | 9.95e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 15 | 6.51e-01 | 6.74e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS | 8 | 7.41e-01 | -6.74e-02 | 9.98e-01 |
| GOBP INTERLEUKIN 4 PRODUCTION | 32 | 5.10e-01 | 6.74e-02 | 9.95e-01 |
| GOBP BONE REMODELING | 89 | 2.72e-01 | 6.73e-02 | 9.73e-01 |
| GOBP RESPONSE TO NICOTINE | 49 | 4.15e-01 | 6.73e-02 | 9.95e-01 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 14 | 6.63e-01 | -6.73e-02 | 9.98e-01 |
| GOBP VITAMIN METABOLIC PROCESS | 107 | 2.29e-01 | 6.72e-02 | 9.50e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 18 | 6.22e-01 | 6.72e-02 | 9.98e-01 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 31 | 5.17e-01 | 6.72e-02 | 9.95e-01 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 211 | 9.25e-02 | 6.72e-02 | 8.55e-01 |
| GOBP DETERMINATION OF DIGESTIVE TRACT LEFT RIGHT ASYMMETRY | 6 | 7.76e-01 | -6.71e-02 | 9.98e-01 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 38 | 4.74e-01 | -6.71e-02 | 9.95e-01 |
| GOMF DOUBLE STRANDED RNA ADENOSINE DEAMINASE ACTIVITY | 6 | 7.76e-01 | 6.71e-02 | 9.98e-01 |
| GOBP THALAMUS DEVELOPMENT | 11 | 7.00e-01 | 6.71e-02 | 9.98e-01 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 20 | 6.04e-01 | -6.71e-02 | 9.98e-01 |
| GOBP STABILIZATION OF MEMBRANE POTENTIAL | 17 | 6.32e-01 | -6.70e-02 | 9.98e-01 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 72 | 3.25e-01 | -6.70e-02 | 9.87e-01 |
| GOMF LIPID KINASE ACTIVITY | 40 | 4.63e-01 | 6.70e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 49 | 4.17e-01 | 6.70e-02 | 9.95e-01 |
| GOBP CHOLINE TRANSPORT | 9 | 7.28e-01 | -6.69e-02 | 9.98e-01 |
| GOBP DNA DEAMINATION | 13 | 6.76e-01 | 6.69e-02 | 9.98e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY | 12 | 6.88e-01 | 6.69e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF COLLATERAL SPROUTING | 10 | 7.14e-01 | 6.69e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 36 | 4.87e-01 | -6.69e-02 | 9.95e-01 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 14 | 6.65e-01 | 6.69e-02 | 9.98e-01 |
| GOBP ARGININE METABOLIC PROCESS | 19 | 6.14e-01 | 6.68e-02 | 9.98e-01 |
| GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 7 | 7.60e-01 | -6.68e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 24 | 5.71e-01 | 6.68e-02 | 9.95e-01 |
| GOBP DEVELOPMENTAL INDUCTION | 33 | 5.07e-01 | 6.67e-02 | 9.95e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 5 | 7.96e-01 | 6.67e-02 | 9.98e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 11 | 7.02e-01 | 6.67e-02 | 9.98e-01 |
| GOMF ALPHA TUBULIN BINDING | 37 | 4.82e-01 | 6.67e-02 | 9.95e-01 |
| GOBP SCHWANN CELL PROLIFERATION | 9 | 7.29e-01 | 6.67e-02 | 9.98e-01 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 9 | 7.29e-01 | -6.67e-02 | 9.98e-01 |
| GOBP LIVER MORPHOGENESIS | 25 | 5.64e-01 | 6.67e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1805 | 2.60e-06 | 6.67e-02 | 2.66e-03 |
| GOBP B CELL APOPTOTIC PROCESS | 26 | 5.56e-01 | 6.66e-02 | 9.95e-01 |
| GOCC SARCOPLASMIC RETICULUM | 72 | 3.28e-01 | -6.66e-02 | 9.87e-01 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 102 | 2.45e-01 | 6.66e-02 | 9.58e-01 |
| GOCC ANKYRIN 1 COMPLEX | 7 | 7.60e-01 | 6.66e-02 | 9.98e-01 |
| GOBP MEIOTIC CELL CYCLE PHASE TRANSITION | 13 | 6.78e-01 | -6.66e-02 | 9.98e-01 |
| GOBP COMMA SHAPED BODY MORPHOGENESIS | 5 | 7.97e-01 | 6.65e-02 | 9.98e-01 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 95 | 2.62e-01 | 6.65e-02 | 9.64e-01 |
| GOBP MEMORY | 120 | 2.08e-01 | -6.65e-02 | 9.38e-01 |
| GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 14 | 6.67e-01 | -6.65e-02 | 9.98e-01 |
| GOBP LIPOPHAGY | 7 | 7.61e-01 | 6.65e-02 | 9.98e-01 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 33 | 5.09e-01 | 6.65e-02 | 9.95e-01 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 13 | 6.78e-01 | 6.64e-02 | 9.98e-01 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 17 | 6.35e-01 | -6.64e-02 | 9.98e-01 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 29 | 5.36e-01 | 6.64e-02 | 9.95e-01 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 31 | 5.22e-01 | 6.64e-02 | 9.95e-01 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 161 | 1.46e-01 | -6.64e-02 | 9.02e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 13 | 6.79e-01 | 6.64e-02 | 9.98e-01 |
| GOBP KERATINOCYTE PROLIFERATION | 58 | 3.82e-01 | -6.64e-02 | 9.95e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 32 | 5.16e-01 | -6.63e-02 | 9.95e-01 |
| GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 21 | 5.99e-01 | -6.63e-02 | 9.98e-01 |
| GOBP HINDBRAIN TANGENTIAL CELL MIGRATION | 5 | 7.97e-01 | -6.63e-02 | 9.98e-01 |
| GOBP CELL ADHESION INVOLVED IN HEART MORPHOGENESIS | 6 | 7.79e-01 | 6.63e-02 | 9.98e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 14 | 6.68e-01 | -6.63e-02 | 9.98e-01 |
| GOBP OLIGODENDROCYTE PROGENITOR PROLIFERATION | 8 | 7.46e-01 | -6.63e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 13 | 6.79e-01 | 6.63e-02 | 9.98e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 54 | 4.00e-01 | 6.62e-02 | 9.95e-01 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 121 | 2.08e-01 | -6.62e-02 | 9.38e-01 |
| GOBP ASYMMETRIC CELL DIVISION | 18 | 6.27e-01 | -6.62e-02 | 9.98e-01 |
| GOBP FIBROBLAST PROLIFERATION | 104 | 2.43e-01 | 6.62e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 460 | 1.49e-02 | 6.62e-02 | 6.25e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 84 | 2.94e-01 | 6.62e-02 | 9.80e-01 |
| GOBP EAR DEVELOPMENT | 217 | 9.30e-02 | 6.62e-02 | 8.55e-01 |
| GOBP DETECTION OF CALCIUM ION | 13 | 6.80e-01 | -6.61e-02 | 9.98e-01 |
| GOBP MEMBRANE BIOGENESIS | 59 | 3.80e-01 | 6.61e-02 | 9.95e-01 |
| GOBP HAIR CELL DIFFERENTIATION | 52 | 4.10e-01 | -6.60e-02 | 9.95e-01 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 13 | 6.80e-01 | -6.60e-02 | 9.98e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 57 | 3.89e-01 | 6.60e-02 | 9.95e-01 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 90 | 2.79e-01 | 6.60e-02 | 9.73e-01 |
| GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 9 | 7.32e-01 | 6.60e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 16 | 6.48e-01 | 6.60e-02 | 9.98e-01 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 36 | 4.94e-01 | 6.59e-02 | 9.95e-01 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 223 | 8.98e-02 | 6.59e-02 | 8.51e-01 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 11 | 7.05e-01 | -6.59e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 9 | 7.32e-01 | 6.59e-02 | 9.98e-01 |
| GOBP PEPTIDYL SERINE MODIFICATION | 290 | 5.37e-02 | 6.58e-02 | 7.87e-01 |
| GOBP FERMENTATION | 5 | 7.99e-01 | -6.58e-02 | 9.98e-01 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 271 | 6.23e-02 | 6.58e-02 | 7.98e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION | 6 | 7.80e-01 | 6.57e-02 | 9.98e-01 |
| GOBP TRANSPORT ALONG MICROTUBULE | 164 | 1.46e-01 | 6.57e-02 | 9.03e-01 |
| GOMF MONOSACCHARIDE BINDING | 73 | 3.32e-01 | -6.57e-02 | 9.88e-01 |
| GOBP RNA GUANINE N7 METHYLATION | 6 | 7.81e-01 | -6.57e-02 | 9.98e-01 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 249 | 7.43e-02 | 6.57e-02 | 8.13e-01 |
| GOBP RESPONSE TO LIGHT INTENSITY | 16 | 6.49e-01 | -6.57e-02 | 9.98e-01 |
| GOCC NUCLEAR INCLUSION BODY | 12 | 6.94e-01 | 6.56e-02 | 9.98e-01 |
| GOMF COLLAGEN BINDING INVOLVED IN CELL MATRIX ADHESION | 5 | 7.99e-01 | 6.56e-02 | 9.98e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 169 | 1.41e-01 | 6.56e-02 | 9.02e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 37 | 4.90e-01 | -6.56e-02 | 9.95e-01 |
| GOBP REGULATION OF GLOMERULAR FILTRATION | 8 | 7.48e-01 | 6.55e-02 | 9.98e-01 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 14 | 6.71e-01 | 6.55e-02 | 9.98e-01 |
| GOCC BRCA1 A COMPLEX | 7 | 7.64e-01 | 6.55e-02 | 9.98e-01 |
| GOBP CILIUM DISASSEMBLY | 5 | 8.00e-01 | 6.55e-02 | 9.98e-01 |
| GOCC EXORIBONUCLEASE COMPLEX | 18 | 6.30e-01 | 6.55e-02 | 9.98e-01 |
| GOBP PHAGOCYTOSIS | 228 | 8.83e-02 | 6.55e-02 | 8.47e-01 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 18 | 6.30e-01 | -6.55e-02 | 9.98e-01 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 15 | 6.61e-01 | -6.55e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 10 | 7.20e-01 | -6.55e-02 | 9.98e-01 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 32 | 5.22e-01 | 6.54e-02 | 9.95e-01 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 16 | 6.51e-01 | 6.54e-02 | 9.98e-01 |
| GOMF PHOSPHATIDIC ACID BINDING | 23 | 5.87e-01 | 6.54e-02 | 9.97e-01 |
| GOBP ERBB2 ERBB4 SIGNALING PATHWAY | 5 | 8.00e-01 | -6.54e-02 | 9.98e-01 |
| GOMF DYNEIN LIGHT CHAIN BINDING | 9 | 7.34e-01 | -6.54e-02 | 9.98e-01 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 286 | 5.74e-02 | 6.53e-02 | 7.90e-01 |
| GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 8 | 7.49e-01 | 6.53e-02 | 9.98e-01 |
| GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 22 | 5.96e-01 | 6.53e-02 | 9.98e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 26 | 5.65e-01 | 6.53e-02 | 9.95e-01 |
| GOBP MESONEPHRIC DUCT DEVELOPMENT | 8 | 7.49e-01 | 6.53e-02 | 9.98e-01 |
| GOCC CLATHRIN COAT OF COATED PIT | 17 | 6.41e-01 | -6.52e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 41 | 4.70e-01 | 6.52e-02 | 9.95e-01 |
| GOBP T CELL TOLERANCE INDUCTION | 14 | 6.73e-01 | 6.52e-02 | 9.98e-01 |
| GOBP REGULATION OF NK T CELL PROLIFERATION | 7 | 7.65e-01 | 6.52e-02 | 9.98e-01 |
| GOBP INTERLEUKIN 12 PRODUCTION | 62 | 3.75e-01 | 6.51e-02 | 9.95e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 24 | 5.81e-01 | 6.51e-02 | 9.96e-01 |
| GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 7.21e-01 | 6.51e-02 | 9.98e-01 |
| GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 12 | 6.96e-01 | -6.51e-02 | 9.98e-01 |
| GOBP REGULATION OF B CELL ACTIVATION | 123 | 2.13e-01 | 6.50e-02 | 9.40e-01 |
| GOMF MISMATCHED DNA BINDING | 14 | 6.74e-01 | 6.50e-02 | 9.98e-01 |
| GOMF PHOSPHATASE BINDING | 184 | 1.28e-01 | 6.50e-02 | 8.91e-01 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 11 | 7.09e-01 | 6.50e-02 | 9.98e-01 |
| GOBP EXOCYTIC PROCESS | 82 | 3.09e-01 | -6.50e-02 | 9.87e-01 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 70 | 3.48e-01 | -6.49e-02 | 9.93e-01 |
| GOBP MATURATION OF 5 8S RRNA | 35 | 5.06e-01 | 6.49e-02 | 9.95e-01 |
| GOBP RESPONSE TO FORSKOLIN | 14 | 6.74e-01 | 6.49e-02 | 9.98e-01 |
| GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT | 21 | 6.07e-01 | -6.49e-02 | 9.98e-01 |
| GOBP COLLATERAL SPROUTING | 26 | 5.67e-01 | -6.48e-02 | 9.95e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 13 | 6.86e-01 | 6.48e-02 | 9.98e-01 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 34 | 5.13e-01 | -6.48e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 7 | 7.67e-01 | 6.48e-02 | 9.98e-01 |
| GOBP OSSIFICATION | 424 | 2.22e-02 | 6.47e-02 | 6.41e-01 |
| GOBP SYNAPTIC VESICLE PRIMING | 18 | 6.35e-01 | 6.47e-02 | 9.98e-01 |
| GOCC HOPS COMPLEX | 9 | 7.37e-01 | 6.47e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 192 | 1.22e-01 | 6.47e-02 | 8.86e-01 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 295 | 5.60e-02 | -6.47e-02 | 7.90e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 10 | 7.23e-01 | -6.47e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 12 | 6.98e-01 | 6.46e-02 | 9.98e-01 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 55 | 4.07e-01 | 6.46e-02 | 9.95e-01 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 14 | 6.76e-01 | 6.46e-02 | 9.98e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 36 | 5.02e-01 | 6.46e-02 | 9.95e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 9 | 7.37e-01 | 6.46e-02 | 9.98e-01 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 9 | 7.37e-01 | -6.46e-02 | 9.98e-01 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 99 | 2.67e-01 | 6.46e-02 | 9.68e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 232 | 9.07e-02 | 6.45e-02 | 8.53e-01 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 7.24e-01 | 6.45e-02 | 9.98e-01 |
| GOBP PRESYNAPTIC ACTIVE ZONE ORGANIZATION | 8 | 7.53e-01 | -6.44e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 8.03e-01 | -6.43e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 100 | 2.66e-01 | 6.43e-02 | 9.67e-01 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 254 | 7.76e-02 | 6.43e-02 | 8.25e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 49 | 4.37e-01 | 6.42e-02 | 9.95e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 13 | 6.88e-01 | 6.42e-02 | 9.98e-01 |
| GOMF DEACETYLASE ACTIVITY | 36 | 5.05e-01 | 6.42e-02 | 9.95e-01 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 257 | 7.66e-02 | -6.41e-02 | 8.23e-01 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 21 | 6.11e-01 | 6.41e-02 | 9.98e-01 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 86 | 3.04e-01 | -6.41e-02 | 9.87e-01 |
| GOMF 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE BINDING | 9 | 7.39e-01 | -6.41e-02 | 9.98e-01 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 78 | 3.28e-01 | -6.41e-02 | 9.87e-01 |
| GOBP ENDODERM FORMATION | 57 | 4.03e-01 | -6.41e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 9 | 7.39e-01 | -6.40e-02 | 9.98e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 46 | 4.53e-01 | 6.40e-02 | 9.95e-01 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 148 | 1.79e-01 | -6.40e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 68 | 3.62e-01 | 6.40e-02 | 9.95e-01 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 180 | 1.39e-01 | 6.39e-02 | 9.02e-01 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 14 | 6.79e-01 | 6.39e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 313 | 5.19e-02 | 6.39e-02 | 7.81e-01 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 20 | 6.21e-01 | 6.39e-02 | 9.98e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 15 | 6.68e-01 | 6.39e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 22 | 6.04e-01 | 6.39e-02 | 9.98e-01 |
| GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 16 | 6.58e-01 | 6.38e-02 | 9.98e-01 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 13 | 6.90e-01 | -6.38e-02 | 9.98e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 28 | 5.59e-01 | 6.38e-02 | 9.95e-01 |
| GOCC TUBULAR ENDOSOME | 5 | 8.05e-01 | -6.38e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 15 | 6.69e-01 | -6.38e-02 | 9.98e-01 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 19 | 6.30e-01 | 6.38e-02 | 9.98e-01 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 30 | 5.46e-01 | 6.37e-02 | 9.95e-01 |
| GOBP CHONDROCYTE PROLIFERATION | 24 | 5.89e-01 | 6.37e-02 | 9.97e-01 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 34 | 5.20e-01 | 6.37e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO GLUCAGON STIMULUS | 11 | 7.14e-01 | 6.37e-02 | 9.98e-01 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 403 | 2.82e-02 | 6.37e-02 | 6.86e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 6 | 7.87e-01 | -6.37e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 15 | 6.69e-01 | 6.37e-02 | 9.98e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 84 | 3.13e-01 | 6.37e-02 | 9.87e-01 |
| GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 8 | 7.55e-01 | 6.36e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 49 | 4.41e-01 | 6.36e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 166 | 1.57e-01 | -6.36e-02 | 9.06e-01 |
| GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY | 50 | 4.37e-01 | 6.36e-02 | 9.95e-01 |
| GOMF NADP BINDING | 50 | 4.37e-01 | 6.36e-02 | 9.95e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 36 | 5.10e-01 | -6.35e-02 | 9.95e-01 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 15 | 6.70e-01 | -6.35e-02 | 9.98e-01 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 14 | 6.81e-01 | -6.35e-02 | 9.98e-01 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 15 | 6.70e-01 | 6.35e-02 | 9.98e-01 |
| GOBP VASCULOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS | 5 | 8.06e-01 | 6.35e-02 | 9.98e-01 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 52 | 4.29e-01 | -6.34e-02 | 9.95e-01 |
| GOMF 3 5 RNA HELICASE ACTIVITY | 6 | 7.88e-01 | 6.34e-02 | 9.98e-01 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 67 | 3.70e-01 | 6.33e-02 | 9.95e-01 |
| GOBP REGULATION OF FAS SIGNALING PATHWAY | 6 | 7.88e-01 | -6.33e-02 | 9.98e-01 |
| GOMF GLUCOSIDASE ACTIVITY | 13 | 6.93e-01 | -6.33e-02 | 9.98e-01 |
| GOBP MACROAUTOPHAGY | 317 | 5.26e-02 | 6.33e-02 | 7.82e-01 |
| GOBP RESPONSE TO INACTIVITY | 12 | 7.04e-01 | 6.33e-02 | 9.98e-01 |
| GOBP MACROPHAGE PROLIFERATION | 12 | 7.04e-01 | 6.33e-02 | 9.98e-01 |
| GOBP REGULATION OF CELL DIVISION | 176 | 1.48e-01 | 6.33e-02 | 9.04e-01 |
| GOBP MRNA PSEUDOURIDINE SYNTHESIS | 8 | 7.57e-01 | 6.32e-02 | 9.98e-01 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 23 | 6.00e-01 | -6.32e-02 | 9.98e-01 |
| GOBP RESPONSE TO AXON INJURY | 79 | 3.31e-01 | -6.32e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 39 | 4.95e-01 | -6.32e-02 | 9.95e-01 |
| GOBP MICROTUBULE NUCLEATION | 43 | 4.74e-01 | 6.32e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 6 | 7.89e-01 | -6.31e-02 | 9.98e-01 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 12 | 7.05e-01 | -6.31e-02 | 9.98e-01 |
| GOBP NEURON MATURATION | 47 | 4.54e-01 | -6.31e-02 | 9.95e-01 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1135 | 3.36e-04 | 6.31e-02 | 1.11e-01 |
| GOCC TRAPPIII PROTEIN COMPLEX | 11 | 7.17e-01 | 6.31e-02 | 9.98e-01 |
| GOCC INTEGRATOR COMPLEX | 16 | 6.62e-01 | -6.31e-02 | 9.98e-01 |
| GOCC NBAF COMPLEX | 16 | 6.62e-01 | 6.31e-02 | 9.98e-01 |
| GOBP REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT | 8 | 7.57e-01 | 6.31e-02 | 9.98e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 30 | 5.50e-01 | -6.31e-02 | 9.95e-01 |
| GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS | 8 | 7.58e-01 | -6.30e-02 | 9.98e-01 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 57 | 4.10e-01 | -6.30e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 12 | 7.05e-01 | -6.30e-02 | 9.98e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 5 | 8.07e-01 | -6.30e-02 | 9.98e-01 |
| GOBP NOREPINEPHRINE BIOSYNTHETIC PROCESS | 8 | 7.58e-01 | -6.30e-02 | 9.98e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 27 | 5.71e-01 | -6.30e-02 | 9.95e-01 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 63 | 3.87e-01 | 6.30e-02 | 9.95e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 30 | 5.51e-01 | -6.30e-02 | 9.95e-01 |
| GOBP SELF PROTEOLYSIS | 12 | 7.06e-01 | 6.30e-02 | 9.98e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 49 | 4.46e-01 | -6.29e-02 | 9.95e-01 |
| GOBP TELOMERASE RNA LOCALIZATION | 18 | 6.44e-01 | 6.29e-02 | 9.98e-01 |
| GOBP ADAPTIVE THERMOGENESIS | 165 | 1.63e-01 | 6.29e-02 | 9.12e-01 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 11 | 7.18e-01 | 6.29e-02 | 9.98e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 6 | 7.90e-01 | 6.29e-02 | 9.98e-01 |
| GOBP REGULATION OF GLUCOSE IMPORT | 58 | 4.07e-01 | -6.29e-02 | 9.95e-01 |
| GOBP PHENOL CONTAINING COMPOUND CATABOLIC PROCESS | 7 | 7.74e-01 | -6.28e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 71 | 3.60e-01 | 6.28e-02 | 9.95e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 10 | 7.31e-01 | 6.28e-02 | 9.98e-01 |
| GOBP CELL CELL RECOGNITION | 72 | 3.57e-01 | -6.28e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 14 | 6.84e-01 | 6.28e-02 | 9.98e-01 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 57 | 4.13e-01 | -6.27e-02 | 9.95e-01 |
| GOBP DORSAL AORTA DEVELOPMENT | 10 | 7.31e-01 | 6.27e-02 | 9.98e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 168 | 1.61e-01 | -6.27e-02 | 9.08e-01 |
| GOBP PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN | 16 | 6.64e-01 | 6.26e-02 | 9.98e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 94 | 2.94e-01 | 6.26e-02 | 9.80e-01 |
| GOMF PROTEIN KINASE C ACTIVITY | 16 | 6.65e-01 | 6.25e-02 | 9.98e-01 |
| GOMF PROTEIN PHOSPHATASE BINDING | 139 | 2.03e-01 | 6.25e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION | 6 | 7.91e-01 | -6.25e-02 | 9.98e-01 |
| GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE | 13 | 6.96e-01 | 6.25e-02 | 9.98e-01 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 18 | 6.46e-01 | -6.25e-02 | 9.98e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 158 | 1.75e-01 | 6.25e-02 | 9.21e-01 |
| GOBP LEFT RIGHT AXIS SPECIFICATION | 13 | 6.97e-01 | -6.24e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 6 | 7.91e-01 | -6.24e-02 | 9.98e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 8 | 7.60e-01 | -6.24e-02 | 9.98e-01 |
| GOMF OPSONIN RECEPTOR ACTIVITY | 5 | 8.09e-01 | 6.24e-02 | 9.98e-01 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 454 | 2.26e-02 | 6.24e-02 | 6.41e-01 |
| GOBP NEGATIVE REGULATION OF CHROMATIN ORGANIZATION | 5 | 8.09e-01 | 6.24e-02 | 9.98e-01 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 19 | 6.38e-01 | -6.24e-02 | 9.98e-01 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 92 | 3.01e-01 | 6.24e-02 | 9.87e-01 |
| GOBP MYOTUBE DIFFERENTIATION | 127 | 2.25e-01 | 6.23e-02 | 9.49e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 29 | 5.61e-01 | 6.23e-02 | 9.95e-01 |
| GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE | 9 | 7.46e-01 | 6.23e-02 | 9.98e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 27 | 5.75e-01 | 6.23e-02 | 9.96e-01 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 52 | 4.37e-01 | -6.23e-02 | 9.95e-01 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 16 | 6.66e-01 | -6.22e-02 | 9.98e-01 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 20 | 6.30e-01 | 6.22e-02 | 9.98e-01 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 33 | 5.36e-01 | 6.22e-02 | 9.95e-01 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 129 | 2.22e-01 | 6.22e-02 | 9.45e-01 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 69 | 3.72e-01 | -6.22e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 118 | 2.43e-01 | 6.22e-02 | 9.58e-01 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 17 | 6.57e-01 | 6.22e-02 | 9.98e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 65 | 3.86e-01 | 6.21e-02 | 9.95e-01 |
| GOCC TRANSLATION PREINITIATION COMPLEX | 18 | 6.48e-01 | 6.21e-02 | 9.98e-01 |
| GOBP EPITHELIAL TUBE FORMATION | 136 | 2.11e-01 | 6.21e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 10 | 7.34e-01 | 6.21e-02 | 9.98e-01 |
| GOMF DNA DEMETHYLASE ACTIVITY | 5 | 8.10e-01 | 6.21e-02 | 9.98e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 112 | 2.57e-01 | 6.21e-02 | 9.58e-01 |
| GOBP PARACRINE SIGNALING | 6 | 7.92e-01 | 6.20e-02 | 9.98e-01 |
| GOBP FATTY ACID METABOLIC PROCESS | 384 | 3.70e-02 | 6.20e-02 | 7.37e-01 |
| GOBP GLYOXYLATE METABOLIC PROCESS | 8 | 7.61e-01 | -6.20e-02 | 9.98e-01 |
| GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY | 26 | 5.84e-01 | -6.20e-02 | 9.96e-01 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 20 | 6.32e-01 | -6.19e-02 | 9.98e-01 |
| GOCC PLATELET ALPHA GRANULE MEMBRANE | 16 | 6.68e-01 | 6.19e-02 | 9.98e-01 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 118 | 2.45e-01 | 6.19e-02 | 9.58e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 113 | 2.56e-01 | 6.19e-02 | 9.58e-01 |
| GOBP ACID SECRETION | 43 | 4.83e-01 | -6.19e-02 | 9.95e-01 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 148 | 1.94e-01 | 6.19e-02 | 9.28e-01 |
| GOBP REGULATION OF GLYCOLYTIC PROCESS | 50 | 4.49e-01 | 6.18e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 6 | 7.93e-01 | -6.18e-02 | 9.98e-01 |
| GOBP UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 5 | 8.11e-01 | -6.18e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 34 | 5.33e-01 | -6.18e-02 | 9.95e-01 |
| GOMF COLLAGEN BINDING | 68 | 3.78e-01 | -6.18e-02 | 9.95e-01 |
| GOBP VIRAL PROTEIN PROCESSING | 31 | 5.52e-01 | 6.18e-02 | 9.95e-01 |
| GOBP PROSTANOID METABOLIC PROCESS | 49 | 4.55e-01 | -6.18e-02 | 9.95e-01 |
| GOBP REGULATION OF INSULIN SECRETION | 161 | 1.77e-01 | 6.17e-02 | 9.21e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 67 | 3.83e-01 | -6.16e-02 | 9.95e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 30 | 5.59e-01 | 6.16e-02 | 9.95e-01 |
| GOBP ERBB2 EGFR SIGNALING PATHWAY | 7 | 7.78e-01 | 6.16e-02 | 9.98e-01 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 43 | 4.85e-01 | 6.16e-02 | 9.95e-01 |
| GOBP DEPYRIMIDINATION | 8 | 7.63e-01 | 6.16e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 29 | 5.66e-01 | -6.16e-02 | 9.95e-01 |
| GOMF CYCLOSPORIN A BINDING | 17 | 6.60e-01 | 6.16e-02 | 9.98e-01 |
| GOBP METANEPHRIC DISTAL TUBULE DEVELOPMENT | 7 | 7.78e-01 | -6.16e-02 | 9.98e-01 |
| GOBP VITAMIN K METABOLIC PROCESS | 10 | 7.36e-01 | -6.16e-02 | 9.98e-01 |
| GOMF HISTONE H3 KINASE ACTIVITY | 11 | 7.24e-01 | -6.15e-02 | 9.98e-01 |
| GOBP MIDBODY ABSCISSION | 17 | 6.61e-01 | 6.15e-02 | 9.98e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 7 | 7.78e-01 | -6.15e-02 | 9.98e-01 |
| GOMF CALCIUM ION BINDING | 675 | 6.50e-03 | -6.14e-02 | 4.74e-01 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 245 | 9.79e-02 | 6.14e-02 | 8.61e-01 |
| GOBP POSITIVE REGULATION OF DNA LIGATION | 5 | 8.12e-01 | 6.14e-02 | 9.98e-01 |
| GOBP SYNAPTIC VESICLE CLUSTERING | 15 | 6.81e-01 | -6.14e-02 | 9.98e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 77 | 3.52e-01 | 6.13e-02 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 222 | 1.15e-01 | 6.13e-02 | 8.82e-01 |
| GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 7.79e-01 | -6.13e-02 | 9.98e-01 |
| GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 7.37e-01 | 6.13e-02 | 9.98e-01 |
| GOBP REGULATION OF TRANSLATIONAL TERMINATION | 8 | 7.64e-01 | -6.13e-02 | 9.98e-01 |
| GOBP MESONEPHRIC TUBULE FORMATION | 10 | 7.37e-01 | 6.13e-02 | 9.98e-01 |
| GOCC CHAPERONIN CONTAINING T COMPLEX | 10 | 7.37e-01 | 6.12e-02 | 9.98e-01 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 44 | 4.82e-01 | 6.12e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 17 | 6.62e-01 | -6.12e-02 | 9.98e-01 |
| GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 8 | 7.64e-01 | 6.12e-02 | 9.98e-01 |
| GOBP GROWTH INVOLVED IN HEART MORPHOGENESIS | 5 | 8.13e-01 | 6.12e-02 | 9.98e-01 |
| GOMF SULFURTRANSFERASE ACTIVITY | 11 | 7.25e-01 | -6.12e-02 | 9.98e-01 |
| GOBP FAT CELL PROLIFERATION | 14 | 6.92e-01 | 6.12e-02 | 9.98e-01 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 65 | 3.94e-01 | -6.11e-02 | 9.95e-01 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 59 | 4.17e-01 | 6.11e-02 | 9.95e-01 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 16 | 6.72e-01 | -6.11e-02 | 9.98e-01 |
| GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION | 14 | 6.92e-01 | 6.11e-02 | 9.98e-01 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 198 | 1.38e-01 | -6.11e-02 | 9.02e-01 |
| GOMF GLUTATHIONE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.13e-01 | -6.11e-02 | 9.98e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 19 | 6.45e-01 | 6.10e-02 | 9.98e-01 |
| GOCC GROWTH CONE MEMBRANE | 8 | 7.65e-01 | -6.10e-02 | 9.98e-01 |
| GOBP CHRONIC INFLAMMATORY RESPONSE | 18 | 6.54e-01 | -6.10e-02 | 9.98e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 16 | 6.73e-01 | 6.10e-02 | 9.98e-01 |
| GOBP HISTONE DEACETYLATION | 19 | 6.46e-01 | 6.09e-02 | 9.98e-01 |
| GOMF 2 ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 6 | 7.96e-01 | 6.09e-02 | 9.98e-01 |
| GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 8.14e-01 | 6.09e-02 | 9.98e-01 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 75 | 3.62e-01 | -6.09e-02 | 9.95e-01 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 65 | 3.96e-01 | -6.08e-02 | 9.95e-01 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 34 | 5.39e-01 | 6.08e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 71 | 3.75e-01 | 6.08e-02 | 9.95e-01 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 65 | 3.96e-01 | 6.08e-02 | 9.95e-01 |
| GOMF GAP JUNCTION CHANNEL ACTIVITY | 22 | 6.21e-01 | -6.08e-02 | 9.98e-01 |
| GOCC CHROMOSOME CENTROMERIC REGION | 242 | 1.03e-01 | 6.08e-02 | 8.66e-01 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 25 | 5.99e-01 | -6.08e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 19 | 6.46e-01 | -6.08e-02 | 9.98e-01 |
| GOBP HINDBRAIN MORPHOGENESIS | 44 | 4.85e-01 | -6.08e-02 | 9.95e-01 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 28 | 5.78e-01 | -6.08e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 499 | 2.01e-02 | 6.08e-02 | 6.41e-01 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 71 | 3.76e-01 | -6.08e-02 | 9.95e-01 |
| GOBP REPLICATIVE SENESCENCE | 17 | 6.65e-01 | 6.07e-02 | 9.98e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 21 | 6.30e-01 | 6.07e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 286 | 7.73e-02 | 6.07e-02 | 8.25e-01 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 143 | 2.10e-01 | -6.07e-02 | 9.40e-01 |
| GOBP REGULATION OF DNA METHYLATION | 20 | 6.39e-01 | -6.06e-02 | 9.98e-01 |
| GOCC ACTIN CYTOSKELETON | 484 | 2.24e-02 | -6.06e-02 | 6.41e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 8 | 7.67e-01 | -6.06e-02 | 9.98e-01 |
| GOBP PHAGOSOME LYSOSOME FUSION | 13 | 7.05e-01 | 6.06e-02 | 9.98e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 27 | 5.86e-01 | -6.06e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 21 | 6.31e-01 | 6.05e-02 | 9.98e-01 |
| GOMF R SMAD BINDING | 25 | 6.01e-01 | 6.05e-02 | 9.98e-01 |
| GOBP DIACYLGLYCEROL CATABOLIC PROCESS | 5 | 8.15e-01 | 6.05e-02 | 9.98e-01 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 17 | 6.66e-01 | -6.05e-02 | 9.98e-01 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 118 | 2.57e-01 | -6.04e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 14 | 6.96e-01 | 6.04e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION | 7 | 7.82e-01 | -6.04e-02 | 9.98e-01 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 243 | 1.05e-01 | -6.04e-02 | 8.67e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 447 | 2.88e-02 | -6.03e-02 | 6.86e-01 |
| GOCC BLOC 1 COMPLEX | 9 | 7.54e-01 | -6.03e-02 | 9.98e-01 |
| GOMF 3 CHLOROALLYL ALDEHYDE DEHYDROGENASE ACTIVITY | 5 | 8.15e-01 | -6.03e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION | 8 | 7.68e-01 | -6.03e-02 | 9.98e-01 |
| GOBP CELL JUNCTION MAINTENANCE | 45 | 4.84e-01 | 6.03e-02 | 9.95e-01 |
| GOBP DNA METABOLIC PROCESS | 982 | 1.39e-03 | 6.03e-02 | 2.30e-01 |
| GOBP MALE SEX DETERMINATION | 11 | 7.29e-01 | 6.03e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 28 | 5.81e-01 | -6.02e-02 | 9.96e-01 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 460 | 2.68e-02 | -6.02e-02 | 6.73e-01 |
| GOBP SNRNA METABOLIC PROCESS | 53 | 4.48e-01 | 6.02e-02 | 9.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 11 | 7.30e-01 | -6.02e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 51 | 4.57e-01 | -6.02e-02 | 9.95e-01 |
| GOBP REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 10 | 7.42e-01 | 6.02e-02 | 9.98e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 17 | 6.68e-01 | 6.01e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 31 | 5.63e-01 | 6.01e-02 | 9.95e-01 |
| GOBP SPINDLE ORGANIZATION | 192 | 1.51e-01 | 6.01e-02 | 9.04e-01 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 44 | 4.91e-01 | -6.00e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 22 | 6.26e-01 | 6.00e-02 | 9.98e-01 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 13 | 7.08e-01 | 6.00e-02 | 9.98e-01 |
| GOMF GLUTAMATE BINDING | 8 | 7.69e-01 | -6.00e-02 | 9.98e-01 |
| GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 9 | 7.55e-01 | 6.00e-02 | 9.98e-01 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 7 | 7.83e-01 | 6.00e-02 | 9.98e-01 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 50 | 4.63e-01 | -6.00e-02 | 9.95e-01 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 50 | 4.63e-01 | 5.99e-02 | 9.95e-01 |
| GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 8 | 7.69e-01 | -5.98e-02 | 9.98e-01 |
| GOCC ASTER | 10 | 7.43e-01 | -5.98e-02 | 9.98e-01 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 28 | 5.84e-01 | 5.98e-02 | 9.96e-01 |
| GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT | 10 | 7.43e-01 | -5.98e-02 | 9.98e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 61 | 4.20e-01 | -5.97e-02 | 9.95e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 741 | 5.73e-03 | 5.96e-02 | 4.52e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 12 | 7.21e-01 | 5.96e-02 | 9.98e-01 |
| GOBP PROTEIN PROCESSING | 233 | 1.17e-01 | -5.96e-02 | 8.83e-01 |
| GOBP RRNA 3 END PROCESSING | 10 | 7.44e-01 | -5.96e-02 | 9.98e-01 |
| GOBP NUCLEUS ORGANIZATION | 142 | 2.21e-01 | 5.95e-02 | 9.45e-01 |
| GOBP INNER CELL MASS CELL DIFFERENTIATION | 8 | 7.71e-01 | -5.95e-02 | 9.98e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN ORGANOGENESIS | 5 | 8.18e-01 | -5.95e-02 | 9.98e-01 |
| GOBP TROPHOBLAST CELL MIGRATION | 17 | 6.71e-01 | 5.94e-02 | 9.98e-01 |
| GOBP BUD ELONGATION INVOLVED IN LUNG BRANCHING | 7 | 7.85e-01 | -5.94e-02 | 9.98e-01 |
| GOBP NCRNA CATABOLIC PROCESS | 54 | 4.50e-01 | -5.94e-02 | 9.95e-01 |
| GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION | 12 | 7.22e-01 | -5.93e-02 | 9.98e-01 |
| GOBP MYOBLAST FUSION | 47 | 4.82e-01 | 5.93e-02 | 9.95e-01 |
| GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 7.71e-01 | 5.93e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 13 | 7.11e-01 | -5.93e-02 | 9.98e-01 |
| GOBP PROTEIN SIALYLATION | 5 | 8.18e-01 | -5.93e-02 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 7.22e-01 | 5.93e-02 | 9.98e-01 |
| GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 19 | 6.55e-01 | -5.92e-02 | 9.98e-01 |
| GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS | 7 | 7.86e-01 | -5.92e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 8.19e-01 | -5.92e-02 | 9.98e-01 |
| GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 16 | 6.82e-01 | 5.92e-02 | 9.98e-01 |
| GOMF MONOCARBOXYLIC ACID BINDING | 84 | 3.48e-01 | -5.92e-02 | 9.93e-01 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 17 | 6.73e-01 | 5.92e-02 | 9.98e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION | 10 | 7.46e-01 | -5.92e-02 | 9.98e-01 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 26 | 6.02e-01 | -5.91e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 10 | 7.46e-01 | -5.90e-02 | 9.98e-01 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 34 | 5.52e-01 | -5.90e-02 | 9.95e-01 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 11 | 7.35e-01 | -5.90e-02 | 9.98e-01 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 16 | 6.83e-01 | -5.90e-02 | 9.98e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 39 | 5.24e-01 | -5.90e-02 | 9.95e-01 |
| GOCC L TYPE VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 12 | 7.23e-01 | 5.90e-02 | 9.98e-01 |
| GOCC SHELTERIN COMPLEX | 6 | 8.02e-01 | 5.90e-02 | 9.98e-01 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 14 | 7.02e-01 | 5.90e-02 | 9.98e-01 |
| GOBP NOTCH RECEPTOR PROCESSING | 9 | 7.59e-01 | -5.90e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 37 | 5.35e-01 | 5.90e-02 | 9.95e-01 |
| GOBP BLOOD VESSEL REMODELING | 46 | 4.89e-01 | -5.90e-02 | 9.95e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 8.19e-01 | -5.90e-02 | 9.98e-01 |
| GOMF PHOSPHOLIPASE ACTIVITY | 107 | 2.92e-01 | -5.90e-02 | 9.79e-01 |
| GOBP IMPORT INTO NUCLEUS | 162 | 1.95e-01 | 5.90e-02 | 9.30e-01 |
| GOBP SOMITE DEVELOPMENT | 82 | 3.56e-01 | 5.89e-02 | 9.95e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 13 | 7.13e-01 | 5.89e-02 | 9.98e-01 |
| GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 6 | 8.03e-01 | 5.89e-02 | 9.98e-01 |
| GOBP RESPONSE TO PROGESTERONE | 40 | 5.19e-01 | -5.89e-02 | 9.95e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 38 | 5.30e-01 | 5.89e-02 | 9.95e-01 |
| GOBP MITOTIC NUCLEAR DIVISION | 269 | 9.66e-02 | 5.89e-02 | 8.61e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 8.20e-01 | -5.88e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 7 | 7.88e-01 | 5.88e-02 | 9.98e-01 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 8.03e-01 | -5.88e-02 | 9.98e-01 |
| GOBP MYELOID CELL DEVELOPMENT | 80 | 3.63e-01 | -5.88e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 80 | 3.63e-01 | 5.88e-02 | 9.95e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 29 | 5.84e-01 | 5.88e-02 | 9.96e-01 |
| GOCC BASAL PART OF CELL | 291 | 8.49e-02 | -5.87e-02 | 8.39e-01 |
| GOBP NEURON PROJECTION ORGANIZATION | 84 | 3.52e-01 | -5.87e-02 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 35 | 5.48e-01 | 5.87e-02 | 9.95e-01 |
| GOBP METANEPHROS MORPHOGENESIS | 30 | 5.78e-01 | 5.86e-02 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 14 | 7.04e-01 | 5.86e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 150 | 2.15e-01 | 5.86e-02 | 9.42e-01 |
| GOMF GROWTH FACTOR ACTIVITY | 149 | 2.17e-01 | -5.86e-02 | 9.43e-01 |
| GOBP COGNITION | 303 | 7.94e-02 | -5.86e-02 | 8.31e-01 |
| GOBP SECONDARY PALATE DEVELOPMENT | 26 | 6.05e-01 | -5.86e-02 | 9.98e-01 |
| GOBP NAIL DEVELOPMENT | 11 | 7.37e-01 | 5.86e-02 | 9.98e-01 |
| GOCC NUCLEAR MEMBRANE | 296 | 8.30e-02 | 5.86e-02 | 8.39e-01 |
| GOBP SENSORY PERCEPTION OF TASTE | 66 | 4.11e-01 | 5.85e-02 | 9.95e-01 |
| GOBP SOMATIC MOTOR NEURON DIFFERENTIATION | 5 | 8.21e-01 | 5.85e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 29 | 5.86e-01 | -5.85e-02 | 9.96e-01 |
| GOCC MULTIVESICULAR BODY INTERNAL VESICLE | 6 | 8.04e-01 | -5.85e-02 | 9.98e-01 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 10 | 7.49e-01 | -5.85e-02 | 9.98e-01 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 63 | 4.22e-01 | -5.85e-02 | 9.95e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 19 | 6.59e-01 | 5.84e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 9 | 7.61e-01 | -5.84e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO COLD | 13 | 7.15e-01 | -5.84e-02 | 9.98e-01 |
| GOBP DNA REPAIR | 561 | 1.80e-02 | 5.84e-02 | 6.41e-01 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 40 | 5.23e-01 | -5.84e-02 | 9.95e-01 |
| GOBP ICOSANOID TRANSPORT | 63 | 4.23e-01 | -5.83e-02 | 9.95e-01 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 36 | 5.45e-01 | -5.83e-02 | 9.95e-01 |
| GOBP LEUKOCYTE DEGRANULATION | 76 | 3.80e-01 | 5.82e-02 | 9.95e-01 |
| GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 8.22e-01 | 5.82e-02 | 9.98e-01 |
| GOCC HOST CELLULAR COMPONENT | 9 | 7.62e-01 | 5.82e-02 | 9.98e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 6 | 8.05e-01 | 5.82e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 21 | 6.44e-01 | -5.82e-02 | 9.98e-01 |
| GOCC NUCLEAR BODY | 812 | 4.85e-03 | 5.82e-02 | 4.24e-01 |
| GOBP TRNA METHYLATION | 38 | 5.35e-01 | 5.81e-02 | 9.95e-01 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 59 | 4.40e-01 | -5.81e-02 | 9.95e-01 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 83 | 3.60e-01 | 5.81e-02 | 9.95e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB | 7 | 7.90e-01 | 5.80e-02 | 9.98e-01 |
| GOBP FAT PAD DEVELOPMENT | 8 | 7.76e-01 | 5.80e-02 | 9.98e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 128 | 2.57e-01 | 5.80e-02 | 9.58e-01 |
| GOBP FACE MORPHOGENESIS | 30 | 5.83e-01 | -5.80e-02 | 9.96e-01 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 573 | 1.77e-02 | -5.80e-02 | 6.41e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 63 | 4.26e-01 | 5.79e-02 | 9.95e-01 |
| GOBP COBALAMIN TRANSPORT | 8 | 7.77e-01 | 5.79e-02 | 9.98e-01 |
| GOBP NEUTROPHIL EXTRAVASATION | 11 | 7.39e-01 | 5.79e-02 | 9.98e-01 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 49 | 4.83e-01 | -5.79e-02 | 9.95e-01 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 171 | 1.91e-01 | 5.79e-02 | 9.28e-01 |
| GOBP ADAPTATION OF SIGNALING PATHWAY | 20 | 6.54e-01 | 5.79e-02 | 9.98e-01 |
| GOCC EXOCYST | 14 | 7.08e-01 | 5.79e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 8 | 7.77e-01 | 5.79e-02 | 9.98e-01 |
| GOMF ENDOPEPTIDASE ACTIVITY | 376 | 5.40e-02 | -5.79e-02 | 7.87e-01 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 44 | 5.07e-01 | -5.78e-02 | 9.95e-01 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 84 | 3.60e-01 | 5.78e-02 | 9.95e-01 |
| GOMF 7SK SNRNA BINDING | 9 | 7.64e-01 | 5.78e-02 | 9.98e-01 |
| GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 6 | 8.06e-01 | -5.78e-02 | 9.98e-01 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 49 | 4.84e-01 | -5.78e-02 | 9.95e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 73 | 3.93e-01 | -5.78e-02 | 9.95e-01 |
| GOMF PROFILIN BINDING | 10 | 7.52e-01 | 5.77e-02 | 9.98e-01 |
| GOBP FEEDING BEHAVIOR | 102 | 3.14e-01 | 5.77e-02 | 9.87e-01 |
| GOMF MITOCHONDRION TARGETING SEQUENCE BINDING | 5 | 8.23e-01 | 5.77e-02 | 9.98e-01 |
| GOBP ISOLEUCINE METABOLIC PROCESS | 6 | 8.07e-01 | -5.77e-02 | 9.98e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 32 | 5.72e-01 | 5.77e-02 | 9.95e-01 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 132 | 2.52e-01 | 5.77e-02 | 9.58e-01 |
| GOBP MOTOR BEHAVIOR | 22 | 6.39e-01 | -5.77e-02 | 9.98e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 22 | 6.40e-01 | -5.76e-02 | 9.98e-01 |
| GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 8.23e-01 | 5.76e-02 | 9.98e-01 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 28 | 5.98e-01 | 5.76e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MUCUS SECRETION | 5 | 8.23e-01 | -5.76e-02 | 9.98e-01 |
| GOBP GTP BIOSYNTHETIC PROCESS | 11 | 7.41e-01 | -5.76e-02 | 9.98e-01 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 58 | 4.48e-01 | -5.76e-02 | 9.95e-01 |
| GOBP REGULATION OF PHOSPHATE TRANSPORT | 6 | 8.07e-01 | 5.76e-02 | 9.98e-01 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 142 | 2.36e-01 | 5.76e-02 | 9.52e-01 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 16 | 6.90e-01 | 5.75e-02 | 9.98e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 26 | 6.12e-01 | -5.75e-02 | 9.98e-01 |
| GOBP IRON SULFUR CLUSTER ASSEMBLY | 27 | 6.05e-01 | -5.75e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 55 | 4.61e-01 | 5.75e-02 | 9.95e-01 |
| GOBP PURINE NUCLEOSIDE TRANSMEMBRANE TRANSPORT | 5 | 8.24e-01 | 5.75e-02 | 9.98e-01 |
| GOBP MEMBRANE RAFT ASSEMBLY | 11 | 7.41e-01 | 5.75e-02 | 9.98e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 9 | 7.65e-01 | -5.75e-02 | 9.98e-01 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 37 | 5.45e-01 | 5.75e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 25 | 6.19e-01 | 5.74e-02 | 9.98e-01 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 11 | 7.41e-01 | 5.74e-02 | 9.98e-01 |
| GOBP PLASMA MEMBRANE RAFT ORGANIZATION | 11 | 7.42e-01 | 5.74e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 18 | 6.73e-01 | 5.74e-02 | 9.98e-01 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 105 | 3.10e-01 | -5.74e-02 | 9.87e-01 |
| GOBP PONS DEVELOPMENT | 11 | 7.42e-01 | 5.74e-02 | 9.98e-01 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 12 | 7.31e-01 | 5.73e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 148 | 2.29e-01 | 5.73e-02 | 9.50e-01 |
| GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 8.24e-01 | -5.73e-02 | 9.98e-01 |
| GOBP ICOSANOID SECRETION | 46 | 5.01e-01 | -5.73e-02 | 9.95e-01 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 25 | 6.20e-01 | 5.72e-02 | 9.98e-01 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 68 | 4.14e-01 | 5.72e-02 | 9.95e-01 |
| GOBP GALACTOLIPID METABOLIC PROCESS | 9 | 7.66e-01 | -5.72e-02 | 9.98e-01 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 19 | 6.66e-01 | 5.72e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 65 | 4.25e-01 | 5.72e-02 | 9.95e-01 |
| GOBP ALCOHOL METABOLIC PROCESS | 355 | 6.41e-02 | -5.72e-02 | 7.99e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 54 | 4.67e-01 | 5.72e-02 | 9.95e-01 |
| GOMF CERAMIDE BINDING | 19 | 6.66e-01 | 5.72e-02 | 9.98e-01 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 41 | 5.27e-01 | -5.71e-02 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 26 | 6.14e-01 | 5.71e-02 | 9.98e-01 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 21 | 6.51e-01 | -5.71e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 5 | 8.25e-01 | -5.71e-02 | 9.98e-01 |
| GOBP SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION | 10 | 7.55e-01 | -5.71e-02 | 9.98e-01 |
| GOBP ENDOSOME ORGANIZATION | 92 | 3.44e-01 | 5.71e-02 | 9.92e-01 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 95 | 3.37e-01 | 5.70e-02 | 9.88e-01 |
| GOBP AXO DENDRITIC TRANSPORT | 74 | 3.96e-01 | 5.70e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 48 | 4.94e-01 | -5.70e-02 | 9.95e-01 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 86 | 3.61e-01 | 5.70e-02 | 9.95e-01 |
| GOCC EXCITATORY SYNAPSE | 57 | 4.57e-01 | 5.70e-02 | 9.95e-01 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 87 | 3.58e-01 | 5.70e-02 | 9.95e-01 |
| GOBP DE NOVO NAD BIOSYNTHETIC PROCESS | 8 | 7.80e-01 | 5.70e-02 | 9.98e-01 |
| GOBP CITRULLINE METABOLIC PROCESS | 7 | 7.94e-01 | -5.70e-02 | 9.98e-01 |
| GOBP DNA DAMAGE RESPONSE | 831 | 5.29e-03 | 5.69e-02 | 4.33e-01 |
| GOBP TRACHEA DEVELOPMENT | 18 | 6.76e-01 | 5.69e-02 | 9.98e-01 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 24 | 6.29e-01 | -5.69e-02 | 9.98e-01 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 32 | 5.77e-01 | 5.69e-02 | 9.96e-01 |
| GOMF STEROID HORMONE BINDING | 6 | 8.09e-01 | 5.69e-02 | 9.98e-01 |
| GOBP CARDIAC MUSCLE MYOBLAST PROLIFERATION | 7 | 7.94e-01 | 5.69e-02 | 9.98e-01 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 30 | 5.90e-01 | -5.69e-02 | 9.98e-01 |
| GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 7 | 7.94e-01 | -5.69e-02 | 9.98e-01 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 12 | 7.33e-01 | 5.69e-02 | 9.98e-01 |
| GOBP MAGNESIUM ION HOMEOSTASIS | 10 | 7.56e-01 | -5.69e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 74 | 3.98e-01 | -5.68e-02 | 9.95e-01 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 29 | 5.96e-01 | 5.68e-02 | 9.98e-01 |
| GOBP PROTEIN POLYUBIQUITINATION | 218 | 1.48e-01 | 5.68e-02 | 9.04e-01 |
| GOBP REGULATION OF MESODERMAL CELL DIFFERENTIATION | 9 | 7.68e-01 | -5.68e-02 | 9.98e-01 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 11 | 7.45e-01 | -5.67e-02 | 9.98e-01 |
| GOMF ANTIGEN BINDING | 66 | 4.25e-01 | 5.67e-02 | 9.95e-01 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 12 | 7.34e-01 | 5.67e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 7 | 7.95e-01 | 5.67e-02 | 9.98e-01 |
| GOMF GAMMA CATENIN BINDING | 12 | 7.34e-01 | -5.67e-02 | 9.98e-01 |
| GOBP PENETRATION OF ZONA PELLUCIDA | 9 | 7.68e-01 | -5.67e-02 | 9.98e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 26 | 6.17e-01 | -5.67e-02 | 9.98e-01 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 31 | 5.85e-01 | -5.66e-02 | 9.96e-01 |
| GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 15 | 7.04e-01 | 5.66e-02 | 9.98e-01 |
| GOBP EMBRYONIC RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 6 | 8.10e-01 | 5.66e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 7 | 7.96e-01 | 5.65e-02 | 9.98e-01 |
| GOCC MEMBRANE MICRODOMAIN | 279 | 1.04e-01 | 5.65e-02 | 8.67e-01 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 51 | 4.85e-01 | -5.65e-02 | 9.95e-01 |
| GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 14 | 7.14e-01 | -5.65e-02 | 9.98e-01 |
| GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 13 | 7.24e-01 | -5.65e-02 | 9.98e-01 |
| GOBP NEUROTRANSMITTER METABOLIC PROCESS | 25 | 6.25e-01 | -5.65e-02 | 9.98e-01 |
| GOCC SECONDARY LYSOSOME | 16 | 6.96e-01 | 5.64e-02 | 9.98e-01 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 16 | 6.96e-01 | -5.64e-02 | 9.98e-01 |
| GOBP STORE OPERATED CALCIUM ENTRY | 21 | 6.55e-01 | 5.64e-02 | 9.98e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 225 | 1.45e-01 | 5.64e-02 | 9.02e-01 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 208 | 1.61e-01 | -5.64e-02 | 9.08e-01 |
| GOMF CALCITONIN FAMILY RECEPTOR ACTIVITY | 6 | 8.11e-01 | 5.64e-02 | 9.98e-01 |
| GOBP MIRNA METABOLIC PROCESS | 101 | 3.28e-01 | -5.64e-02 | 9.87e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 10 | 7.58e-01 | -5.63e-02 | 9.98e-01 |
| GOBP RESPONSE TO STEROL | 35 | 5.64e-01 | -5.63e-02 | 9.95e-01 |
| GOBP GRANULOCYTE MIGRATION | 145 | 2.42e-01 | -5.63e-02 | 9.58e-01 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 6 | 8.11e-01 | 5.63e-02 | 9.98e-01 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 47 | 5.04e-01 | 5.63e-02 | 9.95e-01 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 176 | 1.98e-01 | -5.63e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF CGMP MEDIATED SIGNALING | 6 | 8.11e-01 | -5.63e-02 | 9.98e-01 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 37 | 5.54e-01 | 5.63e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION | 6 | 8.11e-01 | -5.62e-02 | 9.98e-01 |
| GOBP KERATAN SULFATE METABOLIC PROCESS | 18 | 6.80e-01 | 5.62e-02 | 9.98e-01 |
| GOCC ENDOCYTIC VESICLE LUMEN | 23 | 6.41e-01 | -5.62e-02 | 9.98e-01 |
| GOMF CYCLASE ACTIVATOR ACTIVITY | 11 | 7.47e-01 | 5.62e-02 | 9.98e-01 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 15 | 7.06e-01 | 5.62e-02 | 9.98e-01 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 15 | 7.06e-01 | 5.62e-02 | 9.98e-01 |
| GOCC CHROMAFFIN GRANULE | 13 | 7.26e-01 | -5.62e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 31 | 5.88e-01 | -5.62e-02 | 9.97e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 101 | 3.29e-01 | 5.62e-02 | 9.87e-01 |
| GOBP SNRNA 3 END PROCESSING | 20 | 6.64e-01 | 5.61e-02 | 9.98e-01 |
| GOCC AXOLEMMA | 15 | 7.07e-01 | -5.61e-02 | 9.98e-01 |
| GOMF DEOXYRIBONUCLEOTIDE BINDING | 5 | 8.28e-01 | -5.61e-02 | 9.98e-01 |
| GOBP PROTEIN DEPHOSPHORYLATION | 194 | 1.78e-01 | -5.61e-02 | 9.22e-01 |
| GOBP RNA DECAPPING | 19 | 6.72e-01 | 5.61e-02 | 9.98e-01 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 61 | 4.49e-01 | 5.60e-02 | 9.95e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP | 6 | 8.12e-01 | 5.60e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 22 | 6.49e-01 | -5.60e-02 | 9.98e-01 |
| GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 10 | 7.59e-01 | 5.60e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 11 | 7.48e-01 | -5.60e-02 | 9.98e-01 |
| GOCC RADIAL SPOKE | 5 | 8.28e-01 | 5.60e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 47 | 5.07e-01 | -5.60e-02 | 9.95e-01 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 19 | 6.73e-01 | 5.60e-02 | 9.98e-01 |
| GOBP AMELOGENESIS | 24 | 6.35e-01 | -5.60e-02 | 9.98e-01 |
| GOBP RESPONSE TO DOPAMINE | 70 | 4.18e-01 | 5.59e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 60 | 4.54e-01 | -5.59e-02 | 9.95e-01 |
| GOBP RRNA CATABOLIC PROCESS | 21 | 6.58e-01 | 5.59e-02 | 9.98e-01 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 68 | 4.26e-01 | -5.58e-02 | 9.95e-01 |
| GOCC TRANSPORT VESICLE | 408 | 5.31e-02 | -5.58e-02 | 7.85e-01 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 24 | 6.36e-01 | 5.57e-02 | 9.98e-01 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 120 | 2.92e-01 | -5.57e-02 | 9.79e-01 |
| GOBP CGMP METABOLIC PROCESS | 16 | 7.00e-01 | 5.57e-02 | 9.98e-01 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 12 | 7.38e-01 | 5.57e-02 | 9.98e-01 |
| GOBP PML BODY ORGANIZATION | 7 | 7.99e-01 | 5.57e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 21 | 6.59e-01 | 5.56e-02 | 9.98e-01 |
| GOBP DISTAL TUBULE DEVELOPMENT | 12 | 7.39e-01 | 5.55e-02 | 9.98e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY | 7 | 7.99e-01 | 5.55e-02 | 9.98e-01 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 658 | 1.51e-02 | 5.55e-02 | 6.25e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 7.10e-01 | -5.55e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 7.86e-01 | 5.55e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 38 | 5.54e-01 | -5.55e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 37 | 5.59e-01 | 5.55e-02 | 9.95e-01 |
| GOMF URIDYLYLTRANSFERASE ACTIVITY | 7 | 7.99e-01 | 5.54e-02 | 9.98e-01 |
| GOCC U2 SNRNP | 24 | 6.38e-01 | 5.54e-02 | 9.98e-01 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 156 | 2.32e-01 | 5.54e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 58 | 4.65e-01 | -5.54e-02 | 9.95e-01 |
| GOBP CHEMOKINE PRODUCTION | 101 | 3.37e-01 | 5.53e-02 | 9.88e-01 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 16 | 7.02e-01 | 5.53e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 8.30e-01 | 5.53e-02 | 9.98e-01 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 14 | 7.20e-01 | 5.53e-02 | 9.98e-01 |
| GOBP TOOTH MINERALIZATION | 28 | 6.13e-01 | -5.53e-02 | 9.98e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 80 | 3.93e-01 | 5.52e-02 | 9.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 32 | 5.89e-01 | 5.52e-02 | 9.97e-01 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 364 | 7.05e-02 | 5.52e-02 | 8.00e-01 |
| GOBP CERAMIDE METABOLIC PROCESS | 106 | 3.26e-01 | -5.52e-02 | 9.87e-01 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 39 | 5.51e-01 | -5.52e-02 | 9.95e-01 |
| GOBP DUCTUS ARTERIOSUS CLOSURE | 5 | 8.31e-01 | 5.51e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO DSRNA | 22 | 6.54e-01 | 5.51e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 6.01e-01 | -5.51e-02 | 9.98e-01 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 182 | 2.00e-01 | 5.51e-02 | 9.36e-01 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 45 | 5.23e-01 | -5.51e-02 | 9.95e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION | 8 | 7.87e-01 | 5.51e-02 | 9.98e-01 |
| GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 10 | 7.63e-01 | -5.51e-02 | 9.98e-01 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 37 | 5.62e-01 | -5.50e-02 | 9.95e-01 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 61 | 4.57e-01 | 5.50e-02 | 9.95e-01 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 8 | 7.88e-01 | -5.50e-02 | 9.98e-01 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 131 | 2.77e-01 | 5.50e-02 | 9.73e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 27 | 6.21e-01 | -5.50e-02 | 9.98e-01 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 338 | 8.24e-02 | 5.50e-02 | 8.38e-01 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 23 | 6.48e-01 | -5.50e-02 | 9.98e-01 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 83 | 3.87e-01 | -5.50e-02 | 9.95e-01 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 107 | 3.26e-01 | -5.49e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 7.64e-01 | 5.49e-02 | 9.98e-01 |
| GOBP VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION | 13 | 7.32e-01 | -5.49e-02 | 9.98e-01 |
| GOCC NUCLEAR LAMINA | 10 | 7.64e-01 | -5.49e-02 | 9.98e-01 |
| GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 7.76e-01 | 5.49e-02 | 9.98e-01 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 43 | 5.34e-01 | -5.48e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF HISTONE ACETYLATION | 10 | 7.64e-01 | 5.47e-02 | 9.98e-01 |
| GOCC VESICLE TETHERING COMPLEX | 56 | 4.79e-01 | 5.47e-02 | 9.95e-01 |
| GOBP REGULATION OF RNA BINDING | 8 | 7.89e-01 | -5.47e-02 | 9.98e-01 |
| GOMF LIPOPEPTIDE BINDING | 10 | 7.65e-01 | -5.47e-02 | 9.98e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 7.43e-01 | -5.47e-02 | 9.98e-01 |
| GOBP KYNURENINE METABOLIC PROCESS | 11 | 7.53e-01 | -5.47e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 74 | 4.16e-01 | -5.47e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 78 | 4.04e-01 | 5.47e-02 | 9.95e-01 |
| GOBP REGULATION OF CYTOKINESIS | 86 | 3.81e-01 | 5.46e-02 | 9.95e-01 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 131 | 2.80e-01 | 5.46e-02 | 9.73e-01 |
| GOBP MRNA METABOLIC PROCESS | 741 | 1.14e-02 | 5.46e-02 | 5.98e-01 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 423 | 5.41e-02 | -5.46e-02 | 7.87e-01 |
| GOBP RESPONSE TO COLD | 43 | 5.36e-01 | 5.46e-02 | 9.95e-01 |
| GOMF INTEGRIN BINDING | 150 | 2.49e-01 | -5.46e-02 | 9.58e-01 |
| GOBP ENDODERMAL CELL FATE COMMITMENT | 15 | 7.15e-01 | -5.45e-02 | 9.98e-01 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 37 | 5.66e-01 | -5.45e-02 | 9.95e-01 |
| GOBP SYNAPTIC TRANSMISSION GLYCINERGIC | 5 | 8.33e-01 | 5.45e-02 | 9.99e-01 |
| GOBP SEROTONIN RECEPTOR SIGNALING PATHWAY | 27 | 6.24e-01 | 5.44e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 31 | 6.00e-01 | 5.44e-02 | 9.98e-01 |
| GOMF QUINONE BINDING | 15 | 7.15e-01 | 5.44e-02 | 9.98e-01 |
| GOMF TITIN BINDING | 13 | 7.34e-01 | 5.43e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 7 | 8.03e-01 | -5.43e-02 | 9.98e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 18 | 6.90e-01 | -5.43e-02 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN SECRETION | 261 | 1.31e-01 | 5.43e-02 | 8.96e-01 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 19 | 6.82e-01 | 5.43e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 10 | 7.67e-01 | 5.42e-02 | 9.98e-01 |
| GOMF LIM DOMAIN BINDING | 5 | 8.34e-01 | 5.42e-02 | 9.99e-01 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 34 | 5.85e-01 | -5.41e-02 | 9.96e-01 |
| GOBP RESPONSE TO CATECHOLAMINE | 86 | 3.86e-01 | 5.41e-02 | 9.95e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 6 | 8.19e-01 | 5.41e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 17 | 6.99e-01 | -5.41e-02 | 9.98e-01 |
| GOBP NON LYTIC VIRAL RELEASE | 14 | 7.26e-01 | 5.41e-02 | 9.98e-01 |
| GOBP INTERLEUKIN 1 ALPHA PRODUCTION | 11 | 7.56e-01 | -5.41e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 363 | 7.68e-02 | 5.41e-02 | 8.23e-01 |
| GOMF DOUBLE STRANDED RNA BINDING | 71 | 4.31e-01 | 5.41e-02 | 9.95e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 17 | 7.00e-01 | -5.41e-02 | 9.98e-01 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 25 | 6.40e-01 | 5.40e-02 | 9.98e-01 |
| GOCC OUTER MEMBRANE | 229 | 1.59e-01 | 5.40e-02 | 9.06e-01 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 249 | 1.42e-01 | 5.40e-02 | 9.02e-01 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 20 | 6.76e-01 | -5.40e-02 | 9.98e-01 |
| GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE | 17 | 7.00e-01 | -5.40e-02 | 9.98e-01 |
| GOBP XENOBIOTIC TRANSPORT | 59 | 4.74e-01 | -5.39e-02 | 9.95e-01 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 37 | 5.70e-01 | -5.39e-02 | 9.95e-01 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 106 | 3.38e-01 | -5.39e-02 | 9.88e-01 |
| GOBP BRADYKININ CATABOLIC PROCESS | 7 | 8.05e-01 | -5.39e-02 | 9.98e-01 |
| GOBP CELL MATRIX ADHESION | 231 | 1.58e-01 | -5.39e-02 | 9.06e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 25 | 6.41e-01 | -5.39e-02 | 9.98e-01 |
| GOBP REPLACEMENT OSSIFICATION | 30 | 6.10e-01 | 5.38e-02 | 9.98e-01 |
| GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 10 | 7.68e-01 | -5.38e-02 | 9.98e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 23 | 6.55e-01 | -5.38e-02 | 9.98e-01 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 54 | 4.94e-01 | -5.38e-02 | 9.95e-01 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 72 | 4.30e-01 | 5.38e-02 | 9.95e-01 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 44 | 5.37e-01 | 5.38e-02 | 9.95e-01 |
| GOBP BRAINSTEM DEVELOPMENT | 7 | 8.05e-01 | 5.38e-02 | 9.98e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 8.35e-01 | 5.38e-02 | 9.99e-01 |
| GOBP CRD MEDIATED MRNA STABILIZATION | 11 | 7.58e-01 | -5.37e-02 | 9.98e-01 |
| GOBP CENTROMERIC SISTER CHROMATID COHESION | 10 | 7.69e-01 | -5.36e-02 | 9.98e-01 |
| GOBP LIPID MODIFICATION | 185 | 2.09e-01 | 5.36e-02 | 9.38e-01 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 13 | 7.38e-01 | -5.36e-02 | 9.98e-01 |
| GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 7.93e-01 | -5.36e-02 | 9.98e-01 |
| GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 8.06e-01 | 5.36e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 69 | 4.42e-01 | 5.35e-02 | 9.95e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 45 | 5.34e-01 | 5.35e-02 | 9.95e-01 |
| GOBP ABSCISSION | 6 | 8.20e-01 | 5.35e-02 | 9.98e-01 |
| GOBP ACTIN CROSSLINK FORMATION | 12 | 7.48e-01 | 5.35e-02 | 9.98e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 66 | 4.52e-01 | -5.35e-02 | 9.95e-01 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 22 | 6.64e-01 | -5.35e-02 | 9.98e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 335 | 9.26e-02 | -5.35e-02 | 8.55e-01 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 422 | 5.96e-02 | 5.35e-02 | 7.90e-01 |
| GOBP ACTIN FILAMENT ORGANIZATION | 441 | 5.43e-02 | -5.34e-02 | 7.87e-01 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 46 | 5.31e-01 | -5.34e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 139 | 2.77e-01 | 5.34e-02 | 9.73e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 18 | 6.95e-01 | 5.34e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 13 | 7.39e-01 | 5.34e-02 | 9.98e-01 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 21 | 6.72e-01 | -5.33e-02 | 9.98e-01 |
| GOBP RENAL ABSORPTION | 32 | 6.02e-01 | -5.33e-02 | 9.98e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 15 | 7.21e-01 | -5.33e-02 | 9.98e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 22 | 6.65e-01 | -5.33e-02 | 9.98e-01 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 32 | 6.02e-01 | 5.32e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 42 | 5.51e-01 | 5.32e-02 | 9.95e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 42 | 5.51e-01 | 5.32e-02 | 9.95e-01 |
| GOCC CILIARY TIP | 45 | 5.37e-01 | 5.32e-02 | 9.95e-01 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 851 | 8.41e-03 | 5.32e-02 | 5.44e-01 |
| GOBP BRUSH BORDER ASSEMBLY | 7 | 8.07e-01 | 5.32e-02 | 9.98e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 8.07e-01 | 5.32e-02 | 9.98e-01 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 86 | 3.94e-01 | 5.32e-02 | 9.95e-01 |
| GOBP SCHWANN CELL DIFFERENTIATION | 38 | 5.71e-01 | -5.32e-02 | 9.95e-01 |
| GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 7 | 8.08e-01 | 5.32e-02 | 9.98e-01 |
| GOBP CELL MIGRATION INVOLVED IN GASTRULATION | 13 | 7.40e-01 | 5.32e-02 | 9.98e-01 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 8.08e-01 | 5.31e-02 | 9.98e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 33 | 5.97e-01 | -5.31e-02 | 9.98e-01 |
| GOCC MICROVILLUS | 94 | 3.74e-01 | 5.31e-02 | 9.95e-01 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 16 | 7.13e-01 | 5.31e-02 | 9.98e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT | 23 | 6.60e-01 | 5.31e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 45 | 5.38e-01 | 5.30e-02 | 9.95e-01 |
| GOBP PROTEIN ACTIVATION CASCADE | 17 | 7.05e-01 | -5.30e-02 | 9.98e-01 |
| GOBP LAMELLIPODIUM ASSEMBLY | 67 | 4.53e-01 | -5.30e-02 | 9.95e-01 |
| GOBP THIOESTER METABOLIC PROCESS | 88 | 3.90e-01 | 5.30e-02 | 9.95e-01 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 18 | 6.97e-01 | -5.30e-02 | 9.98e-01 |
| GOBP SYNAPTIC VESICLE DOCKING | 10 | 7.72e-01 | -5.30e-02 | 9.98e-01 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 40 | 5.62e-01 | 5.30e-02 | 9.95e-01 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 33 | 5.98e-01 | 5.30e-02 | 9.98e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR | 294 | 1.18e-01 | 5.30e-02 | 8.83e-01 |
| GOBP LATERAL SPROUTING FROM AN EPITHELIUM | 10 | 7.72e-01 | 5.30e-02 | 9.98e-01 |
| GOMF FLOPPASE ACTIVITY | 15 | 7.23e-01 | -5.29e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 8 | 7.96e-01 | -5.29e-02 | 9.98e-01 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 15 | 7.23e-01 | 5.29e-02 | 9.98e-01 |
| GOCC CENTROSOME | 607 | 2.60e-02 | 5.29e-02 | 6.71e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 54 | 5.01e-01 | 5.29e-02 | 9.95e-01 |
| GOMF NEUROPEPTIDE RECEPTOR ACTIVITY | 44 | 5.44e-01 | 5.29e-02 | 9.95e-01 |
| GOMF UBIQUITIN BINDING | 99 | 3.63e-01 | 5.29e-02 | 9.95e-01 |
| GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 7.72e-01 | -5.29e-02 | 9.98e-01 |
| GOBP RESPONSE TO FUNGUS | 62 | 4.72e-01 | 5.28e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO PH | 26 | 6.41e-01 | -5.28e-02 | 9.98e-01 |
| GOMF NF KAPPAB BINDING | 28 | 6.28e-01 | 5.28e-02 | 9.98e-01 |
| GOMF CALCIUM RELEASE CHANNEL ACTIVITY | 18 | 6.98e-01 | 5.28e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 8 | 7.96e-01 | -5.28e-02 | 9.98e-01 |
| GOBP DENDRITE EXTENSION | 34 | 5.94e-01 | -5.28e-02 | 9.98e-01 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 508 | 4.16e-02 | 5.28e-02 | 7.56e-01 |
| GOCC RIBONUCLEASE P COMPLEX | 13 | 7.42e-01 | -5.28e-02 | 9.98e-01 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 64 | 4.65e-01 | -5.28e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF AXON GUIDANCE | 5 | 8.38e-01 | 5.28e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 65 | 4.62e-01 | -5.28e-02 | 9.95e-01 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 178 | 2.25e-01 | 5.28e-02 | 9.49e-01 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 33 | 6.00e-01 | 5.27e-02 | 9.98e-01 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 240 | 1.59e-01 | -5.27e-02 | 9.06e-01 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 36 | 5.84e-01 | 5.27e-02 | 9.96e-01 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 14 | 7.33e-01 | -5.27e-02 | 9.98e-01 |
| GOMF LIPASE ACTIVITY | 132 | 2.96e-01 | -5.27e-02 | 9.82e-01 |
| GOBP DIENCEPHALON DEVELOPMENT | 73 | 4.36e-01 | 5.27e-02 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 75 | 4.30e-01 | -5.27e-02 | 9.95e-01 |
| GOMF BMP RECEPTOR BINDING | 11 | 7.62e-01 | -5.27e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 461 | 5.25e-02 | 5.27e-02 | 7.81e-01 |
| GOBP MICROTUBULE BASED TRANSPORT | 204 | 1.95e-01 | 5.27e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 18 | 6.99e-01 | -5.27e-02 | 9.98e-01 |
| GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 7.84e-01 | -5.27e-02 | 9.98e-01 |
| GOCC U6 SNRNP | 8 | 7.97e-01 | -5.26e-02 | 9.98e-01 |
| GOBP PROSTHETIC GROUP METABOLIC PROCESS | 6 | 8.23e-01 | -5.26e-02 | 9.98e-01 |
| GOMF CHANNEL INHIBITOR ACTIVITY | 35 | 5.90e-01 | -5.26e-02 | 9.98e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST CELL | 8 | 7.97e-01 | -5.26e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 25 | 6.49e-01 | 5.26e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 33 | 6.01e-01 | -5.25e-02 | 9.98e-01 |
| GOMF STEROL TRANSFER ACTIVITY | 23 | 6.63e-01 | -5.25e-02 | 9.98e-01 |
| GOBP RESPONSE TO WATER | 13 | 7.43e-01 | -5.25e-02 | 9.98e-01 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 318 | 1.08e-01 | -5.25e-02 | 8.70e-01 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 105 | 3.53e-01 | 5.25e-02 | 9.94e-01 |
| GOBP POSITIVE CHEMOTAXIS | 61 | 4.78e-01 | 5.25e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 12 | 7.53e-01 | 5.24e-02 | 9.98e-01 |
| GOBP REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS | 7 | 8.10e-01 | 5.24e-02 | 9.98e-01 |
| GOBP SEQUESTERING OF BMP IN EXTRACELLULAR MATRIX | 5 | 8.39e-01 | 5.24e-02 | 9.99e-01 |
| GOBP PROTEIN STABILIZATION | 202 | 1.99e-01 | 5.24e-02 | 9.36e-01 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 45 | 5.43e-01 | -5.24e-02 | 9.95e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 5 | 8.39e-01 | 5.24e-02 | 9.99e-01 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 66 | 4.62e-01 | 5.24e-02 | 9.95e-01 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 45 | 5.44e-01 | 5.23e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 26 | 6.44e-01 | -5.23e-02 | 9.98e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 6 | 8.24e-01 | 5.23e-02 | 9.98e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 29 | 6.26e-01 | 5.23e-02 | 9.98e-01 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 106 | 3.52e-01 | 5.23e-02 | 9.94e-01 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 164 | 2.48e-01 | -5.23e-02 | 9.58e-01 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 16 | 7.18e-01 | -5.22e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 71 | 4.47e-01 | -5.22e-02 | 9.95e-01 |
| GOBP VESICLE LOCALIZATION | 208 | 1.94e-01 | 5.22e-02 | 9.28e-01 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 50 | 5.23e-01 | 5.22e-02 | 9.95e-01 |
| GOMF U6 SNRNA BINDING | 14 | 7.36e-01 | -5.21e-02 | 9.98e-01 |
| GOBP PLASMA MEMBRANE TUBULATION | 19 | 6.94e-01 | 5.21e-02 | 9.98e-01 |
| GOBP EMBRYO DEVELOPMENT | 1091 | 3.66e-03 | 5.21e-02 | 3.57e-01 |
| GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 46 | 5.41e-01 | 5.21e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 65 | 4.68e-01 | -5.21e-02 | 9.95e-01 |
| GOBP L SERINE CATABOLIC PROCESS | 5 | 8.40e-01 | -5.21e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 10 | 7.76e-01 | -5.21e-02 | 9.98e-01 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 93 | 3.86e-01 | 5.21e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 41 | 5.64e-01 | 5.20e-02 | 9.95e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 18 | 7.02e-01 | -5.20e-02 | 9.98e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 140 | 2.88e-01 | -5.20e-02 | 9.75e-01 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 18 | 7.02e-01 | -5.20e-02 | 9.98e-01 |
| GOMF FIBRONECTIN BINDING | 29 | 6.28e-01 | -5.20e-02 | 9.98e-01 |
| GOBP RESPONSE TO SALT STRESS | 24 | 6.60e-01 | -5.19e-02 | 9.98e-01 |
| GOMF ATPASE REGULATOR ACTIVITY | 47 | 5.38e-01 | 5.19e-02 | 9.95e-01 |
| GOBP CHONDROCYTE HYPERTROPHY | 6 | 8.26e-01 | 5.19e-02 | 9.98e-01 |
| GOMF PHOSPHOLIPASE A1 ACTIVITY | 18 | 7.03e-01 | 5.19e-02 | 9.98e-01 |
| GOMF UNIPORTER ACTIVITY | 8 | 7.99e-01 | -5.19e-02 | 9.98e-01 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 18 | 7.03e-01 | 5.19e-02 | 9.98e-01 |
| GOBP CALCIUM ION IMPORT | 46 | 5.43e-01 | -5.19e-02 | 9.95e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 57 | 4.98e-01 | 5.19e-02 | 9.95e-01 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 81 | 4.20e-01 | 5.18e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CATECHOLAMINE SECRETION | 12 | 7.56e-01 | -5.18e-02 | 9.98e-01 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 207 | 1.99e-01 | 5.17e-02 | 9.36e-01 |
| GOBP RESPONSE TO GROWTH HORMONE | 34 | 6.02e-01 | -5.17e-02 | 9.98e-01 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 42 | 5.62e-01 | 5.17e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 683 | 2.13e-02 | 5.17e-02 | 6.41e-01 |
| GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 12 | 7.57e-01 | 5.17e-02 | 9.98e-01 |
| GOBP GLIAL CELL PROLIFERATION | 53 | 5.15e-01 | 5.17e-02 | 9.95e-01 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 140 | 2.91e-01 | 5.17e-02 | 9.79e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 30 | 6.25e-01 | 5.16e-02 | 9.98e-01 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 169 | 2.47e-01 | 5.16e-02 | 9.58e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 309 | 1.19e-01 | 5.16e-02 | 8.83e-01 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 13 | 7.47e-01 | 5.16e-02 | 9.98e-01 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 53 | 5.16e-01 | -5.16e-02 | 9.95e-01 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 29 | 6.31e-01 | -5.16e-02 | 9.98e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 8.42e-01 | -5.16e-02 | 9.99e-01 |
| GOBP REGULATION OF MELANOCYTE DIFFERENTIATION | 6 | 8.27e-01 | 5.16e-02 | 9.98e-01 |
| GOBP INTERLEUKIN 8 PRODUCTION | 96 | 3.82e-01 | -5.16e-02 | 9.95e-01 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 17 | 7.13e-01 | -5.15e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 6 | 8.27e-01 | -5.15e-02 | 9.98e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 156 | 2.67e-01 | -5.15e-02 | 9.68e-01 |
| GOCC LAMIN FILAMENT | 5 | 8.42e-01 | -5.14e-02 | 9.99e-01 |
| GOBP MITOTIC CYTOKINESIS | 85 | 4.13e-01 | 5.14e-02 | 9.95e-01 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 289 | 1.33e-01 | 5.14e-02 | 8.96e-01 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 42 | 5.65e-01 | 5.14e-02 | 9.95e-01 |
| GOBP NEPHRON MORPHOGENESIS | 77 | 4.36e-01 | 5.13e-02 | 9.95e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 22 | 6.77e-01 | 5.13e-02 | 9.98e-01 |
| GOBP GLIAL CELL MIGRATION | 57 | 5.03e-01 | 5.13e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF FIBRINOLYSIS | 13 | 7.49e-01 | -5.13e-02 | 9.98e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 9 | 7.90e-01 | 5.13e-02 | 9.98e-01 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 25 | 6.57e-01 | -5.12e-02 | 9.98e-01 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 102 | 3.71e-01 | -5.12e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION | 8 | 8.02e-01 | 5.12e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 104 | 3.67e-01 | 5.12e-02 | 9.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 260 | 1.55e-01 | -5.12e-02 | 9.06e-01 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 7.79e-01 | -5.12e-02 | 9.98e-01 |
| GOBP PODOCYTE CELL MIGRATION | 7 | 8.15e-01 | -5.12e-02 | 9.98e-01 |
| GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 6 | 8.28e-01 | -5.11e-02 | 9.98e-01 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 89 | 4.05e-01 | -5.11e-02 | 9.95e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 38 | 5.86e-01 | 5.11e-02 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 93 | 3.95e-01 | 5.10e-02 | 9.95e-01 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 36 | 5.96e-01 | 5.10e-02 | 9.98e-01 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 52 | 5.25e-01 | 5.10e-02 | 9.95e-01 |
| GOBP HEPATOCYTE DIFFERENTIATION | 15 | 7.32e-01 | -5.10e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF URINE VOLUME | 13 | 7.50e-01 | -5.10e-02 | 9.98e-01 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 261 | 1.56e-01 | -5.10e-02 | 9.06e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 20 | 6.93e-01 | -5.09e-02 | 9.98e-01 |
| GOBP CYSTEINE METABOLIC PROCESS | 11 | 7.70e-01 | 5.09e-02 | 9.98e-01 |
| GOBP REGULATION OF VIRAL PROCESS | 163 | 2.62e-01 | 5.09e-02 | 9.63e-01 |
| GOBP CELLULAR RESPONSE TO UV C | 5 | 8.44e-01 | 5.09e-02 | 9.99e-01 |
| GOCC CONNEXIN COMPLEX | 19 | 7.01e-01 | -5.09e-02 | 9.98e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 8.16e-01 | -5.09e-02 | 9.98e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN AXIS ELONGATION | 6 | 8.29e-01 | -5.09e-02 | 9.98e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 8.16e-01 | 5.09e-02 | 9.98e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 127 | 3.22e-01 | 5.08e-02 | 9.87e-01 |
| GOBP ENTRY INTO HOST | 157 | 2.72e-01 | 5.08e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 167 | 2.57e-01 | 5.08e-02 | 9.58e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 11 | 7.71e-01 | -5.08e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 41 | 5.74e-01 | 5.08e-02 | 9.95e-01 |
| GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY | 16 | 7.25e-01 | -5.08e-02 | 9.98e-01 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 9 | 7.92e-01 | -5.08e-02 | 9.98e-01 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 302 | 1.29e-01 | -5.07e-02 | 8.94e-01 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 98 | 3.85e-01 | -5.07e-02 | 9.95e-01 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 150 | 2.84e-01 | -5.07e-02 | 9.74e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 451 | 6.49e-02 | 5.07e-02 | 7.99e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 10 | 7.82e-01 | -5.06e-02 | 9.98e-01 |
| GOBP GLUTAMATE SECRETION | 28 | 6.43e-01 | 5.06e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 14 | 7.43e-01 | 5.06e-02 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN TARGETING | 77 | 4.43e-01 | -5.06e-02 | 9.95e-01 |
| GOBP STEROID METABOLIC PROCESS | 310 | 1.25e-01 | -5.06e-02 | 8.91e-01 |
| GOBP DNA BIOSYNTHETIC PROCESS | 188 | 2.32e-01 | 5.06e-02 | 9.50e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 12 | 7.62e-01 | 5.05e-02 | 9.98e-01 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 295 | 1.35e-01 | -5.05e-02 | 8.98e-01 |
| GOBP RETICULOPHAGY | 18 | 7.11e-01 | 5.05e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 31 | 6.27e-01 | 5.05e-02 | 9.98e-01 |
| GOMF CARBONATE DEHYDRATASE ACTIVITY | 14 | 7.44e-01 | 5.05e-02 | 9.98e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 9 | 7.93e-01 | -5.05e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 54 | 5.21e-01 | 5.04e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 5 | 8.45e-01 | 5.04e-02 | 9.99e-01 |
| GOBP FEMALE MEIOSIS I | 13 | 7.53e-01 | -5.04e-02 | 9.98e-01 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 28 | 6.44e-01 | 5.04e-02 | 9.98e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 15 | 7.35e-01 | 5.04e-02 | 9.98e-01 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 506 | 5.24e-02 | 5.04e-02 | 7.81e-01 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 16 | 7.27e-01 | -5.04e-02 | 9.98e-01 |
| GOBP PEPTIDYL LYSINE DEACETYLATION | 6 | 8.31e-01 | -5.04e-02 | 9.98e-01 |
| GOBP CELL SUBSTRATE ADHESION | 342 | 1.10e-01 | -5.04e-02 | 8.76e-01 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 28 | 6.45e-01 | 5.03e-02 | 9.98e-01 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 17 | 7.19e-01 | 5.03e-02 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN FOLDING | 8 | 8.05e-01 | -5.03e-02 | 9.98e-01 |
| GOMF HEMOGLOBIN ALPHA BINDING | 5 | 8.46e-01 | -5.03e-02 | 9.99e-01 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 245 | 1.75e-01 | 5.03e-02 | 9.21e-01 |
| GOBP ENERGY HOMEOSTASIS | 76 | 4.48e-01 | 5.03e-02 | 9.95e-01 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 21 | 6.90e-01 | -5.03e-02 | 9.98e-01 |
| GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 8 | 8.05e-01 | -5.03e-02 | 9.98e-01 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 105 | 3.74e-01 | -5.02e-02 | 9.95e-01 |
| GOBP MUSCLE HYPERTROPHY | 103 | 3.79e-01 | 5.02e-02 | 9.95e-01 |
| GOBP CARDIOBLAST DIFFERENTIATION | 17 | 7.20e-01 | -5.01e-02 | 9.98e-01 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 41 | 5.79e-01 | 5.01e-02 | 9.96e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 7.95e-01 | 5.01e-02 | 9.98e-01 |
| GOBP REGULATION OF RESPIRATORY BURST | 15 | 7.37e-01 | 5.01e-02 | 9.98e-01 |
| GOBP CHOLESTEROL CATABOLIC PROCESS | 9 | 7.95e-01 | 5.00e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 18 | 7.14e-01 | 5.00e-02 | 9.98e-01 |
| GOMF EXONUCLEASE ACTIVITY | 81 | 4.37e-01 | 5.00e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 17 | 7.21e-01 | 5.00e-02 | 9.98e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY TYPE I | 5 | 8.47e-01 | 5.00e-02 | 9.99e-01 |
| GOBP SOFT PALATE DEVELOPMENT | 5 | 8.47e-01 | -4.99e-02 | 9.99e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 25 | 6.66e-01 | -4.99e-02 | 9.98e-01 |
| GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 7 | 8.19e-01 | 4.99e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS | 6 | 8.32e-01 | 4.99e-02 | 9.99e-01 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 6 | 8.32e-01 | 4.99e-02 | 9.99e-01 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 17 | 7.22e-01 | 4.99e-02 | 9.98e-01 |
| GOBP IRON ION TRANSPORT | 53 | 5.30e-01 | 4.99e-02 | 9.95e-01 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 70 | 4.71e-01 | 4.99e-02 | 9.95e-01 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 44 | 5.67e-01 | -4.99e-02 | 9.95e-01 |
| GOMF KINESIN BINDING | 43 | 5.72e-01 | 4.99e-02 | 9.95e-01 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 43 | 5.72e-01 | 4.98e-02 | 9.95e-01 |
| GOBP RESPONSE TO FUNGICIDE | 7 | 8.20e-01 | 4.98e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 10 | 7.85e-01 | 4.98e-02 | 9.98e-01 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 12 | 7.65e-01 | -4.98e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 20 | 7.00e-01 | -4.98e-02 | 9.98e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 25 | 6.67e-01 | -4.97e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 23 | 6.80e-01 | -4.97e-02 | 9.98e-01 |
| GOBP RESPONSE TO CARBOHYDRATE | 224 | 2.00e-01 | 4.97e-02 | 9.36e-01 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 14 | 7.48e-01 | -4.96e-02 | 9.98e-01 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 53 | 5.32e-01 | 4.96e-02 | 9.95e-01 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 12 | 7.66e-01 | 4.96e-02 | 9.98e-01 |
| GOCC BRAHMA COMPLEX | 14 | 7.48e-01 | 4.96e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 104 | 3.82e-01 | -4.96e-02 | 9.95e-01 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 808 | 1.67e-02 | -4.95e-02 | 6.37e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 880 | 1.26e-02 | 4.95e-02 | 6.10e-01 |
| GOBP NODAL SIGNALING PATHWAY | 16 | 7.32e-01 | 4.95e-02 | 9.98e-01 |
| GOCC CATALYTIC COMPLEX | 1609 | 9.28e-04 | 4.95e-02 | 1.86e-01 |
| GOBP REGULATION OF BEHAVIOR | 73 | 4.65e-01 | -4.95e-02 | 9.95e-01 |
| GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 7 | 8.21e-01 | -4.95e-02 | 9.98e-01 |
| GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 9 | 7.97e-01 | -4.94e-02 | 9.98e-01 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 482 | 6.31e-02 | -4.94e-02 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 88 | 4.23e-01 | -4.94e-02 | 9.95e-01 |
| GOBP REGULATION OF GLUTAMATE RECEPTOR CLUSTERING | 6 | 8.34e-01 | 4.94e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 17 | 7.24e-01 | 4.94e-02 | 9.98e-01 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 431 | 7.86e-02 | -4.94e-02 | 8.27e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 10 | 7.87e-01 | -4.94e-02 | 9.98e-01 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 62 | 5.01e-01 | -4.94e-02 | 9.95e-01 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 31 | 6.35e-01 | -4.93e-02 | 9.98e-01 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 18 | 7.17e-01 | -4.93e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO ACIDIC PH | 16 | 7.33e-01 | -4.93e-02 | 9.98e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 6 | 8.34e-01 | -4.93e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 9 | 7.98e-01 | -4.93e-02 | 9.98e-01 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 201 | 2.28e-01 | 4.93e-02 | 9.50e-01 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 145 | 3.06e-01 | -4.92e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 7 | 8.22e-01 | -4.92e-02 | 9.98e-01 |
| GOCC CIS GOLGI NETWORK | 55 | 5.28e-01 | 4.92e-02 | 9.95e-01 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 18 | 7.18e-01 | -4.92e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 15 | 7.41e-01 | -4.92e-02 | 9.98e-01 |
| GOBP TRNA CATABOLIC PROCESS | 16 | 7.33e-01 | -4.92e-02 | 9.98e-01 |
| GOBP PROTEIN POLYMERIZATION | 271 | 1.63e-01 | -4.92e-02 | 9.12e-01 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 11 | 7.78e-01 | 4.92e-02 | 9.98e-01 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 22 | 6.90e-01 | -4.92e-02 | 9.98e-01 |
| GOBP REGULATION OF ANOIKIS | 24 | 6.77e-01 | 4.92e-02 | 9.98e-01 |
| GOCC POSTSYNAPTIC ACTIN CYTOSKELETON | 5 | 8.49e-01 | -4.92e-02 | 9.99e-01 |
| GOBP REGULATION OF FLAGELLATED SPERM MOTILITY | 18 | 7.18e-01 | -4.92e-02 | 9.98e-01 |
| GOMF CHANNEL REGULATOR ACTIVITY | 135 | 3.24e-01 | -4.92e-02 | 9.87e-01 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 507 | 5.82e-02 | -4.91e-02 | 7.90e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 35 | 6.15e-01 | 4.91e-02 | 9.98e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 5 | 8.49e-01 | -4.91e-02 | 9.99e-01 |
| GOBP PIGMENT CELL DIFFERENTIATION | 35 | 6.15e-01 | -4.91e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 208 | 2.22e-01 | -4.91e-02 | 9.45e-01 |
| GOMF PROTEIN CARRIER CHAPERONE | 33 | 6.26e-01 | -4.91e-02 | 9.98e-01 |
| GOCC COPI VESICLE COAT | 13 | 7.59e-01 | 4.91e-02 | 9.98e-01 |
| GOCC SERINE TYPE PEPTIDASE COMPLEX | 13 | 7.59e-01 | -4.91e-02 | 9.98e-01 |
| GOCC FICOLIN 1 RICH GRANULE LUMEN | 121 | 3.52e-01 | 4.90e-02 | 9.94e-01 |
| GOCC GAMMA TUBULIN COMPLEX | 16 | 7.34e-01 | 4.90e-02 | 9.98e-01 |
| GOBP REGULATION OF AUTOPHAGY | 337 | 1.22e-01 | 4.90e-02 | 8.86e-01 |
| GOBP LEUKOCYTE PROLIFERATION | 330 | 1.26e-01 | 4.90e-02 | 8.91e-01 |
| GOBP HYALURONAN METABOLIC PROCESS | 33 | 6.27e-01 | -4.89e-02 | 9.98e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 14 | 7.51e-01 | 4.89e-02 | 9.98e-01 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 33 | 6.27e-01 | 4.89e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 10 | 7.89e-01 | 4.89e-02 | 9.98e-01 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 93 | 4.15e-01 | -4.89e-02 | 9.95e-01 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 92 | 4.18e-01 | 4.88e-02 | 9.95e-01 |
| GOBP NEURAL TUBE FORMATION | 103 | 3.92e-01 | 4.88e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 59 | 5.17e-01 | 4.88e-02 | 9.95e-01 |
| GOBP REGULATION OF GROWTH RATE | 5 | 8.50e-01 | 4.88e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 147 | 3.07e-01 | 4.88e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 693 | 2.86e-02 | 4.88e-02 | 6.86e-01 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 232 | 2.01e-01 | -4.87e-02 | 9.36e-01 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 64 | 5.01e-01 | -4.86e-02 | 9.95e-01 |
| GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 5 | 8.51e-01 | -4.86e-02 | 9.99e-01 |
| GOBP BONE DEVELOPMENT | 203 | 2.33e-01 | 4.86e-02 | 9.50e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 26 | 6.68e-01 | 4.86e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 141 | 3.20e-01 | 4.85e-02 | 9.87e-01 |
| GOBP REGULATION OF SREBP SIGNALING PATHWAY | 8 | 8.12e-01 | 4.85e-02 | 9.98e-01 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 155 | 2.97e-01 | 4.85e-02 | 9.83e-01 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 92 | 4.21e-01 | 4.85e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 27 | 6.63e-01 | -4.85e-02 | 9.98e-01 |
| GOCC CLATHRIN VESICLE COAT | 33 | 6.30e-01 | 4.85e-02 | 9.98e-01 |
| GOCC VACUOLAR MEMBRANE | 463 | 7.40e-02 | 4.85e-02 | 8.12e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 45 | 5.74e-01 | 4.84e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR BINDING | 6 | 8.37e-01 | -4.84e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 83 | 4.46e-01 | 4.84e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 71 | 4.81e-01 | 4.84e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 32 | 6.36e-01 | -4.84e-02 | 9.98e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 233 | 2.03e-01 | 4.84e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 14 | 7.54e-01 | -4.83e-02 | 9.98e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 76 | 4.66e-01 | -4.83e-02 | 9.95e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 10 | 7.91e-01 | -4.83e-02 | 9.98e-01 |
| GOBP CARDIAC CONDUCTION | 94 | 4.18e-01 | -4.83e-02 | 9.95e-01 |
| GOBP OXYGEN TRANSPORT | 15 | 7.46e-01 | 4.83e-02 | 9.98e-01 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 12 | 7.72e-01 | -4.83e-02 | 9.98e-01 |
| GOMF CUPROUS ION BINDING | 8 | 8.13e-01 | 4.83e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 9 | 8.02e-01 | -4.82e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MIGRATION | 6 | 8.38e-01 | 4.82e-02 | 9.99e-01 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 13 | 7.64e-01 | -4.82e-02 | 9.98e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 18 | 7.24e-01 | 4.81e-02 | 9.98e-01 |
| GOBP REGULATION OF ODONTOGENESIS | 18 | 7.24e-01 | -4.81e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 39 | 6.03e-01 | -4.81e-02 | 9.98e-01 |
| GOBP RESPONSE TO MONOSACCHARIDE | 200 | 2.41e-01 | 4.81e-02 | 9.57e-01 |
| GOBP MACROPHAGE DIFFERENTIATION | 61 | 5.16e-01 | 4.81e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 70 | 4.87e-01 | 4.81e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS | 7 | 8.26e-01 | -4.81e-02 | 9.98e-01 |
| GOBP AMP CATABOLIC PROCESS | 5 | 8.52e-01 | -4.81e-02 | 9.99e-01 |
| GOBP HINDGUT DEVELOPMENT | 8 | 8.14e-01 | 4.81e-02 | 9.98e-01 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 63 | 5.10e-01 | -4.80e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 19 | 7.17e-01 | -4.80e-02 | 9.98e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 9 | 8.03e-01 | 4.80e-02 | 9.98e-01 |
| GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 8.53e-01 | -4.80e-02 | 9.99e-01 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 37 | 6.14e-01 | -4.80e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 70 | 4.88e-01 | 4.80e-02 | 9.95e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 20 | 7.10e-01 | -4.80e-02 | 9.98e-01 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 330 | 1.34e-01 | 4.80e-02 | 8.96e-01 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 82 | 4.53e-01 | 4.80e-02 | 9.95e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 1133 | 6.48e-03 | 4.79e-02 | 4.74e-01 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 13 | 7.65e-01 | 4.79e-02 | 9.98e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 28 | 6.61e-01 | -4.79e-02 | 9.98e-01 |
| GOBP NCRNA PROCESSING | 415 | 9.42e-02 | 4.79e-02 | 8.55e-01 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 144 | 3.21e-01 | -4.79e-02 | 9.87e-01 |
| GOBP LAMELLIPODIUM ORGANIZATION | 86 | 4.43e-01 | -4.79e-02 | 9.95e-01 |
| GOBP RESPONSE TO ALDOSTERONE | 16 | 7.40e-01 | -4.78e-02 | 9.98e-01 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 195 | 2.50e-01 | 4.78e-02 | 9.58e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 9 | 8.04e-01 | -4.78e-02 | 9.98e-01 |
| GOMF TRNA BINDING | 73 | 4.80e-01 | -4.78e-02 | 9.95e-01 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 36 | 6.20e-01 | 4.78e-02 | 9.98e-01 |
| GOBP TRABECULA MORPHOGENESIS | 47 | 5.71e-01 | -4.77e-02 | 9.95e-01 |
| GOBP REGULATION OF GERMINAL CENTER FORMATION | 8 | 8.15e-01 | -4.77e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 197 | 2.49e-01 | 4.77e-02 | 9.58e-01 |
| GOMF NUCLEOSOME BINDING | 67 | 5.00e-01 | 4.77e-02 | 9.95e-01 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 121 | 3.65e-01 | -4.76e-02 | 9.95e-01 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 18 | 7.26e-01 | 4.76e-02 | 9.98e-01 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 74 | 4.79e-01 | 4.76e-02 | 9.95e-01 |
| GOCC PLASMA MEMBRANE RAFT | 112 | 3.84e-01 | 4.76e-02 | 9.95e-01 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 52 | 5.53e-01 | 4.76e-02 | 9.95e-01 |
| GOBP MEMBRANE DOCKING | 91 | 4.33e-01 | 4.76e-02 | 9.95e-01 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 52 | 5.53e-01 | 4.76e-02 | 9.95e-01 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 24 | 6.87e-01 | -4.76e-02 | 9.98e-01 |
| GOBP CILIUM MOVEMENT | 194 | 2.53e-01 | -4.76e-02 | 9.58e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 13 | 7.67e-01 | 4.75e-02 | 9.98e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 12 | 7.76e-01 | -4.75e-02 | 9.98e-01 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 63 | 5.14e-01 | -4.75e-02 | 9.95e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SKIN EPIDERMIS | 34 | 6.32e-01 | -4.75e-02 | 9.98e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 38 | 6.12e-01 | 4.75e-02 | 9.98e-01 |
| GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 6 | 8.40e-01 | 4.75e-02 | 9.99e-01 |
| GOBP T CELL PROLIFERATION | 202 | 2.45e-01 | 4.75e-02 | 9.58e-01 |
| GOBP MESONEPHROS DEVELOPMENT | 99 | 4.14e-01 | -4.75e-02 | 9.95e-01 |
| GOBP BLASTOCYST DEVELOPMENT | 113 | 3.83e-01 | 4.75e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 21 | 7.07e-01 | 4.74e-02 | 9.98e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 36 | 6.23e-01 | -4.74e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 8.54e-01 | -4.74e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 460 | 8.16e-02 | -4.74e-02 | 8.36e-01 |
| GOMF PHOSPHATE ION BINDING | 11 | 7.86e-01 | -4.74e-02 | 9.98e-01 |
| GOBP REGULATION OF BINDING | 253 | 1.95e-01 | 4.74e-02 | 9.28e-01 |
| GOCC CYTOCHROME COMPLEX | 34 | 6.33e-01 | -4.74e-02 | 9.98e-01 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 45 | 5.83e-01 | 4.73e-02 | 9.96e-01 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 71 | 4.91e-01 | 4.73e-02 | 9.95e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 126 | 3.60e-01 | -4.73e-02 | 9.95e-01 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 14 | 7.60e-01 | -4.72e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 139 | 3.36e-01 | -4.72e-02 | 9.88e-01 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 6.54e-01 | -4.72e-02 | 9.98e-01 |
| GOBP MAST CELL MEDIATED IMMUNITY | 55 | 5.45e-01 | 4.72e-02 | 9.95e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 50 | 5.64e-01 | 4.72e-02 | 9.95e-01 |
| GOBP GOLGI ORGANIZATION | 139 | 3.37e-01 | 4.72e-02 | 9.88e-01 |
| GOBP REGULATION OF T CELL ACTIVATION | 366 | 1.21e-01 | 4.72e-02 | 8.86e-01 |
| GOBP ERK1 AND ERK2 CASCADE | 331 | 1.40e-01 | -4.72e-02 | 9.02e-01 |
| GOMF MICROTUBULE MINUS END BINDING | 13 | 7.68e-01 | 4.72e-02 | 9.98e-01 |
| GOMF ATPASE BINDING | 82 | 4.60e-01 | -4.72e-02 | 9.95e-01 |
| GOMF WNT PROTEIN BINDING | 31 | 6.50e-01 | 4.71e-02 | 9.98e-01 |
| GOBP DAMP METABOLIC PROCESS | 7 | 8.29e-01 | 4.71e-02 | 9.98e-01 |
| GOBP PYRUVATE METABOLIC PROCESS | 112 | 3.89e-01 | 4.71e-02 | 9.95e-01 |
| GOBP GAS TRANSPORT | 22 | 7.03e-01 | 4.70e-02 | 9.98e-01 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 38 | 6.16e-01 | -4.70e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 335 | 1.39e-01 | -4.70e-02 | 9.02e-01 |
| GOBP CGMP MEDIATED SIGNALING | 30 | 6.56e-01 | 4.70e-02 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 18 | 7.30e-01 | -4.70e-02 | 9.98e-01 |
| GOBP REGULATION OF PHAGOCYTOSIS | 94 | 4.31e-01 | 4.70e-02 | 9.95e-01 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 94 | 4.32e-01 | -4.69e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 10 | 7.97e-01 | 4.69e-02 | 9.98e-01 |
| GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 11 | 7.88e-01 | 4.69e-02 | 9.98e-01 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 48 | 5.74e-01 | -4.69e-02 | 9.95e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 45 | 5.86e-01 | -4.69e-02 | 9.96e-01 |
| GOBP REGULATION OF OOCYTE MATURATION | 7 | 8.30e-01 | 4.69e-02 | 9.98e-01 |
| GOCC AXON CYTOPLASM | 60 | 5.30e-01 | 4.69e-02 | 9.95e-01 |
| GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 9 | 8.08e-01 | -4.69e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR BINDING | 12 | 7.79e-01 | 4.69e-02 | 9.98e-01 |
| GOBP REGULATION OF BONE REMODELING | 49 | 5.70e-01 | -4.69e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 10 | 7.97e-01 | 4.69e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION | 5 | 8.56e-01 | -4.69e-02 | 9.99e-01 |
| GOMF DEUBIQUITINASE ACTIVITY | 89 | 4.45e-01 | -4.68e-02 | 9.95e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 10 | 7.98e-01 | 4.68e-02 | 9.98e-01 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 1466 | 2.70e-03 | 4.68e-02 | 3.18e-01 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 26 | 6.79e-01 | 4.68e-02 | 9.98e-01 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 22 | 7.04e-01 | 4.68e-02 | 9.98e-01 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 27 | 6.74e-01 | 4.68e-02 | 9.98e-01 |
| GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION | 9 | 8.08e-01 | -4.68e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 26 | 6.80e-01 | -4.68e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 64 | 5.18e-01 | -4.67e-02 | 9.95e-01 |
| GOBP TEMPERATURE HOMEOSTASIS | 181 | 2.79e-01 | 4.67e-02 | 9.73e-01 |
| GOBP GLOMERULUS DEVELOPMENT | 68 | 5.06e-01 | -4.67e-02 | 9.95e-01 |
| GOCC PERINEURONAL NET | 10 | 7.98e-01 | -4.67e-02 | 9.98e-01 |
| GOMF RIBONUCLEASE P ACTIVITY | 12 | 7.80e-01 | -4.66e-02 | 9.98e-01 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 232 | 2.21e-01 | -4.66e-02 | 9.45e-01 |
| GOCC TRANSFERASE COMPLEX | 789 | 2.61e-02 | 4.66e-02 | 6.71e-01 |
| GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 13 | 7.71e-01 | 4.66e-02 | 9.98e-01 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 13 | 7.71e-01 | -4.65e-02 | 9.98e-01 |
| GOBP ARTERY DEVELOPMENT | 111 | 3.97e-01 | 4.65e-02 | 9.95e-01 |
| GOCC CILIARY BASAL BODY | 158 | 3.13e-01 | 4.65e-02 | 9.87e-01 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 341 | 1.40e-01 | 4.65e-02 | 9.02e-01 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 41 | 6.06e-01 | -4.65e-02 | 9.98e-01 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 72 | 4.95e-01 | -4.65e-02 | 9.95e-01 |
| GOBP PROTEIN DENEDDYLATION | 11 | 7.89e-01 | 4.65e-02 | 9.98e-01 |
| GOMF INSULIN RECEPTOR BINDING | 21 | 7.12e-01 | -4.65e-02 | 9.98e-01 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 39 | 6.16e-01 | -4.65e-02 | 9.98e-01 |
| GOMF ALPHA GLUCOSIDASE ACTIVITY | 5 | 8.57e-01 | 4.64e-02 | 9.99e-01 |
| GOBP UREA METABOLIC PROCESS | 12 | 7.81e-01 | 4.64e-02 | 9.98e-01 |
| GOBP EMBRYONIC SKELETAL JOINT DEVELOPMENT | 15 | 7.56e-01 | 4.63e-02 | 9.98e-01 |
| GOCC RESPIRASOME | 85 | 4.60e-01 | 4.63e-02 | 9.95e-01 |
| GOBP REGULATION OF RESPONSE TO TUMOR CELL | 22 | 7.07e-01 | -4.63e-02 | 9.98e-01 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 20 | 7.20e-01 | 4.63e-02 | 9.98e-01 |
| GOBP DENDRITE DEVELOPMENT | 218 | 2.39e-01 | -4.62e-02 | 9.55e-01 |
| GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 6 | 8.44e-01 | -4.62e-02 | 9.99e-01 |
| GOBP ERYTHROCYTE MATURATION | 17 | 7.42e-01 | 4.62e-02 | 9.98e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 406 | 1.10e-01 | 4.62e-02 | 8.76e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 406 | 1.10e-01 | 4.62e-02 | 8.76e-01 |
| GOBP REGULATION OF HYPERSENSITIVITY | 7 | 8.33e-01 | 4.61e-02 | 9.99e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 17 | 7.42e-01 | -4.61e-02 | 9.98e-01 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 38 | 6.23e-01 | -4.61e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 29 | 6.67e-01 | -4.61e-02 | 9.98e-01 |
| GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 19 | 7.28e-01 | 4.61e-02 | 9.98e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 25 | 6.90e-01 | 4.61e-02 | 9.98e-01 |
| GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 652 | 4.46e-02 | -4.61e-02 | 7.59e-01 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 22 | 7.08e-01 | -4.61e-02 | 9.98e-01 |
| GOBP REGULATION OF NK T CELL ACTIVATION | 11 | 7.91e-01 | 4.61e-02 | 9.98e-01 |
| GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 8.45e-01 | -4.61e-02 | 9.99e-01 |
| GOBP DNA CATABOLIC PROCESS | 29 | 6.68e-01 | 4.61e-02 | 9.98e-01 |
| GOCC ORGANELLAR RIBOSOME | 89 | 4.53e-01 | -4.60e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 20 | 7.22e-01 | 4.60e-02 | 9.98e-01 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 19 | 7.28e-01 | -4.60e-02 | 9.98e-01 |
| GOMF LIPID BINDING | 808 | 2.62e-02 | -4.60e-02 | 6.71e-01 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 15 | 7.58e-01 | 4.60e-02 | 9.98e-01 |
| GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 311 | 1.63e-01 | -4.60e-02 | 9.12e-01 |
| GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 7 | 8.33e-01 | -4.60e-02 | 9.99e-01 |
| GOBP CELL CYCLE | 1732 | 1.46e-03 | 4.60e-02 | 2.30e-01 |
| GOBP STEM CELL FATE SPECIFICATION | 6 | 8.46e-01 | 4.59e-02 | 9.99e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 18 | 7.36e-01 | -4.59e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 9 | 8.12e-01 | -4.59e-02 | 9.98e-01 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 101 | 4.26e-01 | -4.59e-02 | 9.95e-01 |
| GOBP AUTOPHAGOSOME MATURATION | 60 | 5.39e-01 | 4.58e-02 | 9.95e-01 |
| GOBP REGULATION OF CELL PROJECTION SIZE | 12 | 7.83e-01 | -4.58e-02 | 9.98e-01 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 44 | 5.99e-01 | -4.58e-02 | 9.98e-01 |
| GOCC ACTIN BASED CELL PROJECTION | 217 | 2.45e-01 | -4.58e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 8 | 8.22e-01 | 4.58e-02 | 9.98e-01 |
| GOBP PROTEIN HYDROXYLATION | 23 | 7.04e-01 | -4.58e-02 | 9.98e-01 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 70 | 5.07e-01 | 4.58e-02 | 9.95e-01 |
| GOCC RIBONUCLEASE MRP COMPLEX | 10 | 8.02e-01 | -4.58e-02 | 9.98e-01 |
| GOBP DETERMINATION OF LEFT RIGHT ASYMMETRY IN LATERAL MESODERM | 8 | 8.23e-01 | -4.58e-02 | 9.98e-01 |
| GOBP HEART TRABECULA MORPHOGENESIS | 32 | 6.54e-01 | -4.58e-02 | 9.98e-01 |
| GOBP TISSUE HOMEOSTASIS | 264 | 2.01e-01 | -4.57e-02 | 9.36e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 22 | 7.10e-01 | 4.57e-02 | 9.98e-01 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 25 | 6.92e-01 | 4.57e-02 | 9.98e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 59 | 5.44e-01 | 4.57e-02 | 9.95e-01 |
| GOBP CHORION DEVELOPMENT | 10 | 8.03e-01 | -4.56e-02 | 9.98e-01 |
| GOMF TETRAPYRROLE BINDING | 143 | 3.46e-01 | 4.56e-02 | 9.92e-01 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 282 | 1.87e-01 | 4.56e-02 | 9.28e-01 |
| GOBP NEURAL PLATE ANTERIOR POSTERIOR REGIONALIZATION | 5 | 8.60e-01 | -4.56e-02 | 9.99e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING | 76 | 4.92e-01 | 4.56e-02 | 9.95e-01 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 16 | 7.52e-01 | 4.56e-02 | 9.98e-01 |
| GOCC DENSE BODY | 5 | 8.60e-01 | 4.56e-02 | 9.99e-01 |
| GOBP GLUTAMINE METABOLIC PROCESS | 24 | 6.99e-01 | -4.56e-02 | 9.98e-01 |
| GOBP RESPONSE TO HYDROXYUREA | 11 | 7.94e-01 | 4.55e-02 | 9.98e-01 |
| GOBP ADENOHYPOPHYSIS DEVELOPMENT | 16 | 7.52e-01 | -4.55e-02 | 9.98e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 140 | 3.52e-01 | 4.55e-02 | 9.94e-01 |
| GOMF RS DOMAIN BINDING | 5 | 8.60e-01 | 4.55e-02 | 9.99e-01 |
| GOCC APICAL JUNCTION COMPLEX | 140 | 3.53e-01 | -4.55e-02 | 9.94e-01 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 8.13e-01 | 4.55e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 304 | 1.72e-01 | 4.55e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 60 | 5.42e-01 | -4.55e-02 | 9.95e-01 |
| GOBP VIRAL GENE EXPRESSION | 99 | 4.35e-01 | 4.54e-02 | 9.95e-01 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 93 | 4.49e-01 | -4.54e-02 | 9.95e-01 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 11 | 7.94e-01 | 4.54e-02 | 9.98e-01 |
| GOCC POSTSYNAPTIC CYTOSKELETON | 10 | 8.04e-01 | -4.54e-02 | 9.98e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 69 | 5.14e-01 | -4.54e-02 | 9.95e-01 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 19 | 7.32e-01 | 4.53e-02 | 9.98e-01 |
| GOBP TRANSLATIONAL TERMINATION | 15 | 7.61e-01 | -4.53e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 22 | 7.13e-01 | -4.53e-02 | 9.98e-01 |
| GOBP MITOTIC DNA REPLICATION | 15 | 7.61e-01 | 4.53e-02 | 9.98e-01 |
| GOBP NEURON APOPTOTIC PROCESS | 264 | 2.05e-01 | 4.53e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 202 | 2.67e-01 | -4.53e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS | 7 | 8.36e-01 | 4.53e-02 | 9.99e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ASSEMBLY | 7 | 8.36e-01 | -4.53e-02 | 9.99e-01 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 551 | 6.92e-02 | 4.53e-02 | 8.00e-01 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 24 | 7.01e-01 | -4.53e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 22 | 7.13e-01 | 4.52e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 73 | 5.04e-01 | -4.52e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 66 | 5.26e-01 | -4.52e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 8 | 8.25e-01 | 4.52e-02 | 9.98e-01 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 13 | 7.78e-01 | 4.51e-02 | 9.98e-01 |
| GOBP MYOBLAST MIGRATION | 13 | 7.78e-01 | 4.51e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 30 | 6.69e-01 | 4.51e-02 | 9.98e-01 |
| GOBP TRANSDIFFERENTIATION | 7 | 8.36e-01 | 4.51e-02 | 9.99e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 103 | 4.29e-01 | 4.51e-02 | 9.95e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 31 | 6.64e-01 | -4.51e-02 | 9.98e-01 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 84 | 4.75e-01 | 4.51e-02 | 9.95e-01 |
| GOBP PITUITARY GLAND DEVELOPMENT | 40 | 6.22e-01 | 4.51e-02 | 9.98e-01 |
| GOBP G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION | 6 | 8.48e-01 | -4.51e-02 | 9.99e-01 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 45 | 6.01e-01 | -4.50e-02 | 9.98e-01 |
| GOBP CLATHRIN COAT ASSEMBLY | 17 | 7.48e-01 | 4.50e-02 | 9.98e-01 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 18 | 7.41e-01 | 4.50e-02 | 9.98e-01 |
| GOBP NEURAL PLATE REGIONALIZATION | 6 | 8.49e-01 | 4.49e-02 | 9.99e-01 |
| GOMF LAMIN BINDING | 15 | 7.63e-01 | -4.49e-02 | 9.98e-01 |
| GOCC FICOLIN 1 RICH GRANULE | 180 | 2.99e-01 | 4.49e-02 | 9.84e-01 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 26 | 6.92e-01 | 4.49e-02 | 9.98e-01 |
| GOMF PHOSPHOLIPID BINDING | 456 | 1.01e-01 | -4.49e-02 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 52 | 5.76e-01 | 4.48e-02 | 9.96e-01 |
| GOMF GTPASE BINDING | 297 | 1.84e-01 | -4.48e-02 | 9.28e-01 |
| GOCC NEURON SPINE | 168 | 3.16e-01 | -4.48e-02 | 9.87e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 11 | 7.97e-01 | -4.48e-02 | 9.98e-01 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 107 | 4.23e-01 | 4.48e-02 | 9.95e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 12 | 7.88e-01 | -4.48e-02 | 9.98e-01 |
| GOBP NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT | 11 | 7.97e-01 | 4.48e-02 | 9.98e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 81 | 4.86e-01 | 4.48e-02 | 9.95e-01 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 16 | 7.56e-01 | 4.48e-02 | 9.98e-01 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 17 | 7.49e-01 | 4.48e-02 | 9.98e-01 |
| GOMF EXTRACELLULAR MATRIX BINDING | 54 | 5.70e-01 | 4.47e-02 | 9.95e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 6 | 8.50e-01 | 4.47e-02 | 9.99e-01 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 59 | 5.53e-01 | 4.47e-02 | 9.95e-01 |
| GOBP FAS SIGNALING PATHWAY | 8 | 8.27e-01 | 4.47e-02 | 9.98e-01 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 24 | 7.05e-01 | -4.47e-02 | 9.98e-01 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 488 | 9.10e-02 | 4.47e-02 | 8.53e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 61 | 5.46e-01 | -4.47e-02 | 9.95e-01 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 51 | 5.81e-01 | -4.47e-02 | 9.96e-01 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 90 | 4.64e-01 | 4.46e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 46 | 6.00e-01 | 4.46e-02 | 9.98e-01 |
| GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 8.38e-01 | -4.46e-02 | 9.99e-01 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 18 | 7.43e-01 | 4.46e-02 | 9.98e-01 |
| GOMF CCR6 CHEMOKINE RECEPTOR BINDING | 5 | 8.63e-01 | 4.46e-02 | 9.99e-01 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 34 | 6.53e-01 | 4.46e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 152 | 3.43e-01 | -4.46e-02 | 9.91e-01 |
| GOBP OPSONIZATION | 16 | 7.57e-01 | 4.46e-02 | 9.98e-01 |
| GOBP POLYOL CATABOLIC PROCESS | 9 | 8.17e-01 | -4.46e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 40 | 6.26e-01 | 4.46e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 8 | 8.27e-01 | -4.46e-02 | 9.98e-01 |
| GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 8 | 8.27e-01 | -4.46e-02 | 9.98e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 75 | 5.05e-01 | 4.46e-02 | 9.95e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 15 | 7.65e-01 | 4.46e-02 | 9.98e-01 |
| GOCC NUCLEOID | 43 | 6.13e-01 | 4.45e-02 | 9.98e-01 |
| GOBP FIBRINOLYSIS | 27 | 6.89e-01 | -4.45e-02 | 9.98e-01 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 19 | 7.37e-01 | 4.45e-02 | 9.98e-01 |
| GOBP INTRACELLULAR TRANSPORT OF VIRUS | 10 | 8.07e-01 | 4.45e-02 | 9.98e-01 |
| GOMF KINASE INHIBITOR ACTIVITY | 75 | 5.05e-01 | 4.45e-02 | 9.95e-01 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 162 | 3.28e-01 | -4.45e-02 | 9.87e-01 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 342 | 1.57e-01 | 4.45e-02 | 9.06e-01 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 55 | 5.68e-01 | 4.45e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 11 | 7.98e-01 | 4.45e-02 | 9.98e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 5 | 8.63e-01 | -4.44e-02 | 9.99e-01 |
| GOBP PROTEIN METHYLATION | 75 | 5.06e-01 | 4.44e-02 | 9.95e-01 |
| GOBP CYCLOOXYGENASE PATHWAY | 9 | 8.17e-01 | 4.44e-02 | 9.98e-01 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 147 | 3.53e-01 | -4.44e-02 | 9.94e-01 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 183 | 3.00e-01 | -4.44e-02 | 9.85e-01 |
| GOBP CELL RECOGNITION | 152 | 3.45e-01 | -4.44e-02 | 9.92e-01 |
| GOMF NUCLEAR RECEPTOR ACTIVITY | 51 | 5.83e-01 | -4.44e-02 | 9.96e-01 |
| GOBP PEROXISOME ORGANIZATION | 34 | 6.54e-01 | -4.44e-02 | 9.98e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 19 | 7.38e-01 | 4.44e-02 | 9.98e-01 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 468 | 1.00e-01 | -4.44e-02 | 8.65e-01 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 47 | 5.99e-01 | -4.43e-02 | 9.98e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 8.28e-01 | 4.43e-02 | 9.98e-01 |
| GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS | 8 | 8.28e-01 | -4.43e-02 | 9.98e-01 |
| GOCC CORVET COMPLEX | 7 | 8.39e-01 | 4.43e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 66 | 5.34e-01 | 4.43e-02 | 9.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 54 | 5.74e-01 | 4.43e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 7.59e-01 | -4.42e-02 | 9.98e-01 |
| GOBP SNORNA LOCALIZATION | 6 | 8.51e-01 | 4.42e-02 | 9.99e-01 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 559 | 7.39e-02 | -4.42e-02 | 8.12e-01 |
| GOBP RNA MODIFICATION | 168 | 3.23e-01 | 4.42e-02 | 9.87e-01 |
| GOBP GLUTATHIONE CATABOLIC PROCESS | 6 | 8.51e-01 | 4.42e-02 | 9.99e-01 |
| GOBP CHOLESTEROL EFFLUX | 73 | 5.14e-01 | 4.42e-02 | 9.95e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 449 | 1.09e-01 | 4.42e-02 | 8.75e-01 |
| GOBP NEURON PROJECTION EXTENSION | 167 | 3.25e-01 | -4.41e-02 | 9.87e-01 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 70 | 5.23e-01 | 4.41e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 163 | 3.31e-01 | 4.41e-02 | 9.88e-01 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 24 | 7.08e-01 | 4.41e-02 | 9.98e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 56 | 5.68e-01 | -4.41e-02 | 9.95e-01 |
| GOMF PROLINE RICH REGION BINDING | 17 | 7.53e-01 | -4.41e-02 | 9.98e-01 |
| GOBP AXONEME ASSEMBLY | 92 | 4.65e-01 | 4.41e-02 | 9.95e-01 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 9 | 8.19e-01 | 4.41e-02 | 9.98e-01 |
| GOBP LIPID CATABOLIC PROCESS | 328 | 1.70e-01 | 4.41e-02 | 9.20e-01 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 38 | 6.39e-01 | -4.40e-02 | 9.98e-01 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 85 | 4.83e-01 | 4.40e-02 | 9.95e-01 |
| GOCC ENDOLYSOSOME LUMEN | 5 | 8.65e-01 | -4.40e-02 | 9.99e-01 |
| GOBP PROTEIN ACETYLATION | 97 | 4.54e-01 | 4.40e-02 | 9.95e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 17 | 7.53e-01 | -4.40e-02 | 9.98e-01 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 133 | 3.81e-01 | 4.40e-02 | 9.95e-01 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 57 | 5.66e-01 | -4.40e-02 | 9.95e-01 |
| GOMF NUCLEOSIDE BINDING | 8 | 8.30e-01 | -4.39e-02 | 9.98e-01 |
| GOCC SARCOPLASM | 90 | 4.71e-01 | -4.39e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 166 | 3.29e-01 | -4.39e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 60 | 5.56e-01 | 4.39e-02 | 9.95e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 12 | 7.92e-01 | 4.39e-02 | 9.98e-01 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 286 | 2.02e-01 | 4.39e-02 | 9.36e-01 |
| GOMF G QUADRUPLEX DNA BINDING | 11 | 8.01e-01 | -4.38e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 203 | 2.82e-01 | -4.38e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 231 | 2.51e-01 | 4.38e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 149 | 3.56e-01 | -4.38e-02 | 9.95e-01 |
| GOBP MITOCHONDRIAL TRANSPORT | 180 | 3.11e-01 | 4.38e-02 | 9.87e-01 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 97 | 4.56e-01 | 4.38e-02 | 9.95e-01 |
| GOCC P BODY | 98 | 4.54e-01 | -4.38e-02 | 9.95e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 8.41e-01 | -4.37e-02 | 9.99e-01 |
| GOBP ADP BIOSYNTHETIC PROCESS | 5 | 8.66e-01 | 4.37e-02 | 9.99e-01 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 16 | 7.62e-01 | 4.37e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 6 | 8.53e-01 | 4.37e-02 | 9.99e-01 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 13 | 7.85e-01 | 4.36e-02 | 9.98e-01 |
| GOBP PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS | 6 | 8.53e-01 | -4.36e-02 | 9.99e-01 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 8.02e-01 | 4.36e-02 | 9.98e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL ACTIVATION | 8 | 8.31e-01 | 4.36e-02 | 9.98e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 10 | 8.11e-01 | -4.36e-02 | 9.98e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 67 | 5.37e-01 | -4.36e-02 | 9.95e-01 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 11 | 8.02e-01 | 4.36e-02 | 9.98e-01 |
| GOBP REGULATION OF GTP BINDING | 11 | 8.02e-01 | 4.36e-02 | 9.98e-01 |
| GOBP NEURON RECOGNITION | 45 | 6.13e-01 | -4.36e-02 | 9.98e-01 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 23 | 7.18e-01 | 4.35e-02 | 9.98e-01 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 28 | 6.90e-01 | 4.35e-02 | 9.98e-01 |
| GOBP MUSCLE CELL DIFFERENTIATION | 407 | 1.32e-01 | 4.35e-02 | 8.96e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSPORT | 29 | 6.85e-01 | -4.35e-02 | 9.98e-01 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 29 | 6.86e-01 | 4.34e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 11 | 8.03e-01 | -4.34e-02 | 9.98e-01 |
| GOBP METANEPHRIC GLOMERULAR MESANGIUM DEVELOPMENT | 5 | 8.67e-01 | -4.34e-02 | 9.99e-01 |
| GOBP PRESYNAPSE ORGANIZATION | 44 | 6.18e-01 | 4.34e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 14 | 7.79e-01 | -4.34e-02 | 9.98e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 39 | 6.39e-01 | -4.34e-02 | 9.98e-01 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 27 | 6.97e-01 | -4.34e-02 | 9.98e-01 |
| GOBP TYPE II INTERFERON PRODUCTION | 111 | 4.30e-01 | 4.33e-02 | 9.95e-01 |
| GOBP ENDOCARDIUM DEVELOPMENT | 12 | 7.95e-01 | -4.33e-02 | 9.98e-01 |
| GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY | 10 | 8.13e-01 | 4.33e-02 | 9.98e-01 |
| GOCC TRANSPORT VESICLE MEMBRANE | 223 | 2.65e-01 | -4.33e-02 | 9.66e-01 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 104 | 4.46e-01 | 4.33e-02 | 9.95e-01 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 540 | 8.54e-02 | -4.33e-02 | 8.39e-01 |
| GOBP RIBONUCLEOTIDE CATABOLIC PROCESS | 48 | 6.04e-01 | -4.33e-02 | 9.98e-01 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 159 | 3.47e-01 | 4.32e-02 | 9.92e-01 |
| GOCC PORE COMPLEX | 24 | 7.14e-01 | 4.32e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 201 | 2.91e-01 | -4.32e-02 | 9.79e-01 |
| GOCC NUCLEAR ENVELOPE | 464 | 1.11e-01 | 4.32e-02 | 8.76e-01 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 66 | 5.44e-01 | 4.32e-02 | 9.95e-01 |
| GOBP MITRAL VALVE DEVELOPMENT | 13 | 7.87e-01 | 4.32e-02 | 9.98e-01 |
| GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 14 | 7.80e-01 | 4.32e-02 | 9.98e-01 |
| GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY | 11 | 8.04e-01 | 4.32e-02 | 9.98e-01 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 19 | 7.45e-01 | -4.31e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 14 | 7.80e-01 | -4.31e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 112 | 4.32e-01 | 4.30e-02 | 9.95e-01 |
| GOBP INTERMEDIATE FILAMENT BUNDLE ASSEMBLY | 8 | 8.33e-01 | -4.30e-02 | 9.99e-01 |
| GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.55e-01 | 4.30e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 132 | 3.94e-01 | 4.30e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 52 | 5.92e-01 | -4.30e-02 | 9.98e-01 |
| GOBP FAT CELL DIFFERENTIATION | 243 | 2.49e-01 | 4.30e-02 | 9.58e-01 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 30 | 6.84e-01 | 4.30e-02 | 9.98e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 626 | 6.65e-02 | 4.30e-02 | 7.99e-01 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 684 | 5.55e-02 | -4.29e-02 | 7.90e-01 |
| GOBP MEMBRANE FUSION | 174 | 3.28e-01 | -4.29e-02 | 9.87e-01 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 17 | 7.59e-01 | -4.29e-02 | 9.98e-01 |
| GOBP LYMPHOCYTE MIGRATION | 114 | 4.28e-01 | -4.29e-02 | 9.95e-01 |
| GOBP MICROTUBULE ANCHORING | 23 | 7.22e-01 | 4.29e-02 | 9.98e-01 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 16 | 7.67e-01 | 4.29e-02 | 9.98e-01 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 22 | 7.28e-01 | -4.29e-02 | 9.98e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 11 | 8.06e-01 | -4.28e-02 | 9.98e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 8.34e-01 | -4.28e-02 | 9.99e-01 |
| GOBP ENDOTHELIUM DEVELOPMENT | 142 | 3.78e-01 | 4.28e-02 | 9.95e-01 |
| GOBP RESPONSE TO ESTROGEN | 66 | 5.47e-01 | 4.28e-02 | 9.95e-01 |
| GOCC VESICLE LUMEN | 311 | 1.94e-01 | 4.28e-02 | 9.28e-01 |
| GOBP BLOOD COAGULATION INTRINSIC PATHWAY | 6 | 8.56e-01 | 4.28e-02 | 9.99e-01 |
| GOCC FEMALE PRONUCLEUS | 10 | 8.15e-01 | -4.28e-02 | 9.98e-01 |
| GOCC ORGANELLE ENVELOPE LUMEN | 86 | 4.93e-01 | -4.27e-02 | 9.95e-01 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 182 | 3.20e-01 | 4.27e-02 | 9.87e-01 |
| GOBP RESPONSE TO VITAMIN | 82 | 5.04e-01 | 4.27e-02 | 9.95e-01 |
| GOMF ESTROGEN RESPONSE ELEMENT BINDING | 10 | 8.15e-01 | -4.27e-02 | 9.98e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGNALING PATHWAY | 6 | 8.56e-01 | 4.27e-02 | 9.99e-01 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 188 | 3.13e-01 | 4.27e-02 | 9.87e-01 |
| GOBP REGULATION OF CENTROSOME CYCLE | 54 | 5.89e-01 | 4.26e-02 | 9.97e-01 |
| GOBP SPERM MOTILITY | 127 | 4.08e-01 | -4.25e-02 | 9.95e-01 |
| GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 16 | 7.69e-01 | 4.25e-02 | 9.98e-01 |
| GOBP ELECTRON TRANSPORT CHAIN | 155 | 3.61e-01 | 4.25e-02 | 9.95e-01 |
| GOBP PROSTAGLANDIN SECRETION | 17 | 7.62e-01 | -4.25e-02 | 9.98e-01 |
| GOMF DEAMINASE ACTIVITY | 33 | 6.73e-01 | 4.25e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 329 | 1.85e-01 | 4.25e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 74 | 5.28e-01 | 4.25e-02 | 9.95e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 28 | 6.97e-01 | -4.25e-02 | 9.98e-01 |
| GOBP RRNA METABOLIC PROCESS | 253 | 2.45e-01 | 4.24e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 39 | 6.47e-01 | -4.24e-02 | 9.98e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 61 | 5.67e-01 | 4.24e-02 | 9.95e-01 |
| GOBP NEUROTRANSMITTER TRANSPORT | 198 | 3.04e-01 | -4.24e-02 | 9.87e-01 |
| GOBP RESPONSE TO FATTY ACID | 55 | 5.87e-01 | 4.24e-02 | 9.97e-01 |
| GOBP NEURON REMODELING | 15 | 7.76e-01 | 4.23e-02 | 9.98e-01 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 45 | 6.23e-01 | 4.23e-02 | 9.98e-01 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 235 | 2.64e-01 | 4.23e-02 | 9.64e-01 |
| GOBP GLUCOSE METABOLIC PROCESS | 183 | 3.24e-01 | 4.23e-02 | 9.87e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 451 | 1.24e-01 | 4.23e-02 | 8.90e-01 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 215 | 2.85e-01 | -4.23e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 63 | 5.62e-01 | -4.23e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 32 | 6.79e-01 | 4.23e-02 | 9.98e-01 |
| GOBP ACTION POTENTIAL | 139 | 3.90e-01 | -4.22e-02 | 9.95e-01 |
| GOBP ADP METABOLIC PROCESS | 8 | 8.36e-01 | 4.22e-02 | 9.99e-01 |
| GOBP RESPONSE TO OSMOTIC STRESS | 79 | 5.16e-01 | 4.22e-02 | 9.95e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 55 | 5.88e-01 | -4.22e-02 | 9.97e-01 |
| GOBP RIBOSOME BIOGENESIS | 303 | 2.07e-01 | 4.22e-02 | 9.38e-01 |
| GOBP SKELETAL MUSCLE ATROPHY | 5 | 8.70e-01 | 4.22e-02 | 9.99e-01 |
| GOMF CYTOKINE BINDING | 133 | 4.01e-01 | -4.22e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 33 | 6.75e-01 | -4.21e-02 | 9.98e-01 |
| GOCC GOLGI ASSOCIATED VESICLE | 88 | 4.95e-01 | -4.21e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 18 | 7.57e-01 | -4.21e-02 | 9.98e-01 |
| GOBP CAMP CATABOLIC PROCESS | 9 | 8.27e-01 | 4.20e-02 | 9.98e-01 |
| GOBP LEUKOCYTE HOMEOSTASIS | 103 | 4.61e-01 | -4.20e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 19 | 7.51e-01 | -4.20e-02 | 9.98e-01 |
| GOBP SLEEP | 22 | 7.33e-01 | -4.20e-02 | 9.98e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 57 | 5.83e-01 | 4.20e-02 | 9.96e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 117 | 4.33e-01 | 4.20e-02 | 9.95e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 23 | 7.27e-01 | -4.20e-02 | 9.98e-01 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 52 | 6.01e-01 | -4.20e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 591 | 8.13e-02 | 4.20e-02 | 8.36e-01 |
| GOMF POTASSIUM ION BINDING | 13 | 7.93e-01 | 4.20e-02 | 9.98e-01 |
| GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION | 6 | 8.59e-01 | -4.19e-02 | 9.99e-01 |
| GOBP HISTONE H4 ACETYLATION | 11 | 8.10e-01 | 4.19e-02 | 9.98e-01 |
| GOBP RESPONSE TO FOOD | 35 | 6.68e-01 | -4.19e-02 | 9.98e-01 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 20 | 7.46e-01 | -4.19e-02 | 9.98e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 304 | 2.10e-01 | 4.18e-02 | 9.39e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 37 | 6.60e-01 | 4.18e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 18 | 7.59e-01 | -4.18e-02 | 9.98e-01 |
| GOCC HAUS COMPLEX | 7 | 8.48e-01 | -4.18e-02 | 9.99e-01 |
| GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 53 | 5.99e-01 | 4.18e-02 | 9.98e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 24 | 7.23e-01 | 4.17e-02 | 9.98e-01 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 44 | 6.32e-01 | -4.17e-02 | 9.98e-01 |
| GOBP MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 6 | 8.60e-01 | 4.17e-02 | 9.99e-01 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 63 | 5.67e-01 | 4.17e-02 | 9.95e-01 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 129 | 4.14e-01 | 4.17e-02 | 9.95e-01 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 8.19e-01 | 4.17e-02 | 9.98e-01 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 29 | 6.98e-01 | -4.16e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 22 | 7.35e-01 | -4.16e-02 | 9.98e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 102 | 4.68e-01 | -4.16e-02 | 9.95e-01 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 15 | 7.80e-01 | -4.16e-02 | 9.98e-01 |
| GOBP SMOOTH MUSCLE CELL CHEMOTAXIS | 9 | 8.29e-01 | 4.16e-02 | 9.98e-01 |
| GOMF CHROMO SHADOW DOMAIN BINDING | 5 | 8.72e-01 | -4.15e-02 | 9.99e-01 |
| GOCC CAVEOLA | 81 | 5.18e-01 | 4.15e-02 | 9.95e-01 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 71 | 5.45e-01 | 4.15e-02 | 9.95e-01 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 74 | 5.37e-01 | 4.15e-02 | 9.95e-01 |
| GOMF PEPTIDE BINDING | 302 | 2.15e-01 | -4.15e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 21 | 7.42e-01 | 4.15e-02 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 81 | 5.19e-01 | -4.15e-02 | 9.95e-01 |
| GOCC COPI COATED VESICLE | 25 | 7.20e-01 | 4.14e-02 | 9.98e-01 |
| GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 8.12e-01 | -4.14e-02 | 9.98e-01 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 29 | 7.00e-01 | -4.14e-02 | 9.98e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 24 | 7.26e-01 | -4.14e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 1007 | 2.66e-02 | 4.13e-02 | 6.73e-01 |
| GOBP RESPONSE TO COCAINE | 47 | 6.24e-01 | -4.13e-02 | 9.98e-01 |
| GOMF MYOSIN II BINDING | 12 | 8.04e-01 | 4.13e-02 | 9.98e-01 |
| GOBP MITOCHONDRION ORGANIZATION | 522 | 1.06e-01 | 4.13e-02 | 8.68e-01 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 44 | 6.36e-01 | -4.13e-02 | 9.98e-01 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 9 | 8.30e-01 | -4.13e-02 | 9.98e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 15 | 7.82e-01 | 4.12e-02 | 9.98e-01 |
| GOBP METANEPHRIC GLOMERULUS DEVELOPMENT | 16 | 7.75e-01 | 4.12e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 56 | 5.94e-01 | 4.12e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 12 | 8.05e-01 | -4.12e-02 | 9.98e-01 |
| GOMF TYPE 2 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 5 | 8.73e-01 | -4.12e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 482 | 1.22e-01 | 4.12e-02 | 8.86e-01 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 141 | 3.99e-01 | 4.11e-02 | 9.95e-01 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 84 | 5.15e-01 | 4.11e-02 | 9.95e-01 |
| GOMF GDP PHOSPHATASE ACTIVITY | 10 | 8.22e-01 | 4.11e-02 | 9.98e-01 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 117 | 4.42e-01 | 4.11e-02 | 9.95e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 125 | 4.27e-01 | 4.11e-02 | 9.95e-01 |
| GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 14 | 7.90e-01 | -4.11e-02 | 9.98e-01 |
| GOBP HEART VALVE MORPHOGENESIS | 60 | 5.82e-01 | 4.10e-02 | 9.96e-01 |
| GOBP GLYCOLYTIC PROCESS | 85 | 5.13e-01 | 4.10e-02 | 9.95e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 39 | 6.57e-01 | -4.10e-02 | 9.98e-01 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 41 | 6.49e-01 | -4.10e-02 | 9.98e-01 |
| GOMF ELECTRON TRANSFER ACTIVITY | 99 | 4.81e-01 | 4.10e-02 | 9.95e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 18 | 7.63e-01 | 4.10e-02 | 9.98e-01 |
| GOMF ALPHA ACTININ BINDING | 28 | 7.07e-01 | -4.10e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 9 | 8.31e-01 | -4.10e-02 | 9.99e-01 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 11 | 8.14e-01 | 4.10e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 62 | 5.77e-01 | 4.10e-02 | 9.96e-01 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 58 | 5.89e-01 | -4.10e-02 | 9.97e-01 |
| GOBP ACTIN FILAMENT SEVERING | 16 | 7.77e-01 | 4.10e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 32 | 6.89e-01 | 4.09e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 146 | 3.94e-01 | 4.09e-02 | 9.95e-01 |
| GOBP CORTICOTROPIN SECRETION | 7 | 8.51e-01 | 4.09e-02 | 9.99e-01 |
| GOBP MYELOID CELL HOMEOSTASIS | 165 | 3.65e-01 | 4.09e-02 | 9.95e-01 |
| GOBP MALE SEX DIFFERENTIATION | 163 | 3.68e-01 | 4.09e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 89 | 5.05e-01 | -4.09e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 22 | 7.40e-01 | -4.08e-02 | 9.98e-01 |
| GOBP SISTER CHROMATID COHESION | 52 | 6.11e-01 | 4.08e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 146 | 3.95e-01 | 4.08e-02 | 9.95e-01 |
| GOBP FATTY ACID ELONGATION | 12 | 8.07e-01 | -4.08e-02 | 9.98e-01 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 158 | 3.76e-01 | -4.08e-02 | 9.95e-01 |
| GOMF ACYL COA BINDING | 19 | 7.58e-01 | -4.08e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 37 | 6.68e-01 | 4.08e-02 | 9.98e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 117 | 4.46e-01 | 4.08e-02 | 9.95e-01 |
| GOBP REGULATION OF MYELINATION | 45 | 6.36e-01 | 4.07e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING | 9 | 8.32e-01 | 4.07e-02 | 9.99e-01 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 12 | 8.07e-01 | -4.07e-02 | 9.98e-01 |
| GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS | 12 | 8.07e-01 | -4.07e-02 | 9.98e-01 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 47 | 6.30e-01 | 4.06e-02 | 9.98e-01 |
| GOBP RESPONSE TO CAMP | 81 | 5.27e-01 | -4.06e-02 | 9.95e-01 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 31 | 6.95e-01 | -4.06e-02 | 9.98e-01 |
| GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 10 | 8.24e-01 | 4.06e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 72 | 5.51e-01 | 4.06e-02 | 9.95e-01 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 110 | 4.62e-01 | 4.06e-02 | 9.95e-01 |
| GOMF METALLOCHAPERONE ACTIVITY | 12 | 8.08e-01 | 4.06e-02 | 9.98e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 13 | 8.00e-01 | -4.05e-02 | 9.98e-01 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 16 | 7.79e-01 | -4.05e-02 | 9.98e-01 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 16 | 7.79e-01 | -4.05e-02 | 9.98e-01 |
| GOBP PARENTAL BEHAVIOR | 10 | 8.24e-01 | -4.05e-02 | 9.98e-01 |
| GOCC ROD PHOTORECEPTOR OUTER SEGMENT | 5 | 8.75e-01 | 4.05e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 23 | 7.37e-01 | 4.05e-02 | 9.98e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 436 | 1.48e-01 | 4.04e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 132 | 4.23e-01 | 4.04e-02 | 9.95e-01 |
| GOBP LIPID IMPORT INTO CELL | 20 | 7.54e-01 | 4.04e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 28 | 7.11e-01 | 4.04e-02 | 9.98e-01 |
| GOMF ENZYME INHIBITOR ACTIVITY | 370 | 1.82e-01 | -4.04e-02 | 9.27e-01 |
| GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 12 | 8.09e-01 | -4.04e-02 | 9.98e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 41 | 6.55e-01 | 4.04e-02 | 9.98e-01 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 658 | 7.74e-02 | -4.04e-02 | 8.25e-01 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 155 | 3.86e-01 | -4.04e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 68 | 5.65e-01 | -4.03e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 24 | 7.32e-01 | 4.03e-02 | 9.98e-01 |
| GOBP AGGREPHAGY | 10 | 8.25e-01 | -4.03e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 112 | 4.61e-01 | -4.03e-02 | 9.95e-01 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 677 | 7.38e-02 | 4.03e-02 | 8.12e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 62 | 5.83e-01 | -4.03e-02 | 9.96e-01 |
| GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN | 107 | 4.72e-01 | 4.03e-02 | 9.95e-01 |
| GOMF INORGANIC DIPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 8.76e-01 | 4.03e-02 | 9.99e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE | 780 | 5.57e-02 | 4.03e-02 | 7.90e-01 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 9 | 8.34e-01 | 4.03e-02 | 9.99e-01 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 113 | 4.60e-01 | 4.02e-02 | 9.95e-01 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 85 | 5.22e-01 | -4.02e-02 | 9.95e-01 |
| GOBP DOPAMINE SECRETION | 41 | 6.56e-01 | -4.02e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 18 | 7.68e-01 | -4.02e-02 | 9.98e-01 |
| GOCC ENDOSOME LUMEN | 37 | 6.73e-01 | -4.02e-02 | 9.98e-01 |
| GOBP PEPTIDYL LYSINE TRIMETHYLATION | 9 | 8.35e-01 | 4.01e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 9 | 8.35e-01 | -4.01e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 8 | 8.44e-01 | 4.01e-02 | 9.99e-01 |
| GOBP PROTEIN UNFOLDING | 5 | 8.76e-01 | 4.01e-02 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 39 | 6.65e-01 | -4.01e-02 | 9.98e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 8 | 8.44e-01 | -4.01e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 134 | 4.23e-01 | 4.01e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO X RAY | 11 | 8.18e-01 | -4.01e-02 | 9.98e-01 |
| GOBP REGULATION OF APPETITE | 19 | 7.63e-01 | 4.00e-02 | 9.98e-01 |
| GOBP GLUCOSE IMPORT | 75 | 5.49e-01 | 4.00e-02 | 9.95e-01 |
| GOMF ACROSIN BINDING | 5 | 8.77e-01 | -4.00e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 28 | 7.14e-01 | 4.00e-02 | 9.98e-01 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 11 | 8.19e-01 | 4.00e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 34 | 6.87e-01 | -4.00e-02 | 9.98e-01 |
| GOBP RIG I SIGNALING PATHWAY | 28 | 7.14e-01 | 3.99e-02 | 9.98e-01 |
| GOBP MALE GENITALIA DEVELOPMENT | 23 | 7.40e-01 | -3.99e-02 | 9.98e-01 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 360 | 1.93e-01 | 3.99e-02 | 9.28e-01 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 15 | 7.89e-01 | 3.99e-02 | 9.98e-01 |
| GOBP SPHINGOMYELIN CATABOLIC PROCESS | 8 | 8.45e-01 | 3.99e-02 | 9.99e-01 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 173 | 3.66e-01 | -3.99e-02 | 9.95e-01 |
| GOCC CHROMOSOME CENTROMERIC CORE DOMAIN | 17 | 7.76e-01 | 3.98e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 41 | 6.59e-01 | -3.98e-02 | 9.98e-01 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 13 | 8.04e-01 | 3.98e-02 | 9.98e-01 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 129 | 4.35e-01 | 3.98e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 72 | 5.59e-01 | -3.98e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 26 | 7.25e-01 | 3.98e-02 | 9.98e-01 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 8.11e-01 | 3.98e-02 | 9.98e-01 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 82 | 5.34e-01 | 3.98e-02 | 9.95e-01 |
| GOCC LSM2 8 COMPLEX | 7 | 8.56e-01 | 3.97e-02 | 9.99e-01 |
| GOBP REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 8.78e-01 | -3.97e-02 | 9.99e-01 |
| GOBP AMINO ACID SALVAGE | 7 | 8.56e-01 | 3.97e-02 | 9.99e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 8 | 8.46e-01 | 3.96e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 9 | 8.37e-01 | -3.96e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CORTICOSTEROID HORMONE SECRETION | 7 | 8.56e-01 | -3.96e-02 | 9.99e-01 |
| GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY | 13 | 8.05e-01 | -3.96e-02 | 9.98e-01 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 65 | 5.81e-01 | 3.96e-02 | 9.96e-01 |
| GOBP REGULATION OF HEART CONTRACTION | 199 | 3.36e-01 | -3.96e-02 | 9.88e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 6 | 8.67e-01 | 3.96e-02 | 9.99e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLIPPASE ACTIVITY | 5 | 8.78e-01 | 3.96e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 32 | 6.99e-01 | -3.96e-02 | 9.98e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 20 | 7.60e-01 | 3.95e-02 | 9.98e-01 |
| GOMF RNA STEM LOOP BINDING | 14 | 7.98e-01 | -3.95e-02 | 9.98e-01 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 20 | 7.60e-01 | 3.95e-02 | 9.98e-01 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 90 | 5.18e-01 | -3.95e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 170 | 3.75e-01 | 3.94e-02 | 9.95e-01 |
| GOBP RESPONSE TO SODIUM ARSENITE | 6 | 8.67e-01 | -3.94e-02 | 9.99e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 73 | 5.60e-01 | -3.94e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 21 | 7.54e-01 | 3.94e-02 | 9.98e-01 |
| GOBP LOCOMOTORY BEHAVIOR | 198 | 3.39e-01 | 3.94e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 752 | 6.61e-02 | 3.94e-02 | 7.99e-01 |
| GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 6 | 8.67e-01 | -3.94e-02 | 9.99e-01 |
| GOBP REGULATION OF HEART RATE | 99 | 4.99e-01 | -3.93e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 11 | 8.21e-01 | -3.93e-02 | 9.98e-01 |
| GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 18 | 7.73e-01 | 3.93e-02 | 9.98e-01 |
| GOBP TRANSLATIONAL ELONGATION | 68 | 5.75e-01 | 3.93e-02 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 107 | 4.83e-01 | -3.93e-02 | 9.95e-01 |
| GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 85 | 5.31e-01 | -3.93e-02 | 9.95e-01 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 118 | 4.62e-01 | -3.92e-02 | 9.95e-01 |
| GOCC ENDOPEPTIDASE COMPLEX | 83 | 5.37e-01 | 3.92e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 83 | 5.37e-01 | -3.92e-02 | 9.95e-01 |
| GOBP B CELL ACTIVATION | 261 | 2.76e-01 | 3.92e-02 | 9.73e-01 |
| GOBP CYTOKINESIS | 177 | 3.68e-01 | 3.92e-02 | 9.95e-01 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 19 | 7.68e-01 | -3.92e-02 | 9.98e-01 |
| GOBP RESPONSE TO ANGIOTENSIN | 35 | 6.88e-01 | -3.92e-02 | 9.98e-01 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 8.00e-01 | 3.92e-02 | 9.98e-01 |
| GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS | 8 | 8.48e-01 | -3.92e-02 | 9.99e-01 |
| GOCC PLASMA MEMBRANE REGION | 1248 | 2.00e-02 | -3.91e-02 | 6.41e-01 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 16 | 7.86e-01 | 3.91e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 61 | 5.97e-01 | 3.91e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 11 | 8.22e-01 | -3.91e-02 | 9.98e-01 |
| GOBP RESPONSE TO HEAT | 99 | 5.01e-01 | 3.91e-02 | 9.95e-01 |
| GOBP ENDOPLASMIC RETICULUM PLASMA MEMBRANE TETHERING | 6 | 8.68e-01 | -3.91e-02 | 9.99e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 16 | 7.87e-01 | 3.91e-02 | 9.98e-01 |
| GOBP HEART GROWTH | 94 | 5.13e-01 | 3.91e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 53 | 6.23e-01 | 3.91e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 12 | 8.15e-01 | 3.91e-02 | 9.98e-01 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 80 | 5.46e-01 | -3.91e-02 | 9.95e-01 |
| GOBP CELL CYCLE PROCESS | 1242 | 2.06e-02 | 3.91e-02 | 6.41e-01 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 52 | 6.26e-01 | -3.91e-02 | 9.98e-01 |
| GOBP REGULATION OF AXON EXTENSION | 85 | 5.34e-01 | 3.90e-02 | 9.95e-01 |
| GOMF FRIZZLED BINDING | 36 | 6.85e-01 | -3.90e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 11 | 8.23e-01 | -3.90e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 35 | 6.90e-01 | -3.90e-02 | 9.98e-01 |
| GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 8.49e-01 | -3.90e-02 | 9.99e-01 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 54 | 6.20e-01 | 3.90e-02 | 9.98e-01 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 292 | 2.52e-01 | 3.90e-02 | 9.58e-01 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 64 | 5.90e-01 | -3.89e-02 | 9.98e-01 |
| GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 11 | 8.23e-01 | 3.89e-02 | 9.98e-01 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 7.94e-01 | 3.89e-02 | 9.98e-01 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 78 | 5.53e-01 | -3.89e-02 | 9.95e-01 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 200 | 3.43e-01 | -3.89e-02 | 9.91e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 203 | 3.39e-01 | 3.89e-02 | 9.88e-01 |
| GOCC NEURON PROJECTION CYTOPLASM | 82 | 5.43e-01 | 3.89e-02 | 9.95e-01 |
| GOBP RESPONSE TO METAL ION | 344 | 2.16e-01 | -3.88e-02 | 9.42e-01 |
| GOBP MICROGLIAL CELL PROLIFERATION | 8 | 8.49e-01 | -3.88e-02 | 9.99e-01 |
| GOMF KINASE BINDING | 737 | 7.29e-02 | 3.88e-02 | 8.07e-01 |
| GOCC CORNIFIED ENVELOPE | 55 | 6.19e-01 | -3.88e-02 | 9.98e-01 |
| GOBP CELL CYCLE DNA REPLICATION | 42 | 6.64e-01 | 3.88e-02 | 9.98e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 255 | 2.87e-01 | 3.88e-02 | 9.75e-01 |
| GOBP PEROXISOME FISSION | 9 | 8.40e-01 | 3.87e-02 | 9.99e-01 |
| GOMF ACTIN BINDING | 415 | 1.76e-01 | -3.87e-02 | 9.21e-01 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 450 | 1.59e-01 | 3.87e-02 | 9.06e-01 |
| GOBP NCRNA METABOLIC PROCESS | 603 | 1.05e-01 | 3.87e-02 | 8.67e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 102 | 4.99e-01 | -3.87e-02 | 9.95e-01 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 32 | 7.05e-01 | -3.87e-02 | 9.98e-01 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 16 | 7.89e-01 | -3.87e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 161 | 3.97e-01 | -3.87e-02 | 9.95e-01 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 24 | 7.43e-01 | -3.87e-02 | 9.98e-01 |
| GOBP PROTEIN DEPOLYMERIZATION | 111 | 4.82e-01 | -3.87e-02 | 9.95e-01 |
| GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 144 | 4.23e-01 | 3.86e-02 | 9.95e-01 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 82 | 5.45e-01 | -3.86e-02 | 9.95e-01 |
| GOBP CELL JUNCTION ORGANIZATION | 713 | 7.88e-02 | -3.86e-02 | 8.27e-01 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 36 | 6.88e-01 | 3.86e-02 | 9.98e-01 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 38 | 6.80e-01 | 3.86e-02 | 9.98e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 360 | 2.09e-01 | -3.86e-02 | 9.38e-01 |
| GOBP HYPOTHALAMUS CELL DIFFERENTIATION | 12 | 8.17e-01 | 3.86e-02 | 9.98e-01 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 12 | 8.17e-01 | 3.86e-02 | 9.98e-01 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 168 | 3.89e-01 | -3.86e-02 | 9.95e-01 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 35 | 6.93e-01 | 3.86e-02 | 9.98e-01 |
| GOMF FILAMIN BINDING | 14 | 8.03e-01 | 3.85e-02 | 9.98e-01 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 17 | 7.83e-01 | -3.85e-02 | 9.98e-01 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 11 | 8.25e-01 | -3.85e-02 | 9.98e-01 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 35 | 6.94e-01 | 3.85e-02 | 9.98e-01 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 7.34e-01 | 3.85e-02 | 9.98e-01 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 24 | 7.44e-01 | 3.85e-02 | 9.98e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 30 | 7.15e-01 | -3.85e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 10 | 8.33e-01 | 3.85e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 16 | 7.90e-01 | 3.85e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING | 1396 | 1.61e-02 | 3.84e-02 | 6.28e-01 |
| GOBP VIRAL RNA GENOME REPLICATION | 29 | 7.20e-01 | -3.84e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 7 | 8.60e-01 | -3.84e-02 | 9.99e-01 |
| GOCC MICOS COMPLEX | 6 | 8.71e-01 | 3.84e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 151 | 4.15e-01 | -3.84e-02 | 9.95e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 566 | 1.19e-01 | 3.84e-02 | 8.83e-01 |
| GOBP TRNA SURVEILLANCE | 8 | 8.51e-01 | -3.84e-02 | 9.99e-01 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 28 | 7.25e-01 | 3.84e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 66 | 5.90e-01 | 3.83e-02 | 9.98e-01 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 139 | 4.35e-01 | -3.83e-02 | 9.95e-01 |
| GOBP TOXIN TRANSPORT | 11 | 8.26e-01 | 3.83e-02 | 9.98e-01 |
| GOCC CATION TRANSPORTING ATPASE COMPLEX | 18 | 7.79e-01 | 3.83e-02 | 9.98e-01 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 23 | 7.51e-01 | -3.83e-02 | 9.98e-01 |
| GOCC MIB COMPLEX | 11 | 8.26e-01 | 3.82e-02 | 9.98e-01 |
| GOBP GOLGI VESICLE TRANSPORT | 284 | 2.67e-01 | 3.82e-02 | 9.68e-01 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 329 | 2.33e-01 | 3.82e-02 | 9.51e-01 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 39 | 6.79e-01 | 3.82e-02 | 9.98e-01 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 100 | 5.09e-01 | -3.82e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 29 | 7.22e-01 | -3.82e-02 | 9.98e-01 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 44 | 6.61e-01 | -3.82e-02 | 9.98e-01 |
| GOBP T CELL LINEAGE COMMITMENT | 31 | 7.13e-01 | -3.81e-02 | 9.98e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 7 | 8.61e-01 | -3.81e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 139 | 4.38e-01 | 3.81e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 67 | 5.89e-01 | 3.81e-02 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 8.83e-01 | -3.81e-02 | 9.99e-01 |
| GOBP PROTEIN FOLDING | 208 | 3.43e-01 | 3.81e-02 | 9.92e-01 |
| GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 8 | 8.52e-01 | 3.81e-02 | 9.99e-01 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 46 | 6.55e-01 | -3.81e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 59 | 6.13e-01 | -3.81e-02 | 9.98e-01 |
| GOBP COCHLEA DEVELOPMENT | 46 | 6.55e-01 | 3.81e-02 | 9.98e-01 |
| GOMF LRR DOMAIN BINDING | 16 | 7.92e-01 | 3.81e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MAINTENANCE | 5 | 8.83e-01 | -3.80e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 12 | 8.19e-01 | -3.80e-02 | 9.98e-01 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 20 | 7.68e-01 | -3.80e-02 | 9.98e-01 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 266 | 2.86e-01 | -3.80e-02 | 9.75e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL BUD | 14 | 8.05e-01 | 3.80e-02 | 9.98e-01 |
| GOBP DEPHOSPHORYLATION | 286 | 2.69e-01 | -3.80e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 30 | 7.19e-01 | 3.80e-02 | 9.98e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 20 | 7.69e-01 | 3.80e-02 | 9.98e-01 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 33 | 7.06e-01 | -3.79e-02 | 9.98e-01 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 16 | 7.93e-01 | -3.79e-02 | 9.98e-01 |
| GOCC ENDOSOME MEMBRANE | 524 | 1.37e-01 | -3.79e-02 | 9.02e-01 |
| GOBP ERYTHROCYTE DEVELOPMENT | 37 | 6.90e-01 | -3.79e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 263 | 2.90e-01 | 3.79e-02 | 9.77e-01 |
| GOCC CELL PROJECTION MEMBRANE | 338 | 2.31e-01 | -3.79e-02 | 9.50e-01 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 95 | 5.23e-01 | 3.79e-02 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 140 | 4.39e-01 | 3.79e-02 | 9.95e-01 |
| GOMF POLY A BINDING | 23 | 7.53e-01 | 3.79e-02 | 9.98e-01 |
| GOCC PEPTIDASE COMPLEX | 116 | 4.81e-01 | 3.79e-02 | 9.95e-01 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 59 | 6.15e-01 | -3.79e-02 | 9.98e-01 |
| GOBP KERATINOCYTE DIFFERENTIATION | 169 | 3.96e-01 | -3.79e-02 | 9.95e-01 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 26 | 7.39e-01 | 3.78e-02 | 9.98e-01 |
| GOBP PLACENTA DEVELOPMENT | 146 | 4.31e-01 | 3.78e-02 | 9.95e-01 |
| GOBP GLYCINE TRANSPORT | 14 | 8.07e-01 | 3.77e-02 | 9.98e-01 |
| GOBP BLASTODERM SEGMENTATION | 24 | 7.49e-01 | -3.77e-02 | 9.98e-01 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 454 | 1.69e-01 | -3.77e-02 | 9.17e-01 |
| GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 7 | 8.63e-01 | -3.77e-02 | 9.99e-01 |
| GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 8.63e-01 | -3.77e-02 | 9.99e-01 |
| GOBP TRANSITION METAL ION TRANSPORT | 93 | 5.30e-01 | 3.77e-02 | 9.95e-01 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 134 | 4.52e-01 | 3.77e-02 | 9.95e-01 |
| GOBP KINETOCHORE ORGANIZATION | 20 | 7.71e-01 | 3.76e-02 | 9.98e-01 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 45 | 6.62e-01 | 3.76e-02 | 9.98e-01 |
| GOBP RESPONSE TO IRON ION | 28 | 7.31e-01 | -3.76e-02 | 9.98e-01 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 10 | 8.37e-01 | 3.76e-02 | 9.99e-01 |
| GOBP TRNA METABOLIC PROCESS | 188 | 3.74e-01 | 3.76e-02 | 9.95e-01 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 10 | 8.37e-01 | 3.76e-02 | 9.99e-01 |
| GOBP INTESTINAL EPITHELIAL CELL MATURATION | 6 | 8.73e-01 | 3.76e-02 | 9.99e-01 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 62 | 6.09e-01 | 3.75e-02 | 9.98e-01 |
| GOBP RHYTHMIC BEHAVIOR | 44 | 6.67e-01 | -3.75e-02 | 9.98e-01 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 51 | 6.43e-01 | -3.75e-02 | 9.98e-01 |
| GOCC SUPRAMOLECULAR POLYMER | 978 | 4.71e-02 | -3.75e-02 | 7.65e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 5 | 8.85e-01 | -3.75e-02 | 9.99e-01 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 35 | 7.01e-01 | 3.74e-02 | 9.98e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 29 | 7.27e-01 | 3.74e-02 | 9.98e-01 |
| GOMF LYSINE N ACETYLTRANSFERASE ACTIVITY ACTING ON ACETYL PHOSPHATE AS DONOR | 6 | 8.74e-01 | -3.74e-02 | 9.99e-01 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 28 | 7.32e-01 | 3.74e-02 | 9.98e-01 |
| GOBP T CELL DIFFERENTIATION | 300 | 2.65e-01 | 3.74e-02 | 9.65e-01 |
| GOBP REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY | 7 | 8.64e-01 | 3.74e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 5 | 8.85e-01 | 3.74e-02 | 9.99e-01 |
| GOCC ASTROCYTE END FOOT | 9 | 8.46e-01 | 3.74e-02 | 9.99e-01 |
| GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 13 | 8.15e-01 | 3.74e-02 | 9.98e-01 |
| GOMF AMINOACYL TRNA EDITING ACTIVITY | 13 | 8.15e-01 | 3.74e-02 | 9.98e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 36 | 6.98e-01 | 3.74e-02 | 9.98e-01 |
| GOBP REGULATION OF IMMUNE RESPONSE | 865 | 6.21e-02 | 3.74e-02 | 7.98e-01 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 24 | 7.51e-01 | 3.74e-02 | 9.98e-01 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 302 | 2.64e-01 | 3.73e-02 | 9.65e-01 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 38 | 6.90e-01 | 3.73e-02 | 9.98e-01 |
| GOBP GERM CELL DEVELOPMENT | 344 | 2.34e-01 | 3.73e-02 | 9.52e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 624 | 1.12e-01 | 3.73e-02 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 8 | 8.55e-01 | -3.73e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 58 | 6.23e-01 | 3.73e-02 | 9.98e-01 |
| GOBP PORE COMPLEX ASSEMBLY | 19 | 7.79e-01 | -3.73e-02 | 9.98e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 10 | 8.38e-01 | 3.73e-02 | 9.99e-01 |
| GOMF LBD DOMAIN BINDING | 6 | 8.74e-01 | -3.73e-02 | 9.99e-01 |
| GOMF GATED CHANNEL ACTIVITY | 308 | 2.61e-01 | -3.73e-02 | 9.62e-01 |
| GOMF POLY A RNA POLYMERASE ACTIVITY | 11 | 8.31e-01 | 3.73e-02 | 9.98e-01 |
| GOBP SKELETAL MUSCLE CONTRACTION | 43 | 6.73e-01 | 3.72e-02 | 9.98e-01 |
| GOBP VESICLE DOCKING | 64 | 6.07e-01 | 3.72e-02 | 9.98e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 57 | 6.27e-01 | -3.72e-02 | 9.98e-01 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 61 | 6.15e-01 | 3.72e-02 | 9.98e-01 |
| GOMF PDZ DOMAIN BINDING | 84 | 5.56e-01 | -3.72e-02 | 9.95e-01 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 81 | 5.63e-01 | -3.72e-02 | 9.95e-01 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 459 | 1.73e-01 | 3.71e-02 | 9.21e-01 |
| GOBP GENERAL ADAPTATION SYNDROME | 6 | 8.75e-01 | -3.71e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 148 | 4.36e-01 | -3.71e-02 | 9.95e-01 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 88 | 5.48e-01 | 3.71e-02 | 9.95e-01 |
| GOBP AMYLIN RECEPTOR SIGNALING PATHWAY | 6 | 8.75e-01 | -3.71e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 21 | 7.69e-01 | 3.71e-02 | 9.98e-01 |
| GOBP REGULATION OF CHEMOTAXIS | 220 | 3.44e-01 | 3.70e-02 | 9.92e-01 |
| GOMF EXOPEPTIDASE ACTIVITY | 100 | 5.23e-01 | 3.70e-02 | 9.95e-01 |
| GOBP RNA METHYLATION | 84 | 5.58e-01 | 3.70e-02 | 9.95e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 27 | 7.40e-01 | -3.69e-02 | 9.98e-01 |
| GOMF P53 BINDING | 64 | 6.09e-01 | 3.69e-02 | 9.98e-01 |
| GOCC MULTIVESICULAR BODY | 65 | 6.07e-01 | 3.69e-02 | 9.98e-01 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 14 | 8.11e-01 | 3.69e-02 | 9.98e-01 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 731 | 8.93e-02 | -3.69e-02 | 8.48e-01 |
| GOCC PROTEASOME CORE COMPLEX | 20 | 7.75e-01 | -3.69e-02 | 9.98e-01 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 194 | 3.76e-01 | 3.69e-02 | 9.95e-01 |
| GOMF KINASE ACTIVITY | 706 | 9.52e-02 | 3.69e-02 | 8.58e-01 |
| GOBP CELL CELL JUNCTION DISASSEMBLY | 5 | 8.87e-01 | -3.68e-02 | 9.99e-01 |
| GOMF THIOREDOXIN DISULFIDE REDUCTASE NADP ACTIVITY | 7 | 8.66e-01 | -3.68e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 92 | 5.42e-01 | -3.68e-02 | 9.95e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 92 | 5.42e-01 | -3.68e-02 | 9.95e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 70 | 5.94e-01 | 3.68e-02 | 9.98e-01 |
| GOBP VITAMIN A METABOLIC PROCESS | 8 | 8.57e-01 | -3.68e-02 | 9.99e-01 |
| GOCC PRERIBOSOME | 104 | 5.17e-01 | 3.68e-02 | 9.95e-01 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 10 | 8.40e-01 | -3.68e-02 | 9.99e-01 |
| GOBP BASIC AMINO ACID TRANSPORT | 21 | 7.70e-01 | -3.68e-02 | 9.98e-01 |
| GOBP CELLULAR RESPIRATION | 216 | 3.52e-01 | 3.68e-02 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 8.76e-01 | -3.68e-02 | 9.99e-01 |
| GOMF DIACYLGLYCEROL BINDING | 13 | 8.19e-01 | 3.67e-02 | 9.98e-01 |
| GOBP DERMATAN SULFATE METABOLIC PROCESS | 8 | 8.57e-01 | -3.67e-02 | 9.99e-01 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 57 | 6.32e-01 | 3.67e-02 | 9.98e-01 |
| GOMF HISTONE H4K20 MONOMETHYLTRANSFERASE ACTIVITY | 6 | 8.76e-01 | -3.67e-02 | 9.99e-01 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 24 | 7.56e-01 | 3.67e-02 | 9.98e-01 |
| GOCC INTERCELLULAR BRIDGE | 90 | 5.48e-01 | -3.67e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 24 | 7.56e-01 | 3.66e-02 | 9.98e-01 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 42 | 6.81e-01 | 3.66e-02 | 9.98e-01 |
| GOBP NEUROTRANSMITTER SECRETION | 138 | 4.58e-01 | -3.66e-02 | 9.95e-01 |
| GOMF HYDROPEROXY ICOSATETRAENOATE DEHYDRATASE ACTIVITY | 7 | 8.67e-01 | -3.66e-02 | 9.99e-01 |
| GOBP POLYOL METABOLIC PROCESS | 103 | 5.22e-01 | -3.65e-02 | 9.95e-01 |
| GOCC MITOCHONDRION | 1569 | 1.57e-02 | 3.65e-02 | 6.27e-01 |
| GOMF TRANSPORTER ACTIVITY | 1171 | 3.52e-02 | -3.65e-02 | 7.25e-01 |
| GOBP MITOTIC CELL CYCLE | 898 | 6.34e-02 | 3.65e-02 | 7.99e-01 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 8.42e-01 | 3.65e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 325 | 2.59e-01 | -3.64e-02 | 9.59e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 38 | 6.98e-01 | 3.64e-02 | 9.98e-01 |
| GOBP GERM CELL PROLIFERATION | 10 | 8.42e-01 | 3.64e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 60 | 6.26e-01 | 3.64e-02 | 9.98e-01 |
| GOMF T CELL RECEPTOR BINDING | 11 | 8.35e-01 | 3.64e-02 | 9.99e-01 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 45 | 6.73e-01 | -3.63e-02 | 9.98e-01 |
| GOCC ENDOCYTIC VESICLE | 325 | 2.60e-01 | -3.63e-02 | 9.60e-01 |
| GOBP REGULATION OF CELL SHAPE | 134 | 4.68e-01 | -3.63e-02 | 9.95e-01 |
| GOBP REGULATION OF BLOOD CIRCULATION | 247 | 3.26e-01 | -3.63e-02 | 9.87e-01 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 366 | 2.33e-01 | -3.63e-02 | 9.50e-01 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 101 | 5.29e-01 | 3.63e-02 | 9.95e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 9 | 8.51e-01 | -3.63e-02 | 9.99e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 24 | 7.58e-01 | 3.63e-02 | 9.98e-01 |
| GOBP MEMBRANE RAFT LOCALIZATION | 8 | 8.59e-01 | -3.63e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS | 22 | 7.68e-01 | 3.63e-02 | 9.98e-01 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 126 | 4.82e-01 | 3.62e-02 | 9.95e-01 |
| GOMF ANAPHASE PROMOTING COMPLEX BINDING | 9 | 8.51e-01 | -3.62e-02 | 9.99e-01 |
| GOBP INTRACELLULAR PH ELEVATION | 7 | 8.68e-01 | -3.62e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 25 | 7.54e-01 | 3.62e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 12 | 8.28e-01 | -3.62e-02 | 9.98e-01 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 58 | 6.33e-01 | 3.62e-02 | 9.98e-01 |
| GOBP LIPID DIGESTION | 21 | 7.74e-01 | -3.62e-02 | 9.98e-01 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 14 | 8.15e-01 | 3.62e-02 | 9.98e-01 |
| GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY | 16 | 8.02e-01 | -3.62e-02 | 9.98e-01 |
| GOBP SPECIFICATION OF SYMMETRY | 136 | 4.67e-01 | 3.62e-02 | 9.95e-01 |
| GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION | 23 | 7.64e-01 | 3.61e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 75 | 5.89e-01 | 3.61e-02 | 9.97e-01 |
| GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY | 6 | 8.78e-01 | -3.61e-02 | 9.99e-01 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 12 | 8.29e-01 | -3.61e-02 | 9.98e-01 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 618 | 1.26e-01 | 3.61e-02 | 8.91e-01 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 225 | 3.51e-01 | 3.61e-02 | 9.94e-01 |
| GOBP CANNABINOID SIGNALING PATHWAY | 9 | 8.51e-01 | 3.61e-02 | 9.99e-01 |
| GOBP CIRCADIAN RHYTHM | 196 | 3.84e-01 | 3.61e-02 | 9.95e-01 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 47 | 6.69e-01 | 3.60e-02 | 9.98e-01 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 91 | 5.52e-01 | -3.60e-02 | 9.95e-01 |
| GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 59 | 6.32e-01 | 3.60e-02 | 9.98e-01 |
| GOBP RESPONSE TO NUTRIENT | 147 | 4.51e-01 | 3.60e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 14 | 8.16e-01 | 3.60e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 7 | 8.69e-01 | -3.60e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 44 | 6.79e-01 | -3.60e-02 | 9.98e-01 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 57 | 6.38e-01 | -3.60e-02 | 9.98e-01 |
| GOBP TESTOSTERONE BIOSYNTHETIC PROCESS | 11 | 8.36e-01 | 3.60e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 376 | 2.31e-01 | 3.60e-02 | 9.50e-01 |
| GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION | 8 | 8.60e-01 | 3.59e-02 | 9.99e-01 |
| GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 8 | 8.60e-01 | 3.59e-02 | 9.99e-01 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 62 | 6.25e-01 | -3.59e-02 | 9.98e-01 |
| GOBP ERBB4 SIGNALING PATHWAY | 10 | 8.44e-01 | -3.59e-02 | 9.99e-01 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 27 | 7.47e-01 | -3.59e-02 | 9.98e-01 |
| GOMF SH3 DOMAIN BINDING | 114 | 5.08e-01 | 3.59e-02 | 9.95e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 46 | 6.74e-01 | 3.59e-02 | 9.98e-01 |
| GOBP NEURAL RETINA DEVELOPMENT | 78 | 5.84e-01 | 3.58e-02 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 474 | 1.81e-01 | -3.58e-02 | 9.27e-01 |
| GOBP CORNIFICATION | 9 | 8.52e-01 | 3.58e-02 | 9.99e-01 |
| GOBP PROLINE TRANSMEMBRANE TRANSPORT | 9 | 8.53e-01 | 3.58e-02 | 9.99e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 294 | 2.92e-01 | -3.58e-02 | 9.79e-01 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 59 | 6.35e-01 | -3.58e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 8.90e-01 | 3.57e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 83 | 5.74e-01 | -3.57e-02 | 9.95e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 16 | 8.05e-01 | 3.57e-02 | 9.98e-01 |
| GOBP RESPONSE TO ALCOHOL | 246 | 3.35e-01 | 3.57e-02 | 9.88e-01 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 74 | 5.96e-01 | -3.57e-02 | 9.98e-01 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 89 | 5.61e-01 | -3.57e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 21 | 7.77e-01 | 3.57e-02 | 9.98e-01 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 152 | 4.48e-01 | 3.57e-02 | 9.95e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 36 | 7.11e-01 | -3.57e-02 | 9.98e-01 |
| GOBP REGULATION OF NEUROGENESIS | 373 | 2.37e-01 | 3.56e-02 | 9.52e-01 |
| GOBP REGULATION OF CELL CYCLE | 1068 | 4.92e-02 | 3.56e-02 | 7.74e-01 |
| GOCC MICROTUBULE MINUS END | 7 | 8.70e-01 | -3.56e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 13 | 8.24e-01 | -3.56e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 20 | 7.83e-01 | 3.55e-02 | 9.98e-01 |
| GOCC DESMOSOME | 25 | 7.58e-01 | -3.55e-02 | 9.98e-01 |
| GOBP REGENERATION | 181 | 4.10e-01 | -3.55e-02 | 9.95e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 18 | 7.94e-01 | -3.55e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 274 | 3.12e-01 | 3.55e-02 | 9.87e-01 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 37 | 7.09e-01 | -3.55e-02 | 9.98e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 102 | 5.36e-01 | 3.55e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 125 | 4.93e-01 | -3.55e-02 | 9.95e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 114 | 5.13e-01 | 3.55e-02 | 9.95e-01 |
| GOBP METAPHASE ANAPHASE TRANSITION OF MEIOTIC CELL CYCLE | 5 | 8.91e-01 | 3.55e-02 | 9.99e-01 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 115 | 5.11e-01 | 3.55e-02 | 9.95e-01 |
| GOMF PHOSPHOPROTEIN BINDING | 88 | 5.65e-01 | 3.55e-02 | 9.95e-01 |
| GOCC EARLY PHAGOSOME | 12 | 8.32e-01 | -3.54e-02 | 9.99e-01 |
| GOBP MYELIN ASSEMBLY | 24 | 7.64e-01 | -3.54e-02 | 9.98e-01 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 46 | 6.78e-01 | -3.54e-02 | 9.98e-01 |
| GOBP ANATOMICAL STRUCTURE REGRESSION | 16 | 8.06e-01 | 3.54e-02 | 9.98e-01 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 15 | 8.12e-01 | -3.54e-02 | 9.98e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 23 | 7.69e-01 | 3.54e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL PROLIFERATION | 5 | 8.91e-01 | 3.54e-02 | 9.99e-01 |
| GOCC MICROTUBULE | 441 | 2.03e-01 | 3.54e-02 | 9.36e-01 |
| GOMF PEPTIDASE ACTIVITY | 561 | 1.52e-01 | -3.54e-02 | 9.04e-01 |
| GOCC SET1C COMPASS COMPLEX | 14 | 8.19e-01 | -3.54e-02 | 9.98e-01 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 263 | 3.24e-01 | -3.53e-02 | 9.87e-01 |
| GOBP DETECTION OF LIGHT STIMULUS | 61 | 6.33e-01 | -3.53e-02 | 9.98e-01 |
| GOBP VIRAL BUDDING | 25 | 7.60e-01 | 3.53e-02 | 9.98e-01 |
| GOBP RNA PROCESSING | 1248 | 3.60e-02 | 3.53e-02 | 7.27e-01 |
| GOBP SIALYLATION | 8 | 8.63e-01 | 3.53e-02 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 8.81e-01 | -3.53e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 21 | 7.80e-01 | -3.53e-02 | 9.98e-01 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 101 | 5.40e-01 | -3.53e-02 | 9.95e-01 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 23 | 7.70e-01 | 3.53e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 73 | 6.02e-01 | -3.53e-02 | 9.98e-01 |
| GOMF POLY ADP D RIBOSE BINDING | 5 | 8.91e-01 | -3.53e-02 | 9.99e-01 |
| GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 8.55e-01 | 3.52e-02 | 9.99e-01 |
| GOBP AMYLOID BETA CLEARANCE | 39 | 7.03e-01 | 3.52e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 68 | 6.15e-01 | -3.52e-02 | 9.98e-01 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 13 | 8.26e-01 | 3.52e-02 | 9.98e-01 |
| GOBP MRNA CATABOLIC PROCESS | 294 | 2.99e-01 | 3.52e-02 | 9.84e-01 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 79 | 5.89e-01 | 3.52e-02 | 9.97e-01 |
| GOBP T CELL ACTIVATION | 537 | 1.63e-01 | 3.52e-02 | 9.12e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 49 | 6.70e-01 | 3.52e-02 | 9.98e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY | 8 | 8.63e-01 | 3.52e-02 | 9.99e-01 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 547 | 1.60e-01 | 3.51e-02 | 9.06e-01 |
| GOBP LONG TERM MEMORY | 36 | 7.16e-01 | 3.51e-02 | 9.98e-01 |
| GOBP RESPONSE TO OXYGEN LEVELS | 321 | 2.80e-01 | 3.51e-02 | 9.73e-01 |
| GOBP OOCYTE DIFFERENTIATION | 64 | 6.27e-01 | 3.51e-02 | 9.98e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 85 | 5.76e-01 | -3.51e-02 | 9.96e-01 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 217 | 3.73e-01 | 3.51e-02 | 9.95e-01 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 66 | 6.22e-01 | 3.51e-02 | 9.98e-01 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 38 | 7.09e-01 | -3.50e-02 | 9.98e-01 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 22 | 7.76e-01 | -3.50e-02 | 9.98e-01 |
| GOBP GTP METABOLIC PROCESS | 24 | 7.66e-01 | 3.50e-02 | 9.98e-01 |
| GOBP SYNCYTIUM FORMATION | 65 | 6.26e-01 | 3.50e-02 | 9.98e-01 |
| GOBP REGULATION OF MIRNA METABOLIC PROCESS | 83 | 5.82e-01 | -3.50e-02 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 310 | 2.90e-01 | 3.50e-02 | 9.77e-01 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 181 | 4.17e-01 | 3.50e-02 | 9.95e-01 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 348 | 2.63e-01 | -3.50e-02 | 9.64e-01 |
| GOMF ACETYLCHOLINE RECEPTOR ACTIVITY | 21 | 7.82e-01 | -3.49e-02 | 9.98e-01 |
| GOBP GALACTOSE TRANSMEMBRANE TRANSPORT | 5 | 8.92e-01 | 3.49e-02 | 9.99e-01 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 117 | 5.14e-01 | 3.49e-02 | 9.95e-01 |
| GOBP CDP CHOLINE PATHWAY | 6 | 8.82e-01 | 3.49e-02 | 9.99e-01 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 400 | 2.31e-01 | 3.49e-02 | 9.50e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 8.28e-01 | -3.49e-02 | 9.98e-01 |
| GOBP L AMINO ACID TRANSPORT | 84 | 5.80e-01 | -3.49e-02 | 9.96e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 28 | 7.49e-01 | -3.49e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 11 | 8.41e-01 | 3.48e-02 | 9.99e-01 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 206 | 3.89e-01 | 3.48e-02 | 9.95e-01 |
| GOCC CELL CELL JUNCTION | 485 | 1.89e-01 | -3.48e-02 | 9.28e-01 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 164 | 4.42e-01 | -3.48e-02 | 9.95e-01 |
| GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 8 | 8.65e-01 | 3.48e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TISSUE REMODELING | 23 | 7.73e-01 | 3.48e-02 | 9.98e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 251 | 3.42e-01 | -3.48e-02 | 9.91e-01 |
| GOBP DEVELOPMENTAL PIGMENTATION | 47 | 6.80e-01 | -3.48e-02 | 9.98e-01 |
| GOBP CYTOLYSIS | 7 | 8.74e-01 | 3.47e-02 | 9.99e-01 |
| GOMF FATTY ACID DERIVATIVE BINDING | 17 | 8.04e-01 | 3.47e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL TRANSLATION | 130 | 4.94e-01 | -3.47e-02 | 9.95e-01 |
| GOBP VIRAL PROCESS | 412 | 2.27e-01 | 3.47e-02 | 9.50e-01 |
| GOBP BODY FLUID SECRETION | 87 | 5.76e-01 | -3.47e-02 | 9.96e-01 |
| GOBP DOPAMINE TRANSPORT | 55 | 6.56e-01 | -3.47e-02 | 9.98e-01 |
| GOBP EXTRACELLULAR EXOSOME ASSEMBLY | 7 | 8.74e-01 | 3.47e-02 | 9.99e-01 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 42 | 6.98e-01 | 3.47e-02 | 9.98e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 595 | 1.49e-01 | 3.47e-02 | 9.04e-01 |
| GOBP REGULATION OF RESPONSE TO STRESS | 1430 | 2.83e-02 | 3.46e-02 | 6.86e-01 |
| GOBP MICROTUBULE BUNDLE FORMATION | 121 | 5.11e-01 | 3.46e-02 | 9.95e-01 |
| GOMF TRANSCRIPTION FACTOR BINDING | 570 | 1.58e-01 | 3.46e-02 | 9.06e-01 |
| GOCC CASPASE COMPLEX | 10 | 8.50e-01 | -3.46e-02 | 9.99e-01 |
| GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 10 | 8.50e-01 | -3.46e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 97 | 5.56e-01 | 3.46e-02 | 9.95e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 55 | 6.57e-01 | 3.46e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO STRESS | 1864 | 1.35e-02 | 3.45e-02 | 6.15e-01 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 199 | 4.01e-01 | -3.45e-02 | 9.95e-01 |
| GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS | 8 | 8.66e-01 | -3.45e-02 | 9.99e-01 |
| GOCC CHROMATOID BODY | 13 | 8.29e-01 | 3.45e-02 | 9.98e-01 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 27 | 7.56e-01 | 3.45e-02 | 9.98e-01 |
| GOBP RESPONSE TO HISTAMINE | 11 | 8.43e-01 | -3.45e-02 | 9.99e-01 |
| GOMF DNA POLYMERASE ACTIVITY | 29 | 7.48e-01 | -3.45e-02 | 9.98e-01 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 122 | 5.11e-01 | 3.45e-02 | 9.95e-01 |
| GOBP NOTOCHORD DEVELOPMENT | 19 | 7.95e-01 | -3.45e-02 | 9.98e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSPORT | 8 | 8.66e-01 | 3.44e-02 | 9.99e-01 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 9 | 8.58e-01 | -3.44e-02 | 9.99e-01 |
| GOCC KINESIN COMPLEX | 46 | 6.86e-01 | -3.44e-02 | 9.98e-01 |
| GOBP CITRATE TRANSPORT | 5 | 8.94e-01 | 3.44e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 135 | 4.90e-01 | 3.44e-02 | 9.95e-01 |
| GOMF PRE MIRNA BINDING | 9 | 8.58e-01 | -3.44e-02 | 9.99e-01 |
| GOBP ERBB SIGNALING PATHWAY | 122 | 5.12e-01 | 3.43e-02 | 9.95e-01 |
| GOBP INTERLEUKIN 6 PRODUCTION | 165 | 4.47e-01 | 3.43e-02 | 9.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 49 | 6.78e-01 | 3.43e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 66 | 6.30e-01 | 3.43e-02 | 9.98e-01 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 102 | 5.49e-01 | -3.43e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 7 | 8.75e-01 | -3.43e-02 | 9.99e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 25 | 7.67e-01 | 3.43e-02 | 9.98e-01 |
| GOCC PEPTIDASE INHIBITOR COMPLEX | 11 | 8.44e-01 | 3.42e-02 | 9.99e-01 |
| GOMF SULFOTRANSFERASE ACTIVITY | 49 | 6.79e-01 | -3.42e-02 | 9.98e-01 |
| GOMF RNA NUCLEASE ACTIVITY | 128 | 5.04e-01 | -3.42e-02 | 9.95e-01 |
| GOMF PRE MRNA 5 SPLICE SITE BINDING | 6 | 8.85e-01 | -3.42e-02 | 9.99e-01 |
| GOBP MACROMOLECULE METHYLATION | 195 | 4.11e-01 | 3.42e-02 | 9.95e-01 |
| GOCC MICROBODY LUMEN | 51 | 6.73e-01 | 3.42e-02 | 9.98e-01 |
| GOBP CARTILAGE MORPHOGENESIS | 10 | 8.52e-01 | 3.41e-02 | 9.99e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 7 | 8.76e-01 | 3.41e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 94 | 5.67e-01 | -3.41e-02 | 9.95e-01 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 22 | 7.82e-01 | -3.41e-02 | 9.98e-01 |
| GOBP REGULATION OF LIPID TRANSPORT | 153 | 4.67e-01 | -3.41e-02 | 9.95e-01 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 342 | 2.79e-01 | -3.41e-02 | 9.73e-01 |
| GOBP EYE MORPHOGENESIS | 159 | 4.59e-01 | 3.40e-02 | 9.95e-01 |
| GOBP PROLINE TRANSPORT | 11 | 8.45e-01 | 3.40e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF GONAD DEVELOPMENT | 8 | 8.68e-01 | -3.40e-02 | 9.99e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 341 | 2.81e-01 | 3.40e-02 | 9.73e-01 |
| GOBP EXIT FROM MITOSIS | 31 | 7.43e-01 | -3.40e-02 | 9.98e-01 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 65 | 6.36e-01 | 3.40e-02 | 9.98e-01 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1566 | 2.48e-02 | 3.40e-02 | 6.63e-01 |
| GOBP T CELL MIGRATION | 67 | 6.31e-01 | -3.39e-02 | 9.98e-01 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 50 | 6.78e-01 | 3.39e-02 | 9.98e-01 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1451 | 3.06e-02 | 3.39e-02 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 14 | 8.26e-01 | 3.39e-02 | 9.98e-01 |
| GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 8.96e-01 | -3.39e-02 | 9.99e-01 |
| GOMF CO SMAD BINDING | 9 | 8.60e-01 | -3.39e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 41 | 7.08e-01 | -3.39e-02 | 9.98e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 19 | 7.98e-01 | 3.38e-02 | 9.98e-01 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 42 | 7.04e-01 | -3.38e-02 | 9.98e-01 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 218 | 3.89e-01 | -3.38e-02 | 9.95e-01 |
| GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 8 | 8.69e-01 | -3.38e-02 | 9.99e-01 |
| GOCC SMALL SUBUNIT PROCESSOME | 70 | 6.25e-01 | -3.38e-02 | 9.98e-01 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 61 | 6.48e-01 | -3.38e-02 | 9.98e-01 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 8.96e-01 | 3.37e-02 | 9.99e-01 |
| GOBP CELLULAR CATABOLIC PROCESS | 1532 | 2.74e-02 | 3.37e-02 | 6.78e-01 |
| GOBP CENTROSOME DUPLICATION | 74 | 6.16e-01 | 3.37e-02 | 9.98e-01 |
| GOBP REGULATION OF MICROVILLUS ASSEMBLY | 6 | 8.86e-01 | -3.37e-02 | 9.99e-01 |
| GOBP MRNA SPLICE SITE RECOGNITION | 35 | 7.30e-01 | -3.37e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 458 | 2.17e-01 | 3.37e-02 | 9.43e-01 |
| GOBP EPIDERMAL CELL FATE SPECIFICATION | 5 | 8.96e-01 | -3.37e-02 | 9.99e-01 |
| GOBP RETINAL PIGMENT EPITHELIUM DEVELOPMENT | 6 | 8.86e-01 | 3.37e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 61 | 6.50e-01 | -3.36e-02 | 9.98e-01 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 174 | 4.44e-01 | 3.36e-02 | 9.95e-01 |
| GOBP MONOATOMIC ANION TRANSPORT | 161 | 4.62e-01 | -3.36e-02 | 9.95e-01 |
| GOBP TRANSPORT OF VIRUS | 21 | 7.90e-01 | -3.36e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 43 | 7.03e-01 | 3.36e-02 | 9.98e-01 |
| GOBP MEMBRANE INVAGINATION | 62 | 6.47e-01 | 3.36e-02 | 9.98e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 15 | 8.22e-01 | -3.36e-02 | 9.98e-01 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 15 | 8.22e-01 | -3.36e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 70 | 6.27e-01 | -3.36e-02 | 9.98e-01 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 1019 | 7.01e-02 | 3.35e-02 | 8.00e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER | 806 | 1.05e-01 | 3.35e-02 | 8.67e-01 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 108 | 5.47e-01 | 3.35e-02 | 9.95e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 50 | 6.82e-01 | -3.35e-02 | 9.98e-01 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 110 | 5.44e-01 | 3.35e-02 | 9.95e-01 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 32 | 7.43e-01 | 3.35e-02 | 9.98e-01 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 219 | 3.94e-01 | 3.35e-02 | 9.95e-01 |
| GOBP THYROID GLAND DEVELOPMENT | 31 | 7.47e-01 | -3.35e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 109 | 5.46e-01 | 3.34e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 65 | 6.41e-01 | 3.34e-02 | 9.98e-01 |
| GOBP RESPONSE TO GRAVITY | 9 | 8.62e-01 | -3.34e-02 | 9.99e-01 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 68 | 6.34e-01 | -3.34e-02 | 9.98e-01 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 28 | 7.60e-01 | 3.33e-02 | 9.98e-01 |
| GOBP OXIDATIVE PHOSPHORYLATION | 126 | 5.18e-01 | 3.33e-02 | 9.95e-01 |
| GOBP GMP METABOLIC PROCESS | 25 | 7.73e-01 | -3.33e-02 | 9.98e-01 |
| GOMF POLY PURINE TRACT BINDING | 28 | 7.61e-01 | 3.33e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 36 | 7.30e-01 | 3.32e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 19 | 8.02e-01 | 3.32e-02 | 9.98e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR INVOLVED IN MEIOTIC RECOMBINATION | 11 | 8.49e-01 | 3.32e-02 | 9.99e-01 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 11 | 8.49e-01 | -3.32e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 5 | 8.98e-01 | 3.32e-02 | 9.99e-01 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 216 | 4.01e-01 | -3.32e-02 | 9.95e-01 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 54 | 6.74e-01 | 3.31e-02 | 9.98e-01 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 212 | 4.06e-01 | -3.31e-02 | 9.95e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 13 | 8.36e-01 | -3.31e-02 | 9.99e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 8.57e-01 | -3.30e-02 | 9.99e-01 |
| GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE | 9 | 8.64e-01 | 3.30e-02 | 9.99e-01 |
| GOCC NUCLEAR PORE | 89 | 5.91e-01 | 3.30e-02 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 276 | 3.46e-01 | 3.30e-02 | 9.92e-01 |
| GOCC COPI COATED VESICLE MEMBRANE | 18 | 8.09e-01 | 3.29e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE ACTIVATION | 5 | 8.99e-01 | 3.29e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 9 | 8.64e-01 | -3.29e-02 | 9.99e-01 |
| GOCC TRANS GOLGI NETWORK | 246 | 3.74e-01 | -3.29e-02 | 9.95e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC | 8 | 8.72e-01 | 3.29e-02 | 9.99e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 16 | 8.20e-01 | -3.29e-02 | 9.98e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 8 | 8.72e-01 | -3.29e-02 | 9.99e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 50 | 6.87e-01 | -3.29e-02 | 9.98e-01 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 871 | 9.94e-02 | 3.29e-02 | 8.64e-01 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 1011 | 7.68e-02 | 3.29e-02 | 8.23e-01 |
| GOMF SUMO BINDING | 16 | 8.20e-01 | -3.29e-02 | 9.98e-01 |
| GOMF AMIDE BINDING | 381 | 2.71e-01 | -3.29e-02 | 9.72e-01 |
| GOMF LIGASE ACTIVITY | 159 | 4.75e-01 | -3.29e-02 | 9.95e-01 |
| GOCC GLUTAMATERGIC SYNAPSE | 387 | 2.67e-01 | -3.28e-02 | 9.68e-01 |
| GOBP SOMATIC STEM CELL DIVISION | 11 | 8.51e-01 | 3.28e-02 | 9.99e-01 |
| GOBP CHORIO ALLANTOIC FUSION | 7 | 8.81e-01 | -3.28e-02 | 9.99e-01 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 21 | 7.95e-01 | -3.28e-02 | 9.98e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 106 | 5.60e-01 | -3.28e-02 | 9.95e-01 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 28 | 7.64e-01 | -3.28e-02 | 9.98e-01 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 13 | 8.38e-01 | -3.28e-02 | 9.99e-01 |
| GOBP NEUROBLAST DIVISION | 13 | 8.38e-01 | -3.27e-02 | 9.99e-01 |
| GOBP SYNAPSE ORGANIZATION | 446 | 2.36e-01 | -3.27e-02 | 9.52e-01 |
| GOBP OVULATION | 15 | 8.26e-01 | -3.27e-02 | 9.98e-01 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 119 | 5.38e-01 | -3.27e-02 | 9.95e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 9 | 8.65e-01 | 3.27e-02 | 9.99e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 48 | 6.96e-01 | -3.26e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 19 | 8.05e-01 | -3.26e-02 | 9.98e-01 |
| GOBP NUCLEOTIDE TRANSPORT | 40 | 7.21e-01 | 3.26e-02 | 9.98e-01 |
| GOBP REGULATION OF BLOOD PRESSURE | 175 | 4.57e-01 | 3.26e-02 | 9.95e-01 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 1081 | 7.02e-02 | 3.26e-02 | 8.00e-01 |
| GOMF HORMONE ACTIVITY | 119 | 5.39e-01 | 3.26e-02 | 9.95e-01 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 23 | 7.87e-01 | 3.26e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 62 | 6.57e-01 | 3.26e-02 | 9.98e-01 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 64 | 6.52e-01 | 3.26e-02 | 9.98e-01 |
| GOBP PHOTOTRANSDUCTION | 42 | 7.15e-01 | -3.26e-02 | 9.98e-01 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 229 | 3.96e-01 | -3.26e-02 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 18 | 8.11e-01 | 3.26e-02 | 9.98e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 8.52e-01 | -3.25e-02 | 9.99e-01 |
| GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 14 | 8.33e-01 | -3.25e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 27 | 7.71e-01 | -3.24e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 24 | 7.83e-01 | -3.24e-02 | 9.98e-01 |
| GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 400 | 2.66e-01 | 3.24e-02 | 9.67e-01 |
| GOMF HELICASE ACTIVITY | 148 | 4.97e-01 | 3.24e-02 | 9.95e-01 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 9.00e-01 | -3.24e-02 | 9.99e-01 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 10 | 8.59e-01 | 3.24e-02 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 194 | 4.37e-01 | -3.24e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 320 | 3.20e-01 | 3.23e-02 | 9.87e-01 |
| GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 7 | 8.82e-01 | 3.23e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 398 | 2.69e-01 | -3.23e-02 | 9.71e-01 |
| GOBP MEMBRANE REPOLARIZATION | 52 | 6.87e-01 | -3.23e-02 | 9.98e-01 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 135 | 5.18e-01 | 3.22e-02 | 9.95e-01 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 231 | 3.99e-01 | 3.22e-02 | 9.95e-01 |
| GOBP CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 8.91e-01 | -3.22e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 941 | 9.45e-02 | 3.22e-02 | 8.55e-01 |
| GOBP AXIS ELONGATION | 27 | 7.72e-01 | -3.22e-02 | 9.98e-01 |
| GOBP MOLTING CYCLE PROCESS | 92 | 5.94e-01 | 3.21e-02 | 9.98e-01 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 56 | 6.77e-01 | 3.21e-02 | 9.98e-01 |
| GOBP TRANSMEMBRANE TRANSPORT | 1478 | 3.90e-02 | -3.21e-02 | 7.46e-01 |
| GOBP MATURE B CELL DIFFERENTIATION | 34 | 7.46e-01 | -3.21e-02 | 9.98e-01 |
| GOMF DIHYDROPYRIMIDINASE ACTIVITY | 6 | 8.92e-01 | -3.21e-02 | 9.99e-01 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 46 | 7.07e-01 | -3.21e-02 | 9.98e-01 |
| GOBP CELL JUNCTION ASSEMBLY | 422 | 2.59e-01 | -3.21e-02 | 9.58e-01 |
| GOBP GLIAL CELL FATE SPECIFICATION | 7 | 8.83e-01 | 3.20e-02 | 9.99e-01 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 13 | 8.42e-01 | -3.20e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF SECRETION | 163 | 4.81e-01 | 3.20e-02 | 9.95e-01 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 1554 | 3.54e-02 | 3.20e-02 | 7.25e-01 |
| GOBP BONE MARROW DEVELOPMENT | 9 | 8.68e-01 | 3.19e-02 | 9.99e-01 |
| GOBP COLLATERAL SPROUTING IN ABSENCE OF INJURY | 5 | 9.02e-01 | -3.19e-02 | 9.99e-01 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 15 | 8.31e-01 | 3.19e-02 | 9.98e-01 |
| GOBP INNATE IMMUNE RESPONSE | 896 | 1.05e-01 | 3.19e-02 | 8.67e-01 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 81 | 6.20e-01 | -3.19e-02 | 9.98e-01 |
| GOMF PURINE NUCLEOTIDE BINDING | 1888 | 2.17e-02 | 3.19e-02 | 6.41e-01 |
| GOBP RIBOFLAVIN TRANSPORT | 6 | 8.92e-01 | 3.19e-02 | 9.99e-01 |
| GOMF RIBOFLAVIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.92e-01 | 3.19e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 18 | 8.15e-01 | 3.19e-02 | 9.98e-01 |
| GOBP REGULATION OF JNK CASCADE | 127 | 5.35e-01 | 3.19e-02 | 9.95e-01 |
| GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 9 | 8.69e-01 | -3.19e-02 | 9.99e-01 |
| GOBP URINARY BLADDER SMOOTH MUSCLE CONTRACTION | 7 | 8.84e-01 | -3.18e-02 | 9.99e-01 |
| GOCC PIGMENT GRANULE | 109 | 5.66e-01 | 3.18e-02 | 9.95e-01 |
| GOBP ENDOTHELIAL CELL ACTIVATION | 11 | 8.55e-01 | 3.18e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN | 88 | 6.06e-01 | -3.18e-02 | 9.98e-01 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 127 | 5.37e-01 | -3.18e-02 | 9.95e-01 |
| GOBP APOPTOTIC PROCESS | 1853 | 2.35e-02 | 3.18e-02 | 6.49e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 34 | 7.49e-01 | 3.17e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 13 | 8.43e-01 | 3.17e-02 | 9.99e-01 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 21 | 8.01e-01 | 3.17e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 31 | 7.60e-01 | 3.17e-02 | 9.98e-01 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 28 | 7.72e-01 | 3.17e-02 | 9.98e-01 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 130 | 5.33e-01 | 3.17e-02 | 9.95e-01 |
| GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 131 | 5.32e-01 | -3.17e-02 | 9.95e-01 |
| GOBP SUBSTANTIA NIGRA DEVELOPMENT | 40 | 7.29e-01 | -3.16e-02 | 9.98e-01 |
| GOBP VITAMIN D BIOSYNTHETIC PROCESS | 10 | 8.62e-01 | 3.16e-02 | 9.99e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 430 | 2.61e-01 | -3.16e-02 | 9.62e-01 |
| GOMF CAMP BINDING | 22 | 7.98e-01 | -3.15e-02 | 9.98e-01 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 20 | 8.07e-01 | 3.15e-02 | 9.98e-01 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 102 | 5.83e-01 | 3.15e-02 | 9.96e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 89 | 6.08e-01 | -3.15e-02 | 9.98e-01 |
| GOBP NOTCH SIGNALING PATHWAY | 173 | 4.76e-01 | 3.14e-02 | 9.95e-01 |
| GOBP MYOBLAST DIFFERENTIATION | 109 | 5.71e-01 | 3.14e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 160 | 4.93e-01 | 3.14e-02 | 9.95e-01 |
| GOMF ACETYLCHOLINE RECEPTOR BINDING | 11 | 8.57e-01 | -3.14e-02 | 9.99e-01 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 599 | 1.89e-01 | 3.14e-02 | 9.28e-01 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 22 | 7.99e-01 | -3.13e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 11 | 8.57e-01 | 3.13e-02 | 9.99e-01 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 33 | 7.56e-01 | -3.13e-02 | 9.98e-01 |
| GOMF DNA HELICASE ACTIVITY | 57 | 6.83e-01 | -3.13e-02 | 9.98e-01 |
| GOBP INTERLEUKIN 1 PRODUCTION | 123 | 5.49e-01 | 3.13e-02 | 9.95e-01 |
| GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 19 | 8.13e-01 | 3.13e-02 | 9.98e-01 |
| GOBP LYSOSOMAL MICROAUTOPHAGY | 13 | 8.45e-01 | 3.13e-02 | 9.99e-01 |
| GOMF ISOMERASE ACTIVITY | 154 | 5.03e-01 | -3.13e-02 | 9.95e-01 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 52 | 6.97e-01 | -3.12e-02 | 9.98e-01 |
| GOBP HYPEROSMOTIC RESPONSE | 26 | 7.83e-01 | -3.12e-02 | 9.98e-01 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 21 | 8.04e-01 | 3.12e-02 | 9.98e-01 |
| GOBP OSTEOBLAST DIFFERENTIATION | 248 | 3.97e-01 | 3.12e-02 | 9.95e-01 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 418 | 2.73e-01 | 3.12e-02 | 9.73e-01 |
| GOBP SECOND MESSENGER MEDIATED SIGNALING | 298 | 3.54e-01 | 3.12e-02 | 9.95e-01 |
| GOMF U3 SNORNA BINDING | 10 | 8.64e-01 | 3.12e-02 | 9.99e-01 |
| GOMF C PALMITOYLTRANSFERASE ACTIVITY | 5 | 9.04e-01 | -3.12e-02 | 9.99e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 24 | 7.91e-01 | -3.12e-02 | 9.98e-01 |
| GOBP HEAT ACCLIMATION | 5 | 9.04e-01 | -3.12e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 48 | 7.09e-01 | 3.12e-02 | 9.98e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN | 31 | 7.64e-01 | -3.12e-02 | 9.98e-01 |
| GOMF DENEDDYLASE ACTIVITY | 6 | 8.95e-01 | -3.11e-02 | 9.99e-01 |
| GOMF GROWTH FACTOR BINDING | 130 | 5.40e-01 | -3.11e-02 | 9.95e-01 |
| GOBP RESPONSE TO BILE ACID | 7 | 8.87e-01 | -3.11e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 32 | 7.61e-01 | 3.11e-02 | 9.98e-01 |
| GOBP ASPARTATE METABOLIC PROCESS | 8 | 8.79e-01 | -3.11e-02 | 9.99e-01 |
| GOBP SPHINGOLIPID TRANSLOCATION | 5 | 9.04e-01 | 3.11e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 67 | 6.60e-01 | -3.11e-02 | 9.98e-01 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 71 | 6.51e-01 | -3.11e-02 | 9.98e-01 |
| GOBP HEPOXILIN METABOLIC PROCESS | 9 | 8.72e-01 | 3.11e-02 | 9.99e-01 |
| GOBP PLATELET ACTIVATION | 128 | 5.44e-01 | 3.11e-02 | 9.95e-01 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 60 | 6.77e-01 | 3.11e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 86 | 6.19e-01 | 3.10e-02 | 9.98e-01 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 155 | 5.05e-01 | -3.10e-02 | 9.95e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 41 | 7.31e-01 | 3.10e-02 | 9.98e-01 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 262 | 3.88e-01 | 3.10e-02 | 9.95e-01 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 106 | 5.81e-01 | -3.10e-02 | 9.96e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 58 | 6.83e-01 | 3.10e-02 | 9.98e-01 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 13 | 8.47e-01 | 3.10e-02 | 9.99e-01 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 37 | 7.45e-01 | 3.09e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 16 | 8.30e-01 | 3.09e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 22 | 8.02e-01 | 3.09e-02 | 9.98e-01 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 81 | 6.31e-01 | 3.09e-02 | 9.98e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 89 | 6.14e-01 | -3.09e-02 | 9.98e-01 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 260 | 3.92e-01 | 3.08e-02 | 9.95e-01 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 185 | 4.70e-01 | 3.08e-02 | 9.95e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 8 | 8.80e-01 | -3.08e-02 | 9.99e-01 |
| GOBP TRNA PROCESSING | 126 | 5.51e-01 | 3.08e-02 | 9.95e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 71 | 6.54e-01 | -3.08e-02 | 9.98e-01 |
| GOBP VESTIBULOCOCHLEAR NERVE MORPHOGENESIS | 7 | 8.88e-01 | 3.08e-02 | 9.99e-01 |
| GOMF RIBOSOME BINDING | 101 | 5.93e-01 | 3.08e-02 | 9.98e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 85 | 6.24e-01 | -3.08e-02 | 9.98e-01 |
| GOBP EPITHELIAL MESENCHYMAL CELL SIGNALING | 6 | 8.96e-01 | -3.08e-02 | 9.99e-01 |
| GOBP OOCYTE CONSTRUCTION | 8 | 8.80e-01 | -3.08e-02 | 9.99e-01 |
| GOBP ENDOTHELIAL CELL MIGRATION | 270 | 3.85e-01 | -3.07e-02 | 9.95e-01 |
| GOMF NADPLUS BINDING | 18 | 8.21e-01 | 3.07e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 11 | 8.60e-01 | -3.07e-02 | 9.99e-01 |
| GOBP INTERFERON BETA PRODUCTION | 56 | 6.91e-01 | 3.07e-02 | 9.98e-01 |
| GOBP CELL DIVISION | 613 | 1.95e-01 | 3.07e-02 | 9.28e-01 |
| GOBP REGULATION OF NEURON MATURATION | 8 | 8.81e-01 | 3.06e-02 | 9.99e-01 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 15 | 8.37e-01 | 3.06e-02 | 9.99e-01 |
| GOMF PYRUVATE DEHYDROGENASE LIPOAMIDE PHOSPHATASE ACTIVITY | 5 | 9.06e-01 | -3.06e-02 | 9.99e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 75 | 6.47e-01 | 3.06e-02 | 9.98e-01 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 125 | 5.55e-01 | -3.06e-02 | 9.95e-01 |
| GOMF BETA CATENIN BINDING | 80 | 6.36e-01 | -3.06e-02 | 9.98e-01 |
| GOBP RESPONSE TO MINERALOCORTICOID | 33 | 7.61e-01 | 3.06e-02 | 9.98e-01 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 59 | 6.85e-01 | -3.06e-02 | 9.98e-01 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 28 | 7.80e-01 | -3.06e-02 | 9.98e-01 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 24 | 7.96e-01 | 3.05e-02 | 9.98e-01 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 21 | 8.09e-01 | -3.05e-02 | 9.98e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 210 | 4.46e-01 | 3.05e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 6 | 8.97e-01 | 3.05e-02 | 9.99e-01 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 57 | 6.91e-01 | 3.05e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1672 | 3.81e-02 | 3.05e-02 | 7.44e-01 |
| GOMF NADPH BINDING | 15 | 8.38e-01 | -3.04e-02 | 9.99e-01 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 7 | 8.89e-01 | -3.04e-02 | 9.99e-01 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 682 | 1.76e-01 | 3.04e-02 | 9.21e-01 |
| GOBP UTP METABOLIC PROCESS | 12 | 8.55e-01 | 3.04e-02 | 9.99e-01 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 32 | 7.66e-01 | 3.04e-02 | 9.98e-01 |
| GOBP RESPONSE TO ETHANOL | 117 | 5.71e-01 | 3.04e-02 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 21 | 8.10e-01 | 3.04e-02 | 9.98e-01 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 208 | 4.51e-01 | -3.04e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 10 | 8.68e-01 | -3.03e-02 | 9.99e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 40 | 7.40e-01 | 3.03e-02 | 9.98e-01 |
| GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.06e-01 | 3.03e-02 | 9.99e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 38 | 7.46e-01 | 3.03e-02 | 9.98e-01 |
| GOBP TISSUE REGENERATION | 73 | 6.54e-01 | -3.03e-02 | 9.98e-01 |
| GOBP FOCAL ADHESION ASSEMBLY | 83 | 6.33e-01 | -3.03e-02 | 9.98e-01 |
| GOBP REGULATION OF LIPID LOCALIZATION | 183 | 4.80e-01 | -3.03e-02 | 9.95e-01 |
| GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 8.82e-01 | 3.03e-02 | 9.99e-01 |
| GOBP TRNA MODIFICATION | 87 | 6.26e-01 | 3.03e-02 | 9.98e-01 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 101 | 5.99e-01 | 3.03e-02 | 9.98e-01 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 130 | 5.51e-01 | -3.03e-02 | 9.95e-01 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 20 | 8.15e-01 | -3.02e-02 | 9.98e-01 |
| GOBP PLASMA CELL DIFFERENTIATION | 8 | 8.82e-01 | -3.02e-02 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 180 | 4.84e-01 | 3.02e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 94 | 6.13e-01 | 3.02e-02 | 9.98e-01 |
| GOCC PSEUDOPODIUM | 16 | 8.34e-01 | 3.02e-02 | 9.99e-01 |
| GOMF DIPEPTIDASE ACTIVITY | 16 | 8.34e-01 | 3.02e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 28 | 7.82e-01 | 3.02e-02 | 9.98e-01 |
| GOBP ENDOCARDIUM MORPHOGENESIS | 6 | 8.98e-01 | 3.02e-02 | 9.99e-01 |
| GOMF KINETOCHORE BINDING | 6 | 8.98e-01 | -3.02e-02 | 9.99e-01 |
| GOBP RESPONSE TO BACTERIUM | 660 | 1.86e-01 | -3.02e-02 | 9.28e-01 |
| GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA | 13 | 8.51e-01 | -3.02e-02 | 9.99e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 150 | 5.24e-01 | 3.02e-02 | 9.95e-01 |
| GOCC INCLUSION BODY | 69 | 6.65e-01 | 3.01e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 155 | 5.17e-01 | 3.01e-02 | 9.95e-01 |
| GOBP PHOSPHORYLATION | 1518 | 4.98e-02 | 3.01e-02 | 7.77e-01 |
| GOBP RNA CATABOLIC PROCESS | 348 | 3.35e-01 | 3.01e-02 | 9.88e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 98 | 6.07e-01 | -3.01e-02 | 9.98e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 310 | 3.62e-01 | 3.01e-02 | 9.95e-01 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 26 | 7.91e-01 | 3.01e-02 | 9.98e-01 |
| GOBP PROTEIN PHOSPHORYLATION | 1268 | 7.18e-02 | 3.01e-02 | 8.03e-01 |
| GOBP MEMBRANOUS SEPTUM MORPHOGENESIS | 8 | 8.83e-01 | 3.00e-02 | 9.99e-01 |
| GOBP MEMBRANE FISSION | 42 | 7.36e-01 | 3.00e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 37 | 7.52e-01 | 3.00e-02 | 9.98e-01 |
| GOBP POLYPRENOL METABOLIC PROCESS | 23 | 8.03e-01 | -3.00e-02 | 9.98e-01 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 177 | 4.91e-01 | -3.00e-02 | 9.95e-01 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 44 | 7.31e-01 | -3.00e-02 | 9.98e-01 |
| GOCC RUFFLE | 178 | 4.90e-01 | -3.00e-02 | 9.95e-01 |
| GOBP CARBOHYDRATE TRANSPORT | 153 | 5.22e-01 | -3.00e-02 | 9.95e-01 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 50 | 7.14e-01 | -2.99e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 16 | 8.36e-01 | -2.99e-02 | 9.99e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 8.77e-01 | 2.99e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 19 | 8.22e-01 | 2.99e-02 | 9.98e-01 |
| GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 9 | 8.77e-01 | -2.99e-02 | 9.99e-01 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 6.99e-01 | -2.99e-02 | 9.98e-01 |
| GOBP STEROL METABOLIC PROCESS | 149 | 5.29e-01 | -2.99e-02 | 9.95e-01 |
| GOBP PURINE NUCLEOTIDE TRANSPORT | 34 | 7.63e-01 | 2.99e-02 | 9.98e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 77 | 6.51e-01 | 2.99e-02 | 9.98e-01 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 25 | 7.96e-01 | -2.98e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 10 | 8.70e-01 | -2.98e-02 | 9.99e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 82 | 6.40e-01 | 2.98e-02 | 9.98e-01 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 561 | 2.27e-01 | 2.98e-02 | 9.50e-01 |
| GOMF ANTIPORTER ACTIVITY | 127 | 5.62e-01 | -2.98e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 90 | 6.25e-01 | 2.98e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 22 | 8.09e-01 | -2.98e-02 | 9.98e-01 |
| GOCC CELL SURFACE | 838 | 1.43e-01 | -2.98e-02 | 9.02e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION | 158 | 5.18e-01 | 2.98e-02 | 9.95e-01 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 27 | 7.89e-01 | 2.97e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 6 | 9.00e-01 | 2.97e-02 | 9.99e-01 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 39 | 7.48e-01 | 2.97e-02 | 9.98e-01 |
| GOMF NEUROTROPHIN RECEPTOR ACTIVITY | 5 | 9.09e-01 | -2.97e-02 | 9.99e-01 |
| GOCC RIBOSOMAL SUBUNIT | 177 | 4.96e-01 | -2.97e-02 | 9.95e-01 |
| GOCC RUFFLE MEMBRANE | 99 | 6.10e-01 | -2.96e-02 | 9.98e-01 |
| GOBP RESPONSE TO RADIATION | 410 | 3.03e-01 | 2.96e-02 | 9.87e-01 |
| GOMF FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVITY | 5 | 9.09e-01 | 2.96e-02 | 9.99e-01 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 26 | 7.94e-01 | -2.96e-02 | 9.98e-01 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 18 | 8.28e-01 | 2.96e-02 | 9.98e-01 |
| GOMF ATP HYDROLYSIS ACTIVITY | 392 | 3.15e-01 | 2.96e-02 | 9.87e-01 |
| GOBP CYTOSOLIC TRANSPORT | 174 | 5.01e-01 | 2.95e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 39 | 7.50e-01 | -2.95e-02 | 9.98e-01 |
| GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY | 5 | 9.09e-01 | -2.95e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 45 | 7.32e-01 | 2.95e-02 | 9.98e-01 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 36 | 7.60e-01 | -2.95e-02 | 9.98e-01 |
| GOBP REGULATION OF CELL ACTIVATION | 626 | 2.08e-01 | 2.95e-02 | 9.38e-01 |
| GOMF MICROTUBULE BINDING | 261 | 4.13e-01 | 2.95e-02 | 9.95e-01 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 8.72e-01 | 2.94e-02 | 9.99e-01 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 43 | 7.38e-01 | 2.94e-02 | 9.98e-01 |
| GOCC SUPRAMOLECULAR COMPLEX | 1323 | 7.25e-02 | -2.94e-02 | 8.07e-01 |
| GOMF PROTEIN CONTAINING COMPLEX BINDING | 1668 | 4.55e-02 | 2.94e-02 | 7.59e-01 |
| GOBP HYALURONAN CATABOLIC PROCESS | 16 | 8.39e-01 | -2.94e-02 | 9.99e-01 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 23 | 8.07e-01 | 2.94e-02 | 9.98e-01 |
| GOBP REGULATION OF DNA DEMETHYLATION | 11 | 8.66e-01 | 2.94e-02 | 9.99e-01 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 182 | 4.95e-01 | 2.94e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 31 | 7.77e-01 | -2.93e-02 | 9.98e-01 |
| GOBP REGULATION OF NUCLEAR DIVISION | 146 | 5.41e-01 | 2.93e-02 | 9.95e-01 |
| GOCC CENTRIOLAR SATELLITE | 107 | 6.00e-01 | 2.93e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 314 | 3.72e-01 | 2.93e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 133 | 5.60e-01 | -2.93e-02 | 9.95e-01 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 149 | 5.38e-01 | -2.93e-02 | 9.95e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 544 | 2.43e-01 | -2.93e-02 | 9.58e-01 |
| GOBP METANEPHRIC TUBULE MORPHOGENESIS | 11 | 8.67e-01 | 2.92e-02 | 9.99e-01 |
| GOCC SIDE OF MEMBRANE | 674 | 1.96e-01 | -2.92e-02 | 9.30e-01 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 34 | 7.68e-01 | 2.92e-02 | 9.98e-01 |
| GOCC OUTER KINETOCHORE | 20 | 8.21e-01 | 2.92e-02 | 9.98e-01 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 19 | 8.26e-01 | 2.92e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL MIGRATION | 5 | 9.10e-01 | -2.92e-02 | 9.99e-01 |
| GOMF RRNA BINDING | 62 | 6.91e-01 | -2.92e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 6 | 9.02e-01 | -2.91e-02 | 9.99e-01 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 68 | 6.79e-01 | 2.91e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 461 | 2.85e-01 | 2.91e-02 | 9.75e-01 |
| GOBP RENAL FILTRATION | 25 | 8.02e-01 | 2.90e-02 | 9.98e-01 |
| GOBP AXO DENDRITIC PROTEIN TRANSPORT | 9 | 8.80e-01 | 2.90e-02 | 9.99e-01 |
| GOBP OVULATION CYCLE PROCESS | 50 | 7.22e-01 | 2.90e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 35 | 7.66e-01 | 2.90e-02 | 9.98e-01 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 145 | 5.46e-01 | -2.90e-02 | 9.95e-01 |
| GOBP SENSORY PERCEPTION OF SWEET TASTE | 7 | 8.94e-01 | -2.90e-02 | 9.99e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 20 | 8.23e-01 | 2.90e-02 | 9.98e-01 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 12 | 8.62e-01 | 2.90e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 94 | 6.27e-01 | 2.90e-02 | 9.98e-01 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 183 | 4.99e-01 | 2.90e-02 | 9.95e-01 |
| GOBP ICOSANOID METABOLIC PROCESS | 115 | 5.92e-01 | 2.89e-02 | 9.98e-01 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 91 | 6.33e-01 | 2.89e-02 | 9.98e-01 |
| GOBP TRANSCYTOSIS | 20 | 8.23e-01 | -2.89e-02 | 9.98e-01 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 8 | 8.87e-01 | -2.89e-02 | 9.99e-01 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 61 | 6.96e-01 | -2.89e-02 | 9.98e-01 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 47 | 7.32e-01 | 2.89e-02 | 9.98e-01 |
| GOBP MANNOSYLATION | 22 | 8.15e-01 | -2.89e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 91 | 6.34e-01 | 2.89e-02 | 9.98e-01 |
| GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS | 5 | 9.11e-01 | 2.89e-02 | 9.99e-01 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 14 | 8.52e-01 | 2.88e-02 | 9.99e-01 |
| GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 12 | 8.63e-01 | -2.88e-02 | 9.99e-01 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1521 | 6.07e-02 | 2.88e-02 | 7.94e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 89 | 6.39e-01 | -2.88e-02 | 9.98e-01 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 298 | 3.93e-01 | 2.88e-02 | 9.95e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 11 | 8.69e-01 | 2.88e-02 | 9.99e-01 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 95 | 6.28e-01 | 2.88e-02 | 9.98e-01 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 98 | 6.23e-01 | -2.88e-02 | 9.98e-01 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 509 | 2.68e-01 | 2.87e-02 | 9.68e-01 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 26 | 8.00e-01 | -2.87e-02 | 9.98e-01 |
| GOBP REGULATION OF HORMONE LEVELS | 518 | 2.64e-01 | -2.87e-02 | 9.64e-01 |
| GOBP SERINE TRANSPORT | 9 | 8.82e-01 | -2.87e-02 | 9.99e-01 |
| GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 8.82e-01 | -2.87e-02 | 9.99e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 47 | 7.34e-01 | 2.87e-02 | 9.98e-01 |
| GOBP NEUROTRANSMITTER UPTAKE | 44 | 7.42e-01 | -2.87e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 126 | 5.79e-01 | -2.87e-02 | 9.96e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 392 | 3.30e-01 | 2.86e-02 | 9.88e-01 |
| GOBP REGULATION OF CD40 SIGNALING PATHWAY | 6 | 9.03e-01 | 2.86e-02 | 9.99e-01 |
| GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 8.82e-01 | 2.86e-02 | 9.99e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 52 | 7.21e-01 | -2.86e-02 | 9.98e-01 |
| GOBP FIBROBLAST MIGRATION | 52 | 7.21e-01 | 2.86e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 122 | 5.86e-01 | 2.86e-02 | 9.96e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 12 | 8.64e-01 | -2.86e-02 | 9.99e-01 |
| GOBP GLIOGENESIS | 327 | 3.75e-01 | 2.85e-02 | 9.95e-01 |
| GOBP REGULATION OF CGMP MEDIATED SIGNALING | 11 | 8.70e-01 | -2.85e-02 | 9.99e-01 |
| GOBP NAD TRANSPORT | 5 | 9.12e-01 | -2.85e-02 | 9.99e-01 |
| GOBP REGULATION OF PINOCYTOSIS | 12 | 8.64e-01 | 2.85e-02 | 9.99e-01 |
| GOMF RDNA BINDING | 10 | 8.76e-01 | 2.85e-02 | 9.99e-01 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 20 | 8.26e-01 | 2.85e-02 | 9.98e-01 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 32 | 7.81e-01 | 2.85e-02 | 9.98e-01 |
| GOBP CEREBROSPINAL FLUID CIRCULATION | 15 | 8.49e-01 | 2.84e-02 | 9.99e-01 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 157 | 5.39e-01 | 2.84e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 8 | 8.89e-01 | 2.84e-02 | 9.99e-01 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 75 | 6.71e-01 | 2.84e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 13 | 8.60e-01 | 2.83e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 24 | 8.10e-01 | 2.83e-02 | 9.98e-01 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 24 | 8.10e-01 | -2.83e-02 | 9.98e-01 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 20 | 8.27e-01 | -2.83e-02 | 9.98e-01 |
| GOBP GENITALIA DEVELOPMENT | 46 | 7.40e-01 | -2.82e-02 | 9.98e-01 |
| GOBP LATERAL MESODERM DEVELOPMENT | 15 | 8.50e-01 | 2.82e-02 | 9.99e-01 |
| GOCC ENVELOPE | 1183 | 1.02e-01 | 2.82e-02 | 8.66e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 48 | 7.36e-01 | 2.82e-02 | 9.98e-01 |
| GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 813 | 1.72e-01 | -2.82e-02 | 9.21e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 55 | 7.18e-01 | -2.82e-02 | 9.98e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 15 | 8.50e-01 | -2.82e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 138 | 5.68e-01 | -2.82e-02 | 9.95e-01 |
| GOMF SODIUM ION BINDING | 8 | 8.90e-01 | 2.81e-02 | 9.99e-01 |
| GOBP THYMUS DEVELOPMENT | 49 | 7.34e-01 | 2.81e-02 | 9.98e-01 |
| GOBP MYOBLAST PROLIFERATION | 34 | 7.77e-01 | -2.81e-02 | 9.98e-01 |
| GOBP SPERM AXONEME ASSEMBLY | 27 | 8.00e-01 | -2.81e-02 | 9.98e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 155 | 5.46e-01 | 2.81e-02 | 9.95e-01 |
| GOBP ENSHEATHMENT OF NEURONS | 143 | 5.63e-01 | -2.80e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 15 | 8.51e-01 | -2.80e-02 | 9.99e-01 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 236 | 4.59e-01 | -2.80e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 5 | 9.14e-01 | -2.80e-02 | 9.99e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 19 | 8.33e-01 | -2.80e-02 | 9.99e-01 |
| GOBP REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY | 6 | 9.06e-01 | -2.80e-02 | 9.99e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 10 | 8.78e-01 | 2.80e-02 | 9.99e-01 |
| GOBP CHROMOSOME SEPARATION | 81 | 6.64e-01 | -2.80e-02 | 9.98e-01 |
| GOBP RESPONSE TO GROWTH FACTOR | 729 | 1.99e-01 | 2.79e-02 | 9.36e-01 |
| GOBP RECEPTOR SIGNALING PATHWAY VIA STAT | 177 | 5.22e-01 | 2.79e-02 | 9.95e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 170 | 5.30e-01 | 2.79e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 191 | 5.06e-01 | -2.79e-02 | 9.95e-01 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 51 | 7.30e-01 | 2.79e-02 | 9.98e-01 |
| GOBP RENAL TUBULE DEVELOPMENT | 99 | 6.32e-01 | 2.79e-02 | 9.98e-01 |
| GOCC INNER KINETOCHORE | 17 | 8.42e-01 | 2.79e-02 | 9.99e-01 |
| GOBP AMIDE CATABOLIC PROCESS | 20 | 8.29e-01 | -2.78e-02 | 9.98e-01 |
| GOBP ORGAN GROWTH | 168 | 5.34e-01 | 2.78e-02 | 9.95e-01 |
| GOBP NEPHRIC DUCT FORMATION | 5 | 9.14e-01 | 2.78e-02 | 9.99e-01 |
| GOCC AGGRESOME | 33 | 7.82e-01 | 2.78e-02 | 9.98e-01 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 38 | 7.67e-01 | -2.78e-02 | 9.98e-01 |
| GOBP RESPONSE TO EXTRACELLULAR STIMULUS | 499 | 2.89e-01 | 2.77e-02 | 9.77e-01 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 70 | 6.88e-01 | -2.77e-02 | 9.98e-01 |
| GOBP SYNAPTIC VESICLE BUDDING | 10 | 8.79e-01 | 2.77e-02 | 9.99e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 17 | 8.43e-01 | 2.77e-02 | 9.99e-01 |
| GOBP INFLAMMATORY RESPONSE | 844 | 1.72e-01 | 2.77e-02 | 9.21e-01 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 45 | 7.48e-01 | 2.77e-02 | 9.98e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 18 | 8.39e-01 | 2.76e-02 | 9.99e-01 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 124 | 5.95e-01 | 2.76e-02 | 9.98e-01 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 66 | 6.98e-01 | -2.76e-02 | 9.98e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 8 | 8.92e-01 | 2.76e-02 | 9.99e-01 |
| GOBP CARBON DIOXIDE TRANSPORT | 15 | 8.53e-01 | 2.76e-02 | 9.99e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 39 | 7.66e-01 | 2.76e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 452 | 3.16e-01 | -2.75e-02 | 9.87e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION | 113 | 6.13e-01 | 2.75e-02 | 9.98e-01 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 87 | 6.57e-01 | -2.75e-02 | 9.98e-01 |
| GOBP PARANODAL JUNCTION ASSEMBLY | 6 | 9.07e-01 | -2.75e-02 | 9.99e-01 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 34 | 7.82e-01 | -2.75e-02 | 9.98e-01 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 19 | 8.36e-01 | -2.75e-02 | 9.99e-01 |
| GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX | 5 | 9.15e-01 | 2.75e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 24 | 8.16e-01 | 2.74e-02 | 9.98e-01 |
| GOBP MRNA MODIFICATION | 31 | 7.91e-01 | 2.74e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 37 | 7.73e-01 | 2.74e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 15 | 8.54e-01 | 2.74e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 37 | 7.73e-01 | 2.74e-02 | 9.98e-01 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 59 | 7.16e-01 | 2.74e-02 | 9.98e-01 |
| GOBP MONOAMINE TRANSPORT | 86 | 6.61e-01 | 2.74e-02 | 9.98e-01 |
| GOBP BONE RESORPTION | 65 | 7.03e-01 | 2.74e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 33 | 7.86e-01 | 2.74e-02 | 9.98e-01 |
| GOBP CRANIAL SUTURE MORPHOGENESIS | 8 | 8.93e-01 | -2.73e-02 | 9.99e-01 |
| GOBP INTERLEUKIN 10 PRODUCTION | 57 | 7.21e-01 | -2.73e-02 | 9.98e-01 |
| GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 25 | 8.13e-01 | 2.73e-02 | 9.98e-01 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 242 | 4.66e-01 | -2.72e-02 | 9.95e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 43 | 7.57e-01 | 2.72e-02 | 9.98e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 15 | 8.55e-01 | 2.72e-02 | 9.99e-01 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 115 | 6.14e-01 | 2.72e-02 | 9.98e-01 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 928 | 1.60e-01 | 2.72e-02 | 9.06e-01 |
| GOBP RESPONSE TO DEXAMETHASONE | 38 | 7.72e-01 | 2.72e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 22 | 8.25e-01 | 2.72e-02 | 9.98e-01 |
| GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 6 | 9.08e-01 | -2.72e-02 | 9.99e-01 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 337 | 3.92e-01 | 2.72e-02 | 9.95e-01 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 734 | 2.10e-01 | -2.71e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 139 | 5.81e-01 | 2.71e-02 | 9.96e-01 |
| GOBP PRE MIRNA PROCESSING | 17 | 8.47e-01 | 2.71e-02 | 9.99e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 445 | 3.28e-01 | 2.71e-02 | 9.87e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY | 666 | 2.34e-01 | -2.71e-02 | 9.51e-01 |
| GOMF TORC2 COMPLEX BINDING | 5 | 9.17e-01 | 2.71e-02 | 9.99e-01 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 32 | 7.91e-01 | 2.70e-02 | 9.98e-01 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 169 | 5.45e-01 | 2.70e-02 | 9.95e-01 |
| GOCC MICROBODY MEMBRANE | 62 | 7.13e-01 | -2.70e-02 | 9.98e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 507 | 2.98e-01 | 2.70e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 11 | 8.77e-01 | -2.70e-02 | 9.99e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 28 | 8.05e-01 | 2.70e-02 | 9.98e-01 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 353 | 3.85e-01 | 2.69e-02 | 9.95e-01 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 487 | 3.10e-01 | 2.69e-02 | 9.87e-01 |
| GOBP NEUROTRANSMITTER REUPTAKE | 34 | 7.86e-01 | 2.69e-02 | 9.98e-01 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 10 | 8.83e-01 | -2.69e-02 | 9.99e-01 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 72 | 6.94e-01 | -2.69e-02 | 9.98e-01 |
| GOBP GLUTAMINE TRANSPORT | 9 | 8.89e-01 | 2.68e-02 | 9.99e-01 |
| GOBP RESPONSE TO KETONE | 197 | 5.16e-01 | 2.68e-02 | 9.95e-01 |
| GOBP REGULATION OF EXOCYTOSIS | 176 | 5.39e-01 | -2.68e-02 | 9.95e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 175 | 5.41e-01 | 2.68e-02 | 9.95e-01 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 15 | 8.57e-01 | 2.68e-02 | 9.99e-01 |
| GOBP MELANOCYTE PROLIFERATION | 5 | 9.17e-01 | -2.68e-02 | 9.99e-01 |
| GOCC VESICLE COAT | 61 | 7.18e-01 | 2.68e-02 | 9.98e-01 |
| GOBP SEXUAL REPRODUCTION | 985 | 1.55e-01 | 2.68e-02 | 9.06e-01 |
| GOMF CYCLASE REGULATOR ACTIVITY | 16 | 8.53e-01 | -2.68e-02 | 9.99e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 27 | 8.10e-01 | -2.68e-02 | 9.98e-01 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 24 | 8.21e-01 | 2.67e-02 | 9.98e-01 |
| GOBP GALACTOSE METABOLIC PROCESS | 8 | 8.96e-01 | 2.67e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF HEART RATE | 11 | 8.78e-01 | -2.67e-02 | 9.99e-01 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 123 | 6.09e-01 | 2.67e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 12 | 8.73e-01 | -2.67e-02 | 9.99e-01 |
| GOMF CADMIUM ION BINDING | 5 | 9.18e-01 | 2.67e-02 | 9.99e-01 |
| GOMF ALPHA KETOGLUTARATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.10e-01 | 2.67e-02 | 9.99e-01 |
| GOBP MAST CELL CHEMOTAXIS | 10 | 8.84e-01 | -2.67e-02 | 9.99e-01 |
| GOBP REGULATION OF DNA REPLICATION | 121 | 6.13e-01 | 2.66e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 8 | 8.96e-01 | 2.66e-02 | 9.99e-01 |
| GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 13 | 8.68e-01 | -2.66e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 853 | 1.87e-01 | 2.66e-02 | 9.28e-01 |
| GOBP MAPK CASCADE | 737 | 2.19e-01 | -2.66e-02 | 9.43e-01 |
| GOBP CELL MATURATION | 191 | 5.26e-01 | -2.66e-02 | 9.95e-01 |
| GOCC POSTSYNAPTIC MEMBRANE | 256 | 4.64e-01 | 2.66e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING | 15 | 8.59e-01 | -2.66e-02 | 9.99e-01 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 12 | 8.73e-01 | -2.66e-02 | 9.99e-01 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 93 | 6.58e-01 | 2.66e-02 | 9.98e-01 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 42 | 7.66e-01 | 2.66e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 121 | 6.14e-01 | -2.66e-02 | 9.98e-01 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 188 | 5.30e-01 | 2.66e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 317 | 4.16e-01 | 2.65e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1615 | 7.55e-02 | 2.65e-02 | 8.18e-01 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 27 | 8.11e-01 | -2.65e-02 | 9.98e-01 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 8.79e-01 | -2.65e-02 | 9.99e-01 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 45 | 7.58e-01 | -2.65e-02 | 9.98e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 46 | 7.56e-01 | 2.65e-02 | 9.98e-01 |
| GOBP GOLGI VESICLE FUSION TO TARGET MEMBRANE | 5 | 9.18e-01 | 2.65e-02 | 9.99e-01 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 242 | 4.78e-01 | -2.65e-02 | 9.95e-01 |
| GOBP GLUCOSE IMPORT ACROSS PLASMA MEMBRANE | 5 | 9.18e-01 | -2.65e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 26 | 8.15e-01 | -2.65e-02 | 9.98e-01 |
| GOBP REGULATION OF HOMOPHILIC CELL ADHESION | 5 | 9.18e-01 | 2.64e-02 | 9.99e-01 |
| GOBP POSTSYNAPSE ORGANIZATION | 177 | 5.44e-01 | -2.64e-02 | 9.95e-01 |
| GOBP PROTEIN TRIMERIZATION | 17 | 8.50e-01 | 2.64e-02 | 9.99e-01 |
| GOMF ODORANT BINDING | 100 | 6.48e-01 | 2.64e-02 | 9.98e-01 |
| GOBP MONOATOMIC CATION TRANSPORT | 996 | 1.58e-01 | -2.64e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 495 | 3.15e-01 | 2.64e-02 | 9.87e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY | 7 | 9.04e-01 | -2.64e-02 | 9.99e-01 |
| GOBP REGULATION OF INTESTINAL LIPID ABSORPTION | 10 | 8.85e-01 | 2.63e-02 | 9.99e-01 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 197 | 5.24e-01 | -2.63e-02 | 9.95e-01 |
| GOCC COPII VESICLE COAT | 16 | 8.55e-01 | -2.63e-02 | 9.99e-01 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 204 | 5.17e-01 | -2.63e-02 | 9.95e-01 |
| GOCC NUCLEAR ENVELOPE LUMEN | 10 | 8.85e-01 | 2.63e-02 | 9.99e-01 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 139 | 5.92e-01 | -2.63e-02 | 9.98e-01 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 265 | 4.61e-01 | -2.63e-02 | 9.95e-01 |
| GOBP LUNG ASSOCIATED MESENCHYME DEVELOPMENT | 8 | 8.98e-01 | 2.62e-02 | 9.99e-01 |
| GOBP T CELL SELECTION | 52 | 7.43e-01 | 2.62e-02 | 9.98e-01 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 28 | 8.10e-01 | 2.62e-02 | 9.98e-01 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 23 | 8.28e-01 | 2.62e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 14 | 8.65e-01 | 2.62e-02 | 9.99e-01 |
| GOCC CONTRACTILE RING | 10 | 8.86e-01 | -2.62e-02 | 9.99e-01 |
| GOBP MICROTUBULE SEVERING | 8 | 8.98e-01 | -2.61e-02 | 9.99e-01 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 66 | 7.13e-01 | 2.61e-02 | 9.98e-01 |
| GOMF ARYLSULFATASE ACTIVITY | 9 | 8.92e-01 | 2.61e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 200 | 5.24e-01 | 2.61e-02 | 9.95e-01 |
| GOBP METHYLATION | 260 | 4.68e-01 | 2.61e-02 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN STABILITY | 305 | 4.33e-01 | 2.61e-02 | 9.95e-01 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 290 | 4.45e-01 | -2.61e-02 | 9.95e-01 |
| GOBP NEUTROPHIL CLEARANCE | 6 | 9.12e-01 | 2.61e-02 | 9.99e-01 |
| GOBP REGULATION OF RETINAL GANGLION CELL AXON GUIDANCE | 6 | 9.12e-01 | 2.60e-02 | 9.99e-01 |
| GOBP CELLULAR COMPONENT MORPHOGENESIS | 751 | 2.25e-01 | -2.60e-02 | 9.49e-01 |
| GOCC ENDOSOME | 986 | 1.67e-01 | -2.60e-02 | 9.15e-01 |
| GOBP TOR SIGNALING | 157 | 5.74e-01 | 2.60e-02 | 9.95e-01 |
| GOMF G PROTEIN COUPLED ADENOSINE RECEPTOR ACTIVITY | 5 | 9.20e-01 | -2.60e-02 | 9.99e-01 |
| GOBP MICROTUBULE BASED PROCESS | 897 | 1.87e-01 | 2.60e-02 | 9.28e-01 |
| GOBP PHOSPHOLIPID EFFLUX | 14 | 8.66e-01 | -2.60e-02 | 9.99e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 65 | 7.17e-01 | 2.60e-02 | 9.98e-01 |
| GOBP VIRION ASSEMBLY | 34 | 7.94e-01 | -2.59e-02 | 9.98e-01 |
| GOBP HEMOPOIESIS | 911 | 1.85e-01 | 2.59e-02 | 9.28e-01 |
| GOBP MRNA METHYLATION | 17 | 8.53e-01 | -2.59e-02 | 9.99e-01 |
| GOBP MYOTUBE CELL DEVELOPMENT | 40 | 7.77e-01 | 2.59e-02 | 9.98e-01 |
| GOBP ENDOCYTOSIS | 681 | 2.49e-01 | 2.59e-02 | 9.58e-01 |
| GOBP SYNAPSE ASSEMBLY | 184 | 5.45e-01 | -2.59e-02 | 9.95e-01 |
| GOBP ASTROCYTE DIFFERENTIATION | 84 | 6.82e-01 | 2.59e-02 | 9.98e-01 |
| GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 12 | 8.77e-01 | -2.58e-02 | 9.99e-01 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 25 | 8.23e-01 | -2.58e-02 | 9.98e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 9.20e-01 | 2.58e-02 | 9.99e-01 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 65 | 7.19e-01 | 2.58e-02 | 9.98e-01 |
| GOBP REGULATED EXOCYTOSIS | 214 | 5.16e-01 | -2.58e-02 | 9.95e-01 |
| GOCC DENDRITE CYTOPLASM | 26 | 8.20e-01 | -2.58e-02 | 9.98e-01 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 30 | 8.07e-01 | 2.57e-02 | 9.98e-01 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 70 | 7.10e-01 | 2.57e-02 | 9.98e-01 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 46 | 7.63e-01 | 2.57e-02 | 9.98e-01 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 305 | 4.40e-01 | 2.57e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 12 | 8.78e-01 | -2.57e-02 | 9.99e-01 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 33 | 7.99e-01 | 2.57e-02 | 9.98e-01 |
| GOMF METAL CLUSTER BINDING | 66 | 7.19e-01 | 2.57e-02 | 9.98e-01 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 8.94e-01 | -2.56e-02 | 9.99e-01 |
| GOBP REGULATION OF PIGMENTATION | 17 | 8.55e-01 | 2.56e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 53 | 7.47e-01 | -2.56e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 1211 | 1.33e-01 | 2.56e-02 | 8.96e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 79 | 6.94e-01 | 2.56e-02 | 9.98e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 337 | 4.19e-01 | -2.56e-02 | 9.95e-01 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 110 | 6.43e-01 | -2.56e-02 | 9.98e-01 |
| GOCC FLEMMING BODY | 34 | 7.96e-01 | -2.56e-02 | 9.98e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 10 | 8.89e-01 | 2.56e-02 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 11 | 8.83e-01 | 2.55e-02 | 9.99e-01 |
| GOBP RESPONSE TO ACID CHEMICAL | 131 | 6.14e-01 | 2.55e-02 | 9.98e-01 |
| GOBP NUCLEAR TRANSPORT | 312 | 4.39e-01 | 2.55e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 21 | 8.40e-01 | 2.55e-02 | 9.99e-01 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 31 | 8.06e-01 | 2.55e-02 | 9.98e-01 |
| GOMF NAD BINDING | 55 | 7.44e-01 | 2.55e-02 | 9.98e-01 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 32 | 8.03e-01 | 2.55e-02 | 9.98e-01 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 503 | 3.29e-01 | -2.54e-02 | 9.87e-01 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 605 | 2.86e-01 | 2.54e-02 | 9.75e-01 |
| GOBP REGULATION OF PLATELET AGGREGATION | 27 | 8.19e-01 | -2.54e-02 | 9.98e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 19 | 8.48e-01 | -2.54e-02 | 9.99e-01 |
| GOMF ACTIN FILAMENT BINDING | 203 | 5.35e-01 | -2.53e-02 | 9.95e-01 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 148 | 5.96e-01 | 2.53e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 209 | 5.30e-01 | 2.52e-02 | 9.95e-01 |
| GOBP REGULATION OF CELL DEVELOPMENT | 814 | 2.22e-01 | 2.52e-02 | 9.45e-01 |
| GOCC SPECIFIC GRANULE LUMEN | 60 | 7.36e-01 | 2.52e-02 | 9.98e-01 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 9.08e-01 | 2.52e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 182 | 5.58e-01 | 2.52e-02 | 9.95e-01 |
| GOBP T TUBULE ORGANIZATION | 6 | 9.15e-01 | -2.51e-02 | 9.99e-01 |
| GOCC CHROMATIN SILENCING COMPLEX | 12 | 8.80e-01 | 2.51e-02 | 9.99e-01 |
| GOBP CHOLESTEROL STORAGE | 25 | 8.28e-01 | -2.51e-02 | 9.98e-01 |
| GOBP THYROID HORMONE TRANSPORT | 10 | 8.91e-01 | -2.51e-02 | 9.99e-01 |
| GOBP SUCKLING BEHAVIOR | 12 | 8.80e-01 | 2.51e-02 | 9.99e-01 |
| GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 6 | 9.15e-01 | 2.50e-02 | 9.99e-01 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 126 | 6.27e-01 | 2.50e-02 | 9.98e-01 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 597 | 2.96e-01 | 2.50e-02 | 9.82e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 865 | 2.13e-01 | 2.50e-02 | 9.40e-01 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 39 | 7.87e-01 | 2.50e-02 | 9.98e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 14 | 8.72e-01 | -2.50e-02 | 9.99e-01 |
| GOCC EARLY ENDOSOME MEMBRANE | 181 | 5.63e-01 | -2.49e-02 | 9.95e-01 |
| GOCC AUTOPHAGOSOME MEMBRANE | 50 | 7.60e-01 | 2.49e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 56 | 7.47e-01 | 2.49e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 154 | 5.94e-01 | 2.49e-02 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 913 | 2.03e-01 | 2.49e-02 | 9.36e-01 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 39 | 7.88e-01 | -2.49e-02 | 9.98e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 46 | 7.71e-01 | -2.49e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 118 | 6.41e-01 | -2.48e-02 | 9.98e-01 |
| GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 15 | 8.68e-01 | 2.48e-02 | 9.99e-01 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 54 | 7.52e-01 | 2.48e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 19 | 8.51e-01 | 2.48e-02 | 9.99e-01 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 58 | 7.44e-01 | 2.48e-02 | 9.98e-01 |
| GOBP PHAGOSOME MATURATION | 28 | 8.20e-01 | -2.48e-02 | 9.98e-01 |
| GOBP STEM CELL PROLIFERATION | 120 | 6.39e-01 | 2.48e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 17 | 8.59e-01 | -2.48e-02 | 9.99e-01 |
| GOCC BRCA1 C COMPLEX | 6 | 9.16e-01 | 2.48e-02 | 9.99e-01 |
| GOCC RNAI EFFECTOR COMPLEX | 357 | 4.21e-01 | 2.48e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 146 | 6.05e-01 | 2.48e-02 | 9.98e-01 |
| GOCC SEROTONIN RECEPTOR COMPLEX | 8 | 9.03e-01 | -2.48e-02 | 9.99e-01 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 207 | 5.39e-01 | 2.48e-02 | 9.95e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION | 8 | 9.03e-01 | -2.48e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 5 | 9.24e-01 | 2.48e-02 | 9.99e-01 |
| GOBP STEROL TRANSPORT | 141 | 6.12e-01 | -2.48e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 8 | 9.04e-01 | -2.47e-02 | 9.99e-01 |
| GOBP PEPTIDE CATABOLIC PROCESS | 22 | 8.41e-01 | -2.47e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 21 | 8.44e-01 | -2.47e-02 | 9.99e-01 |
| GOBP TRACHEA MORPHOGENESIS | 11 | 8.87e-01 | 2.47e-02 | 9.99e-01 |
| GOMF DIOXYGENASE ACTIVITY | 86 | 6.92e-01 | 2.47e-02 | 9.98e-01 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 83 | 6.98e-01 | -2.47e-02 | 9.98e-01 |
| GOBP AMINO ACID TRANSPORT | 142 | 6.12e-01 | 2.46e-02 | 9.98e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 67 | 7.27e-01 | -2.46e-02 | 9.98e-01 |
| GOBP MALE GAMETE GENERATION | 568 | 3.16e-01 | 2.46e-02 | 9.87e-01 |
| GOMF MYOSIN V BINDING | 16 | 8.65e-01 | -2.46e-02 | 9.99e-01 |
| GOBP INTRACELLULAR TRANSPORT | 1507 | 1.10e-01 | 2.46e-02 | 8.76e-01 |
| GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 10 | 8.93e-01 | -2.46e-02 | 9.99e-01 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 945 | 2.00e-01 | 2.46e-02 | 9.36e-01 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 29 | 8.19e-01 | 2.46e-02 | 9.98e-01 |
| GOMF AROMATASE ACTIVITY | 26 | 8.28e-01 | -2.46e-02 | 9.98e-01 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 973 | 1.95e-01 | -2.46e-02 | 9.28e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 20 | 8.49e-01 | -2.46e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 272 | 4.86e-01 | 2.45e-02 | 9.95e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 71 | 7.21e-01 | -2.45e-02 | 9.98e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 47 | 7.71e-01 | -2.45e-02 | 9.98e-01 |
| GOCC METHYLTRANSFERASE COMPLEX | 88 | 6.91e-01 | 2.45e-02 | 9.98e-01 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 230 | 5.23e-01 | -2.45e-02 | 9.95e-01 |
| GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 28 | 8.23e-01 | -2.45e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 179 | 5.72e-01 | -2.45e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 772 | 2.48e-01 | 2.45e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF BINDING | 122 | 6.41e-01 | -2.44e-02 | 9.98e-01 |
| GOBP LYMPHOCYTE ACTIVATION | 753 | 2.54e-01 | 2.44e-02 | 9.58e-01 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 36 | 8.00e-01 | -2.44e-02 | 9.98e-01 |
| GOBP PROSTATIC BUD FORMATION | 8 | 9.05e-01 | 2.44e-02 | 9.99e-01 |
| GOCC SECRETORY GRANULE | 855 | 2.25e-01 | 2.44e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 11 | 8.89e-01 | -2.44e-02 | 9.99e-01 |
| GOCC MEMBRANE COAT | 93 | 6.84e-01 | 2.44e-02 | 9.98e-01 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 359 | 4.27e-01 | -2.44e-02 | 9.95e-01 |
| GOBP COPII COATED VESICLE BUDDING | 42 | 7.85e-01 | -2.44e-02 | 9.98e-01 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 61 | 7.42e-01 | 2.44e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 19 | 8.54e-01 | 2.44e-02 | 9.99e-01 |
| GOBP CALCIUM ION TRANSPORT | 426 | 3.89e-01 | -2.43e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION | 14 | 8.75e-01 | -2.43e-02 | 9.99e-01 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 29 | 8.21e-01 | 2.43e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 19 | 8.54e-01 | 2.43e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 267 | 4.94e-01 | 2.43e-02 | 9.95e-01 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 60 | 7.45e-01 | 2.43e-02 | 9.98e-01 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 914 | 2.13e-01 | 2.43e-02 | 9.40e-01 |
| GOBP WALKING BEHAVIOR | 35 | 8.04e-01 | -2.43e-02 | 9.98e-01 |
| GOBP REPRODUCTION | 1408 | 1.27e-01 | 2.43e-02 | 8.91e-01 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 84 | 7.01e-01 | 2.42e-02 | 9.98e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 27 | 8.28e-01 | -2.42e-02 | 9.98e-01 |
| GOCC CMG COMPLEX | 11 | 8.89e-01 | 2.42e-02 | 9.99e-01 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 65 | 7.36e-01 | -2.42e-02 | 9.98e-01 |
| GOCC SPINDLE | 404 | 4.04e-01 | 2.42e-02 | 9.95e-01 |
| GOBP PROTEASOME ASSEMBLY | 11 | 8.90e-01 | 2.42e-02 | 9.99e-01 |
| GOBP RNA EXPORT FROM NUCLEUS | 82 | 7.05e-01 | -2.41e-02 | 9.98e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 96 | 6.83e-01 | -2.41e-02 | 9.98e-01 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 41 | 7.89e-01 | 2.41e-02 | 9.98e-01 |
| GOBP CARDIOCYTE DIFFERENTIATION | 163 | 5.95e-01 | 2.41e-02 | 9.98e-01 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 47 | 7.75e-01 | -2.41e-02 | 9.98e-01 |
| GOMF ENZYME REGULATOR ACTIVITY | 1202 | 1.60e-01 | -2.41e-02 | 9.06e-01 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 104 | 6.72e-01 | -2.41e-02 | 9.98e-01 |
| GOCC GLYCINERGIC SYNAPSE | 7 | 9.12e-01 | 2.41e-02 | 9.99e-01 |
| GOMF ARRESTIN FAMILY PROTEIN BINDING | 9 | 9.01e-01 | -2.40e-02 | 9.99e-01 |
| GOBP REGULATION OF ACTION POTENTIAL | 55 | 7.58e-01 | 2.40e-02 | 9.98e-01 |
| GOMF CELL ADHESION MOLECULE BINDING | 541 | 3.39e-01 | -2.40e-02 | 9.88e-01 |
| GOBP DETECTION OF STIMULUS | 571 | 3.28e-01 | 2.40e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 241 | 5.22e-01 | -2.39e-02 | 9.95e-01 |
| GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 6 | 9.19e-01 | 2.39e-02 | 9.99e-01 |
| GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 12 | 8.86e-01 | -2.39e-02 | 9.99e-01 |
| GOCC NEUROFIBRILLARY TANGLE | 5 | 9.26e-01 | 2.39e-02 | 9.99e-01 |
| GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 8.57e-01 | 2.39e-02 | 9.99e-01 |
| GOBP REGULATION OF FEVER GENERATION | 9 | 9.01e-01 | -2.39e-02 | 9.99e-01 |
| GOBP MULTICELLULAR ORGANISM REPRODUCTION | 873 | 2.31e-01 | 2.39e-02 | 9.50e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY | 10 | 8.96e-01 | -2.39e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO AMMONIUM ION | 5 | 9.26e-01 | 2.39e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 124 | 6.47e-01 | 2.38e-02 | 9.98e-01 |
| GOBP CELL CHEMOTAXIS | 304 | 4.75e-01 | -2.38e-02 | 9.95e-01 |
| GOMF VINCULIN BINDING | 11 | 8.91e-01 | 2.38e-02 | 9.99e-01 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 24 | 8.40e-01 | 2.38e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 18 | 8.61e-01 | 2.38e-02 | 9.99e-01 |
| GOBP SENSORY ORGAN DEVELOPMENT | 576 | 3.29e-01 | 2.38e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 38 | 8.00e-01 | -2.38e-02 | 9.98e-01 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 128 | 6.43e-01 | -2.37e-02 | 9.98e-01 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 79 | 7.16e-01 | -2.37e-02 | 9.98e-01 |
| GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 9 | 9.02e-01 | -2.36e-02 | 9.99e-01 |
| GOBP MITOTIC CELL CYCLE PROCESS | 746 | 2.72e-01 | 2.36e-02 | 9.73e-01 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 108 | 6.71e-01 | -2.36e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 1306 | 1.52e-01 | 2.36e-02 | 9.04e-01 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 9.27e-01 | 2.36e-02 | 9.99e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 233 | 5.35e-01 | -2.36e-02 | 9.95e-01 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 20 | 8.55e-01 | -2.36e-02 | 9.99e-01 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 469 | 3.81e-01 | -2.36e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 15 | 8.74e-01 | 2.36e-02 | 9.99e-01 |
| GOBP ANIMAL ORGAN FORMATION | 66 | 7.41e-01 | 2.36e-02 | 9.98e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 219 | 5.48e-01 | 2.35e-02 | 9.95e-01 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 94 | 6.93e-01 | -2.35e-02 | 9.98e-01 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 63 | 7.47e-01 | -2.35e-02 | 9.98e-01 |
| GOBP JNK CASCADE | 154 | 6.14e-01 | 2.35e-02 | 9.98e-01 |
| GOBP MESENCHYME DEVELOPMENT | 310 | 4.76e-01 | 2.35e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF SECRETION | 304 | 4.81e-01 | 2.35e-02 | 9.95e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 183 | 5.84e-01 | 2.35e-02 | 9.96e-01 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 56 | 7.61e-01 | -2.35e-02 | 9.98e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 62 | 7.49e-01 | -2.35e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE | 5 | 9.28e-01 | -2.35e-02 | 9.99e-01 |
| GOMF APOLIPOPROTEIN BINDING | 17 | 8.67e-01 | 2.35e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 18 | 8.63e-01 | 2.35e-02 | 9.99e-01 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 382 | 4.31e-01 | 2.35e-02 | 9.95e-01 |
| GOBP SPERM CAPACITATION | 30 | 8.24e-01 | 2.35e-02 | 9.98e-01 |
| GOBP CHLORIDE TRANSPORT | 116 | 6.63e-01 | -2.34e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 45 | 7.86e-01 | 2.34e-02 | 9.98e-01 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 12 | 8.88e-01 | 2.34e-02 | 9.99e-01 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 42 | 7.93e-01 | 2.34e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 189 | 5.80e-01 | -2.34e-02 | 9.96e-01 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 11 | 8.93e-01 | -2.33e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 111 | 6.71e-01 | 2.33e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 21 | 8.53e-01 | -2.33e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 28 | 8.31e-01 | -2.33e-02 | 9.98e-01 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 382 | 4.34e-01 | 2.33e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE | 27 | 8.34e-01 | -2.33e-02 | 9.99e-01 |
| GOBP PROTEIN PALMITOYLATION | 28 | 8.31e-01 | 2.33e-02 | 9.98e-01 |
| GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 11 | 8.94e-01 | 2.33e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 7 | 9.15e-01 | -2.33e-02 | 9.99e-01 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 143 | 6.31e-01 | 2.33e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 10 | 8.99e-01 | 2.32e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 6 | 9.21e-01 | 2.32e-02 | 9.99e-01 |
| GOBP LIPID LOCALIZATION | 495 | 3.76e-01 | -2.32e-02 | 9.95e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS | 230 | 5.44e-01 | -2.32e-02 | 9.95e-01 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 711 | 2.92e-01 | 2.32e-02 | 9.79e-01 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 12 | 8.89e-01 | -2.32e-02 | 9.99e-01 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 17 | 8.69e-01 | 2.32e-02 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 1244 | 1.70e-01 | 2.32e-02 | 9.19e-01 |
| GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 9.16e-01 | 2.31e-02 | 9.99e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 21 | 8.54e-01 | 2.31e-02 | 9.99e-01 |
| GOMF DNA BINDING BENDING | 16 | 8.73e-01 | -2.31e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF GROWTH | 236 | 5.41e-01 | 2.31e-02 | 9.95e-01 |
| GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 17 | 8.69e-01 | -2.31e-02 | 9.99e-01 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 16 | 8.73e-01 | 2.31e-02 | 9.99e-01 |
| GOMF HISTONE BINDING | 220 | 5.56e-01 | 2.30e-02 | 9.95e-01 |
| GOBP B CELL DIFFERENTIATION | 142 | 6.36e-01 | 2.30e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION | 5 | 9.29e-01 | 2.30e-02 | 9.99e-01 |
| GOCC AMPHISOME MEMBRANE | 11 | 8.95e-01 | 2.30e-02 | 9.99e-01 |
| GOBP REGULATION OF HIPPOCAMPAL NEURON APOPTOTIC PROCESS | 5 | 9.29e-01 | 2.29e-02 | 9.99e-01 |
| GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 8 | 9.11e-01 | -2.29e-02 | 9.99e-01 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 94 | 7.01e-01 | -2.29e-02 | 9.98e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 9.23e-01 | 2.29e-02 | 9.99e-01 |
| GOBP EXOCYTOSIS | 329 | 4.75e-01 | -2.29e-02 | 9.95e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 44 | 7.93e-01 | 2.29e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 17 | 8.70e-01 | 2.29e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 887 | 2.48e-01 | -2.29e-02 | 9.58e-01 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 39 | 8.05e-01 | 2.29e-02 | 9.98e-01 |
| GOCC CENTRIOLE | 151 | 6.28e-01 | 2.28e-02 | 9.98e-01 |
| GOMF HYALURONIC ACID BINDING | 24 | 8.46e-01 | -2.28e-02 | 9.99e-01 |
| GOBP SKELETAL MUSCLE FIBER DIFFERENTIATION | 8 | 9.11e-01 | -2.28e-02 | 9.99e-01 |
| GOMF PROTEIN KINASE ACTIVITY | 551 | 3.59e-01 | 2.28e-02 | 9.95e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 19 | 8.63e-01 | 2.28e-02 | 9.99e-01 |
| GOBP GENOMIC IMPRINTING | 18 | 8.67e-01 | 2.28e-02 | 9.99e-01 |
| GOBP FACE DEVELOPMENT | 49 | 7.83e-01 | -2.28e-02 | 9.98e-01 |
| GOBP RESPONSE TO BMP | 170 | 6.08e-01 | 2.28e-02 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN BINDING | 139 | 6.43e-01 | -2.28e-02 | 9.98e-01 |
| GOMF IRON ION BINDING | 145 | 6.36e-01 | -2.28e-02 | 9.98e-01 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 1143 | 1.95e-01 | 2.28e-02 | 9.28e-01 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 23 | 8.50e-01 | 2.27e-02 | 9.99e-01 |
| GOMF CGMP BINDING | 15 | 8.79e-01 | 2.27e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 59 | 7.63e-01 | -2.27e-02 | 9.98e-01 |
| GOBP PROTEIN GERANYLGERANYLATION | 6 | 9.23e-01 | 2.27e-02 | 9.99e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 36 | 8.14e-01 | 2.27e-02 | 9.98e-01 |
| GOBP REGULATION OF MRNA PROCESSING | 116 | 6.73e-01 | 2.27e-02 | 9.98e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 70 | 7.43e-01 | -2.27e-02 | 9.98e-01 |
| GOCC CILIARY PLASM | 158 | 6.23e-01 | -2.27e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 8 | 9.12e-01 | -2.26e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 5 | 9.30e-01 | -2.26e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 479 | 3.96e-01 | -2.26e-02 | 9.95e-01 |
| GOBP HEART VALVE DEVELOPMENT | 72 | 7.40e-01 | 2.26e-02 | 9.98e-01 |
| GOBP HEART PROCESS | 245 | 5.42e-01 | -2.26e-02 | 9.95e-01 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 36 | 8.15e-01 | -2.26e-02 | 9.98e-01 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 92 | 7.08e-01 | -2.26e-02 | 9.98e-01 |
| GOBP MICROTUBULE POLYMERIZATION | 91 | 7.10e-01 | 2.26e-02 | 9.98e-01 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 885 | 2.55e-01 | 2.25e-02 | 9.58e-01 |
| GOBP RNA CAPPING | 35 | 8.18e-01 | 2.25e-02 | 9.98e-01 |
| GOMF MRNA 3 UTR BINDING | 230 | 5.56e-01 | -2.25e-02 | 9.95e-01 |
| GOCC RNA POLYMERASE I COMPLEX | 13 | 8.88e-01 | 2.25e-02 | 9.99e-01 |
| GOBP T CELL APOPTOTIC PROCESS | 57 | 7.69e-01 | 2.25e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 32 | 8.26e-01 | 2.25e-02 | 9.98e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 12 | 8.93e-01 | 2.24e-02 | 9.99e-01 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 65 | 7.54e-01 | -2.24e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 33 | 8.23e-01 | -2.24e-02 | 9.98e-01 |
| GOCC TIGHT JUNCTION | 122 | 6.69e-01 | -2.24e-02 | 9.98e-01 |
| GOBP METANEPHRIC NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 6 | 9.24e-01 | 2.24e-02 | 9.99e-01 |
| GOBP ASTROCYTE DEVELOPMENT | 42 | 8.02e-01 | -2.24e-02 | 9.98e-01 |
| GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 13 | 8.89e-01 | 2.24e-02 | 9.99e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 349 | 4.73e-01 | -2.24e-02 | 9.95e-01 |
| GOBP OXALOACETATE METABOLIC PROCESS | 9 | 9.08e-01 | 2.24e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 42 | 8.02e-01 | 2.23e-02 | 9.98e-01 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 42 | 8.02e-01 | -2.23e-02 | 9.98e-01 |
| GOMF ATP DEPENDENT ACTIVITY | 546 | 3.72e-01 | 2.23e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 20 | 8.63e-01 | 2.23e-02 | 9.99e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 26 | 8.44e-01 | -2.23e-02 | 9.99e-01 |
| GOBP INSULIN SECRETION | 193 | 5.93e-01 | 2.23e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 9.08e-01 | -2.23e-02 | 9.99e-01 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 32 | 8.27e-01 | -2.23e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 166 | 6.20e-01 | 2.23e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 126 | 6.66e-01 | -2.23e-02 | 9.98e-01 |
| GOCC CLATHRIN COAT | 47 | 7.92e-01 | 2.23e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 15 | 8.81e-01 | 2.23e-02 | 9.99e-01 |
| GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX | 11 | 8.98e-01 | -2.23e-02 | 9.99e-01 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 20 | 8.63e-01 | 2.23e-02 | 9.99e-01 |
| GOCC LIPID DROPLET | 93 | 7.11e-01 | 2.22e-02 | 9.98e-01 |
| GOBP HYPOTONIC RESPONSE | 13 | 8.90e-01 | 2.22e-02 | 9.99e-01 |
| GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING | 38 | 8.13e-01 | 2.22e-02 | 9.98e-01 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 282 | 5.21e-01 | 2.22e-02 | 9.95e-01 |
| GOBP RNA LOCALIZATION | 182 | 6.05e-01 | 2.22e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 1128 | 2.09e-01 | 2.22e-02 | 9.38e-01 |
| GOBP OLIGOPEPTIDE IMPORT ACROSS PLASMA MEMBRANE | 5 | 9.32e-01 | -2.22e-02 | 9.99e-01 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 136 | 6.55e-01 | 2.22e-02 | 9.98e-01 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 9.03e-01 | 2.22e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 11 | 8.99e-01 | 2.22e-02 | 9.99e-01 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 5 | 9.32e-01 | -2.22e-02 | 9.99e-01 |
| GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 9 | 9.08e-01 | -2.22e-02 | 9.99e-01 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 57 | 7.73e-01 | -2.21e-02 | 9.98e-01 |
| GOBP CELL ACTIVATION | 1058 | 2.24e-01 | 2.21e-02 | 9.48e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 336 | 4.86e-01 | -2.21e-02 | 9.95e-01 |
| GOCC MEMBRANE PROTEIN COMPLEX | 1147 | 2.07e-01 | 2.21e-02 | 9.38e-01 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 99 | 7.04e-01 | 2.21e-02 | 9.98e-01 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 129 | 6.65e-01 | 2.21e-02 | 9.98e-01 |
| GOBP REGULATION OF SARCOMERE ORGANIZATION | 9 | 9.09e-01 | -2.21e-02 | 9.99e-01 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 41 | 8.07e-01 | 2.20e-02 | 9.98e-01 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 507 | 3.97e-01 | -2.20e-02 | 9.95e-01 |
| GOBP REGULATION OF PLATELET ACTIVATION | 47 | 7.95e-01 | 2.20e-02 | 9.98e-01 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 70 | 7.51e-01 | -2.19e-02 | 9.98e-01 |
| GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY | 6 | 9.26e-01 | -2.19e-02 | 9.99e-01 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 165 | 6.28e-01 | -2.19e-02 | 9.98e-01 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 130 | 6.67e-01 | -2.19e-02 | 9.98e-01 |
| GOBP PULMONARY VALVE DEVELOPMENT | 23 | 8.56e-01 | -2.19e-02 | 9.99e-01 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 65 | 7.61e-01 | -2.18e-02 | 9.98e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 125 | 6.73e-01 | 2.18e-02 | 9.98e-01 |
| GOCC MIDBODY | 196 | 5.99e-01 | -2.18e-02 | 9.98e-01 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 115 | 6.86e-01 | -2.18e-02 | 9.98e-01 |
| GOBP B 1 B CELL DIFFERENTIATION | 5 | 9.33e-01 | 2.18e-02 | 9.99e-01 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 15 | 8.84e-01 | 2.18e-02 | 9.99e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 8 | 9.15e-01 | 2.18e-02 | 9.99e-01 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 78 | 7.40e-01 | -2.17e-02 | 9.98e-01 |
| GOMF TELOMERIC DNA BINDING | 38 | 8.17e-01 | -2.17e-02 | 9.98e-01 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 219 | 5.80e-01 | -2.17e-02 | 9.96e-01 |
| GOCC ZYMOGEN GRANULE | 14 | 8.88e-01 | 2.17e-02 | 9.99e-01 |
| GOBP ORGANELLE MEMBRANE FUSION | 118 | 6.84e-01 | -2.17e-02 | 9.98e-01 |
| GOBP MONOATOMIC ION TRANSPORT | 1194 | 2.07e-01 | -2.17e-02 | 9.38e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 129 | 6.71e-01 | -2.17e-02 | 9.98e-01 |
| GOBP GAMETE GENERATION | 721 | 3.21e-01 | 2.17e-02 | 9.87e-01 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 21 | 8.63e-01 | -2.17e-02 | 9.99e-01 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 14 | 8.88e-01 | 2.17e-02 | 9.99e-01 |
| GOBP REGULATION OF AXONOGENESIS | 145 | 6.53e-01 | -2.17e-02 | 9.98e-01 |
| GOBP DEVELOPMENTAL CELL GROWTH | 225 | 5.76e-01 | -2.16e-02 | 9.96e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 26 | 8.49e-01 | -2.16e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 92 | 7.20e-01 | -2.16e-02 | 9.98e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 87 | 7.28e-01 | -2.16e-02 | 9.98e-01 |
| GOCC SPINDLE MIDZONE | 35 | 8.25e-01 | 2.16e-02 | 9.98e-01 |
| GOMF PRIMARY AMINE OXIDASE ACTIVITY | 7 | 9.21e-01 | 2.15e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 5 | 9.34e-01 | 2.15e-02 | 9.99e-01 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 206 | 5.95e-01 | 2.15e-02 | 9.98e-01 |
| GOBP MUSCLE CELL FATE COMMITMENT | 20 | 8.68e-01 | -2.15e-02 | 9.99e-01 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 9 | 9.11e-01 | -2.15e-02 | 9.99e-01 |
| GOBP RENAL SODIUM ION ABSORPTION | 12 | 8.97e-01 | 2.15e-02 | 9.99e-01 |
| GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 9.07e-01 | 2.14e-02 | 9.99e-01 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1773 | 1.34e-01 | 2.14e-02 | 8.96e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 102 | 7.09e-01 | -2.14e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 21 | 8.65e-01 | 2.14e-02 | 9.99e-01 |
| GOBP RESPONSE TO DISACCHARIDE | 7 | 9.22e-01 | 2.14e-02 | 9.99e-01 |
| GOCC VACUOLE | 809 | 3.01e-01 | 2.14e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 9 | 9.12e-01 | 2.14e-02 | 9.99e-01 |
| GOBP REGULATION OF HORMONE SECRETION | 248 | 5.63e-01 | 2.13e-02 | 9.95e-01 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 67 | 7.63e-01 | -2.13e-02 | 9.98e-01 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 38 | 8.20e-01 | -2.13e-02 | 9.98e-01 |
| GOBP REGULATION OF TUBE SIZE | 142 | 6.62e-01 | 2.13e-02 | 9.98e-01 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 31 | 8.38e-01 | -2.12e-02 | 9.99e-01 |
| GOBP ORGANIC ANION TRANSPORT | 428 | 4.51e-01 | -2.12e-02 | 9.95e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 18 | 8.76e-01 | -2.12e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 42 | 8.12e-01 | -2.12e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 37 | 8.24e-01 | -2.12e-02 | 9.98e-01 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 10 | 9.08e-01 | -2.12e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 17 | 8.80e-01 | 2.12e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 198 | 6.08e-01 | 2.12e-02 | 9.98e-01 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 700 | 3.40e-01 | 2.11e-02 | 9.88e-01 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 29 | 8.44e-01 | 2.11e-02 | 9.99e-01 |
| GOBP CALCIUM MEDIATED SIGNALING | 203 | 6.04e-01 | 2.11e-02 | 9.98e-01 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 68 | 7.63e-01 | 2.11e-02 | 9.98e-01 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 110 | 7.02e-01 | 2.11e-02 | 9.98e-01 |
| GOBP COPPER ION HOMEOSTASIS | 17 | 8.81e-01 | 2.10e-02 | 9.99e-01 |
| GOBP HEART DEVELOPMENT | 598 | 3.80e-01 | 2.10e-02 | 9.95e-01 |
| GOBP METHYLGUANOSINE CAP DECAPPING | 16 | 8.84e-01 | 2.10e-02 | 9.99e-01 |
| GOCC SAGA COMPLEX | 23 | 8.62e-01 | 2.10e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 228 | 5.85e-01 | 2.10e-02 | 9.96e-01 |
| GOBP PROTEIN REFOLDING | 27 | 8.50e-01 | -2.10e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 19 | 8.74e-01 | 2.09e-02 | 9.99e-01 |
| GOBP RESPONSE TO SALT | 350 | 5.01e-01 | 2.09e-02 | 9.95e-01 |
| GOMF TUBULIN BINDING | 357 | 4.97e-01 | 2.09e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 8 | 9.18e-01 | 2.09e-02 | 9.99e-01 |
| GOCC CONDENSIN COMPLEX | 8 | 9.18e-01 | 2.09e-02 | 9.99e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 16 | 8.85e-01 | 2.09e-02 | 9.99e-01 |
| GOBP REGULATION OF ORGAN GROWTH | 93 | 7.27e-01 | 2.09e-02 | 9.98e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 12 | 9.00e-01 | 2.09e-02 | 9.99e-01 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 48 | 8.02e-01 | -2.09e-02 | 9.98e-01 |
| GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 10 | 9.09e-01 | -2.09e-02 | 9.99e-01 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 20 | 8.72e-01 | -2.08e-02 | 9.99e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 17 | 8.82e-01 | 2.08e-02 | 9.99e-01 |
| GOBP MESENCHYMAL CELL MIGRATION | 61 | 7.78e-01 | 2.08e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 65 | 7.72e-01 | 2.08e-02 | 9.98e-01 |
| GOMF FATZ BINDING | 5 | 9.36e-01 | 2.08e-02 | 9.99e-01 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 101 | 7.18e-01 | -2.08e-02 | 9.98e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 11 | 9.05e-01 | -2.08e-02 | 9.99e-01 |
| GOBP REGULATION OF ARTERY MORPHOGENESIS | 11 | 9.05e-01 | 2.08e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 1463 | 1.84e-01 | 2.08e-02 | 9.28e-01 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 36 | 8.29e-01 | -2.08e-02 | 9.98e-01 |
| GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 28 | 8.49e-01 | -2.07e-02 | 9.99e-01 |
| GOMF METALLOPEPTIDASE ACTIVITY | 179 | 6.33e-01 | -2.07e-02 | 9.98e-01 |
| GOBP CELL REDOX HOMEOSTASIS | 38 | 8.25e-01 | 2.07e-02 | 9.98e-01 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 127 | 6.87e-01 | -2.07e-02 | 9.98e-01 |
| GOBP SPERM EGG RECOGNITION | 51 | 7.98e-01 | -2.07e-02 | 9.98e-01 |
| GOBP AXONAL FASCICULATION | 21 | 8.70e-01 | 2.06e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 203 | 6.12e-01 | 2.06e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 98 | 7.24e-01 | -2.06e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 14 | 8.94e-01 | -2.06e-02 | 9.99e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 16 | 8.86e-01 | 2.06e-02 | 9.99e-01 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 422 | 4.67e-01 | 2.06e-02 | 9.95e-01 |
| GOBP HISTONE UBIQUITINATION | 8 | 9.20e-01 | 2.06e-02 | 9.99e-01 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 541 | 4.12e-01 | 2.06e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE | 364 | 5.00e-01 | -2.06e-02 | 9.95e-01 |
| GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS | 13 | 8.98e-01 | 2.06e-02 | 9.99e-01 |
| GOBP TETRAPYRROLE CATABOLIC PROCESS | 13 | 8.98e-01 | 2.06e-02 | 9.99e-01 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 468 | 4.45e-01 | 2.06e-02 | 9.95e-01 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 145 | 6.69e-01 | -2.06e-02 | 9.98e-01 |
| GOBP PROTEIN ACYLATION | 134 | 6.81e-01 | 2.05e-02 | 9.98e-01 |
| GOCC FIBRILLAR CENTER | 144 | 6.71e-01 | 2.05e-02 | 9.98e-01 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 55 | 7.92e-01 | 2.05e-02 | 9.98e-01 |
| GOCC UBIQUITIN LIGASE COMPLEX | 299 | 5.42e-01 | 2.05e-02 | 9.95e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 116 | 7.03e-01 | -2.05e-02 | 9.98e-01 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 27 | 8.54e-01 | 2.05e-02 | 9.99e-01 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 227 | 5.95e-01 | -2.05e-02 | 9.98e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN THERMOCEPTION | 5 | 9.37e-01 | 2.05e-02 | 9.99e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 17 | 8.84e-01 | 2.04e-02 | 9.99e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 9 | 9.15e-01 | 2.04e-02 | 9.99e-01 |
| GOCC KINOCILIUM | 9 | 9.15e-01 | -2.04e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 18 | 8.81e-01 | -2.04e-02 | 9.99e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 278 | 5.58e-01 | -2.04e-02 | 9.95e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 115 | 7.05e-01 | 2.04e-02 | 9.98e-01 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 135 | 6.82e-01 | 2.04e-02 | 9.98e-01 |
| GOBP BONE TRABECULA MORPHOGENESIS | 13 | 8.99e-01 | 2.04e-02 | 9.99e-01 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 68 | 7.71e-01 | -2.04e-02 | 9.98e-01 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 118 | 7.02e-01 | 2.04e-02 | 9.98e-01 |
| GOBP TRANSLESION SYNTHESIS | 25 | 8.60e-01 | -2.04e-02 | 9.99e-01 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 208 | 6.13e-01 | -2.04e-02 | 9.98e-01 |
| GOMF SYNTAXIN 1 BINDING | 19 | 8.78e-01 | -2.03e-02 | 9.99e-01 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 73 | 7.64e-01 | -2.03e-02 | 9.98e-01 |
| GOMF SMAD BINDING | 75 | 7.61e-01 | 2.03e-02 | 9.98e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 92 | 7.36e-01 | -2.03e-02 | 9.98e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 6 | 9.31e-01 | -2.03e-02 | 9.99e-01 |
| GOBP REGULATION OF STEROL TRANSPORT | 80 | 7.54e-01 | -2.03e-02 | 9.98e-01 |
| GOMF LONG CHAIN FATTY ACID BINDING | 17 | 8.85e-01 | -2.02e-02 | 9.99e-01 |
| GOMF FIBRINOGEN BINDING | 5 | 9.38e-01 | 2.02e-02 | 9.99e-01 |
| GOBP VASOCONSTRICTION | 80 | 7.55e-01 | -2.02e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 12 | 9.04e-01 | 2.02e-02 | 9.99e-01 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 34 | 8.39e-01 | -2.02e-02 | 9.99e-01 |
| GOCC ADHERENS JUNCTION | 179 | 6.42e-01 | -2.01e-02 | 9.98e-01 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 993 | 2.83e-01 | 2.01e-02 | 9.73e-01 |
| GOCC CUTICULAR PLATE | 8 | 9.22e-01 | -2.01e-02 | 9.99e-01 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 379 | 5.02e-01 | 2.01e-02 | 9.95e-01 |
| GOBP ORGANELLE ASSEMBLY | 957 | 2.93e-01 | 2.01e-02 | 9.79e-01 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 44 | 8.18e-01 | 2.00e-02 | 9.98e-01 |
| GOBP INTRACELLULAR PHOSPHATE ION HOMEOSTASIS | 10 | 9.13e-01 | -2.00e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 120 | 7.05e-01 | 2.00e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 29 | 8.52e-01 | -2.00e-02 | 9.99e-01 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 370 | 5.10e-01 | -2.00e-02 | 9.95e-01 |
| GOBP DEFENSE RESPONSE TO FUNGUS | 52 | 8.03e-01 | 2.00e-02 | 9.98e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR I BINDING | 13 | 9.01e-01 | -2.00e-02 | 9.99e-01 |
| GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 29 | 8.53e-01 | 1.99e-02 | 9.99e-01 |
| GOBP FOREBRAIN CELL MIGRATION | 63 | 7.84e-01 | -1.99e-02 | 9.98e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 121 | 7.05e-01 | -1.99e-02 | 9.98e-01 |
| GOCC CYTOPLASMIC STRESS GRANULE | 83 | 7.54e-01 | -1.99e-02 | 9.98e-01 |
| GOCC ARYL HYDROCARBON RECEPTOR COMPLEX | 8 | 9.22e-01 | -1.99e-02 | 9.99e-01 |
| GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 9 | 9.18e-01 | -1.99e-02 | 9.99e-01 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 460 | 4.64e-01 | 1.99e-02 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 123 | 7.03e-01 | 1.99e-02 | 9.98e-01 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 319 | 5.41e-01 | 1.99e-02 | 9.95e-01 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 175 | 6.50e-01 | -1.99e-02 | 9.98e-01 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 380 | 5.06e-01 | 1.99e-02 | 9.95e-01 |
| GOBP PSEUDOPODIUM ORGANIZATION | 15 | 8.94e-01 | 1.99e-02 | 9.99e-01 |
| GOCC POSTSYNAPSE | 614 | 4.01e-01 | -1.98e-02 | 9.95e-01 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 25 | 8.64e-01 | 1.98e-02 | 9.99e-01 |
| GOCC DYNEIN COMPLEX | 53 | 8.03e-01 | 1.98e-02 | 9.98e-01 |
| GOBP REGULATION OF SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 6 | 9.33e-01 | 1.98e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 127 | 7.00e-01 | -1.98e-02 | 9.98e-01 |
| GOCC MICROTUBULE CYTOSKELETON | 1297 | 2.30e-01 | 1.98e-02 | 9.50e-01 |
| GOBP MEMBRANE RAFT ORGANIZATION | 26 | 8.61e-01 | -1.98e-02 | 9.99e-01 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 143 | 6.83e-01 | 1.98e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 12 | 9.06e-01 | -1.98e-02 | 9.99e-01 |
| GOMF FAD BINDING | 39 | 8.31e-01 | 1.98e-02 | 9.98e-01 |
| GOMF CORECEPTOR ACTIVITY | 47 | 8.15e-01 | 1.98e-02 | 9.98e-01 |
| GOMF MOLECULAR TAG ACTIVITY | 13 | 9.02e-01 | -1.98e-02 | 9.99e-01 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 57 | 7.97e-01 | 1.97e-02 | 9.98e-01 |
| GOBP HARD PALATE DEVELOPMENT | 8 | 9.23e-01 | -1.97e-02 | 9.99e-01 |
| GOMF PEROXISOME TARGETING SEQUENCE BINDING | 5 | 9.39e-01 | 1.97e-02 | 9.99e-01 |
| GOCC OXIDOREDUCTASE COMPLEX | 108 | 7.23e-01 | 1.97e-02 | 9.98e-01 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 24 | 8.67e-01 | 1.97e-02 | 9.99e-01 |
| GOCC CYTOSKELETON OF PRESYNAPTIC ACTIVE ZONE | 8 | 9.23e-01 | 1.97e-02 | 9.99e-01 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 26 | 8.62e-01 | 1.97e-02 | 9.99e-01 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 14 | 8.99e-01 | 1.97e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 12 | 9.06e-01 | -1.97e-02 | 9.99e-01 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 54 | 8.03e-01 | -1.97e-02 | 9.98e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 74 | 7.70e-01 | 1.96e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL FUSION | 32 | 8.48e-01 | 1.96e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 102 | 7.32e-01 | -1.96e-02 | 9.98e-01 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 197 | 6.36e-01 | -1.96e-02 | 9.98e-01 |
| GOBP ORGANIC CATION TRANSPORT | 62 | 7.90e-01 | 1.96e-02 | 9.98e-01 |
| GOBP NCRNA TRANSCRIPTION | 134 | 6.96e-01 | 1.95e-02 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 103 | 7.32e-01 | -1.95e-02 | 9.98e-01 |
| GOCC MITOCHONDRIAL ENVELOPE | 747 | 3.64e-01 | 1.95e-02 | 9.95e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 221 | 6.17e-01 | 1.95e-02 | 9.98e-01 |
| GOMF MOLECULAR TRANSDUCER ACTIVITY | 1357 | 2.28e-01 | 1.95e-02 | 9.50e-01 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 34 | 8.44e-01 | -1.95e-02 | 9.99e-01 |
| GOBP TAURINE TRANSPORT | 8 | 9.24e-01 | 1.95e-02 | 9.99e-01 |
| GOCC PLATELET ALPHA GRANULE | 82 | 7.60e-01 | -1.95e-02 | 9.98e-01 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 41 | 8.29e-01 | 1.95e-02 | 9.98e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 42 | 8.27e-01 | -1.94e-02 | 9.98e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 36 | 8.40e-01 | 1.94e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 11 | 9.11e-01 | 1.94e-02 | 9.99e-01 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 285 | 5.73e-01 | -1.94e-02 | 9.95e-01 |
| GOBP N GLYCAN PROCESSING | 17 | 8.90e-01 | -1.94e-02 | 9.99e-01 |
| GOBP B CELL MEDIATED IMMUNITY | 127 | 7.06e-01 | -1.94e-02 | 9.98e-01 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 50 | 8.13e-01 | -1.94e-02 | 9.98e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 35 | 8.43e-01 | 1.93e-02 | 9.99e-01 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 150 | 6.83e-01 | 1.93e-02 | 9.98e-01 |
| GOBP SIGNAL RELEASE | 467 | 4.75e-01 | -1.93e-02 | 9.95e-01 |
| GOBP CARDIAC MUSCLE CONTRACTION | 131 | 7.03e-01 | -1.93e-02 | 9.98e-01 |
| GOCC SECRETORY VESICLE | 1019 | 2.98e-01 | 1.93e-02 | 9.83e-01 |
| GOBP REGULATION OF CELL CELL ADHESION | 476 | 4.72e-01 | 1.93e-02 | 9.95e-01 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 259 | 5.94e-01 | -1.92e-02 | 9.98e-01 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 38 | 8.37e-01 | 1.92e-02 | 9.99e-01 |
| GOMF ALKALI METAL ION BINDING | 19 | 8.85e-01 | 1.92e-02 | 9.99e-01 |
| GOBP RHYTHMIC PROCESS | 287 | 5.76e-01 | 1.92e-02 | 9.96e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 62 | 7.94e-01 | 1.92e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 20 | 8.82e-01 | 1.92e-02 | 9.99e-01 |
| GOBP REGULATION OF PHOSPHORYLATION | 1004 | 3.04e-01 | 1.92e-02 | 9.87e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 100 | 7.41e-01 | 1.91e-02 | 9.98e-01 |
| GOBP SENSORY PERCEPTION | 862 | 3.40e-01 | 1.91e-02 | 9.88e-01 |
| GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 13 | 9.05e-01 | -1.91e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 9.09e-01 | 1.91e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL CHEMOTAXIS | 5 | 9.41e-01 | 1.90e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 85 | 7.62e-01 | 1.90e-02 | 9.98e-01 |
| GOBP REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION | 12 | 9.09e-01 | -1.90e-02 | 9.99e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 66 | 7.89e-01 | -1.90e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 23 | 8.75e-01 | -1.90e-02 | 9.99e-01 |
| GOMF SUPERCOILED DNA BINDING | 6 | 9.36e-01 | -1.90e-02 | 9.99e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 48 | 8.20e-01 | 1.90e-02 | 9.98e-01 |
| GOCC HEMOGLOBIN COMPLEX | 12 | 9.09e-01 | 1.90e-02 | 9.99e-01 |
| GOBP GLAND DEVELOPMENT | 428 | 5.02e-01 | 1.89e-02 | 9.95e-01 |
| GOBP MIDGUT DEVELOPMENT | 10 | 9.17e-01 | 1.89e-02 | 9.99e-01 |
| GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 10 | 9.18e-01 | -1.89e-02 | 9.99e-01 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 284 | 5.83e-01 | -1.89e-02 | 9.96e-01 |
| GOMF SIGNALING RECEPTOR BINDING | 1396 | 2.37e-01 | -1.89e-02 | 9.52e-01 |
| GOBP HEMOSTASIS | 220 | 6.29e-01 | 1.89e-02 | 9.98e-01 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 34 | 8.49e-01 | 1.89e-02 | 9.99e-01 |
| GOBP RRNA TRANSCRIPTION | 37 | 8.43e-01 | -1.89e-02 | 9.99e-01 |
| GOBP AMINO ACID ACTIVATION | 43 | 8.30e-01 | 1.89e-02 | 9.98e-01 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 153 | 6.87e-01 | 1.88e-02 | 9.98e-01 |
| GOBP CORNEA DEVELOPMENT IN CAMERA TYPE EYE | 12 | 9.10e-01 | -1.88e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE | 12 | 9.10e-01 | 1.88e-02 | 9.99e-01 |
| GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 9.31e-01 | 1.88e-02 | 9.99e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 9.31e-01 | 1.88e-02 | 9.99e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST | 12 | 9.10e-01 | -1.88e-02 | 9.99e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 27 | 8.66e-01 | 1.88e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 27 | 8.66e-01 | 1.88e-02 | 9.99e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 51 | 8.17e-01 | -1.87e-02 | 9.98e-01 |
| GOMF CERAMIDE 1 PHOSPHATE BINDING | 7 | 9.32e-01 | 1.87e-02 | 9.99e-01 |
| GOBP BRANCH ELONGATION OF AN EPITHELIUM | 18 | 8.91e-01 | 1.87e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 26 | 8.69e-01 | 1.87e-02 | 9.99e-01 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 1037 | 3.10e-01 | 1.86e-02 | 9.87e-01 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 131 | 7.13e-01 | 1.86e-02 | 9.98e-01 |
| GOBP T CELL CHEMOTAXIS | 26 | 8.70e-01 | -1.86e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 527 | 4.66e-01 | 1.86e-02 | 9.95e-01 |
| GOBP SPINDLE LOCALIZATION | 62 | 8.01e-01 | 1.85e-02 | 9.98e-01 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 198 | 6.54e-01 | -1.85e-02 | 9.98e-01 |
| GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 25 | 8.73e-01 | 1.85e-02 | 9.99e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 44 | 8.32e-01 | 1.85e-02 | 9.99e-01 |
| GOMF PHOSPHODIESTERASE I ACTIVITY | 5 | 9.43e-01 | 1.85e-02 | 9.99e-01 |
| GOBP SYNAPSE PRUNING | 14 | 9.05e-01 | -1.84e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 46 | 8.29e-01 | 1.84e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE MATURATION | 9 | 9.24e-01 | 1.84e-02 | 9.99e-01 |
| GOBP ELASTIN CATABOLIC PROCESS | 5 | 9.43e-01 | 1.84e-02 | 9.99e-01 |
| GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 9.38e-01 | 1.84e-02 | 9.99e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 9.38e-01 | -1.84e-02 | 9.99e-01 |
| GOCC MITOTIC SPINDLE | 174 | 6.76e-01 | 1.83e-02 | 9.98e-01 |
| GOMF DYNEIN HEAVY CHAIN BINDING | 16 | 8.99e-01 | 1.83e-02 | 9.99e-01 |
| GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION | 9 | 9.24e-01 | -1.83e-02 | 9.99e-01 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 13 | 9.09e-01 | 1.83e-02 | 9.99e-01 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 30 | 8.62e-01 | -1.83e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 21 | 8.85e-01 | 1.83e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 25 | 8.74e-01 | -1.83e-02 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN GLYCOSYLATION | 12 | 9.13e-01 | 1.83e-02 | 9.99e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 1422 | 2.48e-01 | 1.83e-02 | 9.58e-01 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 189 | 6.65e-01 | -1.83e-02 | 9.98e-01 |
| GOMF WD40 REPEAT DOMAIN BINDING | 5 | 9.44e-01 | -1.82e-02 | 9.99e-01 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 10 | 9.21e-01 | 1.82e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO SALT | 191 | 6.65e-01 | 1.82e-02 | 9.98e-01 |
| GOBP AXON DEVELOPMENT | 480 | 4.95e-01 | 1.82e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 126 | 7.25e-01 | 1.81e-02 | 9.98e-01 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 106 | 7.47e-01 | 1.81e-02 | 9.98e-01 |
| GOBP CILIUM ORGANIZATION | 408 | 5.31e-01 | 1.81e-02 | 9.95e-01 |
| GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 13 | 9.10e-01 | 1.81e-02 | 9.99e-01 |
| GOCC GOLGI APPARATUS | 1535 | 2.37e-01 | -1.81e-02 | 9.52e-01 |
| GOBP GLIAL CELL DEVELOPMENT | 118 | 7.35e-01 | -1.81e-02 | 9.98e-01 |
| GOBP DNA REPLICATION | 272 | 6.08e-01 | 1.81e-02 | 9.98e-01 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 913 | 3.55e-01 | 1.81e-02 | 9.95e-01 |
| GOMF DYNACTIN BINDING | 12 | 9.14e-01 | 1.80e-02 | 9.99e-01 |
| GOBP RESPONSE TO ISCHEMIA | 62 | 8.06e-01 | 1.80e-02 | 9.98e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 19 | 8.92e-01 | -1.80e-02 | 9.99e-01 |
| GOBP INORGANIC ANION TRANSPORT | 162 | 6.92e-01 | -1.80e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 49 | 8.27e-01 | -1.80e-02 | 9.98e-01 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 109 | 7.46e-01 | 1.80e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS | 146 | 7.08e-01 | 1.80e-02 | 9.98e-01 |
| GOMF L PROLINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 9.34e-01 | -1.80e-02 | 9.99e-01 |
| GOCC PHAGOCYTIC CUP | 28 | 8.69e-01 | 1.80e-02 | 9.99e-01 |
| GOMF BUBBLE DNA BINDING | 8 | 9.30e-01 | 1.79e-02 | 9.99e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 22 | 8.85e-01 | 1.79e-02 | 9.99e-01 |
| GOBP LYMPHOCYTE COSTIMULATION | 46 | 8.34e-01 | 1.79e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 25 | 8.77e-01 | 1.79e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 195 | 6.67e-01 | -1.79e-02 | 9.98e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 76 | 7.88e-01 | 1.78e-02 | 9.98e-01 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 43 | 8.40e-01 | 1.78e-02 | 9.99e-01 |
| GOMF LAMININ BINDING | 28 | 8.70e-01 | -1.78e-02 | 9.99e-01 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 13 | 9.12e-01 | -1.78e-02 | 9.99e-01 |
| GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 53 | 8.23e-01 | 1.78e-02 | 9.98e-01 |
| GOMF ORGANIC ACID BINDING | 207 | 6.60e-01 | 1.78e-02 | 9.98e-01 |
| GOBP TISSUE REMODELING | 179 | 6.82e-01 | 1.77e-02 | 9.98e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 21 | 8.88e-01 | -1.77e-02 | 9.99e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 9.40e-01 | -1.77e-02 | 9.99e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 8 | 9.31e-01 | 1.77e-02 | 9.99e-01 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 83 | 7.80e-01 | -1.77e-02 | 9.98e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 14 | 9.09e-01 | 1.77e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF COMPLEMENT ACTIVATION | 6 | 9.40e-01 | -1.77e-02 | 9.99e-01 |
| GOBP REGULATION OF ARACHIDONIC ACID SECRETION | 7 | 9.36e-01 | 1.76e-02 | 9.99e-01 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 9.40e-01 | 1.76e-02 | 9.99e-01 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 201 | 6.67e-01 | 1.76e-02 | 9.98e-01 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 491 | 5.04e-01 | -1.76e-02 | 9.95e-01 |
| GOBP STEM CELL DIVISION | 30 | 8.68e-01 | -1.76e-02 | 9.99e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 37 | 8.53e-01 | 1.76e-02 | 9.99e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS | 5 | 9.46e-01 | -1.76e-02 | 9.99e-01 |
| GOBP REGULATION OF TISSUE REMODELING | 86 | 7.78e-01 | -1.76e-02 | 9.98e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 26 | 8.77e-01 | -1.75e-02 | 9.99e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 45 | 8.39e-01 | -1.75e-02 | 9.99e-01 |
| GOMF MRNA BINDING | 540 | 4.86e-01 | 1.75e-02 | 9.95e-01 |
| GOBP RESCUE OF STALLED RIBOSOME | 29 | 8.70e-01 | 1.75e-02 | 9.99e-01 |
| GOBP VESICLE UNCOATING | 8 | 9.32e-01 | -1.75e-02 | 9.99e-01 |
| GOBP RRNA MODIFICATION | 32 | 8.64e-01 | -1.75e-02 | 9.99e-01 |
| GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY | 11 | 9.20e-01 | 1.75e-02 | 9.99e-01 |
| GOBP KIDNEY MORPHOGENESIS | 94 | 7.70e-01 | 1.75e-02 | 9.98e-01 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 20 | 8.92e-01 | -1.75e-02 | 9.99e-01 |
| GOBP GLYCINE METABOLIC PROCESS | 15 | 9.07e-01 | -1.75e-02 | 9.99e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER | 5 | 9.46e-01 | -1.74e-02 | 9.99e-01 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 28 | 8.73e-01 | -1.74e-02 | 9.99e-01 |
| GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 6 | 9.41e-01 | -1.74e-02 | 9.99e-01 |
| GOCC RIBOSOME | 224 | 6.54e-01 | -1.74e-02 | 9.98e-01 |
| GOMF PROTEASOME BINDING | 17 | 9.01e-01 | -1.74e-02 | 9.99e-01 |
| GOMF OLIGOSACCHARIDE BINDING | 15 | 9.07e-01 | -1.74e-02 | 9.99e-01 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 82 | 7.86e-01 | -1.74e-02 | 9.98e-01 |
| GOBP MAINTENANCE OF LENS TRANSPARENCY | 7 | 9.37e-01 | -1.74e-02 | 9.99e-01 |
| GOBP IRIS MORPHOGENESIS | 10 | 9.24e-01 | -1.73e-02 | 9.99e-01 |
| GOMF MITOCHONDRIAL RIBOSOME BINDING | 9 | 9.28e-01 | 1.73e-02 | 9.99e-01 |
| GOBP DENDRITE MORPHOGENESIS | 129 | 7.34e-01 | -1.73e-02 | 9.98e-01 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 205 | 6.69e-01 | -1.73e-02 | 9.98e-01 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 122 | 7.41e-01 | 1.73e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 218 | 6.59e-01 | -1.73e-02 | 9.98e-01 |
| GOBP ZINC ION TRANSPORT | 28 | 8.74e-01 | -1.73e-02 | 9.99e-01 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 7 | 9.37e-01 | -1.73e-02 | 9.99e-01 |
| GOBP PROGESTERONE METABOLIC PROCESS | 16 | 9.05e-01 | 1.72e-02 | 9.99e-01 |
| GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 11 | 9.21e-01 | -1.72e-02 | 9.99e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 20 | 8.94e-01 | -1.72e-02 | 9.99e-01 |
| GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY | 7 | 9.37e-01 | 1.72e-02 | 9.99e-01 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 17 | 9.02e-01 | 1.72e-02 | 9.99e-01 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 11 | 9.21e-01 | 1.72e-02 | 9.99e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY | 687 | 4.43e-01 | 1.72e-02 | 9.95e-01 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 110 | 7.56e-01 | 1.72e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 50 | 8.34e-01 | 1.71e-02 | 9.99e-01 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 39 | 8.53e-01 | 1.71e-02 | 9.99e-01 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 69 | 8.06e-01 | 1.71e-02 | 9.98e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 9.38e-01 | 1.71e-02 | 9.99e-01 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 45 | 8.43e-01 | 1.71e-02 | 9.99e-01 |
| GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 16 | 9.06e-01 | 1.71e-02 | 9.99e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 8 | 9.33e-01 | -1.71e-02 | 9.99e-01 |
| GOBP PROTEIN DESTABILIZATION | 46 | 8.41e-01 | 1.71e-02 | 9.99e-01 |
| GOBP EPITHELIAL CELL MATURATION | 24 | 8.85e-01 | 1.70e-02 | 9.99e-01 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 72 | 8.03e-01 | -1.70e-02 | 9.98e-01 |
| GOMF ESTROGEN 16 ALPHA HYDROXYLASE ACTIVITY | 8 | 9.33e-01 | 1.70e-02 | 9.99e-01 |
| GOMF PHOSPHATASE ACTIVITY | 255 | 6.40e-01 | -1.70e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 25 | 8.83e-01 | 1.70e-02 | 9.99e-01 |
| GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 11 | 9.22e-01 | -1.70e-02 | 9.99e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 16 | 9.07e-01 | -1.69e-02 | 9.99e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 108 | 7.61e-01 | 1.69e-02 | 9.98e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 187 | 6.90e-01 | 1.69e-02 | 9.98e-01 |
| GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 31 | 8.71e-01 | 1.69e-02 | 9.99e-01 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 18 | 9.01e-01 | 1.69e-02 | 9.99e-01 |
| GOCC CYTOPLASMIC MICROTUBULE | 96 | 7.75e-01 | -1.69e-02 | 9.98e-01 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 53 | 8.32e-01 | -1.69e-02 | 9.99e-01 |
| GOBP CARDIAC CELL DEVELOPMENT | 92 | 7.80e-01 | -1.68e-02 | 9.98e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 121 | 7.49e-01 | 1.68e-02 | 9.98e-01 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 183 | 6.95e-01 | 1.68e-02 | 9.98e-01 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 89 | 7.84e-01 | 1.68e-02 | 9.98e-01 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 8.71e-01 | 1.68e-02 | 9.99e-01 |
| GOBP STEM CELL DIFFERENTIATION | 240 | 6.54e-01 | 1.68e-02 | 9.98e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 516 | 5.14e-01 | 1.68e-02 | 9.95e-01 |
| GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT | 6 | 9.43e-01 | -1.68e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 1207 | 3.26e-01 | -1.68e-02 | 9.87e-01 |
| GOMF RETINOIC ACID BINDING | 26 | 8.82e-01 | 1.67e-02 | 9.99e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 259 | 6.43e-01 | -1.67e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 5 | 9.48e-01 | 1.67e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 49 | 8.40e-01 | 1.67e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MIRNA PROCESSING | 5 | 9.49e-01 | -1.66e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 5 | 9.49e-01 | 1.66e-02 | 9.99e-01 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 162 | 7.16e-01 | -1.65e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 974 | 3.82e-01 | -1.65e-02 | 9.95e-01 |
| GOBP POST EMBRYONIC DEVELOPMENT | 91 | 7.85e-01 | 1.65e-02 | 9.98e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM AXON REGENERATION | 8 | 9.35e-01 | 1.65e-02 | 9.99e-01 |
| GOBP RESPONSE TO CYTOKINE | 901 | 4.00e-01 | 1.65e-02 | 9.95e-01 |
| GOBP CAMP METABOLIC PROCESS | 23 | 8.91e-01 | 1.65e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 39 | 8.59e-01 | -1.65e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 31 | 8.74e-01 | 1.65e-02 | 9.99e-01 |
| GOBP MICROGLIAL CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 5 | 9.49e-01 | 1.65e-02 | 9.99e-01 |
| GOBP DETOXIFICATION | 152 | 7.26e-01 | -1.65e-02 | 9.98e-01 |
| GOMF COPPER ION BINDING | 58 | 8.28e-01 | -1.65e-02 | 9.98e-01 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 357 | 5.93e-01 | -1.65e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 22 | 8.94e-01 | -1.65e-02 | 9.99e-01 |
| GOBP DELAMINATION | 7 | 9.40e-01 | -1.64e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 141 | 7.36e-01 | -1.64e-02 | 9.98e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 888 | 4.06e-01 | -1.64e-02 | 9.95e-01 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 338 | 6.04e-01 | 1.64e-02 | 9.98e-01 |
| GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 11 | 9.25e-01 | 1.64e-02 | 9.99e-01 |
| GOMF SNARE BINDING | 104 | 7.73e-01 | 1.64e-02 | 9.98e-01 |
| GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE | 7 | 9.40e-01 | 1.64e-02 | 9.99e-01 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 102 | 7.75e-01 | 1.64e-02 | 9.98e-01 |
| GOBP SPERMATID DIFFERENTIATION | 201 | 6.89e-01 | 1.64e-02 | 9.98e-01 |
| GOBP RIBOSOME ASSEMBLY | 58 | 8.29e-01 | 1.64e-02 | 9.98e-01 |
| GOBP AXON EXTENSION | 111 | 7.66e-01 | -1.64e-02 | 9.98e-01 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 483 | 5.38e-01 | -1.64e-02 | 9.95e-01 |
| GOCC SUPER ELONGATION COMPLEX | 5 | 9.50e-01 | 1.63e-02 | 9.99e-01 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 208 | 6.85e-01 | -1.63e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CELL MATURATION | 7 | 9.40e-01 | -1.63e-02 | 9.99e-01 |
| GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 18 | 9.05e-01 | 1.63e-02 | 9.99e-01 |
| GOBP CAVEOLA ASSEMBLY | 5 | 9.50e-01 | 1.63e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF EPINEPHRINE SECRETION | 5 | 9.50e-01 | -1.63e-02 | 9.99e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 60 | 8.27e-01 | 1.63e-02 | 9.98e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 134 | 7.44e-01 | -1.63e-02 | 9.98e-01 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 234 | 6.68e-01 | 1.63e-02 | 9.98e-01 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 1131 | 3.56e-01 | 1.63e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 123 | 7.56e-01 | 1.62e-02 | 9.98e-01 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 80 | 8.02e-01 | 1.62e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 31 | 8.76e-01 | -1.62e-02 | 9.99e-01 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 20 | 9.00e-01 | 1.62e-02 | 9.99e-01 |
| GOBP REGULATION OF HEMOPOIESIS | 405 | 5.76e-01 | 1.62e-02 | 9.96e-01 |
| GOBP RESPONSE TO INSULIN | 262 | 6.52e-01 | 1.62e-02 | 9.98e-01 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 20 | 9.00e-01 | 1.62e-02 | 9.99e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 35 | 8.68e-01 | -1.62e-02 | 9.99e-01 |
| GOBP PEPTIDE METABOLIC PROCESS | 927 | 4.04e-01 | -1.62e-02 | 9.95e-01 |
| GOBP INTERLEUKIN 17 PRODUCTION | 46 | 8.50e-01 | 1.61e-02 | 9.99e-01 |
| GOBP GLIAL CELL DIFFERENTIATION | 246 | 6.64e-01 | 1.61e-02 | 9.98e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 73 | 8.13e-01 | -1.61e-02 | 9.98e-01 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 22 | 8.96e-01 | -1.60e-02 | 9.99e-01 |
| GOCC CLATHRIN COATED PIT | 73 | 8.13e-01 | -1.60e-02 | 9.98e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 74 | 8.12e-01 | -1.60e-02 | 9.98e-01 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 30 | 8.79e-01 | -1.60e-02 | 9.99e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 6 | 9.46e-01 | -1.60e-02 | 9.99e-01 |
| GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 6 | 9.46e-01 | -1.60e-02 | 9.99e-01 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 56 | 8.36e-01 | 1.60e-02 | 9.99e-01 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 1036 | 3.85e-01 | -1.59e-02 | 9.95e-01 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 28 | 8.84e-01 | 1.59e-02 | 9.99e-01 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 17 | 9.10e-01 | 1.59e-02 | 9.99e-01 |
| GOBP OOCYTE MATURATION | 33 | 8.74e-01 | 1.59e-02 | 9.99e-01 |
| GOBP REGULATION OF MALE GONAD DEVELOPMENT | 8 | 9.38e-01 | 1.59e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 13 | 9.21e-01 | 1.59e-02 | 9.99e-01 |
| GOBP RETINA LAYER FORMATION | 23 | 8.95e-01 | 1.59e-02 | 9.99e-01 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 9.51e-01 | 1.59e-02 | 9.99e-01 |
| GOCC AP 3 ADAPTOR COMPLEX | 9 | 9.34e-01 | 1.59e-02 | 9.99e-01 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 945 | 4.09e-01 | -1.58e-02 | 9.95e-01 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 10 | 9.31e-01 | 1.58e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 573 | 5.18e-01 | 1.58e-02 | 9.95e-01 |
| GOBP RESPONSE TO IMMOBILIZATION STRESS | 21 | 9.00e-01 | 1.58e-02 | 9.99e-01 |
| GOMF OXYGEN BINDING | 38 | 8.66e-01 | 1.58e-02 | 9.99e-01 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 36 | 8.70e-01 | -1.58e-02 | 9.99e-01 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 239 | 6.74e-01 | 1.58e-02 | 9.98e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 37 | 8.68e-01 | 1.58e-02 | 9.99e-01 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 93 | 7.93e-01 | 1.58e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 8 | 9.39e-01 | 1.57e-02 | 9.99e-01 |
| GOBP DENTATE GYRUS DEVELOPMENT | 23 | 8.96e-01 | 1.57e-02 | 9.99e-01 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 11 | 9.28e-01 | -1.57e-02 | 9.99e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 16 | 9.13e-01 | 1.57e-02 | 9.99e-01 |
| GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 10 | 9.32e-01 | -1.57e-02 | 9.99e-01 |
| GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY | 7 | 9.43e-01 | -1.57e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 177 | 7.19e-01 | 1.57e-02 | 9.98e-01 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 93 | 7.94e-01 | 1.57e-02 | 9.98e-01 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 461 | 5.64e-01 | 1.57e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 141 | 7.48e-01 | -1.57e-02 | 9.98e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 77 | 8.12e-01 | -1.57e-02 | 9.98e-01 |
| GOBP HISTONE H4 K16 ACETYLATION | 6 | 9.47e-01 | -1.57e-02 | 9.99e-01 |
| GOCC BASAL CORTEX | 5 | 9.52e-01 | -1.56e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 44 | 8.58e-01 | -1.56e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 33 | 8.77e-01 | 1.56e-02 | 9.99e-01 |
| GOBP NEPHRIC DUCT DEVELOPMENT | 14 | 9.20e-01 | 1.56e-02 | 9.99e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 8.93e-01 | -1.56e-02 | 9.99e-01 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 101 | 7.87e-01 | -1.55e-02 | 9.98e-01 |
| GOBP ENDOCARDIAL CUSHION FUSION | 5 | 9.52e-01 | 1.55e-02 | 9.99e-01 |
| GOCC PODOSOME | 31 | 8.81e-01 | 1.55e-02 | 9.99e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 223 | 6.90e-01 | 1.55e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 71 | 8.22e-01 | 1.55e-02 | 9.98e-01 |
| GOBP PHAGOCYTOSIS RECOGNITION | 27 | 8.89e-01 | 1.55e-02 | 9.99e-01 |
| GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 9 | 9.36e-01 | 1.55e-02 | 9.99e-01 |
| GOBP REGULATION OF CORTISOL BIOSYNTHETIC PROCESS | 7 | 9.44e-01 | 1.54e-02 | 9.99e-01 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 12 | 9.26e-01 | 1.54e-02 | 9.99e-01 |
| GOBP O GLYCAN PROCESSING | 42 | 8.63e-01 | 1.54e-02 | 9.99e-01 |
| GOBP ALPHA BETA T CELL ACTIVATION | 167 | 7.31e-01 | 1.54e-02 | 9.98e-01 |
| GOBP NEURON MIGRATION | 166 | 7.33e-01 | 1.54e-02 | 9.98e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 51 | 8.50e-01 | -1.54e-02 | 9.99e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 76 | 8.17e-01 | 1.54e-02 | 9.98e-01 |
| GOCC AXON INITIAL SEGMENT | 21 | 9.03e-01 | -1.54e-02 | 9.99e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 10 | 9.33e-01 | 1.53e-02 | 9.99e-01 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 9 | 9.37e-01 | 1.53e-02 | 9.99e-01 |
| GOBP KINETOCHORE ASSEMBLY | 16 | 9.16e-01 | -1.53e-02 | 9.99e-01 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 18 | 9.10e-01 | 1.53e-02 | 9.99e-01 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 44 | 8.61e-01 | -1.53e-02 | 9.99e-01 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 1076 | 3.97e-01 | 1.53e-02 | 9.95e-01 |
| GOBP LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION | 8 | 9.40e-01 | -1.53e-02 | 9.99e-01 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 139 | 7.56e-01 | 1.53e-02 | 9.98e-01 |
| GOCC LATE ENDOSOME | 296 | 6.51e-01 | -1.53e-02 | 9.98e-01 |
| GOBP TUBE DEVELOPMENT | 1120 | 3.88e-01 | 1.53e-02 | 9.95e-01 |
| GOBP FATTY ACID TRANSPORT | 114 | 7.78e-01 | -1.53e-02 | 9.98e-01 |
| GOBP REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS | 7 | 9.44e-01 | 1.52e-02 | 9.99e-01 |
| GOCC MITOTIC SPINDLE POLE | 35 | 8.76e-01 | 1.52e-02 | 9.99e-01 |
| GOBP RESPONSE TO ESTRADIOL | 109 | 7.84e-01 | 1.52e-02 | 9.98e-01 |
| GOBP C TERMINAL PROTEIN LIPIDATION | 5 | 9.53e-01 | -1.52e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 300 | 6.51e-01 | -1.52e-02 | 9.98e-01 |
| GOCC SECRETORY GRANULE MEMBRANE | 302 | 6.50e-01 | 1.52e-02 | 9.98e-01 |
| GOBP ESTROGEN METABOLIC PROCESS | 36 | 8.75e-01 | -1.52e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 9 | 9.37e-01 | 1.51e-02 | 9.99e-01 |
| GOCC MLL3 4 COMPLEX | 10 | 9.34e-01 | 1.51e-02 | 9.99e-01 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 15 | 9.19e-01 | -1.51e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 1240 | 3.71e-01 | 1.51e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 31 | 8.84e-01 | -1.51e-02 | 9.99e-01 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 9.53e-01 | -1.51e-02 | 9.99e-01 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 30 | 8.86e-01 | -1.51e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 76 | 8.20e-01 | 1.51e-02 | 9.98e-01 |
| GOBP VESICLE MEDIATED TRANSPORT | 1459 | 3.37e-01 | 1.50e-02 | 9.88e-01 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 28 | 8.91e-01 | 1.50e-02 | 9.99e-01 |
| GOBP LIPID HYDROXYLATION | 7 | 9.45e-01 | -1.50e-02 | 9.99e-01 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 96 | 8.00e-01 | -1.50e-02 | 9.98e-01 |
| GOMF NEDD8 TRANSFERASE ACTIVITY | 7 | 9.45e-01 | -1.50e-02 | 9.99e-01 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 11 | 9.32e-01 | 1.49e-02 | 9.99e-01 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 163 | 7.43e-01 | -1.49e-02 | 9.98e-01 |
| GOBP RESPONSE TO ZINC ION | 48 | 8.58e-01 | 1.49e-02 | 9.99e-01 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 715 | 4.98e-01 | 1.49e-02 | 9.95e-01 |
| GOBP TYPE II PNEUMOCYTE DIFFERENTIATION | 6 | 9.50e-01 | -1.49e-02 | 9.99e-01 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 18 | 9.13e-01 | 1.49e-02 | 9.99e-01 |
| GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS | 8 | 9.42e-01 | -1.49e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 114 | 7.84e-01 | -1.49e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 35 | 8.79e-01 | -1.49e-02 | 9.99e-01 |
| GOBP LEUKOCYTE DIFFERENTIATION | 594 | 5.36e-01 | 1.49e-02 | 9.95e-01 |
| GOBP SYNAPTIC SIGNALING | 746 | 4.90e-01 | -1.49e-02 | 9.95e-01 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 11 | 9.32e-01 | 1.49e-02 | 9.99e-01 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 20 | 9.08e-01 | 1.48e-02 | 9.99e-01 |
| GOCC EXOCYTIC VESICLE | 222 | 7.03e-01 | -1.48e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 546 | 5.53e-01 | 1.48e-02 | 9.95e-01 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 29 | 8.90e-01 | 1.48e-02 | 9.99e-01 |
| GOBP MACROMOLECULE DEPALMITOYLATION | 11 | 9.32e-01 | -1.48e-02 | 9.99e-01 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 11 | 9.32e-01 | -1.48e-02 | 9.99e-01 |
| GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 9 | 9.39e-01 | 1.48e-02 | 9.99e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 67 | 8.34e-01 | -1.48e-02 | 9.99e-01 |
| GOBP REGULATION OF COAGULATION | 73 | 8.28e-01 | -1.47e-02 | 9.98e-01 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 1078 | 4.13e-01 | 1.47e-02 | 9.95e-01 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 362 | 6.30e-01 | -1.47e-02 | 9.98e-01 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 26 | 8.97e-01 | 1.47e-02 | 9.99e-01 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 684 | 5.12e-01 | 1.47e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 13 | 9.27e-01 | -1.47e-02 | 9.99e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 85 | 8.15e-01 | -1.47e-02 | 9.98e-01 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 30 | 8.89e-01 | 1.47e-02 | 9.99e-01 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 11 | 9.33e-01 | 1.47e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 31 | 8.87e-01 | -1.47e-02 | 9.99e-01 |
| GOBP REGULATION OF RESTING MEMBRANE POTENTIAL | 10 | 9.36e-01 | -1.47e-02 | 9.99e-01 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 29 | 8.91e-01 | 1.47e-02 | 9.99e-01 |
| GOBP REGULATION OF GROWTH | 585 | 5.45e-01 | 1.47e-02 | 9.95e-01 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 249 | 6.91e-01 | 1.46e-02 | 9.98e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 772 | 4.89e-01 | 1.46e-02 | 9.95e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 40 | 8.73e-01 | -1.46e-02 | 9.99e-01 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 14 | 9.25e-01 | 1.46e-02 | 9.99e-01 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 5 | 9.55e-01 | -1.46e-02 | 9.99e-01 |
| GOBP BODY MORPHOGENESIS | 46 | 8.64e-01 | 1.46e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 15 | 9.22e-01 | 1.46e-02 | 9.99e-01 |
| GOBP S SHAPED BODY MORPHOGENESIS | 7 | 9.47e-01 | -1.45e-02 | 9.99e-01 |
| GOBP SNRNA PROCESSING | 25 | 9.00e-01 | -1.45e-02 | 9.99e-01 |
| GOBP CELL MORPHOGENESIS | 911 | 4.58e-01 | -1.45e-02 | 9.95e-01 |
| GOBP PURINE RIBONUCLEOSIDE SALVAGE | 6 | 9.51e-01 | 1.45e-02 | 9.99e-01 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 43 | 8.70e-01 | 1.44e-02 | 9.99e-01 |
| GOBP VIRAL LIFE CYCLE | 307 | 6.64e-01 | 1.44e-02 | 9.98e-01 |
| GOBP CORPUS CALLOSUM MORPHOGENESIS | 6 | 9.51e-01 | -1.44e-02 | 9.99e-01 |
| GOCC SITE OF POLARIZED GROWTH | 162 | 7.51e-01 | 1.44e-02 | 9.98e-01 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 24 | 9.03e-01 | -1.44e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 9.55e-01 | 1.44e-02 | 9.99e-01 |
| GOBP ALKALOID METABOLIC PROCESS | 7 | 9.47e-01 | 1.44e-02 | 9.99e-01 |
| GOCC MICROBODY | 143 | 7.67e-01 | -1.44e-02 | 9.98e-01 |
| GOBP CELL ADHESION | 1462 | 3.59e-01 | -1.43e-02 | 9.95e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 103 | 8.02e-01 | 1.43e-02 | 9.98e-01 |
| GOBP RESPONSE TO CALCIUM ION | 139 | 7.71e-01 | -1.43e-02 | 9.98e-01 |
| GOBP MANNOSE METABOLIC PROCESS | 9 | 9.41e-01 | 1.43e-02 | 9.99e-01 |
| GOBP APICAL JUNCTION ASSEMBLY | 73 | 8.33e-01 | 1.43e-02 | 9.99e-01 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 80 | 8.25e-01 | -1.43e-02 | 9.98e-01 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 19 | 9.14e-01 | 1.43e-02 | 9.99e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 107 | 7.99e-01 | 1.43e-02 | 9.98e-01 |
| GOMF INTRACELLULAR CGMP ACTIVATED CATION CHANNEL ACTIVITY | 6 | 9.52e-01 | 1.43e-02 | 9.99e-01 |
| GOMF SYNTAXIN BINDING | 65 | 8.43e-01 | 1.42e-02 | 9.99e-01 |
| GOMF HEAT SHOCK PROTEIN BINDING | 124 | 7.84e-01 | -1.42e-02 | 9.98e-01 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 53 | 8.58e-01 | 1.42e-02 | 9.99e-01 |
| GOBP REGULATION OF GLUCOCORTICOID SECRETION | 10 | 9.38e-01 | -1.42e-02 | 9.99e-01 |
| GOBP RRNA 5 END PROCESSING | 5 | 9.56e-01 | -1.42e-02 | 9.99e-01 |
| GOBP DNA CYTOSINE DEAMINATION | 9 | 9.41e-01 | -1.42e-02 | 9.99e-01 |
| GOMF DYSTROGLYCAN BINDING | 10 | 9.38e-01 | -1.42e-02 | 9.99e-01 |
| GOCC CDC73 PAF1 COMPLEX | 7 | 9.48e-01 | 1.42e-02 | 9.99e-01 |
| GOBP REGULATION OF PLASMA CELL DIFFERENTIATION | 5 | 9.56e-01 | -1.42e-02 | 9.99e-01 |
| GOBP CAMP MEDIATED SIGNALING | 53 | 8.58e-01 | -1.42e-02 | 9.99e-01 |
| GOCC EMC COMPLEX | 9 | 9.41e-01 | 1.42e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 27 | 8.99e-01 | -1.42e-02 | 9.99e-01 |
| GOBP NUCLEAR BODY ORGANIZATION | 15 | 9.25e-01 | -1.41e-02 | 9.99e-01 |
| GOMF ANTIOXIDANT ACTIVITY | 80 | 8.27e-01 | -1.41e-02 | 9.98e-01 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 13 | 9.30e-01 | 1.41e-02 | 9.99e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 43 | 8.73e-01 | 1.41e-02 | 9.99e-01 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 64 | 8.46e-01 | 1.41e-02 | 9.99e-01 |
| GOBP NERVOUS SYSTEM PROCESS | 1381 | 3.81e-01 | 1.41e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 183 | 7.43e-01 | 1.40e-02 | 9.98e-01 |
| GOBP CYTOKINE PRODUCTION | 835 | 4.91e-01 | 1.40e-02 | 9.95e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 54 | 8.58e-01 | 1.40e-02 | 9.99e-01 |
| GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 23 | 9.07e-01 | -1.40e-02 | 9.99e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 45 | 8.71e-01 | 1.40e-02 | 9.99e-01 |
| GOBP CELL JUNCTION DISASSEMBLY | 27 | 9.00e-01 | 1.40e-02 | 9.99e-01 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 613 | 5.55e-01 | 1.40e-02 | 9.95e-01 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 120 | 7.92e-01 | 1.40e-02 | 9.98e-01 |
| GOBP BONE GROWTH | 32 | 8.92e-01 | 1.39e-02 | 9.99e-01 |
| GOCC VESICLE MEMBRANE | 1170 | 4.23e-01 | -1.39e-02 | 9.95e-01 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 28 | 8.99e-01 | 1.39e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 112 | 7.99e-01 | -1.39e-02 | 9.98e-01 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 257 | 7.01e-01 | 1.39e-02 | 9.98e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 59 | 8.54e-01 | 1.39e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF COAGULATION | 30 | 8.95e-01 | -1.39e-02 | 9.99e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 37 | 8.84e-01 | -1.39e-02 | 9.99e-01 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 17 | 9.21e-01 | 1.39e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 36 | 8.86e-01 | -1.39e-02 | 9.99e-01 |
| GOBP PROSTATE GLAND DEVELOPMENT | 49 | 8.67e-01 | 1.38e-02 | 9.99e-01 |
| GOCC MICROVILLUS MEMBRANE | 32 | 8.92e-01 | -1.38e-02 | 9.99e-01 |
| GOCC CTF18 RFC LIKE COMPLEX | 7 | 9.50e-01 | 1.38e-02 | 9.99e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 272 | 6.95e-01 | 1.38e-02 | 9.98e-01 |
| GOMF PHOTORECEPTOR ACTIVITY | 13 | 9.32e-01 | 1.38e-02 | 9.99e-01 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 63 | 8.50e-01 | 1.37e-02 | 9.99e-01 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 8.90e-01 | 1.37e-02 | 9.99e-01 |
| GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY | 15 | 9.27e-01 | 1.37e-02 | 9.99e-01 |
| GOMF U1 SNRNA BINDING | 8 | 9.46e-01 | 1.37e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 82 | 8.30e-01 | 1.37e-02 | 9.98e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 14 | 9.29e-01 | 1.37e-02 | 9.99e-01 |
| GOBP HYPOTHALAMUS CELL MIGRATION | 6 | 9.54e-01 | 1.37e-02 | 9.99e-01 |
| GOBP REGULATION OF KINASE ACTIVITY | 561 | 5.80e-01 | 1.37e-02 | 9.96e-01 |
| GOCC CELL LEADING EDGE | 408 | 6.36e-01 | -1.36e-02 | 9.98e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 81 | 8.32e-01 | -1.36e-02 | 9.99e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 9.58e-01 | 1.36e-02 | 9.99e-01 |
| GOMF RNA POLYMERASE I GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 5 | 9.58e-01 | -1.36e-02 | 9.99e-01 |
| GOMF SPHINGOSINE N ACYLTRANSFERASE ACTIVITY | 7 | 9.50e-01 | 1.36e-02 | 9.99e-01 |
| GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 9.41e-01 | -1.36e-02 | 9.99e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 60 | 8.56e-01 | -1.36e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1187 | 4.31e-01 | 1.36e-02 | 9.95e-01 |
| GOBP MOTILE CILIUM ASSEMBLY | 64 | 8.51e-01 | -1.36e-02 | 9.99e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 38 | 8.85e-01 | -1.35e-02 | 9.99e-01 |
| GOCC CILIARY TRANSITION ZONE | 71 | 8.44e-01 | 1.35e-02 | 9.99e-01 |
| GOBP MRNA TRANSPORT | 112 | 8.04e-01 | 1.35e-02 | 9.98e-01 |
| GOBP APICAL PROTEIN LOCALIZATION | 14 | 9.30e-01 | 1.35e-02 | 9.99e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 36 | 8.88e-01 | -1.35e-02 | 9.99e-01 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 217 | 7.31e-01 | -1.35e-02 | 9.98e-01 |
| GOBP STRIATED MUSCLE CONTRACTION | 175 | 7.58e-01 | -1.35e-02 | 9.98e-01 |
| GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 8 | 9.47e-01 | -1.35e-02 | 9.99e-01 |
| GOCC F ACTIN CAPPING PROTEIN COMPLEX | 8 | 9.47e-01 | -1.35e-02 | 9.99e-01 |
| GOBP RESPONSE TO ACTINOMYCIN D | 5 | 9.58e-01 | -1.35e-02 | 9.99e-01 |
| GOBP TOLERANCE INDUCTION DEPENDENT UPON IMMUNE RESPONSE | 5 | 9.58e-01 | 1.35e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 7 | 9.51e-01 | 1.35e-02 | 9.99e-01 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 25 | 9.07e-01 | 1.34e-02 | 9.99e-01 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 246 | 7.16e-01 | 1.34e-02 | 9.98e-01 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 77 | 8.39e-01 | -1.34e-02 | 9.99e-01 |
| GOBP RESPONSE TO OXYGEN RADICAL | 27 | 9.04e-01 | -1.34e-02 | 9.99e-01 |
| GOBP SMOOTH MUSCLE CONTRACTION | 109 | 8.09e-01 | 1.34e-02 | 9.98e-01 |
| GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING | 20 | 9.18e-01 | -1.33e-02 | 9.99e-01 |
| GOBP ETHANOL CATABOLIC PROCESS | 10 | 9.42e-01 | -1.33e-02 | 9.99e-01 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 32 | 8.96e-01 | -1.33e-02 | 9.99e-01 |
| GOBP MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 7 | 9.51e-01 | 1.33e-02 | 9.99e-01 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 216 | 7.37e-01 | -1.32e-02 | 9.98e-01 |
| GOBP VITAMIN E METABOLIC PROCESS | 6 | 9.55e-01 | -1.32e-02 | 9.99e-01 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 309 | 6.90e-01 | 1.32e-02 | 9.98e-01 |
| GOBP GENERATION OF NEURONS | 1416 | 4.05e-01 | 1.32e-02 | 9.95e-01 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 959 | 4.88e-01 | 1.32e-02 | 9.95e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 39 | 8.86e-01 | -1.32e-02 | 9.99e-01 |
| GOBP ORGANIC ACID TRANSPORT | 340 | 6.76e-01 | -1.32e-02 | 9.98e-01 |
| GOBP MELANOCYTE DIFFERENTIATION | 24 | 9.11e-01 | -1.32e-02 | 9.99e-01 |
| GOBP NEURON CELL CELL ADHESION | 13 | 9.34e-01 | 1.32e-02 | 9.99e-01 |
| GOMF CYTOKINE RECEPTOR BINDING | 250 | 7.20e-01 | -1.32e-02 | 9.98e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 32 | 8.98e-01 | 1.32e-02 | 9.99e-01 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 45 | 8.79e-01 | -1.31e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 151 | 7.81e-01 | -1.31e-02 | 9.98e-01 |
| GOBP REGULATION OF NCRNA TRANSCRIPTION | 91 | 8.29e-01 | 1.31e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 36 | 8.92e-01 | -1.31e-02 | 9.99e-01 |
| GOBP ENDODERM DEVELOPMENT | 81 | 8.39e-01 | -1.31e-02 | 9.99e-01 |
| GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER | 6 | 9.56e-01 | 1.31e-02 | 9.99e-01 |
| GOBP HEPARIN METABOLIC PROCESS | 17 | 9.26e-01 | 1.31e-02 | 9.99e-01 |
| GOBP DENDRITIC SPINE MAINTENANCE | 21 | 9.17e-01 | 1.31e-02 | 9.99e-01 |
| GOBP REGULATION OF CELL MATURATION | 20 | 9.20e-01 | 1.31e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 21 | 9.18e-01 | 1.30e-02 | 9.99e-01 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 139 | 7.91e-01 | 1.30e-02 | 9.98e-01 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 84 | 8.37e-01 | -1.30e-02 | 9.99e-01 |
| GOBP GLOMERULUS VASCULATURE MORPHOGENESIS | 6 | 9.56e-01 | -1.30e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 249 | 7.25e-01 | 1.29e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 140 | 7.92e-01 | -1.29e-02 | 9.98e-01 |
| GOBP TISSUE MORPHOGENESIS | 618 | 5.83e-01 | 1.29e-02 | 9.96e-01 |
| GOCC EARLY ENDOSOME | 412 | 6.53e-01 | -1.29e-02 | 9.98e-01 |
| GOBP RESPONSE TO CORTICOSTEROID | 142 | 7.91e-01 | -1.29e-02 | 9.98e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 12 | 9.39e-01 | 1.28e-02 | 9.99e-01 |
| GOMF SIGNAL SEQUENCE BINDING | 46 | 8.80e-01 | -1.28e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 33 | 8.98e-01 | -1.28e-02 | 9.99e-01 |
| GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 12 | 9.39e-01 | 1.28e-02 | 9.99e-01 |
| GOBP LOCOMOTORY EXPLORATION BEHAVIOR | 14 | 9.34e-01 | -1.28e-02 | 9.99e-01 |
| GOBP REGULATION OF CATABOLIC PROCESS | 1026 | 4.88e-01 | 1.28e-02 | 9.95e-01 |
| GOMF CALMODULIN BINDING | 197 | 7.57e-01 | -1.28e-02 | 9.98e-01 |
| GOBP NEURON PROJECTION REGENERATION | 54 | 8.71e-01 | 1.28e-02 | 9.99e-01 |
| GOBP EXTRACELLULAR TRANSPORT | 45 | 8.82e-01 | 1.28e-02 | 9.99e-01 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 74 | 8.49e-01 | -1.28e-02 | 9.99e-01 |
| GOMF ZINC ION BINDING | 774 | 5.46e-01 | -1.28e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 81 | 8.43e-01 | -1.28e-02 | 9.99e-01 |
| GOCC MRNA CAP BINDING COMPLEX | 11 | 9.42e-01 | -1.27e-02 | 9.99e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 34 | 8.98e-01 | 1.27e-02 | 9.99e-01 |
| GOBP QUINONE METABOLIC PROCESS | 39 | 8.91e-01 | -1.27e-02 | 9.99e-01 |
| GOMF TRACE AMINE RECEPTOR ACTIVITY | 7 | 9.54e-01 | 1.26e-02 | 9.99e-01 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 62 | 8.64e-01 | 1.26e-02 | 9.99e-01 |
| GOMF OXYGEN CARRIER ACTIVITY | 14 | 9.35e-01 | 1.26e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING | 12 | 9.40e-01 | -1.26e-02 | 9.99e-01 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 9.21e-01 | 1.26e-02 | 9.99e-01 |
| GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 7 | 9.54e-01 | -1.26e-02 | 9.99e-01 |
| GOBP DEFINITIVE HEMOPOIESIS | 19 | 9.25e-01 | -1.25e-02 | 9.99e-01 |
| GOCC LAMELLIPODIUM | 194 | 7.64e-01 | -1.25e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 466 | 6.44e-01 | -1.25e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 89 | 8.39e-01 | 1.25e-02 | 9.99e-01 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 106 | 8.24e-01 | -1.25e-02 | 9.98e-01 |
| GOBP HEART FORMATION | 33 | 9.01e-01 | -1.25e-02 | 9.99e-01 |
| GOBP ECTODERMAL PLACODE DEVELOPMENT | 13 | 9.38e-01 | -1.24e-02 | 9.99e-01 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 25 | 9.14e-01 | 1.24e-02 | 9.99e-01 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 197 | 7.63e-01 | 1.24e-02 | 9.98e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 151 | 7.92e-01 | -1.24e-02 | 9.98e-01 |
| GOMF HYDRO LYASE ACTIVITY | 57 | 8.71e-01 | -1.24e-02 | 9.99e-01 |
| GOBP DETECTION OF VISIBLE LIGHT | 46 | 8.84e-01 | -1.24e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 139 | 8.01e-01 | -1.24e-02 | 9.98e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 46 | 8.85e-01 | 1.24e-02 | 9.99e-01 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 254 | 7.35e-01 | 1.23e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 229 | 7.48e-01 | 1.23e-02 | 9.98e-01 |
| GOBP RESPONSE TO ACTIVITY | 72 | 8.56e-01 | 1.23e-02 | 9.99e-01 |
| GOMF CADHERIN BINDING | 329 | 7.01e-01 | -1.23e-02 | 9.98e-01 |
| GOBP NEUROENDOCRINE CELL DIFFERENTIATION | 16 | 9.32e-01 | -1.23e-02 | 9.99e-01 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 17 | 9.30e-01 | -1.23e-02 | 9.99e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 9 | 9.49e-01 | 1.23e-02 | 9.99e-01 |
| GOCC SOMATODENDRITIC COMPARTMENT | 799 | 5.54e-01 | 1.23e-02 | 9.95e-01 |
| GOMF CYCLIN BINDING | 34 | 9.01e-01 | 1.23e-02 | 9.99e-01 |
| GOCC FILOPODIUM | 103 | 8.30e-01 | -1.23e-02 | 9.98e-01 |
| GOCC NEURON TO NEURON SYNAPSE | 345 | 6.96e-01 | -1.23e-02 | 9.98e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 26 | 9.14e-01 | -1.22e-02 | 9.99e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 8 | 9.52e-01 | 1.22e-02 | 9.99e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 38 | 8.96e-01 | 1.22e-02 | 9.99e-01 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 240 | 7.44e-01 | -1.22e-02 | 9.98e-01 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 12 | 9.42e-01 | 1.22e-02 | 9.99e-01 |
| GOCC RECEPTOR COMPLEX | 380 | 6.83e-01 | -1.22e-02 | 9.98e-01 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 19 | 9.27e-01 | 1.22e-02 | 9.99e-01 |
| GOCC NUCLEAR INNER MEMBRANE | 54 | 8.77e-01 | -1.22e-02 | 9.99e-01 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 118 | 8.20e-01 | 1.22e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO STARVATION | 171 | 7.84e-01 | 1.21e-02 | 9.98e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1616 | 4.17e-01 | 1.21e-02 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 214 | 7.60e-01 | -1.21e-02 | 9.98e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 42 | 8.92e-01 | 1.21e-02 | 9.99e-01 |
| GOMF INTERMEDIATE FILAMENT BINDING | 10 | 9.47e-01 | 1.21e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS | 5 | 9.63e-01 | -1.21e-02 | 9.99e-01 |
| GOCC GOLGI TRANSPORT COMPLEX | 9 | 9.50e-01 | -1.21e-02 | 9.99e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 394 | 6.81e-01 | 1.20e-02 | 9.98e-01 |
| GOBP MYOBLAST FATE COMMITMENT | 6 | 9.59e-01 | 1.20e-02 | 9.99e-01 |
| GOMF TAU PROTEIN BINDING | 42 | 8.93e-01 | 1.20e-02 | 9.99e-01 |
| GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 9.63e-01 | 1.20e-02 | 9.99e-01 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 87 | 8.47e-01 | 1.20e-02 | 9.99e-01 |
| GOBP SEQUESTERING OF CALCIUM ION | 137 | 8.08e-01 | 1.20e-02 | 9.98e-01 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 190 | 7.76e-01 | -1.20e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 26 | 9.16e-01 | -1.20e-02 | 9.99e-01 |
| GOBP PROTEOLYSIS | 1550 | 4.31e-01 | -1.20e-02 | 9.95e-01 |
| GOBP TIGHT JUNCTION ORGANIZATION | 78 | 8.55e-01 | 1.20e-02 | 9.99e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 23 | 9.21e-01 | 1.20e-02 | 9.99e-01 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 196 | 7.73e-01 | -1.20e-02 | 9.98e-01 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 32 | 9.07e-01 | 1.19e-02 | 9.99e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY | 12 | 9.43e-01 | 1.19e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 65 | 8.68e-01 | -1.19e-02 | 9.99e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 7 | 9.57e-01 | -1.19e-02 | 9.99e-01 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 278 | 7.33e-01 | -1.19e-02 | 9.98e-01 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 54 | 8.80e-01 | 1.19e-02 | 9.99e-01 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 325 | 7.13e-01 | -1.19e-02 | 9.98e-01 |
| GOMF METALLODIPEPTIDASE ACTIVITY | 8 | 9.54e-01 | 1.19e-02 | 9.99e-01 |
| GOBP HETEROCYCLE CATABOLIC PROCESS | 516 | 6.45e-01 | 1.18e-02 | 9.98e-01 |
| GOMF VITAMIN B6 BINDING | 54 | 8.80e-01 | 1.18e-02 | 9.99e-01 |
| GOCC ANCHORING JUNCTION | 863 | 5.55e-01 | -1.18e-02 | 9.95e-01 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 9.63e-01 | 1.18e-02 | 9.99e-01 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 10 | 9.48e-01 | -1.18e-02 | 9.99e-01 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 65 | 8.69e-01 | 1.18e-02 | 9.99e-01 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1705 | 4.18e-01 | -1.18e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 8 | 9.54e-01 | 1.18e-02 | 9.99e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 755 | 5.82e-01 | 1.18e-02 | 9.96e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 25 | 9.19e-01 | 1.17e-02 | 9.99e-01 |
| GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT | 8 | 9.54e-01 | 1.17e-02 | 9.99e-01 |
| GOCC PHOTORECEPTOR DISC MEMBRANE | 19 | 9.30e-01 | -1.17e-02 | 9.99e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING SA NODE CELL ACTION POTENTIAL | 5 | 9.64e-01 | 1.17e-02 | 9.99e-01 |
| GOMF MONOAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 9.44e-01 | 1.17e-02 | 9.99e-01 |
| GOMF MHC PROTEIN COMPLEX BINDING | 34 | 9.07e-01 | 1.16e-02 | 9.99e-01 |
| GOCC GOLGI CISTERNA | 97 | 8.43e-01 | -1.16e-02 | 9.99e-01 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 147 | 8.08e-01 | -1.16e-02 | 9.98e-01 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 21 | 9.27e-01 | -1.16e-02 | 9.99e-01 |
| GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 10 | 9.49e-01 | 1.16e-02 | 9.99e-01 |
| GOCC ISWI TYPE COMPLEX | 12 | 9.45e-01 | 1.16e-02 | 9.99e-01 |
| GOCC GOLGI MEMBRANE | 640 | 6.18e-01 | -1.16e-02 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 16 | 9.36e-01 | -1.16e-02 | 9.99e-01 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 38 | 9.02e-01 | -1.16e-02 | 9.99e-01 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 108 | 8.36e-01 | -1.16e-02 | 9.99e-01 |
| GOBP RESPONSE TO EPINEPHRINE | 14 | 9.40e-01 | 1.15e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 193 | 7.82e-01 | 1.15e-02 | 9.98e-01 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 44 | 8.95e-01 | -1.15e-02 | 9.99e-01 |
| GOBP VESICLE ORGANIZATION | 350 | 7.12e-01 | 1.15e-02 | 9.98e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 11 | 9.47e-01 | 1.15e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 556 | 6.43e-01 | 1.15e-02 | 9.98e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 6 | 9.61e-01 | 1.14e-02 | 9.99e-01 |
| GOBP CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 11 | 9.48e-01 | -1.14e-02 | 9.99e-01 |
| GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 15 | 9.39e-01 | -1.14e-02 | 9.99e-01 |
| GOBP NEUROGENESIS | 1643 | 4.42e-01 | 1.14e-02 | 9.95e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 85 | 8.56e-01 | 1.14e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 16 | 9.37e-01 | 1.14e-02 | 9.99e-01 |
| GOBP CYTOPLASMIC TRANSLATION | 142 | 8.15e-01 | 1.14e-02 | 9.98e-01 |
| GOBP WOUND HEALING | 407 | 6.94e-01 | 1.14e-02 | 9.98e-01 |
| GOCC TRAPP COMPLEX | 16 | 9.37e-01 | 1.13e-02 | 9.99e-01 |
| GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 11 | 9.48e-01 | 1.13e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 12 | 9.46e-01 | -1.13e-02 | 9.99e-01 |
| GOBP REGULATION OF ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 5 | 9.65e-01 | -1.13e-02 | 9.99e-01 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 1129 | 5.22e-01 | 1.13e-02 | 9.95e-01 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 101 | 8.44e-01 | -1.13e-02 | 9.99e-01 |
| GOMF NUCLEASE ACTIVITY | 206 | 7.80e-01 | 1.13e-02 | 9.98e-01 |
| GOBP EPIDERMIS DEVELOPMENT | 369 | 7.10e-01 | -1.13e-02 | 9.98e-01 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 25 | 9.22e-01 | 1.13e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 418 | 6.93e-01 | 1.13e-02 | 9.98e-01 |
| GOBP NK T CELL PROLIFERATION | 8 | 9.56e-01 | -1.12e-02 | 9.99e-01 |
| GOBP CHONDROCYTE DEVELOPMENT | 32 | 9.12e-01 | 1.12e-02 | 9.99e-01 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 37 | 9.06e-01 | 1.12e-02 | 9.99e-01 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 66 | 8.75e-01 | 1.12e-02 | 9.99e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 614 | 6.36e-01 | -1.12e-02 | 9.98e-01 |
| GOBP VASCULOGENESIS | 81 | 8.62e-01 | -1.12e-02 | 9.99e-01 |
| GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 18 | 9.34e-01 | 1.12e-02 | 9.99e-01 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 53 | 8.88e-01 | -1.12e-02 | 9.99e-01 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 194 | 7.88e-01 | -1.12e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 24 | 9.25e-01 | 1.12e-02 | 9.99e-01 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 27 | 9.20e-01 | -1.12e-02 | 9.99e-01 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 146 | 8.16e-01 | -1.11e-02 | 9.98e-01 |
| GOBP REGULATION OF MICROVILLUS LENGTH | 7 | 9.59e-01 | 1.11e-02 | 9.99e-01 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 369 | 7.13e-01 | -1.11e-02 | 9.98e-01 |
| GOBP VITAMIN D3 METABOLIC PROCESS | 6 | 9.62e-01 | 1.11e-02 | 9.99e-01 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 77 | 8.66e-01 | 1.11e-02 | 9.99e-01 |
| GOBP AMIDE METABOLIC PROCESS | 1219 | 5.14e-01 | -1.11e-02 | 9.95e-01 |
| GOBP NEURON DEVELOPMENT | 1086 | 5.37e-01 | -1.11e-02 | 9.95e-01 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 74 | 8.69e-01 | 1.11e-02 | 9.99e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 749 | 6.06e-01 | -1.11e-02 | 9.98e-01 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 61 | 8.81e-01 | 1.11e-02 | 9.99e-01 |
| GOCC COATED VESICLE MEMBRANE | 191 | 7.92e-01 | 1.10e-02 | 9.98e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 503 | 6.72e-01 | 1.10e-02 | 9.98e-01 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 134 | 8.26e-01 | 1.10e-02 | 9.98e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 95 | 8.53e-01 | -1.10e-02 | 9.99e-01 |
| GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 18 | 9.35e-01 | 1.10e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 34 | 9.12e-01 | -1.10e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 10 | 9.52e-01 | -1.10e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 108 | 8.44e-01 | 1.10e-02 | 9.99e-01 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 393 | 7.09e-01 | 1.10e-02 | 9.98e-01 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 139 | 8.24e-01 | 1.10e-02 | 9.98e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 13 | 9.46e-01 | -1.09e-02 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN OLIGOMERIZATION | 5 | 9.66e-01 | 1.09e-02 | 9.99e-01 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 79 | 8.67e-01 | -1.09e-02 | 9.99e-01 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 18 | 9.36e-01 | 1.09e-02 | 9.99e-01 |
| GOBP INCLUSION BODY ASSEMBLY | 23 | 9.28e-01 | 1.09e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 323 | 7.36e-01 | 1.09e-02 | 9.98e-01 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 30 | 9.18e-01 | 1.09e-02 | 9.99e-01 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 121 | 8.36e-01 | -1.09e-02 | 9.99e-01 |
| GOBP RESPONSE TO LIPID | 890 | 5.82e-01 | 1.09e-02 | 9.96e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 11 | 9.50e-01 | -1.08e-02 | 9.99e-01 |
| GOCC GOLGI CISTERNA MEMBRANE | 73 | 8.73e-01 | -1.08e-02 | 9.99e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 11 | 9.51e-01 | 1.08e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 33 | 9.15e-01 | -1.08e-02 | 9.99e-01 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 64 | 8.81e-01 | 1.08e-02 | 9.99e-01 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 6 | 9.64e-01 | -1.08e-02 | 9.99e-01 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 9.67e-01 | -1.08e-02 | 9.99e-01 |
| GOBP VIRAL GENOME REPLICATION | 124 | 8.36e-01 | 1.08e-02 | 9.99e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 14 | 9.45e-01 | -1.07e-02 | 9.99e-01 |
| GOBP SECRETORY GRANULE ORGANIZATION | 63 | 8.83e-01 | 1.07e-02 | 9.99e-01 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 577 | 6.60e-01 | 1.07e-02 | 9.98e-01 |
| GOBP CELL PROLIFERATION IN HINDBRAIN | 16 | 9.41e-01 | -1.07e-02 | 9.99e-01 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 18 | 9.37e-01 | -1.07e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 34 | 9.14e-01 | -1.07e-02 | 9.99e-01 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 20 | 9.34e-01 | -1.07e-02 | 9.99e-01 |
| GOCC NEURON PROJECTION TERMINUS | 123 | 8.38e-01 | -1.07e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF ACTION POTENTIAL | 8 | 9.59e-01 | 1.06e-02 | 9.99e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 302 | 7.51e-01 | 1.06e-02 | 9.98e-01 |
| GOBP CELL PART MORPHOGENESIS | 642 | 6.47e-01 | -1.06e-02 | 9.98e-01 |
| GOBP G0 TO G1 TRANSITION | 36 | 9.13e-01 | -1.06e-02 | 9.99e-01 |
| GOCC RISC LOADING COMPLEX | 8 | 9.59e-01 | -1.06e-02 | 9.99e-01 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 19 | 9.37e-01 | -1.05e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 898 | 5.93e-01 | 1.05e-02 | 9.98e-01 |
| GOBP NUCLEAR EXPORT | 156 | 8.21e-01 | -1.05e-02 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 9.59e-01 | 1.05e-02 | 9.99e-01 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 122 | 8.41e-01 | -1.05e-02 | 9.99e-01 |
| GOBP IRON IMPORT INTO CELL | 10 | 9.54e-01 | 1.05e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 24 | 9.29e-01 | -1.05e-02 | 9.99e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 203 | 7.97e-01 | -1.05e-02 | 9.98e-01 |
| GOBP 10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS | 6 | 9.65e-01 | 1.05e-02 | 9.99e-01 |
| GOBP MUSCLE SYSTEM PROCESS | 438 | 7.08e-01 | 1.04e-02 | 9.98e-01 |
| GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 11 | 9.52e-01 | -1.04e-02 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 402 | 7.19e-01 | -1.04e-02 | 9.98e-01 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 21 | 9.34e-01 | 1.04e-02 | 9.99e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 30 | 9.21e-01 | 1.04e-02 | 9.99e-01 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 47 | 9.02e-01 | -1.04e-02 | 9.99e-01 |
| GOCC PHAGOCYTIC VESICLE LUMEN | 5 | 9.68e-01 | -1.04e-02 | 9.99e-01 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 15 | 9.44e-01 | -1.04e-02 | 9.99e-01 |
| GOBP HORMONE TRANSPORT | 311 | 7.52e-01 | -1.04e-02 | 9.98e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 55 | 8.94e-01 | 1.04e-02 | 9.99e-01 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 67 | 8.83e-01 | 1.04e-02 | 9.99e-01 |
| GOCC ACROSOMAL VESICLE | 138 | 8.33e-01 | -1.04e-02 | 9.99e-01 |
| GOBP CRISTAE FORMATION | 15 | 9.45e-01 | -1.04e-02 | 9.99e-01 |
| GOMF GTPASE ACTIVITY | 305 | 7.56e-01 | -1.04e-02 | 9.98e-01 |
| GOBP URETERIC BUD FORMATION | 7 | 9.62e-01 | -1.03e-02 | 9.99e-01 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 564 | 6.74e-01 | -1.03e-02 | 9.98e-01 |
| GOCC PLATELET ALPHA GRANULE LUMEN | 60 | 8.90e-01 | 1.03e-02 | 9.99e-01 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 17 | 9.41e-01 | -1.03e-02 | 9.99e-01 |
| GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 9.57e-01 | -1.03e-02 | 9.99e-01 |
| GOBP FEMALE SEX DIFFERENTIATION | 117 | 8.48e-01 | 1.03e-02 | 9.99e-01 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 29 | 9.24e-01 | -1.03e-02 | 9.99e-01 |
| GOBP RESPONSE TO MUSCLE STRETCH | 24 | 9.31e-01 | -1.03e-02 | 9.99e-01 |
| GOMF SELENIUM BINDING | 9 | 9.58e-01 | -1.02e-02 | 9.99e-01 |
| GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 9.37e-01 | 1.02e-02 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 8 | 9.60e-01 | -1.02e-02 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 12 | 9.51e-01 | 1.02e-02 | 9.99e-01 |
| GOMF LYSINE ACETYLATED HISTONE BINDING | 24 | 9.31e-01 | -1.02e-02 | 9.99e-01 |
| GOBP ADENINE TRANSPORT | 5 | 9.69e-01 | -1.02e-02 | 9.99e-01 |
| GOBP REGULATION OF MESODERM DEVELOPMENT | 6 | 9.66e-01 | -1.02e-02 | 9.99e-01 |
| GOBP SECRETION BY TISSUE | 44 | 9.07e-01 | -1.02e-02 | 9.99e-01 |
| GOBP CYTOSKELETON ORGANIZATION | 1438 | 5.20e-01 | -1.01e-02 | 9.95e-01 |
| GOMF GUANYL NUCLEOTIDE BINDING | 370 | 7.38e-01 | 1.01e-02 | 9.98e-01 |
| GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 9.50e-01 | 1.01e-02 | 9.99e-01 |
| GOBP RESPONSE TO BLUE LIGHT | 6 | 9.66e-01 | -1.01e-02 | 9.99e-01 |
| GOCC SYMMETRIC SYNAPSE | 8 | 9.61e-01 | -1.01e-02 | 9.99e-01 |
| GOBP CUT CATABOLIC PROCESS | 5 | 9.69e-01 | 1.01e-02 | 9.99e-01 |
| GOCC INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED CATION CHANNEL COMPLEX | 5 | 9.69e-01 | -1.01e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 6 | 9.66e-01 | 1.01e-02 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 44 | 9.08e-01 | 1.01e-02 | 9.99e-01 |
| GOBP CELLULAR HOMEOSTASIS | 779 | 6.33e-01 | 1.01e-02 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO HISTAMINE | 7 | 9.63e-01 | -1.00e-02 | 9.99e-01 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 19 | 9.40e-01 | 1.00e-02 | 9.99e-01 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 17 | 9.43e-01 | -1.00e-02 | 9.99e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 31 | 9.23e-01 | 1.00e-02 | 9.99e-01 |
| GOMF AMINOPEPTIDASE ACTIVITY | 38 | 9.15e-01 | -1.00e-02 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 13 | 9.50e-01 | -1.00e-02 | 9.99e-01 |
| GOBP PEPTIDYL LYSINE OXIDATION | 5 | 9.69e-01 | -1.00e-02 | 9.99e-01 |
| GOMF PROTEIN LYSINE 6 OXIDASE ACTIVITY | 5 | 9.69e-01 | -1.00e-02 | 9.99e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 61 | 8.93e-01 | -9.98e-03 | 9.99e-01 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 35 | 9.19e-01 | -9.98e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 391 | 7.35e-01 | 9.97e-03 | 9.98e-01 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 47 | 9.06e-01 | -9.96e-03 | 9.99e-01 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 129 | 8.45e-01 | 9.94e-03 | 9.99e-01 |
| GOBP IRON COORDINATION ENTITY TRANSPORT | 12 | 9.52e-01 | 9.93e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 43 | 9.10e-01 | -9.93e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 271 | 7.79e-01 | -9.92e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 143 | 8.38e-01 | 9.91e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 21 | 9.37e-01 | -9.91e-03 | 9.99e-01 |
| GOBP SINGLE FERTILIZATION | 158 | 8.30e-01 | -9.89e-03 | 9.98e-01 |
| GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 80 | 8.79e-01 | 9.88e-03 | 9.99e-01 |
| GOBP FERTILIZATION | 194 | 8.13e-01 | 9.86e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 14 | 9.49e-01 | -9.85e-03 | 9.99e-01 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 49 | 9.05e-01 | -9.85e-03 | 9.99e-01 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 19 | 9.41e-01 | -9.84e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 17 | 9.44e-01 | -9.84e-03 | 9.99e-01 |
| GOMF UNFOLDED PROTEIN BINDING | 115 | 8.55e-01 | 9.84e-03 | 9.99e-01 |
| GOMF MONOOXYGENASE ACTIVITY | 102 | 8.64e-01 | -9.81e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 255 | 7.88e-01 | 9.79e-03 | 9.98e-01 |
| GOBP CELL MOTILITY | 1713 | 5.01e-01 | -9.79e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 100 | 8.66e-01 | 9.77e-03 | 9.99e-01 |
| GOMF G PROTEIN COUPLED OPIOID RECEPTOR ACTIVITY | 7 | 9.64e-01 | -9.76e-03 | 9.99e-01 |
| GOMF CHEMOATTRACTANT ACTIVITY | 34 | 9.22e-01 | 9.75e-03 | 9.99e-01 |
| GOMF NADP RETINOL DEHYDROGENASE ACTIVITY | 13 | 9.51e-01 | 9.75e-03 | 9.99e-01 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 568 | 6.92e-01 | 9.73e-03 | 9.98e-01 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 72 | 8.86e-01 | 9.73e-03 | 9.99e-01 |
| GOCC NURF COMPLEX | 5 | 9.70e-01 | 9.71e-03 | 9.99e-01 |
| GOMF NUCLEAR RECEPTOR BINDING | 132 | 8.48e-01 | -9.66e-03 | 9.99e-01 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 27 | 9.31e-01 | 9.66e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 7 | 9.65e-01 | 9.66e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 189 | 8.19e-01 | 9.65e-03 | 9.98e-01 |
| GOBP CARDIOLIPIN ACYL CHAIN REMODELING | 5 | 9.70e-01 | 9.64e-03 | 9.99e-01 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 23 | 9.36e-01 | -9.63e-03 | 9.99e-01 |
| GOBP XMP METABOLIC PROCESS | 7 | 9.65e-01 | -9.63e-03 | 9.99e-01 |
| GOCC CBM COMPLEX | 5 | 9.70e-01 | -9.60e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 587 | 6.91e-01 | 9.60e-03 | 9.98e-01 |
| GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS | 5 | 9.70e-01 | 9.58e-03 | 9.99e-01 |
| GOBP AUTOPHAGIC CELL DEATH | 9 | 9.60e-01 | -9.57e-03 | 9.99e-01 |
| GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 9 | 9.60e-01 | 9.56e-03 | 9.99e-01 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 13 | 9.52e-01 | -9.56e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 27 | 9.32e-01 | 9.55e-03 | 9.99e-01 |
| GOBP REGULATION OF HEART GROWTH | 68 | 8.92e-01 | -9.54e-03 | 9.99e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 13 | 9.53e-01 | -9.54e-03 | 9.99e-01 |
| GOBP ENDOCYTIC RECYCLING | 82 | 8.82e-01 | -9.51e-03 | 9.99e-01 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 1694 | 5.15e-01 | 9.50e-03 | 9.95e-01 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 669 | 6.76e-01 | 9.48e-03 | 9.98e-01 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 115 | 8.61e-01 | -9.47e-03 | 9.99e-01 |
| GOBP MICROTUBULE BASED MOVEMENT | 401 | 7.45e-01 | 9.46e-03 | 9.98e-01 |
| GOCC INHIBITORY SYNAPSE | 14 | 9.51e-01 | -9.46e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION | 5 | 9.71e-01 | -9.45e-03 | 9.99e-01 |
| GOBP HYPERSENSITIVITY | 10 | 9.59e-01 | 9.45e-03 | 9.99e-01 |
| GOBP REGULATION OF CHROMATIN BINDING | 11 | 9.57e-01 | 9.45e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 65 | 8.95e-01 | 9.43e-03 | 9.99e-01 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 224 | 8.08e-01 | 9.42e-03 | 9.98e-01 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 478 | 7.24e-01 | 9.41e-03 | 9.98e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 90 | 8.78e-01 | 9.40e-03 | 9.99e-01 |
| GOBP REGULATION OF SYNAPSE MATURATION | 20 | 9.42e-01 | 9.39e-03 | 9.99e-01 |
| GOBP REGULATION OF NEURON MIGRATION | 44 | 9.14e-01 | -9.38e-03 | 9.99e-01 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 40 | 9.18e-01 | 9.37e-03 | 9.99e-01 |
| GOBP REGULATION OF TRANSPORT | 1706 | 5.20e-01 | -9.36e-03 | 9.95e-01 |
| GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 6 | 9.68e-01 | 9.36e-03 | 9.99e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 68 | 8.94e-01 | -9.36e-03 | 9.99e-01 |
| GOBP PROTEIN POLYGLUTAMYLATION | 12 | 9.55e-01 | 9.36e-03 | 9.99e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 57 | 9.03e-01 | 9.35e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 54 | 9.05e-01 | -9.34e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 5 | 9.71e-01 | -9.25e-03 | 9.99e-01 |
| GOBP MUCUS SECRETION | 18 | 9.46e-01 | 9.24e-03 | 9.99e-01 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 132 | 8.55e-01 | 9.24e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 78 | 8.88e-01 | 9.24e-03 | 9.99e-01 |
| GOBP ENDOSOMAL TRANSPORT | 239 | 8.06e-01 | 9.22e-03 | 9.98e-01 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 48 | 9.12e-01 | 9.19e-03 | 9.99e-01 |
| GOBP SENSORY PERCEPTION OF PAIN | 76 | 8.90e-01 | -9.18e-03 | 9.99e-01 |
| GOBP BLOOD VESSEL MATURATION | 8 | 9.64e-01 | 9.16e-03 | 9.99e-01 |
| GOMF CYCLASE ACTIVITY | 21 | 9.42e-01 | -9.15e-03 | 9.99e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 387 | 7.57e-01 | 9.15e-03 | 9.98e-01 |
| GOCC SYNAPSE | 1375 | 5.70e-01 | -9.15e-03 | 9.95e-01 |
| GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 15 | 9.51e-01 | 9.14e-03 | 9.99e-01 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 198 | 8.25e-01 | 9.13e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 44 | 9.17e-01 | -9.13e-03 | 9.99e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 443 | 7.42e-01 | -9.11e-03 | 9.98e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 50 | 9.11e-01 | -9.10e-03 | 9.99e-01 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 21 | 9.43e-01 | -9.08e-03 | 9.99e-01 |
| GOBP PHASIC SMOOTH MUSCLE CONTRACTION | 24 | 9.39e-01 | -9.05e-03 | 9.99e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 72 | 8.94e-01 | 9.05e-03 | 9.99e-01 |
| GOCC MOTILE CILIUM | 248 | 8.06e-01 | -9.04e-03 | 9.98e-01 |
| GOBP PROTEIN MATURATION | 515 | 7.27e-01 | -8.99e-03 | 9.98e-01 |
| GOCC MITOCHONDRIAL MATRIX | 466 | 7.40e-01 | 8.98e-03 | 9.98e-01 |
| GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 13 | 9.55e-01 | -8.98e-03 | 9.99e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 93 | 8.81e-01 | -8.97e-03 | 9.99e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 37 | 9.25e-01 | 8.97e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 339 | 7.77e-01 | 8.96e-03 | 9.98e-01 |
| GOBP REGULATION OF LIPASE ACTIVITY | 76 | 8.93e-01 | -8.96e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 155 | 8.47e-01 | 8.95e-03 | 9.99e-01 |
| GOCC MYOFILAMENT | 26 | 9.37e-01 | -8.94e-03 | 9.99e-01 |
| GOBP BEHAVIOR | 629 | 7.02e-01 | 8.93e-03 | 9.98e-01 |
| GOMF DNA DNA ANNEALING ACTIVITY | 7 | 9.67e-01 | 8.92e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 60 | 9.05e-01 | -8.89e-03 | 9.99e-01 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 314 | 7.87e-01 | 8.87e-03 | 9.98e-01 |
| GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 13 | 9.56e-01 | 8.87e-03 | 9.99e-01 |
| GOBP MUSCLE CELL DEVELOPMENT | 191 | 8.33e-01 | 8.86e-03 | 9.99e-01 |
| GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 8 | 9.65e-01 | -8.84e-03 | 9.99e-01 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 138 | 8.58e-01 | -8.83e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 15 | 9.53e-01 | 8.83e-03 | 9.99e-01 |
| GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 8 | 9.66e-01 | 8.82e-03 | 9.99e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 135 | 8.60e-01 | 8.80e-03 | 9.99e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 74 | 8.96e-01 | -8.79e-03 | 9.99e-01 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 111 | 8.73e-01 | -8.79e-03 | 9.99e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 127 | 8.64e-01 | 8.79e-03 | 9.99e-01 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 23 | 9.42e-01 | 8.79e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 692 | 6.95e-01 | 8.76e-03 | 9.98e-01 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 23 | 9.42e-01 | -8.71e-03 | 9.99e-01 |
| GOBP POLE PLASM ASSEMBLY | 6 | 9.71e-01 | 8.69e-03 | 9.99e-01 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 558 | 7.26e-01 | 8.67e-03 | 9.98e-01 |
| GOBP AEROBIC RESPIRATION | 170 | 8.45e-01 | 8.67e-03 | 9.99e-01 |
| GOBP EMBRYONIC HEMOPOIESIS | 23 | 9.43e-01 | 8.65e-03 | 9.99e-01 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 9.66e-01 | -8.65e-03 | 9.99e-01 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 65 | 9.04e-01 | 8.65e-03 | 9.99e-01 |
| GOBP RESPONSE TO TESTOSTERONE | 41 | 9.24e-01 | -8.61e-03 | 9.99e-01 |
| GOBP HEART MORPHOGENESIS | 262 | 8.11e-01 | -8.58e-03 | 9.98e-01 |
| GOBP PHOSPHATE ION HOMEOSTASIS | 20 | 9.47e-01 | -8.58e-03 | 9.99e-01 |
| GOBP DEVELOPMENTAL MATURATION | 317 | 7.93e-01 | 8.56e-03 | 9.98e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 15 | 9.54e-01 | 8.55e-03 | 9.99e-01 |
| GOCC PRESYNAPTIC MEMBRANE | 158 | 8.53e-01 | -8.55e-03 | 9.99e-01 |
| GOBP ANIMAL ORGAN REGENERATION | 60 | 9.09e-01 | -8.54e-03 | 9.99e-01 |
| GOBP REGULATION OF METAL ION TRANSPORT | 380 | 7.75e-01 | -8.53e-03 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 306 | 7.98e-01 | 8.51e-03 | 9.98e-01 |
| GOMF DEMETHYLASE ACTIVITY | 35 | 9.31e-01 | 8.51e-03 | 9.99e-01 |
| GOBP SPROUTING ANGIOGENESIS | 183 | 8.43e-01 | -8.49e-03 | 9.99e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 713 | 6.99e-01 | 8.49e-03 | 9.98e-01 |
| GOMF PRE MRNA INTRONIC BINDING | 12 | 9.59e-01 | 8.47e-03 | 9.99e-01 |
| GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 9 | 9.65e-01 | 8.47e-03 | 9.99e-01 |
| GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 11 | 9.61e-01 | 8.45e-03 | 9.99e-01 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 23 | 9.44e-01 | -8.42e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 88 | 8.91e-01 | -8.42e-03 | 9.99e-01 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 100 | 8.84e-01 | -8.42e-03 | 9.99e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 45 | 9.22e-01 | -8.40e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 212 | 8.33e-01 | -8.39e-03 | 9.99e-01 |
| GOBP NECROPTOTIC PROCESS | 45 | 9.23e-01 | -8.38e-03 | 9.99e-01 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 29 | 9.38e-01 | -8.37e-03 | 9.99e-01 |
| GOMF ALDEHYDE LYASE ACTIVITY | 9 | 9.65e-01 | -8.36e-03 | 9.99e-01 |
| GOBP INORGANIC ION HOMEOSTASIS | 514 | 7.46e-01 | -8.36e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 855 | 6.79e-01 | 8.35e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 7 | 9.70e-01 | -8.33e-03 | 9.99e-01 |
| GOBP REGULATION OF STEM CELL DIVISION | 11 | 9.62e-01 | 8.33e-03 | 9.99e-01 |
| GOBP CELLULAR PIGMENTATION | 60 | 9.11e-01 | 8.31e-03 | 9.99e-01 |
| GOCC GOLGI STACK | 128 | 8.71e-01 | -8.30e-03 | 9.99e-01 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 1148 | 6.35e-01 | 8.30e-03 | 9.98e-01 |
| GOMF TRANSITION METAL ION BINDING | 1035 | 6.52e-01 | -8.29e-03 | 9.98e-01 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 69 | 9.05e-01 | 8.28e-03 | 9.99e-01 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 148 | 8.62e-01 | 8.27e-03 | 9.99e-01 |
| GOMF SIGNAL RECOGNITION PARTICLE BINDING | 7 | 9.70e-01 | 8.26e-03 | 9.99e-01 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 166 | 8.55e-01 | -8.24e-03 | 9.99e-01 |
| GOBP LINOLEIC ACID METABOLIC PROCESS | 19 | 9.51e-01 | 8.17e-03 | 9.99e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 18 | 9.52e-01 | 8.16e-03 | 9.99e-01 |
| GOCC GOLGI MEDIAL CISTERNA | 11 | 9.63e-01 | 8.16e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL | 5 | 9.75e-01 | -8.14e-03 | 9.99e-01 |
| GOCC SITE OF DOUBLE STRAND BREAK | 82 | 8.99e-01 | -8.11e-03 | 9.99e-01 |
| GOBP MOLTING CYCLE | 112 | 8.82e-01 | 8.10e-03 | 9.99e-01 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 35 | 9.34e-01 | 8.09e-03 | 9.99e-01 |
| GOBP PROTEIN MONOUBIQUITINATION | 41 | 9.29e-01 | -8.08e-03 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 10 | 9.65e-01 | -8.08e-03 | 9.99e-01 |
| GOMF G PROTEIN ACTIVITY | 42 | 9.28e-01 | -8.06e-03 | 9.99e-01 |
| GOBP DEFENSE RESPONSE | 1720 | 5.79e-01 | 8.04e-03 | 9.96e-01 |
| GOMF GUANYLATE CYCLASE ACTIVITY | 7 | 9.71e-01 | -8.00e-03 | 9.99e-01 |
| GOBP RESPONSE TO RETINOIC ACID | 105 | 8.88e-01 | 7.96e-03 | 9.99e-01 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 66 | 9.11e-01 | -7.95e-03 | 9.99e-01 |
| GOBP REGULATION OF LOCOMOTION | 1080 | 6.59e-01 | 7.94e-03 | 9.98e-01 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 9.58e-01 | 7.93e-03 | 9.99e-01 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 42 | 9.29e-01 | -7.93e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 327 | 8.05e-01 | -7.92e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 66 | 9.12e-01 | -7.90e-03 | 9.99e-01 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 64 | 9.13e-01 | 7.89e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO HEAT | 62 | 9.15e-01 | 7.87e-03 | 9.99e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY | 5 | 9.76e-01 | -7.85e-03 | 9.99e-01 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 25 | 9.46e-01 | 7.84e-03 | 9.99e-01 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 976 | 6.79e-01 | 7.84e-03 | 9.98e-01 |
| GOBP GLYCINE BIOSYNTHETIC PROCESS | 7 | 9.71e-01 | -7.83e-03 | 9.99e-01 |
| GOBP UBIQUITIN DEPENDENT ERAD PATHWAY | 82 | 9.02e-01 | 7.83e-03 | 9.99e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 29 | 9.42e-01 | -7.81e-03 | 9.99e-01 |
| GOBP HEAD MORPHOGENESIS | 35 | 9.36e-01 | -7.79e-03 | 9.99e-01 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 129 | 8.79e-01 | 7.78e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 52 | 9.23e-01 | -7.77e-03 | 9.99e-01 |
| GOBP CELL CELL ADHESION | 918 | 6.91e-01 | 7.74e-03 | 9.98e-01 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 64 | 9.15e-01 | -7.70e-03 | 9.99e-01 |
| GOBP PROTEIN DEGLYCOSYLATION | 15 | 9.59e-01 | -7.70e-03 | 9.99e-01 |
| GOMF CARBOHYDRATE BINDING | 260 | 8.31e-01 | 7.69e-03 | 9.98e-01 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 126 | 8.82e-01 | -7.68e-03 | 9.99e-01 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 19 | 9.54e-01 | -7.68e-03 | 9.99e-01 |
| GOBP OLFACTORY NERVE DEVELOPMENT | 6 | 9.74e-01 | -7.67e-03 | 9.99e-01 |
| GOBP RRNA TRANSPORT | 5 | 9.76e-01 | -7.67e-03 | 1.00e+00 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 52 | 9.24e-01 | 7.64e-03 | 9.99e-01 |
| GOBP REGULATION OF SECRETION | 601 | 7.49e-01 | 7.64e-03 | 9.98e-01 |
| GOBP URINARY TRACT SMOOTH MUSCLE CONTRACTION | 9 | 9.68e-01 | -7.63e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 426 | 7.88e-01 | 7.61e-03 | 9.98e-01 |
| GOBP REGULATION OF BODY FLUID LEVELS | 351 | 8.07e-01 | -7.61e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 50 | 9.26e-01 | -7.60e-03 | 9.99e-01 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 137 | 8.78e-01 | -7.59e-03 | 9.99e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 9.69e-01 | 7.57e-03 | 9.99e-01 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 38 | 9.36e-01 | -7.56e-03 | 9.99e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 14 | 9.61e-01 | 7.56e-03 | 9.99e-01 |
| GOBP NEURAL PLATE DEVELOPMENT | 8 | 9.71e-01 | -7.53e-03 | 9.99e-01 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 31 | 9.42e-01 | -7.53e-03 | 9.99e-01 |
| GOBP RESPONSE TO PEPTIDE | 498 | 7.74e-01 | -7.51e-03 | 9.98e-01 |
| GOCC CELL CORTEX | 296 | 8.25e-01 | 7.48e-03 | 9.98e-01 |
| GOBP REGULATION OF MIRNA TRANSCRIPTION | 69 | 9.14e-01 | -7.48e-03 | 9.99e-01 |
| GOCC AUTOPHAGOSOME | 110 | 8.92e-01 | -7.47e-03 | 9.99e-01 |
| GOBP PROTEIN CATABOLIC PROCESS | 930 | 7.00e-01 | 7.46e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 26 | 9.48e-01 | -7.44e-03 | 9.99e-01 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 1175 | 6.68e-01 | 7.43e-03 | 9.98e-01 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 35 | 9.40e-01 | 7.41e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 23 | 9.51e-01 | -7.39e-03 | 9.99e-01 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 803 | 7.22e-01 | -7.39e-03 | 9.98e-01 |
| GOBP DNA METHYLATION | 47 | 9.30e-01 | -7.38e-03 | 9.99e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 235 | 8.46e-01 | -7.37e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING | 1720 | 6.12e-01 | -7.35e-03 | 9.98e-01 |
| GOCC SITE OF DNA DAMAGE | 113 | 8.93e-01 | -7.35e-03 | 9.99e-01 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 679 | 7.44e-01 | 7.34e-03 | 9.98e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 13 | 9.64e-01 | 7.32e-03 | 9.99e-01 |
| GOBP G QUADRUPLEX DNA UNWINDING | 7 | 9.73e-01 | 7.31e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 14 | 9.62e-01 | -7.31e-03 | 9.99e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 15 | 9.61e-01 | 7.31e-03 | 9.99e-01 |
| GOBP TORC1 SIGNALING | 95 | 9.02e-01 | 7.30e-03 | 9.99e-01 |
| GOBP ALCOHOL CATABOLIC PROCESS | 33 | 9.42e-01 | -7.26e-03 | 9.99e-01 |
| GOBP RESPIRATORY SYSTEM PROCESS | 37 | 9.39e-01 | -7.26e-03 | 9.99e-01 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 18 | 9.58e-01 | -7.24e-03 | 9.99e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 70 | 9.17e-01 | 7.23e-03 | 9.99e-01 |
| GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 8 | 9.72e-01 | -7.19e-03 | 9.99e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 71 | 9.17e-01 | 7.16e-03 | 9.99e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 12 | 9.66e-01 | -7.15e-03 | 9.99e-01 |
| GOBP RNA DESTABILIZATION | 162 | 8.75e-01 | 7.15e-03 | 9.99e-01 |
| GOBP CELL PROJECTION ASSEMBLY | 586 | 7.68e-01 | -7.13e-03 | 9.98e-01 |
| GOBP GLUCAN METABOLIC PROCESS | 73 | 9.16e-01 | 7.13e-03 | 9.99e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1605 | 6.34e-01 | 7.13e-03 | 9.98e-01 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 27 | 9.49e-01 | 7.13e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 71 | 9.17e-01 | -7.11e-03 | 9.99e-01 |
| GOBP TNFSF11 MEDIATED SIGNALING PATHWAY | 5 | 9.78e-01 | 7.08e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 16 | 9.61e-01 | -7.08e-03 | 9.99e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 85 | 9.10e-01 | 7.07e-03 | 9.99e-01 |
| GOBP PROSTAGLANDIN TRANSPORT | 28 | 9.48e-01 | -7.07e-03 | 9.99e-01 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 16 | 9.61e-01 | 7.06e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 108 | 8.99e-01 | -7.06e-03 | 9.99e-01 |
| GOBP CELL CELL SIGNALING | 1625 | 6.36e-01 | -7.05e-03 | 9.98e-01 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 116 | 8.96e-01 | -7.03e-03 | 9.99e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 331 | 8.26e-01 | 7.02e-03 | 9.98e-01 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 17 | 9.60e-01 | -7.00e-03 | 9.99e-01 |
| GOBP GANGLION DEVELOPMENT | 17 | 9.60e-01 | -6.99e-03 | 9.99e-01 |
| GOBP MRNA EXPORT FROM NUCLEUS | 61 | 9.25e-01 | -6.96e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 370 | 8.18e-01 | 6.96e-03 | 9.98e-01 |
| GOBP REGULATION OF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 8 | 9.73e-01 | -6.94e-03 | 9.99e-01 |
| GOMF MODIFIED AMINO ACID BINDING | 81 | 9.14e-01 | -6.94e-03 | 9.99e-01 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 248 | 8.51e-01 | 6.93e-03 | 9.99e-01 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 96 | 9.07e-01 | 6.93e-03 | 9.99e-01 |
| GOBP OVULATION CYCLE | 72 | 9.19e-01 | -6.92e-03 | 9.99e-01 |
| GOBP CELL KILLING | 212 | 8.62e-01 | 6.92e-03 | 9.99e-01 |
| GOCC DENDRITIC TREE | 589 | 7.74e-01 | 6.92e-03 | 9.98e-01 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 980 | 7.14e-01 | 6.92e-03 | 9.98e-01 |
| GOBP PIGMENTATION | 108 | 9.01e-01 | -6.91e-03 | 9.99e-01 |
| GOMF GABA RECEPTOR BINDING | 18 | 9.60e-01 | -6.88e-03 | 9.99e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 341 | 8.27e-01 | 6.87e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 33 | 9.46e-01 | -6.86e-03 | 9.99e-01 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 102 | 9.05e-01 | 6.85e-03 | 9.99e-01 |
| GOCC MISMATCH REPAIR COMPLEX | 8 | 9.73e-01 | 6.84e-03 | 9.99e-01 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 278 | 8.45e-01 | 6.83e-03 | 9.99e-01 |
| GOBP REGULATION OF GERM CELL PROLIFERATION | 7 | 9.75e-01 | -6.82e-03 | 9.99e-01 |
| GOBP TUBE MORPHOGENESIS | 914 | 7.27e-01 | 6.81e-03 | 9.98e-01 |
| GOBP FOLIC ACID TRANSPORT | 10 | 9.70e-01 | -6.81e-03 | 9.99e-01 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 74 | 9.19e-01 | -6.81e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF FEVER GENERATION | 7 | 9.75e-01 | -6.81e-03 | 9.99e-01 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 46 | 9.36e-01 | -6.79e-03 | 9.99e-01 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 10 | 9.70e-01 | 6.76e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 56 | 9.30e-01 | -6.75e-03 | 9.99e-01 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 119 | 8.99e-01 | -6.74e-03 | 9.99e-01 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 178 | 8.77e-01 | 6.73e-03 | 9.99e-01 |
| GOBP PRENYLATION | 11 | 9.69e-01 | 6.73e-03 | 9.99e-01 |
| GOCC AXON | 618 | 7.76e-01 | 6.71e-03 | 9.98e-01 |
| GOBP VASCULATURE DEVELOPMENT | 794 | 7.49e-01 | 6.69e-03 | 9.98e-01 |
| GOCC SPINDLE POLE | 166 | 8.82e-01 | -6.68e-03 | 9.99e-01 |
| GOBP REGULATION OF CELL SIZE | 176 | 8.79e-01 | 6.67e-03 | 9.99e-01 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 50 | 9.35e-01 | -6.63e-03 | 9.99e-01 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 25 | 9.55e-01 | 6.57e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 91 | 9.14e-01 | 6.56e-03 | 9.99e-01 |
| GOBP GLAND MORPHOGENESIS | 119 | 9.02e-01 | 6.56e-03 | 9.99e-01 |
| GOBP PROTEIN TETRAMERIZATION | 88 | 9.16e-01 | 6.54e-03 | 9.99e-01 |
| GOBP CELL GROWTH | 474 | 8.07e-01 | -6.53e-03 | 9.98e-01 |
| GOMF ENDONUCLEASE ACTIVITY | 118 | 9.03e-01 | 6.50e-03 | 9.99e-01 |
| GOBP CD40 SIGNALING PATHWAY | 15 | 9.65e-01 | 6.50e-03 | 9.99e-01 |
| GOBP REGULATION OF HISTONE ACETYLATION | 18 | 9.62e-01 | -6.50e-03 | 9.99e-01 |
| GOMF S METHYLTRANSFERASE ACTIVITY | 8 | 9.75e-01 | -6.46e-03 | 9.99e-01 |
| GOMF CHLORIDE ION BINDING | 10 | 9.72e-01 | -6.39e-03 | 9.99e-01 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 8 | 9.75e-01 | 6.36e-03 | 9.99e-01 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 268 | 8.58e-01 | 6.36e-03 | 9.99e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 8 | 9.75e-01 | -6.35e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS | 10 | 9.72e-01 | -6.32e-03 | 9.99e-01 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 29 | 9.53e-01 | -6.31e-03 | 9.99e-01 |
| GOBP EATING BEHAVIOR | 37 | 9.47e-01 | 6.31e-03 | 9.99e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 18 | 9.63e-01 | 6.31e-03 | 9.99e-01 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 146 | 8.95e-01 | 6.30e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 107 | 9.11e-01 | 6.29e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 9.81e-01 | 6.28e-03 | 1.00e+00 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 166 | 8.89e-01 | 6.28e-03 | 9.99e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 170 | 8.88e-01 | 6.27e-03 | 9.99e-01 |
| GOBP PEXOPHAGY | 6 | 9.79e-01 | -6.26e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 73 | 9.26e-01 | -6.25e-03 | 9.99e-01 |
| GOBP MONONUCLEAR CELL MIGRATION | 196 | 8.81e-01 | -6.23e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 630 | 7.90e-01 | 6.22e-03 | 9.98e-01 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 27 | 9.55e-01 | -6.21e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 15 | 9.67e-01 | 6.20e-03 | 9.99e-01 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1345 | 7.03e-01 | 6.19e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 951 | 7.48e-01 | -6.16e-03 | 9.98e-01 |
| GOCC CILIUM | 704 | 7.81e-01 | -6.16e-03 | 9.98e-01 |
| GOMF RNA CAP BINDING | 20 | 9.62e-01 | 6.14e-03 | 9.99e-01 |
| GOCC ORGANELLE SUBCOMPARTMENT | 1414 | 7.02e-01 | 6.07e-03 | 9.98e-01 |
| GOBP AMINO ACID CATABOLIC PROCESS | 108 | 9.13e-01 | -6.07e-03 | 9.99e-01 |
| GOBP REGULATION OF ODONTOBLAST DIFFERENTIATION | 5 | 9.81e-01 | -6.04e-03 | 1.00e+00 |
| GOBP G1 TO G0 TRANSITION | 19 | 9.64e-01 | 6.02e-03 | 9.99e-01 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 239 | 8.73e-01 | -6.01e-03 | 9.99e-01 |
| GOBP IMMUNE EFFECTOR PROCESS | 604 | 8.01e-01 | -5.99e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 71 | 9.31e-01 | -5.98e-03 | 9.99e-01 |
| GOBP MEMBRANE ORGANIZATION | 773 | 7.78e-01 | -5.95e-03 | 9.98e-01 |
| GOBP TAXIS | 442 | 8.30e-01 | 5.95e-03 | 9.98e-01 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 66 | 9.33e-01 | -5.94e-03 | 9.99e-01 |
| GOBP ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 9.82e-01 | -5.94e-03 | 1.00e+00 |
| GOMF CARD DOMAIN BINDING | 16 | 9.67e-01 | -5.91e-03 | 9.99e-01 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 46 | 9.45e-01 | -5.88e-03 | 9.99e-01 |
| GOMF SCAFFOLD PROTEIN BINDING | 64 | 9.35e-01 | -5.87e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION | 8 | 9.77e-01 | -5.87e-03 | 1.00e+00 |
| GOBP SALIVA SECRETION | 13 | 9.71e-01 | 5.87e-03 | 9.99e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 9.77e-01 | 5.86e-03 | 1.00e+00 |
| GOMF RNA EXONUCLEASE ACTIVITY | 44 | 9.46e-01 | 5.86e-03 | 9.99e-01 |
| GOBP ADP TRANSPORT | 10 | 9.75e-01 | -5.84e-03 | 9.99e-01 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 96 | 9.21e-01 | 5.83e-03 | 9.99e-01 |
| GOBP GASTRULATION | 188 | 8.91e-01 | 5.82e-03 | 9.99e-01 |
| GOBP REGULATION OF CELL KILLING | 110 | 9.16e-01 | 5.81e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 52 | 9.42e-01 | 5.81e-03 | 9.99e-01 |
| GOBP PHOSPHATE ION TRANSPORT | 28 | 9.58e-01 | 5.79e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 61 | 9.38e-01 | -5.77e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 32 | 9.55e-01 | -5.77e-03 | 9.99e-01 |
| GOBP IMP METABOLIC PROCESS | 17 | 9.67e-01 | -5.77e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 73 | 9.32e-01 | -5.74e-03 | 9.99e-01 |
| GOBP PLATELET AGGREGATION | 71 | 9.34e-01 | 5.68e-03 | 9.99e-01 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 220 | 8.85e-01 | 5.64e-03 | 9.99e-01 |
| GOBP MYELOID CELL DIFFERENTIATION | 413 | 8.44e-01 | 5.64e-03 | 9.99e-01 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 51 | 9.45e-01 | 5.63e-03 | 9.99e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 42 | 9.50e-01 | 5.62e-03 | 9.99e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 365 | 8.54e-01 | -5.59e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 102 | 9.22e-01 | -5.59e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 72 | 9.35e-01 | -5.59e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 181 | 8.97e-01 | 5.58e-03 | 9.99e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 22 | 9.64e-01 | 5.57e-03 | 9.99e-01 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 9 | 9.77e-01 | -5.55e-03 | 1.00e+00 |
| GOBP VESICLE CARGO LOADING | 29 | 9.59e-01 | 5.53e-03 | 9.99e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 26 | 9.61e-01 | 5.52e-03 | 9.99e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 41 | 9.52e-01 | -5.48e-03 | 9.99e-01 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 86 | 9.30e-01 | -5.47e-03 | 9.99e-01 |
| GOBP GROWTH | 881 | 7.83e-01 | 5.47e-03 | 9.98e-01 |
| GOBP INTEGRIN ACTIVATION | 26 | 9.62e-01 | -5.45e-03 | 9.99e-01 |
| GOBP CIRCULATORY SYSTEM PROCESS | 577 | 8.23e-01 | -5.45e-03 | 9.98e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 837 | 7.89e-01 | 5.44e-03 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 172 | 9.02e-01 | -5.42e-03 | 9.99e-01 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 702 | 8.08e-01 | 5.39e-03 | 9.98e-01 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 62 | 9.42e-01 | 5.37e-03 | 9.99e-01 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 541 | 8.32e-01 | -5.34e-03 | 9.99e-01 |
| GOBP RECEPTOR INTERNALIZATION | 122 | 9.20e-01 | -5.30e-03 | 9.99e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 42 | 9.53e-01 | 5.29e-03 | 9.99e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 39 | 9.55e-01 | -5.28e-03 | 9.99e-01 |
| GOBP ERAD PATHWAY | 108 | 9.25e-01 | 5.27e-03 | 9.99e-01 |
| GOMF RETINYL PALMITATE ESTERASE ACTIVITY | 6 | 9.82e-01 | 5.26e-03 | 1.00e+00 |
| GOBP AMIDE TRANSPORT | 344 | 8.68e-01 | -5.22e-03 | 9.99e-01 |
| GOBP DNA CONFORMATION CHANGE | 87 | 9.33e-01 | -5.21e-03 | 9.99e-01 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 28 | 9.62e-01 | -5.15e-03 | 9.99e-01 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 64 | 9.43e-01 | 5.14e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 31 | 9.61e-01 | -5.14e-03 | 9.99e-01 |
| GOBP IMPORT INTO CELL | 897 | 7.94e-01 | 5.13e-03 | 9.98e-01 |
| GOCC JUNCTIONAL SARCOPLASMIC RETICULUM MEMBRANE | 9 | 9.79e-01 | 5.11e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 17 | 9.71e-01 | 5.11e-03 | 9.99e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 197 | 9.02e-01 | -5.08e-03 | 9.99e-01 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 437 | 8.56e-01 | 5.08e-03 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 38 | 9.57e-01 | -5.08e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 6 | 9.83e-01 | -5.06e-03 | 1.00e+00 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 122 | 9.23e-01 | 5.05e-03 | 9.99e-01 |
| GOCC CELL CORTEX REGION | 38 | 9.57e-01 | -5.03e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 165 | 9.11e-01 | -5.02e-03 | 9.99e-01 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 967 | 7.92e-01 | 5.01e-03 | 9.98e-01 |
| GOBP NEUTROPHIL DEGRANULATION | 13 | 9.75e-01 | -5.01e-03 | 9.99e-01 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 142 | 9.18e-01 | 5.00e-03 | 9.99e-01 |
| GOBP CELL CYCLE PHASE TRANSITION | 549 | 8.41e-01 | -4.99e-03 | 9.99e-01 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 13 | 9.75e-01 | -4.98e-03 | 9.99e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 953 | 7.95e-01 | -4.98e-03 | 9.98e-01 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 208 | 9.03e-01 | -4.92e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 23 | 9.68e-01 | -4.90e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 336 | 8.77e-01 | -4.90e-03 | 9.99e-01 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 26 | 9.66e-01 | -4.89e-03 | 9.99e-01 |
| GOBP CYTIDINE TO URIDINE EDITING | 12 | 9.77e-01 | -4.89e-03 | 1.00e+00 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 35 | 9.60e-01 | 4.87e-03 | 9.99e-01 |
| GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 8 | 9.81e-01 | 4.84e-03 | 1.00e+00 |
| GOBP RESPONSE TO AMMONIUM ION | 6 | 9.84e-01 | -4.83e-03 | 1.00e+00 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 93 | 9.36e-01 | -4.81e-03 | 9.99e-01 |
| GOMF HSP70 PROTEIN BINDING | 50 | 9.53e-01 | 4.81e-03 | 9.99e-01 |
| GOBP ARGININE CATABOLIC PROCESS | 11 | 9.78e-01 | -4.80e-03 | 1.00e+00 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 485 | 8.57e-01 | -4.77e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CGMP MEDIATED SIGNALING | 5 | 9.85e-01 | 4.73e-03 | 1.00e+00 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 14 | 9.76e-01 | -4.73e-03 | 9.99e-01 |
| GOCC PHAGOCYTIC VESICLE | 131 | 9.26e-01 | -4.72e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 1243 | 7.80e-01 | -4.71e-03 | 9.98e-01 |
| GOCC COP9 SIGNALOSOME | 16 | 9.74e-01 | 4.70e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 15 | 9.75e-01 | -4.70e-03 | 9.99e-01 |
| GOBP RESPONSE TO LIGHT STIMULUS | 302 | 8.89e-01 | -4.67e-03 | 9.99e-01 |
| GOBP ODONTOGENESIS | 126 | 9.28e-01 | 4.66e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 41 | 9.59e-01 | -4.64e-03 | 9.99e-01 |
| GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 9 | 9.81e-01 | -4.63e-03 | 1.00e+00 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE RAFT | 5 | 9.86e-01 | 4.62e-03 | 1.00e+00 |
| GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY | 7 | 9.83e-01 | 4.62e-03 | 1.00e+00 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 19 | 9.72e-01 | 4.61e-03 | 9.99e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 220 | 9.06e-01 | 4.60e-03 | 9.99e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 18 | 9.73e-01 | 4.60e-03 | 9.99e-01 |
| GOBP NERVE DEVELOPMENT | 94 | 9.39e-01 | -4.59e-03 | 9.99e-01 |
| GOBP RESPONSE TO LEAD ION | 19 | 9.73e-01 | -4.55e-03 | 9.99e-01 |
| GOBP PHOTOPERIODISM | 28 | 9.67e-01 | -4.52e-03 | 9.99e-01 |
| GOBP LUTEOLYSIS | 6 | 9.85e-01 | -4.51e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 65 | 9.50e-01 | -4.51e-03 | 9.99e-01 |
| GOMF VITAMIN BINDING | 144 | 9.26e-01 | 4.50e-03 | 9.99e-01 |
| GOCC SYNAPTIC CLEFT | 21 | 9.72e-01 | 4.48e-03 | 9.99e-01 |
| GOBP RESPONSE TO PAIN | 34 | 9.64e-01 | 4.46e-03 | 9.99e-01 |
| GOBP ATP TRANSPORT | 17 | 9.75e-01 | 4.45e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 35 | 9.64e-01 | 4.43e-03 | 9.99e-01 |
| GOCC NUCLEOLUS | 1318 | 7.88e-01 | -4.41e-03 | 9.98e-01 |
| GOBP PROTEIN TARGETING | 316 | 8.93e-01 | -4.39e-03 | 9.99e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 22 | 9.72e-01 | 4.38e-03 | 9.99e-01 |
| GOMF CASPASE BINDING | 13 | 9.78e-01 | -4.37e-03 | 1.00e+00 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 46 | 9.59e-01 | 4.33e-03 | 9.99e-01 |
| GOCC ORGANELLE INNER MEMBRANE | 512 | 8.67e-01 | 4.33e-03 | 9.99e-01 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 53 | 9.57e-01 | 4.32e-03 | 9.99e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 10 | 9.81e-01 | 4.32e-03 | 1.00e+00 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 139 | 9.30e-01 | -4.31e-03 | 9.99e-01 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 935 | 8.25e-01 | 4.28e-03 | 9.98e-01 |
| GOBP PEPTIDE TRANSPORT | 254 | 9.07e-01 | 4.24e-03 | 9.99e-01 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 450 | 8.78e-01 | -4.23e-03 | 9.99e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 114 | 9.38e-01 | 4.22e-03 | 9.99e-01 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 1417 | 7.92e-01 | -4.19e-03 | 9.98e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION | 467 | 8.77e-01 | 4.19e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 60 | 9.55e-01 | -4.18e-03 | 9.99e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 89 | 9.46e-01 | 4.17e-03 | 9.99e-01 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 325 | 8.97e-01 | -4.17e-03 | 9.99e-01 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 108 | 9.40e-01 | -4.16e-03 | 9.99e-01 |
| GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 17 | 9.76e-01 | -4.16e-03 | 1.00e+00 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 64 | 9.54e-01 | -4.14e-03 | 9.99e-01 |
| GOBP RENAL SYSTEM DEVELOPMENT | 316 | 8.99e-01 | -4.14e-03 | 9.99e-01 |
| GOMF ACETYLCHOLINE GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY | 22 | 9.73e-01 | 4.13e-03 | 9.99e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 44 | 9.62e-01 | 4.12e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 1065 | 8.21e-01 | 4.09e-03 | 9.98e-01 |
| GOMF GLUCOSE BINDING | 10 | 9.82e-01 | -4.09e-03 | 1.00e+00 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 340 | 8.97e-01 | 4.09e-03 | 9.99e-01 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 90 | 9.46e-01 | -4.09e-03 | 9.99e-01 |
| GOBP LIPID METABOLIC PROCESS | 1343 | 8.02e-01 | -4.08e-03 | 9.98e-01 |
| GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 11 | 9.81e-01 | 4.07e-03 | 1.00e+00 |
| GOBP RESPONSE TO SELENIUM ION | 8 | 9.84e-01 | -4.06e-03 | 1.00e+00 |
| GOBP SECRETION | 923 | 8.36e-01 | -4.01e-03 | 9.99e-01 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 137 | 9.36e-01 | -4.00e-03 | 9.99e-01 |
| GOBP AMINO ACID METABOLIC PROCESS | 277 | 9.09e-01 | 4.00e-03 | 9.99e-01 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 542 | 8.74e-01 | -3.99e-03 | 9.99e-01 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 54 | 9.60e-01 | -3.97e-03 | 9.99e-01 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 85 | 9.50e-01 | -3.97e-03 | 9.99e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 717 | 8.57e-01 | -3.96e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 82 | 9.51e-01 | 3.94e-03 | 9.99e-01 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 63 | 9.57e-01 | 3.93e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 71 | 9.54e-01 | -3.92e-03 | 9.99e-01 |
| GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 10 | 9.83e-01 | 3.91e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF GROWTH | 233 | 9.18e-01 | 3.91e-03 | 9.99e-01 |
| GOCC CYTOSOLIC RIBOSOME | 107 | 9.45e-01 | -3.89e-03 | 9.99e-01 |
| GOCC CEREBELLAR MOSSY FIBER | 7 | 9.86e-01 | 3.88e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS | 5 | 9.88e-01 | 3.86e-03 | 1.00e+00 |
| GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 298 | 9.09e-01 | 3.85e-03 | 9.99e-01 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 201 | 9.25e-01 | -3.84e-03 | 9.99e-01 |
| GOCC CELL DIVISION SITE | 70 | 9.56e-01 | -3.83e-03 | 9.99e-01 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 248 | 9.18e-01 | 3.80e-03 | 9.99e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 23 | 9.75e-01 | -3.80e-03 | 9.99e-01 |
| GOCC JUXTAPARANODE REGION OF AXON | 12 | 9.82e-01 | 3.79e-03 | 1.00e+00 |
| GOBP T CELL MEDIATED IMMUNITY | 121 | 9.43e-01 | -3.78e-03 | 9.99e-01 |
| GOBP SEX DETERMINATION | 18 | 9.78e-01 | -3.77e-03 | 1.00e+00 |
| GOBP TRANSLATIONAL INITIATION | 110 | 9.46e-01 | -3.75e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 120 | 9.43e-01 | 3.75e-03 | 9.99e-01 |
| GOBP LOCOMOTION | 1260 | 8.23e-01 | 3.74e-03 | 9.98e-01 |
| GOMF PROTEASE BINDING | 139 | 9.39e-01 | 3.73e-03 | 9.99e-01 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 17 | 9.79e-01 | -3.71e-03 | 1.00e+00 |
| GOBP REGULATION OF WOUND HEALING | 129 | 9.42e-01 | -3.70e-03 | 9.99e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 111 | 9.46e-01 | -3.70e-03 | 9.99e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 102 | 9.49e-01 | -3.69e-03 | 9.99e-01 |
| GOBP LIPID STORAGE | 93 | 9.51e-01 | -3.67e-03 | 9.99e-01 |
| GOBP REGULATION OF CELL ADHESION | 771 | 8.63e-01 | 3.64e-03 | 9.99e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 325 | 9.10e-01 | 3.63e-03 | 9.99e-01 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 94 | 9.52e-01 | 3.63e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 100 | 9.50e-01 | 3.63e-03 | 9.99e-01 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 40 | 9.68e-01 | -3.62e-03 | 9.99e-01 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING | 10 | 9.84e-01 | 3.62e-03 | 1.00e+00 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 271 | 9.18e-01 | 3.61e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 354 | 9.07e-01 | 3.61e-03 | 9.99e-01 |
| GOCC LATE ENDOSOME MEMBRANE | 165 | 9.36e-01 | 3.61e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 50 | 9.65e-01 | 3.60e-03 | 9.99e-01 |
| GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 24 | 9.76e-01 | -3.60e-03 | 9.99e-01 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 387 | 9.03e-01 | -3.59e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 27 | 9.74e-01 | 3.57e-03 | 9.99e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 39 | 9.69e-01 | -3.55e-03 | 9.99e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 29 | 9.74e-01 | 3.54e-03 | 9.99e-01 |
| GOCC SEH1 ASSOCIATED COMPLEX | 8 | 9.86e-01 | 3.53e-03 | 1.00e+00 |
| GOBP THORAX AND ANTERIOR ABDOMEN DETERMINATION | 5 | 9.89e-01 | -3.53e-03 | 1.00e+00 |
| GOCC ENDONUCLEASE COMPLEX | 37 | 9.70e-01 | -3.53e-03 | 9.99e-01 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 123 | 9.46e-01 | 3.52e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 90 | 9.54e-01 | 3.52e-03 | 9.99e-01 |
| GOBP ORGANELLE FUSION | 156 | 9.40e-01 | -3.50e-03 | 9.99e-01 |
| GOMF BETA TUBULIN BINDING | 35 | 9.71e-01 | -3.50e-03 | 9.99e-01 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 206 | 9.31e-01 | -3.50e-03 | 9.99e-01 |
| GOBP ACUTE PHASE RESPONSE | 46 | 9.67e-01 | 3.49e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 31 | 9.73e-01 | 3.46e-03 | 9.99e-01 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 25 | 9.76e-01 | 3.41e-03 | 1.00e+00 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 376 | 9.10e-01 | -3.40e-03 | 9.99e-01 |
| GOBP REGULATION OF ENDOCYTOSIS | 281 | 9.22e-01 | 3.38e-03 | 9.99e-01 |
| GOBP LEUKOCYTE AGGREGATION | 12 | 9.84e-01 | 3.32e-03 | 1.00e+00 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 8 | 9.87e-01 | 3.31e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 8 | 9.87e-01 | -3.31e-03 | 1.00e+00 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1735 | 8.19e-01 | 3.30e-03 | 9.98e-01 |
| GOBP NK T CELL ACTIVATION | 12 | 9.84e-01 | -3.28e-03 | 1.00e+00 |
| GOBP METANEPHRIC TUBULE FORMATION | 6 | 9.89e-01 | 3.28e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 6 | 9.89e-01 | 3.28e-03 | 1.00e+00 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 24 | 9.78e-01 | 3.27e-03 | 1.00e+00 |
| GOCC CELL SUBSTRATE JUNCTION | 418 | 9.09e-01 | 3.27e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 179 | 9.40e-01 | 3.27e-03 | 9.99e-01 |
| GOBP FOLATE TRANSMEMBRANE TRANSPORT | 5 | 9.90e-01 | 3.25e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 24 | 9.78e-01 | 3.25e-03 | 1.00e+00 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 20 | 9.80e-01 | -3.25e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 139 | 9.47e-01 | 3.24e-03 | 9.99e-01 |
| GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 10 | 9.86e-01 | -3.22e-03 | 1.00e+00 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 15 | 9.83e-01 | 3.20e-03 | 1.00e+00 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 247 | 9.31e-01 | 3.18e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 60 | 9.66e-01 | 3.18e-03 | 9.99e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 31 | 9.76e-01 | -3.18e-03 | 9.99e-01 |
| GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 14 | 9.84e-01 | -3.17e-03 | 1.00e+00 |
| GOBP REGULATION OF SYSTEM PROCESS | 539 | 9.01e-01 | -3.15e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 65 | 9.65e-01 | 3.15e-03 | 9.99e-01 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 252 | 9.33e-01 | 3.09e-03 | 9.99e-01 |
| GOBP MUSCLE CONTRACTION | 338 | 9.23e-01 | -3.07e-03 | 9.99e-01 |
| GOBP CELLULAR HYPEROSMOTIC RESPONSE | 19 | 9.82e-01 | 3.06e-03 | 1.00e+00 |
| GOBP RESPONSE TO VITAMIN D | 36 | 9.75e-01 | 3.05e-03 | 9.99e-01 |
| GOMF LYASE ACTIVITY | 190 | 9.43e-01 | -3.03e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 50 | 9.70e-01 | -3.03e-03 | 9.99e-01 |
| GOBP SKIN DEVELOPMENT | 306 | 9.28e-01 | -3.00e-03 | 9.99e-01 |
| GOBP CELL PROJECTION ORGANIZATION | 1539 | 8.45e-01 | -2.99e-03 | 9.99e-01 |
| GOCC AMPHISOME | 13 | 9.85e-01 | -2.97e-03 | 1.00e+00 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 42 | 9.74e-01 | 2.95e-03 | 9.99e-01 |
| GOCC CLATHRIN COATED VESICLE | 201 | 9.43e-01 | -2.95e-03 | 9.99e-01 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 29 | 9.78e-01 | 2.94e-03 | 1.00e+00 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 18 | 9.83e-01 | 2.93e-03 | 1.00e+00 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 146 | 9.52e-01 | -2.89e-03 | 9.99e-01 |
| GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 27 | 9.79e-01 | 2.88e-03 | 1.00e+00 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 22 | 9.81e-01 | 2.87e-03 | 1.00e+00 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 12 | 9.86e-01 | -2.84e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 72 | 9.67e-01 | 2.84e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 39 | 9.76e-01 | -2.83e-03 | 9.99e-01 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 11 | 9.87e-01 | 2.83e-03 | 1.00e+00 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 11 | 9.87e-01 | 2.79e-03 | 1.00e+00 |
| GOCC NEURON PROJECTION | 1246 | 8.68e-01 | -2.79e-03 | 9.99e-01 |
| GOCC TRANSPORTER COMPLEX | 391 | 9.25e-01 | -2.78e-03 | 9.99e-01 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 127 | 9.57e-01 | 2.78e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 101 | 9.62e-01 | 2.71e-03 | 9.99e-01 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 208 | 9.46e-01 | -2.70e-03 | 9.99e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 24 | 9.82e-01 | -2.69e-03 | 1.00e+00 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 29 | 9.80e-01 | -2.69e-03 | 1.00e+00 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 29 | 9.80e-01 | -2.69e-03 | 1.00e+00 |
| GOBP LIPID HOMEOSTASIS | 169 | 9.52e-01 | 2.66e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 25 | 9.82e-01 | -2.65e-03 | 1.00e+00 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 86 | 9.66e-01 | -2.64e-03 | 9.99e-01 |
| GOMF EXOGENOUS PROTEIN BINDING | 78 | 9.68e-01 | 2.64e-03 | 9.99e-01 |
| GOMF LIPASE INHIBITOR ACTIVITY | 18 | 9.85e-01 | -2.60e-03 | 1.00e+00 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 78 | 9.68e-01 | -2.60e-03 | 9.99e-01 |
| GOBP POSTREPLICATION REPAIR | 33 | 9.80e-01 | -2.58e-03 | 1.00e+00 |
| GOBP SYNAPSE MATURATION | 33 | 9.80e-01 | 2.57e-03 | 1.00e+00 |
| GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING | 8 | 9.90e-01 | 2.56e-03 | 1.00e+00 |
| GOBP PINOCYTOSIS | 22 | 9.83e-01 | -2.56e-03 | 1.00e+00 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 34 | 9.79e-01 | 2.56e-03 | 1.00e+00 |
| GOBP CYTOKINETIC PROCESS | 42 | 9.77e-01 | -2.56e-03 | 1.00e+00 |
| GOCC ESCRT COMPLEX | 27 | 9.82e-01 | -2.52e-03 | 1.00e+00 |
| GOBP NATURAL KILLER CELL ACTIVATION | 91 | 9.67e-01 | 2.51e-03 | 9.99e-01 |
| GOMF GAMMA AMINOBUTYRIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 9.90e-01 | 2.51e-03 | 1.00e+00 |
| GOMF CLATHRIN HEAVY CHAIN BINDING | 10 | 9.89e-01 | 2.48e-03 | 1.00e+00 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 9 | 9.90e-01 | -2.48e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 6 | 9.92e-01 | -2.48e-03 | 1.00e+00 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 15 | 9.87e-01 | -2.47e-03 | 1.00e+00 |
| GOBP INTERLEUKIN 2 PRODUCTION | 59 | 9.74e-01 | 2.46e-03 | 9.99e-01 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 59 | 9.74e-01 | 2.46e-03 | 9.99e-01 |
| GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 5 | 9.92e-01 | 2.43e-03 | 1.00e+00 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 16 | 9.87e-01 | -2.43e-03 | 1.00e+00 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 19 | 9.85e-01 | 2.42e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 61 | 9.74e-01 | -2.41e-03 | 9.99e-01 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 1268 | 8.85e-01 | 2.41e-03 | 9.99e-01 |
| GOBP TRANSEPITHELIAL TRANSPORT | 34 | 9.81e-01 | 2.41e-03 | 1.00e+00 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 780 | 9.09e-01 | -2.41e-03 | 9.99e-01 |
| GOBP REGULATION OF CELL GROWTH | 397 | 9.35e-01 | 2.40e-03 | 9.99e-01 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1758 | 8.67e-01 | 2.40e-03 | 9.99e-01 |
| GOCC LYSOSOMAL LUMEN | 91 | 9.68e-01 | -2.40e-03 | 9.99e-01 |
| GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT | 6 | 9.92e-01 | 2.39e-03 | 1.00e+00 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 240 | 9.49e-01 | 2.39e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO ZINC ION | 23 | 9.84e-01 | -2.38e-03 | 1.00e+00 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 46 | 9.78e-01 | -2.37e-03 | 1.00e+00 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DEVELOPMENT | 5 | 9.93e-01 | 2.36e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 297 | 9.45e-01 | -2.35e-03 | 9.99e-01 |
| GOBP OSTEOCLAST DIFFERENTIATION | 103 | 9.67e-01 | -2.34e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 10 | 9.90e-01 | -2.33e-03 | 1.00e+00 |
| GOBP PENTOSE METABOLIC PROCESS | 11 | 9.89e-01 | -2.33e-03 | 1.00e+00 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 655 | 9.20e-01 | -2.30e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 25 | 9.84e-01 | -2.30e-03 | 1.00e+00 |
| GOCC SYNAPTIC MEMBRANE | 368 | 9.40e-01 | -2.29e-03 | 9.99e-01 |
| GOCC ESC E Z COMPLEX | 9 | 9.91e-01 | -2.26e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 110 | 9.67e-01 | -2.26e-03 | 9.99e-01 |
| GOBP NCRNA EXPORT FROM NUCLEUS | 9 | 9.91e-01 | -2.25e-03 | 1.00e+00 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 156 | 9.61e-01 | -2.25e-03 | 9.99e-01 |
| GOBP TISSUE MIGRATION | 364 | 9.41e-01 | 2.25e-03 | 9.99e-01 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 14 | 9.89e-01 | -2.18e-03 | 1.00e+00 |
| GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 27 | 9.84e-01 | -2.18e-03 | 1.00e+00 |
| GOBP DEVELOPMENTAL GROWTH | 629 | 9.26e-01 | 2.18e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO LIPID | 591 | 9.28e-01 | 2.17e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 19 | 9.87e-01 | 2.17e-03 | 1.00e+00 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 17 | 9.88e-01 | -2.16e-03 | 1.00e+00 |
| GOCC CELL BODY | 529 | 9.33e-01 | -2.15e-03 | 9.99e-01 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 140 | 9.65e-01 | 2.14e-03 | 9.99e-01 |
| GOMF NEUREXIN FAMILY PROTEIN BINDING | 9 | 9.91e-01 | -2.13e-03 | 1.00e+00 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 13 | 9.89e-01 | 2.13e-03 | 1.00e+00 |
| GOBP DETOXIFICATION OF COPPER ION | 15 | 9.89e-01 | 2.09e-03 | 1.00e+00 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 152 | 9.65e-01 | -2.08e-03 | 9.99e-01 |
| GOBP REGULATION OF HISTONE DEACETYLATION | 5 | 9.94e-01 | 2.07e-03 | 1.00e+00 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 8 | 9.92e-01 | 2.05e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 48 | 9.81e-01 | -2.04e-03 | 1.00e+00 |
| GOCC DISTAL AXON | 261 | 9.55e-01 | 2.03e-03 | 9.99e-01 |
| GOBP MUSCULAR SEPTUM MORPHOGENESIS | 5 | 9.94e-01 | 2.01e-03 | 1.00e+00 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 9 | 9.92e-01 | -2.01e-03 | 1.00e+00 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR | 14 | 9.90e-01 | 2.00e-03 | 1.00e+00 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 172 | 9.64e-01 | -2.00e-03 | 9.99e-01 |
| GOBP CATECHOLAMINE SECRETION | 60 | 9.79e-01 | 1.98e-03 | 1.00e+00 |
| GOBP RECEPTOR TRANSACTIVATION | 5 | 9.94e-01 | 1.98e-03 | 1.00e+00 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 165 | 9.65e-01 | 1.95e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 658 | 9.33e-01 | -1.92e-03 | 9.99e-01 |
| GOBP RNA STABILIZATION | 66 | 9.79e-01 | 1.92e-03 | 1.00e+00 |
| GOBP TORC2 SIGNALING | 12 | 9.91e-01 | -1.90e-03 | 1.00e+00 |
| GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 6 | 9.94e-01 | -1.90e-03 | 1.00e+00 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 116 | 9.72e-01 | 1.89e-03 | 9.99e-01 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 563 | 9.40e-01 | -1.86e-03 | 9.99e-01 |
| GOBP RESPONSE TO STARVATION | 208 | 9.64e-01 | 1.82e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 143 | 9.70e-01 | -1.81e-03 | 9.99e-01 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 23 | 9.88e-01 | -1.79e-03 | 1.00e+00 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 587 | 9.42e-01 | -1.74e-03 | 9.99e-01 |
| GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 12 | 9.92e-01 | -1.73e-03 | 1.00e+00 |
| GOBP MAST CELL ACTIVATION | 66 | 9.81e-01 | 1.73e-03 | 1.00e+00 |
| GOBP REGULATION OF MICROTUBULE NUCLEATION | 17 | 9.90e-01 | -1.73e-03 | 1.00e+00 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 254 | 9.63e-01 | -1.71e-03 | 9.99e-01 |
| GOBP MAINTENANCE OF LOCATION | 334 | 9.57e-01 | -1.71e-03 | 9.99e-01 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 26 | 9.88e-01 | -1.71e-03 | 1.00e+00 |
| GOCC TRANSCRIPTION FACTOR TFIIA COMPLEX | 5 | 9.95e-01 | -1.70e-03 | 1.00e+00 |
| GOBP RESPONSE TO ALKALOID | 90 | 9.78e-01 | 1.69e-03 | 1.00e+00 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 41 | 9.85e-01 | -1.68e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 39 | 9.86e-01 | 1.68e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 395 | 9.56e-01 | -1.60e-03 | 9.99e-01 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 54 | 9.84e-01 | -1.60e-03 | 1.00e+00 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 290 | 9.63e-01 | 1.59e-03 | 9.99e-01 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 55 | 9.84e-01 | -1.58e-03 | 1.00e+00 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 40 | 9.87e-01 | 1.54e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 689 | 9.45e-01 | -1.54e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 48 | 9.85e-01 | 1.52e-03 | 1.00e+00 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 15 | 9.92e-01 | 1.52e-03 | 1.00e+00 |
| GOBP REGULATION OF SENSORY PERCEPTION | 17 | 9.91e-01 | -1.51e-03 | 1.00e+00 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 39 | 9.87e-01 | -1.50e-03 | 1.00e+00 |
| GOBP RESPONSE TO HORMONE | 838 | 9.42e-01 | 1.47e-03 | 9.99e-01 |
| GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 60 | 9.84e-01 | -1.46e-03 | 1.00e+00 |
| GOCC PROTEIN LIPID COMPLEX | 38 | 9.88e-01 | -1.42e-03 | 1.00e+00 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 298 | 9.67e-01 | -1.40e-03 | 9.99e-01 |
| GOMF TYPE 1 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 5 | 9.96e-01 | -1.39e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 26 | 9.90e-01 | -1.39e-03 | 1.00e+00 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 116 | 9.79e-01 | 1.39e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 96 | 9.81e-01 | 1.38e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 9.95e-01 | 1.37e-03 | 1.00e+00 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 18 | 9.92e-01 | -1.36e-03 | 1.00e+00 |
| GOBP AMINE TRANSPORT | 106 | 9.81e-01 | 1.35e-03 | 1.00e+00 |
| GOBP PODOSOME ASSEMBLY | 19 | 9.92e-01 | 1.35e-03 | 1.00e+00 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 283 | 9.69e-01 | 1.35e-03 | 9.99e-01 |
| GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 7 | 9.95e-01 | 1.32e-03 | 1.00e+00 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 25 | 9.91e-01 | -1.32e-03 | 1.00e+00 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 51 | 9.87e-01 | 1.32e-03 | 1.00e+00 |
| GOBP POTASSIUM ION HOMEOSTASIS | 34 | 9.89e-01 | -1.32e-03 | 1.00e+00 |
| GOBP CALCIUM ION HOMEOSTASIS | 319 | 9.68e-01 | -1.30e-03 | 9.99e-01 |
| GOCC PRESYNAPSE | 539 | 9.59e-01 | -1.29e-03 | 9.99e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 42 | 9.89e-01 | 1.28e-03 | 1.00e+00 |
| GOCC GOLGI TRANS CISTERNA | 9 | 9.95e-01 | 1.25e-03 | 1.00e+00 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 35 | 9.90e-01 | 1.25e-03 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 161 | 9.78e-01 | 1.24e-03 | 1.00e+00 |
| GOBP RESPONSE TO WOUNDING | 538 | 9.62e-01 | -1.20e-03 | 9.99e-01 |
| GOBP CARTILAGE DEVELOPMENT | 199 | 9.77e-01 | 1.17e-03 | 1.00e+00 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 155 | 9.80e-01 | -1.17e-03 | 1.00e+00 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 89 | 9.85e-01 | 1.16e-03 | 1.00e+00 |
| GOMF INTRACELLULAR CAMP ACTIVATED CATION CHANNEL ACTIVITY | 8 | 9.96e-01 | 1.15e-03 | 1.00e+00 |
| GOBP INTERMEMBRANE LIPID TRANSFER | 54 | 9.88e-01 | -1.14e-03 | 1.00e+00 |
| GOMF LIPID TRANSFER ACTIVITY | 54 | 9.88e-01 | -1.14e-03 | 1.00e+00 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 131 | 9.82e-01 | 1.14e-03 | 1.00e+00 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 298 | 9.73e-01 | 1.13e-03 | 9.99e-01 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 119 | 9.83e-01 | 1.10e-03 | 1.00e+00 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 13 | 9.95e-01 | 1.10e-03 | 1.00e+00 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 53 | 9.89e-01 | -1.05e-03 | 1.00e+00 |
| GOMF SNRNA BINDING | 48 | 9.90e-01 | 1.05e-03 | 1.00e+00 |
| GOCC LEADING EDGE MEMBRANE | 174 | 9.81e-01 | 1.04e-03 | 1.00e+00 |
| GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 9.96e-01 | 1.04e-03 | 1.00e+00 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 23 | 9.93e-01 | -1.03e-03 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 42 | 9.91e-01 | -1.02e-03 | 1.00e+00 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 30 | 9.92e-01 | 1.02e-03 | 1.00e+00 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 106 | 9.86e-01 | 1.00e-03 | 1.00e+00 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 21 | 9.94e-01 | -1.00e-03 | 1.00e+00 |
| GOBP REGULATION OF PROTEOLYSIS | 587 | 9.68e-01 | 9.67e-04 | 9.99e-01 |
| GOBP EXPORT FROM CELL | 867 | 9.62e-01 | 9.64e-04 | 9.99e-01 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 15 | 9.95e-01 | -9.46e-04 | 1.00e+00 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 92 | 9.88e-01 | 9.40e-04 | 1.00e+00 |
| GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 10 | 9.96e-01 | -9.39e-04 | 1.00e+00 |
| GOBP VASODILATION | 46 | 9.91e-01 | -9.39e-04 | 1.00e+00 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 9 | 9.96e-01 | 9.27e-04 | 1.00e+00 |
| GOCC INTERSTITIAL MATRIX | 11 | 9.96e-01 | -8.91e-04 | 1.00e+00 |
| GOBP MUSCLE CELL MIGRATION | 100 | 9.88e-01 | -8.79e-04 | 1.00e+00 |
| GOBP RESPONSE TO GONADOTROPIN RELEASING HORMONE | 7 | 9.97e-01 | -8.66e-04 | 1.00e+00 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 64 | 9.91e-01 | 8.51e-04 | 1.00e+00 |
| GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 6 | 9.97e-01 | 8.36e-04 | 1.00e+00 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 271 | 9.81e-01 | 8.27e-04 | 1.00e+00 |
| GOBP AXON GUIDANCE | 223 | 9.83e-01 | 8.22e-04 | 1.00e+00 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 57 | 9.92e-01 | -8.10e-04 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 9 | 9.97e-01 | 7.95e-04 | 1.00e+00 |
| GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 13 | 9.96e-01 | -7.89e-04 | 1.00e+00 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 9 | 9.97e-01 | 7.75e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 6 | 9.97e-01 | -7.60e-04 | 1.00e+00 |
| GOCC TRAPPII PROTEIN COMPLEX | 11 | 9.97e-01 | -7.34e-04 | 1.00e+00 |
| GOBP GLYCOSYLATION | 214 | 9.85e-01 | 7.30e-04 | 1.00e+00 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 579 | 9.76e-01 | -7.29e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 142 | 9.88e-01 | 7.15e-04 | 1.00e+00 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 10 | 9.97e-01 | -7.11e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 26 | 9.95e-01 | -7.02e-04 | 1.00e+00 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 155 | 9.88e-01 | 6.98e-04 | 1.00e+00 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 34 | 9.94e-01 | -6.87e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 67 | 9.92e-01 | 6.69e-04 | 1.00e+00 |
| GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 6 | 9.98e-01 | 6.69e-04 | 1.00e+00 |
| GOBP MAMMARY GLAND DEVELOPMENT | 125 | 9.90e-01 | -6.63e-04 | 1.00e+00 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 322 | 9.84e-01 | 6.61e-04 | 1.00e+00 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 75 | 9.92e-01 | -6.49e-04 | 1.00e+00 |
| GOBP LEUKOCYTE MIGRATION | 380 | 9.83e-01 | -6.37e-04 | 1.00e+00 |
| GOBP EPITHELIUM DEVELOPMENT | 1196 | 9.71e-01 | -6.16e-04 | 9.99e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 46 | 9.95e-01 | -5.80e-04 | 1.00e+00 |
| GOBP REGULATION OF LIPID STORAGE | 54 | 9.94e-01 | 5.69e-04 | 1.00e+00 |
| GOCC CYTOPLASMIC REGION | 277 | 9.87e-01 | 5.53e-04 | 1.00e+00 |
| GOCC CILIARY MEMBRANE | 72 | 9.94e-01 | -5.47e-04 | 1.00e+00 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 23 | 9.97e-01 | -5.26e-04 | 1.00e+00 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 9.96e-01 | -5.21e-04 | 1.00e+00 |
| GOBP COENZYME A METABOLIC PROCESS | 19 | 9.97e-01 | -5.16e-04 | 1.00e+00 |
| GOBP MDA 5 SIGNALING PATHWAY | 11 | 9.98e-01 | 5.06e-04 | 1.00e+00 |
| GOBP CHEMICAL HOMEOSTASIS | 992 | 9.79e-01 | 5.03e-04 | 1.00e+00 |
| GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 9 | 9.98e-01 | -5.02e-04 | 1.00e+00 |
| GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 9.98e-01 | 4.60e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 16 | 9.97e-01 | 4.56e-04 | 1.00e+00 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 24 | 9.97e-01 | -4.52e-04 | 1.00e+00 |
| GOBP SUPEROXIDE ANION GENERATION | 36 | 9.96e-01 | -4.34e-04 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 67 | 9.95e-01 | 4.20e-04 | 1.00e+00 |
| GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 53 | 9.96e-01 | 4.11e-04 | 1.00e+00 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 14 | 9.98e-01 | 4.04e-04 | 1.00e+00 |
| GOBP DE NOVO PROTEIN FOLDING | 41 | 9.96e-01 | -4.00e-04 | 1.00e+00 |
| GOBP CELL CELL SIGNALING BY WNT | 441 | 9.89e-01 | -3.73e-04 | 1.00e+00 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 257 | 9.92e-01 | -3.72e-04 | 1.00e+00 |
| GOCC COATED VESICLE | 296 | 9.91e-01 | 3.69e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 380 | 9.91e-01 | 3.46e-04 | 1.00e+00 |
| GOBP EMBRYO IMPLANTATION | 57 | 9.97e-01 | 2.80e-04 | 1.00e+00 |
| GOBP CELLULAR EXTRAVASATION | 71 | 9.97e-01 | -2.79e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 157 | 9.95e-01 | 2.68e-04 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 11 | 9.99e-01 | -2.61e-04 | 1.00e+00 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 15 | 9.99e-01 | -2.52e-04 | 1.00e+00 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 478 | 9.93e-01 | -2.24e-04 | 1.00e+00 |
| GOBP CRANIAL NERVE DEVELOPMENT | 61 | 9.98e-01 | -2.12e-04 | 1.00e+00 |
| GOBP VESICLE COATING | 38 | 9.98e-01 | 2.09e-04 | 1.00e+00 |
| GOBP REGULATION OF HIPPO SIGNALING | 25 | 9.99e-01 | 1.99e-04 | 1.00e+00 |
| GOBP RESPONSE TO STEROID HORMONE | 317 | 9.95e-01 | 1.91e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 24 | 9.99e-01 | -1.71e-04 | 1.00e+00 |
| GOMF RNA POLYMERASE ACTIVITY | 31 | 9.99e-01 | 1.69e-04 | 1.00e+00 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 89 | 9.98e-01 | -1.54e-04 | 1.00e+00 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 15 | 9.99e-01 | 1.37e-04 | 1.00e+00 |
| GOCC POSTSYNAPTIC ENDOSOME | 13 | 9.99e-01 | -1.30e-04 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 307 | 9.97e-01 | 1.27e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 40 | 9.99e-01 | -1.26e-04 | 1.00e+00 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 84 | 9.98e-01 | 1.24e-04 | 1.00e+00 |
| GOBP NEPHRON DEVELOPMENT | 152 | 9.98e-01 | -1.20e-04 | 1.00e+00 |
| GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 1.00e+00 | 1.03e-04 | 1.00e+00 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 148 | 9.98e-01 | 9.86e-05 | 1.00e+00 |
| GOCC NON MOTILE CILIUM | 152 | 9.99e-01 | -8.03e-05 | 1.00e+00 |
| GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 88 | 9.99e-01 | 7.80e-05 | 1.00e+00 |
| GOBP CENTRIOLE ASSEMBLY | 47 | 9.99e-01 | 7.68e-05 | 1.00e+00 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 412 | 9.99e-01 | -4.53e-05 | 1.00e+00 |
| GOBP HOMEOSTATIC PROCESS | 1655 | 9.98e-01 | -3.53e-05 | 1.00e+00 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 23 | 1.00e+00 | -3.37e-05 | 1.00e+00 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 1213 | 9.99e-01 | -2.32e-05 | 1.00e+00 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 19 | 1.00e+00 | 1.68e-05 | 1.00e+00 |
Detailed Gene set reports
GOBP_CHORIONIC_TROPHOBLAST_CELL_PROLIFERATION
| set | GOBP_CHORIONIC_TROPHOBLAST_CELL_PROLIFERATION |
| setSize | 5 |
| pANOVA | 0.000541 |
| s.dist | 0.893 |
| p.adjustANOVA | 0.136 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| INSL4 | 9231 |
| FZD5 | 9176 |
| NODAL | 8753 |
| ACVR1C | 7835 |
| BOK | 7071 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| INSL4 | 9231 |
| FZD5 | 9176 |
| NODAL | 8753 |
| ACVR1C | 7835 |
| BOK | 7071 |
GOMF_PEPTIDOGLYCAN_IMMUNE_RECEPTOR_ACTIVITY
| set | GOMF_PEPTIDOGLYCAN_IMMUNE_RECEPTOR_ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00224 |
| s.dist | -0.789 |
| p.adjustANOVA | 0.295 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PGLYRP2 | -10719 |
| PGLYRP3 | -10183 |
| PGLYRP1 | -10062 |
| CD14 | -9848 |
| PGLYRP4 | -9397 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PGLYRP2 | -10719 |
| PGLYRP3 | -10183 |
| PGLYRP1 | -10062 |
| CD14 | -9848 |
| PGLYRP4 | -9397 |
GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY
| set | GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY |
| setSize | 8 |
| pANOVA | 6e-04 |
| s.dist | -0.701 |
| p.adjustANOVA | 0.138 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MIRLET7E | -11779 |
| MIR125B1 | -11712 |
| MIR125A | -11679 |
| MIR99A | -11182 |
| MIRLET7A1 | -10597 |
| MIRLET7C | -8481 |
| MIR26A1 | -7905 |
| PTPN2 | 793 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MIRLET7E | -11779 |
| MIR125B1 | -11712 |
| MIR125A | -11679 |
| MIR99A | -11182 |
| MIRLET7A1 | -10597 |
| MIRLET7C | -8481 |
| MIR26A1 | -7905 |
| PTPN2 | 793 |
GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION_INVOLVED_IN_NEPHRON_DEVELOPMENT
| set | GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION_INVOLVED_IN_NEPHRON_DEVELOPMENT |
| setSize | 5 |
| pANOVA | 0.00826 |
| s.dist | 0.682 |
| p.adjustANOVA | 0.542 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IRX3 | 7904 |
| OSR1 | 7373 |
| IRX2 | 6572 |
| IRX1 | 4987 |
| HES5 | 3648 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IRX3 | 7904 |
| OSR1 | 7373 |
| IRX2 | 6572 |
| IRX1 | 4987 |
| HES5 | 3648 |
GOCC_FC_RECEPTOR_COMPLEX
| set | GOCC_FC_RECEPTOR_COMPLEX |
| setSize | 5 |
| pANOVA | 0.00858 |
| s.dist | 0.679 |
| p.adjustANOVA | 0.544 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FCER1G | 9314 |
| FCGR3A | 9009 |
| LILRA4 | 8927 |
| CD247 | 3266 |
| MS4A2 | -219 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FCER1G | 9314 |
| FCGR3A | 9009 |
| LILRA4 | 8927 |
| CD247 | 3266 |
| MS4A2 | -219 |
GOBP_XYLULOSE_5_PHOSPHATE_METABOLIC_PROCESS
| set | GOBP_XYLULOSE_5_PHOSPHATE_METABOLIC_PROCESS |
| setSize | 6 |
| pANOVA | 0.00517 |
| s.dist | 0.659 |
| p.adjustANOVA | 0.433 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TKT | 8665 |
| SORD | 8017 |
| AKR1A1 | 7345 |
| CRYL1 | 5921 |
| DCXR | 5404 |
| XYLB | -286 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TKT | 8665 |
| SORD | 8017 |
| AKR1A1 | 7345 |
| CRYL1 | 5921 |
| DCXR | 5404 |
| XYLB | -286 |
GOBP_PEPTIDOGLYCAN_METABOLIC_PROCESS
| set | GOBP_PEPTIDOGLYCAN_METABOLIC_PROCESS |
| setSize | 6 |
| pANOVA | 0.00627 |
| s.dist | -0.644 |
| p.adjustANOVA | 0.472 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PGLYRP2 | -10719 |
| PGLYRP3 | -10183 |
| PGLYRP1 | -10062 |
| PGLYRP4 | -9397 |
| LYG2 | -6359 |
| LYG1 | -3986 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PGLYRP2 | -10719 |
| PGLYRP3 | -10183 |
| PGLYRP1 | -10062 |
| PGLYRP4 | -9397 |
| LYG2 | -6359 |
| LYG1 | -3986 |
GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS
| set | GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS |
| setSize | 5 |
| pANOVA | 0.0139 |
| s.dist | 0.635 |
| p.adjustANOVA | 0.625 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PPARG | 8310 |
| IL4 | 8031 |
| DLX1 | 7107 |
| MIR29B1 | 4820 |
| CFLAR | -347 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PPARG | 8310 |
| IL4 | 8031 |
| DLX1 | 7107 |
| MIR29B1 | 4820 |
| CFLAR | -347 |
GOCC_CLATHRIN_COMPLEX
| set | GOCC_CLATHRIN_COMPLEX |
| setSize | 6 |
| pANOVA | 0.00752 |
| s.dist | -0.63 |
| p.adjustANOVA | 0.513 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SCN10A | -11480 |
| BAIAP2L2 | -9976 |
| CLTA | -9859 |
| CLTCL1 | -9696 |
| SCLT1 | -8106 |
| CLTC | -656 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SCN10A | -11480 |
| BAIAP2L2 | -9976 |
| CLTA | -9859 |
| CLTCL1 | -9696 |
| SCLT1 | -8106 |
| CLTC | -656 |
GOCC_B_CELL_RECEPTOR_COMPLEX
| set | GOCC_B_CELL_RECEPTOR_COMPLEX |
| setSize | 5 |
| pANOVA | 0.0163 |
| s.dist | 0.62 |
| p.adjustANOVA | 0.628 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CD79B | 8712 |
| TMIGD2 | 7559 |
| LIME1 | 6445 |
| CD79A | 6180 |
| SYK | -1790 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CD79B | 8712 |
| TMIGD2 | 7559 |
| LIME1 | 6445 |
| CD79A | 6180 |
| SYK | -1790 |
GOBP_GLUCURONATE_CATABOLIC_PROCESS_TO_XYLULOSE_5_PHOSPHATE
| set | GOBP_GLUCURONATE_CATABOLIC_PROCESS_TO_XYLULOSE_5_PHOSPHATE |
| setSize | 5 |
| pANOVA | 0.0186 |
| s.dist | 0.608 |
| p.adjustANOVA | 0.641 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SORD | 8017 |
| AKR1A1 | 7345 |
| CRYL1 | 5921 |
| DCXR | 5404 |
| XYLB | -286 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SORD | 8017 |
| AKR1A1 | 7345 |
| CRYL1 | 5921 |
| DCXR | 5404 |
| XYLB | -286 |
GOBP_SPERMIDINE_TRANSPORT
| set | GOBP_SPERMIDINE_TRANSPORT |
| setSize | 5 |
| pANOVA | 0.0201 |
| s.dist | 0.6 |
| p.adjustANOVA | 0.641 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLC22A16 | 8212 |
| SLC22A3 | 6442 |
| SLC22A2 | 4853 |
| SLC22A1 | 4475 |
| SLC18B1 | 2027 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SLC22A16 | 8212 |
| SLC22A3 | 6442 |
| SLC22A2 | 4853 |
| SLC22A1 | 4475 |
| SLC18B1 | 2027 |
GOBP_CILIARY_BODY_MORPHOGENESIS
| set | GOBP_CILIARY_BODY_MORPHOGENESIS |
| setSize | 5 |
| pANOVA | 0.0213 |
| s.dist | -0.595 |
| p.adjustANOVA | 0.641 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NOTCH2 | -10735 |
| VHL | -9309 |
| FOXE3 | -8958 |
| JAG1 | -7739 |
| TSKU | -2797 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NOTCH2 | -10735 |
| VHL | -9309 |
| FOXE3 | -8958 |
| JAG1 | -7739 |
| TSKU | -2797 |
GOBP_ACTIN_FILAMENT_NETWORK_FORMATION
| set | GOBP_ACTIN_FILAMENT_NETWORK_FORMATION |
| setSize | 8 |
| pANOVA | 0.00361 |
| s.dist | -0.594 |
| p.adjustANOVA | 0.357 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CARMIL1 | -11381 |
| PLS1 | -9688 |
| SPIRE1 | -9038 |
| SPIRE2 | -7116 |
| LCP1 | -6891 |
| COBL | -6824 |
| ACTN1 | -6690 |
| CARMIL2 | -5572 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CARMIL1 | -11381 |
| PLS1 | -9688 |
| SPIRE1 | -9038 |
| SPIRE2 | -7116 |
| LCP1 | -6891 |
| COBL | -6824 |
| ACTN1 | -6690 |
| CARMIL2 | -5572 |
GOBP_NEGATIVE_REGULATION_OF_FEEDING_BEHAVIOR
| set | GOBP_NEGATIVE_REGULATION_OF_FEEDING_BEHAVIOR |
| setSize | 6 |
| pANOVA | 0.0128 |
| s.dist | -0.587 |
| p.adjustANOVA | 0.611 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| UCN | -12139 |
| MC4R | -11999 |
| RETN | -10793 |
| NPSR1 | -8482 |
| INS | -2587 |
| TTC21B | -933 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| UCN | -12139 |
| MC4R | -11999 |
| RETN | -10793 |
| NPSR1 | -8482 |
| INS | -2587 |
| TTC21B | -933 |
GOMF_ALCOHOL_DEHYDROGENASE_ACTIVITY_ZINC_DEPENDENT
| set | GOMF_ALCOHOL_DEHYDROGENASE_ACTIVITY_ZINC_DEPENDENT |
| setSize | 7 |
| pANOVA | 0.00746 |
| s.dist | -0.584 |
| p.adjustANOVA | 0.513 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ADH4 | -12337 |
| ADH1A | -12170 |
| ADH1C | -11297 |
| ADH6 | -10660 |
| ADH1B | -6236 |
| ADH7 | -5404 |
| ADH5 | 3584 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ADH4 | -12337 |
| ADH1A | -12170 |
| ADH1C | -11297 |
| ADH6 | -10660 |
| ADH1B | -6236 |
| ADH7 | -5404 |
| ADH5 | 3584 |
GOBP_ADENYLATE_CYCLASE_INHIBITING_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY
| set | GOBP_ADENYLATE_CYCLASE_INHIBITING_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY |
| setSize | 7 |
| pANOVA | 0.00789 |
| s.dist | 0.58 |
| p.adjustANOVA | 0.535 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTR1D | 8763 |
| HTR1F | 8326 |
| HTR1A | 8039 |
| HTR1E | 5917 |
| HTR5A | 4392 |
| HTR1B | 4316 |
| DRD4 | -4928 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTR1D | 8763 |
| HTR1F | 8326 |
| HTR1A | 8039 |
| HTR1E | 5917 |
| HTR5A | 4392 |
| HTR1B | 4316 |
| DRD4 | -4928 |
GOMF_NFAT_PROTEIN_BINDING
| set | GOMF_NFAT_PROTEIN_BINDING |
| setSize | 5 |
| pANOVA | 0.0255 |
| s.dist | 0.577 |
| p.adjustANOVA | 0.669 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SPI1 | 7632 |
| MAPK14 | 6078 |
| GATA6 | 4748 |
| GATA4 | 3623 |
| PPARA | 2625 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SPI1 | 7632 |
| MAPK14 | 6078 |
| GATA6 | 4748 |
| GATA4 | 3623 |
| PPARA | 2625 |
GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_5_PHOSPHATASE_ACTIVITY
| set | GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_5_PHOSPHATASE_ACTIVITY |
| setSize | 6 |
| pANOVA | 0.0144 |
| s.dist | -0.577 |
| p.adjustANOVA | 0.625 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| INPP5K | -10569 |
| INPP5J | -9821 |
| INPP5B | -9704 |
| INPP5D | -9122 |
| INPP5A | -3615 |
| SYNJ1 | -3420 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| INPP5K | -10569 |
| INPP5J | -9821 |
| INPP5B | -9704 |
| INPP5D | -9122 |
| INPP5A | -3615 |
| SYNJ1 | -3420 |
GOBP_POSITIVE_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION
| set | GOBP_POSITIVE_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION |
| setSize | 5 |
| pANOVA | 0.0258 |
| s.dist | 0.576 |
| p.adjustANOVA | 0.669 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IL1A | 7490 |
| IL1B | 7276 |
| SHH | 7155 |
| BMI1 | 2202 |
| RIPK2 | 532 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IL1A | 7490 |
| IL1B | 7276 |
| SHH | 7155 |
| BMI1 | 2202 |
| RIPK2 | 532 |
GOBP_LEUKOCYTE_CHEMOTAXIS_INVOLVED_IN_INFLAMMATORY_RESPONSE
| set | GOBP_LEUKOCYTE_CHEMOTAXIS_INVOLVED_IN_INFLAMMATORY_RESPONSE |
| setSize | 8 |
| pANOVA | 0.00506 |
| s.dist | 0.572 |
| p.adjustANOVA | 0.431 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FFAR2 | 8904 |
| PTN | 8421 |
| NINJ1 | 7128 |
| SLAMF1 | 6183 |
| SLAMF8 | 3922 |
| LBP | 3804 |
| ALOX5 | 3522 |
| MDK | -2746 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FFAR2 | 8904 |
| PTN | 8421 |
| NINJ1 | 7128 |
| SLAMF1 | 6183 |
| SLAMF8 | 3922 |
| LBP | 3804 |
| ALOX5 | 3522 |
| MDK | -2746 |
GOMF_NADPLUS_PROTEIN_CYSTEINE_ADP_RIBOSYLTRANSFERASE_ACTIVITY
| set | GOMF_NADPLUS_PROTEIN_CYSTEINE_ADP_RIBOSYLTRANSFERASE_ACTIVITY |
| setSize | 6 |
| pANOVA | 0.0155 |
| s.dist | -0.571 |
| p.adjustANOVA | 0.625 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PARP8 | -10935 |
| PARP12 | -8252 |
| PARP6 | -7551 |
| SIRT4 | -7189 |
| TIPARP | -6082 |
| PARP11 | -5855 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PARP8 | -10935 |
| PARP12 | -8252 |
| PARP6 | -7551 |
| SIRT4 | -7189 |
| TIPARP | -6082 |
| PARP11 | -5855 |
GOMF_METAL_ION_SENSOR_ACTIVITY
| set | GOMF_METAL_ION_SENSOR_ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0283 |
| s.dist | -0.566 |
| p.adjustANOVA | 0.686 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| EFCAB9 | -12088 |
| SYT1 | -11512 |
| EFHB | -10600 |
| SLC39A4 | -9974 |
| EFHD1 | 6198 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| EFCAB9 | -12088 |
| SYT1 | -11512 |
| EFHB | -10600 |
| SLC39A4 | -9974 |
| EFHD1 | 6198 |
GOBP_REGULATION_OF_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL
| set | GOBP_REGULATION_OF_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL |
| setSize | 5 |
| pANOVA | 0.0285 |
| s.dist | 0.565 |
| p.adjustANOVA | 0.686 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PTH | 9095 |
| FGFR2 | 7966 |
| MIR146A | 4276 |
| PLK2 | 2484 |
| LEF1 | 268 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PTH | 9095 |
| FGFR2 | 7966 |
| MIR146A | 4276 |
| PLK2 | 2484 |
| LEF1 | 268 |
GOBP_MULTI_PASS_TRANSMEMBRANE_PROTEIN_INSERTION_INTO_ER_MEMBRANE
| set | GOBP_MULTI_PASS_TRANSMEMBRANE_PROTEIN_INSERTION_INTO_ER_MEMBRANE |
| setSize | 7 |
| pANOVA | 0.01 |
| s.dist | 0.562 |
| p.adjustANOVA | 0.557 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NOMO1 | 8489 |
| RAB5IF | 6614 |
| NCLN | 5880 |
| TMEM147 | 5875 |
| WDR83OS | 3892 |
| CCDC47 | 3409 |
| TMCO1 | -717 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NOMO1 | 8489 |
| RAB5IF | 6614 |
| NCLN | 5880 |
| TMEM147 | 5875 |
| WDR83OS | 3892 |
| CCDC47 | 3409 |
| TMCO1 | -717 |
GOCC_MULTI_PASS_TRANSLOCON_COMPLEX
| set | GOCC_MULTI_PASS_TRANSLOCON_COMPLEX |
| setSize | 7 |
| pANOVA | 0.01 |
| s.dist | 0.562 |
| p.adjustANOVA | 0.557 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NOMO1 | 8489 |
| RAB5IF | 6614 |
| NCLN | 5880 |
| TMEM147 | 5875 |
| WDR83OS | 3892 |
| CCDC47 | 3409 |
| TMCO1 | -717 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NOMO1 | 8489 |
| RAB5IF | 6614 |
| NCLN | 5880 |
| TMEM147 | 5875 |
| WDR83OS | 3892 |
| CCDC47 | 3409 |
| TMCO1 | -717 |
GOBP_LOBAR_BRONCHUS_EPITHELIUM_DEVELOPMENT
| set | GOBP_LOBAR_BRONCHUS_EPITHELIUM_DEVELOPMENT |
| setSize | 5 |
| pANOVA | 0.03 |
| s.dist | -0.56 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HOXA5 | -12348 |
| AGR2 | -11770 |
| SPDEF | -10362 |
| ADAMTSL2 | -9425 |
| IL13 | 6251 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HOXA5 | -12348 |
| AGR2 | -11770 |
| SPDEF | -10362 |
| ADAMTSL2 | -9425 |
| IL13 | 6251 |
GOBP_FOREBRAIN_NEURON_FATE_COMMITMENT
| set | GOBP_FOREBRAIN_NEURON_FATE_COMMITMENT |
| setSize | 7 |
| pANOVA | 0.0103 |
| s.dist | 0.56 |
| p.adjustANOVA | 0.564 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NKX2-1 | 8418 |
| BCL11B | 6640 |
| GATA2 | 5561 |
| TBR1 | 5426 |
| FEZF2 | 4951 |
| PAX6 | 3603 |
| ASCL1 | -1280 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NKX2-1 | 8418 |
| BCL11B | 6640 |
| GATA2 | 5561 |
| TBR1 | 5426 |
| FEZF2 | 4951 |
| PAX6 | 3603 |
| ASCL1 | -1280 |
GOMF_LEUKOTRIENE_C4_SYNTHASE_ACTIVITY
| set | GOMF_LEUKOTRIENE_C4_SYNTHASE_ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0304 |
| s.dist | 0.559 |
| p.adjustANOVA | 0.702 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LTC4S | 9044 |
| ALOX5AP | 7856 |
| MGST3 | 5960 |
| MGST2 | 2153 |
| GSTM4 | -1269 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| LTC4S | 9044 |
| ALOX5AP | 7856 |
| MGST3 | 5960 |
| MGST2 | 2153 |
| GSTM4 | -1269 |
GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_MAINTENANCE_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION
| set | GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_MAINTENANCE_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION |
| setSize | 5 |
| pANOVA | 0.0306 |
| s.dist | -0.558 |
| p.adjustANOVA | 0.702 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FZD7 | -12118 |
| EZH2 | -8845 |
| IGF1 | -8364 |
| SELENON | -7761 |
| WNT7A | -448 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FZD7 | -12118 |
| EZH2 | -8845 |
| IGF1 | -8364 |
| SELENON | -7761 |
| WNT7A | -448 |
GOMF_PROTEIN_ARGININE_DEIMINASE_ACTIVITY
| set | GOMF_PROTEIN_ARGININE_DEIMINASE_ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0308 |
| s.dist | -0.558 |
| p.adjustANOVA | 0.702 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PADI2 | -9756 |
| PADI3 | -9456 |
| PADI4 | -9360 |
| PADI1 | -4970 |
| PADI6 | -3962 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PADI2 | -9756 |
| PADI3 | -9456 |
| PADI4 | -9360 |
| PADI1 | -4970 |
| PADI6 | -3962 |
GOMF_PHOSPHOLIPASE_A2_INHIBITOR_ACTIVITY
| set | GOMF_PHOSPHOLIPASE_A2_INHIBITOR_ACTIVITY |
| setSize | 6 |
| pANOVA | 0.0181 |
| s.dist | -0.557 |
| p.adjustANOVA | 0.641 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ANXA1 | -11987 |
| ANXA2 | -10412 |
| ANXA3 | -9737 |
| ANXA9 | -9246 |
| ANXA2P2 | -5200 |
| SCGB1A1 | 1621 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ANXA1 | -11987 |
| ANXA2 | -10412 |
| ANXA3 | -9737 |
| ANXA9 | -9246 |
| ANXA2P2 | -5200 |
| SCGB1A1 | 1621 |
GOBP_REGULATION_OF_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY
| set | GOBP_REGULATION_OF_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY |
| setSize | 11 |
| pANOVA | 0.00142 |
| s.dist | -0.556 |
| p.adjustANOVA | 0.23 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MIRLET7E | -11779 |
| MIR125B1 | -11712 |
| MIR125A | -11679 |
| MIR99A | -11182 |
| MIRLET7A1 | -10597 |
| MIRLET7C | -8481 |
| MIR26A1 | -7905 |
| C1QTNF4 | -5695 |
| RIPK1 | -4393 |
| GFI1 | 375 |
| PTPN2 | 793 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MIRLET7E | -11779 |
| MIR125B1 | -11712 |
| MIR125A | -11679 |
| MIR99A | -11182 |
| MIRLET7A1 | -10597 |
| MIRLET7C | -8481 |
| MIR26A1 | -7905 |
| C1QTNF4 | -5695 |
| RIPK1 | -4393 |
| GFI1 | 375 |
| PTPN2 | 793 |
GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_ENDOTHELIN
| set | GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_ENDOTHELIN |
| setSize | 6 |
| pANOVA | 0.0188 |
| s.dist | -0.554 |
| p.adjustANOVA | 0.641 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| EDN2 | -11635 |
| EDN1 | -8084 |
| ECE1 | -6806 |
| EDN3 | -6422 |
| RHOA | -6123 |
| NOS3 | -5690 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| EDN2 | -11635 |
| EDN1 | -8084 |
| ECE1 | -6806 |
| EDN3 | -6422 |
| RHOA | -6123 |
| NOS3 | -5690 |
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE
| set | GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE |
| setSize | 5 |
| pANOVA | 0.0335 |
| s.dist | -0.549 |
| p.adjustANOVA | 0.714 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DMTN | -11643.0 |
| USP17L2 | -11463.5 |
| KCNE1 | -11225.0 |
| INPP5K | -10569.0 |
| ITGB1BP1 | 7870.0 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| DMTN | -11643.0 |
| USP17L2 | -11463.5 |
| KCNE1 | -11225.0 |
| INPP5K | -10569.0 |
| ITGB1BP1 | 7870.0 |
GOBP_DETOXIFICATION_OF_NITROGEN_COMPOUND
| set | GOBP_DETOXIFICATION_OF_NITROGEN_COMPOUND |
| setSize | 5 |
| pANOVA | 0.0337 |
| s.dist | 0.548 |
| p.adjustANOVA | 0.714 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GSTM1 | 9548 |
| GSTM3 | 6912 |
| MTARC1 | 4473 |
| GSTM2 | 3383 |
| MTARC2 | -1169 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GSTM1 | 9548 |
| GSTM3 | 6912 |
| MTARC1 | 4473 |
| GSTM2 | 3383 |
| MTARC2 | -1169 |
GOBP_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL
| set | GOBP_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL |
| setSize | 6 |
| pANOVA | 0.0205 |
| s.dist | 0.546 |
| p.adjustANOVA | 0.641 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PTH | 9095 |
| FGFR2 | 7966 |
| MIR146A | 4276 |
| BCL2L1 | 3557 |
| PLK2 | 2484 |
| LEF1 | 268 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PTH | 9095 |
| FGFR2 | 7966 |
| MIR146A | 4276 |
| BCL2L1 | 3557 |
| PLK2 | 2484 |
| LEF1 | 268 |
GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION
| set | GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION |
| setSize | 19 |
| pANOVA | 4.01e-05 |
| s.dist | -0.544 |
| p.adjustANOVA | 0.0228 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PF4 | -12138 |
| CSF2 | -11802 |
| PLA2G3 | -11696 |
| AGT | -11543 |
| PLA2G2A | -11404 |
| MIR185 | -10543 |
| NFKB1 | -10256 |
| APOB | -9636 |
| PLA2G10 | -9578 |
| ALOX15B | -8490 |
| PRKCH | -8329 |
| CD36 | -8160 |
| PLA2G5 | -7214 |
| CSF1 | -6209 |
| AGTR1 | -5154 |
| MSR1 | -4599 |
| IL18 | -2378 |
| MAPK9 | 2002 |
| LPL | 7489 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PF4 | -12138 |
| CSF2 | -11802 |
| PLA2G3 | -11696 |
| AGT | -11543 |
| PLA2G2A | -11404 |
| MIR185 | -10543 |
| NFKB1 | -10256 |
| APOB | -9636 |
| PLA2G10 | -9578 |
| ALOX15B | -8490 |
| PRKCH | -8329 |
| CD36 | -8160 |
| PLA2G5 | -7214 |
| CSF1 | -6209 |
| AGTR1 | -5154 |
| MSR1 | -4599 |
| IL18 | -2378 |
| MAPK9 | 2002 |
| LPL | 7489 |
GOBP_REGULATION_OF_SYNAPTIC_VESICLE_MEMBRANE_ORGANIZATION
| set | GOBP_REGULATION_OF_SYNAPTIC_VESICLE_MEMBRANE_ORGANIZATION |
| setSize | 12 |
| pANOVA | 0.00113 |
| s.dist | -0.543 |
| p.adjustANOVA | 0.203 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CPLX2 | -11722 |
| SYT1 | -11512 |
| DOC2B | -11196 |
| STXBP1 | -10310 |
| GRIK5 | -10092 |
| SYT9 | -9799 |
| CPLX3 | -8149 |
| DOC2A | -7179 |
| ERC2 | -4819 |
| CPLX1 | -4565 |
| RAB3A | -371 |
| PRRT2 | 1702 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CPLX2 | -11722 |
| SYT1 | -11512 |
| DOC2B | -11196 |
| STXBP1 | -10310 |
| GRIK5 | -10092 |
| SYT9 | -9799 |
| CPLX3 | -8149 |
| DOC2A | -7179 |
| ERC2 | -4819 |
| CPLX1 | -4565 |
| RAB3A | -371 |
| PRRT2 | 1702 |
GOBP_NEGATIVE_REGULATION_OF_PHOTORECEPTOR_CELL_DIFFERENTIATION
| set | GOBP_NEGATIVE_REGULATION_OF_PHOTORECEPTOR_CELL_DIFFERENTIATION |
| setSize | 6 |
| pANOVA | 0.0216 |
| s.dist | 0.542 |
| p.adjustANOVA | 0.641 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SOX9 | 8322 |
| CNTF | 7362 |
| DLX1 | 7107 |
| NOTCH1 | 3524 |
| DLX2 | 2808 |
| SOX8 | -1789 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SOX9 | 8322 |
| CNTF | 7362 |
| DLX1 | 7107 |
| NOTCH1 | 3524 |
| DLX2 | 2808 |
| SOX8 | -1789 |
GOBP_NEGATIVE_REGULATION_OF_MATRIX_METALLOPEPTIDASE_SECRETION
| set | GOBP_NEGATIVE_REGULATION_OF_MATRIX_METALLOPEPTIDASE_SECRETION |
| setSize | 6 |
| pANOVA | 0.0216 |
| s.dist | 0.541 |
| p.adjustANOVA | 0.641 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MIR199A1 | 7453 |
| MIR19A | 4900 |
| MIR29B1 | 4820 |
| MIR146A | 4276 |
| MIR19B1 | 3008 |
| CD200 | 2864 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MIR199A1 | 7453 |
| MIR19A | 4900 |
| MIR29B1 | 4820 |
| MIR146A | 4276 |
| MIR19B1 | 3008 |
| CD200 | 2864 |
GOBP_NEGATIVE_REGULATION_OF_GONADOTROPIN_SECRETION
| set | GOBP_NEGATIVE_REGULATION_OF_GONADOTROPIN_SECRETION |
| setSize | 7 |
| pANOVA | 0.0133 |
| s.dist | -0.541 |
| p.adjustANOVA | 0.615 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| INHA | -11125 |
| TACR2 | -11021 |
| OPRK1 | -10729 |
| INHBA | -10702 |
| INHBB | -9792 |
| GJA1 | -3530 |
| NPVF | 5706 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| INHA | -11125 |
| TACR2 | -11021 |
| OPRK1 | -10729 |
| INHBA | -10702 |
| INHBB | -9792 |
| GJA1 | -3530 |
| NPVF | 5706 |
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS
| set | GOBP_NEGATIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS |
| setSize | 6 |
| pANOVA | 0.0222 |
| s.dist | -0.539 |
| p.adjustANOVA | 0.641 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PARK7 | -9148 |
| CDK5 | -8927 |
| SP100 | -8085 |
| BARD1 | -7328 |
| RANGAP1 | -6548 |
| TXN | -3741 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PARK7 | -9148 |
| CDK5 | -8927 |
| SP100 | -8085 |
| BARD1 | -7328 |
| RANGAP1 | -6548 |
| TXN | -3741 |
GOBP_SPONTANEOUS_NEUROTRANSMITTER_SECRETION
| set | GOBP_SPONTANEOUS_NEUROTRANSMITTER_SECRETION |
| setSize | 8 |
| pANOVA | 0.00852 |
| s.dist | -0.537 |
| p.adjustANOVA | 0.544 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SYT1 | -11512 |
| DOC2B | -11196 |
| STX1B | -9277 |
| RPH3A | -9233 |
| DOC2A | -7179 |
| PRKN | -5905 |
| RPH3AL | -4700 |
| RIMS2 | 805 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SYT1 | -11512 |
| DOC2B | -11196 |
| STX1B | -9277 |
| RPH3A | -9233 |
| DOC2A | -7179 |
| PRKN | -5905 |
| RPH3AL | -4700 |
| RIMS2 | 805 |
GOCC_ALPHA_BETA_T_CELL_RECEPTOR_COMPLEX
| set | GOCC_ALPHA_BETA_T_CELL_RECEPTOR_COMPLEX |
| setSize | 5 |
| pANOVA | 0.038 |
| s.dist | 0.536 |
| p.adjustANOVA | 0.744 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CD3E | 7773 |
| CD3D | 7359 |
| CD3G | 3732 |
| CD247 | 3266 |
| PTPN6 | 325 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CD3E | 7773 |
| CD3D | 7359 |
| CD3G | 3732 |
| CD247 | 3266 |
| PTPN6 | 325 |
GOCC_VOLTAGE_GATED_SODIUM_CHANNEL_COMPLEX
| set | GOCC_VOLTAGE_GATED_SODIUM_CHANNEL_COMPLEX |
| setSize | 14 |
| pANOVA | 0.000525 |
| s.dist | -0.535 |
| p.adjustANOVA | 0.136 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SCN10A | -11480 |
| SCN7A | -11324 |
| SCN1A | -11304 |
| SCN3A | -10653 |
| SCN2A | -10382 |
| SCN4B | -10070 |
| SCN8A | -7824 |
| SCN2B | -7103 |
| SCN1B | -5798 |
| SCN11A | -4470 |
| SCN3B | -4095 |
| SCN5A | -2717 |
| SCN4A | -2617 |
| SCN9A | -1694 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SCN10A | -11480 |
| SCN7A | -11324 |
| SCN1A | -11304 |
| SCN3A | -10653 |
| SCN2A | -10382 |
| SCN4B | -10070 |
| SCN8A | -7824 |
| SCN2B | -7103 |
| SCN1B | -5798 |
| SCN11A | -4470 |
| SCN3B | -4095 |
| SCN5A | -2717 |
| SCN4A | -2617 |
| SCN9A | -1694 |
GOBP_URATE_METABOLIC_PROCESS
| set | GOBP_URATE_METABOLIC_PROCESS |
| setSize | 12 |
| pANOVA | 0.00143 |
| s.dist | -0.532 |
| p.adjustANOVA | 0.23 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| URAD | -12297 |
| CARMIL1 | -11381 |
| SLC22A12 | -11044 |
| SLC22A11 | -9603 |
| SLC2A9 | -8444 |
| G6PC1 | -7743 |
| GCKR | -7262 |
| ABCG2 | -6223 |
| SLC17A3 | -6040 |
| SLC17A1 | -4929 |
| PNP | -4373 |
| SLC16A9 | 2786 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| URAD | -12297 |
| CARMIL1 | -11381 |
| SLC22A12 | -11044 |
| SLC22A11 | -9603 |
| SLC2A9 | -8444 |
| G6PC1 | -7743 |
| GCKR | -7262 |
| ABCG2 | -6223 |
| SLC17A3 | -6040 |
| SLC17A1 | -4929 |
| PNP | -4373 |
| SLC16A9 | 2786 |
GOMF_ALCOHOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY
| set | GOMF_ALCOHOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY |
| setSize | 6 |
| pANOVA | 0.0242 |
| s.dist | -0.531 |
| p.adjustANOVA | 0.658 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| STRA6 | -11916 |
| RBP4 | -11040 |
| ABCA4 | -8710 |
| SLC44A2 | -7237 |
| MFSD10 | -7163 |
| SLC44A1 | 2787 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| STRA6 | -11916 |
| RBP4 | -11040 |
| ABCA4 | -8710 |
| SLC44A2 | -7237 |
| MFSD10 | -7163 |
| SLC44A1 | 2787 |
GOBP_HISTONE_H3_ACETYLATION
| set | GOBP_HISTONE_H3_ACETYLATION |
| setSize | 6 |
| pANOVA | 0.025 |
| s.dist | 0.528 |
| p.adjustANOVA | 0.664 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| KAT2A | 8971 |
| SUPT3H | 7054 |
| MAP3K7 | 5166 |
| KAT2B | 4597 |
| TAF9 | 3102 |
| SGF29 | -2420 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| KAT2A | 8971 |
| SUPT3H | 7054 |
| MAP3K7 | 5166 |
| KAT2B | 4597 |
| TAF9 | 3102 |
| SGF29 | -2420 |
GOMF_INOSITOL_POLYPHOSPHATE_5_PHOSPHATASE_ACTIVITY
| set | GOMF_INOSITOL_POLYPHOSPHATE_5_PHOSPHATASE_ACTIVITY |
| setSize | 6 |
| pANOVA | 0.0256 |
| s.dist | -0.526 |
| p.adjustANOVA | 0.669 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| INPP5K | -10569 |
| INPP5J | -9821 |
| INPP5D | -9122 |
| INPP5E | -5761 |
| INPPL1 | -4052 |
| INPP5A | -3615 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| INPP5K | -10569 |
| INPP5J | -9821 |
| INPP5D | -9122 |
| INPP5E | -5761 |
| INPPL1 | -4052 |
| INPP5A | -3615 |
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.4.0 (2024-04-24)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 22.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.3.4
## [2] GGally_2.2.1
## [3] ggplot2_3.5.1
## [4] reshape2_1.4.4
## [5] gplots_3.1.3.1
## [6] gtools_3.9.5
## [7] tibble_3.2.1
## [8] dplyr_1.1.4
## [9] echarts4r_0.4.5
## [10] plyr_1.8.9
## [11] png_0.1-8
## [12] gridExtra_2.3
## [13] missMethyl_1.36.0
## [14] beeswarm_0.4.0
## [15] kableExtra_1.4.0
## [16] mitch_1.15.6
## [17] tictoc_1.2.1
## [18] HGNChelper_0.8.1
## [19] IlluminaHumanMethylationEPICanno.ilm10b4.hg19_0.6.0
## [20] IlluminaHumanMethylation450kanno.ilmn12.hg19_0.6.1
## [21] minfi_1.48.0
## [22] bumphunter_1.44.0
## [23] locfit_1.5-9.9
## [24] iterators_1.0.14
## [25] foreach_1.5.2
## [26] Biostrings_2.70.2
## [27] XVector_0.42.0
## [28] SummarizedExperiment_1.32.0
## [29] Biobase_2.62.0
## [30] MatrixGenerics_1.14.0
## [31] matrixStats_1.3.0
## [32] GenomicRanges_1.54.1
## [33] GenomeInfoDb_1.38.6
## [34] IRanges_2.36.0
## [35] S4Vectors_0.40.2
## [36] BiocGenerics_0.48.1
## [37] eulerr_7.0.2
## [38] limma_3.58.1
##
## loaded via a namespace (and not attached):
## [1] splines_4.4.0 later_1.3.2
## [3] BiocIO_1.12.0 bitops_1.0-7
## [5] filelock_1.0.3 preprocessCore_1.64.0
## [7] XML_3.99-0.16.1 lifecycle_1.0.4
## [9] lattice_0.22-6 MASS_7.3-60.2
## [11] base64_2.0.1 scrime_1.3.5
## [13] magrittr_2.0.3 sass_0.4.9
## [15] rmarkdown_2.26 jquerylib_0.1.4
## [17] yaml_2.3.8 httpuv_1.6.15
## [19] doRNG_1.8.6 askpass_1.2.0
## [21] DBI_1.2.2 RColorBrewer_1.1-3
## [23] abind_1.4-5 zlibbioc_1.48.0
## [25] quadprog_1.5-8 purrr_1.0.2
## [27] RCurl_1.98-1.14 rappdirs_0.3.3
## [29] GenomeInfoDbData_1.2.11 genefilter_1.84.0
## [31] annotate_1.80.0 svglite_2.1.3
## [33] DelayedMatrixStats_1.24.0 codetools_0.2-20
## [35] DelayedArray_0.28.0 xml2_1.3.6
## [37] tidyselect_1.2.1 farver_2.1.1
## [39] beanplot_1.3.1 BiocFileCache_2.10.1
## [41] illuminaio_0.44.0 GenomicAlignments_1.38.2
## [43] jsonlite_1.8.8 multtest_2.58.0
## [45] survival_3.6-4 systemfonts_1.0.6
## [47] tools_4.4.0 progress_1.2.3
## [49] Rcpp_1.0.12 glue_1.7.0
## [51] SparseArray_1.2.4 xfun_0.43
## [53] HDF5Array_1.30.1 withr_3.0.0
## [55] fastmap_1.1.1 rhdf5filters_1.14.1
## [57] fansi_1.0.6 openssl_2.1.2
## [59] caTools_1.18.2 digest_0.6.35
## [61] R6_2.5.1 mime_0.12
## [63] colorspace_2.1-0 biomaRt_2.58.2
## [65] RSQLite_2.3.6 utf8_1.2.4
## [67] tidyr_1.3.1 generics_0.1.3
## [69] data.table_1.15.4 rtracklayer_1.62.0
## [71] prettyunits_1.2.0 httr_1.4.7
## [73] htmlwidgets_1.6.4 S4Arrays_1.2.0
## [75] ggstats_0.6.0 pkgconfig_2.0.3
## [77] gtable_0.3.5 blob_1.2.4
## [79] siggenes_1.76.0 htmltools_0.5.8.1
## [81] scales_1.3.0 knitr_1.46
## [83] rstudioapi_0.16.0 tzdb_0.4.0
## [85] rjson_0.2.21 nlme_3.1-164
## [87] curl_5.2.1 org.Hs.eg.db_3.18.0
## [89] cachem_1.0.8 rhdf5_2.46.1
## [91] stringr_1.5.1 KernSmooth_2.23-22
## [93] AnnotationDbi_1.64.1 restfulr_0.0.15
## [95] GEOquery_2.70.0 pillar_1.9.0
## [97] grid_4.4.0 reshape_0.8.9
## [99] vctrs_0.6.5 promises_1.3.0
## [101] dbplyr_2.5.0 xtable_1.8-4
## [103] evaluate_0.23 readr_2.1.5
## [105] GenomicFeatures_1.54.3 cli_3.6.2
## [107] compiler_4.4.0 Rsamtools_2.18.0
## [109] rlang_1.1.3 crayon_1.5.2
## [111] rngtools_1.5.2 labeling_0.4.3
## [113] nor1mix_1.3-3 mclust_6.1.1
## [115] stringi_1.8.3 viridisLite_0.4.2
## [117] BiocParallel_1.36.0 munsell_0.5.1
## [119] Matrix_1.7-0 hms_1.1.3
## [121] sparseMatrixStats_1.14.0 bit64_4.0.5
## [123] Rhdf5lib_1.24.2 KEGGREST_1.42.0
## [125] statmod_1.5.0 shiny_1.8.1.1
## [127] highr_0.10 memoise_2.0.1.9000
## [129] bslib_0.7.0 bit_4.0.5END of report